Citrus Sinensis ID: 038580

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350------
Protein Sequence
MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHHHHEEccccccccccccccccccccccccccccEEEccccccccHHHHHHccccccccccccEEEEEEEccccEEEEEEEccccccccccHHHHHHHHHHcccccccccccEEEEcccccEEEEEcccccccHHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEcccccccccccccccccEEcccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEccccccccHHHHHHHHHHHHHcccccEccEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEEccHHHHEEEcccccccHccccHHEEccccccEEEEEEEEccccccHHHHHcccccccHHHHHHHHEEEHHHccccccccccccccccHHHHHHHHHHHcccHHHHccHHHcccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccc
Coil and Loop (DISEMBL)
MLKLVLGLALATLLIILILIFFFyrkrlpkehdhndleinqqsknggeegetedlvtfrggedlticdildapgevigksnygTLYKALLQRSGSvrllrflrpvcttrdKEFGDLIELLgcirhpnlvpllgfyagprgeklivhpfykrgnlaqcirggsgeahkWSIIYRISIGIaggldylhtgfhrpiihgnlksknilldrnyqpyvsdfglhlllnptaGQEMLEASasqgykapelikmkdaseetdiySFGVIMLELisgkepinenptpdedfhlptfmrNAVLdhritdlyhpdmllcsnsnhenpvsEERILKFFQLAmaccspspslrpnIKQVLWKLEDLGK
Flexible Loop (DISEMBL)
MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLeinqqsknggeegeTEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCspspslrpnikqVLWKLEDLGK
Low Complexity Region (SEG)
MlklvlglalatlliililiFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK
Disordered region (IsUnstruct)
**KLVLGLALATLLIILILIFFFYRKRL**************************LVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA***************************TDIYSFGVIMLELISG************DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN****VSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL*****
Disordered Region (DISOPRED)
MLKLVLGLALATLLIILILIFFFY********************************TFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRF*R***********DLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN*****DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG*
Disordered Region (DISEMBL)
MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQS*********EDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK
Disordered Region (DISPRO)
MLKLVLGLALATLLIILILIFFFYRKRL***************************VTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN*KQVLWKLE****
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	356	2.2.26 [Sep-21-2011]
C0LGP9	784	Probable leucine-rich rep	no	no	0.941	0.427	0.378	3e-54
P33543	674	Putative kinase-like prot	no	no	0.823	0.434	0.375	9e-54
Q9SCT4	836	Probably inactive leucine	no	no	0.825	0.351	0.358	6e-46
Q9LP77	655	Probable inactive recepto	no	no	0.764	0.415	0.375	1e-44
O48788	658	Probable inactive recepto	no	no	0.873	0.472	0.333	1e-42
Q9FHK7	640	Probable leucine-rich rep	no	no	0.946	0.526	0.301	1e-41
Q9SUQ3	638	Probable inactive recepto	no	no	0.766	0.427	0.329	7e-41
Q9LVM0	654	Probable inactive recepto	no	no	0.834	0.454	0.312	3e-40
Q9C9Y8	640	Probable inactive recepto	no	no	0.955	0.531	0.294	3e-40
Q9SH71	587	Putative inactive recepto	no	no	0.938	0.568	0.310	7e-39

>sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1

 Score =  212 bits (540), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 135/357 (37%), Positives = 198/357 (55%), Gaps = 22/357 (6%)

Query: 7   GLALATLLIILILIFFFYRKRL----PKEHDHNDLEINQQSKNGGEE---GETE-DLVTF 58
           G  L  +LI++ ++    RK+      K  +     +  +++ GGE    GET   LV F
Sbjct: 416 GALLIVMLILVCVLCCLLRKKANETKAKGGEAGPGAVAAKTEKGGEAEAGGETGGKLVHF 475

Query: 59  RGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE 118
            G    T  D+L A  E++GKS YGT+YKA L+    V + R LR   T   KEF + I 
Sbjct: 476 DGPMAFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKR-LREKITKSQKEFENEIN 534

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIG 177
           +LG IRHPNL+ L  +Y GP+GEKL+V  +  RG+LA  +     + H  W     +  G
Sbjct: 535 VLGRIRHPNLLALRAYYLGPKGEKLVVFDYMSRGSLATFLHARGPDVHINWPTRMSLIKG 594

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +A GL YLHT  H  IIHGNL S N+LLD N    +SD+GL  L+   AG  ++  + + 
Sbjct: 595 MARGLFYLHT--HANIIHGNLTSSNVLLDENITAKISDYGLSRLMTAAAGSSVIATAGAL 652

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
           GY+APEL K+K A+ +TD+YS GVI+LEL++GK P       D    LP ++  AV +  
Sbjct: 653 GYRAPELSKLKKANTKTDVYSLGVIILELLTGKSPSEALNGVD----LPQWVATAVKEEW 708

Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +++  ++L     N  N + +E IL   +LA+ C   +PS RP  +QV+ +L ++
Sbjct: 709 TNEVFDLELL-----NDVNTMGDE-ILNTLKLALHCVDATPSTRPEAQQVMTQLGEI 759

Can phosphorylate AGL24.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P33543|TMKL1_ARATH Putative kinase-like protein TMKL1 OS=Arabidopsis thaliana GN=TMKL1 PE=1 SV=1

 Score =  211 bits (536), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 185/301 (61%), Gaps = 8/301 (2%)

Query: 55  LVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFG 114
           LV F+GGE+LT+ D+L+A G+V+ K++YGT+YKA L   G++ L       C  R     
Sbjct: 357 LVVFQGGENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGTCKDRSSCL- 415

Query: 115 DLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE--AHKWSIIY 172
            +I  LG IRH NLVPL  FY G RGEKL+++ +    +L   +        A  W+  +
Sbjct: 416 PVIRQLGRIRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKPALNWARRH 475

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
           +I++GIA GL YLHTG   PIIHGN++SKN+L+D  +   +++FGL  ++      E++ 
Sbjct: 476 KIALGIARGLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQAVADEIVS 535

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA 292
            + S GYKAPEL KMK  +  +D+Y+FG+++LE++ GK+P       +E   LP+ ++ A
Sbjct: 536 QAKSDGYKAPELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVDLPSLVKAA 595

Query: 293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
           VL+    +++  + +        +P+ EE ++   +LAM CC+P  ++RP++++V+ +LE
Sbjct: 596 VLEETTMEVFDLEAM----KGIRSPM-EEGLVHALKLAMGCCAPVTTVRPSMEEVVKQLE 650

Query: 353 D 353
           +
Sbjct: 651 E 651

Does not seem to have conserved a kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1

 Score =  185 bits (469), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 171/310 (55%), Gaps = 16/310 (5%)

Query: 46  GGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV 105
           GGE G    LV F G    T  D+L A  E++GKS YGT YKA L+    V + R LR  
Sbjct: 514 GGEMGG--KLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKR-LREK 570

Query: 106 CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
            T   KEF   +  LG IRH NL+ L  +Y GP+GEKL+V  +  +G+L+  +     E 
Sbjct: 571 TTKGVKEFEGEVTALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHARGPET 630

Query: 166 H-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP 224
              W    +I+ GI+ GL +LH+  +  +IH NL + NILLD     +++D+GL  L+  
Sbjct: 631 LIPWETRMKIAKGISRGLAHLHS--NENMIHENLTASNILLDEQTNAHIADYGLSRLMTA 688

Query: 225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
            A   ++  + + GY+APE  K+K+AS +TD+YS G+I+LEL++GK P      P     
Sbjct: 689 AAATNVIATAGTLGYRAPEFSKIKNASAKTDVYSLGIIILELLTGKSP----GEPTNGMD 744

Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
           LP ++ + V +    +++  +++       E     + +L   +LA+ C  PSP+ RP  
Sbjct: 745 LPQWVASIVKEEWTNEVFDLELM------RETQSVGDELLNTLKLALHCVDPSPAARPEA 798

Query: 345 KQVLWKLEDL 354
            QV+ +LE++
Sbjct: 799 NQVVEQLEEI 808

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  181 bits (458), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/290 (37%), Positives = 165/290 (56%), Gaps = 18/290 (6%)

Query: 68  DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
           D+L A  EV+GK  +GT YKA+L  + +V  ++ L+ V    DKEF + IEL+G + H N
Sbjct: 368 DLLRASAEVLGKGTFGTAYKAVLD-AVTVVAVKRLKDVMMA-DKEFKEKIELVGAMDHEN 425

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK---WSIIYRISIGIAGGLDY 184
           LVPL  +Y   R EKL+V+ F   G+L+  + G  G       W +  RI+IG A GLDY
Sbjct: 426 LVPLRAYYFS-RDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDY 484

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH+       HGN+KS NILL +++   VSDFGL  L+    G      + + GY+APE+
Sbjct: 485 LHSQ-GTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLV----GSSATNPNRATGYRAPEV 539

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
              K  S++ D+YSFGV++LELI+GK P N +   +E   LP ++++   D    +++  
Sbjct: 540 TDPKRVSQKGDVYSFGVVLLELITGKAPSN-SVMNEEGVDLPRWVKSVARDEWRREVFDS 598

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           ++L  +         EE + +  QL + C S  P  RP + +V+ K+E+L
Sbjct: 599 ELLSLATD------EEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642

Arabidopsis thaliana (taxid: 3702)

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  174 bits (441), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/333 (33%), Positives = 183/333 (54%), Gaps = 22/333 (6%)

Query: 28  LPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGE-DLTICDILDAPGEVIGKSNYGTLY 86
           LP     +  E+   S   G E E   LV   GG     + D+L A  EV+GK + GT Y
Sbjct: 307 LPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSY 366

Query: 87  KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH 146
           KA+L+  G+  +++ L+ V  ++ KEF   +E++G I+HPN++PL  +Y   + EKL+V 
Sbjct: 367 KAVLEE-GTTVVVKRLKDVMASK-KEFETQMEVVGKIKHPNVIPLRAYYYS-KDEKLLVF 423

Query: 147 PFYKRGNLAQCIRGGSGEAHK---WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNI 203
            F   G+L+  + G  G       W    RI+I  A GL +LH      ++HGN+K+ NI
Sbjct: 424 DFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSAK--LVHGNIKASNI 481

Query: 204 LLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIM 263
           LL  N    VSD+GL+ L + ++    L      GY APE+++ +  + ++D+YSFGV++
Sbjct: 482 LLHPNQDTCVSDYGLNQLFSNSSPPNRL-----AGYHAPEVLETRKVTFKSDVYSFGVLL 536

Query: 264 LELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERI 323
           LEL++GK P N+    +E   LP ++ + V +    +++  +++   N        EE +
Sbjct: 537 LELLTGKSP-NQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHN-------IEEEM 588

Query: 324 LKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           ++  Q+AMAC S  P  RP +++VL  +ED+ +
Sbjct: 589 VQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNR 621

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  171 bits (432), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 112/371 (30%), Positives = 200/371 (53%), Gaps = 34/371 (9%)

Query: 1   MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEIN---------QQSKNGGEEGE 51
           ++ +V+G ++A L + ++ +    +K   +E     +            Q   +G ++ E
Sbjct: 267 IIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPE 326

Query: 52  TEDLVTF-RGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD 110
              L  F R   +  + D+L A  EV+GK ++GT YKA+L+ + +V + R LR V  ++ 
Sbjct: 327 KNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKR-LREVVASK- 384

Query: 111 KEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE-AHKW 168
           KEF   +E++G I +H N VPLL +Y   + EKL+V+ +  +G+L   + G  G+    W
Sbjct: 385 KEFEQQMEIVGKINQHSNFVPLLAYYYS-KDEKLLVYKYMTKGSLFGIMHGNRGDRGVDW 443

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN-PTAG 227
               +I+ G +  + YLH+      +HG++KS NILL  + +P +SD  L  L N PT  
Sbjct: 444 ETRMKIATGTSKAISYLHS---LKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHT 500

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED--FHL 285
              +      GY APE+I+ +  S+ +D+YSFGV++LE+++GK P+ +    DE     L
Sbjct: 501 PRTI------GYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDL 554

Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
           P ++R+ V +    +++  ++L   N        EE +++  QLA+AC + +P  RP ++
Sbjct: 555 PRWVRSVVREEWTAEVFDVELLKFQN-------IEEEMVQMLQLALACVARNPESRPKME 607

Query: 346 QVLWKLEDLGK 356
           +V   +ED+ +
Sbjct: 608 EVARMIEDVRR 618

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  168 bits (425), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 163/291 (56%), Gaps = 18/291 (6%)

Query: 68  DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
           D+L A  EV+GK  +GT YKA+L+ + SV + R        RD  F   +E++G I+H N
Sbjct: 334 DLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRD--FEQQMEIIGGIKHEN 391

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH---KWSIIYRISIGIAGGLDY 184
           +V L  +Y   + EKL+V+ ++ RG++A  + G  GE      W    +I+IG A G+  
Sbjct: 392 VVELKAYYYS-KDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIAR 450

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           +H   +  ++HGN+KS NI L+      VSD GL  +++P A       S   GY+APE+
Sbjct: 451 IHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPP----ISRQAGYRAPEV 506

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
              + +S+ +D+YSFGV++LEL++GK PI+     DE  HL  ++ + V +    +++  
Sbjct: 507 TDTRKSSQLSDVYSFGVVLLELLTGKSPIHTT-AGDEIIHLVRWVHSVVREEWTAEVFDI 565

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG 355
           ++L  +N        EE +++  Q+AM+C   +   RP +  ++  +E++G
Sbjct: 566 ELLRYTN-------IEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVG 609

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  166 bits (419), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 100/320 (31%), Positives = 181/320 (56%), Gaps = 23/320 (7%)

Query: 41  QQSKNGGEEGETEDLVTFRGGE-DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLL 99
           Q+  +G +E E   LV F G   +  + D+L A  EV+GK +YGT YKA+L+ S +V + 
Sbjct: 327 QEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 386

Query: 100 RFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI 158
           R L+ V   + +EF   +E++  +  HP++VPL  +Y   + EKL+V  +Y  GNL+  +
Sbjct: 387 R-LKEVAAGK-REFEQQMEIISRVGNHPSVVPLRAYYYS-KDEKLMVCDYYPAGNLSSLL 443

Query: 159 RGGSGEAHK---WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD 215
            G  G       W    +I++  A G+ +LH        HGN+KS N+++ +     +SD
Sbjct: 444 HGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISD 503

Query: 216 FGLH-LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           FGL  L+  P A           GY+APE+++ +  + ++D+YSFGV++LE+++GK P+ 
Sbjct: 504 FGLTPLMAVPIAPMR------GAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV- 556

Query: 275 ENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACC 334
           ++P+ D+   LP ++++ V +   ++++  +++   N        EE +++  Q+AMAC 
Sbjct: 557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQN-------IEEEMVQMLQIAMACV 609

Query: 335 SPSPSLRPNIKQVLWKLEDL 354
           +  P +RP +  V+  +E++
Sbjct: 610 AQVPEVRPTMDDVVRMIEEI 629

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  166 bits (419), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 108/367 (29%), Positives = 197/367 (53%), Gaps = 27/367 (7%)

Query: 1   MLKLVLGLALATLLIILILIFFFYRKR--------LPKEHDHNDLEINQQSKNGGEEGET 52
           ++ + +G ++   +I+ I+     +KR        +PK          ++  +G +E E 
Sbjct: 262 IVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKPGRSDNKAEEFGSGVQEAEK 321

Query: 53  EDLVTFRGGE-DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK 111
             LV F G   +  + D+L A  EV+GK +YGT YKA+L+  G+  +++ L+ V   + +
Sbjct: 322 NKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVAAGK-R 379

Query: 112 EFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG---GSGEAHK 167
           EF   +E +G I  H N+ PL  +Y   + EKL+V+ +Y+ GN +  + G   G   A  
Sbjct: 380 EFEQQMEAVGRISPHVNVAPLRAYYFS-KDEKLLVYDYYQGGNFSMLLHGNNEGGRAALD 438

Query: 168 WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
           W    RI +  A G+ ++H+     ++HGN+KS N+LL +     VSDFG+     P   
Sbjct: 439 WETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIA----PLMS 494

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
              L  S S GY+APE I+ +  ++++D+YSFGV++LE+++GK    +    +E   LP 
Sbjct: 495 HHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKA-AGKTTGHEEVVDLPK 553

Query: 288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           ++++ V +    +++  +++      H     EE +++  Q+AMAC S  P  RP++++V
Sbjct: 554 WVQSVVREEWTGEVFDVELI---KQQHN---VEEEMVQMLQIAMACVSKHPDSRPSMEEV 607

Query: 348 LWKLEDL 354
           +  +E++
Sbjct: 608 VNMMEEI 614

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  161 bits (408), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 115/370 (31%), Positives = 192/370 (51%), Gaps = 36/370 (9%)

Query: 2   LKLVLGLALATLLII----LILIFFFYRKRLP---KEHDHNDLEINQQSKN-GGEEGETE 53
           L  +L L+ A +L +     I+I  F + R+    ++ D +    N  S++   EEG   
Sbjct: 231 LAFLLILSAACVLCVSGLSFIMITCFGKTRISGKLRKRDSSSPPGNWTSRDDNTEEGGK- 289

Query: 54  DLVTFRGGED--LTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK 111
             + F GG +    + D+L +  EV+GK  +GT YK  ++   +V + R L+ V   R +
Sbjct: 290 --IIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKR-LKEVVVGR-R 345

Query: 112 EFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK---- 167
           EF   +E++G IRH N+  L  +Y   + +KL V+ +Y  G+L + + G  G  H+    
Sbjct: 346 EFEQQMEIIGMIRHENVAELKAYYY-SKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLD 404

Query: 168 WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
           W    RI+ G A GL  +H G     IHGN+KS NI LD      + D GL  ++     
Sbjct: 405 WDARLRIATGAARGLAKIHEG---KFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQ 461

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN---PTPDEDFH 284
              L    + GY APE+   + +++ +D+YSFGV++LEL++GK P+++    PT  E+  
Sbjct: 462 TTCL----TSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENMD 517

Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
           L +++R+ V      +++  DM + S S       EE +++  Q+ +AC +     RP+I
Sbjct: 518 LASWIRSVVAKEWTGEVF--DMEILSQSGG----FEEEMVEMLQIGLACVALKQQERPHI 571

Query: 345 KQVLWKLEDL 354
            QVL  +ED+
Sbjct: 572 AQVLKLIEDI 581

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
255539865	359	Nodulation receptor kinase precursor, pu	0.988	0.980	0.758	1e-155
224129876	363	predicted protein [Populus trichocarpa]	0.994	0.975	0.721	1e-146
356526387	355	PREDICTED: putative kinase-like protein	0.991	0.994	0.714	1e-144
356554806	430	PREDICTED: putative kinase-like protein	0.988	0.818	0.709	1e-142
225466029	353	PREDICTED: putative kinase-like protein	0.963	0.971	0.646	1e-129
449458349	357	PREDICTED: probable leucine-rich repeat	0.926	0.924	0.683	1e-127
38260653	362	protein kinase [Capsella rubella]	0.966	0.950	0.640	1e-126
357515927	337	MAP/microtubule affinity-regulating kina	0.941	0.994	0.658	1e-126
38260620	365	protein kinase [Sisymbrium irio]	0.896	0.873	0.671	1e-126
38260689	362	protein kinase [Arabidopsis arenosa]	0.898	0.883	0.673	1e-125

>gi|255539865|ref|XP_002510997.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223550112|gb|EEF51599.1| Nodulation receptor kinase precursor, putative [Ricinus communis]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 270/356 (75%), Positives = 315/356 (88%), Gaps = 4/356 (1%)

Query: 1   MLKLVLGLALATLLIILILIFF-FYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFR 59
           MLKL+LGL  A +LI LIL+ F ++RKR  K    ND+E + + K+G +E ETEDLVTF+
Sbjct: 6   MLKLILGLTSAIVLISLILVIFRYFRKRARKSQ--NDVE-SPELKHGDDETETEDLVTFQ 62

Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL 119
           GG+DLTI DILDAPGEVIGKSNYGTLY+ALL RS SVRLLRFLRP+C  R K+F ++I+L
Sbjct: 63  GGQDLTIDDILDAPGEVIGKSNYGTLYRALLHRSNSVRLLRFLRPICIARFKDFDEVIQL 122

Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA 179
           LG +RHPNLVPLLGFYAGPRGEKL++HPF +RGNLAQ I+ G+ E+HKW+ +Y+ISIGIA
Sbjct: 123 LGYVRHPNLVPLLGFYAGPRGEKLLIHPFLRRGNLAQFIKDGNAESHKWTTMYKISIGIA 182

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            GLD+LHTG  RPI+HGNLKSKNILLDRNYQ Y+SDFGLHLLLNPTAGQEMLEASA++GY
Sbjct: 183 KGLDHLHTGLQRPIVHGNLKSKNILLDRNYQSYISDFGLHLLLNPTAGQEMLEASAAEGY 242

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT 299
           KAPELIKMKDASE TDIYS G+I+LELISGKEPINENPTPDEDFHLPTFMRNAVLD RIT
Sbjct: 243 KAPELIKMKDASERTDIYSLGIILLELISGKEPINENPTPDEDFHLPTFMRNAVLDRRIT 302

Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG 355
           DLYHPD+LL ++S++E PV+EE ILK+FQLAM+CCSPSPSLRPNIKQVL KLE++G
Sbjct: 303 DLYHPDILLSNHSDNETPVTEECILKYFQLAMSCCSPSPSLRPNIKQVLLKLEEIG 358

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129876|ref|XP_002328825.1| predicted protein [Populus trichocarpa] gi|222839123|gb|EEE77474.1| predicted protein [Populus trichocarpa]

 Score =  525 bits (1352), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 257/356 (72%), Positives = 304/356 (85%), Gaps = 2/356 (0%)

Query: 2   LKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGET-EDLVTFRG 60
           LKLV+GL LA  L +++ + F + KR  +    ND+E N + K+G    ET EDLVTF+G
Sbjct: 8   LKLVVGLTLAIFLFVVVAVVFVFFKRKAERKTCNDIE-NTEEKHGDHGAETTEDLVTFQG 66

Query: 61  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL 120
           G+DLTI DILDAPGEVIGKSNYGTLYKALLQRS  VRLLRFLRP+CT R ++FGD+++LL
Sbjct: 67  GQDLTISDILDAPGEVIGKSNYGTLYKALLQRSNCVRLLRFLRPICTARVEDFGDVVQLL 126

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           GCIRHPNLVPLLGFYAGPRGEKL+VHPF +RGNL+  IR G  E HKW++IY+ISIGIA 
Sbjct: 127 GCIRHPNLVPLLGFYAGPRGEKLLVHPFLRRGNLSDFIRDGKSEFHKWTVIYKISIGIAK 186

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GLD+LH G  +P+IHGNLKSKNILLDRN+ P +SDFGLHLLLN TAGQEMLEASA++GYK
Sbjct: 187 GLDHLHAGLQKPVIHGNLKSKNILLDRNFHPCISDFGLHLLLNLTAGQEMLEASAAEGYK 246

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APELIKMK+ + ETDIYS G+I+LEL+SGKEPINENPT DEDF+LPTFMRNAVLD RI D
Sbjct: 247 APELIKMKEVTLETDIYSLGIILLELLSGKEPINENPTADEDFYLPTFMRNAVLDRRIAD 306

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           LYHPD+LL +  ++E PV+EE +LK+FQLAMACCSPSPSLRPNIKQVLWKLE++G+
Sbjct: 307 LYHPDILLSNGDDNERPVTEECVLKYFQLAMACCSPSPSLRPNIKQVLWKLEEIGR 362

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526387|ref|XP_003531799.1| PREDICTED: putative kinase-like protein TMKL1-like [Glycine max]

 Score =  516 bits (1329), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 253/354 (71%), Positives = 296/354 (83%), Gaps = 1/354 (0%)

Query: 1   MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRG 60
           ML LVLGLA AT L+ + +  F+ ++R+ K ++  D+E + + K   E  + EDL+ F+G
Sbjct: 1   MLILVLGLASATFLVFVAVYLFYSKRRVSKYNESKDIE-SSEHKEDEEMAQKEDLMIFQG 59

Query: 61  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL 120
           GEDLTICDILDAPGEVIGKSNYGTLYKALLQRS  V LLRFLRPVCT R +E  ++I  L
Sbjct: 60  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSNKVSLLRFLRPVCTARGEELDEMIHFL 119

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           G IRHPNLVPLLGFY GPRGEKL+VHPFY+ G+L Q IR G+GE +KWS I RISIGIA 
Sbjct: 120 GRIRHPNLVPLLGFYTGPRGEKLLVHPFYRHGSLTQFIRDGNGECYKWSNICRISIGIAK 179

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL++LHT   +PIIHGNLKSKNILLDR+YQPY+SD GLHLLLNPTAGQEMLE+SA+QGYK
Sbjct: 180 GLEHLHTSQEKPIIHGNLKSKNILLDRSYQPYISDSGLHLLLNPTAGQEMLESSAAQGYK 239

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APELIKMKDASEE+DIYS GVI+LEL+SGKEPINE+PTPDEDF+LP FMRNAVL HRI D
Sbjct: 240 APELIKMKDASEESDIYSLGVILLELLSGKEPINEHPTPDEDFYLPNFMRNAVLGHRIAD 299

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           LYHP +LL ++ +   PV+EE ILK FQLAMACCSPSPS+RPNIKQVL KLE++
Sbjct: 300 LYHPAILLRNSRDDSIPVTEECILKVFQLAMACCSPSPSVRPNIKQVLKKLEEI 353

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554806|ref|XP_003545733.1| PREDICTED: putative kinase-like protein TMKL1-like [Glycine max]

 Score =  510 bits (1314), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 251/354 (70%), Positives = 293/354 (82%), Gaps = 2/354 (0%)

Query: 1   MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRG 60
           ML LVLGLA AT L+ + +  F+ ++R+ K  +  D+E ++  +   +  + EDL+ F+G
Sbjct: 77  MLILVLGLASATFLVFVAVYVFYCKRRVSKYDESKDIESSEHKEE--DVAQKEDLMIFQG 134

Query: 61  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL 120
           GEDLTICDILDAPGEVIGKSNYGTLYKALLQRS  VRLLRFLRPVCT R +E  ++I+ L
Sbjct: 135 GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSNKVRLLRFLRPVCTARGEELDEMIQFL 194

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           G IRHPNLVPLLGFY GPRGEKL+VHPFY+ G+L Q IR G+GE +KWS I RISIGIA 
Sbjct: 195 GRIRHPNLVPLLGFYTGPRGEKLLVHPFYRHGSLTQYIRDGNGECYKWSNICRISIGIAK 254

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL++LHT   +PIIHGNLKSKNILLDR+YQPY+SD GLHLLLNPTAGQEMLE SA+QGYK
Sbjct: 255 GLEHLHTSQEKPIIHGNLKSKNILLDRSYQPYISDSGLHLLLNPTAGQEMLENSAAQGYK 314

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APELIKMKDASE TDIYS GVI+LEL+SGKEPINE+PTPDEDF+LP FMRNAVL HRI D
Sbjct: 315 APELIKMKDASEVTDIYSLGVILLELLSGKEPINEHPTPDEDFYLPNFMRNAVLGHRIAD 374

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           LY P  LL ++ +   PV+EE ILK FQLAMACCSPSPS+RPNIKQVL KLE++
Sbjct: 375 LYQPAFLLRNSRDDNIPVTEECILKVFQLAMACCSPSPSVRPNIKQVLKKLEEI 428

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225466029|ref|XP_002267207.1| PREDICTED: putative kinase-like protein TMKL1-like [Vitis vinifera]

 Score =  467 bits (1202), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 232/359 (64%), Positives = 284/359 (79%), Gaps = 16/359 (4%)

Query: 2   LKLVLGLALATLL-IILILIFFFYRKRLPKEHDHN-DLEINQQSKNGGEEGETEDLVTFR 59
           LKL+L L  A  L  +L  I+   ++R   E D    LE+ +      +E   E+LVTF 
Sbjct: 7   LKLILTLCSAAFLATVLCFIYLCCKQRRQNEDDEKASLELKES-----DEENKENLVTFE 61

Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALL--QRSGSVRLLRFLRPVCTTRDKEFGDLI 117
           GG+DLTI DILDAPGEVIGKSNYGTLYKA    +R+GS+RLLRFLRP C+ R +E   +I
Sbjct: 62  GGQDLTIYDILDAPGEVIGKSNYGTLYKASFTGRRAGSLRLLRFLRPACSGRMEEVVGVI 121

Query: 118 ELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
            +LGCIRH  LVPL  FYAGP+GEKL+VHPFY  GNLA+ IR G+GE+HKW++IYRIS+G
Sbjct: 122 HMLGCIRHNRLVPLEAFYAGPKGEKLLVHPFYGYGNLARFIRDGNGESHKWAVIYRISVG 181

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA GLD+LHTG  +P+IHGNLKSKNILLDRN+QPY+SDFG HLLLNP+AGQEMLE+  +Q
Sbjct: 182 IAQGLDHLHTGLQKPVIHGNLKSKNILLDRNFQPYISDFGQHLLLNPSAGQEMLESCGAQ 241

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
           GY+APELIKMKD  +ETDIYS GVI+LEL++G+EPINENP+ DEDF+LP F RNAVLDHR
Sbjct: 242 GYRAPELIKMKDVCQETDIYSLGVILLELLTGREPINENPSADEDFYLPNFHRNAVLDHR 301

Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           I D+++P +LL       +PVSEE +LK FQLAMACCSPSP+LRPNIKQ+L K+E++GK
Sbjct: 302 INDVFNPCILL-------SPVSEECVLKLFQLAMACCSPSPTLRPNIKQILRKMEEIGK 353

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449458349|ref|XP_004146910.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase IMK3-like [Cucumis sativus] gi|449502236|ref|XP_004161584.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase IMK3-like [Cucumis sativus]

 Score =  460 bits (1184), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 229/335 (68%), Positives = 282/335 (84%), Gaps = 5/335 (1%)

Query: 22  FFYRKRLPKEHD-HNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKS 80
           F  R+   K++D +ND+E  Q+ +    E E E+LV F+GG+DLTI DIL+APGEVIGK+
Sbjct: 24  FLNRRGKGKDNDEYNDIERKQEREK--GEEEREELVRFQGGQDLTIVDILEAPGEVIGKA 81

Query: 81  NYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG 140
           N+GTLYKA LQ S +VRLLRFLRPVCT   ++F   IE LG IRHPNLVPLLGFY+GPR 
Sbjct: 82  NHGTLYKAYLQGSNAVRLLRFLRPVCTAGLEDFVSEIEFLGSIRHPNLVPLLGFYSGPRA 141

Query: 141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKS 200
           EKL++HPFY+RGNLAQ IR G+G++H+W +I +IS+GIA GLD+LHTG  +P IHGNL+S
Sbjct: 142 EKLLIHPFYRRGNLAQFIRDGNGDSHRWGVINKISVGIAKGLDHLHTGLQKPTIHGNLQS 201

Query: 201 KNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFG 260
           KN+LLDRNY+PYVSDFGLHLLLN ++ QE++EASA+ GYKAPELIKMKDA+EETDIYS+G
Sbjct: 202 KNVLLDRNYEPYVSDFGLHLLLNSSSAQEVVEASAANGYKAPELIKMKDATEETDIYSYG 261

Query: 261 VIMLELISGKEPINENPT-PDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVS 319
           VI+LEL+SGKEP NE PT PDEDF+LP+FMRNAVL HRI DL+HP++LL S S   N V+
Sbjct: 262 VILLELLSGKEPFNEKPTVPDEDFYLPSFMRNAVLGHRIADLFHPEILLYS-SIDGNHVT 320

Query: 320 EERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           EE+ILKFFQLAMACCSPSP+LRP++KQVL KL ++
Sbjct: 321 EEKILKFFQLAMACCSPSPALRPSMKQVLRKLNEI 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38260653|gb|AAR15469.1| protein kinase [Capsella rubella]

 Score =  458 bits (1178), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 228/356 (64%), Positives = 281/356 (78%), Gaps = 12/356 (3%)

Query: 7   GLALATLLIILILIFFFYRK----RLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGE 62
           G++L+  LI+++ I FF RK        E D  D+E    +K G   G TE+LVTF+GGE
Sbjct: 12  GVSLSAFLIVILFIVFFRRKVSSSSSSTESDQYDVESLDHNKQGHSSG-TEELVTFQGGE 70

Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELL 120
           DLTICDILDAPGEVIGKS+YGTLYKA LQRSG  R+LRFLRPVCT R   KEF  +IE L
Sbjct: 71  DLTICDILDAPGEVIGKSSYGTLYKASLQRSGKTRVLRFLRPVCTVRSDSKEFKGVIETL 130

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           G +RH NLVPLLGFY G RGEKL+VHPF+   NL++ IR G  E+ KW  I  I+IGI+ 
Sbjct: 131 GFVRHENLVPLLGFYGGNRGEKLMVHPFFASWNLSEFIRSGDDESKKWINILSITIGIST 190

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
            LD+LHTG  +PI+HGNLK+KN+LL  +++P +SDFGLHLLLN  AGQE+L+ SA++GYK
Sbjct: 191 ALDHLHTGMQKPIVHGNLKTKNVLLSPSFEPRISDFGLHLLLNLAAGQEILDVSAAEGYK 250

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APELIKMK+ S E+D+YS GVIMLEL+SGKEPINENPT D++F+LP FMRNAVLDHR++D
Sbjct: 251 APELIKMKEVSIESDVYSLGVIMLELVSGKEPINENPTGDDEFYLPDFMRNAVLDHRLSD 310

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           LY P++L  S++N    +SEER+LK+FQLAM+CCSPSPSLRPNIKQVL KLE++ K
Sbjct: 311 LYRPEILR-SDAN----LSEERVLKYFQLAMSCCSPSPSLRPNIKQVLRKLEEIRK 361

Source: Capsella rubella

Species: Capsella rubella

Genus: Capsella

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357515927|ref|XP_003628252.1| MAP/microtubule affinity-regulating kinase [Medicago truncatula] gi|355522274|gb|AET02728.1| MAP/microtubule affinity-regulating kinase [Medicago truncatula]

 Score =  458 bits (1178), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 233/354 (65%), Positives = 277/354 (78%), Gaps = 19/354 (5%)

Query: 1   MLKLVLGLALATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRG 60
           ML LVLGL  ATLL+I++ ++ F   +    +D  D+E    S    +E   EDL+ F G
Sbjct: 1   MLILVLGLISATLLVIIVAVYGFCYIKRSSTNDTKDIE----SLEEKQEEVKEDLIIFEG 56

Query: 61  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL 120
           GEDLTICDILDAPGEVIGKSNYGTLYKALLQRS  VRLLRFLRPVCTTR +E  ++I  L
Sbjct: 57  GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSNKVRLLRFLRPVCTTRGEELDEMILFL 116

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           G ++               GEKL+VHPFY+ GNL Q IR G+GE++KWS I  IS GIA 
Sbjct: 117 GRLK---------------GEKLLVHPFYRHGNLTQFIRDGNGESYKWSNICTISTGIAK 161

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL++LHT   +PIIHGNLKSKNILLD +Y P++SD GLHLLLNPTAGQEMLE+S++QGYK
Sbjct: 162 GLEHLHTSHEKPIIHGNLKSKNILLDSSYHPHISDSGLHLLLNPTAGQEMLESSSAQGYK 221

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
            PELIKMKDASEETDIYS GVI+LEL+SGKEPINE+PTPDEDF+LP FMRNAVL HRI+D
Sbjct: 222 PPELIKMKDASEETDIYSLGVILLELLSGKEPINEHPTPDEDFYLPNFMRNAVLGHRISD 281

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           LYHP +LL ++ + E  V+EE +LKFFQLAMACCSPSPS+RPNIKQV+ KLE++
Sbjct: 282 LYHPAILLRNSIDDEIQVTEECVLKFFQLAMACCSPSPSIRPNIKQVIRKLEEI 335

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38260620|gb|AAR15438.1| protein kinase [Sisymbrium irio]

 Score =  456 bits (1173), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 221/329 (67%), Positives = 269/329 (81%), Gaps = 10/329 (3%)

Query: 30  KEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKAL 89
           +EHD   L+ ++Q    G   ETE LVTF+GGEDLTICDILDAPGEVIGKS+YGTLYKA 
Sbjct: 44  EEHDVESLDHDKQ----GFSSETEKLVTFQGGEDLTICDILDAPGEVIGKSSYGTLYKAS 99

Query: 90  LQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP 147
           LQRSG VR+LRFLRPVC  R   KEF  +IE LG +RH NLVPLLGFYAG RGEKL+VHP
Sbjct: 100 LQRSGKVRVLRFLRPVCAVRSDSKEFSGVIETLGFVRHENLVPLLGFYAGTRGEKLMVHP 159

Query: 148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR 207
           F+  GNL+  IR G GE+ KWS I RI+IG++  LDYLH+G  + I+HGNLKSKN+LL+ 
Sbjct: 160 FFSSGNLSDIIRSGDGESIKWSNILRITIGMSEALDYLHSGMQKTIVHGNLKSKNVLLNS 219

Query: 208 NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELI 267
           +++P +SDFGLHLLLN  AGQE+L+ SA++GYKAPELIKMKD S+E+D+YS GVIMLEL+
Sbjct: 220 SFEPRISDFGLHLLLNLAAGQEILDVSAAEGYKAPELIKMKDVSKESDVYSLGVIMLELV 279

Query: 268 SGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFF 327
           SGKEPIN+NPT D +F+LP FMRNAVLDH+++DLY P++L  S +N    +SEE +LK+F
Sbjct: 280 SGKEPINDNPTGDSEFYLPDFMRNAVLDHKLSDLYRPEILTSSGNN----LSEECVLKYF 335

Query: 328 QLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           QLAM+CCSPSPSLRPN+KQVL KLED+ K
Sbjct: 336 QLAMSCCSPSPSLRPNMKQVLRKLEDIRK 364

Source: Sisymbrium irio

Species: Sisymbrium irio

Genus: Sisymbrium

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38260689|gb|AAR15503.1| protein kinase [Arabidopsis arenosa]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 221/328 (67%), Positives = 267/328 (81%), Gaps = 8/328 (2%)

Query: 31  EHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALL 90
           E D  D+E    +K G    ETE+LVTF+GGEDLTICDILDAPGEVIGKS+YGTLYKA L
Sbjct: 40  ESDQYDVESLDHNKQGFS-SETEELVTFQGGEDLTICDILDAPGEVIGKSSYGTLYKASL 98

Query: 91  QRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF 148
           QRSG +R+LRFLRPVCT R   KEF  +IE LG +RH NLVPLLGFYAG RGEKL+VHPF
Sbjct: 99  QRSGKIRVLRFLRPVCTVRSDSKEFNGIIETLGFVRHENLVPLLGFYAGNRGEKLMVHPF 158

Query: 149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN 208
           +  GNL+  IR    E+ KW  I RI+IGI+  LDYLHTG  +PI+HGNLKSKN+LL  +
Sbjct: 159 FGSGNLSDFIRSEDDESRKWINILRITIGISTALDYLHTGMQKPIVHGNLKSKNVLLSLS 218

Query: 209 YQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS 268
           ++P +SDFGLHLLLN  AGQE+L+ SA++GYKAPELIKMK+ S+E+D+YS GVIMLEL+S
Sbjct: 219 FEPRISDFGLHLLLNLAAGQEILDVSAAEGYKAPELIKMKEVSKESDVYSLGVIMLELVS 278

Query: 269 GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQ 328
           GKEPINENPT D++F+LP FMRNAVLDHR++DLY P++L       ++ +SEE +LK+FQ
Sbjct: 279 GKEPINENPTGDDEFYLPDFMRNAVLDHRLSDLYRPEIL-----RSDDNLSEECVLKYFQ 333

Query: 329 LAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           LAM+CCSPSPSLRPNIKQVL KLE++GK
Sbjct: 334 LAMSCCSPSPSLRPNIKQVLRKLEEIGK 361

Source: Arabidopsis arenosa

Species: Arabidopsis arenosa

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
TAIR|locus:2160344	359	AT5G07620 [Arabidopsis thalian	0.924	0.916	0.662	1.3e-116
TAIR|locus:2151651	361	AT5G61570 [Arabidopsis thalian	0.901	0.889	0.594	3e-101
TAIR|locus:2093121	674	TMKL1 "transmembrane kinase-li	0.904	0.477	0.375	2.3e-55
TAIR|locus:2098267	836	IMK2 "inflorescence meristem r	0.825	0.351	0.374	1.5e-44
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.823	0.447	0.378	6.4e-44
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.873	0.472	0.339	2.2e-42
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.831	0.462	0.320	2.6e-40
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.834	0.454	0.312	7.1e-40
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.828	0.460	0.331	9.9e-40
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.766	0.427	0.329	3.6e-39

TAIR|locus:2160344 AT5G07620 [Arabidopsis thaliana (taxid:3702)]

 Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
 Identities = 224/338 (66%), Positives = 271/338 (80%)

Query:    22 FFYRKRLPK-EHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKS 80
             F  RK     E D  D+E    +K G    ETE+LV F+GGEDLTICDILDAPGEVIGKS
Sbjct:    27 FLRRKESSSTESDQYDVESLDHNKQGFSS-ETEELVIFQGGEDLTICDILDAPGEVIGKS 85

Query:    81 NYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGP 138
             +YGTLYKA LQRSG +R+LRFLRPVCT R   KEF  +IE LG +RH NLVPLLGFYAG 
Sbjct:    86 SYGTLYKASLQRSGKIRVLRFLRPVCTVRSDSKEFNGIIETLGFVRHENLVPLLGFYAGN 145

Query:   139 RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNL 198
             RGEKL+VHPF+  GNL+  IR G  E+ KW  I RI+IGI+  LD+LHTG  +PI+HGNL
Sbjct:   146 RGEKLMVHPFFGSGNLSDFIRSGDDESRKWINILRITIGISKALDHLHTGMQKPIVHGNL 205

Query:   199 KSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYS 258
             KSKN+LL  +++P +SDFGLHLLLN +AGQE+L+ SA++GYKAPELIKMKD S+E+D+YS
Sbjct:   206 KSKNVLLSSSFEPRISDFGLHLLLNLSAGQEILDVSAAEGYKAPELIKMKDVSKESDVYS 265

Query:   259 FGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPV 318
              GVIMLEL+SGKEPINEN T D++F+LP FMRNAVLDHR++DLY P+ +L S+ N    +
Sbjct:   266 LGVIMLELVSGKEPINENATGDDEFYLPDFMRNAVLDHRLSDLYRPE-ILGSDDN----L 320

Query:   319 SEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
             SEE +LK+FQLAM+CCSPSPSLRPN+KQVL KLE++GK
Sbjct:   321 SEECVLKYFQLAMSCCSPSPSLRPNVKQVLRKLEEIGK 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151651 AT5G61570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1004 (358.5 bits), Expect = 3.0e-101, P = 3.0e-101
 Identities = 207/348 (59%), Positives = 261/348 (75%)

Query:    21 FFFYRKRLPKEHD-HNDLEI---NQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEV 76
             F F R+   + ++   D+E     Q+  + G E E E+L+ F GGEDLTICDILDAPGEV
Sbjct:    29 FIFCRRTTTETNEVQYDVESPYEKQEFSDNGSETE-EELIIFNGGEDLTICDILDAPGEV 87

Query:    77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGF 134
             IGKS+YGTLYKA LQRSG VR+LRFLRP+C      KEF  +IE LG +RH NLVPLLGF
Sbjct:    88 IGKSSYGTLYKATLQRSGKVRVLRFLRPLCAVNSDSKEFNGVIESLGFVRHDNLVPLLGF 147

Query:   135 YAGPRGEKLIVHPFY-KRGNLAQCIR---GGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
             Y G RGEKL++HPF+   GNL+  I+   GG  +AHKWS I  I+IGIA  LD+LHTG  
Sbjct:   148 YVGNRGEKLMIHPFFGSSGNLSAFIKFLAGGDVDAHKWSNILSITIGIAKALDHLHTGMQ 207

Query:   191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
             +PI+HGNLKSKN+LLD++++P VSDFGLHLLLN  AGQE+LEASA++GYKAPELIKMK+ 
Sbjct:   208 KPIVHGNLKSKNVLLDKSFRPRVSDFGLHLLLNLAAGQEVLEASAAEGYKAPELIKMKEV 267

Query:   251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD-HRITDLYHPDMLL- 308
             S+E+D+YSFGVIMLEL+SGKEP N+NPT             +VLD +R++DLY P+++  
Sbjct:   268 SKESDVYSFGVIMLELVSGKEPTNKNPT------------GSVLDRNRLSDLYRPEIIRR 315

Query:   309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
             C      N V+EE +L++FQLAM+CCSPSP+LRP+ KQVL KLE++ K
Sbjct:   316 CLKDG--NGVTEECVLEYFQLAMSCCSPSPTLRPSFKQVLRKLEEIRK 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093121 TMKL1 "transmembrane kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
 Identities = 125/333 (37%), Positives = 200/333 (60%)

Query:    25 RKRLPKEHDHNDLEINQQSKNGGE-EGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYG 83
             +KR       +DLE   +    GE EG    LV F+GGE+LT+ D+L+A G+V+ K++YG
Sbjct:   326 KKRKSSIESEDDLEEGDEEDEIGEKEGGEGKLVVFQGGENLTLDDVLNATGQVMEKTSYG 385

Query:    84 TLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEK 142
             T+YKA L   G++ L R LR   C  R      +I  LG IRH NLVPL  FY G RGEK
Sbjct:   386 TVYKAKLSDGGNIAL-RLLREGTCKDRSSCL-PVIRQLGRIRHENLVPLRAFYQGKRGEK 443

Query:   143 LIVHPFYKRGNLAQCIRGGSGE--AHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKS 200
             L+++ +    +L   +        A  W+  ++I++GIA GL YLHTG   PIIHGN++S
Sbjct:   444 LLIYDYLPNISLHDLLHESKPRKPALNWARRHKIALGIARGLAYLHTGQEVPIIHGNIRS 503

Query:   201 KNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFG 260
             KN+L+D  +   +++FGL  ++      E++  + S GYKAPEL KMK  +  +D+Y+FG
Sbjct:   504 KNVLVDDFFFARLTEFGLDKIMVQAVADEIVSQAKSDGYKAPELHKMKKCNPRSDVYAFG 563

Query:   261 VIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSE 320
             +++LE++ GK+P       +E   LP+ ++ AVL+    +++  + +        +P+ E
Sbjct:   564 ILLLEILMGKKPGKSGRNGNEFVDLPSLVKAAVLEETTMEVFDLEAM----KGIRSPM-E 618

Query:   321 ERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
             E ++   +LAM CC+P  ++RP++++V+ +LE+
Sbjct:   619 EGLVHALKLAMGCCAPVTTVRPSMEEVVKQLEE 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2098267 IMK2 "inflorescence meristem receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 1.5e-44, P = 1.5e-44
 Identities = 116/310 (37%), Positives = 177/310 (57%)

Query:    46 GGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV 105
             GGE G    LV F G    T  D+L A  E++GKS YGT YKA L+    V + R LR  
Sbjct:   514 GGEMGGK--LVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKR-LREK 570

Query:   106 CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
              T   KEF   +  LG IRH NL+ L  +Y GP+GEKL+V  +  +G+L+  +     E 
Sbjct:   571 TTKGVKEFEGEVTALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHARGPET 630

Query:   166 H-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP 224
                W    +I+ GI+ GL +LH+  +  +IH NL + NILLD     +++D+GL  L+  
Sbjct:   631 LIPWETRMKIAKGISRGLAHLHS--NENMIHENLTASNILLDEQTNAHIADYGLSRLMTA 688

Query:   225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
              A   ++  + + GY+APE  K+K+AS +TD+YS G+I+LEL++GK P  E PT   D  
Sbjct:   689 AAATNVIATAGTLGYRAPEFSKIKNASAKTDVYSLGIIILELLTGKSP-GE-PTNGMD-- 744

Query:   285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
             LP ++ + V +    +++  +++  + S     V +E +L   +LA+ C  PSP+ RP  
Sbjct:   745 LPQWVASIVKEEWTNEVFDLELMRETQS-----VGDE-LLNTLKLALHCVDPSPAARPEA 798

Query:   345 KQVLWKLEDL 354
              QV+ +LE++
Sbjct:   799 NQVVEQLEEI 808

GO:0004672 "protein kinase activity" evidence=IEA;NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0008283 "cell proliferation" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 463 (168.0 bits), Expect = 6.4e-44, P = 6.4e-44
 Identities = 118/312 (37%), Positives = 176/312 (56%)

Query:    47 GEEGETEDLVTFRGGEDL-TICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV 105
             G    T+ LV F     +  + D+L A  EV+GK  +GT YKA+L     V + R L+ V
Sbjct:   346 GNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKR-LKDV 404

Query:   106 CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG--GSG 163
                 DKEF + IEL+G + H NLVPL  +Y   R EKL+V+ F   G+L+  + G  G+G
Sbjct:   405 MMA-DKEFKEKIELVGAMDHENLVPLRAYYFS-RDEKLLVYDFMPMGSLSALLHGNRGAG 462

Query:   164 EAH-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL 222
              +   W +  RI+IG A GLDYLH+       HGN+KS NILL +++   VSDFGL  L+
Sbjct:   463 RSPLNWDVRSRIAIGAARGLDYLHSQ-GTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLV 521

Query:   223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
                 G      + + GY+APE+   K  S++ D+YSFGV++LELI+GK P N +   +E 
Sbjct:   522 ----GSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSN-SVMNEEG 576

Query:   283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP 342
               LP ++++   D    +++  ++L  S +  E    EE + +  QL + C S  P  RP
Sbjct:   577 VDLPRWVKSVARDEWRREVFDSELL--SLATDE----EEMMAEMVQLGLECTSQHPDQRP 630

Query:   343 NIKQVLWKLEDL 354
              + +V+ K+E+L
Sbjct:   631 EMSEVVRKMENL 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 450 (163.5 bits), Expect = 2.2e-42, P = 2.2e-42
 Identities = 113/333 (33%), Positives = 185/333 (55%)

Query:    28 LPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGE-DLTICDILDAPGEVIGKSNYGTLY 86
             LP     +  E+   S   G E E   LV   GG     + D+L A  EV+GK + GT Y
Sbjct:   307 LPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSY 366

Query:    87 KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH 146
             KA+L+  G+  +++ L+ V  ++ KEF   +E++G I+HPN++PL  +Y   + EKL+V 
Sbjct:   367 KAVLEE-GTTVVVKRLKDVMASK-KEFETQMEVVGKIKHPNVIPLRAYYYS-KDEKLLVF 423

Query:   147 PFYKRGNLAQCIRG--GSGEAH-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNI 203
              F   G+L+  + G  GSG     W    RI+I  A GL +LH      ++HGN+K+ NI
Sbjct:   424 DFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS--AKLVHGNIKASNI 481

Query:   204 LLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIM 263
             LL  N    VSD+GL+ L + ++    L      GY APE+++ +  + ++D+YSFGV++
Sbjct:   482 LLHPNQDTCVSDYGLNQLFSNSSPPNRLA-----GYHAPEVLETRKVTFKSDVYSFGVLL 536

Query:   264 LELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERI 323
             LEL++GK P N+    +E   LP ++ + V +    +++  +++   N        EE +
Sbjct:   537 LELLTGKSP-NQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNI-------EEEM 588

Query:   324 LKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
             ++  Q+AMAC S  P  RP +++VL  +ED+ +
Sbjct:   589 VQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNR 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 431 (156.8 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 101/315 (32%), Positives = 177/315 (56%)

Query:    45 NGGEEGETEDLVTFRGGE-DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLR 103
             +G +E E   LV F G   +  + D+L A  EV+GK +YGT YKA+L+  G+  +++ L+
Sbjct:   314 SGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLK 372

Query:   104 PVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG-- 160
              V   + +EF   +E +G I  H N+ PL  +Y   + EKL+V+ +Y+ GN +  + G  
Sbjct:   373 EVAAGK-REFEQQMEAVGRISPHVNVAPLRAYYFS-KDEKLLVYDYYQGGNFSMLLHGNN 430

Query:   161 -GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
              G   A  W    RI +  A G+ ++H+     ++HGN+KS N+LL +     VSDFG+ 
Sbjct:   431 EGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIA 490

Query:   220 LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP 279
                 P      L  S S GY+APE I+ +  ++++D+YSFGV++LE+++GK    +    
Sbjct:   491 ----PLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAA-GKTTGH 545

Query:   280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPS 339
             +E   LP ++++ V +    +++  +++      H     EE +++  Q+AMAC S  P 
Sbjct:   546 EEVVDLPKWVQSVVREEWTGEVFDVELI---KQQHN---VEEEMVQMLQIAMACVSKHPD 599

Query:   340 LRPNIKQVLWKLEDL 354
              RP++++V+  +E++
Sbjct:   600 SRPSMEEVVNMMEEI 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 7.1e-40, P = 7.1e-40
 Identities = 100/320 (31%), Positives = 181/320 (56%)

Query:    41 QQSKNGGEEGETEDLVTFRG-GEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLL 99
             Q+  +G +E E   LV F G   +  + D+L A  EV+GK +YGT YKA+L+ S +V + 
Sbjct:   327 QEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 386

Query:   100 RFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI 158
             R L+ V   + +EF   +E++  +  HP++VPL  +Y   + EKL+V  +Y  GNL+  +
Sbjct:   387 R-LKEVAAGK-REFEQQMEIISRVGNHPSVVPLRAYYYS-KDEKLMVCDYYPAGNLSSLL 443

Query:   159 RGGSGEAHK---WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD 215
              G  G       W    +I++  A G+ +LH        HGN+KS N+++ +     +SD
Sbjct:   444 HGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISD 503

Query:   216 FGLH-LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
             FGL  L+  P A           GY+APE+++ +  + ++D+YSFGV++LE+++GK P+ 
Sbjct:   504 FGLTPLMAVPIAPMR------GAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV- 556

Query:   275 ENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACC 334
             ++P+ D+   LP ++++ V +   ++++  +++   N        EE +++  Q+AMAC 
Sbjct:   557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNI-------EEEMVQMLQIAMACV 609

Query:   335 SPSPSLRPNIKQVLWKLEDL 354
             +  P +RP +  V+  +E++
Sbjct:   610 AQVPEVRPTMDDVVRMIEEI 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 426 (155.0 bits), Expect = 9.9e-40, P = 9.9e-40
 Identities = 106/320 (33%), Positives = 180/320 (56%)

Query:    41 QQSKNGGEEGETEDLVTF-RGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLL 99
             Q   +G ++ E   L  F R   +  + D+L A  EV+GK ++GT YKA+L+ + +V + 
Sbjct:   316 QDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVK 375

Query:   100 RFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI 158
             R LR V  ++ KEF   +E++G I +H N VPLL +Y   + EKL+V+ +  +G+L   +
Sbjct:   376 R-LREVVASK-KEFEQQMEIVGKINQHSNFVPLLAYYYS-KDEKLLVYKYMTKGSLFGIM 432

Query:   159 RGGSGEAH-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG 217
              G  G+    W    +I+ G +  + YLH+      +HG++KS NILL  + +P +SD  
Sbjct:   433 HGNRGDRGVDWETRMKIATGTSKAISYLHS---LKFVHGDIKSSNILLTEDLEPCLSDTS 489

Query:   218 LHLLLN-PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN 276
             L  L N PT     +      GY APE+I+ +  S+ +D+YSFGV++LE+++GK P+ + 
Sbjct:   490 LVTLFNLPTHTPRTI------GYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQP 543

Query:   277 PTPDED--FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACC 334
                DE     LP ++R+ V +    +++  ++L   N        EE +++  QLA+AC 
Sbjct:   544 GLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNI-------EEEMVQMLQLALACV 596

Query:   335 SPSPSLRPNIKQVLWKLEDL 354
             + +P  RP +++V   +ED+
Sbjct:   597 ARNPESRPKMEEVARMIEDV 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 421 (153.3 bits), Expect = 3.6e-39, P = 3.6e-39
 Identities = 96/291 (32%), Positives = 167/291 (57%)

Query:    68 DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
             D+L A  EV+GK  +GT YKA+L+ + SV + R L+ V   + ++F   +E++G I+H N
Sbjct:   334 DLLRASAEVLGKGTFGTTYKAVLEDATSVAVKR-LKDVAAGK-RDFEQQMEIIGGIKHEN 391

Query:   128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH---KWSIIYRISIGIAGGLDY 184
             +V L  +Y   + EKL+V+ ++ RG++A  + G  GE      W    +I+IG A G+  
Sbjct:   392 VVELKAYYYS-KDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIAR 450

Query:   185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
             +H   +  ++HGN+KS NI L+      VSD GL  +++P A       S   GY+APE+
Sbjct:   451 IHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPP----ISRQAGYRAPEV 506

Query:   245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
                + +S+ +D+YSFGV++LEL++GK PI+     DE  HL  ++ + V +    +++  
Sbjct:   507 TDTRKSSQLSDVYSFGVVLLELLTGKSPIHTT-AGDEIIHLVRWVHSVVREEWTAEVFDI 565

Query:   305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG 355
             ++L  +N        EE +++  Q+AM+C   +   RP +  ++  +E++G
Sbjct:   566 ELLRYTNI-------EEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVG 609

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	356
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-31
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-21
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-18
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-16
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-08
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-05
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.001
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.001
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003
PRK06007	542	PRK06007, fliF, flagellar MS-ring protein; Reviewe	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  116 bits (294), Expect = 4e-31
 Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 9/193 (4%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLL-RFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +GT+Y A  +++G    +    +   ++  +E    IE+L  + HPN+V L G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
                   +V  + + G+L   ++   G+      I RI + I  GL+YLH      IIH
Sbjct: 61  EDEN-HLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 196 GNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-MKDASEE 253
            +LK +NILLD  N +  ++DFGL  LL       +     +  Y APE++      SE+
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 254 TDIYSFGVIMLEL 266
           +DI+S GVI+ EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  105 bits (264), Expect = 2e-26
 Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 35/281 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL--IELLGCIRHPNLVPL 131
              +G  ++GT+YKA  + +G +  ++ L+       K+      I +L  + HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK---WSIIYRISIGIAGGLDYLHTG 188
           +  +   +    +V  + + G+L   +                 +I++ I  GL+YLH  
Sbjct: 64  IDAFE-DKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLH-- 115

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM- 247
               IIH +LK +NILLD N    ++DFGL   L   +   +     +  Y APE++   
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
                + D++S GVI+ EL++GK P +     D+   +   +   +              
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW------- 226

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                   +  SEE       L   C +  PS RP  +++L
Sbjct: 227 --------SSGSEE----AKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 98.0 bits (245), Expect = 8e-24
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 37/279 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLL 132
            E +G+ ++G +Y A  +++G +  ++ ++     +D+E     I++L  ++HPN+V L 
Sbjct: 4   LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIAGGLDYLHTGF 189
             +     +KL +V  + + G+L   ++      E      + +I       L+YLH+  
Sbjct: 64  DVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI----LSALEYLHS-- 115

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            + I+H +LK +NILLD +    ++DFGL   L+P   +++     +  Y APE++  K 
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFVGTPEYMAPEVLLGKG 172

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
             +  DI+S GVI+ EL++GK P   +    E F             +I     P     
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF------------KKIGKPKPPFP--- 217

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                E  +S E       L        P  R   ++ L
Sbjct: 218 ---PPEWDISPE----AKDLIRKLLVKDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 91.4 bits (228), Expect = 3e-21
 Identities = 63/286 (22%), Positives = 123/286 (43%), Gaps = 40/286 (13%)

Query: 74  GEVIGKSNYGTLYKALL-QRSGSVRLL---RFLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
           G+ +G+  +G +YK  L  + G  ++    + L+   + +  +EF     ++  + HPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LLG          IV  + + G+L   +R  +      S +   ++ IA G++YL   
Sbjct: 64  VKLLGV-CTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK--APELIK 246
             +  IH +L ++N L+  N    +SDFGL   L         +       +  APE +K
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD--DDYYRKRGGKLPIRWMAPESLK 176

Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
               + ++D++SFGV++ E+ + G++P         +  +  +++N    +R   L  P 
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLEYLKN---GYR---LPQPP 226

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
              C               + + L + C +  P  RP   +++  L
Sbjct: 227 --NCPP-------------ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 63/286 (22%), Positives = 121/286 (42%), Gaps = 39/286 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF----LRPVCTTRD-KEFGDLIELLGCIRHPNL 128
           G+ +G+  +G +YK  L+  G  + +      L+   + +  +EF     ++  + HPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LLG         +IV  +   G+L   +R    +    S +   ++ IA G++YL   
Sbjct: 64  VKLLGV-CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK--APELIK 246
             +  IH +L ++N L+  N    +SDFGL   L                 +  APE +K
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD--DDYYKVKGGKLPIRWMAPESLK 177

Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
               + ++D++SFGV++ E+ + G+EP         +  +  +++     +R   L  P 
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP----YPGMSNAEVLEYLKK---GYR---LPKPP 227

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
              C               + ++L + C +  P  RP   +++  L
Sbjct: 228 --NCPP-------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 9/216 (4%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
             E IGK  +G +YKA  +R+G    ++ ++     + ++  + I++L   +HPN+V   
Sbjct: 4   ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G Y   + E  IV  F   G+L   ++  +    +  I Y +   +  GL+YLH+  +  
Sbjct: 64  GSYL-KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKGLEYLHS--NG- 118

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKDAS 251
           IIH ++K+ NILL  + +  + DFGL   L+ T A   M+    +  + APE+I  K   
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYD 175

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
            + DI+S G+  +EL  GK P +E P     F + T
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT 211

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 57/301 (18%), Positives = 113/301 (37%), Gaps = 62/301 (20%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV-------CTTRD--KEFGDLIELLGCIRH 125
           + +G+  +G +YK  L+             V         + +  K+F     ++  + H
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKT-----TEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK-------WSIIYRISIGI 178
           PN+V LLG          +V  + + G+L   +R                  +   +I I
Sbjct: 56  PNVVRLLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
           A G++YL     +  +H +L ++N L+  +    +SDFGL   +             + G
Sbjct: 115 AKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK----KTGG 167

Query: 239 -----YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA 292
                + APE +K    + ++D++SFGV++ E+ + G  P                + N 
Sbjct: 168 KLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-------------LSNE 214

Query: 293 VLDHRITDLYHPDM-LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
            +   +   Y       C +             + ++L ++C    P  RP   +++ +L
Sbjct: 215 EVLEYLRKGYRLPKPEYCPD-------------ELYELMLSCWQLDPEDRPTFSELVERL 261

Query: 352 E 352
           E
Sbjct: 262 E 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 96/348 (27%), Positives = 161/348 (46%), Gaps = 39/348 (11%)

Query: 10  LATLLIILILIFFFYRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTF--RGGEDLTIC 67
           L   L++ ++ F F   R       N+LE+ +     G    T +L  F  +  + +TI 
Sbjct: 636 LGAFLVLALVAFGFVFIR-----GRNNLELKRVENEDG----TWELQFFDSKVSKSITIN 686

Query: 68  DILDAPGE--VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH 125
           DIL +  E  VI +   G  YK    ++G   +++ +  V +    E  D+    G ++H
Sbjct: 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM----GKLQH 742

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           PN+V L+G     +G  LI H + +  NL++ +R  S E  +     +I+IGIA  L +L
Sbjct: 743 PNIVKLIGLCRSEKGAYLI-HEYIEGKNLSEVLRNLSWERRR-----KIAIGIAKALRFL 796

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM-LEASASQGYKAPEL 244
           H      ++ GNL  + I++D   +P       HL L+         +   S  Y APE 
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEP-------HLRLSLPGLLCTDTKCFISSAYVAPET 849

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
            + KD +E++DIY FG+I++EL++GK P +          +  + R    D       H 
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IVEWARYCYSD------CHL 901

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
           DM +  +   +  V++  I++   LA+ C +  P+ RP    VL  LE
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS-------VRLLRFLRPVCTTRDKEFGDLIE---LLGCI 123
           G+ +G+  +G +YK  L+  G        V+ L+         ++E  + +E   ++  +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-----EGASEEEREEFLEEASIMKKL 58

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
            HPN+V LLG          IV  +   G+L   +R   GE      + ++++ IA G++
Sbjct: 59  SHPNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGME 116

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK--- 240
           YL +   +  +H +L ++N L+  N    +SDFGL          E        G K   
Sbjct: 117 YLES---KNFVHRDLAARNCLVTENLVVKISDFGL-----SRDIYEDDYYRKRGGGKLPI 168

Query: 241 ---APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
              APE +K    + ++D++SFGV++ E+ + G++P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 83.6 bits (205), Expect = 7e-18
 Identities = 63/286 (22%), Positives = 110/286 (38%), Gaps = 28/286 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLL 132
              +G+ ++G +Y A  ++  ++++L       +   + F   I++L      PN+V L 
Sbjct: 5   LRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIR-GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
            F+    G   +V  +   G+L   ++  G       S    I   I   L+YLH+   +
Sbjct: 65  DFFQDE-GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---K 120

Query: 192 PIIHGNLKSKNILLDRNY-QPYVSDFGL-----HLLLNPTAGQEMLEASASQGYKAPELI 245
            IIH ++K +NILLDR+     + DFGL           +       +  + GY APE++
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 246 KMK---DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY 302
                  AS  +DI+S G+ + EL++G  P                ++       I +L 
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPF---EGEKNSSATSQTLKI------ILELP 231

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            P +     S       E        L     +  P  R +    L
Sbjct: 232 TPSLA----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 52/289 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSG------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
           GE++G+ ++G++Y AL + +G      SV L           ++E    I +L  ++HPN
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALERE----IRILSSLQHPN 60

Query: 128 LVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIAGGLDY 184
           +V   G         L I   +   G+L+  ++      E     +I + +  I  GL Y
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE----PVIRKYTRQILEGLAY 116

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKA 241
           LH+     I+H ++K  NIL+D +    ++DFG    L      E     + +G   + A
Sbjct: 117 LHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT--GSVRGTPYWMA 171

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           PE+I+ ++     DI+S G  ++E+ +GK P +E                  L + +  L
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE------------------LGNPMAAL 213

Query: 302 YHPDMLLCSNSNHENP--VSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           Y    +  S    E P  +SEE   K F     C    P  RP   ++L
Sbjct: 214 YK---IGSSGEPPEIPEHLSEE--AKDF--LRKCLRRDPKKRPTADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 13/209 (6%)

Query: 76  VIGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG- 133
           V+G+ + G +YK   + +G    L +          K+    ++ L     P +V   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS--IIYRISIGIAGGLDYLHTGFHR 191
           FY    GE  IV  +   G+LA  ++    +  K    ++  I+  I  GLDYLHT  H 
Sbjct: 68  FYKE--GEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKRH- 120

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            IIH ++K  N+L++   +  ++DFG+  +L  T  Q       +  Y +PE I+ +  S
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN-TFVGTVTYMSPERIQGESYS 178

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPD 280
              DI+S G+ +LE   GK P      P 
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPS 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 24/216 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSG------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
           G++IG+  +G +YK L   +G       + L +       +  +E    I+LL  ++HPN
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQE----IDLLKNLKHPN 60

Query: 128 LVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDY 184
           +V  +G       + L I+  + + G+L Q I+  G   E    S++      +  GL Y
Sbjct: 61  IVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPE----SLVAVYVYQVLQGLAY 114

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH    + +IH ++K+ NIL  ++    ++DFG+   LN  +  +      +  + APE+
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD-ASVVGTPYWMAPEV 170

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPI-NENPTP 279
           I+M  AS  +DI+S G  ++EL++G  P  + NP  
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G  IG   +G +Y A+   +G   +V+ +R       T  KE  D +++L  ++HPNLV 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNLV- 62

Query: 131 LLGFYAGP--RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              +Y     R +  I   +   G L + +  G        +I   ++ +  GL YLH+ 
Sbjct: 63  --KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH--VIRVYTLQLLEGLAYLHS- 117

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP---TAGQEMLEASASQGYKAPELI 245
            H  I+H ++K  NI LD N    + DFG  + L     T G+E+   + +  Y APE+I
Sbjct: 118 -HG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 246 KMKDASEE---TDIYSFGVIMLELISGKEP 272
                       DI+S G ++LE+ +GK P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 18/228 (7%)

Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +VIG   +G +++ +L+  G       ++ L+P  T + + +F     ++G   H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G     +   +I+  + + G L + +R   GE   + ++  +  GIA G+ YL    +
Sbjct: 71  LEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNY 128

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIKMK 248
              +H +L ++NIL++ N +  VSDFGL  +L  +P              + APE I  +
Sbjct: 129 ---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFM 289
             +  +D++SFG++M E++S G+ P  +    +      + F LP  M
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF--LRPVCTTRDKE--------FGDLIELLGCI 123
           GE+IGK  YG +Y AL   +G +  ++   L      R               IE L  +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGL 182
            H N+V  LGF        + +  +   G++  C+R  G  E     ++   +  +  GL
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLE-YVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGL 121

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKA 241
            YLH+   + I+H +LK+ N+L+D +    +SDFG+     +     + +    S  + A
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 242 PELI--KMKDASEETDIYSFGVIMLELISGKEP 272
           PE+I    +  S + DI+S G ++LE+ +G+ P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRF--LRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
             IGK ++G ++K + +    V  ++   L  +     +E  D   +L  +    ++   
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
             +   +G+  IV  + + G+L + ++   G       ++R  I I  GL +LH+   + 
Sbjct: 66  ESFL-DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KK 121

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA--GQEMLEASASQGYKAPELIKMKDA 250
           I+H ++KS N+ LD      + D G+  LL+        ++    +  Y +PEL + K  
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPELCEDKPY 178

Query: 251 SEETDIYSFGVIMLELISGKEPINEN 276
           +E++D+++ GV++ E  +GK P + N
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 72.5 bits (179), Expect = 1e-14
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 44/283 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + IGK ++G +Y    +  G + +L+ +  +    +KE  D    +++L  + HPN++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              +      KL IV  +   G+L+Q I  +   G+      I    + +   L YLH+ 
Sbjct: 65  YESFE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS- 121

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELI 245
             R I+H ++K +NI L  N    + DFG+  +L+ T   ++  A    G   Y +PEL 
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDL--AKTVVGTPYYLSPELC 175

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
           + K  + ++DI+S G ++ EL + K P        E  +L            I    +P 
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPF-------EGENLLELALK------ILKGQYPP 222

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           +         +  S E       L  +     P  RP+I Q+L
Sbjct: 223 I--------PSQYSSE----LRNLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +VIG   +G + +  L+  G   +    + L+   + + + +F     ++G   HPN++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL--HTG 188
           L G     R   +I+  + + G+L + +R   G+      +  +  GIA G+ YL     
Sbjct: 70  LEGVVTKSR-PVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGMKYLSEMNY 127

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
            HR     +L ++NIL++ N    VSDFGL   L  +          ++G K      AP
Sbjct: 128 VHR-----DLAARNILVNSNLVCKVSDFGLSRRLEDSEA-----TYTTKGGKIPIRWTAP 177

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           E I  +  +  +D++SFG++M E++S G+ P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 20/203 (9%)

Query: 74  GEVIGKSNYGTLYKA-LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           GE+IG+  +G + +     +  +V+ ++     C    + F +   ++  + H NLV LL
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKVAVKNIK-----CDVTAQAFLEETAVMTKLHHKNLVRLL 65

Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           G   + G      IV     +GNL   +R           + + S+ +A G++YL +   
Sbjct: 66  GVILHNGLY----IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES--- 118

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + ++H +L ++NIL+  +    VSDFGL  + +       L       + APE +K K  
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKF 174

Query: 251 SEETDIYSFGVIMLELIS-GKEP 272
           S ++D++S+GV++ E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 73/292 (25%), Positives = 133/292 (45%), Gaps = 49/292 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
            VIGK ++G +Y   L  S   ++   ++ +   R  +  ++ + L  G I     HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G++YL 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIR---SETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD ++   V+DFG   L      +E        G K P    
Sbjct: 116 S---KKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
             E ++ +  + ++D++SFGV++ EL++   P    P PD D      +   +L  R   
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVD---SFDITVYLLQGR--R 220

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
           L  P+   C +               +++ ++C  P P +RP   +++ ++E
Sbjct: 221 LLQPE--YCPDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 35/225 (15%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLL 132
            +G  N G + K L + +G +  ++ +R      +     ++  L  +     P +V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIV--- 62

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIR---GGS-----GEAHKW---SIIYRISIGIAGG 181
           GFY            FY  G+++ C+    GGS      E        I+ +I++ +  G
Sbjct: 63  GFYGA----------FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKG 112

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           L YLH      IIH ++K  NIL++   Q  + DFG+   L  +  +  +  S+   Y A
Sbjct: 113 LTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMA 167

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPI-NENPTPDEDFHL 285
           PE I+  D S ++DI+S G+ ++EL +G+ P   EN  PD  F L
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL 212

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 48/282 (17%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPLLG 133
           +GK +YG++YK           L+ +  + +   KE  D    I +L  + HPN++    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHPNII---S 63

Query: 134 FY-AGPRGEKL-IVHPFYKRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGF 189
           +  A   G KL IV  +   G+L++ I       +      I+RI I +  GL  LH   
Sbjct: 64  YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-- 121

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            + I+H +LKS NILL  N    + D G+  +L     +  +    +  Y APE+ K + 
Sbjct: 122 -QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRP 177

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLYHPDM 306
            S ++DI+S G ++ E+ +   P       D        +R  V       I  +Y  D+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYPPIPPIYSQDL 229

Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                                    +     P LRPN  ++L
Sbjct: 230 Q--------------------NFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 36/238 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVP 130
           EVIG   +G + +  L+  G   +   ++ L+   T +  ++F     ++G   HPN++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G     R   +I+  F + G L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 70  LEGVVTKSR-PVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLS-- 123

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL-----NPTAGQEMLEASASQG----- 238
                +H +L ++NIL++ N    VSDFGL   L     +PT        S+  G     
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT------YTSSLGGKIPIR 176

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFM 289
           + APE I  +  +  +D++S+G++M E++S G+ P  +    D      +D+ LP  M
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 55/289 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           G  IGK  +G +     +  G    ++ L+   T     F     ++  +RHPNLV LLG
Sbjct: 11  GATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLG 67

Query: 134 --FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH---KWSIIYRISIGIAGGLDYLHTG 188
                 P     IV  +  +G+L   +R   G A       + +  ++ +  G++YL   
Sbjct: 68  VVLQGNPL---YIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGF--ALDVCEGMEYLEE- 120

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYKAPELI 245
             +  +H +L ++N+L+  +    VSDFGL       A +      + +    + APE +
Sbjct: 121 --KNFVHRDLAARNVLVSEDLVAKVSDFGL-------AKEASQGQDSGKLPVKWTAPEAL 171

Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
           + K  S ++D++SFG+++ E+ S G+ P    P  D            V+ H        
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------VVPH-------- 211

Query: 305 DMLLCSNSNHENPVSEERILKF-FQLAMACCSPSPSLRPNIKQVLWKLE 352
              +      E P   E      +++   C    P+ RP  KQ+  +L 
Sbjct: 212 ---VEKGYRMEAP---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLRP-----VCTTRDKEFGDLIELLGCIRHPNLVP 130
           IG+  YG +YKA  + +G  V + +         +  T  +E    I+LL  + HPN++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIGIAGGLDYLHT 187
           LL  +       L+    +   +L + I+       E+   S +Y++      GL + H+
Sbjct: 63  LLDVFRHKGDLYLVFE--FMDTDLYKLIKDRQRGLPESLIKSYLYQL----LQGLAFCHS 116

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
             H  I+H +LK +N+L++      ++DFGL         +       ++ Y+APEL+  
Sbjct: 117 --HG-ILHRDLKPENLLINTEGVLKLADFGLARSFGSP-VRPYTHYVVTRWYRAPELLLG 172

Query: 247 MKDASEETDIYSFGVIMLELISGK 270
            K  S   DI+S G I  EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 43/285 (15%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 73  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-- 122

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 123 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 182 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 219

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                E P  E    K ++L  AC   +PS RP+  ++    E +
Sbjct: 220 KGYRMERP--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-------IELLGCIRHPN 127
           E IGK N+G +YK +L+ +  V        V T R     DL        E+L    HPN
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-------AVKTCRSTLPPDLKRKFLQEAEILKQYDHPN 53

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V L+G     +    IV      G+L   +R          ++ ++S+  A G++YL +
Sbjct: 54  IVKLIGV-CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-QMSLDAAAGMEYLES 111

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------- 240
              +  IH +L ++N L+  N    +SDFG+      +  +E    + S G K       
Sbjct: 112 ---KNCIHRDLAARNCLVGENNVLKISDFGM------SREEEGGIYTVSDGLKQIPIKWT 162

Query: 241 APELIKMKDASEETDIYSFGVIMLELISG 269
           APE +     + E+D++S+G+++ E  S 
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 38/219 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           E IG+   G +YKA  + +G   +++ +R  +       +   + I ++   +HPN+V  
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDY 80

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIGIAGGLDYLHTG 188
              Y     E  +V  +   G+L   I        E      I  +   +  GL+YLH+ 
Sbjct: 81  YDSYL-VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ----IAYVCREVLQGLEYLHS- 134

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGY 239
             + +IH ++KS NILL ++    ++DFG    L     +          M         
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM--------- 183

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
            APE+IK KD   + DI+S G++ +E+  G+ P + E P
Sbjct: 184 -APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 20/213 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL------IELLGCIR 124
           G +IG  ++G++Y  +   SG   +V+ +       +++D++   L      I LL  ++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           H N+V  LG  +    + L +   Y  G     +    G A + +++      I  GL+Y
Sbjct: 65  HENIVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNY 121

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQG---Y 239
           LH    R IIH ++K  NIL+D      +SDFG+   L  N  + +      + QG   +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++K    + + DI+S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 9e-13
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRH---PNL 128
           E+IG+  YG +Y+     +G V  L+ +     T D +  D+   + LL  +R    PN+
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 129 VPLLGFY-AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
               G Y  GPR    I+  + + G++   ++ G       S+I R  + +A  L Y+H 
Sbjct: 65  TKYYGSYLKGPR--LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-VA--LKYIH- 118

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-- 245
                +IH ++K+ NIL+       + DFG+  LLN  + +          + APE+I  
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-WMAPEVITE 175

Query: 246 -KMKDASEETDIYSFGVIMLELISGKEP 272
            K  D   + DI+S G+ + E+ +G  P
Sbjct: 176 GKYYDT--KADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-----DKEFGDLIE---LLGCIR 124
            G++IG+ ++ T+  A  + +     ++    +   R      K     IE   L     
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIK----ILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 125 HPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           HP ++ L   +     E L  V  +   G L Q IR       K +  Y   I +A  L+
Sbjct: 61  HPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA--LE 116

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG----LHLLLNPTAGQEMLEASASQG- 238
           YLH+   + IIH +LK +NILLD++    ++DFG    L    +P + +       SQ  
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 239 --------------YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                         Y +PEL+  K A + +D+++ G I+ ++++GK P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVC--TTRDK-------EFGDLIELLGCI 123
            +++G   +GT++K +    G S+++     PV   T +D+       E  D +  +G +
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHMLAMGSL 66

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
            H  +V LLG   G   +  +V      G+L   +R           +    + IA G+ 
Sbjct: 67  DHAYIVRLLGICPGASLQ--LVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMY 123

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASASQGYKAP 242
           YL    HR ++H NL ++NILL  +    ++DFG+  LL P   +    E      + A 
Sbjct: 124 YLEE--HR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           E I     + ++D++S+GV + E++S G EP
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 40/283 (14%)

Query: 77  IGKSNYGTLYKALLQRSG-------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
           +G+ ++G +        G       +V+ L          D  F   IE+L  + H N+V
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD--FEREIEILRTLDHENIV 69

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDY 184
              G    P G  L ++  +   G+L   ++      H+  I    +   S  I  G+DY
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-----HRDQINLKRLLLFSSQICKGMDY 124

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ---EMLEASASQGYKA 241
           L +   +  IH +L ++NIL++      +SDFGL  +L         +    S    Y A
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           PE ++    S  +D++SFGV + EL +  +P    P          F+R   +      +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP--------AEFLRMIGIAQGQMIV 232

Query: 302 YHPDMLLCSNSNHENPVS--EERILKFFQLAMACCSPSPSLRP 342
                LL        P S  +E     + L   C    P  RP
Sbjct: 233 TRLLELLKEGERLPRPPSCPDE----VYDLMKLCWEAEPQDRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L+YLH+   + IIH ++K  NILLD     +++DF +   +  T        S + 
Sbjct: 109 IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTP 163

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           GY APE++  +  S   D +S GV   E + GK P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 53/183 (28%), Positives = 92/183 (50%), Gaps = 20/183 (10%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI-- 176
           ++G   HPN++ L G     +   +IV  + + G+L   +R   G+   +++I  + +  
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSK-PVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLR 113

Query: 177 GIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEA 233
           GIA G+ YL   G+    +H +L ++NIL++ N    VSDFGL  +L  +P A       
Sbjct: 114 GIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLP 286
                + APE I  +  +  +D++S+G++M E++S G+ P  E    D      E + LP
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229

Query: 287 TFM 289
             M
Sbjct: 230 APM 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 16/206 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNL 128
           GE++G  ++G++Y+ L    G    V+ +       T ++  K+    I LL  ++HPN+
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           V  LG       + L I       G+LA+ ++     +    +I   +  I  GL+YLH 
Sbjct: 65  VQYLG--TEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
              R  +H ++K  NIL+D N    ++DFG+   +             S  + APE+I  
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 248 KDA-SEETDIYSFGVIMLELISGKEP 272
           +       DI+S G  +LE+ +GK P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 21/159 (13%)

Query: 123 IRHPNLVPLLGFYA-GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           +RH  LV L   YA     E + IV  +  +G+L   ++ G G+  +   +  ++  IA 
Sbjct: 58  LRHDKLVQL---YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ YL +   R  IH +L ++NIL+  N    ++DFGL  L+      E  E +A +G K
Sbjct: 115 GMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLI------EDDEYTAREGAK 165

Query: 241 ------APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                 APE       + ++D++SFG+++ E+++ G+ P
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 8e-12
 Identities = 70/282 (24%), Positives = 127/282 (45%), Gaps = 38/282 (13%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G +++ L   +  V + + L+P  T   K+F    +++  +RHP L+ L   YA
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAV-KTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQL---YA 68

Query: 137 -GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
                E + IV    K G+L + ++GG+G A K   +  ++  +A G+ YL     +  I
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYI 125

Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEET 254
           H +L ++N+L+  N    V+DFGL  ++     +    A     + APE       S ++
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 255 DIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA-VLDHRITDLYHPDMLLCSNS 312
           D++SFG+++ E+++ G+ P             P  M NA VL            +   + 
Sbjct: 186 DVWSFGILLTEIVTYGRMP------------YPG-MTNAEVL----------QQV---DQ 219

Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            +  P       + + + + C    P  RP  + + WKLED 
Sbjct: 220 GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 22/158 (13%)

Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +RH NLV LLG     +G   IV  +  +G+L   +R           + + S+ +   +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---- 238
           +YL        +H +L ++N+L+  +    VSDFGL             EAS++Q     
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----------TKEASSTQDTGKL 161

Query: 239 ---YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
              + APE ++ K  S ++D++SFG+++ E+ S G+ P
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 8/111 (7%)

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH-LLLNPTAGQ 228
           ++ +I+  +  GL YLH+   R IIH ++K  NILL R  Q  + DFG+   L+N  AG 
Sbjct: 106 VLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162

Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP 279
                + +  Y APE I+ K  S  +D++S G+ +LE+   + P      P
Sbjct: 163 ----FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 39/124 (31%), Positives = 67/124 (54%), Gaps = 13/124 (10%)

Query: 153 NLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ 210
           +L Q IR G    +AH  S IY+I  G    L Y+H+     ++H +LK  N+L++ + +
Sbjct: 91  DLHQIIRSGQPLTDAHFQSFIYQILCG----LKYIHSA---NVLHRDLKPGNLLVNADCE 143

Query: 211 PYVSDFGLHLLLNPTAGQE---MLEASASQGYKAPE-LIKMKDASEETDIYSFGVIMLEL 266
             + DFGL    +   G+    M E  A++ Y+APE ++  +  ++  D++S G I+ EL
Sbjct: 144 LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Query: 267 ISGK 270
           +  K
Sbjct: 204 LGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVC--TTRD-------KEFGDLIELLGCI 123
            +V+G   +GT+YK +    G  V++     PV     R+       KE  D   ++  +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKI-----PVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
            HP++V LLG     +    ++      G L   +R          ++    + IA G+ 
Sbjct: 67  DHPHVVRLLGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLL-NWCVQIAKGMS 123

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYK 240
           YL     + ++H +L ++N+L+       ++DFGL  LL+    ++   A   +    + 
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV--DEKEYHAEGGKVPIKWM 178

Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           A E I  +  + ++D++S+GV + EL++ G +P    P  +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 30/254 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG- 133
           E IGK  YG +YK   ++ GS+  ++ L P+    ++   +   L     HPN+V   G 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 134 FYAGPR---GEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           FY   +   G+  +V      G++ + ++G    G+    ++I  I  G   GL +LH  
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH-- 145

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELI 245
            +  IIH ++K  NILL       + DFG+   L  T     L  + S G   + APE+I
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST----RLRRNTSVGTPFWMAPEVI 200

Query: 246 ---KMKDASEET--DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
              +  D S +   D++S G+  +EL  G  P+ +       F +P   RN         
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPP-----PT 252

Query: 301 LYHPDMLLCSNSNH 314
           L HP+   C + NH
Sbjct: 253 LLHPEK-WCRSFNH 265

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 14/159 (8%)

Query: 126 PNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           P +  L  +Y+    + L +V  +   G+ A  I+   G    W+  Y   + +  G++ 
Sbjct: 57  PYVAKL--YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVL--GVED 112

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH    R IIH ++K +N+L+D+     ++DFGL        G E  +   +  Y APE 
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDYLAPET 164

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           I      + +D +S G ++ E + G  P +   TPD  F
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVF 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E++GK N+G ++K  L+    V +      +      +F     +L    HPN+V L+G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
               R    IV      G+    +R    E  K   + + ++  A G+ YL +   +  I
Sbjct: 61  -CTQRQPIYIVMELVPGGDFLSFLRKKKDEL-KTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK-------APELIKM 247
           H +L ++N L+  N    +SDFG+       + QE     +S G K       APE +  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGM-------SRQEDDGIYSSSGLKQIPIKWTAPEALNY 168

Query: 248 KDASEETDIYSFGVIMLELIS 268
              S E+D++S+G+++ E  S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 4e-11
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 17/163 (10%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGS--GEAHKWSI 170
           I+LL  +RH N++ LL     P  E      IV       +L + I+      + H    
Sbjct: 50  IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYF 108

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
           +Y+I  G+     YLH+     +IH +LK  NIL++ N    + DFGL   +  +     
Sbjct: 109 LYQILRGLK----YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 229 EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGK 270
            + E   ++ Y+APEL+      ++  DI+S G I  EL++ K
Sbjct: 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E IGK ++G ++K +  R+  V  ++ +       + E  D+   I +L     P +   
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            G Y   +G KL I+  +   G+    +R G  +  + + + +    I  GLDYLH+   
Sbjct: 68  YGSYL--KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHS--- 119

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K+ N+LL       ++DFG+   L  T  +       +  + APE+I+    
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRITDLYHPDMLLC 309
             + DI+S G+  +EL  G EP N +  P    F +P                +P  L  
Sbjct: 179 DSKADIWSLGITAIELAKG-EPPNSDMHPMRVLFLIPKN--------------NPPTLTG 223

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             S             F +   AC +  PS RP  K++L
Sbjct: 224 EFSKP-----------FKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  YG +Y+A    SG +  L+ +R        P+ + R+      I LL  +RHPN+
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE------ITLLLNLRHPNI 68

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V L     G   + + +   Y   +LA  +        + S +  + + +  GL YLH  
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-SQVKCLMLQLLRGLQYLHEN 127

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KM 247
           F   IIH +LK  N+LL       ++DFGL       A   M     +  Y+APEL+   
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGC 183

Query: 248 KDASEETDIYSFGVIMLELISGK 270
              +   D+++ G I+ EL++ K
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.4 bits (149), Expect = 8e-11
 Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 47/289 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSG---------SVRLLRFLRPVCTTRDKEFGDLIELLGCI-- 123
           E +G   +G +YK   + +G         +V    F       RDK  GD++  +  I  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAF-GKDKRERDKSIGDIVSEVTIIKE 64

Query: 124 --RHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWS--IIYRISIGI 178
             RHPN+V    +      ++L IV    +   L +       +  +++   I+ I + +
Sbjct: 65  QLRHPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
              L YLH    + I+H +L   NI+L  + +  ++DFGL     P +  ++     +  
Sbjct: 123 VLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTIL 178

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI 298
           Y  PE++K +   E+ D+++FG I+ ++ + + P            L T +  AV +   
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSLATKIVEAVYEPLP 234

Query: 299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
             +Y  D+     S                    C +P    RP+I QV
Sbjct: 235 EGMYSEDVTDVITS--------------------CLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 137

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++KS NILL  +    ++DFG    + P   +       +  + APE++  K    +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPK 196

Query: 254 TDIYSFGVIMLELISGKEP-INENP 277
            DI+S G++ +E+I G+ P +NENP
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 37/118 (31%), Positives = 66/118 (55%), Gaps = 10/118 (8%)

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH-LLLNPTAG 227
            I+ +I++ I   L+YLH+     +IH ++K  N+L++RN Q  + DFG+   L++  A 
Sbjct: 103 DILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159

Query: 228 QEMLEASASQGYKAPELI----KMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
            + ++A     Y APE I      K    ++D++S G+ M+EL +G+ P +   TP +
Sbjct: 160 -KTIDAGCKP-YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 41/243 (16%)

Query: 117 IELLGCIRHPNLVPLLGFY-----AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII 171
           I+ L  I   N++ + GF        PR    ++  +  RG L + +      + K  + 
Sbjct: 69  IKNLRRIDSNNILKIYGFIIDIVDDLPRL--SLILEYCTRGYLREVLDKEKDLSFKTKL- 125

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
             ++I    GL  L+   ++P  + NL S + L+  NY+  +   GL  +L+    +  +
Sbjct: 126 -DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-V 181

Query: 232 EASASQGYKAPELIK--MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM 289
                  Y + +++     + + + DIYS GV++ E+ +GK P  EN T           
Sbjct: 182 NFMV---YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLT----------- 226

Query: 290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW 349
                     ++Y  D+++  N++ + P+     +K   +  AC S     RPNIK++L+
Sbjct: 227 --------TKEIY--DLIINKNNSLKLPLDCPLEIK--CIVEACTSHDSIKRPNIKEILY 274

Query: 350 KLE 352
            L 
Sbjct: 275 NLS 277

Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 21/231 (9%)

Query: 59  RGGEDLTICDILDAPG-----EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEF 113
           R  +D+ +  + D  G     EV+G   YG +YK    ++G +  ++ +  V    ++E 
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEI 59

Query: 114 GDLIELLGCI-RHPNLVPLLGFY-----AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK 167
              I +L     H N+    G +      G   +  +V  F   G++   ++   G A K
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119

Query: 168 WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
              I  I   I  GL +LH   H+ +IH ++K +N+LL  N +  + DFG+   L+ T G
Sbjct: 120 EDWIAYICREILRGLAHLHA--HK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176

Query: 228 QEMLEASASQGYKAPELIKMKDASEET-----DIYSFGVIMLELISGKEPI 273
           +       +  + APE+I   +  + T     DI+S G+  +E+  G  P+
Sbjct: 177 RRN-TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 69/294 (23%), Positives = 134/294 (45%), Gaps = 38/294 (12%)

Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 133 G--FYAGPRGEKLIVH--PF-----YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           G  + AG R  +L++   P+     Y + +  +         H+  ++Y  +  I  G++
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-------DHRKLLLY--ASQICKGME 122

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YK 240
           YL +   +  +H +L ++NIL++   +  + DFGL  +L P   +        +    + 
Sbjct: 123 YLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWY 178

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE +     S  +D++SFGV++ EL +  +  + +P P E   +   M N      I  
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSD-KSCSP-PAEFMRM---MGNDKQGQMI-- 231

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +YH   LL   +N   P       + + +   C +  PS RP+  ++  ++E +
Sbjct: 232 VYHLIELL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 57/288 (19%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-----KEFGDLIELLGCIRHPNLVPL 131
           IG   +G ++         V        + T R+     ++F +  +++  + HP LV L
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-------AIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
            G     R    +V  F + G L+  +R   G+  + +++  + + +  G+ YL +    
Sbjct: 65  YGV-CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL-GMCLDVCEGMAYLESS--- 119

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYK------APEL 244
            +IH +L ++N L+  N    VSDFG+   +L+        + ++S G K      +PE+
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-------QYTSSTGTKFPVKWSSPEV 172

Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
                 S ++D++SFGV+M E+ S GK P  EN +  E       +       R   LY 
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSE------VVETINAGFR---LYK 222

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
           P   L S S              ++L   C    P  RP+   +L +L
Sbjct: 223 PR--LASQS-------------VYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 16/262 (6%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLG 133
           E++G   YG +YK    ++G +  ++ +  V    ++E    I +L     H N+    G
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 134 FY--AGPRG---EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            +    P G   +  +V  F   G++   I+   G   K   I  I   I  GL +LH  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
               +IH ++K +N+LL  N +  + DFG+   L+ T G+       +  + APE+I   
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186

Query: 249 DASEET-----DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           +  + T     D++S G+  +E+  G  P+ +       F +P      +   + +  + 
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246

Query: 304 PDMLLCSNSNHENPVSEERILK 325
             +  C   NH    + E+++K
Sbjct: 247 SFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 46/263 (17%)

Query: 99  LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQC 157
           ++ L+P  T   + F    +++  +RH  LVPL   YA    E + IV  F  +G+L   
Sbjct: 35  IKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPL---YAVVSEEPIYIVTEFMGKGSLLDF 90

Query: 158 IRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG 217
           ++ G G+  K   +  ++  IA G+ Y+        IH +L++ NIL+  N    ++DFG
Sbjct: 91  LKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147

Query: 218 LHLLLNPTAGQEMLEASASQGYK------APELIKMKDASEETDIYSFGVIMLELIS-GK 270
           L  L+      E  E +A QG K      APE       + ++D++SFG+++ EL++ G+
Sbjct: 148 LARLI------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Query: 271 EPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLA 330
            P             P  +   VL+        P    C  S HE             L 
Sbjct: 202 VP------------YPGMVNREVLEQVERGYRMPCPQGCPESLHE-------------LM 236

Query: 331 MACCSPSPSLRPNIKQVLWKLED 353
             C    P  RP  + +   LED
Sbjct: 237 KLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)

Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           + H NL+ L G         ++V      G+L   +R  +      S +   ++ IA G+
Sbjct: 53  LDHENLIRLYGVVLTH--PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ----G 238
            YL +   +  IH +L ++NILL  + +  + DFGL   L     ++             
Sbjct: 111 RYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALP--QNEDHYVMEEHLKVPFA 165

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           + APE ++ +  S  +D++ FGV + E+ + G+EP
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL YLH+     I+H ++K  N+L++ N    + DFGL  +  P   + M +   +Q
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 238 GYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
            Y+APE L+  +  +   DI+S G I  EL+  +
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    ++ +      + +   + I ++   ++PN+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     LD+LH+     +
Sbjct: 85  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALDFLHSN---QV 136

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++KS NILL  +    ++DFG    + P   +          + APE++  K    +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPK 195

Query: 254 TDIYSFGVIMLELISGKEP-INENP 277
            DI+S G++ +E++ G+ P +NENP
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 34/217 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCTTRD-KEFGDLIELLGCI-RHPNLVP 130
           +VIG+ N+G + +A++++ G      ++ L+   +  D ++F   +E+L  +  HPN++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRG--------------GSGEAHKWSIIYRISI 176
           LLG     RG   I   +   GNL   +R               G+        + + + 
Sbjct: 68  LLGACEN-RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            +A G+ YL     +  IH +L ++N+L+  N    ++DFGL      + G+E+     +
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGL------SRGEEVY-VKKT 176

Query: 237 QG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
            G     + A E +     + ++D++SFGV++ E++S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 41/212 (19%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-------KEFGDLIELLGCIRHPNLV 129
           IG+  YGT+YKA    +G    L+ +R V  + +       +E   L +L     HPN+V
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVR-VPLSEEGIPLSTLREIALLKQLESF-EHPNIV 64

Query: 130 PLLGFYAGPRGEKLIV------------HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
            LL    GPR ++ +               +     L++C + G         I  +   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATY-----LSKCPKPGLPP----ETIKDLMRQ 115

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--A 235
           +  G+D+LH+  HR I+H +LK +NIL+  + Q  ++DFGL  +       EM   S   
Sbjct: 116 LLRGVDFLHS--HR-IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVV 168

Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLEL 266
           +  Y+APE L++   A+   D++S G I  EL
Sbjct: 169 TLWYRAPEVLLQSSYAT-PVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 75  EVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IG+ ++G +Y A  +       ++ +   +     ++    ++I LL  ++HPN+V  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIV-- 62

Query: 132 LGFYAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
             F+A     G   IV  +   G+L + I    G       I    + I+ GL ++H   
Sbjct: 63  -TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119

Query: 190 HRPIIHGNLKSKNILLDRNYQ-PYVSDFGLHLLLNPTAGQEMLEASASQGYK-APELIKM 247
            R I+H ++KS+NI L +N     + DFG+   LN +   E+        Y  +PE+ + 
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQN 176

Query: 248 KDASEETDIYSFGVIMLELISGKEPINEN 276
           +  + +TDI+S G ++ EL + K P   N
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 40/278 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E IGK ++G ++K +  R+  V  ++ +       + E  D+   I +L     P +   
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            G Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+   
Sbjct: 68  YGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS--- 119

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K+ N+LL  + +  ++DFG+   L  T  +       +  + APE+IK    
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS 310
             + DI+S G+  +EL  G+ P +E       F +P   +N           +P  L   
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP---KN-----------NPPTL--- 221

Query: 311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             N+  P+ E           AC +  PS RP  K++L
Sbjct: 222 EGNYSKPLKE--------FVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 48/211 (22%), Positives = 100/211 (47%), Gaps = 16/211 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDK---EFGDLIELLGCIRHPN 127
           G+ +G   + + Y+A   ++G+   V+ + ++R   + +++        I L+  + HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ +LG         L V  +   G+++  +      A K ++I   +  +  GL YLH 
Sbjct: 65  IIRMLGATCEDSHFNLFVE-WMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH- 120

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPT---AGQEMLEASASQGYKAPE 243
                IIH ++K  N+L+D   Q   ++DFG    L      AG+   +   +  + APE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           +++ +      D++S G +++E+ + K P N
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 11/113 (9%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL--LLNPTAGQEMLEASA 235
           I   L+YLH+     IIH +LK  NIL+D N    ++DFGL    L+         E   
Sbjct: 102 IVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 236 SQ-----GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
            +      Y APE+I  +  S+  D +S G I+ E + G  P +   TP+E F
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIF 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 22/204 (10%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++      +  V + + L+P  T   + F +  +++  +RH  LV L   YA
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAV-KTLKP-GTMSPESFLEEAQIMKKLRHDKLVQL---YA 68

Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
               E + IV  +  +G+L   ++ G G A K   +  ++  +A G+ Y+        IH
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMKD 249
            +L+S NIL+       ++DFGL  L+      E  E +A QG K      APE      
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 250 ASEETDIYSFGVIMLELIS-GKEP 272
            + ++D++SFG+++ EL++ G+ P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 40/278 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E IGK ++G +YK +  R+  V  ++ +       + E  D+   I +L     P +   
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            G Y   +G KL I+  +   G+    ++ G  E    + I R    I  GLDYLH+   
Sbjct: 68  YGSYL--KGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLHS--- 119

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K+ N+LL       ++DFG+   L  T  +       +  + APE+IK    
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS 310
             + DI+S G+  +EL  G EP      P+ D H            R+  L   +     
Sbjct: 179 DFKADIWSLGITAIELAKG-EP------PNSDLH----------PMRVLFLIPKNSPPTL 221

Query: 311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
              +  P        F +   AC +  P  RP  K++L
Sbjct: 222 EGQYSKP--------FKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 49/204 (24%), Positives = 99/204 (48%), Gaps = 15/204 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
              +G   +G +++ L      VR+ ++ L+     + ++F   ++ L  +RH +L+ L 
Sbjct: 11  ERKLGSGYFGEVWEGLW--KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
              +   GE + I+    ++G+L   +R   G+    + +  ++  +A G+ YL     +
Sbjct: 69  AVCS--VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---Q 123

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK--APELIKMKD 249
             IH +L ++NIL+  +    V+DFGL  L+        L +     YK  APE      
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAPEAASHGT 180

Query: 250 ASEETDIYSFGVIMLELIS-GKEP 272
            S ++D++SFG+++ E+ + G+ P
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 48/221 (21%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +GK NYG++YK L + +G    ++ +R      + +F  +I  L  +       ++ FY 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 137 GPRGEKLIVHPFYKRGNLAQCIR---GGS-----GEAHKWSII-----YRISIGIAGGLD 183
                      F+  G +  C+     GS             I      RI+  +  GL 
Sbjct: 67  A----------FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS------Q 237
           +L    +  IIH ++K  N+L++ N Q  + DFG+       +G   L AS +      Q
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGV-------SGN--LVASLAKTNIGCQ 165

Query: 238 GYKAPELIKMKDASE------ETDIYSFGVIMLELISGKEP 272
            Y APE IK    ++      ++D++S G+ +LE+  G+ P
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 61/262 (23%), Positives = 94/262 (35%), Gaps = 62/262 (23%)

Query: 124 RHPNLVPLLG-FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +HPN++P +  F      E  +V P    G+    ++    E      I  I   +   L
Sbjct: 57  QHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNAL 114

Query: 183 DYLHTGFHRPIIHGNLKSKNILLD----------RNYQPYVS---------DFGLHLLLN 223
           DY+H    +  IH ++K+ +ILL           R     +          DF    + N
Sbjct: 115 DYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 224 -PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
            P    E+L+ +  QGY           +E++DIYS G+   EL +G  P  + P     
Sbjct: 172 LPWLSPEVLQQNL-QGY-----------NEKSDIYSVGITACELANGHVPFKDMP----- 214

Query: 283 FHLPTFM-----RNAV---LDHRITDLYHPDMLL--------CSNSNHENPVSEERILKF 326
               T M     R  V   LD     LY   M           +  + ++P +      F
Sbjct: 215 ---ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF 271

Query: 327 FQLAMACCSPSPSLRPNIKQVL 348
            Q    C    P  RP+  Q+L
Sbjct: 272 HQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  YG +YKA  +++G +  L+ +R        P+   R+      I+LL  +RHPN+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE------IKLLQKLRHPNI 60

Query: 129 VPLLGFYAGP-RGEKLIVHPFYK---RGNLAQCIRGGSGEAHKWSI--IYRISIGIAGGL 182
           V L        +G   +V  +      G L            K++   I      +  GL
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLLEGL 113

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
            YLH      I+H ++K  NIL++ +    ++DFGL          +      +  Y+ P
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 243 E-LIKMKDASEETDIYSFGVIMLELISGK 270
           E L+       E D++S G I+ EL  GK
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 44/217 (20%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLL--------------RFLRPVCTTRDKEFGDLIELLGC 122
           +GK  YG ++KA+ +R+  V  L              R  R +   +  E GD       
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQ--ELGD------- 65

Query: 123 IRHPNLVPLLGFYAGPRGE--KLIVHPF-YKRGNLAQCIRGGS-GEAHKWSIIYRISIGI 178
             HPN+V LL      + E  K I   F Y   +L   IR     + HK  I+Y++   +
Sbjct: 66  --HPNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE----MLEAS 234
                Y+H+G    +IH +LK  NILL+ + +  ++DFGL   L+          + +  
Sbjct: 121 K----YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 235 ASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           A++ Y+APE L+     ++  D++S G I+ E++ GK
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLG 133
           E IGK  YG ++K L +++GS   ++ L P+    D+E      +L  +  HPN+V   G
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYG 82

Query: 134 FYAGP---RGEKL-IVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHT 187
            Y       G++L +V      G++   ++G    GE  +  II  I      GL +LH 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
                 IH ++K  NILL       + DFG+   L  T     L  + S G   + APE+
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST----RLRRNTSVGTPFWMAPEV 195

Query: 245 IKMKDASEET-----DIYSFGVIMLELISGKEPINE 275
           I  +   + T     D++S G+  +EL  G  P+ +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFGDLIELLGCI-RHPNLV 129
           +VIG+ N+G + KA +++ G +R+   ++ ++   +  D ++F   +E+L  +  HPN++
Sbjct: 1   DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG--------------GSGEAHKWSIIYRIS 175
            LLG     RG   +   +   GNL   +R                +        +   +
Sbjct: 60  NLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
             +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL      + GQE+     
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL------SRGQEVY-VKK 168

Query: 236 SQG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
           + G     + A E +     +  +D++S+GV++ E++S
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)

Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 14  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 67

Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+        +
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 226

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 227 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 32/224 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTR----DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK +    G +V++   ++ +  T     + EF D   ++  + HP+LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYL 185
            LLG    P  +  +V      G L   +       HK +I    +    + IA G+ YL
Sbjct: 73  RLLGVCLSPTIQ--LVTQLMPHGCLLDYV-----HEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----YK 240
                R ++H +L ++N+L+       ++DFGL  LL    G E  E +A  G     + 
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---GDEK-EYNADGGKMPIKWM 178

Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPT---PD 280
           A E I  +  + ++D++S+GV + EL++ G +P +  PT   PD
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 7/159 (4%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGI 178
           LL  ++HPN+V     +    G   IV  +   G+L Q I+   G+      I +  + +
Sbjct: 51  LLAKMKHPNIVAFKESFEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG-LHLLLNPTAGQEMLEASASQ 237
             G+ ++H    + ++H ++KSKNI L +N +  + DFG   LL +P A         + 
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTP 164

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN 276
            Y  PE+ +    + ++DI+S G I+ EL + K P   N
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 28/208 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E +G+ +YG++YKA+ + +G V  ++ + PV    +++  ++   I +L     P +V  
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVV-PV----EEDLQEIIKEISILKQCDSPYIVKY 63

Query: 132 LGFYAGPRGEKL-IVHPFYKRG---NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            G Y   +   L IV  +   G   ++ +       E    +I+Y        GL+YLH+
Sbjct: 64  YGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY----QTLKGLEYLHS 117

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
                 IH ++K+ NILL+   Q  ++DFG+   L  T    M + +   G   + APE+
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT----MAKRNTVIGTPFWMAPEV 170

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEP 272
           I+    + + DI+S G+  +E+  GK P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 125 HPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           HPN+V +   Y    G++L +V  F + G L   +        +   I  + + +   L 
Sbjct: 75  HPNIVEMYSSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQ---IATVCLAVLKALS 129

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YK 240
           +LH    + +IH ++KS +ILL  + +  +SDFG    ++    +E+    +  G   + 
Sbjct: 130 FLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS----KEVPRRKSLVGTPYWM 182

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           APE+I       E DI+S G++++E++ G+ P  NE P
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 43/215 (20%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFL---------RPVCTTRDKEFGDLIELLGCIRHPN 127
           IG    GT+YK + + +G +  L+ +         R +C    +E    IE+L  + HPN
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQIC----RE----IEILRDVNHPN 133

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIY--RISIGIAGGLDYL 185
           +V     +    GE  ++  F   G+L           H     +   ++  I  G+ YL
Sbjct: 134 VVKCHDMFD-HNGEIQVLLEFMDGGSLEG--------THIADEQFLADVARQILSGIAYL 184

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAP 242
           H    R I+H ++K  N+L++      ++DFG+  +L     Q M   ++S G   Y +P
Sbjct: 185 H---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSSVGTIAYMSP 237

Query: 243 ELIK--MKDASEE---TDIYSFGVIMLELISGKEP 272
           E I   +   + +    DI+S GV +LE   G+ P
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 55/218 (25%), Positives = 106/218 (48%), Gaps = 36/218 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFGDLIELLGCI-RHPNLV 129
           +VIG+ N+G + KA +++ G +R+   ++ ++   +  D ++F   +E+L  +  HPN++
Sbjct: 13  DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGS--------GEAHKWSI------IYRIS 175
            LLG     RG   +   +   GNL   +R             A+  +       +   +
Sbjct: 72  NLLG-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
             +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL      + GQE+     
Sbjct: 131 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL------SRGQEVY-VKK 180

Query: 236 SQG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
           + G     + A E +     +  +D++S+GV++ E++S
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG +  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 68

Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 124

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 181

Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPI---PPPD 206

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 54/241 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTTRDKEFGDLI---------ELLGCIR 124
             +G   YG +  A   ++G  V + +  RP        F   I          LL  + 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELRLLKHMD 72

Query: 125 HPNLVPLLG-FYAGPRGEKL----IVHPFYKR--GNLAQCIRGGSGEAHKWSIIYRISIG 177
           H N++ LL  F      E      +V         N+ +C +    + H   ++Y+I   
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQI--- 127

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
              GL Y+H+     IIH +LK  NI ++ + +  + DFGL    +     EM    A++
Sbjct: 128 -LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATR 179

Query: 238 GYKAPELI--KMKDASEETDIYSFGVIMLELISGK------EPINE-------NPTPDED 282
            Y+APE++   M   ++  DI+S G IM EL++GK      + I++         TPDE+
Sbjct: 180 WYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238

Query: 283 F 283
            
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 173 RISIG-IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           R+ I  I   LD+LH      II+ ++K +NILLD      ++DFGL         +   
Sbjct: 108 RVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164

Query: 232 EASASQGYKAPELIKMKDA--SEETDIYSFGVIMLELISGKEP 272
               +  Y APE+I+       +  D +S GV+  EL++G  P
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 124 RHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +HPN+V  L  Y    G++L +V  +   G+L   +     +  + + + R  +     L
Sbjct: 74  KHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---AL 128

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
           ++LH+     +IH ++KS NILL  +    ++DFG    + P    E  + S   G   +
Sbjct: 129 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPYW 181

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
            APE++  K    + DI+S G++ +E++ G+ P +NENP
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 68/298 (22%), Positives = 132/298 (44%), Gaps = 46/298 (15%)

Query: 74  GEVIGKSNYGTLYKALLQR---SGSVRLLRFLRP--VCTTRDKEFGDLIELLGCIRHPNL 128
           G ++GK  +G++ +A L+    S     ++ L+     ++  +EF      +    HPN+
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 129 VPLLGFYAGPRGEK-----LIVHPFYKRGNL-AQCIRGGSGEAH---KWSIIYRISIGIA 179
           + L+G     R +      +++ PF K G+L    +    GE         + R  I IA
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ-- 237
            G++YL +   +  IH +L ++N +L+ N    V+DFGL   +   +G    +  AS+  
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDYYRQGCASKLP 178

Query: 238 -GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + A E +     +  +D+++FGV M E+++      + P           + N+    
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYAG--------VENS---- 222

Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              ++Y  + L+  N   + P   E +   ++L   C SP P  RP+ + +  +LE +
Sbjct: 223 ---EIY--NYLIKGNRLKQPPDCLEDV---YELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 19/111 (17%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           I  GL +LH    + II+ +LK  N+LLD++    ++DFG+         + M  E  AS
Sbjct: 105 IICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGM-------CKENMNGEGKAS 154

Query: 237 Q-----GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
                  Y APE++K +  +E  D +SFGV++ E++ G+ P +     DED
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE---DED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 61

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL         KL +   +   +L + +           +I      +  GL + H+ 
Sbjct: 62  VKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN---PTAGQEMLEASASQGYKAPE-L 244
            HR ++H +LK +N+L++      ++DFGL         T   E++    +  Y+APE L
Sbjct: 119 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172

Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +  K  S   DI+S G I  E+++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 46/203 (22%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++ A   +   V + + ++P  +   + F     ++  ++H  LV L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAV-KTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
             +    I+  F  +G+L   ++   G       +   S  IA G+ ++     R  IH 
Sbjct: 72  --KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126

Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMKDA 250
           +L++ NIL+  +    ++DFGL  ++      E  E +A +G K      APE I     
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVI------EDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 251 SEETDIYSFGVIMLELIS-GKEP 272
           + ++D++SFG++++E+++ G+ P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 54.8 bits (133), Expect = 1e-08
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 24/206 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E +G+  YG +YKA  +++G +  L+ +R        P    R+      I LL  ++HP
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE------ISLLKELKHP 58

Query: 127 NLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V LL      R  KL +V  +    +L + +    G     ++I  I   +  GL Y 
Sbjct: 59  NIVKLLDVIHTER--KLYLVFEYCDM-DLKKYLDKRPGPLSP-NLIKSIMYQLLRGLAYC 114

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H+  HR I+H +LK +NIL++R+    ++DFGL         +       +  Y+APE L
Sbjct: 115 HS--HR-ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLWYRAPEIL 170

Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +  K  S   DI+S G I  E+I+GK
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 30/95 (31%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL++LH    R I++ +LK +N+LLD +    +SD GL + L    G+++   + + 
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTP 158

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           GY APE+++ +      D ++ G  + E+I+G+ P
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 12/204 (5%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLR--FLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           V+GK +YG +     +  G   +++   LR       K      +LL  ++HPN+V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            + G  G   IV  F + G+L   ++   G+    + +    + IA  L YLH    + I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHI 123

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMKDA 250
           +H +LK++N+ L R     V D G+  +L          AS   G   Y +PEL   K  
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM----ASTLIGTPYYMSPELFSNKPY 179

Query: 251 SEETDIYSFGVIMLELISGKEPIN 274
           + ++D+++ G  + E+ + K   N
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.4 bits (132), Expect = 1e-08
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L+YLH+     II+ +LK +NILLD +    ++DFGL          E    +   
Sbjct: 102 IVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGL----AKELSSEGSRTNTFC 154

Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y APE++  K   +  D +S GV++ E+++GK P
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           ++LL  +RH N++ L   +  P  +   V       +L + +     E      I     
Sbjct: 60  LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQ---FIQYFLY 115

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            I  GL Y+H+     ++H +LK  NIL++ N    + DFGL  + +P    +M    ++
Sbjct: 116 QILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVST 168

Query: 237 QGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           + Y+APE ++  +    E DI+S G I  E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 15/236 (6%)

Query: 74  GEVIGKSNYGTLY---KALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           G+++G+  +G +Y    A   R  +V+ ++F  P      KE   L   I+LL  + H  
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQF-DPESPETSKEVNALECEIQLLKNLLHER 65

Query: 128 LVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           +V   G    P    L I       G++   ++  S  A   ++  + +  I  G+ YLH
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLH 123

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT--AGQEMLEASASQGYKAPEL 244
           +     I+H ++K  NIL D      + DFG    L     +G  M   + +  + +PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           I  +    + DI+S G  ++E+++ K P  E       F + T   N VL   ++D
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 22/193 (11%)

Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG--- 140
           Y A+L+R+ +++ L   RP    T   + + +L+ L+ C+ H N++ LL  +   +    
Sbjct: 44  YDAILERNVAIKKLS--RPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEE 100

Query: 141 -EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
            + + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK
Sbjct: 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI----KHLHSA---GIIHRDLK 153

Query: 200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIY 257
             NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+
Sbjct: 154 PSNIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

Query: 258 SFGVIMLELISGK 270
           S G IM E+I G 
Sbjct: 210 SVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 22/215 (10%)

Query: 75  EVIGKSNYGTLYKAL-LQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           EVIG      +Y A+ L  +  V + R     C T   E    ++ +    HPN+V    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---K 63

Query: 134 FYAG-PRGEKL-IVHPFYKRGNLAQCIR-----GGSGEAHKWSIIYRISIGIAGGLDYLH 186
           +Y     G++L +V P+   G+L   ++     GG  EA    II  +   +  GL+YLH
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA----IIATVLKEVLKGLEYLH 119

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPE 243
           +      IH ++K+ NILL  +    ++DFG+   L     +         G   + APE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 244 LIKMKDA-SEETDIYSFGVIMLELISGKEPINENP 277
           +++       + DI+SFG+  +EL +G  P ++ P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL + L    GQ   +  A +
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160

Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            G+ APEL++ ++     D ++ GV + E+I+ + P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 51/235 (21%)

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           HPNLV L G     +    IV  +   G L   +R   G+      +  +   +   ++Y
Sbjct: 58  HPNLVQLYGV-CTKQRPIFIVTEYMANGCLLNYLRERKGKLGT-EWLLDMCSDVCEAMEY 115

Query: 185 LHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYK-- 240
           L + GF    IH +L ++N L+  +    VSDFGL   +L+        + ++SQG K  
Sbjct: 116 LESNGF----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-------QYTSSQGTKFP 164

Query: 241 ----APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD 295
                PE+      S ++D++SFGV+M E+ S GK P               F  + V++
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP------------YERFSNSEVVE 212

Query: 296 HRITD--LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  LY P   L                + + +  +C    P  RP  K++L
Sbjct: 213 SVSAGYRLYRPK--LAPT-------------EVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 31/112 (27%), Positives = 58/112 (51%), Gaps = 5/112 (4%)

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           I+ +I++ +  GL YL+      I+H ++K  NIL++   Q  + DFG+   L  +    
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
            +  S    Y +PE I+    + ++D++S G+ ++EL  GK P   +   D+
Sbjct: 162 FVGTST---YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP  +    K     + LL  ++H N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 138

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFGL          EM    A++ Y+APE ++ 
Sbjct: 139 A---DIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATRWYRAPEIMLN 191

Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 52/221 (23%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 74  GEVIGKSNYGTLYKALL-QRSGS-----VRLLRFLRPVCTTRDKEFGDLIELLGCIR--- 124
           G+++G+  +G++ +  L Q  GS     V+ ++    + T  + E  + +    C++   
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIE--EFLSEAACMKDFD 59

Query: 125 HPNLVPLLG--FYAGPRGE---KLIVHPFYKRGNLAQCI---RGGSGEAH-KWSIIYRIS 175
           HPN++ L+G  F A    +    +++ PF K G+L   +   R G          + +  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
           + IA G++YL     R  IH +L ++N +L  +    V+DFGL   +   +G    +   
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRI 174

Query: 236 SQ---GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           ++    + A E +  +  + ++D+++FGV M E+ + G+ P
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 39/226 (17%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A   R+  V  ++ +       ++++ D+I+    L  I+HPN +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  I+ G   GL YLH+  
Sbjct: 93  CYLREHTAWLVME--YCLGSASDLL-----EVHKKPLQEVEIAAITHGALQGLAYLHS-- 143

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              +IH ++K+ NILL    Q  ++DFG   + +P           +  + APE+I   D
Sbjct: 144 -HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVILAMD 197

Query: 250 ASE---ETDIYSFGVIMLELISGKEPI--------------NENPT 278
             +   + D++S G+  +EL   K P+              NE+PT
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 243

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 4e-08
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 11/157 (7%)

Query: 123 IRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           +++PN+V  L  +    G++L +V  +   G+L   +     +  + + + R  +     
Sbjct: 73  LKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ---A 127

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           L++LH      +IH ++KS N+LL  +    ++DFG    + P   +          + A
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMA 183

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           PE++  K    + DI+S G++ +E++ G+ P +NENP
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 32/223 (14%)

Query: 75  EVIGKSNYGTLYKA-LLQRSGSVRLLRFLRPVCTTRDK-------EFGDLIELLGCIRHP 126
           E +G+  +G +YK  L   +   RL      + T ++        EF    EL+  ++HP
Sbjct: 11  EELGEGAFGKVYKGELTGPNE--RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 127 NLVPLLG-----------FYAGPRG---EKLIVH-PFYKRGNLAQCIRGGSGEAHKWSII 171
           N+V LLG           F     G   E L+ + P    G  A+        +   S  
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVG--AESGDETVKSSLDCSDF 126

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
             I+I IA G++YL +      +H +L ++N L+       +SDFGL   +       + 
Sbjct: 127 LHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 232 EASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             S     +  PE I     + E+DI+SFGV++ E+ S G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 46/248 (18%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLA----QCIRGGSGEAHKWSIIYRI 174
           LL  + H N++P+L           +++P+   GNL     QC  G +      S    +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 175 SIG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
            +   IA G+ YLH    R +IH ++ ++N ++D   Q  ++D  L   L P      L 
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP-MDYHCLG 176

Query: 233 ASASQGYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEPINE-NPTPDEDFHLPTF 288
            + ++  K  A E +  K+ S  +D++SFGV++ EL++ G+ P  E +P     F +  +
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAY 231

Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVS--EERILKFFQLAMACC-SPSPSLRPNIK 345
           +++    +R+                  P++  +E     F + MACC +  P  RP+  
Sbjct: 232 LKDG---YRL----------------AQPINCPDE----LFAV-MACCWALDPEERPSFS 267

Query: 346 QVLWKLED 353
           Q++  L D
Sbjct: 268 QLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC----TTRDK-----EFGDLIELLGCIRH 125
           E IGK ++GT+ K   +R    ++L   + +     T ++K     E   L EL    +H
Sbjct: 6   ETIGKGSFGTVRKV--RRKSDGKIL-VWKEIDYGNMTEKEKQQLVSEVNILREL----KH 58

Query: 126 PNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKW--SIIYRISIGIAGGL 182
           PN+V           + L IV  + + G+LAQ I+    E        I+RI   +   L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 183 DYLHTGFH--RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
              H        ++H +LK  NI LD N    + DFGL  +L    G +   A    G  
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----GHDSSFAKTYVGTP 174

Query: 239 -YKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
            Y +PE +      E++DI+S G ++ EL +   P  
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+G    I++ +LK +N++LD++    ++DFGL      T    M     + 
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL-CKEGITDAATMKTFCGTP 159

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A   R+  V  ++ +       ++++ D+I+    L  +RHPN +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  ++ G   GL YLH+  
Sbjct: 83  CYLREHTAWLVME--YCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              +IH ++K+ NILL       + DFG   ++ P           +  + APE+I   D
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMD 187

Query: 250 ASE---ETDIYSFGVIMLELISGKEPI 273
             +   + D++S G+  +EL   K P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 11/156 (7%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS--IIYRI 174
           I+ L   +HP +V LL  +  P G   ++   Y   +L++ +R    E        +   
Sbjct: 50  IKALQACQHPYVVKLLDVF--PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSY 104

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
              +  G+ Y+H      I+H +LK  N+L+  +    ++DFGL  L +    +      
Sbjct: 105 MRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161

Query: 235 ASQGYKAPELI-KMKDASEETDIYSFGVIMLELISG 269
           A++ Y+APEL+   +      D+++ G I  EL++G
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 18/106 (16%)

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-----GQEMLEASAS 236
            +YLH   +R II+ +LK +N+LLD N    + DFG        A     GQ+      +
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFG-------FAKKLKSGQKTWTFCGT 155

Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
             Y APE+I  K      D +S G+++ EL++G+ P  E    DED
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE---DDED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 53/221 (23%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 72  APGEVIGKSNYGTLYKALLQRSGSVR--LLRFLRPVCTTRDKEFGDLIELLGCIR---HP 126
           A G+ +G+  +G++ +  L +  S+    ++ ++    TR  E  D +    C++   HP
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHP 60

Query: 127 NLVPLLGF---------YAGPRGEKLIVHPFYKRGNLAQCIR----GGSGEAHKWSIIYR 173
           N++ L+G          Y  P    +++ PF K G+L   +     G   +     ++ +
Sbjct: 61  NVMRLIGVCLQTVESEGYPSP----VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLE 232
               IA G++YL +   +  IH +L ++N +L+ N    V+DFGL   + N    ++   
Sbjct: 117 FMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           A     + A E +  +  + ++D++SFGV M E+ + G+ P
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 13/235 (5%)

Query: 74  GEVIGKSNYGTLY---KALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           G+++G+  +G +Y    A   R  +V+ + F  P      KE   L   I+LL  +RH  
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V   G    P  +KL +   Y  G   +      G A   ++  R +  I  G+ YLH+
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS 124

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEMLEASASQGYKAPELI 245
                I+H ++K  NIL D      + DFG    +     +G  +   + +  + +PE+I
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
             +    + D++S    ++E+++ K P  E       F + T     +L   ++D
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 78  GKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPLLGFYA 136
           GK   G  Y    +    +  ++ L+   +   ++ F    ELL   +H N+V   G   
Sbjct: 19  GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG--V 76

Query: 137 GPRGEKLI-VHPFYKRGNLAQCIRGGSGEAHKW------------SIIYRISIGIAGGLD 183
              G+  I V  + + G+L + +R    +A               S + +I++ IA G+ 
Sbjct: 77  CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV 136

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASASQG 238
           YL    H   +H +L ++N L+  +    + DFG+   +  T      G  ML       
Sbjct: 137 YL-ASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR---- 189

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           +  PE I  +  + E+D++SFGV++ E+ + GK+P
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 50/222 (22%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI-ELLGCIRHPNLVPLLGFY 135
           IG+  +GT+ K L + SG++  ++ +R   T  +KE   L+ +L   +R  +   ++ FY
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 136 AG--PRGEKLI--------VHPFYKR--GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
                 G+  I        +  FYK     L   I           I+ +I++     L+
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLKSVI--------PEEILGKIAVATVKALN 121

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL       IIH ++K  NILLDRN    + DFG+       +GQ  L  S ++      
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI-------SGQ--LVDSIAKTRDAGC 170

Query: 239 --YKAPELIKMKDASEE------TDIYSFGVIMLELISGKEP 272
             Y APE I   D S        +D++S G+ + E+ +GK P
Sbjct: 171 RPYMAPERI---DPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 30/103 (29%), Positives = 58/103 (56%), Gaps = 6/103 (5%)

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           +I+  S  I  G+ +LH+     I++ ++K +N+LLD      +SD GL + L    G+ 
Sbjct: 97  VIH-YSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKT 150

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           + + + + GY APE++K +  S   D ++ G  + E+++G+ P
Sbjct: 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 53/259 (20%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCI---RGGSGEAHKWSIIY 172
           +++L  +RH N+V L   +   R  +L +V  + +R  L + +    GG       S I+
Sbjct: 51  VKVLRQLRHENIVNLKEAFR--RKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW 107

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
           ++   IA    Y H+     IIH ++K +NIL+  +    + DFG    L       + +
Sbjct: 108 QLLQAIA----YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 233 ASASQGYKAPELIKMKDAS--EETDIYSFGVIMLELISGKEPI----NE----------- 275
             A++ Y+APEL+ + D +  +  D+++ G IM EL+ G EP+    ++           
Sbjct: 161 YVATRWYRAPELL-VGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCL 218

Query: 276 NPTPDEDFHLPTFMRNAVLD-HRITDLYHPDMLLCSNSNHENPVSEERILKFF-----QL 329
            P P    H   F  N         +   P+ L            E R            
Sbjct: 219 GPLPPS--HQELFSSNPRFAGVAFPEPSQPESL------------ERRYPGKVSSPALDF 264

Query: 330 AMACCSPSPSLRPNIKQVL 348
             AC    P  R    ++L
Sbjct: 265 LKACLRMDPKERLTCDELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G + K   + SG +  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 68

Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIR---GGS-----GEAHKW--SIIYRISIGIAGGLDY 184
           Y            FY  G ++ C+    GGS      EA +    I+ ++SI +  GL Y
Sbjct: 69  YGA----------FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           L       I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE 
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPER 173

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
           ++    S ++DI+S G+ ++EL  G+ PI   P PD
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPI---PPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 34/209 (16%)

Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG 133
           +G   YG++  A+ +R+G  V + +  RP  +     + + +L  LL  ++H N++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT-LLKHMQHENVIGLLD 81

Query: 134 -FYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWS------IIYRISIGIAGGL 182
            F +   G++     +V P Y + +L Q I G     H  S      ++Y++      GL
Sbjct: 82  VFTSAVSGDEFQDFYLVMP-YMQTDL-QKIMG-----HPLSEDKVQYLVYQM----LCGL 130

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
            Y+H+     IIH +LK  N+ ++ + +  + DFGL       A  EM     ++ Y+AP
Sbjct: 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL----ARHADAEMTGYVVTRWYRAP 183

Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGK 270
           E+I      ++  DI+S G IM E+++GK
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 51/220 (23%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YG +YKA  + +G +  L+ +R        P    R+      I LL  + HP
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE------ISLLKELNHP 58

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYK------------RGNLAQCIRGGSGEAHKWSIIYRI 174
           N+V LL           +VH   K            +  +      G       S +Y++
Sbjct: 59  NIVRLLD----------VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN-P--TAGQEML 231
             GIA    Y H+  HR ++H +LK +N+L+DR     ++DFGL      P  T   E++
Sbjct: 109 LQGIA----YCHS--HR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161

Query: 232 EASASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
               +  Y+APE L+  +  S   DI+S G I  E+++ +
Sbjct: 162 ----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIR 124
           P   IG   YGT+YKA    SG    L+ +R        P+ T R+     L++ L    
Sbjct: 4   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA---LLKRLEAFD 60

Query: 125 HPNLVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           HPN+V L+   A  R +   K+ +   +   +L   +            I  +      G
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL------HLLLNPTAGQEMLEASA 235
           LD+LH      I+H +LK +NIL+    Q  ++DFGL       + L P           
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV--------V 169

Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGK 270
           +  Y+APE++     +   D++S G I  E+   K
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 64/281 (22%), Positives = 124/281 (44%), Gaps = 44/281 (15%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE--LLGCIRHPNLVPLLG 133
           V+G+  +G ++    +    + +++ +     T+D+      E  +L  + HPN++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63

Query: 134 FYAGPRGEK--LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +Y     +K  +IV  +   G LA+ I+           I    + I   L ++HT   +
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---K 120

Query: 192 PIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKM 247
            I+H +LK++NILLD++     + DFG+  +L+  +     +A    G   Y +PEL + 
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-----KAYTVVGTPCYISPELCEG 175

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
           K  ++++DI++ G ++ EL S K          E  +LP                   ++
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF-------EAANLPA------------------LV 210

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           L   S    P+S+       QL ++  +  PS RP + Q++
Sbjct: 211 LKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 35/214 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + IG   YG +YKA    +G +  ++    +      +F  +   I +L   RHPN+V  
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKV---IKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            G Y   R +KL IV  +   G+L    +   G   +  I Y +      GL YLH    
Sbjct: 66  FGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKGLAYLH---E 119

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGYKA 241
              IH ++K  NILL  +    ++DFG+   L  T  +          M          A
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM----------A 169

Query: 242 PELI---KMKDASEETDIYSFGVIMLELISGKEP 272
           PE+    +      + DI++ G+  +EL   + P
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 33/209 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-------IELLGCIRHPN 127
           E IG+ N+G ++      SG +R       V + R+    DL         +L    HPN
Sbjct: 1   ERIGRGNFGEVF------SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 54

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V L+G     +    IV    + G+    +R   G   K   + ++    A G++YL +
Sbjct: 55  IVRLIGV-CTQKQPIYIVMELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLES 112

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--------Y 239
              +  IH +L ++N L+       +SDFG+       + +E     AS G        +
Sbjct: 113 ---KHCIHRDLAARNCLVTEKNVLKISDFGM-------SREEEDGVYASTGGMKQIPVKW 162

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELIS 268
            APE +     S E+D++SFG+++ E  S
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV------CTTRDKEFGDLIELLGCIRHPNL 128
           EVIGK +YG +  A+   +G    ++ +  V       T   +E    I+LL  +RHP++
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDI 61

Query: 129 VPLLGFYAGP--RGEKLIVHPF-YKRGNLAQCIRGG---SGEAHKWSIIYRISIGIAGGL 182
           V +      P  R  K I   F     +L Q I+     + E H++  +Y++       L
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-FLYQL----LRAL 116

Query: 183 DYLHTG--FHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEM-LEASASQG 238
            Y+HT   FHR     +LK KNIL + + +  + DFGL  +  N T       +  A++ 
Sbjct: 117 KYIHTANVFHR-----DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 239 YKAPELIK--MKDASEETDIYSFGVIMLELISGK 270
           Y+APEL        +   DI+S G I  E+++GK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 3/95 (3%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           E++G  N GT+YKA    +  +  ++ + P+  T +  K+    +E+L     P ++   
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYII--- 62

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQC---IRGGSGEAHKWSI----IYRISIGIAGGLDYL 185
           GFY            F+    ++ C   + GGS + +   I    + RI++ +  GL YL
Sbjct: 63  GFYGA----------FFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYL 111

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL-LLNPTAGQEMLEASASQGYKAPEL 244
              +   I+H ++K  N+L++   Q  + DFG+   L+N  A   +     +  Y APE 
Sbjct: 112 ---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAPER 164

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEP 272
           I  +     +D++S G+  +EL  G+ P
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 24/194 (12%)

Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKL 143
           Y A+L R+ +++ L   RP    T   + + +L+ L+ C+ H N++ LL  +  P+    
Sbjct: 37  YDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFT-PQKSLE 92

Query: 144 IVHPFY-----KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNL 198
                Y        NL Q I+          ++Y++  GI     +LH+     IIH +L
Sbjct: 93  EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI----KHLHSA---GIIHRDL 145

Query: 199 KSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDI 256
           K  NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI
Sbjct: 146 KPSNIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 257 YSFGVIMLELISGK 270
           +S G IM E++  K
Sbjct: 202 WSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 28/95 (29%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L+YLH+   R +++ ++K +N++LD++    ++DFGL      + G  M     + 
Sbjct: 104 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTP 159

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 11/107 (10%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA--GQEMLEASASQG 238
           GL Y+H+     ++H +LK  N+LL+ N    + DFGL  + +P       + E  A++ 
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 239 YKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
           Y+APE ++  K  ++  DI+S G I+ E++S + P+     P +D+ 
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL----FPGKDYL 216

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--A 235
           +A  LD+LH+     II+ +LK +NILLD      ++DFGL      +   E    S   
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFCG 160

Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           +  Y APE++  +  ++  D +SFGV+M E+++G  P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 9/112 (8%)

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEA 233
           S  I+  L+YLH    R II+ +LK  N+LLD      ++D+G+    L P  G      
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTF 156

Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP---INENPTPDED 282
             +  Y APE+++ +D     D ++ GV+M E+++G+ P   +  +  PD++
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 43/162 (26%), Positives = 82/162 (50%), Gaps = 20/162 (12%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++HP LV L   YA    E + I+  + + G+L   ++   G     + +  ++  
Sbjct: 54  LMKQLQHPRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     +  IH +L++ NIL+       ++DFGL  L+      E  E +A +
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI------EDNEYTARE 161

Query: 238 GYK------APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           G K      APE I     + ++D++SFG+++ E+++ G+ P
Sbjct: 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++      S  V + + L+P  T   + F +   L+  ++H  LV L   YA
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAV-KTLKP-GTMSVQAFLEEANLMKTLQHDKLVRL---YA 68

Query: 137 GPRGEK--LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
               E+   I+  +  +G+L   ++   G       +   S  IA G+ Y+     +  I
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125

Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ N+L+  +    ++DFGL  ++      E  E +A +G K      APE I   
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI------EDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 249 DASEETDIYSFGVIMLELIS-GKEP 272
             + ++D++SFG+++ E+++ GK P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 34/221 (15%)

Query: 77  IGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           +G+  +G ++ A     L ++   +  ++ L+    +  ++F    ELL  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 132 LGFYAGPRGEKLI-VHPFYKRGNLAQCIRGGSGEAH-------------KWSIIYRISIG 177
            G      G  L+ V  + + G+L + +R    +A                  +  I+  
Sbjct: 73  YGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLE 232
           IA G+ YL    H   +H +L ++N L+ +     + DFG+   +  T      G+ ML 
Sbjct: 131 IASGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                 +  PE I  +  + E+DI+SFGV++ E+ + GK+P
Sbjct: 188 IR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 31/219 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 130 PLLGFYAGPRGEKLIVH--PF-----YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
            LLG        +LI    PF     Y R +       GS     W +       IA G+
Sbjct: 73  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCV------QIAKGM 122

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GY 239
           +YL     R ++H +L ++N+L+       ++DFGL  LL   A ++   A   +    +
Sbjct: 123 NYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKW 177

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENP 277
            A E I  +  + ++D++S+GV + EL++ G +P +  P
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 35/222 (15%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRG----EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           LL C+ H N++ LL  +   +     + + +       NL Q I           ++Y++
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
             GI     +LH+     IIH +LK  NI++  +    + DFGL           M    
Sbjct: 133 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL--ARTACTNFMMTPYV 183

Query: 235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISG-------------KEPINENPTPDE 281
            ++ Y+APE+I      E  DI+S G IM EL+ G              + I +  TP  
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243

Query: 282 DF--HLPTFMRNAVLDH------RITDLYHPDMLLCSNSNHE 315
           +F   L   +RN V +          +L+ PD +  S S  +
Sbjct: 244 EFMNRLQPTVRNYVENRPQYPGISFEELF-PDWIFPSESERD 284

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG 133
           +G   YGT+  AL +R+G+ V + +  RP  +     + + +L  LL  ++H N++ LL 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL-RLLKHMKHENVIGLLD 81

Query: 134 -FYAGPRGEKL----IVHPFYKR--GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
            F      ++     +V PF     G L +  +    E     ++Y++      GL Y+H
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQM----LKGLKYIH 135

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                 IIH +LK  N+ ++ + +  + DFGL          EM     ++ Y+APE+I 
Sbjct: 136 AA---GIIHRDLKPGNLAVNEDCELKILDFGL----ARQTDSEMTGYVVTRWYRAPEVIL 188

Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
                ++  DI+S G IM E+++GK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 41/235 (17%)

Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IEL 119
           DL   ++ +  GE +G   +G +YKA  + +G++   + +    T  ++E  D    IE+
Sbjct: 7   DLDPNEVWEIIGE-LGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYMVEIEI 62

Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR---GGSGEAHKWSI------ 170
           L    HP +V LLG              FY  G L   I    GG+ +A    +      
Sbjct: 63  LATCNHPYIVKLLG-------------AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE 109

Query: 171 --IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
             I  I   +   L YLH+     IIH +LK+ N+LL  +    ++DFG+    N    Q
Sbjct: 110 PQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQ 165

Query: 229 EMLEASASQGYKAPELI---KMKDASEE--TDIYSFGVIMLELISGKEPINE-NP 277
                  +  + APE++    MKD   +   DI+S G+ ++E+   + P +E NP
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 5/98 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+ LH      I++ +LK +NILLD +    +SD GL   ++   GQ +     + 
Sbjct: 111 ICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGTV 165

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE 275
           GY APE++K +  +   D ++ G ++ E+I+G+ P  +
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 63/284 (22%), Positives = 118/284 (41%), Gaps = 68/284 (23%)

Query: 99  LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI-VHPFYKRGNLAQC 157
           ++ L+       K+F    ELL  ++H ++V   G      G+ LI V  + K G+L + 
Sbjct: 40  VKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDPLIMVFEYMKHGDLNKF 97

Query: 158 IRGGSGEA-----------HKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD 206
           +R    +A              S +  I+  IA G+ YL +   +  +H +L ++N L+ 
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVG 154

Query: 207 RNYQPYVSDFGLHLLLNPT-----AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGV 261
            N    + DFG+   +  T      G  ML       +  PE I  +  + E+D++S GV
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSLGV 210

Query: 262 IMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSE 320
           ++ E+ + GK+P  +                         L + +++ C        +++
Sbjct: 211 VLWEIFTYGKQPWYQ-------------------------LSNNEVIEC--------ITQ 237

Query: 321 ERILK--------FFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
            R+L+         + L + C    P +R NIK++   L++L K
Sbjct: 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 57/268 (21%)

Query: 111 KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRGGSGEAH--- 166
           K+F    ELL  ++H ++V   G      G+ LI V  + K G+L + +R    +A    
Sbjct: 52  KDFQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 109

Query: 167 -----------KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD 215
                        S +  I+  IA G+ YL +   +  +H +L ++N L+  N    + D
Sbjct: 110 DGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGD 166

Query: 216 FGLHLLLNPT-----AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
           FG+   +  T      G  ML       +  PE I  +  + E+D++SFGVI+ E+ + G
Sbjct: 167 FGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222

Query: 270 KEPINENPTPDEDFHL-PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQ 328
           K+P          F L  T +   +   R+  L  P   +C               + + 
Sbjct: 223 KQPW---------FQLSNTEVIECITQGRV--LERPR--VCPK-------------EVYD 256

Query: 329 LAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           + + C    P  R NIK++   L  LGK
Sbjct: 257 IMLGCWQREPQQRLNIKEIYKILHALGK 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 21/214 (9%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPLLGF 134
           V+GK  YG +Y A    S  VR+     P   +R  +   + I L   ++H N+V  LG 
Sbjct: 15  VLGKGTYGIVYAAR-DLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            +   G   I       G+L+  +R   G  + ++ +II+  +  I  GL YLH      
Sbjct: 74  DS-ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQILEGLKYLH---DNQ 128

Query: 193 IIHGNLKSKNILLDRNYQPYV--SDFGLHLLL---NPTAGQEMLEASASQGYKAPELIK- 246
           I+H ++K  N+L++  Y   V  SDFG    L   NP    E    +    Y APE+I  
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCT--ETFTGTLQ--YMAPEVIDK 183

Query: 247 -MKDASEETDIYSFGVIMLELISGKEPINENPTP 279
             +      DI+S G  ++E+ +GK P  E   P
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 20/216 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSG--SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNL 128
           GEV+GK  YGT+Y  L  +    +V+ +          +KE+  L   ++LL  ++H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLH 186
           V  LG         + +  F   G+++  +   G   E     +  + +  I  G+ YLH
Sbjct: 65  VQYLGTCLDDNTISIFME-FVPGGSISSILNRFGPLPEP----VFCKYTKQILDGVAYLH 119

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFG----LHLLLNPTAGQEMLEASASQGY-KA 241
              +  ++H ++K  N++L  N    + DFG    L  +        ML++     Y  A
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENP 277
           PE+I       ++DI+S G  + E+ +GK P+    
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 22/157 (14%)

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           HP LV L G     +    IV  F + G L   +R   G+  K  ++  +   +  G++Y
Sbjct: 58  HPKLVQLYGVCTQQK-PLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEY 115

Query: 185 LH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYK-- 240
           L    F    IH +L ++N L+       VSDFG+   +L+        E ++S G K  
Sbjct: 116 LERNSF----IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFP 164

Query: 241 ----APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                PE+      S ++D++SFGV+M E+ + GK P
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 64/297 (21%), Positives = 123/297 (41%), Gaps = 52/297 (17%)

Query: 76  VIGKSNYGTLYKALLQRS--GSVRLLRFLRPVCTTRDK----EFGDLIELLGCIRHPNLV 129
            +G+  +G ++ A  +         L  ++ +  T+D+    EF   +++   + H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 130 PLLGFY--AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKW-----SIIYRISIG--IAG 180
            LLG    A P     ++  +   G+L Q +R    +  K      S   ++++   IA 
Sbjct: 72  RLLGLCREAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---MLEASASQ 237
           G+D+L     R  +H +L ++N L+    +  VS   L          E   +  A    
Sbjct: 129 GMDHLSN--AR-FVHRDLAARNCLVSSQREVKVSLLSLS---KDVYNSEYYKLRNALIPL 182

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE ++  D S ++D++SFGV+M E+ + G+ P       DE+              
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG--LSDEEV------------- 227

Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            +  L    + L        PV E    + ++L   C + +P  RP+  +++  L +
Sbjct: 228 -LNRLQAGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 51/299 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSG----SVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLV 129
           E +G+  +G +YK  L   G     +  ++ L+ +   +   EF     L+  + HPN+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQ------------CIRGGSGEAHKWSI----IYR 173
            LLG     +    ++  +  +G+L +            C     G   K S+       
Sbjct: 71  CLLGVVTQEQ-PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV-KSSLDHGDFLH 128

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I+I IA G++YL + F    +H +L ++NIL+       +SD GL   +       +   
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 234 SA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA 292
           S     +  PE I     S ++DI+SFGV++ E+ S              F L  +    
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--------------FGLQPYY--G 229

Query: 293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
             +  + ++     LL        P SE+   + + L   C    PS RP  K +  +L
Sbjct: 230 FSNQEVIEMVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 20/171 (11%)

Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           + EF +  +++  + H  LV L G     R    IV  +   G L   +R   G+  + S
Sbjct: 43  EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEYMSNGCLLNYLREH-GKRFQPS 100

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQ 228
            +  +   +  G+ YL +   +  IH +L ++N L+D      VSDFGL   +L+     
Sbjct: 101 QLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD---- 153

Query: 229 EMLEASASQGYK------APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
              E ++S G K       PE++     S ++D+++FGV+M E+ S GK P
Sbjct: 154 ---EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL Y+H+     IIH +LK  N+ ++ + +  + DFGL       A  EM    A++ Y+
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL----ARQADDEMTGYVATRWYR 182

Query: 241 APE-LIKMKDASEETDIYSFGVIMLELISGK 270
           APE ++     ++  DI+S G IM EL+ GK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL Y+H+     ++H +LK  N+LL+ N    + DFGL    +   G  M E   ++ Y+
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYR 175

Query: 241 APELI-KMKDASEETDIYSFGVIMLELISGKEPI 273
           APEL+    + +   D++S G I  EL+ G++P+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 19/181 (10%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G+ YLH+  +   IH +L ++N+LLD +    + DFGL   + P  G E        
Sbjct: 116 ICEGMAYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PE-GHEYYRVREDG 170

Query: 238 G----YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV 293
                + A E +K    S  +D++SFGV + EL++  +     P   E+   P   +  V
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230

Query: 294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
           +  R+ +L    M L        P  +    + + L   C       RP  + ++  L++
Sbjct: 231 V--RLIELLERGMRL--------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280

Query: 354 L 354
           +
Sbjct: 281 M 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L YLH+     +++ +LK +N++LD++    ++DFGL      + G  M     + 
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTP 159

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 11/157 (7%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           + +L  ++HPN+V     +    G   IV  + + G+L + I    G       I    +
Sbjct: 50  VAVLSNMKHPNIVQYQESFE-ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            I   L ++H    R I+H ++KS+NI L ++    + DFG+  +LN T    +  A   
Sbjct: 109 QICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----VELARTC 161

Query: 237 QG---YKAPELIKMKDASEETDIYSFGVIMLELISGK 270
            G   Y +PE+ + +  + ++DI++ G ++ E+ + K
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 23/277 (8%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 88  --VGDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLKALSVLHA---QGVIH 139

Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++            +  + APELI       E D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 256 IYSFGVIMLELISGKEP-INENPTPDEDF---HLPTFMRNAVLDHRITDLYHP--DMLLC 309
           I+S G++++E++ G+ P  NE P         +LP  ++N    H+++       D LL 
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNL---HKVSPSLKGFLDRLLV 255

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
            +       +E  +LK   LA A   P   + P ++Q
Sbjct: 256 RDPAQRATAAE--LLKHPFLAKA--GPPSCIVPLMRQ 288

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 36/118 (30%), Positives = 63/118 (53%), Gaps = 11/118 (9%)

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEM 230
           Y   I IA  L++LH    R II+ +LK  N+LLD +    ++D+G+    L P  G   
Sbjct: 101 YAAEICIA--LNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153

Query: 231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP---INENPTPDEDFHL 285
                +  Y APE+++ ++     D ++ GV+M E+++G+ P   I +NP  + + +L
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A    +  V  ++ +       ++++ D+I+    L  ++HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  I+ G   GL YLH+  
Sbjct: 89  CYLKEHTAWLVME--YCLGSASDLL-----EVHKKPLQEVEIAAITHGALQGLAYLHS-- 139

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              +IH ++K+ NILL    Q  ++DFG     +P           +  + APE+I   D
Sbjct: 140 -HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----SFVGTPYWMAPEVILAMD 193

Query: 250 ASE---ETDIYSFGVIMLELISGKEPI 273
             +   + D++S G+  +EL   K P+
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 11/111 (9%)

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           I  + + +   L YLH    + +IH ++KS +ILL  + +  +SDFG          +E+
Sbjct: 120 IATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGF----CAQVSKEV 172

Query: 231 LEASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
            +  +  G   + APE+I       E DI+S G++++E+I G+ P  NE P
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 31/159 (19%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQG 238
           G+ +LH+     IIH +LK  NI++  +    + DFGL      TAG    M     ++ 
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRY 182

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGK-------------EPINENPTPDEDF-- 283
           Y+APE+I      E  DI+S G IM E+I G              + I +  TP ++F  
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 284 HLPTFMRNAVLD------HRITDLYHPDMLLCSNSNHEN 316
            L   +RN V +      +   +L+ PD+L   +S   N
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELF-PDVLFPPDSESHN 280

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 29/102 (28%), Positives = 54/102 (52%), Gaps = 7/102 (6%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL+++H  F   +++ +LK  NILLD +    +SD GL    +         +  + GY 
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 162

Query: 241 APELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
           APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 58/274 (21%)

Query: 24  YRKRLPKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAP------GEVI 77
              +        D E    + N GE+ + E ++           DI  +P      G +I
Sbjct: 24  GSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMID---------NDINRSPNKSYKLGNII 74

Query: 78  GKSNYGTLYKAL-LQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           G  ++G +Y+A+ +  S  V + + L+ P    R+      + ++  + H N++ L  +Y
Sbjct: 75  GNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE------LLIMKNLNHINIIFLKDYY 128

Query: 136 ---AGPRGEKLI------------VHPF---YKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
                 + EK I            VH +   Y R N           A    ++   S  
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN----------HALPLFLVKLYSYQ 178

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
           +   L Y+H+ F   I H +LK +N+L+D   +   + DFG     N  AGQ  +    S
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS--AKNLLAGQRSVSYICS 233

Query: 237 QGYKAPEL-IKMKDASEETDIYSFGVIMLELISG 269
           + Y+APEL +   + +   D++S G I+ E+I G
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 34/118 (28%), Positives = 65/118 (55%), Gaps = 18/118 (15%)

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
           +I+ +ISI +  GL YL       I+H ++K  NIL++   +  + DFG+       +GQ
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-------SGQ 149

Query: 229 EMLEASA-----SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
            ++++ A     ++ Y +PE ++    + ++DI+S G+ ++E+  G+ PI   P PD 
Sbjct: 150 -LIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI---PPPDA 203

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 33/211 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E IGK ++G +YKA+ +R+  V  ++ +       + E  D+   I+ L   R P +   
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIR-GGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            G +   +G KL I+  +   G+    ++ G   E +   I+  + +G    L+YLH   
Sbjct: 65  YGSFL--KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLG----LEYLHEE- 117

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ-----G---YKA 241
               IH ++K+ NILL       ++DFG+       +GQ  L ++ S+     G   + A
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGV-------SGQ--LTSTMSKRNTFVGTPFWMA 166

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE+IK     E+ DI+S G+  +EL  G+ P
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 12/122 (9%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA GL +LH+   + II+ +LK  N++LD      ++DFG+    N   G+       + 
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGM-CKENIFGGKTTRTFCGTP 165

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE+I  +   +  D ++FGV++ E+++G+ P  +    DE F        ++++H 
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELF-------QSIMEHN 217

Query: 298 IT 299
           ++
Sbjct: 218 VS 219

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 42/189 (22%)

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           I+ ++++ I   L YL       +IH ++K  NILLD +    + DFG+       +G+ 
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGI-------SGR- 164

Query: 230 MLEASA---SQG---YKAPELIKMKDASEETDI----YSFGVIMLELISGKEPINENPTP 279
           ++++ A   S G   Y APE I   D + + DI    +S G+ ++EL +G+ P     T 
Sbjct: 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT- 223

Query: 280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPS 339
             +F + T         +I     P +          P +E     F      C +    
Sbjct: 224 --EFEVLT---------KILQEEPPSL----------PPNEGFSPDFCSFVDLCLTKDHR 262

Query: 340 LRPNIKQVL 348
            RP  +++L
Sbjct: 263 KRPKYRELL 271

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 77  IGKSNYGTLYKAL-LQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPN 127
           IG+  YG ++KA  L+  G    L+ +R        P+ T R+     ++  L    HPN
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA---VLRHLETFEHPN 65

Query: 128 LVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L       R +   KL +   +   +L   +            I  +   +  GLD+
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH+  HR ++H +LK +NIL+  + Q  ++DFGL  + +       +    +  Y+APE+
Sbjct: 126 LHS--HR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVTLWYRAPEV 180

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
           +     +   D++S G I  E+   K     +   D+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 43/232 (18%)

Query: 68  DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE----FGDLIELLGCI 123
           DI +  GE +G   +G +YKA  + +G     +    +     +E    F   I++L   
Sbjct: 5   DIWEIIGE-LGDGAFGKVYKAQHKETGLFAAAK----IIQIESEEELEDFMVEIDILSEC 59

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR---GGS--------GEAHKWSIIY 172
           +HPN+V L   Y             +    L   I    GG+                I 
Sbjct: 60  KHPNIVGLYEAY-------------FYENKLWILIEFCDGGALDSIMLELERGLTEPQIR 106

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
            +   +   L++LH+     +IH +LK+ NILL  +    ++DFG+      T  Q+   
Sbjct: 107 YVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDT 162

Query: 233 ASASQGYKAPELI---KMKDA--SEETDIYSFGVIMLELISGKEPINE-NPT 278
              +  + APE++     KD     + DI+S G+ ++EL   + P +E NP 
Sbjct: 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 30/206 (14%)

Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLR----PVC---TTRDKEFGDLIELLGCIRHPNL 128
           IG+ +YG ++K   + +G  V + +F+     PV      R+      I +L  ++HPNL
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE------IRMLKQLKHPNL 62

Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIAGGLDYL 185
           V L+  +   R  KL +V  +     L +  +   G  E     II++        +++ 
Sbjct: 63  VNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT----LQAVNFC 116

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
           H       IH ++K +NIL+ +  Q  + DFG   +L    G +  +  A++ Y+APEL+
Sbjct: 117 HK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP-GDDYTDYVATRWYRAPELL 172

Query: 246 KMKDASEET--DIYSFGVIMLELISG 269
            + D       D+++ G +  EL++G
Sbjct: 173 -VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 11/157 (7%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           I +L  ++HPN++     +       LI   +   G L   I    G+  +  ++     
Sbjct: 50  IVILSLLQHPNIIAYYNHFM-DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            I   + Y+H      I+H ++K+ NI L +     + DFG+  +L    G E   A   
Sbjct: 109 QIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL----GSEYSMAETV 161

Query: 237 QG---YKAPELIKMKDASEETDIYSFGVIMLELISGK 270
            G   Y +PEL +    + ++DI++ G ++ EL++ K
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 63/267 (23%), Positives = 118/267 (44%), Gaps = 52/267 (19%)

Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 166 HKWSI-IYRIS-------------IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+                +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVM 176

Query: 212 YVSDFGLHL-LLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   + N    ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236

Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 237 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 271

Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 272 MRDCWHAIPSHRPTFKQL---VEDLDR 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 33/248 (13%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVPL 131
           VIGK ++G +  A  +  G    ++ L+     + KE   ++     LL  ++HP LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              Y+    +KL  V  +   G L   ++         +  Y  +  IA  L YLH+   
Sbjct: 62  --HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLHS--- 114

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-------YKAPE 243
             II+ +LK +NILLD      ++DFGL         +E +E S +         Y APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGL--------CKEGIEHSKTTSTFCGTPEYLAPE 166

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPI---NENPTPDEDFHLPTFMRNAV---LDHR 297
           +++ +      D +  G ++ E++ G  P    +     D   + P  ++  +     H 
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHL 226

Query: 298 ITDLYHPD 305
           +  L   D
Sbjct: 227 LEGLLQKD 234

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 33/122 (27%), Positives = 62/122 (50%), Gaps = 19/122 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I+ GL +LH    R II+ +LK  N++LD      ++DFG+         + M++   ++
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM-------CKEHMVDGVTTR 159

Query: 238 ------GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN 291
                  Y APE+I  +   +  D +++GV++ E+++G+ P +     DED    + M +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE---DEDELFQSIMEH 216

Query: 292 AV 293
            V
Sbjct: 217 NV 218

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 33/213 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
           +VIGK ++G +  A  +  GS   ++ L+     + KE   ++     LL  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 131 LLGFYAGPRGEKL-IVHPFYKRGNL------AQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           L   Y+    EKL  V  +   G L       +C        +        +  +A  + 
Sbjct: 61  L--HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY--------AAEVASAIG 110

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA----SQGY 239
           YLH+     II+ +LK +NILLD      ++DFGL        G E  E ++    +  Y
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGL-----CKEGVEPEETTSTFCGTPEY 162

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE+++ +      D +  G ++ E++ G  P
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFG----DLIELLGCIRHPNLVPLL 132
           IG   YG +YKA    +G +  ++ ++       ++F     ++I +  C +H N+V   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDC-KHSNIVAYF 72

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G Y   R +KL +   +  G   Q I   +G   +  I Y +S     GL YLH+   + 
Sbjct: 73  GSYL--RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHS---KG 126

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA-- 250
            +H ++K  NILL  N    ++DFG+   +  T  +       +  + APE+  ++    
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK-SFIGTPYWMAPEVAAVERKGG 185

Query: 251 -SEETDIYSFGVIMLELISGKEPI 273
            ++  DI++ G+  +EL   + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 7/105 (6%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL +LH    R II+ +LK  N+LLD      ++DFG+        G        + 
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGM-CKEGILGGVTTSTFCGTP 160

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
            Y APE++  +      D ++ GV++ E+++G+ P       DED
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF---EGDDED 202

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA GL +LH+   + II+ +LK  N++LD      ++DFG+    N   G        + 
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENMWDGVTTKTFCGTP 165

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV 293
            Y APE+I  +   +  D ++FGV++ E+++G+ P       DED    + M + V
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNV 218

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 52/254 (20%)

Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHK 167
              F +   L+  + H +LV L G     R E ++V  + K G L   +     +   H 
Sbjct: 45  SLAFFETASLMSQLSHKHLVKLYGVCV--RDENIMVEEYVKFGPLDVFLHREKNNVSLH- 101

Query: 168 WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-----NYQPYV--SDFGLHL 220
           W +   ++  +A  L YL     + ++HGN+  KNIL+ R      Y P++  SD G+ +
Sbjct: 102 WKLD--VAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Query: 221 LLNPTAGQEMLEASASQGYKAPELIKMKDAS--EETDIYSFGVIMLELIS-GKEPINENP 277
            +     +E +E      + APE I+   AS     D +SFG  +LE+ S G+EP++   
Sbjct: 157 TVLSR--EERVERIP---WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS--- 208

Query: 278 TPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPS 337
                                  L   +        H  P+ +    +   L   C +  
Sbjct: 209 ----------------------TLSSSEKERFYQDQHRLPMPD--CAELANLINQCWTYD 244

Query: 338 PSLRPNIKQVLWKL 351
           P+ RP+ + +L  L
Sbjct: 245 PTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 11/111 (9%)

Query: 167 KWSIIYRISIGIAGGLDYLHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT 225
           KW+  Y   + +A  LD +H+ GF    IH ++K  N+LLD++    ++DFG  + +N  
Sbjct: 142 KWARFYTAEVVLA--LDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195

Query: 226 AGQEMLEASASQGYKAPELIKMKDAS----EETDIYSFGVIMLELISGKEP 272
                  A  +  Y +PE++K +        E D +S GV + E++ G  P
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGS-VRLLRFLRP--VCTTRDKEFGDLIELLGCIRHPNLV 129
           P E IG   YG +  A+  RSG  V + +      V T   +   +L ++L   +H N++
Sbjct: 9   PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLREL-KILRHFKHDNII 67

Query: 130 PLLGFY--AGPRGEKLIVHPFYKRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYL 185
            +       G   + + V       +L   I       E H    +Y+    +  GL Y+
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ----LLRGLKYI 123

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQE-MLEASASQGYKAP 242
           H+     +IH +LK  N+L++ + +  + DFG+   L  +PT  +  M E  A++ Y+AP
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGKE 271
           EL+  + + +   D++S G I  E++  ++
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 15/236 (6%)

Query: 74  GEVIGKSNYGTL---YKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           G+++G+  +G +   Y     R  + + ++F  P      KE   L   I+LL  ++H  
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQF-DPESPETSKEVSALECEIQLLKNLQHER 65

Query: 128 LVPLLGFYAGPRGEK-LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           +V   G     R EK L +   Y  G   +      G A   S+  + +  I  G+ YLH
Sbjct: 66  IVQYYGCLRD-RAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH 123

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEMLEASASQGYKAPEL 244
           +     I+H ++K  NIL D      + DFG    L     +G  +   + +  + +PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           I  +    + D++S G  ++E+++ K P  E       F + T   N  L   I++
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L++LH      II+ ++K +NILLD N    ++DFGL    +    +       + 
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 238 GYKAPELIKMKDASEE--TDIYSFGVIMLELISGKEP 272
            Y AP++++  D   +   D +S GV+M EL++G  P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 7/105 (6%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL +LH+   + II+ +LK  N++LDR+    ++DFG+    N            + 
Sbjct: 105 IVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGM-CKENVFGDNRASTFCGTP 160

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
            Y APE+++    +   D +SFGV++ E++ G+ P + +   DED
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+ LH       ++ +LK +NILLD      +SD GL + +    G+ +     + 
Sbjct: 111 ILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI--PEGESIRGRVGTV 165

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           GY APE++  +  +   D +  G ++ E+I G+ P
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 9/110 (8%)

Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
           KW+  Y   + +A  LD +H+     +IH ++K  N+LLD++    ++DFG  + ++ T 
Sbjct: 142 KWAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196

Query: 227 GQEMLEASASQGYKAPELIKMKDAS----EETDIYSFGVIMLELISGKEP 272
                 A  +  Y +PE++K +        E D +S GV + E++ G  P
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 41/188 (21%)

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL  N    + DFGL   +  +P   ++  +
Sbjct: 185 SFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-D 240

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK 296

Query: 287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
              R    D+   ++Y                         Q  + C    PS RP   +
Sbjct: 297 EGTRMRAPDYTTPEMY-------------------------QTMLDCWHGEPSQRPTFSE 331

Query: 347 VLWKLEDL 354
           ++  L +L
Sbjct: 332 LVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 30/218 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR----HPNLV 129
            EVIG+  YG +YKA  +++G +  ++ +  +    ++E  +   +L   R    HPN+ 
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNIL---RKYSNHPNIA 66

Query: 130 PLLGFY-----AGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGL 182
              G +      G   +  +V      G++   ++G    G+  K   I  I      GL
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
            YLH      +IH ++K +NILL +N +  + DFG+   L+ T G+     +   G   +
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR----NTFIGTPYW 179

Query: 240 KAPELIKMKDASEET-----DIYSFGVIMLELISGKEP 272
            APE+I   +  + +     D++S G+  +EL  GK P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 9/103 (8%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-ASQGY 239
           GL+++H  F   +++ +LK  NILLD +    +SD GL    +    ++   AS  + GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGY 161

Query: 240 KAPELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
            APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 1/91 (1%)

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPE 243
           +H    + +IH ++KS NILL  N    + DFG   +   T   ++      +  Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           + + K  S++ D++S GV++ EL++ K P +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 24/189 (12%)

Query: 96  VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLA 155
           ++LLR   P    +   F     L   + HPN+V LL     P G    V  +     L 
Sbjct: 8   IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67

Query: 156 QCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPY 212
           + +   G         ++ ++       LD L    ++ I+H +LK +NI++     +P+
Sbjct: 68  EVLAADGALPAGETGRLMLQV-------LDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 213 --VSDFGLHLLL---------NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGV 261
             V DFG+  LL           T   E+L    +  Y APE ++ +  +  +D+Y++G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVL---GTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 262 IMLELISGK 270
           I LE ++G+
Sbjct: 178 IFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 77  IGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLL 132
           +G  N+G++ K +        +   ++ L+       K EF     ++  + HP +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI-----GIAGGLDYLHT 187
           G   G     ++V      G L + ++       K   I    +      +A G+ YL +
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYLK-------KRREIPVSDLKELAHQVAMGMAYLES 113

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
              +  +H +L ++N+LL   +Q  +SDFG+   L   AG +     A+   +      A
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALG--AGSD--YYRATTAGRWPLKWYA 166

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           PE I     S ++D++S+GV + E  S G +P
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 14/204 (6%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           ++G   +G L +  L+      L      LR  C+ + +  F      LG   H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL-HTGF 189
            G     RG  + IV  +   G L   +R   G+     ++  +  G+A G+ YL   G+
Sbjct: 72  EGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP-GLASGMKYLSEMGY 128

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
               +H  L +  +L++ +    +S F         A    +   +   + APE I+   
Sbjct: 129 ----VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 250 ASEETDIYSFGVIMLELIS-GKEP 272
            S  +D++SFG++M E++S G+ P
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 7/106 (6%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL YLH    R IIH ++K++NI ++   Q  + D G      P      L  + + 
Sbjct: 166 ILEGLRYLHA--QR-IIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP--TPDE 281
              APE++     + + DI+S G+++ E+++    I E+P  TP+E
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266

Length = 357

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 46.4 bits (111), Expect = 9e-06
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 44/216 (20%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNL 128
           + +G   +G++Y A  + +G +    ++ +       C    +E   L +L     HPN+
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKL---NEHPNI 60

Query: 129 VPLLGFYAGPRGEKLIVHPF---YKRGNLAQCIRGGSG----EAHKWSIIYRISIGIAGG 181
           V L   +     E   ++ F   Y  GNL Q ++   G    E+   SIIY+I      G
Sbjct: 61  VKLKEVFR----ENDELY-FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI----LQG 111

Query: 182 LDYLHTG--FHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNP--TAGQEMLEASA 235
           L ++H    FHR     +LK +N+L+       ++DFGL   +   P  T      +  +
Sbjct: 112 LAHIHKHGFFHR-----DLKPENLLVSGPEVVKIADFGLAREIRSRPPYT------DYVS 160

Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE L++    S   DI++ G IM EL + +
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 16/227 (7%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
           +VIGK ++G +  A  +  G    ++ L+       KE   ++     LL  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 131 LLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L   Y+    EKL  V  F   G L   ++         +  Y  +  IA  L YLH+  
Sbjct: 61  L--HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLHS-- 114

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I++ +LK +NILLD      ++DFGL                 +  Y APE+I+ + 
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGL-CKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTP---DEDFHLPTFMRNAV 293
                D +  G ++ E++ G  P          D   H P  +R   
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA 219

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 44/230 (19%)

Query: 73  PGEVIGKSNYGTLYKALLQRSG-SVRLLRFLR-------PVCTTRDKEFGDLIELLGCIR 124
               +G+  +G +YKA   ++G  V L + L        P+   R+      I++L  ++
Sbjct: 12  ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE------IKILKKLK 65

Query: 125 HPNLVPLLG-FYAGP------RGEKLIVHPFYKRGNLAQCIRGGS---GEAHKWSIIYRI 174
           HPN+VPL+      P      RG   +V P Y   +L+  +   S    E+     + ++
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTP-YMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL-----NPTAGQE 229
             GI     YLH      I+H ++K+ NIL+D      ++DFGL         NP  G  
Sbjct: 125 LEGIN----YLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 230 MLEAS-----ASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGKEPI 273
                      ++ Y+ PEL+   +  +   DI+  G +  E+ + + PI
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 14/184 (7%)

Query: 92  RSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPLLGFYA--GPRGEKLIVH 146
            +G    ++ L+P   +      DL   IE+L  + H N+V   G     G  G KLI+ 
Sbjct: 31  NTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD 206
            F   G+L + +     + +      + ++ I  G+DYL +   R  +H +L ++N+L++
Sbjct: 89  -FLPSGSLKEYLPRNKNKIN-LKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVE 143

Query: 207 RNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPELIKMKDASEETDIYSFGVIML 264
             +Q  + DFGL   +        ++        + APE +        +D++SFGV + 
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 265 ELIS 268
           EL++
Sbjct: 204 ELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+ LH      I++ +LK +NILLD      +SD GL + +    G+ +     + 
Sbjct: 111 ITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI--PEGETIRGRVGTV 165

Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           GY APE++K +  +   D +  G ++ E+I GK P
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 9/114 (7%)

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           Y   I +A  L++LH    R II+ +LK  N+LLD      ++D+G+        G    
Sbjct: 101 YSAEISLA--LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM-CKEGIRPGDTTS 154

Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP---INENPTPDED 282
               +  Y APE+++ +D     D ++ GV+M E+++G+ P   +  +  PD++
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A   R+  V  ++ +       ++++ D+I+    L  +RHPN +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  I  G   GL YLH+  
Sbjct: 83  CYLREHTAWLVME--YCLGSASDIL-----EVHKKPLQEVEIAAICHGALQGLAYLHS-- 133

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIK 246
               IH ++K+ NILL       ++DFG   L++P        A++  G   + APE+I 
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--------ANSFVGTPYWMAPEVIL 184

Query: 247 MKDASE---ETDIYSFGVIMLELISGKEPI 273
             D  +   + D++S G+  +EL   K P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 5/86 (5%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ Y+H    R I+H +LK+KNI L  N    + DFG+  LL  +        + +  Y 
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLAT-TFTGTPYYM 172

Query: 241 APELIKMKDASEETDIYSFGVIMLEL 266
           +PE +K +    ++DI+S G I+ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 18/112 (16%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--------TAGQE 229
           ++ G+ YL     +  +H +L ++N+LL   +   +SDFGL   L          +AG+ 
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
            L+      + APE I  +  S  +D++S+G+ M E  S G++P  +   P+
Sbjct: 161 PLK------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 36/157 (22%), Positives = 72/157 (45%), Gaps = 23/157 (14%)

Query: 126 PNLVPLLGFYAGPRGEK-LIVHPFYKRGNLAQCIRGGSGEAHKWSI--------IYRISI 176
            ++V LLG  +   G+  L+V     +G+L   +R    EA               +++ 
Sbjct: 69  HHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEML 231
            IA G+ YL     +  +H +L ++N ++  +    + DFG+   +  T      G+ +L
Sbjct: 127 EIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS 268
                  + APE +K    + ++D++SFGV++ E+ +
Sbjct: 184 PVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 61/271 (22%)

Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           DK+  DLI   EL+  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 58  DKDLADLISEMELMKLIGKHKNIINLLGV-CTQEGPLYVIVEYAAKGNLREFLRARRPPG 116

Query: 166 HKWSI-IYRISIG-------------IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
             ++  I ++                +A G++YL +   R  IH +L ++N+L+  +   
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVM 173

Query: 212 YVSDFGLHLLLNPTAGQEMLE--ASASQG-----YKAPELIKMKDASEETDIYSFGVIML 264
            ++DFGL        G   ++     S G     + APE +  +  + ++D++SFG++M 
Sbjct: 174 KIADFGL------ARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227

Query: 265 ELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERI 323
           E+ + G  P    P  +E F L   +R     HR        M   SN  HE        
Sbjct: 228 EIFTLGGSPYPGIPV-EELFKL---LREG---HR--------MDKPSNCTHE-------- 264

Query: 324 LKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              + L   C    P+ RP  KQ++  L+ +
Sbjct: 265 --LYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 17/149 (11%)

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL  N    + DFGL   +  +P   ++  +
Sbjct: 179 SFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-D 234

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  K  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQIDEEFCRRLK 290

Query: 287 TFMRNAVLDHRITDLYHPDMLLCSNSNHE 315
              R    ++   ++Y   ML C ++N E
Sbjct: 291 EGTRMRAPEYATPEIYSI-MLDCWHNNPE 318

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.2 bits (108), Expect = 2e-05
 Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 17/116 (14%)

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQEMLE 232
           I   +   L+ LH   H  IIH ++K +N+L DR   + Y+ D+GL        G     
Sbjct: 114 IIRQLVEALNDLHK--HN-IIHNDIKLENVLYDRAKDRIYLCDYGL----CKIIGTP--- 163

Query: 233 ASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
            S   G   Y +PE IK  +     D ++ GV+  EL++GK P  E+   DE+  L
Sbjct: 164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED--EDEELDL 216

Length = 267

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 35/115 (30%), Positives = 61/115 (53%), Gaps = 14/115 (12%)

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL  N    + DFGL   +  +P   ++   
Sbjct: 180 SFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-S 235

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF 283
           A     + APE I  K  + ++D++SFGV++ E+ S    +  +P P    +E+F
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQINEEF 286

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 11/111 (9%)

Query: 167 KWSIIYRISIGIAGGLDYLHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT 225
           KW+  Y   + +A  LD +H+ GF    IH ++K  N+LLD++    ++DFG  + ++  
Sbjct: 142 KWARFYTAEVVLA--LDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195

Query: 226 AGQEMLEASASQGYKAPELIKMKDAS----EETDIYSFGVIMLELISGKEP 272
                  A  +  Y +PE++K +        E D +S GV + E++ G  P
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 18/165 (10%)

Query: 124 RHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           RHPN++     +    G  L ++ PF   G+    ++    E    ++I  I  G   GL
Sbjct: 57  RHPNIMTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGL 114

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEA-------S 234
           +YLH   +   IH N+K+ +IL+  +    VS  GL HL      GQ+           +
Sbjct: 115 NYLHQNGY---IHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 235 ASQGYKAPELIK--MKDASEETDIYSFGVIMLELISGKEPINENP 277
           +   + +PEL++  +   + ++DIYS G+   EL +G+ P  +  
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 29/105 (27%), Positives = 58/105 (55%), Gaps = 16/105 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--- 234
           I   L+YLH+   + I++ +LK +NILLD+     ++DFG          +++ + +   
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGF--------AKKLRDRTWTL 158

Query: 235 -ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NENP 277
             +  Y APE+I+ K  ++  D ++ G+++ E++ G  P  ++NP
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 16/103 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           I  GL +LH+   + I++ +LK  NILLD +    ++DFG+         + ML +A   
Sbjct: 105 IICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGM-------CKENMLGDAKTC 154

Query: 237 Q-----GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
                  Y APE++  +  +   D +SFGV++ E++ G+ P +
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 7/113 (6%)

Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
           G  G   + +I Y  +  +  GL+ L       I++ +LK +NILLD      +SD GL 
Sbjct: 95  GNPGFDEQRAIFY--AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA 149

Query: 220 LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           + +    G+ +     + GY APE+I  +  +   D +  G ++ E+I G+ P
Sbjct: 150 VQI--PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-MKDAS- 251
           +H ++K  N+LLD+N    ++DFG  L L      +   A  +  Y +PE+++ M+D   
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 252 ---EETDIYSFGVIMLELISGKEP 272
               E D +S GV M E++ G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 25/209 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTTRDKEFGDL----IELLGCIRHPNLV 129
            ++G+ +YG + K   + +G  V + +FL    +  DK    +    I +L  +RH NLV
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLE---SEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLH 186
            L+  +   R ++L +V  F     L    +   G  E+     +++I  GI    ++ H
Sbjct: 64  NLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI----EFCH 117

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
           +     IIH ++K +NIL+ ++    + DFG    L    G+   +  A++ Y+APEL+ 
Sbjct: 118 S---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELL- 172

Query: 247 MKDAS--EETDIYSFGVIMLELISGKEPI 273
           + D       DI++ G ++ E+++G EP+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG-EPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           +H+      +H ++K  N+LLD N    ++DFG  L +N     +   A  +  Y +PE+
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 245 IK-MKDA----SEETDIYSFGVIMLELISGKEP 272
           ++ M+D       E D +S GV M E++ G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 14/164 (8%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYR 173
           I+LL  ++H  +V   G       E L I   +   G++   ++  G   E    ++  +
Sbjct: 55  IQLLKNLQHERIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTE----TVTRK 108

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEML 231
            +  I  G++YLH+     I+H ++K  NIL D      + DFG    L    ++G  M 
Sbjct: 109 YTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165

Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE 275
             + +  + +PE+I  +    + D++S G  ++E+++ K P  E
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 5/98 (5%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
            L YLH+   + +IH ++KS +ILL  + +  +SDFG    ++    +       +  + 
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-SLVGTPYWM 184

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           APE+I       E DI+S G++++E++ G+ P  +++P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           E +G+ +Y T+YK + + +G +  L+ +        P    R+        LL  ++H N
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS------LLKGLKHAN 64

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V L         E L     Y   +LAQ +    G  H +++       +  GL Y+H 
Sbjct: 65  IVLLHDIIH--TKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH- 120

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
              + I+H +LK +N+L+    +  ++DFGL         Q       +  Y+ P+ L+ 
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGL-ARAKSIPSQTYSSEVVTLWYRPPDVLLG 177

Query: 247 MKDASEETDIYSFGVIMLELISGK 270
             D S   DI+  G I +E++ G+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 65/268 (24%), Positives = 116/268 (43%), Gaps = 54/268 (20%)

Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGE 164
           DK+  DL+   E++  I +H N++ LLG  A  +   L V   Y  +GNL + +R     
Sbjct: 58  DKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVLVEYASKGNLREYLRARRPP 115

Query: 165 AHKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ 210
              +S               +   +  +A G++YL +   +  IH +L ++N+L+  +  
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNV 172

Query: 211 PYVSDFGLHL-LLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS- 268
             ++DFGL   + N    ++         + APE +  +  + ++D++SFGV++ E+ + 
Sbjct: 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232

Query: 269 GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQ 328
           G  P    P  +E F L   ++     HR        M   +N  HE           + 
Sbjct: 233 GGSPYPGIPV-EELFKL---LKEG---HR--------MDKPANCTHE----------LYM 267

Query: 329 LAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           +   C    PS RP  KQ+   +EDL +
Sbjct: 268 IMRECWHAVPSQRPTFKQL---VEDLDR 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 12/101 (11%)

Query: 178 IAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
           ++ G+ YL  T F    +H +L ++N+LL   +   +SDFGL   L   A +   +A   
Sbjct: 104 VSMGMKYLEETNF----VHRDLAARNVLLVTQHYAKISDFGLSKAL--GADENYYKAKTH 157

Query: 237 QGYK----APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             +     APE +     S ++D++SFGV+M E  S G++P
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 24/208 (11%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPLLG 133
           IGK  +  +YKA+    G V  L+ ++       K   D    I+LL  + HPN++  L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSG------EAHKWSIIYRISIGIAGGLDYLHT 187
            +     E  IV      G+L++ I+          E   W    ++       L+++H+
Sbjct: 70  SFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----CSALEHMHS 124

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
              + I+H ++K  N+ +       + D GL    +     +   A +  G   Y +PE 
Sbjct: 125 ---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGTPYYMSPER 177

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEP 272
           I     + ++DI+S G ++ E+ + + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGY 239
           G+ +LH      I+H +LK+ N+LL+      + DFGL     +P   +   +   +  Y
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWY 172

Query: 240 KAPE-LIKMKDASEETDIYSFGVIMLELISGKEPI 273
           +APE L+  K+ S   D++S G I  EL++ K+P+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 59/278 (21%), Positives = 111/278 (39%), Gaps = 78/278 (28%)

Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   +V  +   GNL   +R      
Sbjct: 56  EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPLYVVVEYAAHGNLRDFLRARRPPG 114

Query: 166 HKWSIIYRISIG--------------IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
              S                      +A G+++L +   +  IH +L ++N+L+  ++  
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVM 171

Query: 212 YVSDFGLHLLLN-------PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIML 264
            ++DFGL   ++        T G+  ++      + APE +  +  + ++D++SFGV++ 
Sbjct: 172 KIADFGLARDIHHIDYYRKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLW 225

Query: 265 ELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRI-------TDLYHPDMLLCSNSNHEN 316
           E+ + G  P    P  +    L   ++     +R+        +LYH   L+        
Sbjct: 226 EIFTLGGSPYPGIPVEE----LFKLLKEG---YRMEKPQNCTQELYH---LMRD------ 269

Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                           C    PS RP  KQ+   +EDL
Sbjct: 270 ----------------CWHEVPSQRPTFKQL---VEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 60/271 (22%)

Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 64  EKDLSDLISEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++                +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 179

Query: 212 YVSDFGL-----HLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLEL 266
            ++DFGL     H+          L       + APE +  +  + ++D++SFGV++ E+
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Query: 267 IS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILK 325
            + G  P    P  +E F L   ++     HR        M   SN  +E          
Sbjct: 236 FTLGGSPYPGVPV-EELFKL---LKEG---HR--------MDKPSNCTNE---------- 270

Query: 326 FFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
            + +   C    PS RP  KQ+   +EDL +
Sbjct: 271 LYMMMRDCWHAVPSQRPTFKQL---VEDLDR 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 40/280 (14%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI---ELLGCIRHPNLVPLLG 133
           IG+  +  +Y+A     G    L+ ++       K   D I   +LL  + HPN++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK--- 66

Query: 134 FYAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHTGF 189
           +YA      E  IV      G+L++ I+    +        +++  + +   L+++H+  
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-- 124

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEMLEASASQGYKAPELIKM 247
            R ++H ++K  N+ +       + D GL    +   TA   ++    +  Y +PE I  
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 180

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
              + ++DI+S G ++ E+ + + P   +            M    L  +I    +P + 
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKIEQCDYPPL- 228

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
               S+H    SEE      QL   C +P P  RP+I  V
Sbjct: 229 ---PSDH---YSEE----LRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPLLG 133
           +G   +G +YKA  + +G   +L   + + T  ++E  D    I++L    HPN+V LL 
Sbjct: 13  LGDGAFGKVYKAQNKETG---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL- 68

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIR---GGSGEAHKWSI--------IYRISIGIAGGL 182
                         FY   NL   I    GG+ +A    +        I  +       L
Sbjct: 69  ------------DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
           +YLH      IIH +LK+ NIL   +    ++DFG+    N    Q       +  + AP
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRDSFIGTPYWMAP 172

Query: 243 ELIKMKDASE-----ETDIYSFGVIMLELISGKEPINE-NP 277
           E++  + + +     + D++S G+ ++E+   + P +E NP
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 29/120 (24%), Positives = 49/120 (40%), Gaps = 26/120 (21%)

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
            I   I   ++Y+H+   + ++H +LK  NILL    +  + D+G  +       +E   
Sbjct: 117 SIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK---LEEEDL 170

Query: 233 ASASQG--------------------YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                                     Y APE +    ASE TDIY+ GVI+ ++++   P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)

Query: 123 IRHPNLVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIG 177
           + HPN++  LG    + P    L+V  F   G+L   +R   G   +  +  ++ R++  
Sbjct: 52  LNHPNVLQCLGQCIESIPY---LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +A GL +LH       IH +L  +N  L  +    + D+GL L   P       +  A  
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 238 -GYKAPEL-------IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTP--------D 280
             + APEL       +  KD +++++I+S GV M EL +   +P  +            +
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225

Query: 281 EDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEE 321
           +D  LP       LD + +D ++  M  C       P +EE
Sbjct: 226 QDIKLP----KPQLDLKYSDRWYEVMQFCWLDPETRPTAEE 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA--SQGYKAPELIKMKDA 250
            IH +LK +N L+D +    ++DFGL      + G      S   S  Y APE+++ K  
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
               D +S G ++ E + G  P + + TP+E +
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGS-TPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 48/236 (20%), Positives = 95/236 (40%), Gaps = 33/236 (13%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRI 174
           I+LL  + HPN++  L  +     E  IV      G+L+Q I+    +        +++ 
Sbjct: 53  IDLLKQLNHPNVIKYLDSFI-EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEMLE 232
            + +   ++++H+   R ++H ++K  N+ +       + D GL    +   TA   ++ 
Sbjct: 112 FVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV- 167

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA 292
              +  Y +PE I     + ++DI+S G ++ E+ + + P   +            M   
Sbjct: 168 --GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLF 214

Query: 293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            L  +I    +P +            +E    K  +L   C  P P  RP+I  V 
Sbjct: 215 SLCQKIEQCDYPPL-----------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVH 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 173 RISIG-IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           R   G I   L++LH      I++ ++K +NILLD      ++DFGL         +   
Sbjct: 108 RFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164

Query: 232 EASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEP 272
               +  Y APE+I+ K    +  D +S G+++ EL++G  P
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGS---GEAHKWSIIYR 173
           I+LL  ++HPN++ LL  +       L+    +   +L + I+  S     A   S +  
Sbjct: 53  IKLLQELKHPNIIGLLDVFGHKSNINLVFE--FMETDLEKVIKDKSIVLTPADIKSYM-- 108

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
             +    GL+YLH      I+H +LK  N+L+  +    ++DFGL      +  ++M   
Sbjct: 109 --LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQ 162

Query: 234 SASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
             ++ Y+APEL+   +      D++S G I  EL+   
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-MKDAS- 251
           +H ++K  NIL+D N    ++DFG  L L      +   A  +  Y +PE+++ M+D   
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 252 ---EETDIYSFGVIMLELISGKEP 272
               E D +S GV M E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 32/222 (14%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNLV 129
           +G+  Y T++K   + + ++  L+ +R       P    R+      + LL  ++H N+V
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE------VSLLKNLKHANIV 66

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            L       R   L+    Y   +L Q +   G     H   I       +  GL Y H 
Sbjct: 67  TLHDIIHTERCLTLVFE--YLDSDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCH- 120

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGYKAPE- 243
              R I+H +LK +N+L++   +  ++DFGL     +   T   E++    +  Y+ P+ 
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDV 174

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
           L+   + S   D++  G I+ E+ +G+ P+    T  E+ HL
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
           +YLH+   + II+ +LK +N+LLD      V+DFG                  +  Y AP
Sbjct: 132 EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGF----AKKVPDRTFTLCGTPEYLAP 184

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPI-NENP 277
           E+I+ K   +  D ++ GV++ E I+G  P  ++ P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 12/162 (7%)

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           HPN+VP    +     E  +V  F   G+    I     +      I  I  G+   LDY
Sbjct: 58  HPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDY 116

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDF-GLHLLLNPTAGQEMLEASASQGYK--- 240
           +H   H   +H ++K+ +IL+  + + Y+S       ++N      ++        K   
Sbjct: 117 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173

Query: 241 --APELIK--MKDASEETDIYSFGVIMLELISGKEPINENPT 278
             +PE+++  ++    ++DIYS G+   EL +G  P  + P 
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           E +G+  Y T++K   + + ++  L+ +R       P    R+      + LL  ++H N
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE------VSLLKDLKHAN 65

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKWSI-IYRISIGIAGGLDY 184
           +V L       +   L+    Y   +L Q +   G     H   I +Y+I  G+A    Y
Sbjct: 66  IVTLHDIVHTDKSLTLVFE--YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----Y 119

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGYKA 241
            H    R ++H +LK +N+L++   +  ++DFGL     +   T   E++    +  Y+ 
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRP 172

Query: 242 PE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
           P+ L+   + S + D++  G I  E+ SG+ P+    T +++ HL
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +     L+ +R       V +T  +E    I LL  ++H N+
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIRE----ISLLKEMQHGNI 63

Query: 129 VPLLGFYAGPRGEKLIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           V L         EK +   F Y   +L + +      A    +I      I  G+ Y H+
Sbjct: 64  VRL---QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 188 GFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLN---PTAGQEMLEASASQGYKAPE 243
             HR ++H +LK +N+L+DR      ++DFGL         T   E++    +  Y+APE
Sbjct: 121 --HR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPE 173

Query: 244 -LIKMKDASEETDIYSFGVIMLELISGK 270
            L+  +  S   DI+S G I  E+++ K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 51/169 (30%)

Query: 182 LDYLHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-----------------HLLLN 223
           LD +H  GF    IH ++K  NIL+D +    ++DFGL                 H LL 
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 224 PTAG--------QEMLEASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                       Q  + A+++ G   Y APE+++      E D +S GVI+ E++ G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Query: 273 INENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEE 321
              + T  E     T+ +  +++ + + L  P          + PVS E
Sbjct: 230 FY-SDTLQE-----TYNK--IINWKES-LRFP---------PDPPVSPE 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 39/224 (17%)

Query: 77  IGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDK------EFGDLIEL--LGC 122
           +G+  YG + KA    +G       V+++     V   R         F  L EL  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAG 180
           I+H N++ L+  Y    G+ + +       +L + +  +    E+    I+ +    I  
Sbjct: 77  IKHENIMGLVDVYV--EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQ----ILN 130

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-------------HLLLNPTAG 227
           GL+ LH  +    +H +L   NI ++      ++DFGL                      
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 228 QEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGK 270
           +EM     +  Y+APEL+   +      D++S G I  EL++GK
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YK   +++G +  ++ +R       V +T  +E    I LL  ++HPN+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQHPNI 61

Query: 129 VPLLGFYAGPRGEKLIVH--PFYKRGNLAQCIRGGSGEAHKW-SIIYRISIGIAGGLDYL 185
           V L           LI        +  L    +G   +A    S +Y+I  GI     + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FC 117

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H+   R ++H +LK +N+L+D      ++DFGL             E   +  Y+APE L
Sbjct: 118 HS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV-VTLWYRAPEVL 173

Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     S   DI+S G I  E+ + K
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 28/221 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP---------VCTTRDKEFGDLIELLGCIRH 125
            V+GK ++G +  A L+ SG +  ++ L+           CT  +K     I  L    H
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKR----ILSLAR-NH 55

Query: 126 PNLVPLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           P L  L  +      ++L  V  F   G+L   I+         +  Y  +  I   L +
Sbjct: 56  PFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEITSALMF 111

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQGYKAP 242
           LH    + II+ +LK  N+LLD      ++DFG+    + N   G+       +  Y AP
Sbjct: 112 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAP 165

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           E+++        D ++ GV++ E++ G  P  E    D+ F
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 4/91 (4%)

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           L +LH      +I+ +LK  NILLD      ++DFG+        G        +  Y A
Sbjct: 109 LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGM-CKEGILNGVTTTTFCGTPDYIA 164

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE+++  +     D ++ GV+M E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 41/187 (21%), Positives = 86/187 (45%), Gaps = 26/187 (13%)

Query: 99  LRFLRP-VCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQ 156
           ++ LR  V  T   +F   I+++  +++PN++ LLG       + L ++  + + G+L Q
Sbjct: 49  VKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV--SDDPLCMITEYMENGDLNQ 106

Query: 157 C-----IRGGSGEAHKWSIIYR-----ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD 206
                 I      A+    +       +++ IA G+ YL +      +H +L ++N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163

Query: 207 RNYQPYVSDFGLHLLLNPT-----AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGV 261
            +Y   ++DFG+   L         G+ +L       + A E I +   +  +D+++FGV
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGV 219

Query: 262 IMLELIS 268
            + E+ +
Sbjct: 220 TLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LD +H+   R ++H +LKS NI L       + DFG     + +   ++  AS+  
Sbjct: 178 IVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV--ASSFC 232

Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y APEL + K  S++ D++S GVI+ EL++   P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 141 EKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
           E ++V  F + G L  C+R   G     W I   ++  +A  L YL     + ++HGN+ 
Sbjct: 90  ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT--VAQQLASALSYLE---DKNLVHGNVC 144

Query: 200 SKNILLDR-----NYQPYV--SDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-MKDAS 251
           +KNILL R        P++  SD G+       + +E +E      + APE +      S
Sbjct: 145 AKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERIP---WIAPECVPGGNSLS 199

Query: 252 EETDIYSFGVIMLEL-ISGKEPINE-NPTPDEDFH 284
              D +SFG  +LE+   G+ P+ E  P+  E F+
Sbjct: 200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 48/221 (21%)

Query: 76  VIGKSNYGTLY---KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE------LLGCIRHP 126
           V+GK  YG ++   K     +G +  ++ L+     R+++  D         +L  ++HP
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK--DTAHTKAERNILEAVKHP 60

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH---------KWSIIYRISIG 177
            +V L+  YA   G KL +        + + + GG    H           +  Y   I 
Sbjct: 61  FIVDLI--YAFQTGGKLYL--------ILEYLSGGELFMHLEREGIFMEDTACFYLSEIS 110

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +A  L++LH    + II+ +LK +NILLD      ++DFGL         + + E + + 
Sbjct: 111 LA--LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGL-------CKESIHEGTVTH 158

Query: 238 G------YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                  Y APE++      +  D +S G +M ++++G  P
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           L++LH      I++ +LK +NILLD      + DFGL    N T  +       +  Y A
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS-KANLTDNKTTNTFCGTTEYLA 164

Query: 242 PE-LIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE L+  K  ++  D +S GV++ E+  G  P
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 118 ELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
            +L  IRHP LV L G +       L +V  +   G L   +R         +  Y   +
Sbjct: 53  RILQSIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            +A  L+YLH      I++ +LK +N+LLD +    ++DFG    +        L    +
Sbjct: 111 VLA--LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--RTYTL--CGT 161

Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
             Y APE+I  K   +  D ++ G+++ E+++G  P
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           E +G+ +Y T+YK   + +G +  L+ +R       P    R+        LL  ++H N
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS------LLKGLKHAN 64

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V L           L+    Y   +L Q +    G  H  ++   +   +  GL Y+H 
Sbjct: 65  IVLLHDIIHTKETLTLVFE--YVHTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH- 120

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGYKAPE- 243
              R I+H +LK +N+L+    +  ++DFGL     + + T   E++    +  Y+ P+ 
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV----TLWYRPPDV 174

Query: 244 LIKMKDASEETDIYSFGVIMLELISG 269
           L+   + S   D++  G I +E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YGT++KA  + +  +  L+ +R        P    R+      I LL  ++H 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE------ICLLKELKHK 59

Query: 127 NLVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V L   Y     +K +   F Y   +L +     +G+     I+      +  GL + 
Sbjct: 60  NIVRL---YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKGLAFC 115

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H+  H  ++H +LK +N+L+++N +  ++DFGL             E   +  Y+ P+ L
Sbjct: 116 HS--HN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV-VTLWYRPPDVL 171

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPI 273
              K  S   D++S G I  EL +   P+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNLV 129
           +G+  Y T+YK   + + ++  L+ +R       P    R+      + LL  ++H N+V
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIRE------VSLLKDLKHANIV 67

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            L       +   L+    Y   +L Q +   G S   H   +       +  GL+Y H 
Sbjct: 68  TLHDIIHTEKSLTLVFE--YLDKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCH- 121

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGYKAPE- 243
              R ++H +LK +N+L++   +  ++DFGL     +   T   E++    +  Y+ P+ 
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----TLWYRPPDI 175

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
           L+   D S + D++  G I  E+ +G+ P+    T +E  H 
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHF 216

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 45/227 (19%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
           +VIGK ++G +  A  +       ++ L+     + KE   ++     LL  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 131 L-LGFYAGPR---------GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           L   F    +         G +L  H   +R  L    R  + E             IA 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------------IAS 107

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
            L YLH+     I++ +LK +NILLD      ++DFGL         +E +E + +    
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL--------CKENIEHNGTTSTF 156

Query: 239 -----YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
                Y APE++  +      D +  G ++ E++ G  P     T +
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 31/221 (14%)

Query: 76  VIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVP 130
           V+G   +GT+YK +    G +V++   ++ LR   + + +KE  D   ++  +  P +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLDYL 185
           LLG       +  +V      G L   +R      GS +   W +       IA G+ YL
Sbjct: 74  LLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV------QIAKGMSYL 125

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----YK 240
                  ++H +L ++N+L+       ++DFGL  LL+     +  E  A  G     + 
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD----IDETEYHADGGKVPIKWM 178

Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 44/187 (23%), Positives = 77/187 (41%), Gaps = 32/187 (17%)

Query: 111 KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS- 169
            +F     L+    HPN+V LLG  A  +   L+   +   G+L + +R  S  A     
Sbjct: 53  ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE-YMAYGDLNEFLRHRSPRAQCSLS 111

Query: 170 -------------------IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ 210
                                  I+  +A G+ YL     R  +H +L ++N L+  N  
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 168

Query: 211 PYVSDFGLHLLLNPTAGQEMLEASASQG----YKAPELIKMKDASEETDIYSFGVIMLEL 266
             ++DFGL          +  +AS +      +  PE I     + E+D++++GV++ E+
Sbjct: 169 VKIADFGLS---RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Query: 267 IS-GKEP 272
            S G +P
Sbjct: 226 FSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 51/243 (20%), Positives = 100/243 (41%), Gaps = 51/243 (20%)

Query: 52  TEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLL--RFLRP-VCTT 108
            E L   + GE + +C       E  G  ++     A    + +  L+  + LRP     
Sbjct: 10  VEKLGEGQFGE-VHLC-------EADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 109 RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY-KRGNLAQ----CIRGGSG 163
             ++F   +++L  +  PN+  LLG         L +   Y + G+L Q     +   SG
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLG--VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119

Query: 164 EAHKWS------IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG 217
            A          ++Y ++  IA G+ YL +      +H +L ++N L+ +NY   ++DFG
Sbjct: 120 LACNSKSLSFSTLLY-MATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG 175

Query: 218 LHLLLNPTAGQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLE 265
           +                +S  Y+            A E + +   + ++D+++FGV + E
Sbjct: 176 MS-----------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224

Query: 266 LIS 268
           +++
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 6/88 (6%)

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE- 252
           +H ++K +N+L+DR     ++DFG    L             +  Y APE++   +    
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 253 -----ETDIYSFGVIMLELISGKEPINE 275
                E D +S GVI  E+I G+ P +E
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG--------CIRHPNL 128
           +G   YG +YKA    +G +  ++ ++        E GD   L+         C +H N+
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIK-------LEPGDDFSLIQQEIFMVKEC-KHCNI 68

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V   G Y     EKL +   Y  G   Q I   +G   +  I Y +      GL YLH+ 
Sbjct: 69  VAYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHS- 124

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
             +  +H ++K  NILL  N    ++DFG+   +  T  +       +  + APE+  ++
Sbjct: 125 --KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK-SFIGTPYWMAPEVAAVE 181

Query: 249 DA---SEETDIYSFGVIMLELISGKEPI 273
                ++  DI++ G+  +EL   + P+
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 63/248 (25%)

Query: 74  GEVIGKSNYGTLYKA----LLQRSG----SVRLLRFLRPVCTTRDKEFGDLI---ELLGC 122
           G+ +G+  +G + KA    L  R+G    +V++L+           E  DL+    LL  
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-----NASSSELRDLLSEFNLLKQ 59

Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG---------GSGEAHKWSIIYR 173
           + HP+++ L G  +      LIV  + K G+L   +R          GS      S +  
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVE-YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 174 -----ISIG--------IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL 220
                +++G        I+ G+ YL       ++H +L ++N+L+    +  +SDFGL  
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGL-- 173

Query: 221 LLNPTAGQEMLEASA----SQG-----YKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
                  +++ E  +    S+G     + A E +     + ++D++SFGV++ E+++   
Sbjct: 174 ------SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--- 224

Query: 272 PINENPTP 279
            +  NP P
Sbjct: 225 -LGGNPYP 231

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 4/99 (4%)

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           L+ LH      +I+ +LK +NILLD      + DFGL   LN     +      +  Y A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPEYLA 161

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
           PEL+     ++  D ++ GV++ E+++G  P  +    +
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 29/111 (26%), Positives = 46/111 (41%), Gaps = 18/111 (16%)

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
              I   +   L YLH    R IIH ++K++NI LD      + DFG        A +  
Sbjct: 187 AITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG-------AACKLD 236

Query: 231 LEASASQGY--------KAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
                 Q Y         +PEL+ +     +TDI+S G+++ E+      +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 25/173 (14%)

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK---------RGNLAQCIRGGSGEAHKWS 169
           +L  I HP+++ L G +   +   LI+ P YK         + N+A C            
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLIL-PRYKTDLYCYLAAKRNIAICD----------- 183

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
            I  I   +   + YLH      IIH ++K++NI ++      + DFG           +
Sbjct: 184 -ILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
               + +    APEL+         DI+S G+++ E+ +  + + E    D D
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292

Length = 391

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 44/213 (20%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKE-FGDLIELLGCIRHPN 127
             G  IG+  +G +Y+ +     + ++   ++  +   +   +E F     ++    HP+
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI----SIGIAGGLD 183
           +V L+G          IV      G L   +     + +K+S+        S  ++  L 
Sbjct: 69  IVKLIGVITEN--PVWIVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALA 121

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYK 240
           YL +   +  +H ++ ++N+L+       + DFGL   L     +   +AS  +    + 
Sbjct: 122 YLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED---ESYYKASKGKLPIKWM 175

Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           APE I  +  +  +D++ FGV M E++  G +P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 25/117 (21%)

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL--DRNYQPYV--SDFGLHLLLNP 224
           S++++I  G+     YLH+ +   ++H +LK  NIL+  +   +  V   D GL  L N 
Sbjct: 112 SLLWQILNGVH----YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Query: 225 TAGQEMLEASASQG-------YKAPELI-KMKDASEETDIYSFGVIMLELISGKEPI 273
                 L+  A          Y+APEL+   +  ++  DI++ G I  EL++  EPI
Sbjct: 165 -----PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 44/237 (18%)

Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDK 111
           G   +   DI+      IG+  YG +YKA  + +G +  L+ +R        P+   R+ 
Sbjct: 2   GKRCVDKFDIIG----QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE- 56

Query: 112 EFGDLIELLGCIRHPNLVPL----------LGFYAGPRGEKLIVHPFYKRGNLAQCIRGG 161
                I++L  + H N+V L          L F        L+    Y   +L   +  G
Sbjct: 57  -----IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE--YMDHDLMGLLESG 109

Query: 162 S---GEAHKWSIIYRISIGIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFG 217
                E H  S + ++      GL+Y H   F    +H ++K  NILL+   Q  ++DFG
Sbjct: 110 LVHFSEDHIKSFMKQL----LEGLNYCHKKNF----LHRDIKCSNILLNNKGQIKLADFG 161

Query: 218 LHLLLNPTAGQEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPI 273
           L  L N    +       +  Y+ PEL+  ++      D++S G I+ EL + K+PI
Sbjct: 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 31/210 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           E +G+  Y T+YK   + +G +  L+ +        P    R+      I L+  ++H N
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE------ISLMKELKHEN 59

Query: 128 LVPLLGFYAGPRGEKLIVHPF-YKRGNLAQC--IRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L   +     E  ++  F Y   +L +     G  G A   + +   +  +  G+ +
Sbjct: 60  IVRL---HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAF 115

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN---PTAGQEMLEASASQGYKA 241
            H   +R ++H +LK +N+L+++  +  ++DFGL         T   E++    +  Y+A
Sbjct: 116 CHE--NR-VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRA 168

Query: 242 PE-LIKMKDASEETDIYSFGVIMLELISGK 270
           P+ L+  +  S   DI+S G IM E+I+G+
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 23/78 (29%), Positives = 42/78 (53%)

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K +N+L+  N    + DFG    L+  +     E  A++ Y++PEL+      +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 253 ETDIYSFGVIMLELISGK 270
             D++S G I+ EL  G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 31/123 (25%), Positives = 47/123 (38%), Gaps = 38/123 (30%)

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGL-------HL-----LLNPTAGQEMLEASASQ---- 237
           IH ++K  N+LLD      +SDFGL       H      +L+       L+  +      
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 238 ---------------------GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP-INE 275
                                 Y APE+      ++E D +S GVIM E++ G  P  ++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 276 NPT 278
           NP 
Sbjct: 243 NPQ 245

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 59/312 (18%), Positives = 133/312 (42%), Gaps = 60/312 (19%)

Query: 62  EDLTICDILDAPGEVIGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGD 115
           E +T+   L       G+ ++G +Y    K +++     R+ ++ +    + R++ EF +
Sbjct: 6   EKITMSREL-------GQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 58

Query: 116 LIELLGCIRHPNLVPLLGFYAGPRGE-KLIVHPFYKRGNLAQCIR-------GGSGEA-H 166
              ++      ++V LLG  +  +G+  L++     RG+L   +R           +A  
Sbjct: 59  EASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT- 225
               + +++  IA G+ YL+       +H +L ++N ++  ++   + DFG+   +  T 
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 226 ----AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
                G+ +L       + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++
Sbjct: 174 YYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229

Query: 282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR 341
                  M   +LD        PDML                   F+L   C   +P +R
Sbjct: 230 VLRF--VMEGGLLDKPDN---CPDML-------------------FELMRMCWQYNPKMR 265

Query: 342 PNIKQVLWKLED 353
           P+  +++  +++
Sbjct: 266 PSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 31/181 (17%)

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
           S  +A G+ +L +   +  IH +L ++NILL       + DFGL   +       +++ +
Sbjct: 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGN 275

Query: 235 ASQGYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRN 291
           A    K  APE I     + E+D++S+G+++ E+ S G  P    P  D  F+       
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFY------- 327

Query: 292 AVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
                 I + Y      C+ S            + + +  +C    P  RP  KQ++  +
Sbjct: 328 ----KMIKEGYRMLSPECAPS------------EMYDIMKSCWDADPLKRPTFKQIVQLI 371

Query: 352 E 352
           E
Sbjct: 372 E 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 50/231 (21%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 75  EVIGKSNYGTLYKALL------QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL 128
           E +G+  +G +YK  L      +++ +V +            +EF     +   ++HPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------IYRI 174
           V LLG     +   +I   +    +L + +   S  +   S                  I
Sbjct: 71  VCLLGVVTKEQPLSMIF-SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
              IA G+++L +     ++H +L ++N+L+       +SD GL             E  
Sbjct: 130 VTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGL-----------FREVY 175

Query: 235 ASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           A+  YK            +PE I     S ++DI+S+GV++ E+ S G +P
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (90), Expect = 0.003
 Identities = 26/121 (21%), Positives = 42/121 (34%), Gaps = 33/121 (27%)

Query: 181 GLDYLHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG- 238
            L+YLH  G    I++ +LK +NILL  +    +SDF L    +                
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 239 ---------------------------YKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
                                      Y APE+I         D ++ G+++ E++ G  
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 272 P 272
           P
Sbjct: 231 P 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|235668 PRK06007, fliF, flagellar MS-ring protein; Reviewed

 Score = 38.7 bits (91), Expect = 0.004
 Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 6   LGLALATLLIILILIFFFYRKRL-PKEHDHNDLEINQQSKNGGEEGETEDLVTFRGGEDL 64
           L    A  L+ILILIFF  R RL P   +    E    ++    E + E  +     +D 
Sbjct: 440 LIKLAAGALLILILIFFVLRPRLRPLLPEEELAEEEAAAEEAALEEDEEAALEVELSDDE 499

Query: 65  TI 66
            +
Sbjct: 500 EL 501

Length = 542

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	356
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.11
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
COG4248	637	Uncharacterized protein with protein kinase and he	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.95
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
PRK09902	216	hypothetical protein; Provisional	98.66
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.48
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.12
PF01636	239	APH: Phosphotransferase enzyme family This family	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.01
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.99
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.95
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.95
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.94
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.77
PRK10593	297	hypothetical protein; Provisional	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.66
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.54
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.14
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.89
PRK05231	319	homoserine kinase; Provisional	96.88
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.88
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.83
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.54
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.44
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.4
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.08
COG2334	331	Putative homoserine kinase type II (protein kinase	96.06
PRK06148	1013	hypothetical protein; Provisional	95.76
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	95.69
PLN02236	344	choline kinase	95.49
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.47
PRK12396	409	5-methylribose kinase; Reviewed	95.45
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.39
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.39
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.93
PLN02756	418	S-methyl-5-thioribose kinase	94.89
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	94.74
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.51
KOG2270	520	consensus Serine/threonine protein kinase involved	94.43
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.34
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	94.02
PTZ00384	383	choline kinase; Provisional	92.99
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.83

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=404.96  Aligned_cols=251  Identities=22%  Similarity=0.383  Sum_probs=217.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|.||.||.|.++ +...+|+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++ .++||||||+.||
T Consensus       211 ~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPKGS  287 (468)
T ss_pred             HHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEecccCc
Confidence            478999999999999997 3445788887754 445578999999999999999999999998644 8999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++|+...+..+...+.+.++.|||+||+||++   +++|||||.++|||++++..+||+|||+++...++.+......
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            9999997677889999999999999999999999   9999999999999999999999999999997665555555555


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .-+..|.|||++..+.++.||||||||++|||++| |+.||.+++..+.       +.. +                 ..
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~~-l-----------------e~  419 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LEL-L-----------------ER  419 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HHH-H-----------------hc
Confidence            66788999999999999999999999999999999 9999987653221       111 1                 12


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      +.+.+.|+.||..++++|..||+.+|++|||++.+...|+++.
T Consensus       420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            3345677889999999999999999999999999999999874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-54  Score=393.37  Aligned_cols=272  Identities=32%  Similarity=0.624  Sum_probs=228.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .++||+|+||.||+|...++ ..+|+|.+........++|.+|++++.+++|||+|+++|||.+.+.+.+||+|||++||
T Consensus        80 ~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGs  158 (361)
T KOG1187|consen   80 SNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGS  158 (361)
T ss_pred             hcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCC
Confidence            47899999999999999854 77888877654433156799999999999999999999999854435999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++|+.....+++|.++++||.++|+||+|||..+.++|+||||||+|||+|+++++||+|||+++..... .......
T Consensus       159 L~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~  237 (361)
T KOG1187|consen  159 LEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTT  237 (361)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeee
Confidence            999998654438999999999999999999999988889999999999999999999999999999654321 1222222


Q ss_pred             -cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 -SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 -~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                       .||.+|+|||+...+..+.|+||||||++++|++||+.|.+... ......+..|....+.+..+.+..|+.+..    
T Consensus       238 ~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~----  312 (361)
T KOG1187|consen  238 VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLREIVDPRLKE----  312 (361)
T ss_pred             cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHCcchhheeCCCccC----
Confidence             89999999999999999999999999999999999998877543 233344788888877777888888887631    


Q ss_pred             CCCCCCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSE-ERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ...+. .....+..++..|++.+|++||+|.++++.|+.+.
T Consensus       313 ---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  313 ---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             ---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence               22332 67888999999999999999999999999997654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-54  Score=390.57  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=210.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|.++ +...+|+|.+.......  .++|.+|+.+|++++|||||+++|+|..+.+..++|||||++
T Consensus        46 ~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            466999999999999997 33338899887654333  348999999999999999999999999766579999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP-IIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      |+|.++++......+++..++.++.|||.||.|||+   .+ ||||||||+|+|++.++ ++||+|||+++...... ..
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~  200 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS  200 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence            999999986456789999999999999999999999   77 99999999999999997 99999999998754332 23


Q ss_pred             eecccCCCcccCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 MLEASASQGYKAPELIK--MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .....||..|||||++.  ...|+.|+||||||+++|||+||..||.+.....    ....+.                 
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~~v~-----------------  259 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ----VASAVV-----------------  259 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-----------------
Confidence            33468999999999999  5689999999999999999999999998754311    111110                 


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ..+.+...+..++..+..+|.+||+.||+.||++.+++..|+.+.
T Consensus       260 ---~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  260 ---VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence               011223345558888999999999999999999999999998763

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.8e-54  Score=407.08  Aligned_cols=253  Identities=24%  Similarity=0.429  Sum_probs=216.0

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|.||+||+|...     +....||||.++..... ..++|++|+++++.++|||||+|+|+|.. ++.+++|+|
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~P~~MvFE  569 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GDPLCMVFE  569 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CCeeEEEEE
Confidence            477999999999999875     23468999999987666 55799999999999999999999999995 458999999


Q ss_pred             cccCCChhHhhhcC--------CCCC----CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          148 FYKRGNLAQCIRGG--------SGEA----HKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       148 ~~~~gsL~~~l~~~--------~~~~----~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ||..|||.+||+..        .+.+    ++..+.+.||.|||.||.||-+   +.+|||||..+|||+.++..|||+|
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecc
Confidence            99999999999631        1223    7889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCccee-cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          216 FGLHLLLNPTAGQEML-EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ||+++.....++.+.. ...-+.+||+||.+..+.||++||||||||++||++| |..||.+....+.        ...+
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--------Ie~i  718 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--------IECI  718 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--------HHHH
Confidence            9999887665555443 4556889999999999999999999999999999999 9999987654332        1111


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .                 .+.-.+.|++||.++++||..||+.+|++||+++||-..|+++.
T Consensus       719 ~-----------------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  719 R-----------------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             H-----------------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            1                 22234578899999999999999999999999999999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-52  Score=360.18  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=206.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ...||+|..|+||++.++.+++.+|+|.+...... ..+++.+|+++++..+||+||.+||.|..+.....++||||.+|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            47899999999999999999999999999654333 33689999999999999999999999885443599999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      ||+.++..  .+.+++...-+++.++++||.|||..  .+|+||||||+|+|++..|.+||||||.+....++   ...+
T Consensus       164 SLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t  236 (364)
T KOG0581|consen  164 SLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT  236 (364)
T ss_pred             CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence            99999974  36799999999999999999999954  89999999999999999999999999999876544   3357


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..||..|||||-+.++.|+.++||||||+.++|+++|+.||.......  ....+.+. .+.               .+.
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~~~Ll~-~Iv---------------~~p  298 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDIFELLC-AIV---------------DEP  298 (364)
T ss_pred             ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCHHHHHH-HHh---------------cCC
Confidence            789999999999999999999999999999999999999997641111  11111111 111               111


Q ss_pred             CCCCCCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          313 NHENPVSE-ERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       313 ~~~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ....+. .++.++.+++..||++||.+||+++++++
T Consensus       299 --pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  299 --PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              112333 37788999999999999999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=387.62  Aligned_cols=252  Identities=25%  Similarity=0.459  Sum_probs=215.9

Q ss_pred             CCcccccCCceEEEEEEcCCC---eEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +++||.|.||.|++|.++..+   ..||+|.++.-...+. .+|..|..+|..+.||||++|.|+.... ...+++.|||
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-~PvMIiTEyM  712 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-KPVMIITEYM  712 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-ceeEEEhhhh
Confidence            589999999999999998554   6799999987655444 5899999999999999999999988854 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|+.||+.+.++ +++.++..|+++|+.||.||-+   .++|||||.++|||++.+..+|++|||+++...+.....
T Consensus       713 ENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  713 ENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            999999999976655 9999999999999999999999   999999999999999999999999999999875433222


Q ss_pred             --eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 --MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                        .....-+.+|.|||.+....++.+|||||||+++||.++ |..||.+++..+..        +.+             
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI--------kaI-------------  847 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI--------KAI-------------  847 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH--------HHH-------------
Confidence              222233678999999999999999999999999999888 99999887653321        111             


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                          ..+.+.+.|.+|+..|++||..||++|-++||++.+|+..|+++.
T Consensus       848 ----e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  848 ----EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             ----HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                123355678899999999999999999999999999999999975

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-51  Score=356.19  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=202.7

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-------hHHHHHHHHHHhccCCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.|-+|..+.+|+.+|+|++.......       ....++|+++|++++|||||+++++|..++ ..|
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-s~Y  252 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-SSY  252 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-ceE
Confidence            344688999999999999999999999999997542222       234679999999999999999999999655 789


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEecccccc
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHL  220 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~  220 (356)
                      +||||+.||+|.+++-.  ...+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+|+
T Consensus       253 mVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999963  3456666678899999999999999   999999999999999866   789999999999


Q ss_pred             ccCCCCCcceecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          221 LLNPTAGQEMLEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ...  .+..+.+.+||+.|.|||++.+..   +..+.|+||+||++|-++||.+||++......   +.+.    +..++
T Consensus       328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~eQ----I~~G~  398 (475)
T KOG0615|consen  328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKEQ----ILKGR  398 (475)
T ss_pred             ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHHH----HhcCc
Confidence            865  355567889999999999998654   34578999999999999999999987543321   1111    11111


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .              .-......+..++..+|+.+||..||++|||++++++
T Consensus       399 y--------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  399 Y--------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             c--------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1              1111234567788899999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-50  Score=351.86  Aligned_cols=195  Identities=26%  Similarity=0.427  Sum_probs=173.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||+||+|+++.++..||+|.+....  ....+.+..|+.+|+.++|||||.+++++.++ +..++|||||.+|
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-DFIYLVMEYCNGG   94 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-CeEEEEEEeCCCC
Confidence            56999999999999999999999999987653  23335688999999999999999999988854 4999999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC------CCeEEeccccccccCCCC
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN------YQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~~~~~~~~~  226 (356)
                      +|..+++.  ...+++.....++.|++.||++||+   ++|+||||||+|||++..      -.+||+|||+++...+  
T Consensus        95 DLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~--  167 (429)
T KOG0595|consen   95 DLSDYIRR--RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP--  167 (429)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc--
Confidence            99999984  4479999999999999999999999   999999999999999865      4589999999998763  


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      ..-..+.+|++.|||||++..+.|+.|+|+||.|+++|++++|..||...+
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            333457799999999999999999999999999999999999999998543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-50  Score=365.24  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=210.3

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      |..+++||+|||+.||.+.+..+|+++|+|++.+....   ..+...+|+++.+.|+|||||+++++|++.+ +.|+|.|
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-nVYivLE   98 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-NVYIVLE   98 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-ceEEEEE
Confidence            45579999999999999999889999999999764322   3357899999999999999999999999654 9999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.+++|..+++  ..+++++..+..++.||+.||.|||+   .+|+|||||..|+|++++.++||+|||+|.....+ .
T Consensus        99 LC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~  172 (592)
T KOG0575|consen   99 LCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G  172 (592)
T ss_pred             ecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence            999999999998  56789999999999999999999999   99999999999999999999999999999887643 3


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....+.+||+.|.|||++.....+..+||||+||++|-|++|++||...+-.+        ....+   ...        
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~I---k~~--------  233 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKI---KLN--------  233 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHH---Hhc--------
Confidence            45668899999999999999999999999999999999999999998642111        11111   111        


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             +...|...+.+..+||..+|+.||.+|||+++|+.
T Consensus       234 -------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 -------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   12234456667889999999999999999999985

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=393.00  Aligned_cols=254  Identities=23%  Similarity=0.386  Sum_probs=211.1

Q ss_pred             CCCcccccCCceEEEEEEcCC-C----eEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRS-G----SVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~-~----~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .++.||+|.||.||.|..... +    ..||+|.++.... ....+|.+|..+|++++|||||+++|+|.+ .+..++++
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~i~l  774 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPLILL  774 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcEEEe
Confidence            458899999999999988632 2    2377777765543 344689999999999999999999999997 56899999


Q ss_pred             ecccCCChhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          147 PFYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      |||++|+|..||++.+     ...++....+.++.|||+|+.||++   +++|||||.++|||++....+||+|||+|+.
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHh
Confidence            9999999999998532     3458889999999999999999999   9999999999999999999999999999995


Q ss_pred             cCCCCCcce-ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          222 LNPTAGQEM-LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       222 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      .....+... ....-+.+|||||.+..+.++.|||||||||++||++| |..||...+..+.       +. .+.     
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------~~-~~~-----  918 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------LL-DVL-----  918 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------HH-HHH-----
Confidence            544433333 23355788999999999999999999999999999999 9999986543221       11 011     


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                  ...+.+.|..|++.++++|.+||+.+|++||++..|+++++++.
T Consensus       919 ------------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  919 ------------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ------------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                        12245678889999999999999999999999999999988764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=342.32  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=203.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCC-ceEEEEecccC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-EKLIVHPFYKR  151 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~~~~  151 (356)
                      .++.||+|+||.||++...++|...|+|..........+.+.+|+.+|++++|||||+++|......+ .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            45889999999999999998899999998876533335679999999999999999999996554443 68999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCC--CCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNP--TAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~--~~~~  228 (356)
                      |||.+++.+..+ .+++..+..+..||++||+|||+   ++++||||||+|||++. ++.+||+|||++.....  ....
T Consensus       101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen  101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence            999999986555 79999999999999999999999   99999999999999999 79999999999887653  2223


Q ss_pred             ceecccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......||+.|||||++..+. ...++|||||||++.||+||..||...      ............             
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~-------------  237 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGR-------------  237 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhc-------------
Confidence            344678999999999998643 345999999999999999999999863      000011110000             


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                          .......+...+.+..+++..|++.||++||||++++..
T Consensus       238 ----~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  238 ----EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ----cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                001113455577788899999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-49  Score=327.33  Aligned_cols=251  Identities=20%  Similarity=0.309  Sum_probs=201.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccc-eeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG-FYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~~~~lv~e~~~~  151 (356)
                      ++||+|+||+||++....+|..+|.|-++-...+  ..++...|+.+|+.|+|||||++++ .+..+..-++++||+|..
T Consensus        25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~  104 (375)
T KOG0591|consen   25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA  104 (375)
T ss_pred             HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence            7899999999999999999999999887633222  2357899999999999999999999 444334348999999999


Q ss_pred             CChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |+|.+.++.  ...+.+++..++++..|++.||.++|+-... .++||||||.||+++.+|.+||+|||+++.+.... .
T Consensus       105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-t  183 (375)
T KOG0591|consen  105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-T  183 (375)
T ss_pred             cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh-H
Confidence            999999964  3456799999999999999999999983222 38999999999999999999999999999876432 2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      -..+..|||.||+||.+...+|+.+|||||+||++|||+.-+.||.+.+-       . .+...+....           
T Consensus       184 fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------~-~L~~KI~qgd-----------  244 (375)
T KOG0591|consen  184 FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------L-SLCKKIEQGD-----------  244 (375)
T ss_pred             HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-------H-HHHHHHHcCC-----------
Confidence            33467899999999999999999999999999999999999999987521       1 1111111110           


Q ss_pred             ccCCCCCCCCc-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          309 CSNSNHENPVS-EERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       309 ~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                            -.+.| +-.+..+..|+..|+..||+.||+...++..+
T Consensus       245 ------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  245 ------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                  01133 55678899999999999999999854444433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.5e-48  Score=325.34  Aligned_cols=265  Identities=18%  Similarity=0.283  Sum_probs=204.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .++|+|+||+||+++.+++|++||+|.+.....+.  .+-..+|+++|+.++|||+|.++.+|.. +..++||+|||.. 
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVFE~~dh-   85 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVFEYCDH-   85 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEeeecch-
Confidence            56999999999999999999999999987544322  2457899999999999999999999985 4489999999998 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      ++.+-|.. ....++...+.+++.|++.|+.|+|+   ++++||||||+|||++.++.+||||||+|+.... .+..-+.
T Consensus        86 TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTD  160 (396)
T KOG0593|consen   86 TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTD  160 (396)
T ss_pred             HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhh
Confidence            55455543 33468889999999999999999999   9999999999999999999999999999998764 2333446


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh--------cccccccC
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD--------HRITDLYH  303 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~  303 (356)
                      ...|.+|+|||.+.+ .+|..+.||||.||++.||++|.+.|.+.+..+....+..-+.+...+        +.......
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            678999999999987 689999999999999999999999998876554433333322222211        11111111


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      |.+...  +..+ .-.++....+.+++..||+.||.+|++.++++.
T Consensus       241 P~~~~~--epLe-~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHP--EPLE-RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCc--cchh-hhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111000  0000 112234557889999999999999999999874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=355.63  Aligned_cols=253  Identities=25%  Similarity=0.371  Sum_probs=217.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ...+||.|.||.||.|.|+.-...+|+|.++.. ....++|..|..+|+.++|||+|+++|+|..+. .+|||+|||.+|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-PFYIiTEfM~yG  348 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-PFYIITEFMCYG  348 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-CeEEEEecccCc
Confidence            357899999999999999999999999998753 445679999999999999999999999998544 899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.++|+.-..+.++.-..+.++.||++||+||..   +++|||||.++|||+.++..+|++|||+++.+..+.++....
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            99999987777778888899999999999999999   999999999999999999999999999999987766665555


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..-++.|.|||.+..+.++.|+|||+|||+|||+.| |..||.+.+...       . ... .+                
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------V-Y~L-LE----------------  480 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------V-YGL-LE----------------  480 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------H-HHH-Hh----------------
Confidence            555788999999999999999999999999999999 999998753211       1 111 11                


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .+.+-.-++.|+..+++||++||+.+|.+||++.++-+.+|.+-
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            01111246678889999999999999999999999999999863

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=350.54  Aligned_cols=239  Identities=28%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +-||+|+.|.||+|+++  ++.||+|.++.       .-+.+|+.|++|+||||+.|.|+|.... .+|||||||..|-|
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccccccH
Confidence            56999999999999996  55677776542       2345788999999999999999998654 78999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      ...|+  .+..++...+..+..+||.||.|||.   +.|||||||+-||||+.+..+||+|||-++.....  .....++
T Consensus       200 ~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  200 YEVLK--AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             HHHHh--ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            99998  45678888999999999999999999   99999999999999999999999999998765432  4456889


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ||..|||||++.+.+.+.|.|||||||+||||+||..||.+.+.....+.                        .+.-..
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG------------------------VGsNsL  328 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG------------------------VGSNSL  328 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe------------------------ccCCcc
Confidence            99999999999999999999999999999999999999987543222110                        111122


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ..+.+..|++-+.-|+++||+..|.+||++.+|+..|+-+
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            3457888899999999999999999999999999999754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=335.54  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=209.1

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ...+.||.|..++||+|.....+++||+|++........ ..+.+|+..|+.++||||++++..|.. +..+|+||.||.
T Consensus        29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVmpfMa  107 (516)
T KOG0582|consen   29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVMPFMA  107 (516)
T ss_pred             eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEeehhhc
Confidence            334789999999999999999999999999987655554 789999999999999999999999885 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +||+.+.++......+++..+..|+.++++||.|||.   +|.+|||||+.||||+.+|.+||+|||.+..+........
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            9999999987777779999999999999999999999   9999999999999999999999999999876654332211


Q ss_pred             ---ecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 ---LEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 ---~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                         ....|+++|||||++..  ..|+.|+||||||++..|+.+|..||...+...+.      +.....+..       .
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~pp-------~  251 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDPP-------T  251 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCCC-------C
Confidence               34588999999999764  36999999999999999999999999987643321      111100000       0


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +.   ...............+.+++..||+.||++|||++++++
T Consensus       252 ~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00   011111123345567899999999999999999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=356.08  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             CCcccccCCceEEEEEEcCCC---eE-EEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSG---SV-RLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~---~~-~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +++||+|.||.||+|.++..+   .. ||+|..+...   .....+|.+|.++|+.++|||||+++|++... .++++||
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-~Pl~ivm  240 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-EPLMLVM  240 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CccEEEE
Confidence            488999999999999987532   23 7999887522   23346899999999999999999999998854 4899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      |+|.||+|.++|+.... .++..+...++.+.|.||+|||+   ++++||||.++|||++.++.+||+|||+++.-.. .
T Consensus       241 El~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~  315 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-Y  315 (474)
T ss_pred             EecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc-e
Confidence            99999999999985333 69999999999999999999999   9999999999999999999999999999876431 1


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+....        .+...+..          
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~----------  377 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVK----------  377 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHh----------
Confidence            111112245788999999999999999999999999999999 89999875432        11111111          


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            .+.+-+.+...+..+..++.+||..+|++||+|.++.+.|+.+.
T Consensus       378 ------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  378 ------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             ------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence                  01112234456777889999999999999999999999999864

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-48  Score=333.33  Aligned_cols=236  Identities=22%  Similarity=0.318  Sum_probs=197.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ++||+|+||+||.++.+++++.+|+|++++..-..   .+...+|..+|..++||+||+++..|++++ .+|+|++|+.|
T Consensus        31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kLylVld~~~G  109 (357)
T KOG0598|consen   31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KLYLVLDYLNG  109 (357)
T ss_pred             eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eEEEEEeccCC
Confidence            88999999999999999999999999998654332   356889999999999999999999999655 89999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.|..+|.  ....+++..+.-++..|+.||.|||+   .+|+||||||+|||+|.+|+++|+|||+|+..-. .+....
T Consensus       110 GeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~~~t~  183 (357)
T KOG0598|consen  110 GELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DGDATR  183 (357)
T ss_pred             ccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-CCCccc
Confidence            99999997  34568898899999999999999999   9999999999999999999999999999986432 233445


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      +.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+...        +...+...+.             
T Consensus       184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~-------------  242 (357)
T KOG0598|consen  184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKL-------------  242 (357)
T ss_pred             cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcC-------------
Confidence            6899999999999999999999999999999999999999998654322        1111111110             


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP  342 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  342 (356)
                          ...+.-...+..+++...|+.||++|.
T Consensus       243 ----~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ----PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                011122345667899999999999995

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=348.14  Aligned_cols=263  Identities=26%  Similarity=0.403  Sum_probs=207.4

Q ss_pred             ccchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCC
Q 038580           63 DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG  140 (356)
Q Consensus        63 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  140 (356)
                      .+.+.......+..||+|+||+||+|.|..+   ||||++......  ..+.|++|+..+++-+|.||+-|.|+|..+. 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-  461 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-  461 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-
Confidence            3333333344568899999999999999743   788888654333  3368999999999999999999999998544 


Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                       ..+|+.+|+|.+|..+++..+ ..++..+...|+.||++||.|||.   ++|+|||||..|||+.++++|||+|||++.
T Consensus       462 -~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 -LAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence             499999999999999998644 568999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCC-CCCcceecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          221 LLNP-TAGQEMLEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       221 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      .-.. ..........+...|||||+++.   .+|+..|||||||+++|||+||..||.........+..           
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-----------  605 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-----------  605 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-----------
Confidence            5322 22233344567788999999974   47999999999999999999999999843322221111           


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       ...+..+++         .....++++++.+|+..||..++++||.+.+|+..|+++.
T Consensus       606 -GrG~l~pd~---------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  606 -GRGYLMPDL---------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             -cccccCccc---------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence             111111111         1134567889999999999999999999999999888764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-47  Score=341.16  Aligned_cols=270  Identities=21%  Similarity=0.292  Sum_probs=210.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|++..+|++||+|.++.....  ...-..+||.+|++|+||||+++.+...+. .+.+|+|+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            47899999999999999999999999998765432  235678999999999999999999987765 468999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      + +|.-++.. ....++..++..++.|++.||+|||+   .+++|||||.+|||||++|.+||+|||++++++.......
T Consensus       202 h-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~  276 (560)
T KOG0600|consen  202 H-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY  276 (560)
T ss_pred             c-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence            8 99888863 35579999999999999999999999   9999999999999999999999999999998877766666


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      +...-|.+|+|||++.+. .|+...|+||.||++.||++|++.|.+.+..+....+.+...... +.-|.....|....+
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~-e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT-EDYWPVSKLPHATIF  355 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC-hhccccccCCccccc
Confidence            777889999999998865 699999999999999999999999988655443333333222111 111111111111100


Q ss_pred             cCCCC-CC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNH-EN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~-~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..... ..   ......+....+|+..+|..||.+|.||.+.+.
T Consensus       356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00000 00   012234556778999999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-47  Score=346.64  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             CCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEE
Q 038580           72 APGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ...+.||+|+||.||+|.+.     .++..+|+|.++..... ....+.+|+.+++.+ +||||++++++|..+++..++
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l   89 (338)
T cd05102          10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV   89 (338)
T ss_pred             eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence            34588999999999999752     34567999988754322 235688999999999 899999999998876667899


Q ss_pred             EEecccCCChhHhhhcCC------------------------------------------------------------CC
Q 038580          145 VHPFYKRGNLAQCIRGGS------------------------------------------------------------GE  164 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~------------------------------------------------------------~~  164 (356)
                      +|||+++|+|.+++....                                                            ..
T Consensus        90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (338)
T cd05102          90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS  169 (338)
T ss_pred             EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence            999999999999986321                                                            13


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-cceecccCCCcccCcc
Q 038580          165 AHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPE  243 (356)
Q Consensus       165 ~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE  243 (356)
                      ++++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....... .......++..|+|||
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  246 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE  246 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence            47788889999999999999999   9999999999999999999999999999876432211 1122334567899999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHH
Q 038580          244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEER  322 (356)
Q Consensus       244 ~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (356)
                      ++.+..++.++||||||+++|||++ |..||.+.....       ..........                 ....+...
T Consensus       247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~-----------------~~~~~~~~  302 (338)
T cd05102         247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGT-----------------RMRAPENA  302 (338)
T ss_pred             HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCC-----------------CCCCCCCC
Confidence            9998899999999999999999997 999997643211       1111111100                 00112334


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          323 ILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       323 ~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      +..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=343.34  Aligned_cols=258  Identities=20%  Similarity=0.316  Sum_probs=210.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .++||+|.||.|.++... ++..||+|.++....... ++|..|+++|.+++|||||.++|+|..+ +.+++++|||++|
T Consensus       543 ~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-ePicmI~EYmEnG  620 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-DPLCMITEYMENG  620 (807)
T ss_pred             hhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-CchHHHHHHHhcC
Confidence            578999999999999986 468899999998766665 7999999999999999999999999964 4899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-ee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-ML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~  231 (356)
                      +|.+|+....-....-....+|+.||++||+||.+   .++||||+.++|||+|.++++||+|||+++.+....+.. ..
T Consensus       621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence            99999975533334555677899999999999999   999999999999999999999999999998665444433 34


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS--GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+.+|||+|.+..+.++.+||+|+||+++||+++  .+.||+..+....    .+..... .+.......       
T Consensus       698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~-~~~~~~~~~-------  765 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEF-FRDQGRQVV-------  765 (807)
T ss_pred             ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhh-cCCCCccee-------
Confidence            5566889999999999999999999999999999876  8899986543221    1111111 111111111       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ...|.-|+..++++|.+||..|.++||+++++...|++.
T Consensus       766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  123556788999999999999999999999999998865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-48  Score=341.42  Aligned_cols=268  Identities=21%  Similarity=0.241  Sum_probs=208.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchH-HHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-EFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||.|+||.||+|+...++..||+|.++.......+ .-.+|+..|++++ |||||++..++.+.+..+++|||||..
T Consensus        15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~   94 (538)
T KOG0661|consen   15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC   94 (538)
T ss_pred             HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence            37899999999999999999999999988766554443 3578999999999 999999999998766689999999987


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+.++++ +..+++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+|+....  ..+-+
T Consensus        95 -NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--kpPYT  167 (538)
T KOG0661|consen   95 -NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS--KPPYT  167 (538)
T ss_pred             -hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc--CCCcc
Confidence             999999876 7899999999999999999999999   9999999999999999888999999999987643  22334


Q ss_pred             cccCCCcccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc-----cccccCcc
Q 038580          232 EASASQGYKAPELIK-MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR-----ITDLYHPD  305 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  305 (356)
                      ....|++|+|||++. .+.|+.+.|||++||+++|+.+-++.|.+.+..+....+-+.+.....+.+     +.....-+
T Consensus       168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~  247 (538)
T KOG0661|consen  168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR  247 (538)
T ss_pred             hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence            678899999999875 567899999999999999999999999886654432222222111110000     00000111


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+.+.... ..-.+++.+..+++.+|++.||.+||||++.++
T Consensus       248 ~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  248 FPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            1111111111 112237778889999999999999999999886

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.7e-46  Score=331.89  Aligned_cols=258  Identities=20%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             cchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeC--C
Q 038580           64 LTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAG--P  138 (356)
Q Consensus        64 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  138 (356)
                      ++..++.......||+|++|.||+|.+  +++.+|+|.++......   .+.+.+|+.++++++||||++++|++.+  +
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            344444333346799999999999998  57889999887653333   3567899999999999999999998864  2


Q ss_pred             -CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccc
Q 038580          139 -RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG  217 (356)
Q Consensus       139 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  217 (356)
                       ....+++|||+++|+|.++++.  ...+++.....++.|++.||.|||+.  .+++||||||+||++++++.+||+|||
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccc
Confidence             2468999999999999999974  34688999999999999999999972  378899999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          218 LHLLLNPTAGQEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      ++.......    ....++..|+|||++.+  ..++.++||||||+++|||++|..||.+.+..       .... ....
T Consensus       169 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~-~i~~  236 (283)
T PHA02988        169 LEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYD-LIIN  236 (283)
T ss_pred             hHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHH-HHHh
Confidence            987643221    23457788999999976  67899999999999999999999999754311       1111 1100


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .                ..+.+.+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       237 ~----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        237 K----------------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             c----------------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            0                0011123345677899999999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.8e-46  Score=310.34  Aligned_cols=271  Identities=20%  Similarity=0.263  Sum_probs=207.4

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..+++|+|.||.||+|++..+|+.||+|.++......  .....+|++.|+.++||||+.++++|-. .+.+-+|+|||+
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVfEfm~   84 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVFEFMP   84 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEEEecc
Confidence            3478999999999999999999999999987653332  3568999999999999999999999875 458999999998


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      . +|...+++ ....++...+..++.++++|++|||+   +.|+||||||.|+|++.+|.+||+|||+++.+....... 
T Consensus        85 t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-  158 (318)
T KOG0659|consen   85 T-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-  158 (318)
T ss_pred             c-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence            7 99999985 45678899999999999999999999   999999999999999999999999999999876543332 


Q ss_pred             ecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc--
Q 038580          231 LEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML--  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  307 (356)
                      ....-|..|+|||.+.+ ..|+...||||.||++.||+-|.+-|.+.+..+....+..-......+.+......|+-.  
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            23367899999998875 469999999999999999999998888765443322222222211111111111112111  


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ...+.......-..+.+...+|+..+|..||.+|++++|.++.
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1011111111223455566899999999999999999998863

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=340.87  Aligned_cols=253  Identities=21%  Similarity=0.376  Sum_probs=219.2

Q ss_pred             CCCCcccccCCceEEEEEEcCC----CeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRS----GSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~----~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..++.||+|.||.||+|.....    .--||+|..+...+.. .+.|..|..+|++++|||||+++|+|..  ...++||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEEE
Confidence            3468899999999999987532    2357899988755443 4689999999999999999999999984  4799999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      |.++.|.|..+|+.+ ...++......++.||+.||+|||+   ..+|||||.++|||+....-+|++|||+++......
T Consensus       470 EL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999854 4568999999999999999999999   999999999999999999999999999999987776


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ........-+..|||||.+....++.+||||.|||.+||+++ |..||.+....+....+                    
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------------------  605 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------------------  605 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--------------------
Confidence            666666667888999999999999999999999999999998 99999987655543222                    


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                           ..+.+.+.|++|+..++.||.+||.+||.+||++.+|...|.++.
T Consensus       606 -----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  606 -----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                 233456788999999999999999999999999999999998864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-47  Score=342.64  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=210.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      -..||+|..|.||.|....++..||+|.+........+-+.+|+.+|+..+|+|||+++..|.-. +.+|+|||||++|+
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ggs  356 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYMEGGS  356 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecCCCc
Confidence            36799999999999999999999999999888777888899999999999999999999988744 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+.+.   ...+++.++..|+.+++.||+|||.   ++|+|||||.+|||++.+|.+||+|||+|..+..... .....
T Consensus       357 LTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~Tm  429 (550)
T KOG0578|consen  357 LTDVVT---KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTM  429 (550)
T ss_pred             hhhhhh---cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccc
Confidence            999985   3458999999999999999999999   9999999999999999999999999999988765433 44567


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .||+.|||||+.....|+.+.||||||++++||+-|++||-..+...      .  ...+               ..+..
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------A--lyLI---------------a~ng~  486 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------A--LYLI---------------ATNGT  486 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------H--HHHH---------------hhcCC
Confidence            89999999999999999999999999999999999999986422111      0  0000               11122


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +....++..+..+.+++.+||+.||++||++.++|+
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            334456677888999999999999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=336.22  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=207.9

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ..++||+|.||.||+|.+..+++.||+|++....... .++++.|+.++..++++||.++||.+.. +..++++||||.+
T Consensus        17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~~g   95 (467)
T KOG0201|consen   17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYCGG   95 (467)
T ss_pred             cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHHhcC
Confidence            3478999999999999999999999999998765444 3689999999999999999999998884 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |++.+.++.  +..+++..+.-++.++..|+.|||+   .+.+|||||+.|||+..+|.+|++|||++...+...... .
T Consensus        96 Gsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~  169 (467)
T KOG0201|consen   96 GSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K  169 (467)
T ss_pred             cchhhhhcc--CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence            999999973  3344666677788899999999999   999999999999999999999999999998876655444 6


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      +..||+.|||||++....|+.|+||||||++.+||++|.+|+.+.......+.+++..                      
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~----------------------  227 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA----------------------  227 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC----------------------
Confidence            8899999999999998899999999999999999999999999876644333332211                      


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         .......+...+.+++..||+.||+.||+|.++++.
T Consensus       228 ---PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 ---PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence               111122455568899999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=335.40  Aligned_cols=244  Identities=26%  Similarity=0.405  Sum_probs=203.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccc----cc-cchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV----CT-TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ..++.||+|+||+|+.|.+..++..+|+|++...    .. ...+.+.+|+.+++.++ ||||++++.++..+. ..++|
T Consensus        20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~~~iv   98 (370)
T KOG0583|consen   20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-KIYIV   98 (370)
T ss_pred             eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-eEEEE
Confidence            3458899999999999999999999999987654    11 22346778999999999 999999999999766 69999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEeccccccccCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNP  224 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~  224 (356)
                      |||+.+|+|.+++..  ..++.+..+..++.|+++|++|||+   .+|+||||||+|+|+|.+ +++||+|||++.... 
T Consensus        99 mEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-  172 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-  172 (370)
T ss_pred             EEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence            999999999999985  5678889999999999999999999   999999999999999999 999999999998764 


Q ss_pred             CCCcceecccCCCcccCccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          225 TAGQEMLEASASQGYKAPELIKMKD-AS-EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      .........+||+.|+|||++.+.. |+ .++||||+|+++|-|++|..||.+.+...       .... +.        
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~k-i~--------  236 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRK-IR--------  236 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHH-Hh--------
Confidence            2334556789999999999999877 75 78999999999999999999998732111       1111 11        


Q ss_pred             CcccccccCCCCCCCCcHHH-HHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEER-ILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                                ..+..++... ..++.+|+.+||..||.+|+++.+|+
T Consensus       237 ----------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  237 ----------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ----------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                      1111233333 66788999999999999999999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-46  Score=334.21  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..++.||+|+|++|++|..+.+++.+|+|++.+.--   ...+-...|-..|.+| .||.|++|+..|+++. .+|+|+|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-sLYFvLe  154 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-SLYFVLE  154 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-ceEEEEE
Confidence            346889999999999999999999999999875422   2224567788888888 7999999999999654 8999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++|+|.++++  ....+++....-++.+|+.||+|||+   .|||||||||+|||+|+|+++||.|||.++.+++...
T Consensus       155 ~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  155 YAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             ecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            999999999997  34678888899999999999999999   9999999999999999999999999999987754322


Q ss_pred             c----------ce--ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          228 Q----------EM--LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       228 ~----------~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      .          ..  ..+.||..|.+||++..+..++.+|+|+|||++|.|+.|.+||.+.+...    +.+.+..    
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----iFqkI~~----  301 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----IFQKIQA----  301 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----HHHHHHH----
Confidence            1          11  35789999999999999999999999999999999999999998754211    1111111    


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                                        .+..+++..++.+.+|+...|..||.+|+++++|.+.
T Consensus       302 ------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 ------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                              1223566667788899999999999999999988753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=333.65  Aligned_cols=241  Identities=21%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||.||||+.+.+.++||+|++.+.....  .+.+.+|+++++.++|||||.++.+|++.. ++++|.||+.+ 
T Consensus         8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-~~~vVte~a~g-   85 (808)
T KOG0597|consen    8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-HLWVVTEYAVG-   85 (808)
T ss_pred             HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-eEEEEehhhhh-
Confidence            77999999999999999999999999987643333  256899999999999999999999999654 99999999987 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|..++..  ...+++..+..++.+++.||.|||+   .+|.|||+||+|||++.++++|+||||+++.+.. .......
T Consensus        86 ~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vlts  159 (808)
T KOG0597|consen   86 DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTS  159 (808)
T ss_pred             hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cceeeee
Confidence            99999973  5679999999999999999999999   9999999999999999999999999999988653 2334457


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..||+-|||||+..+++|+..+|+||+||++||+++|++||....       +...+. .+.       .+         
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~-~I~-------~d---------  215 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVK-SIL-------KD---------  215 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHH-HHh-------cC---------
Confidence            789999999999999999999999999999999999999996421       111111 110       01         


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ...++......+..++...|++||.+|.+..+++.
T Consensus       216 --~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 --PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              11245567788999999999999999999988764

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.9e-45  Score=325.83  Aligned_cols=248  Identities=19%  Similarity=0.237  Sum_probs=198.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..++..+|+|.+......   ....+.+|+++++.++|+||+++++++.+ ++..+++|||++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e~~~   83 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEEecC
Confidence            37799999999999999989999999988643222   22357889999999999999999998875 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++.......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++......  ...
T Consensus        84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  158 (285)
T cd05631          84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETV  158 (285)
T ss_pred             CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--Cee
Confidence            9999988865444568999999999999999999999   99999999999999999999999999998764322  122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|+..|+|||++.+..++.++|||||||++|||++|..||........    ...........              
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~--------------  220 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKED--------------  220 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcc--------------
Confidence            345688999999999999999999999999999999999999986433211    11111111000              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                          ....+...+..+.+|+.+||+.||++||+     ++++++
T Consensus       221 ----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 ----QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ----cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                01122334557889999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-44  Score=320.92  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=199.7

Q ss_pred             CCCcccccCCceEEEEEEc---CCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           73 PGEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..+.||+|+||.||+|.++   ..+..+|+|.++...... ...+.+|+..++.++||||+++++++.. ++..++||||
T Consensus         9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   87 (266)
T cd05064           9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMIVTEY   87 (266)
T ss_pred             EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEEEEEe
Confidence            3578999999999999875   345788999887643322 3478899999999999999999998875 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+.........
T Consensus        88 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          88 MSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            9999999999743 3468899999999999999999999   99999999999999999999999999986553222111


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+.+..++.++||||||+++||+++ |..||......       . ......+.           
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~~~-----------  224 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------D-VIKAVEDG-----------  224 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHHCC-----------
Confidence            1222334567999999998999999999999999999775 99999754321       1 11111100           


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ...+.+..++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       225 ------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                  01112344567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-45  Score=324.24  Aligned_cols=248  Identities=29%  Similarity=0.527  Sum_probs=193.3

Q ss_pred             CcccccCCceEEEEEEc----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +.||.|.||.||+|.+.    ..+..|++|.++..... ..+++.+|++.+++++||||++++|+|.. .+..++|+||+
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e~~   83 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE--
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccccc
Confidence            67999999999999998    44678899999654332 24689999999999999999999999984 44799999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-c
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-Q  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  228 (356)
                      ++|+|.+++.......+++..+..|+.|++.||+|||+   .+++|+||+++||+++.++.+||+|||++........ .
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999987656789999999999999999999999   9999999999999999999999999999877632211 1


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ..........|+|||.+....++.++||||||+++||+++ |..||.+.+       ...... ...+..          
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~-~~~~~~----------  222 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIE-KLKQGQ----------  222 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHH-HHHTTE----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccc-cccccc----------
Confidence            2223345677999999998889999999999999999999 778876532       111111 111111          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                             ..+.+..++..+.+++.+||+.||++||++.++++.|
T Consensus       223 -------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 -------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   0112334566788999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=366.12  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=202.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+..++..+|+|.++....    ....|++.+++++|||||+++|+|.++ +..++||||+++|
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~Ey~~~g  768 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIHEYIEGK  768 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC-CCCEEEEeCCCCC
Confidence            34789999999999999988899999998864322    223468889999999999999999864 4789999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.++++     .++|..+.+++.|+++||+|||+.+.++++||||||+||+++.++..++. ||.......     ...
T Consensus       769 ~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~  837 (968)
T PLN00113        769 NLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTK  837 (968)
T ss_pred             cHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCC
Confidence            9999996     38899999999999999999995444899999999999999999888875 665433211     112


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||++.+..++.++|||||||++|||+||+.||....  .....+.+|..............++...     
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  910 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIR-----  910 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCccchhheeCcccc-----
Confidence            357788999999999999999999999999999999999995432  2223344444433222222223333221     


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       .....+.+...++.+++.+||+.||++||+|.++++.|+++.
T Consensus       911 -~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        911 -GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             -CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence             112345567778999999999999999999999999999874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.9e-44  Score=332.30  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=197.7

Q ss_pred             CCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEE
Q 038580           72 APGEVIGKSNYGTLYKALL-----QRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..++.||+|+||.||+|.+     ..++..+|+|+++..... ..+.+.+|+.+++.+ +||||++++++|.. .+..++
T Consensus        38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~~~~l  116 (375)
T cd05104          38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GGPTLV  116 (375)
T ss_pred             ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CCccee
Confidence            3468899999999999975     345678999998754322 235688999999999 89999999999885 458999


Q ss_pred             EEecccCCChhHhhhcCC--------------------------------------------------------------
Q 038580          145 VHPFYKRGNLAQCIRGGS--------------------------------------------------------------  162 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~--------------------------------------------------------------  162 (356)
                      +|||+++|+|.++++...                                                              
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            999999999999985321                                                              


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-e
Q 038580          163 -----------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-M  230 (356)
Q Consensus       163 -----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~  230 (356)
                                 ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.......... .
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                       1247788899999999999999999   999999999999999999999999999987654322111 1


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....++..|+|||++.+..++.++||||||+++|||++ |..||.......   .......    ...     .      
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~----~~~-----~------  335 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIK----EGY-----R------  335 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHH----hCc-----c------
Confidence            12334567999999998899999999999999999998 888887543211   0111111    000     0      


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ...+...+.++.+++..||+.||++||++.++++.|++.
T Consensus       336 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 ------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                  001112345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.1e-44  Score=316.62  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.. .....++.+|+++++.++||||+++++++.. ++..+++|||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   88 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN   88 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEeCCCCc
Confidence            47799999999999999988999999988643 2234578999999999999999999998875 458899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++..............
T Consensus        89 L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          89 LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            9999975555678999999999999999999999   9999999999999999999999999999876543322222222


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..       +.... ...     ..          
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~-~~~-----~~----------  222 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYEL-LEK-----GY----------  222 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH-HHC-----CC----------
Confidence            33567999999988899999999999999999998 89998653211       11111 100     00          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ....+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus       223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              0112233456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-44  Score=321.32  Aligned_cols=268  Identities=18%  Similarity=0.244  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++.++.++..+|+|.++.....  ..+.+.+|+++++.++||||+++++++.. ++..++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   84 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEYVEK   84 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEEecCCC
Confidence            37799999999999999989999999988754322  23568889999999999999999998875 4589999999998


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +++..+..  ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++............
T Consensus        85 ~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          85 NMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            77765543  23468889999999999999999999   99999999999999999999999999998775433332333


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH-------HHhh-hhcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM-------RNAV-LDHRITDLYH  303 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~  303 (356)
                      ...++..|+|||++.+..++.++|+|||||++|||++|..||...+.......+....       .... ..........
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4567889999999998889999999999999999999999997643211110000000       0000 0000000000


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +..  ..............+..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~--~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAV--NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             Ccc--cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000  00000000111224567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-44  Score=332.29  Aligned_cols=244  Identities=21%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .++.||.|+-|.|-+|++..+|+.+|+|++....   ......+++|+-+|+.+.|||++++|+++.+ +.++|+|.||+
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlEyv   94 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLEYV   94 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEEec
Confidence            3688999999999999999999999999997652   2233578999999999999999999999985 44999999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|.|++++.  ...++++.....++.||+.|+.|+|.   .+|+||||||+|+|+|..+++||+|||+|..-.  .+.-
T Consensus        95 ~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gkl  167 (786)
T KOG0588|consen   95 PGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKL  167 (786)
T ss_pred             CCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc--CCcc
Confidence            9999999997  45679999999999999999999999   999999999999999999999999999997643  2344


Q ss_pred             eecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ..+.+|++.|.|||++.+.+| +.++||||.||+++.|+||..||++++.       .. +...+..             
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~-LLlKV~~-------------  226 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RV-LLLKVQR-------------  226 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HH-HHHHHHc-------------
Confidence            567899999999999999988 5799999999999999999999986432       11 1111211             


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                           +....|.+.+.+..+|+.+|+.+||+.|.|+++|++.
T Consensus       227 -----G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 -----GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                 1223456677788899999999999999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=303.90  Aligned_cols=232  Identities=21%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      -+.||.|+||.|.+++.+.+|..+|+|+++...--+.   +...+|..+|+.+.||+++++++.|.+ .+.+++||||.+
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymvmeyv~  127 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMVMEYVP  127 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEEEeccC
Confidence            3779999999999999999999999999976433222   457789999999999999999999885 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ||.|..+++  ...+++.+.+.-++.||+.||+|||+   .+|++|||||+|||+|.+|.+||.|||+++...    ...
T Consensus       128 GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----~rT  198 (355)
T KOG0616|consen  128 GGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----GRT  198 (355)
T ss_pred             CccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec----CcE
Confidence            999999998  45679999999999999999999999   999999999999999999999999999998764    336


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      .+.+||+.|+|||++...+|..++|.||||+++|||+.|.+||...+...        +...+...              
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--------iY~KI~~~--------------  256 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--------IYEKILEG--------------  256 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--------HHHHHHhC--------------
Confidence            68899999999999999999999999999999999999999998754311        11111111              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLR  341 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  341 (356)
                          ...+|.-...++.+|+...|+.|-++|
T Consensus       257 ----~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 ----KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                223566667788899999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=326.35  Aligned_cols=246  Identities=18%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      -..||+|+||.||+|+-+.+|.++|+|++++...-..   ...+.|-.+|....+|+||+++..|++++ ++||||||++
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~LYLiMEylP  224 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YLYLIMEYLP  224 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-eeEEEEEecC
Confidence            3789999999999999999999999999987654433   46788999999999999999999999655 9999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC------
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP------  224 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~------  224 (356)
                      ||++..+|.  ....+++..+..++.+++.|+.-+|.   .|++||||||+|+|||..|++||+|||+|.....      
T Consensus       225 GGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  225 GGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             CccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            999999997  45678999999999999999999999   9999999999999999999999999999853211      


Q ss_pred             ----------------C-CC-----cc------------------eecccCCCcccCccccccCCCCCcchhHHHHHHHH
Q 038580          225 ----------------T-AG-----QE------------------MLEASASQGYKAPELIKMKDASEETDIYSFGVIML  264 (356)
Q Consensus       225 ----------------~-~~-----~~------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~  264 (356)
                                      . ..     ..                  .....|||.|||||++.+..|+..+|.||+||++|
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy  379 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY  379 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence                            0 00     00                  01346889999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-
Q 038580          265 ELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-  343 (356)
Q Consensus       265 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-  343 (356)
                      ||+.|.+||...+.......+..|-....                      .+.......+..|||.+|+. ||++|.- 
T Consensus       380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~----------------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  380 EMLVGYPPFCSETPQETYRKIVNWRETLK----------------------FPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhhhcc----------------------CCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999998665444333333222111                      11122234678899999999 9999974 


Q ss_pred             --HHHHH
Q 038580          344 --IKQVL  348 (356)
Q Consensus       344 --~~~il  348 (356)
                        ++||.
T Consensus       437 ~G~~EIK  443 (550)
T KOG0605|consen  437 KGAEEIK  443 (550)
T ss_pred             ccHHHHh
Confidence              55554

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.2e-44  Score=330.70  Aligned_cols=257  Identities=21%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             cCCCCcccccCCceEEEEEEcC-----CCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.||+|.+..     ++..+|+|.++...... ...+.+|+++++.+ +||||++++++|... +..+
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-~~~~  118 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-GPVL  118 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-CCeE
Confidence            3445889999999999998643     33578999887543322 34688999999999 899999999988854 4899


Q ss_pred             EEEecccCCChhHhhhcCC-------------------------------------------------------------
Q 038580          144 IVHPFYKRGNLAQCIRGGS-------------------------------------------------------------  162 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  162 (356)
                      ++|||+++|+|.++++...                                                             
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            9999999999999885311                                                             


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-eeccc
Q 038580          163 -------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-MLEAS  234 (356)
Q Consensus       163 -------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~  234 (356)
                             ..++++..+.+++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++.......... .....
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                   1247788899999999999999999   999999999999999999999999999987653322111 11223


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      ++..|+|||++.+..++.++||||||+++|||++ |..||.......   .    ....... .    ..          
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~----~~~~~~~-~----~~----------  333 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---K----FYKMVKR-G----YQ----------  333 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---H----HHHHHHc-c----cC----------
Confidence            4567999999988899999999999999999997 999997542211   0    0110000 0    00          


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ...+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       334 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 --MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence              0011123457889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=340.96  Aligned_cols=270  Identities=21%  Similarity=0.293  Sum_probs=215.5

Q ss_pred             cccCCcccchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccce-
Q 038580           57 TFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGF-  134 (356)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-  134 (356)
                      .+..+..+.+........+.|.+|||+.||+|.+..++..+|+|.+-...+...+...+|+++|++|+ |||||.+++. 
T Consensus        25 ~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   25 NYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             cCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            34445555655555555689999999999999999886778887776666666688999999999997 9999999993 


Q ss_pred             ee---CCC--CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC
Q 038580          135 YA---GPR--GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY  209 (356)
Q Consensus       135 ~~---~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  209 (356)
                      ..   ...  -+.+|+||||++|+|-+++..+....+++..+++|+.|+++|+++||. +..+|+|||||.+||||+.++
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC
Confidence            22   112  267899999999999999986666679999999999999999999998 556799999999999999999


Q ss_pred             CeEEeccccccccCCCC-Cc-------ceecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 038580          210 QPYVSDFGLHLLLNPTA-GQ-------EMLEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPT  278 (356)
Q Consensus       210 ~~kl~Dfg~~~~~~~~~-~~-------~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~  278 (356)
                      +.||||||.+....... ..       .......|+.|+|||++.   +.+.+.|+|||+|||+||-|+....||.+...
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            99999999886532222 11       122445688999999874   56789999999999999999999999975311


Q ss_pred             CCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          279 PDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..    +                        .+.+...+..+..+..+.+||+.||+.||.+||++-+++..+.++.
T Consensus       264 la----I------------------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 LA----I------------------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ee----E------------------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence            10    0                        0111223344578889999999999999999999999999998875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.4e-44  Score=321.30  Aligned_cols=258  Identities=20%  Similarity=0.340  Sum_probs=195.0

Q ss_pred             CCcccccCCceEEEEEEcC----------------CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceee
Q 038580           74 GEVIGKSNYGTLYKALLQR----------------SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYA  136 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~----------------~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~  136 (356)
                      .+.||+|+||.||++.+..                ++..+|+|.++..... ...++.+|++++++++||||+++++++.
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            4789999999999998643                3447899988754322 2357899999999999999999999988


Q ss_pred             CCCCceEEEEecccCCChhHhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 038580          137 GPRGEKLIVHPFYKRGNLAQCIRGGS-----------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK  199 (356)
Q Consensus       137 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  199 (356)
                      +. +..+++|||+++|+|.+++....                 ...+++.....++.|++.||+|||+   .+++|||||
T Consensus        90 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlk  165 (304)
T cd05096          90 DE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA  165 (304)
T ss_pred             cC-CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcc
Confidence            54 57999999999999999885321                 1246788899999999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeccccccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 038580          200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS--GKEPINEN  276 (356)
Q Consensus       200 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t--g~~p~~~~  276 (356)
                      |+|||++.++.+||+|||++.......... .....++..|+|||++..+.++.++||||||+++|||++  +..||...
T Consensus       166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            999999999999999999987653322211 123344678999999988889999999999999999987  56677653


Q ss_pred             CCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          277 PTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      +...    ............. ....             ...+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       246 ~~~~----~~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         246 TDEQ----VIENAGEFFRDQG-RQVY-------------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CHHH----HHHHHHHHhhhcc-cccc-------------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            3211    1111111100000 0000             00122345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.4e-44  Score=325.80  Aligned_cols=242  Identities=20%  Similarity=0.277  Sum_probs=195.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++..+.+++.+|+|+++....   .....+..|+.+++.++||||+++++++.. ++..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            369999999999999999999999999875422   122467789999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... .....
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~  153 (323)
T cd05571          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence            999999863  4568899999999999999999999   99999999999999999999999999998653221 22223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...|++.|+|||++.+..++.++|||||||++|||++|..||...+..       . ........               
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~~~~~---------------  210 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME---------------  210 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------H-HHHHHHcC---------------
Confidence            456899999999999889999999999999999999999999653210       0 11111000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence               0112233456788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-44  Score=309.03  Aligned_cols=270  Identities=21%  Similarity=0.265  Sum_probs=204.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCc-cccccceeeCCCC-----ceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPN-LVPLLGFYAGPRG-----EKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-----~~~lv~  146 (356)
                      ++||+|+||+||+|..+.+|+.||+|.++.....  ......+|+.+++.++|+| ||++++++.+.+.     ..++|+
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            5699999999999999999999999999876543  3356799999999999999 9999999886553     788999


Q ss_pred             ecccCCChhHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          147 PFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      ||+.. +|..++.....  ...+...+..++.|++.||+|||+   ++|+||||||+|+|++++|.+||+|||+++...-
T Consensus        97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSI  172 (323)
T ss_pred             Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence            99976 99999975442  467778899999999999999999   9999999999999999999999999999986542


Q ss_pred             CCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc-
Q 038580          225 TAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY-  302 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (356)
                      + ........+|..|+|||++.+. .|+...||||+||++.||++++..|.+....+....+.+.+.....+ .|.... 
T Consensus       173 p-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~-~Wp~v~~  250 (323)
T KOG0594|consen  173 P-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK-DWPGVSS  250 (323)
T ss_pred             C-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc-CCCCccc
Confidence            2 2223455778889999999876 79999999999999999999999998876533333333322211111 111111 


Q ss_pred             CcccccccCCCC-CCCCcHHH---HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          303 HPDMLLCSNSNH-ENPVSEER---ILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       303 ~~~~~~~~~~~~-~~~~~~~~---~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .++-........ ........   .....+++..|++.+|.+|.|++..+..
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111100000000 11111111   1367899999999999999999998874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=338.73  Aligned_cols=252  Identities=22%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             CCCcccccCCceEEEEEEcCCC----eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           73 PGEVIGKSNYGTLYKALLQRSG----SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+||+|+||+||+|.|-..+    -+||+|++...... ...++.+|+-.|.++.|||+++++|+|..+  .+.||++
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvtq  777 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVTQ  777 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHHH
Confidence            3478999999999999986444    36788888765443 347899999999999999999999999854  4889999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      ||+.|+|.++++.. +..+-....+.|+.|||+||.|||.   ++++||||.++|||+..-..+||.|||+++.......
T Consensus       778 ~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             hcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999863 4468888899999999999999999   9999999999999999999999999999988765433


Q ss_pred             cce-ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          228 QEM-LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       228 ~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .-. ......+.|||-|.+....|+.+||||||||++||++| |..||.+.+..+.    +..+.               
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----~dlle---------------  914 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----PDLLE---------------  914 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----hHHHh---------------
Confidence            322 22334677999999999999999999999999999999 9999988654332    11111               


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            .+.+.+.|+.++.+++-+|.+||-.|+..||+++++...+.++.
T Consensus       915 ------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  915 ------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             ------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                  12234567778899999999999999999999999999988765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=311.04  Aligned_cols=259  Identities=22%  Similarity=0.389  Sum_probs=199.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc--cCCCccccccceeeCCCC---ceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAGPRG---EKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~---~~~lv~e~~  149 (356)
                      +.||+|.||.||+|.|+  |+.||+|++.   +.++..+.+|.++.+.  |+|+||+.|++.-..+.+   .++||++|.
T Consensus       217 e~IGkGRyGEVwrG~wr--Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  217 EIIGKGRFGEVWRGRWR--GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEecCccccceeecccc--CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            77999999999999997  7789999986   3455678888888764  699999999986543332   689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF-----HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      +.|||.+||..   ..++....++++..+|+||+|||.+.     ++.|.|||||+.|||+.+++++.|+|+|++.....
T Consensus       292 e~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~  368 (513)
T KOG2052|consen  292 EHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  368 (513)
T ss_pred             cCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence            99999999973   57999999999999999999999743     67899999999999999999999999999976544


Q ss_pred             CCC---cceecccCCCcccCccccccCC------CCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCCCCCch
Q 038580          225 TAG---QEMLEASASQGYKAPELIKMKD------ASEETDIYSFGVIMLELISG----------KEPINENPTPDEDFHL  285 (356)
Q Consensus       225 ~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~sDvwslG~~l~el~tg----------~~p~~~~~~~~~~~~~  285 (356)
                      ...   .......||.+|||||++...-      .-..+||||||.++||++-.          +.||.+....+...  
T Consensus       369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~--  446 (513)
T KOG2052|consen  369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF--  446 (513)
T ss_pred             cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH--
Confidence            322   2345678999999999997542      12469999999999999742          56776654444322  


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       +.+...+=    .+...|.+       +..=.+.++...+.++|+.||..+|.-|-|+-.|.+.|.++.
T Consensus       447 -eeMrkVVC----v~~~RP~i-------pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  447 -EEMRKVVC----VQKLRPNI-------PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             -HHHhccee----ecccCCCC-------CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence             11111110    00111111       011134567888999999999999999999999999998875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-43  Score=309.80  Aligned_cols=250  Identities=20%  Similarity=0.409  Sum_probs=204.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+.. +..+++|.++.........+..|+.+++.++||||+++++++... ...+++|||+++++
T Consensus        11 ~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   88 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIITELMEKGS   88 (261)
T ss_pred             hhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEEeecccCC
Confidence            4789999999999999986 788899998766554567899999999999999999999988854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.+||+|||.+......... ....
T Consensus        89 L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~  164 (261)
T cd05148          89 LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDK  164 (261)
T ss_pred             HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCC
Confidence            9999986666678999999999999999999999   99999999999999999999999999998765432211 2233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+....++.++|+||||+++|+|++ |..||...+..       ..... ....     .          
T Consensus       165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~~-~~~~-----~----------  221 (261)
T cd05148         165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYDQ-ITAG-----Y----------  221 (261)
T ss_pred             CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHH-HHhC-----C----------
Confidence            45667999999988889999999999999999998 89999754310       11111 0000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+..++..+.+++.+||+.||++|||+.++.+.|+.+
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              0112234456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-43  Score=322.60  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             CCCcccccCCceEEEEEEcC-----CCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ..+.||+|+||.||+|....     +++.+|+|.++...... .+.+..|+.++.++ +||||++++++|..++...+++
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v   90 (337)
T cd05054          11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (337)
T ss_pred             hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence            35889999999999997532     35789999887543222 24677899999999 7999999999988777789999


Q ss_pred             EecccCCChhHhhhcCC-----------------------------------------------------------CCCC
Q 038580          146 HPFYKRGNLAQCIRGGS-----------------------------------------------------------GEAH  166 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~-----------------------------------------------------------~~~~  166 (356)
                      +||+++++|.+++....                                                           ..++
T Consensus        91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (337)
T cd05054          91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL  170 (337)
T ss_pred             EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence            99999999999885321                                                           1267


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-cceecccCCCcccCcccc
Q 038580          167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELI  245 (356)
Q Consensus       167 ~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~  245 (356)
                      ++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........ .......++..|+|||++
T Consensus       171 ~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         171 TLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            899999999999999999999   9999999999999999999999999999876532221 112233456679999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHH
Q 038580          246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERIL  324 (356)
Q Consensus       246 ~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (356)
                      .+..++.++|||||||++|||++ |..||.+....+       ..........                 ....+...+.
T Consensus       248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-----------------~~~~~~~~~~  303 (337)
T cd05054         248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGT-----------------RMRAPEYATP  303 (337)
T ss_pred             cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccC-----------------CCCCCccCCH
Confidence            99999999999999999999998 999997532111       0111111000                 0011223445


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          325 KFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       325 ~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ++.+++.+||+.+|++||++.++++.|+++.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-43  Score=312.34  Aligned_cols=250  Identities=20%  Similarity=0.378  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .++||+|+||.||+|... ++..+++|.+.... ...+.+.+|+.+++.++||||+++++.+.. .+..++++||+++++
T Consensus        11 ~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   87 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMAKGS   87 (261)
T ss_pred             eeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCCCCc
Confidence            478999999999999976 45567888765432 234678999999999999999999998775 457899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++++......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++..............
T Consensus        88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            9999976555678899999999999999999999   9999999999999999999999999999876543322222233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++....++.++|+||||+++|||+| |..||......        .........     .          
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~-----~----------  221 (261)
T cd05072         165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRG-----Y----------  221 (261)
T ss_pred             ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcC-----C----------
Confidence            45667999999988889999999999999999998 99999753211        111111110     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.....+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              0011123455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=320.15  Aligned_cols=240  Identities=20%  Similarity=0.270  Sum_probs=193.0

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||.||+|.+..+++.+|+|.++...   ......+..|+.+++.++||||+++++++.. .+..+++|||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            799999999999999899999999986432   2223467889999999999999999998885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...... .......
T Consensus        80 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  153 (312)
T cd05585          80 LFHHLQR--EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTF  153 (312)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccc
Confidence            9999963  3468899999999999999999999   99999999999999999999999999998753222 1222345


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .|++.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ........ ..                 
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~-~~-----------------  208 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKIL-QE-----------------  208 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHH-cC-----------------
Confidence            688999999999988999999999999999999999999975321       11111111 00                 


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPN---IKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~il~  349 (356)
                       ....+...+..+.+++.+||+.||++||+   +.+++.
T Consensus       209 -~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         209 -PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence             01123344567889999999999999985   566553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-43  Score=314.56  Aligned_cols=252  Identities=24%  Similarity=0.423  Sum_probs=200.1

Q ss_pred             CCcccccCCceEEEEEEcCCC-----eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSG-----SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+...+     ..+++|.++..... ....+.+|+++++.++||||+++++++.. .+..+++||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e   88 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPTCMLFE   88 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCceEEEEe
Confidence            377999999999999886544     67888888644322 23468999999999999999999998875 457899999


Q ss_pred             cccCCChhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEE
Q 038580          148 FYKRGNLAQCIRGGSG--------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV  213 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  213 (356)
                      |+++++|.+++.....              ..+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L  165 (283)
T cd05048          89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEE
Confidence            9999999999864211              457888999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHH
Q 038580          214 SDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRN  291 (356)
Q Consensus       214 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  291 (356)
                      +|||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....       + ...
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~-~~~  237 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E-VIE  237 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHH
Confidence            99999875432221 12223345778999999988899999999999999999998 99998764321       1 111


Q ss_pred             hhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          292 AVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      .+....                 ....+..++.++.+|+.+||+.||++||++.+|++.|+++
T Consensus       238 ~i~~~~-----------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 MIRSRQ-----------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHcCC-----------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            111000                 0112345677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-43  Score=309.69  Aligned_cols=250  Identities=24%  Similarity=0.465  Sum_probs=200.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+. ++..+++|.++... ...+++.+|+.++++++||||+++++++.. .+..+++|||+++++
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   87 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKYGS   87 (261)
T ss_pred             EEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecccCCc
Confidence            478999999999999976 45678888886533 345679999999999999999999998875 458899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.|+.|||+   .+++|+||||+||+++.++.+||+|||++..............
T Consensus        88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            9999976555678999999999999999999999   9999999999999999999999999999877643222212222


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||++.+..++.++|+||||+++||++| |..||.+.+...        ........     .          
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~-----~----------  221 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQG-----Y----------  221 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcC-----C----------
Confidence            23457999999998889999999999999999999 999997532110        11111000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+...+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus       222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              0112233456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-43  Score=327.56  Aligned_cols=266  Identities=17%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             ccchhhhhcCCCCcccccCCceEEEEEEcC-----CCeEEEEEEeccccccc-hHHHHHHHHHHhccC-CCcccccccee
Q 038580           63 DLTICDILDAPGEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIR-HPNLVPLLGFY  135 (356)
Q Consensus        63 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~  135 (356)
                      .+.+....+..++.||+|+||.||+|.+..     ++..+|+|.++...... .+.+.+|+++++++. ||||++++++|
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            333333344456889999999999998742     23568999887543322 357899999999996 99999999998


Q ss_pred             eCCCCceEEEEecccCCChhHhhhcCC-----------------------------------------------------
Q 038580          136 AGPRGEKLIVHPFYKRGNLAQCIRGGS-----------------------------------------------------  162 (356)
Q Consensus       136 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  162 (356)
                      .. .+..+++|||+++|+|.+++....                                                     
T Consensus       111 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         111 TK-SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             cc-CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            75 458999999999999999885321                                                     


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 038580          163 -----------------------------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK  201 (356)
Q Consensus       163 -----------------------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~  201 (356)
                                                               ...+++..+..++.|++.||+|||+   .+++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChH
Confidence                                                     1247788889999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 038580          202 NILLDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTP  279 (356)
Q Consensus       202 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~  279 (356)
                      ||++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999999876533221 11223345678999999988889999999999999999997 99998753211


Q ss_pred             CCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                      .       .........                 ...+.+...+..+.+++.+||+.||++||++.++.+.|+++.+
T Consensus       347 ~-------~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 S-------TFYNKIKSG-----------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H-------HHHHHHhcC-----------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1       011111000                 0011233456678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.6e-45  Score=314.52  Aligned_cols=265  Identities=22%  Similarity=0.306  Sum_probs=196.8

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCC-C---ceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-G---EKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~---~~~lv~e  147 (356)
                      ...+++|+|+||.||.|....+++.+|+|..-..    .+--.+|+++|+++.|||||++.-+|.... +   ...+|||
T Consensus        27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            3458999999999999999988888887765432    223456899999999999999988775322 1   4567999


Q ss_pred             cccCCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEeccccccccCC
Q 038580          148 FYKRGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNP  224 (356)
Q Consensus       148 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~  224 (356)
                      ||+. +|.+.++..  .+..++.-.+.-+..|+.+||+|||+   .+|+||||||+|+|+|.+ |.+||||||.|+....
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9998 999999742  24566777788899999999999999   999999999999999976 8999999999988754


Q ss_pred             CCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh------cc
Q 038580          225 TAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD------HR  297 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~  297 (356)
                        +++..+..-|+.|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+..+....+.+.+.....+      ..
T Consensus       179 --~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  179 --GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             --CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence              334456667889999999876 479999999999999999999999999865544332222222111000      00


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..+...|.+.....   ..-+....+.+..+++.++|+.+|.+|.++.+++.
T Consensus       257 y~~~~~p~ik~~~~---~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPW---HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccCcccccccc---eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            01111122211100   00133345667889999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-44  Score=319.45  Aligned_cols=240  Identities=19%  Similarity=0.250  Sum_probs=195.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....+++.+|+|.+.....   ...+.+.+|+.+++.++||||+++++++.+ ++..+++|||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   84 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLMEYVP   84 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEEeCCC
Confidence            4789999999999999998899999999864322   223468889999999999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......    .
T Consensus        85 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~  155 (291)
T cd05612          85 GGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T  155 (291)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence            9999999974  3468889999999999999999999   99999999999999999999999999998765321    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||.+.+..       . .........             
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~-~~~~i~~~~-------------  214 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------G-IYEKILAGK-------------  214 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC-------------
Confidence            2346889999999999888999999999999999999999999753211       1 111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                           ...+......+.+++.+||+.||++||+     +++++.
T Consensus       215 -----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                 0112223456789999999999999995     888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-43  Score=319.75  Aligned_cols=251  Identities=21%  Similarity=0.395  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeE----EEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~----~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..    +|+|.++.... ...+++.+|+.+++.++||||++++|+|...  ..+++++|
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~~v~e~   89 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQL   89 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cceeeeec
Confidence            47899999999999998655543    78888865432 2346788999999999999999999988743  57899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.........
T Consensus        90 ~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  165 (316)
T cd05108          90 MPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE  165 (316)
T ss_pred             CCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence            9999999999743 3458888999999999999999999   99999999999999999999999999999876432221


Q ss_pred             c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      . ......+..|+|||++.+..++.++||||||+++||+++ |..||.+.+..       . ........          
T Consensus       166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~----------  227 (316)
T cd05108         166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------E-ISSILEKG----------  227 (316)
T ss_pred             eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhCC----------
Confidence            1 122234567999999998999999999999999999998 99998753211       1 11111000          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ...+.+..++..+.+++..||+.+|++||++.+++..|.++.
T Consensus       228 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         228 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   000112223456889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-43  Score=322.42  Aligned_cols=242  Identities=21%  Similarity=0.297  Sum_probs=194.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....++..+|+|+++....   .....+.+|+++++.++||||+++++++.. ++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            359999999999999998999999999875422   122457789999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... .....
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~  153 (323)
T cd05595          80 GELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccc
Confidence            999988863  3468899999999999999999999   99999999999999999999999999998653221 12223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...|++.|+|||++.+..++.++|+|||||++|||++|..||...+..       .... .....               
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~-~~~~~---------------  210 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFE-LILME---------------  210 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHH-HHhcC---------------
Confidence            456889999999999889999999999999999999999999753211       1011 00000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               0012223456678999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.9e-43  Score=315.64  Aligned_cols=268  Identities=20%  Similarity=0.248  Sum_probs=192.9

Q ss_pred             CCcccccCCceEEEEEEc-CCCeEEEEEEeccccccc--hHHHHHHHHHHhcc---CCCccccccceeeC----CCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCI---RHPNLVPLLGFYAG----PRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~~~~~  143 (356)
                      .+.||+|+||.||+|.+. .++..+|+|.++......  ...+.+|+.+++.+   +||||++++++|..    .....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            477999999999999985 457888999886543222  23566777776665   69999999998752    234689


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      ++|||+. ++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus        86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  161 (290)
T ss_pred             EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence            9999997 599999976555668999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++|..||.+.+..+....+..................
T Consensus       162 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         162 FQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             CC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            32  2223456788999999998888999999999999999999999999864332111111000000000000000000


Q ss_pred             cccccccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +...  .......   ......+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQA--FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchh--ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000  0000000   011123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=330.39  Aligned_cols=247  Identities=19%  Similarity=0.323  Sum_probs=205.6

Q ss_pred             CCcccccCCceEEEEEEcCC---CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .++||+|.||.|++|.|...   ...||+|+++..... ...+|.+|+.+|-+|+|||+++|||+..+  ....+|+|.+
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELa  192 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELA  192 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhc
Confidence            37899999999999999743   256899999865544 45689999999999999999999999885  3689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +.|||.+.|+......+.......++.|||.||.||.+   +++|||||.++|+++-...++||+|||+.+.+......-
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999987666778889999999999999999999   999999999999999999999999999998775433322


Q ss_pred             ee--cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 ML--EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 ~~--~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ..  ...-+..|+|||.+....++.+||||+|||++|||+| |+.||.+.......    +.+             |   
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----~~i-------------D---  329 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----KNI-------------D---  329 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----Hhc-------------c---
Confidence            11  2234567999999999999999999999999999999 89999875432211    100             0   


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                           .+-+.+.+..|++.++++|..||..+|++||||..|.+.
T Consensus       330 -----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 -----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                 112334577899999999999999999999999999743

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=302.26  Aligned_cols=268  Identities=20%  Similarity=0.215  Sum_probs=205.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~  151 (356)
                      ++|++|+||.||+|+++.++++||+|.++......  .-.-.+|+.+|.+.+|||||.+-.+.... -+..|+|||||+.
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            77999999999999999999999999998654322  23578999999999999999998876532 2479999999998


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|...+.. ..+++.......++.|+++|++|||+   ..|+|||||++|+|++..|.+||+|||+|+.+..+ ....+
T Consensus       162 -DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T  235 (419)
T KOG0663|consen  162 -DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYT  235 (419)
T ss_pred             -hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC-cccCc
Confidence             99999974 34688999999999999999999999   99999999999999999999999999999987644 33445


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc--
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL--  308 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  308 (356)
                      ...-|.+|+|||++.+. .|+++.||||+||++.|++++.+.|.+....+....+...+.. ..+..+..+.......  
T Consensus       236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt-Pte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT-PSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC-CccccCCCccccchhhcc
Confidence            66778999999998765 6999999999999999999999999986554433333332221 1111222222211110  


Q ss_pred             -c---cCCCCCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 -C---SNSNHENPVSEE-RILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 -~---~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       +   .....+..+... ..+.-++|+...|..||.+|.|+++.++
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             0   000011112211 4466789999999999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-44  Score=324.85  Aligned_cols=240  Identities=20%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++....   ...+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~  101 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFLLEFVV  101 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEEEcCCC
Confidence            4789999999999999998999999999865321   223468899999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......    .
T Consensus       102 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~  172 (329)
T PTZ00263        102 GGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----T  172 (329)
T ss_pred             CChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----c
Confidence            9999999974  3467888889999999999999999   99999999999999999999999999998765332    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||.+...        ...........             
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~-------------  231 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGR-------------  231 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC-------------
Confidence            235688999999999988899999999999999999999999975321        01111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                           ...+......+.+++.+||+.||++||+     +++++.
T Consensus       232 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 -----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 0112223456789999999999999997     677764

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-43  Score=312.80  Aligned_cols=246  Identities=20%  Similarity=0.268  Sum_probs=193.9

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||+||++.+..+++.+|+|.+.......   .+.+..|+++++.++||||+++.+++.. ++..+++|||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            799999999999999899999999886432222   2456789999999999999999998875 458999999999999


Q ss_pred             hhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |...+..  .....+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~  155 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTK  155 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccc
Confidence            9988743  234568999999999999999999999   999999999999999999999999999987653322 1223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+++.|+|||++.+..++.++|+||||+++|||++|..||.........    .........        .       
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~--------~-------  216 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILN--------D-------  216 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcc--------c-------
Confidence            446788999999999999999999999999999999999999754321110    000100000        0       


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++.+||+.||++||     +++++++
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 ---SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence               0112334556788999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-43  Score=321.47  Aligned_cols=242  Identities=20%  Similarity=0.288  Sum_probs=194.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....++..+|+|+++....   .....+.+|+.+++.++||||+++++++.. ++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            359999999999999999999999999875422   223467889999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... .....
T Consensus        80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~  153 (328)
T cd05593          80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK  153 (328)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence            999988863  3468899999999999999999999   99999999999999999999999999998653221 11223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...|++.|+|||++.+..++.++|||||||++|||++|..||...+..       .... .....               
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~-~~~~~---------------  210 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFE-LILME---------------  210 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHH-HhccC---------------
Confidence            456889999999999889999999999999999999999999753211       1111 00000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         211 ---DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               0012233455678999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-44  Score=290.61  Aligned_cols=244  Identities=21%  Similarity=0.339  Sum_probs=206.8

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .++.||+|.||.||.|..+.++-.+|+|++.+..   .....++.+|+++-+.|+||||+++|++|.+.. +.||++||.
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riyLilEya  104 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIYLILEYA  104 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeEEEEEec
Confidence            4689999999999999999999999999986542   223467999999999999999999999999654 999999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ..|+|.+.|..+....++......+..|+|.|+.|+|.   ++++||||||+|+|++.++..|++|||-+...+   ...
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k  178 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK  178 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence            99999999998788889999999999999999999999   999999999999999999999999999876532   334


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+||..|.+||...+..++...|+|++|++.||++.|.+||......+   ...     .+   +-.+         
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYk-----rI---~k~~---------  238 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYK-----RI---RKVD---------  238 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHH-----HH---HHcc---------
Confidence            457799999999999999999999999999999999999999997543111   111     11   1111         


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ...+...+....+++.+|+..+|.+|.+..|++.
T Consensus       239 ------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 ------LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                  1134455667889999999999999999998875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.7e-43  Score=307.19  Aligned_cols=246  Identities=20%  Similarity=0.361  Sum_probs=194.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.||+|+||.||++.++. +..+++|.++.. .....++.+|+.++++++||||+++++++.. ++..+++|||+++|+|
T Consensus        10 ~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L   86 (256)
T cd05114          10 KELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMENGCL   86 (256)
T ss_pred             eEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCCCcH
Confidence            679999999999998864 456788877643 2334678999999999999999999998875 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .++++... ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+|++|||.+...............
T Consensus        87 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          87 LNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            99987433 358899999999999999999999   99999999999999999999999999998765332222222334


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      ++..|+|||.+.+..++.++|+||||+++||+++ |..||...+..       +... ......  ..            
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~-~i~~~~--~~------------  220 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVE-MISRGF--RL------------  220 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH-HHHCCC--CC------------
Confidence            4567999999988889999999999999999999 89998653211       1111 111100  00            


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                         ..+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               011122456889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.4e-43  Score=313.15  Aligned_cols=268  Identities=16%  Similarity=0.228  Sum_probs=194.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|....++..+|+|.++..... ....+.+|+.+++.++||||+++++++... +..+++|||+.+ 
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~-   87 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFEYLDS-   87 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEeCCCc-
Confidence            47899999999999999989999999998754322 234678999999999999999999988754 478999999985 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....... .....
T Consensus        88 ~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~  162 (288)
T cd07871          88 DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSN  162 (288)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccC
Confidence            999888632 3457888999999999999999999   999999999999999999999999999987543221 12233


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc-cc--c
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD-ML--L  308 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~  308 (356)
                      ..++..|+|||++.+ ..++.++|+||+||++|||+||..||...+..+....+..... ......+....... ..  .
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-TPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHHhhccccchhhhccc
Confidence            467888999998865 5689999999999999999999999976432211100000000 00000000000000 00  0


Q ss_pred             ccC--CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSN--SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...  .............+..+++.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000  00000001122456779999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-43  Score=319.83  Aligned_cols=196  Identities=23%  Similarity=0.351  Sum_probs=168.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ..+.||+|+||.||++.+..++..+++|.++..... ....+.+|+++++.++||||++++++|.. ++..+++|||+++
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   87 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDG   87 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEecCCC
Confidence            347899999999999999989999999988754322 23568999999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++..  ...+++.....++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++......   ...
T Consensus        88 ~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~  160 (333)
T cd06650          88 GSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN  160 (333)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccc
Confidence            999999974  34588889999999999999999972  47999999999999999999999999998654321   112


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      ...++..|+|||++.+..++.++|+|||||++||+++|..||...
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            346788999999999888999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.2e-43  Score=318.86  Aligned_cols=195  Identities=24%  Similarity=0.348  Sum_probs=168.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++.+..++..+|+|.++..... ....+.+|+++++.++||||+++++++.. ++..+++|||++++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~   88 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGG   88 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEeecCCCC
Confidence            37799999999999999999999999998754322 23578999999999999999999998875 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++..  ...+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++......   ....
T Consensus        89 ~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~  161 (331)
T cd06649          89 SLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS  161 (331)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---cccc
Confidence            99999974  34588899999999999999999982  35999999999999999999999999998754322   1224


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      ..++..|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            46888999999999888999999999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-42  Score=322.95  Aligned_cols=264  Identities=17%  Similarity=0.213  Sum_probs=194.4

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||++.+..+++.+|+|...      ...+.+|+++++.++||||+++++++.. +...++++|++. +
T Consensus        96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~-~  167 (391)
T PHA03212         96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPRYK-T  167 (391)
T ss_pred             EEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEecCC-C
Confidence            3478999999999999999999999999643      2357889999999999999999998885 447899999986 5


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|..++..  ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.............
T Consensus       168 ~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        168 DLYCYLAA--KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence            89888863  3468899999999999999999999   999999999999999999999999999986543322223334


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH---HHHhhhhcccccccCcc----
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF---MRNAVLDHRITDLYHPD----  305 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----  305 (356)
                      ..||+.|+|||++.+..++.++|||||||++|||+||..||...............   +.............+..    
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            57899999999999889999999999999999999999887653322111110000   00000000000000000    


Q ss_pred             -----cccccCCCCC-CC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 -----MLLCSNSNHE-NP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 -----~~~~~~~~~~-~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           .......... .+   .....+.++.+|+.+||+.||++|||++++++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 0000000000 00   01134567889999999999999999999985

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.7e-43  Score=317.93  Aligned_cols=245  Identities=20%  Similarity=0.295  Sum_probs=191.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|....++..+|+|+++.....   ....+..|+.++..+ +||||+++++++.. ++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            4699999999999999999999999998754222   224577888888766 79999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ....
T Consensus        80 ~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~  153 (329)
T cd05618          80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT  153 (329)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence            9999988863  3568999999999999999999999   99999999999999999999999999998653221 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-chhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-HLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....|+..|+|||++.+..++.++|+|||||++|||++|..||.......... ..............            
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------------  221 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------------  221 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------------
Confidence            34568899999999999999999999999999999999999996432221111 11111111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                            ...+...+..+.+++.+||+.||++||++
T Consensus       222 ------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                  11233345567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-42  Score=306.51  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+..++ .+++|.++... ...+.+.+|+++++.++||||+++++++.  .+..+++|||+++|
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~   85 (262)
T cd05071          10 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKG   85 (262)
T ss_pred             EeeecCCCCCCcEEEEEecCCc-eEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCCCC
Confidence            3478999999999999987554 57888876432 23467899999999999999999999764  34689999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+.............
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~  162 (262)
T cd05071          86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  162 (262)
T ss_pred             cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence            99999975445568899999999999999999999   999999999999999999999999999987654333222223


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..++..|+|||+..+..++.++|+||||+++||++| |..||......        .........               
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~---------------  219 (262)
T cd05071         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG---------------  219 (262)
T ss_pred             CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcC---------------
Confidence            345667999999988889999999999999999999 88888654211        111111000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ...+.+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       220 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              00112334566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-43  Score=312.91  Aligned_cols=247  Identities=20%  Similarity=0.258  Sum_probs=197.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....++..+|+|.+......   ....+.+|+.+++.++||||+++++.+... +..+++|||+++
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~   84 (285)
T cd05605           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNG   84 (285)
T ss_pred             EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEEeccCC
Confidence            7799999999999999888999999988643222   123577899999999999999999988754 489999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|..++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++......  ....
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~  159 (285)
T cd05605          85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIR  159 (285)
T ss_pred             CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--Cccc
Confidence            999988865445568999999999999999999999   99999999999999999999999999998764321  1122


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||++.+..++.++|+||+|+++||+++|..||.+.....    ..+.+.......               
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~---------------  220 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKED---------------  220 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhc---------------
Confidence            3467889999999998889999999999999999999999997533211    011111111100               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++..||+.||++||     +++++++
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence               0112334556788999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-42  Score=317.50  Aligned_cols=250  Identities=19%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||++.+..++..+|+|+++.....   ....+..|..++..+ +||||+++++++.+ .+..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            3699999999999999999999999998754222   224578899999888 69999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ....
T Consensus        80 ~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~  153 (329)
T cd05588          80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT  153 (329)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence            9999988863  3568999999999999999999999   99999999999999999999999999998642211 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-CchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....|+..|+|||++.+..++.++|+|||||++|||++|..||......... ...............            
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------------  221 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------------  221 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------------
Confidence            3457889999999999989999999999999999999999999743222211 111111211111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPN------IKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps------~~~il~  349 (356)
                            ...+...+..+.+++.+||+.||++||+      ++++++
T Consensus       222 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 ------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                  0112233456789999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.9e-43  Score=310.47  Aligned_cols=246  Identities=19%  Similarity=0.263  Sum_probs=193.6

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||.||++..+.+++.+|+|.+......   ....+..|+++++.++||||+++++++.. +...+++|||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            79999999999999989999999988643221   22345679999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++......  ......
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~  154 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR  154 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeecc
Confidence            9998865555668999999999999999999999   99999999999999999999999999998765432  222345


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||++.+..++.++|+|||||++|||++|..||........    ............        ..      
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~--------~~------  216 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDE--------VK------  216 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccc--------cc------
Confidence            678899999999988899999999999999999999999975322111    011111000000        00      


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ......+.++.+++..||+.||++||++.++++
T Consensus       217 ---~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 ---FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             ---cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence               001123556889999999999999999976654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=323.22  Aligned_cols=249  Identities=16%  Similarity=0.206  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++....   .....+..|+++++.++||||+++++++.. .+..+++|||++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   84 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLAMEYVP   84 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEEEeCCC
Confidence            3779999999999999998899999999875422   223468889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....    ..
T Consensus        85 g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~  155 (333)
T cd05600          85 GGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA  155 (333)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence            9999999963  3468889999999999999999999   9999999999999999999999999999876433    22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||...+....       . ....... .....+..    
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~-~~i~~~~-~~~~~~~~----  222 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------W-ENLKYWK-ETLQRPVY----  222 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------H-HHHHhcc-ccccCCCC----
Confidence            345688999999999988999999999999999999999999975432110       0 0000000 00000000    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                           .......+.++.+++.+||+.+|++||++.++++.
T Consensus       223 -----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 -----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                 00012345678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-44  Score=321.05  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=210.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.+|+|+||.+++.+++.+...+++|.+.......  .+....|+.++++++|||||.+.+.|..++...+++|+||+|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            478999999999999999888888888887554332  247899999999999999999999998665459999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+.+....+..+++.++..++.|++.|+.|||+   .+|+|||||+.|||++.++.+||+|||+++..+... ....
T Consensus        89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~  164 (426)
T KOG0589|consen   89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLAS  164 (426)
T ss_pred             CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch-hhhh
Confidence            999999987777889999999999999999999998   999999999999999999999999999999886543 2334


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      +..||+.||+||.+.+.+|..|+|||||||++|||++-+.+|...+....       + ..+.+                
T Consensus       165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------i-~ki~~----------------  220 (426)
T KOG0589|consen  165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------I-LKINR----------------  220 (426)
T ss_pred             eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------H-HHHhh----------------
Confidence            67899999999999999999999999999999999999999986443211       1 11100                


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                       ..-.+.+.....++..++..|++.+|+.||++.+++.+
T Consensus       221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             00123456677889999999999999999999999875

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-42  Score=305.54  Aligned_cols=247  Identities=20%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             ccccCCceEEEEEEc--CCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||.||+|.+.  .++..+|+|++....... .+.+.+|+.+++.++||||+++++++..  ...+++|||+++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~~   80 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGGP   80 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCCC
Confidence            899999999999875  455678999887653322 3568999999999999999999998763  37899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce--e
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM--L  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~  231 (356)
                      |.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...........  .
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99998642 3468999999999999999999999   9999999999999999999999999999875433222111  1


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||.+....++.++|+||||+++||+++ |..||.+....       . ........              
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~--------------  214 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------E-VMSFIEQG--------------  214 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHHCC--------------
Confidence            1223567999999988889999999999999999996 99999754321       1 11111100              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                         .....+..++.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus       215 ---~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 ---KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               01112334567888999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-42  Score=304.58  Aligned_cols=249  Identities=23%  Similarity=0.367  Sum_probs=195.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.||+|+||.||+|.+..++..+++|..+.... .....+.+|+++++.++||||++++++|.. .+..+++|||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            369999999999999988899999998764322 223578999999999999999999998885 448999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce-ec
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM-LE  232 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  232 (356)
                      |.+++... ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........... ..
T Consensus        80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99998642 3458899999999999999999999   9999999999999999999999999999865432111110 11


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+..|+|||.+.++.++.++|+||||+++||+++ |..||...+..        ........ .              
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~-~--------------  212 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQ-G--------------  212 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHc-C--------------
Confidence            122456999999988889999999999999999998 88888643210        01111100 0              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                        .....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       213 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         213 --VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             --CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence              0011233345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-43  Score=334.00  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             CCcccccCCceEEEEEEcCC-CeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRS-GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|....+ +..+++|............+..|+.+++.++||||+++++++.. ++..++||||+++|
T Consensus        72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~~~gg  150 (478)
T PTZ00267         72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEYGSGG  150 (478)
T ss_pred             EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEECCCCC
Confidence            47899999999999988766 67777887654433344568889999999999999999999885 45899999999999


Q ss_pred             ChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-cc
Q 038580          153 NLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-QE  229 (356)
Q Consensus       153 sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  229 (356)
                      +|.++++..  ...++++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........ ..
T Consensus       151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            999988532  34468888999999999999999999   9999999999999999999999999999987543222 12


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.       ...... .....    .       
T Consensus       228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~-~~~~~----~-------  288 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQ-VLYGK----Y-------  288 (478)
T ss_pred             ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHhCC----C-------
Confidence            2345689999999999988999999999999999999999999975321       111111 11000    0       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            .+.+...+..+.+++..||+.||++||++.+++.
T Consensus       289 ------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  0112234457889999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-42  Score=305.50  Aligned_cols=247  Identities=20%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             cccccCCceEEEEEEc--CCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           76 VIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .||+|+||.||+|.++  .++..+|+|+++.....  ..+++.+|+.+++.++||||+++++++.  ....+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence            5899999999999763  56788999988644322  2357899999999999999999999875  3367899999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc--
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--  229 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  229 (356)
                      ++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++..........  
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          80 GPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999999963  3468899999999999999999999   999999999999999999999999999987654332211  


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....++..|+|||.+....++.++|+||||+++|||++ |..||......    .......    ...           
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~i~----~~~-----------  215 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQMIE----SGE-----------  215 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----CCC-----------
Confidence            112233568999999988889999999999999999998 99999753211    1111111    000           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ..+.+..++..+.+++.+||+.||++||++++|.+.|+++
T Consensus       216 ------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                  0112233556788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-42  Score=305.00  Aligned_cols=249  Identities=22%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+. ++..+++|.++.... ....+.+|+.++++++|||++++++++.  .+..+++|||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~   86 (260)
T cd05070          11 IKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMSKGS   86 (260)
T ss_pred             hheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecCCCc
Confidence            478999999999999876 445578887765333 3467999999999999999999999775  346899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++..............
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            9999976555668999999999999999999999   9999999999999999999999999999876543222222223


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+.+..++.++|+||||+++||+++ |..||.+.+..       +.. ......                
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~-~~~~~~----------------  219 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVL-EQVERG----------------  219 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HHH-HHHHcC----------------
Confidence            34567999999988889999999999999999999 88898753211       111 111100                


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                       ...+.+...+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence             00112234456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=305.91  Aligned_cols=251  Identities=24%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             CCcccccCCceEEEEEEcCC---CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..+   ...+++|.++..... ...++.+|+.+++.++||||+++++++.. .+..+++|||+
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~   87 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMIITEYM   87 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEEEEEcC
Confidence            47899999999999998643   457889987654332 23578899999999999999999998875 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      ++++|.+++.... ..+++..+..++.|++.|++|||+   .+++|+||||+||++++++.++|+|||++......... 
T Consensus        88 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd05033          88 ENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY  163 (266)
T ss_pred             CCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence            9999999996433 368899999999999999999999   99999999999999999999999999999876422111 


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......       . ........    .      
T Consensus       164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~----~------  225 (266)
T cd05033         164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------D-VIKAVEDG----Y------  225 (266)
T ss_pred             eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------H-HHHHHHcC----C------
Confidence            1122334567999999998889999999999999999998 99998643211       1 11111100    0      


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                             ..+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       226 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 -------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   0011223456788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.6e-42  Score=304.51  Aligned_cols=249  Identities=20%  Similarity=0.398  Sum_probs=199.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .++||+|+||.||+|... ++..+++|.+.... .....+.+|+.++++++||||+++++++.  .+..+++|||+++++
T Consensus        11 ~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~   86 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGS   86 (260)
T ss_pred             eeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcCCCCC
Confidence            478999999999999876 55678899876433 33467899999999999999999999764  347899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++..............
T Consensus        87 L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            9999876556678999999999999999999999   9999999999999999999999999999876543222222233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++....++.++|+||||+++||+++ |..||.+.+...       ... .....     .          
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~-~~~~~-----~----------  220 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQ-NLERG-----Y----------  220 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHH-HHHcC-----C----------
Confidence            45678999999988889999999999999999999 999997543211       111 11000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+...+.++.+++.+||+.+|++||+++++...|+++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              0011223456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.1e-43  Score=319.50  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=192.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....++..+|+|.++....  .....+.+|+.+++.++||||+++++++....    ...+++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            4789999999999999998999999998864322  22346889999999999999999999876432    24799999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........
T Consensus        85 ~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          85 LME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             cCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            996 589998863  3468899999999999999999999   9999999999999999999999999999875432211


Q ss_pred             c--ceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchh-------HHHHHhhhhc
Q 038580          228 Q--EMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP-------TFMRNAVLDH  296 (356)
Q Consensus       228 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~  296 (356)
                      .  ......++..|+|||++.+  ..++.++|||||||++|||+||+.||.+.+.......+.       ..........
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1  1134568899999999875  678999999999999999999999997643211000000       0000000000


Q ss_pred             ccccccCcccccccCCCCCCCCc---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVS---EERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........ +    ......+.+   .+.+..+.+++.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         239 KARRYLSS-M----RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hHHHHHHh-h----cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000 0    000000000   112456789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-42  Score=310.89  Aligned_cols=253  Identities=22%  Similarity=0.383  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||++...     .++..+++|.++.........+.+|++++++++||||+++++++.. .+..++++||
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   88 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEY   88 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEc
Confidence            478999999999999863     3456788898876544445679999999999999999999998885 4589999999


Q ss_pred             ccCCChhHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccc
Q 038580          149 YKRGNLAQCIRGGS-----------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG  217 (356)
Q Consensus       149 ~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  217 (356)
                      +++++|.+++....           ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg  165 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG  165 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCC
Confidence            99999999986321           2348999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          218 LHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       218 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      ++......... ......++..|+|||.+.+..++.++|+||||+++|||+| |..||.......        .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------~~~~i~~  237 (288)
T cd05093         166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQ  237 (288)
T ss_pred             ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHc
Confidence            98754322111 1122334667999999998889999999999999999998 899986543211        1111111


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ...                 ...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       238 ~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         238 GRV-----------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             CCc-----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            000                 0011123456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=305.40  Aligned_cols=262  Identities=22%  Similarity=0.384  Sum_probs=196.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc--cCCCccccccceeeC---CCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAG---PRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~---~~~~~~lv~e~~  149 (356)
                      ++||+|+||.||+|++.  ++.||||++..   ...+.|.+|-++.+.  ++|+||++|++.-..   ....++||++|.
T Consensus       216 eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             HHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            77999999999999996  58899999874   345678888888765  689999999985331   133789999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG------FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +.|||.++|.   ...++|....+|+..+++||+|||.+      .+++|.|||||++|||+.+|+++.|+|||++..+.
T Consensus       291 ~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            9999999997   35699999999999999999999985      36789999999999999999999999999998776


Q ss_pred             CCCCc-ceecccCCCcccCccccccCC-C-----CCcchhHHHHHHHHHHHhCCCCCC-CCCCC-CC-------CCchhH
Q 038580          224 PTAGQ-EMLEASASQGYKAPELIKMKD-A-----SEETDIYSFGVIMLELISGKEPIN-ENPTP-DE-------DFHLPT  287 (356)
Q Consensus       224 ~~~~~-~~~~~~~~~~y~aPE~~~~~~-~-----~~~sDvwslG~~l~el~tg~~p~~-~~~~~-~~-------~~~~~~  287 (356)
                      ..... ......||.+|||||++.+.- +     -.+.||||+|.++|||+++..-+. +.... ..       ...-.+
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            43322 223468999999999997532 1     246899999999999999655442 11111 00       011122


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .++..+...    ...|.+...|..       ...+..+.+.+..||..||+-|.|+.=+.+++.++.
T Consensus       448 ~mq~~VV~k----K~RP~~p~~W~~-------h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  448 EMQELVVRK----KQRPKIPDAWRK-------HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHHHHHHhh----ccCCCChhhhhc-------CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            233333222    222222211211       124567889999999999999999999988887764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=324.36  Aligned_cols=237  Identities=19%  Similarity=0.277  Sum_probs=196.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .++||+|+||+|+++..+.+++.+|+|++++..-   +..+....|-+++... +||.++++++.|++++ ++|.||||+
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-~l~fvmey~  451 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-HLFFVMEYV  451 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-eEEEEEEec
Confidence            4789999999999999999999999999987532   2234567777777666 5999999999999755 999999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      .||++..+.+   ...+++..+.-+++.|+.||.|||+   ++|++||||.+|||+|.+|.+||+|||+|+-.- ..+..
T Consensus       452 ~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~g~~  524 (694)
T KOG0694|consen  452 AGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQGDR  524 (694)
T ss_pred             CCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC-CCCCc
Confidence            9999554443   4568999999999999999999999   999999999999999999999999999998643 23446


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ..+.+||+.|||||++.+..|+...|.|||||++|||+.|+.||.+++..+    +...+.+                  
T Consensus       525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----~FdsI~~------------------  582 (694)
T KOG0694|consen  525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----VFDSIVN------------------  582 (694)
T ss_pred             cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhc------------------
Confidence            678899999999999999999999999999999999999999999765322    1111111                  


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                          .+..+|...+.+..++|+++|..+|++|.-+
T Consensus       583 ----d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 ----DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                1122455566778899999999999999854

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=311.51  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--------------chHHHHHHHHHHhccCCCccccccceee
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--------------RDKEFGDLIELLGCIRHPNLVPLLGFYA  136 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~~~~~~  136 (356)
                      +...+.||+|.||.|-+|+...+++.+|+|++.+....              ..+...+|+.+|+++.|||||+|+.+..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            34457899999999999999999999999999643211              1146889999999999999999999877


Q ss_pred             CCC-CceEEEEecccCCChhHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEe
Q 038580          137 GPR-GEKLIVHPFYKRGNLAQCIRGGSGEA-HKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS  214 (356)
Q Consensus       137 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  214 (356)
                      ++. +.+|+|+|||..|.+...=   ...+ +.+.++++++.+++.||+|||.   ++|+||||||+|+|++.+|++||+
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEee
Confidence            655 4789999999988876542   3444 8999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCC----CcceecccCCCcccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchh
Q 038580          215 DFGLHLLLNPTA----GQEMLEASASQGYKAPELIKMKD----ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP  286 (356)
Q Consensus       215 Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  286 (356)
                      |||.+.......    ........||+.|+|||.+..+.    -+.+.||||+||+||.++.|+.||.+.....    +.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~----l~  328 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE----LF  328 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----HH
Confidence            999987653221    11223568999999999987633    2568999999999999999999998643211    11


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..+.+.                    ....+..++..+.+.+|+.++|.+||+.|.+..+|..
T Consensus       329 ~KIvn~--------------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  329 DKIVND--------------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             HHHhcC--------------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            111110                    0111223345677889999999999999999998864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-42  Score=316.22  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             cCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.||+|.+.     .+++.+|+|.++..... ....+.+|+.++.++ +||||++++++|..++...+
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence            344588999999999999853     45678999998754322 234688899999999 68999999998876666889


Q ss_pred             EEEecccCCChhHhhhcCC-------------------------------------------------------------
Q 038580          144 IVHPFYKRGNLAQCIRGGS-------------------------------------------------------------  162 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  162 (356)
                      ++|||+++|+|.++++...                                                             
T Consensus        89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (343)
T cd05103          89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ  168 (343)
T ss_pred             EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence            9999999999999986321                                                             


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-cceecccCCC
Q 038580          163 ----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQ  237 (356)
Q Consensus       163 ----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~  237 (356)
                          ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++........ .......++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         169 EDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                1236788889999999999999999   9999999999999999999999999999876432211 1112233456


Q ss_pred             cccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCC
Q 038580          238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN  316 (356)
Q Consensus       238 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (356)
                      .|+|||.+.+..++.++|+||||+++||+++ |..||......       ...........                 ..
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-----------------~~  301 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGT-----------------RM  301 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccC-----------------CC
Confidence            7999999988889999999999999999997 89998653211       11111110000                 00


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          317 PVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..+...+..+.+++..||+.||++||++.++++.|+.+.
T Consensus       302 ~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            011122346889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.5e-43  Score=316.67  Aligned_cols=241  Identities=20%  Similarity=0.294  Sum_probs=189.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhc-cCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGC-IRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|+++....   ...+.+..|..++.. .+||||+++++++.. ++..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            369999999999999998999999999875321   222345566666654 489999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        80 gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          80 GGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            9999999864  3468888999999999999999999   999999999999999999999999999987543222 223


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||.+.+..       . ........              
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~-~~~~i~~~--------------  211 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------E-LFDSILND--------------  211 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcC--------------
Confidence            3456899999999999888999999999999999999999999754321       1 11111100              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK-QVL  348 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~il  348 (356)
                          ....+...+..+.+++..||+.||++||++. +++
T Consensus       212 ----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 ----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                0011223345677999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.1e-42  Score=308.38  Aligned_cols=251  Identities=21%  Similarity=0.375  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..     ++..+++|.++..... ..+.+.+|+++++.++||||+++++++... +..+++||
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   88 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPPIMVFE   88 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCeEEEEe
Confidence            3779999999999998753     3578899988765443 346899999999999999999999998854 58999999


Q ss_pred             cccCCChhHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          148 FYKRGNLAQCIRGGS------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      |+++++|.++++...            ...+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECC
Confidence            999999999996421            2347888999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          216 FGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       216 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ||++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+...        .....
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--------~~~~~  237 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECI  237 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHH
Confidence            9998654322111 1123345678999999999999999999999999999999 999987543211        11111


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      ....                 ....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus       238 ~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 TQGR-----------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HcCC-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1100                 001122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-42  Score=306.28  Aligned_cols=253  Identities=20%  Similarity=0.356  Sum_probs=196.0

Q ss_pred             CCcccccCCceEEEEEEcCCCe--EEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCC-----CCceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~--~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~l  144 (356)
                      ++.||+|+||.||+|.+..++.  .+|+|.++....  ...+.+..|+++++.++||||+++++++...     ....++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            5789999999999999876664  578888765422  2235788899999999999999999976422     125689


Q ss_pred             EEecccCCChhHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          145 VHPFYKRGNLAQCIRG----GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      ++||+++|+|.+++..    .....+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            9999999999998732    123457899999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          221 LLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       221 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      ........ ......+++.|+|||.+.+..++.++|+||||+++||+++ |..||......       . ......... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~-~~~~~~~~~-  231 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------E-IYDYLRQGN-  231 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHcCC-
Confidence            65432211 1122345667999999998899999999999999999999 78888653211       1 111111100 


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                      ..+.+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 ----------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                            0011223456688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-42  Score=307.87  Aligned_cols=269  Identities=21%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEE----cCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~  148 (356)
                      .+.||+|+||.||++..    ..++..+++|.++.......+.+.+|+++++.++||||+++++++... ....++++||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            37799999999999974    346788999988765444456889999999999999999999976533 3468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  164 (284)
T cd05081          89 LPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY  164 (284)
T ss_pred             cCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence            9999999998643 3358999999999999999999999   99999999999999999999999999998765432221


Q ss_pred             ce--ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 EM--LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|||++|..|+........     .....    ..........+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~  235 (284)
T cd05081         165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-----RMMGN----DKQGQMIVYHL  235 (284)
T ss_pred             eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-----hhccc----ccccccchHHH
Confidence            11  112234459999999888899999999999999999998777543221100     00000    00000000000


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..........+.+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0000000111123344567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-42  Score=304.93  Aligned_cols=247  Identities=21%  Similarity=0.327  Sum_probs=194.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+.. +..+|+|.++... ....++.+|+.++++++||||+++++++.. .+..+++|||+.+|+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   85 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYMSNGC   85 (256)
T ss_pred             eeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcCCCCc
Confidence            3679999999999998864 4458888776432 334679999999999999999999998875 447899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+..............
T Consensus        86 l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          86 LLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence            999997533 368999999999999999999999   9999999999999999999999999999876543322222223


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..       .... ......    .          
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~-~~~~~~----~----------  219 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVE-KVSQGL----R----------  219 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHH-HHhcCC----C----------
Confidence            34567999999988889999999999999999999 99998653311       1111 111000    0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                         ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               0011123467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=319.36  Aligned_cols=244  Identities=23%  Similarity=0.378  Sum_probs=189.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..+++.+|+|++...... ....+.+|+++++.++|+||+++++++.. ++..+++|||+.++
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~  157 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecCCCC
Confidence            47899999999999999988999999998644322 23578999999999999999999998875 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|....      ..+...+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++....... .....
T Consensus       158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  227 (353)
T PLN00034        158 SLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNS  227 (353)
T ss_pred             cccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccc
Confidence            986532      34567788899999999999999   999999999999999999999999999987654321 12234


Q ss_pred             ccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          233 ASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ..|+..|+|||++..     ...+.++|||||||++|||++|+.||.......    ...........            
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~------------  291 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCAICMS------------  291 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhcc------------
Confidence            568899999998743     223568999999999999999999997322111    11111100000            


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                            .....+...+.++.+++..||+.||++||++.++++.
T Consensus       292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011223445678899999999999999999999863

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3e-43  Score=321.95  Aligned_cols=240  Identities=18%  Similarity=0.231  Sum_probs=193.2

Q ss_pred             CCcccccCCceEEEEEEcCCC-eEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~-~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++ ..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+ ++..+++|||+
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~Ey~  113 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYLVLEFV  113 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEEEEeCC
Confidence            378999999999999876544 688999875432   1223568889999999999999999999885 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.....    .
T Consensus       114 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~  184 (340)
T PTZ00426        114 IGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----R  184 (340)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----C
Confidence            99999999973  3468899999999999999999999   9999999999999999999999999999876532    1


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||...+..        ..........            
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~------------  244 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGI------------  244 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCC------------
Confidence            23457889999999999888999999999999999999999999753221        1111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                            ...+...+..+.+++.+||+.||++|+     +++++++
T Consensus       245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                  011222345577999999999999995     8888875

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-42  Score=320.34  Aligned_cols=264  Identities=19%  Similarity=0.326  Sum_probs=202.1

Q ss_pred             cchhhhhcCCCCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccc-hHHHHHHHHHHhccC-CCccccccceee
Q 038580           64 LTICDILDAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIR-HPNLVPLLGFYA  136 (356)
Q Consensus        64 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~  136 (356)
                      +.+....+..++.||+|+||.||+|.+.     .++..+|+|+++...... .+.+..|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3333334445689999999999999864     345679999987543222 246889999999997 999999999988


Q ss_pred             CCCCceEEEEecccCCChhHhhhcCC------------------------------------------------------
Q 038580          137 GPRGEKLIVHPFYKRGNLAQCIRGGS------------------------------------------------------  162 (356)
Q Consensus       137 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------  162 (356)
                      .. +..++|+||+++|+|.++++...                                                      
T Consensus       112 ~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 KG-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             cC-CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            54 58999999999999999986321                                                      


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 038580          163 ------------------------------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKS  200 (356)
Q Consensus       163 ------------------------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~  200 (356)
                                                                ...+++..+..++.|++.||+|||+   .+++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCc
Confidence                                                      1235677888999999999999999   9999999999


Q ss_pred             CCeeEcCCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 038580          201 KNILLDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPT  278 (356)
Q Consensus       201 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~  278 (356)
                      +|||+++++.+||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+.
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999876432211 11223356778999999988889999999999999999998 8889865321


Q ss_pred             CCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          279 PDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..       ..........                 +.+.+...+.++.+++.+||+.+|++||++++|+..|+++.
T Consensus       348 ~~-------~~~~~~~~~~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NE-------QFYNAIKRGY-----------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hH-------HHHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11       1111111000                 00112234567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.7e-42  Score=310.47  Aligned_cols=267  Identities=19%  Similarity=0.256  Sum_probs=192.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|....++..+|+|+++..... ....+.+|+.+++.++||||+++++++.++ ...++||||+. +
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~   87 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVFEYVH-T   87 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEEECCC-c
Confidence            37899999999999999988999999998754332 234678899999999999999999998854 48999999996 5


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... .....
T Consensus        88 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  162 (303)
T cd07869          88 DLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSN  162 (303)
T ss_pred             CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCC
Confidence            888887642 3457888899999999999999999   999999999999999999999999999986543221 12233


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH--hhhhcccccc-----cCc
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN--AVLDHRITDL-----YHP  304 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-----~~~  304 (356)
                      ..+++.|+|||++.+ ..++.++|+|||||++|||++|..||.+......  .+......  ......+...     ..+
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhcccccc
Confidence            467888999998865 4578999999999999999999999986432110  00000000  0000000000     000


Q ss_pred             c-cccccCCCCCCCC-cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 D-MLLCSNSNHENPV-SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~-~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      . ............. ....+..+.+++..||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 0000000000000 0012345779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.8e-42  Score=302.88  Aligned_cols=249  Identities=23%  Similarity=0.401  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++ .+++|.+.... ...+.+.+|+.+++.++|||++++++++.  .+..+++|||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~   86 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGKGS   86 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCCCC
Confidence            467999999999999987554 47788765432 23467889999999999999999999775  346899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++++......+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++..............
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            9999976555568999999999999999999999   9999999999999999999999999999876543322222233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||...+..++.++|+||||+++||++| |..||.+.....       ... .....     .          
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~-~~~~~-----~----------  220 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLE-QVERG-----Y----------  220 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH-HHHcC-----C----------
Confidence            45667999999988889999999999999999999 899987543211       011 00000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+.+.+..+.+++.+||+.||++||+++++++.|+++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         221 --RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              0112234556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.3e-42  Score=307.09  Aligned_cols=251  Identities=21%  Similarity=0.371  Sum_probs=194.4

Q ss_pred             CCcccccCCceEEEEEEcCCCe----EEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++.    .+++|........ ...++..|+..++.++||||+++++++.  ....++++||
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~~i~e~   89 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQLVTQL   89 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccEEEEEe
Confidence            4789999999999999876654    3666766533222 2256778888899999999999999875  3367889999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        90 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          90 SPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            9999999999742 3468999999999999999999999   99999999999999999999999999998765432221


Q ss_pred             c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      . .....++..|+|||.+.++.++.++||||||+++||+++ |..||.+.....    ......    ...         
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~----~~~---------  228 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLE----KGE---------  228 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH----CCC---------
Confidence            1 123345678999999988899999999999999999998 999997543211    111111    000         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ....+..++..+.+++.+||..||++|||+.++++.|..+.
T Consensus       229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         229 --------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                    00011123446788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3e-42  Score=309.27  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=200.1

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|...     .++..+++|.++.......+.+.+|++++++++||||+++++++.. .+..+++|||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   88 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIMVFEY   88 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEEEEec
Confidence            378999999999999864     2456688888775544445679999999999999999999998885 4589999999


Q ss_pred             ccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEe
Q 038580          149 YKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS  214 (356)
Q Consensus       149 ~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  214 (356)
                      +++++|.+++....              ...+++..++.++.|++.|++|||+   .+++||||||+||+++.++.++|+
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEEC
Confidence            99999999996422              2347899999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHh
Q 038580          215 DFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA  292 (356)
Q Consensus       215 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  292 (356)
                      |||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |..||...+..       . ....
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~-~~~~  237 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E-VIEC  237 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHH
Confidence            99998654332211 1123345678999999998889999999999999999999 99998654321       1 1111


Q ss_pred             hhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ......                 ...+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       238 ~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         238 ITQGRV-----------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HhCCCC-----------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            111100                 0012234567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.4e-42  Score=309.15  Aligned_cols=257  Identities=21%  Similarity=0.346  Sum_probs=200.3

Q ss_pred             hcCCCCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCce
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (356)
                      .+...+.||+|+||.||++.+.     ..+..+|+|.++...... .+.+.+|+.+++++ +||||+++++++.. .+..
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~  114 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GGPI  114 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CCce
Confidence            3444688999999999999752     345678899887543222 34688999999999 79999999998875 4589


Q ss_pred             EEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccccc
Q 038580          143 LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      +++|||+++|+|.++++......+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++++|||++...
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            999999999999999975444458999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          223 NPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       223 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      ...... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...+...       .........    
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~~~~----  260 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLIKEG----  260 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHHHcC----
Confidence            332211 1112344677999999988889999999999999999998 999987543211       011111000    


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                       ..            ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       261 -~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 -YR------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -Cc------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             00            001122345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.8e-43  Score=316.44  Aligned_cols=237  Identities=21%  Similarity=0.296  Sum_probs=189.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.++.++..+|+|+++...   ....+.+..|..++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999999899999999987532   12234567788888766 69999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~  153 (320)
T cd05590          80 GGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTT  153 (320)
T ss_pred             CchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcc
Confidence            9999998863  3468899999999999999999999   99999999999999999999999999998653221 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|+|||||++|||++|..||...+..       . .........             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~-~~~~i~~~~-------------  212 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------D-LFEAILNDE-------------  212 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHhcCC-------------
Confidence            3456899999999999889999999999999999999999999754311       1 111111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                           ...+...+..+.+++.+||+.||++||++
T Consensus       213 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -----VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                 01122234567899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-42  Score=317.22  Aligned_cols=248  Identities=19%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  145 (356)
                      .+.||+|+||.||++...   .++..+|+|+++....    ...+.+..|+.+++.++ ||||+++++++.. ++..+++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv   83 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAKLHLI   83 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCEEEEE
Confidence            377999999999998864   4678899999864321    12245788999999994 9999999998875 4588999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          84 LDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            999999999999863  3468899999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          226 AGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      .........|+..|+|||++.+. .++.++|||||||++|||+||..||.........    ..........        
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~--------  226 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKC--------  226 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcC--------
Confidence            33333455789999999998765 4788999999999999999999999753322111    1111111100        


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                                ..+.+...+..+.+++.+||+.||++||     +++++++
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 ----------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                      0112223455678999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.5e-43  Score=316.77  Aligned_cols=242  Identities=19%  Similarity=0.258  Sum_probs=191.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ++||+|+||.||+|....++..+|+|+++....   .....+..|.++++.+ +||||+++++++.. ++..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            369999999999999998899999999875422   2224567788888765 79999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|...+..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          80 GGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            9999998863  3468888999999999999999999   999999999999999999999999999987532221 122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||...+..       .... ......             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~-~i~~~~-------------  212 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFE-SILHDD-------------  212 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHH-HHHcCC-------------
Confidence            3456889999999999889999999999999999999999999754311       1111 111000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-------NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-------s~~~il~  349 (356)
                           ...+...+.++.+++..||+.||++||       +++++++
T Consensus       213 -----~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -----VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                 001222345678999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-42  Score=304.27  Aligned_cols=253  Identities=21%  Similarity=0.364  Sum_probs=197.4

Q ss_pred             CCcccccCCceEEEEEEcCC---CeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCC-----ceE
Q 038580           74 GEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-----EKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~  143 (356)
                      ++.||+|+||.||+|.+..+   +..+|+|.++.....  ....+..|++.++.++||||+++++++.....     ..+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            47899999999999998643   377899988754322  22478999999999999999999998764332     379


Q ss_pred             EEEecccCCChhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          144 IVHPFYKRGNLAQCIRGG----SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      +++||+++++|..++...    ....+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccce
Confidence            999999999999998432    23468999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+....       +... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~-~~~~~~  232 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYD-YLRHGN  232 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH-HHHcCC
Confidence            7654322211 112234567999999988889999999999999999999 88888653211       1111 111000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                       ....+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus       233 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 -----------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                             0112334556788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-42  Score=313.87  Aligned_cols=242  Identities=19%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|+++...   ......+..|.++++.+ +||||+++++++.. .+..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999999889999999987532   22234567788888877 69999999998885 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ....
T Consensus        80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (318)
T cd05570          80 GGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTT  153 (318)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcc
Confidence            9999998863  3468999999999999999999999   99999999999999999999999999998643211 1122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||++.+..++.++|+|||||++|||++|..||...+.        ...........             
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~-------------  212 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDE-------------  212 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-------------
Confidence            344688899999999999999999999999999999999999975331        11111111000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNI-----KQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++||++     .++++
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 -----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                 01122345568899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.2e-42  Score=307.28  Aligned_cols=256  Identities=21%  Similarity=0.344  Sum_probs=201.7

Q ss_pred             CCCcccccCCceEEEEEEcC----CCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           73 PGEVIGKSNYGTLYKALLQR----SGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~----~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..+.||+|+||.||+|.+..    ++..+++|.++.... .....+.+|+.++++++||||+++++++...+...+++++
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   89 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP   89 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence            35889999999999999875    257788888764322 2235688999999999999999999988765668899999


Q ss_pred             cccCCChhHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          148 FYKRGNLAQCIRGGSG------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      |+++++|.+++.....      ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            9999999999864321      468899999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCcce-ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          222 LNPTAGQEM-LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       222 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      ......... ....++..|+|||++.+..++.++||||||+++||+++ |..||...+..    .+..    .....   
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~---  235 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAA----YLKDG---  235 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHH----HHHcC---
Confidence            533222211 12344667999999988889999999999999999999 99999753221    1111    11100   


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                        .            ....+..++.++.+++.+||+.||++|||+.++++.|+++.+
T Consensus       236 --~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 --Y------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --C------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              0            001122345678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-42  Score=302.37  Aligned_cols=249  Identities=21%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             CcccccCCceEEEEEEcCCC---eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+...+   ..+++|.++..... ..+++.+|+++++.+.||||+++++++.  .+..+++|||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            46999999999999876444   78899988755432 3457899999999999999999999876  336899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      +++|.+++...  ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......... 
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999999743  368999999999999999999999   999999999999999999999999999987653322111 


Q ss_pred             -eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 -MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       .....++..|+|||.+.+..++.++|+||||+++||+++ |..||...+..    .....    .....          
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~----~~~~~----------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAM----LESGE----------  215 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHH----HHcCC----------
Confidence             111223457999999988889999999999999999998 99999754211    11111    11100          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ....+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       216 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 -------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                   00122234567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-42  Score=305.02  Aligned_cols=267  Identities=19%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             CCcccccCCceEEEEEE----cCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e  147 (356)
                      .+.||+|+||+||++..    ..++..+|+|.++.... .....+.+|++++++++||||+++++++.... ...+++||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME   88 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence            37799999999988653    34677899999875433 23457889999999999999999999876433 35789999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        89 ~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          89 YVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             CCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999863   358999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             cc--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          228 QE--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       228 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|||+||..||...........  .............+..+  
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~--  238 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI--GPKQGQMTVVRLIELLE--  238 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh--cccccccchhhhhhhhh--
Confidence            11  1122345679999999888899999999999999999999999865332110000  00000000000000000  


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                            .....+.+...+.++.+++.+||+.+|++|||++++++.|+++.+
T Consensus       239 ------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~  283 (283)
T cd05080         239 ------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH  283 (283)
T ss_pred             ------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence                  001112233456789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.2e-42  Score=302.34  Aligned_cols=252  Identities=23%  Similarity=0.421  Sum_probs=192.6

Q ss_pred             CcccccCCceEEEEEEcC---CCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..   .+..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   345788888753322 2235788899999999999999999988755667899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      +++|.+++.... ...++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.......... 
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997432 346777888999999999999999   999999999999999999999999999987543221111 


Q ss_pred             --eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 --MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG-KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                        .....++..|+|||.+.+..++.++||||||+++|||++| ..||...+.       ... ........         
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~-~~~~~~~~---------  219 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDI-TVYLLQGR---------  219 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHH-HHHHhcCC---------
Confidence              1123446679999999888899999999999999999995 555543211       111 11111000         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ....+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       220 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 --------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                    00112223457889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.8e-42  Score=303.01  Aligned_cols=250  Identities=20%  Similarity=0.280  Sum_probs=196.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|....++..+++|+++.........+.+|+.+++.++||||+++++++.. ++..++++||+++++
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e~~~~~~   92 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICMEYCGGGS   92 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEeCCCCCc
Confidence            4789999999999999988899999999875544445678899999999999999999998885 458899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++++.  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++....... ......
T Consensus        93 L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~  166 (267)
T cd06646          93 LQDIYHV--TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSF  166 (267)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-cccCcc
Confidence            9999863  3468899999999999999999999   999999999999999999999999999987653221 112234


Q ss_pred             cCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          234 SASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       234 ~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      .++..|+|||.+.   ...++.++|+||||+++|||++|..||............        ....   ...+      
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~---~~~~------  229 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSN---FQPP------  229 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCC---CCCC------
Confidence            5778899999874   345788999999999999999999998654321110000        0000   0000      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                          ........+..+.+++.+||+.+|++||+++++++.|
T Consensus       230 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 ----KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                0001122346788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-42  Score=305.93  Aligned_cols=253  Identities=17%  Similarity=0.351  Sum_probs=194.9

Q ss_pred             CCCCcccccCCceEEEEEEc-----CCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...+.||+|+||.||+|.+.     .++..+|+|.++.... ....++.+|+.+++.++||||+++++++.. +++.+++
T Consensus         9 ~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   87 (277)
T cd05062           9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVI   87 (277)
T ss_pred             eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCeEEE
Confidence            33578999999999999864     2356788888764322 223568899999999999999999998874 4589999


Q ss_pred             EecccCCChhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccc
Q 038580          146 HPFYKRGNLAQCIRGGS--------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG  217 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  217 (356)
                      |||+++++|.++++...        ....++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCC
Confidence            99999999999986421        2346788899999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          218 LHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       218 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      ++.......... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+..       .... ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~-~~~~  236 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLR-FVME  236 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH-HHHc
Confidence            987543322211 112344677999999998889999999999999999999 78888653211       1111 1111


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      ...                 ...+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus       237 ~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 GGL-----------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCc-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            000                 01122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-42  Score=313.72  Aligned_cols=241  Identities=19%  Similarity=0.278  Sum_probs=190.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhc-cCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGC-IRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|.++...   ......+..|..++.. ++||||+++++++.+. +..+++|||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            35999999999999999889999999987542   1223456667777765 4899999999998854 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ....
T Consensus        80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (316)
T cd05619          80 GGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKT  153 (316)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCce
Confidence            9999999873  3468889999999999999999999   99999999999999999999999999998653211 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|+..|+|||++.+..++.++|+|||||++|||++|..||...+..       .... .....      .       
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~-~i~~~------~-------  212 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQ-SIRMD------N-------  212 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhC------C-------
Confidence            3456889999999999889999999999999999999999999753211       1111 11000      0       


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK-QVL  348 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~il  348 (356)
                           ...+......+.+++.+||+.||++||++. +++
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         213 -----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                 001222345678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-42  Score=316.73  Aligned_cols=243  Identities=20%  Similarity=0.284  Sum_probs=193.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....++..+|+|+++....   .....+..|+++++.++||||+++++++.. ++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            359999999999999998999999999875422   122467789999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|..++..  ...+++..+..++.|++.||+|||+.  .+++||||||+|||++.++.+||+|||++...... .....
T Consensus        80 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~  154 (325)
T cd05594          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence            999998863  34689999999999999999999962  68999999999999999999999999998653221 11223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...|+..|+|||++.+..++.++|||||||++|||+||..||...+..       . ........               
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~-~~~~i~~~---------------  211 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME---------------  211 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------H-HHHHHhcC---------------
Confidence            456889999999999889999999999999999999999999653210       0 11110000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                         ....+...+..+.+++.+||+.||++|+     ++.++++
T Consensus       212 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 ---EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence               0011223345678999999999999996     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-42  Score=301.99  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.++ ++..+++|.+.... ....++.+|+++++.++||||+++++++.. .+..+++|||+++++
T Consensus         9 ~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   85 (256)
T cd05059           9 LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMANGC   85 (256)
T ss_pred             hhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCCCCC
Confidence            478999999999999886 45567888875432 234578889999999999999999998874 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..+++..+..++.|++.|++|||+   .+++||||||+||++++++.+||+|||++..............
T Consensus        86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence            999997433 368999999999999999999999   9999999999999999999999999999876533222211222


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+.+..++.++|+||||+++||+++ |..||...+...    .    .......     ..         
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~----~~~~~~~-----~~---------  219 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----V----VESVSAG-----YR---------  219 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----H----HHHHHcC-----Cc---------
Confidence            33457999999998899999999999999999999 888887532211    0    1111000     00         


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                         ...+...+.++.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         220 ---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence               0112234567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.9e-42  Score=302.89  Aligned_cols=255  Identities=19%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+|+|.++....   .....+.+|+++++.++||||+++++++... +..++++||++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~   85 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIVLELAD   85 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEEEEecC
Confidence            4789999999999999998899999998754322   2224688899999999999999999988854 48899999999


Q ss_pred             CCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|.+++...  ....++...+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-  161 (267)
T cd08228          86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-
Confidence            99999888531  23457888999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|..||......     ...... ....     ...     
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~-~~~~-----~~~-----  225 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQ-KIEQ-----CDY-----  225 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHH-HHhc-----CCC-----
Confidence            122345778899999998888899999999999999999999998643211     111111 1100     000     


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ........+..+.+++.+||+.+|++||++.++++.|+.++
T Consensus       226 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 ------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  00112345577899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6e-42  Score=312.19  Aligned_cols=244  Identities=18%  Similarity=0.269  Sum_probs=191.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||++....++..+|+|+++.....   ..+.+..|..++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            3699999999999999999999999998754322   224577889988887 69999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (327)
T cd05617          80 GGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT  153 (327)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence            9999988863  3468999999999999999999999   99999999999999999999999999998653221 1223


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|+|||||++|||++|..||......... ..............             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~-------------  219 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKP-------------  219 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCC-------------
Confidence            3457899999999999999999999999999999999999999754322211 11111111111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                           .+.+...+..+.+++.+||+.||++||++
T Consensus       220 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 -----IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                 01222334567799999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-42  Score=314.86  Aligned_cols=242  Identities=20%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             CcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      +.||+|+||.||++...   .++..+|+|+++....    .....+.+|+.+++.++||||+++++++.. ++..+++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence            57999999999999864   4678899999864321    122457789999999999999999998885 458999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++..  ...+.+..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... .
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  154 (323)
T cd05584          81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-G  154 (323)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-C
Confidence            9999999999863  3457788888899999999999999   99999999999999999999999999998653222 1


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......|++.|+|||++.+..++.++||||||+++|||++|..||...+..       .... ......          
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~-~~~~~~----------  216 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTID-KILKGK----------  216 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHH-HHHcCC----------
Confidence            2223456889999999999888999999999999999999999999753311       1111 111100          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                              ...+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       217 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                    012223345678999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=322.98  Aligned_cols=248  Identities=20%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....+++.+|+|+++....   .....+..|+++++.++||||+++++++.+ ++..++||||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   84 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLVMEYMP   84 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEEEcCCC
Confidence            3779999999999999998999999999875422   233568899999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC----
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA----  226 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~----  226 (356)
                      +++|.+++...  ..++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......    
T Consensus        85 ~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          85 GGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99999999743  568899999999999999999999   999999999999999999999999999987654332    


Q ss_pred             ------------------------CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 038580          227 ------------------------GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED  282 (356)
Q Consensus       227 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~  282 (356)
                                              ........|++.|+|||++.+..++.++|||||||++|||++|..||.......  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--  237 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE--  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH--
Confidence                                    112234468899999999999999999999999999999999999997643110  


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-IKQVLWK  350 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~il~~  350 (356)
                            ........ ....             ..+.....+..+.+++..||+ ||.+||+ ++++++.
T Consensus       238 ------~~~~i~~~-~~~~-------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         238 ------TYNKIINW-KESL-------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ------HHHHHhcc-CCcc-------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                  11111000 0000             000111135667899999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-41  Score=297.54  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+++|.+....  .....++.+|+++++.++|||++++++++.. ++..++++||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVMEYAEN   83 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEEeCCC
Confidence            367999999999999999889999999876432  2234578899999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~  159 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-AN  159 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hh
Confidence            999999986556678999999999999999999999   99999999999999999999999999998765432221 22


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||++.+..++.++|+||||+++|||++|..||...+.        ...........              
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~--------------  217 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGV--------------  217 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC--------------
Confidence            34577889999999988899999999999999999999999975431        11111111100              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ..+.+...+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               001222455678899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.3e-42  Score=306.94  Aligned_cols=251  Identities=21%  Similarity=0.354  Sum_probs=196.8

Q ss_pred             CcccccCCceEEEEEEcC-----CCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      +.||+|+||.||+|.+..     .+..+|+|.++...... ...+.+|+.+++.++||||+++++++... +..++++||
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~~~~e~   89 (283)
T cd05091          11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-QPLSMIFSY   89 (283)
T ss_pred             HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-CceEEEEEc
Confidence            779999999999998753     35789999987543322 25688999999999999999999988854 478999999


Q ss_pred             ccCCChhHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEe
Q 038580          149 YKRGNLAQCIRGG--------------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS  214 (356)
Q Consensus       149 ~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  214 (356)
                      +.+++|.+++...              ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEec
Confidence            9999999998421              12357888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHh
Q 038580          215 DFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA  292 (356)
Q Consensus       215 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  292 (356)
                      |||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.+...       .. ....
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~  238 (283)
T cd05091         167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD-VIEM  238 (283)
T ss_pred             ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HH-HHHH
Confidence            99998765322211 1123345678999999988889999999999999999998 8888865321       11 1111


Q ss_pred             hhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      .....                 ..+.+.+++..+.+++..||+.+|++||++.+|++.|+.+
T Consensus       239 i~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  283 (283)
T cd05091         239 IRNRQ-----------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW  283 (283)
T ss_pred             HHcCC-----------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence            11100                 0112344567788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-42  Score=304.17  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=194.2

Q ss_pred             CcccccCCceEEEEEEcCCCe--EEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~--~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+.+++.  .+++|.++.... ...+.+..|+++++++ +||||+++++++.. .+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence            359999999999999987664  467787764322 2335788999999999 79999999998875 457899999999


Q ss_pred             CCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecc
Q 038580          151 RGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDF  216 (356)
Q Consensus       151 ~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  216 (356)
                      +|+|.+++....              ...+++..+..++.|++.|++|||+   .+++||||||+||++++++.+|++||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence            999999986422              2347889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          217 GLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       217 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      |++.....  .........+..|+|||++....++.++|+||||+++|||++ |..||.+.+..       .... ....
T Consensus       157 gl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~-~~~~  226 (270)
T cd05047         157 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE-KLPQ  226 (270)
T ss_pred             CCccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHH-HHhC
Confidence            99753221  111112233567999999988889999999999999999997 99999653211       1111 1100


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .     .            ....+...+..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       227 ~-----~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 G-----Y------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C-----C------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0     0            00112234456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-42  Score=323.76  Aligned_cols=248  Identities=17%  Similarity=0.215  Sum_probs=190.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|.+..++..+|+|+++....   .....+.+|+++++.++||||+++++++.+ .+..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~E~~~   84 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIP   84 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEEecCC
Confidence            3779999999999999999999999999865322   223468899999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC---
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG---  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  227 (356)
                      +|+|.+++..  ...+++.....++.|++.||+|||+   .+|+||||||+|||++.++++||+|||++........   
T Consensus        85 gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          85 GGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999874  3468888889999999999999999   9999999999999999999999999999753311000   


Q ss_pred             -------------------------------------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHH
Q 038580          228 -------------------------------------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIML  264 (356)
Q Consensus       228 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~  264 (356)
                                                                 .......||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                       0012346889999999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhh--ccCCCCCCCC
Q 038580          265 ELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMA--CCSPSPSLRP  342 (356)
Q Consensus       265 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~Rp  342 (356)
                      ||+||..||...+....        ....... ....             ..+.....+.++.+++.+  |+..+|..||
T Consensus       240 elltG~~Pf~~~~~~~~--------~~~i~~~-~~~~-------------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         240 EMLVGQPPFLAPTPTET--------QLKVINW-ENTL-------------HIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             HHHhCCCCCcCCCHHHH--------HHHHHcc-cccc-------------CCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999975432110        0000000 0000             000111233456678876  5666777799


Q ss_pred             CHHHHHH
Q 038580          343 NIKQVLW  349 (356)
Q Consensus       343 s~~~il~  349 (356)
                      ++++++.
T Consensus       298 ~~~~~l~  304 (381)
T cd05626         298 GADDIKA  304 (381)
T ss_pred             CHHHHhc
Confidence            9999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.7e-42  Score=301.20  Aligned_cols=245  Identities=23%  Similarity=0.411  Sum_probs=196.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||++...  +..+++|..+..  ...+.+.+|+.+++.++|+|++++++++...++..++++||+++++
T Consensus        11 ~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~   86 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   86 (256)
T ss_pred             eeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence            478999999999999775  667888887642  2345789999999999999999999977655667899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++++......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.......    ...
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~  159 (256)
T cd05082          87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTG  159 (256)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----CCC
Confidence            9999976555568999999999999999999999   999999999999999999999999999986543221    122


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||++....++.++||||||+++|||++ |..||.....       .. ........     .          
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~-----~----------  216 (256)
T cd05082         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KD-VVPRVEKG-----Y----------  216 (256)
T ss_pred             ccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcC-----C----------
Confidence            34567999999988889999999999999999998 9999864321       11 11111000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0012233456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-42  Score=308.56  Aligned_cols=253  Identities=22%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||++....     +...+++|.++..... ...++.+|+++++++ +||||+++++++.. ++..+++|
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~li~   95 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPLYVVV   95 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-CCCeEEEE
Confidence            4789999999999998763     3478899988754222 224688899999999 79999999998875 45899999


Q ss_pred             ecccCCChhHhhhc--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeE
Q 038580          147 PFYKRGNLAQCIRG--------------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY  212 (356)
Q Consensus       147 e~~~~gsL~~~l~~--------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k  212 (356)
                      ||+++|+|..+++.              .....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+|
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEE
Confidence            99999999999863              223568899999999999999999999   9999999999999999999999


Q ss_pred             EeccccccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHH
Q 038580          213 VSDFGLHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMR  290 (356)
Q Consensus       213 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  290 (356)
                      |+|||++.......... .....++..|+|||++.+..++.++|||||||++||+++ |..||......       . ..
T Consensus       173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~-~~  244 (293)
T cd05053         173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-------E-LF  244 (293)
T ss_pred             eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-------H-HH
Confidence            99999987654322111 122234567999999988889999999999999999998 99998653211       1 11


Q ss_pred             HhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .......                 ....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       245 ~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKEGY-----------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1111000                 00122334567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.2e-42  Score=306.44  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=195.5

Q ss_pred             CCcccccCCceEEEEEEc----CCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~----~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+.    .++..+++|.++...... ...+.+|+.+++.++||||+++++++.. +...+++|||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~   88 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVCMLFEY   88 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceEEEEEc
Confidence            377999999999999863    355788888887533322 2578899999999999999999998875 4488999999


Q ss_pred             ccCCChhHhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEE
Q 038580          149 YKRGNLAQCIRGGS---------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV  213 (356)
Q Consensus       149 ~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  213 (356)
                      +++++|.+++....               ...+++...+.++.|++.||+|||+   .+++||||||+||++++++.+||
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEe
Confidence            99999999985221               2347888999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHH
Q 038580          214 SDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRN  291 (356)
Q Consensus       214 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  291 (356)
                      +|||++........ .......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+...        .....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~~~~~  237 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------QEVIE  237 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            99999876532211 11223344667999999988889999999999999999998 8889865321        01111


Q ss_pred             hhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          292 AVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      ......                 ..+.+..++..+.+++.+||+.||++||++.++++.|..
T Consensus       238 ~~~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQ-----------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            110000                 001223345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.6e-42  Score=305.12  Aligned_cols=251  Identities=21%  Similarity=0.386  Sum_probs=197.3

Q ss_pred             CCcccccCCceEEEEEEcCCCe----EEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||+||+|.+..++.    .+|+|.++..... ...++.+|+.+++.++||||+++++++..  ...+++++|
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~~   89 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLVTQL   89 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEEEEc
Confidence            3789999999999999876554    4788988654332 23578899999999999999999998874  357899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.++++.. ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........
T Consensus        90 ~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          90 MPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            9999999999743 3468899999999999999999999   99999999999999999999999999998765432221


Q ss_pred             c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      . .....++..|+|||.+.+..++.++||||||+++||+++ |..||.....    ..+.....    ...         
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~---------  228 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE----KGE---------  228 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH----CCC---------
Confidence            1 112234567999999988889999999999999999998 8899864321    01111111    000         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ..+.+...+..+.+++..||+.||++||++.+++..|+++.
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         229 --------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                    00112234567889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.7e-42  Score=312.14  Aligned_cols=241  Identities=20%  Similarity=0.272  Sum_probs=190.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhc-cCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGC-IRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|.++...   ......+..|..++.. .+||||+++++++.. ++..++||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            36999999999999999999999999987532   1223456677777765 489999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..... .....
T Consensus        80 ~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~  153 (316)
T cd05620          80 GGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRA  153 (316)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCce
Confidence            9999999863  3468888999999999999999999   9999999999999999999999999999864321 11223


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|+..|+|||++.+..++.++|+|||||++|||++|..||.+.+..       . ........      .+      
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~-~~~~~~~~------~~------  213 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------E-LFESIRVD------TP------  213 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC------CC------
Confidence            3456899999999999889999999999999999999999999754311       1 11111000      00      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK-QVL  348 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~il  348 (356)
                            ..+.....++.+++.+||+.||++||++. +++
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  01122345678999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.4e-42  Score=301.01  Aligned_cols=250  Identities=20%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             CcccccCCceEEEEEEcC-CC--eEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQR-SG--SVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-~~--~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+.. ++  ..+++|.++.... ...+.+..|+.++++++||||+++++++..  ...++++||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999999865 33  3689999876655 345689999999999999999999998875  68999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      +++|.+++.......+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.........  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            9999999975443568999999999999999999999   99999999999999999999999999998776432221  


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..       +..... ....          
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~-~~~~----------  217 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKI-DKEG----------  217 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH-HhcC----------
Confidence            1123345678999999988889999999999999999999 99998643211       111110 0000          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                            .....+...+..+.+++.+||+.+|++||++.++++.|.+
T Consensus       218 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         218 ------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                  0001122345678899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-42  Score=320.70  Aligned_cols=266  Identities=22%  Similarity=0.303  Sum_probs=195.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~  146 (356)
                      ..+.||+|+||.||++.+..++..+|+|.+.....  ...+.+.+|+++++.++||||+++++++..+.    ...++++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            34789999999999999988899999998864322  22357889999999999999999999887543    2689999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+. ++|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus        84 e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          84 ELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9997 488888753  4568999999999999999999999   999999999999999999999999999987654333


Q ss_pred             CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH--------HHHHh---hh
Q 038580          227 GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT--------FMRNA---VL  294 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~---~~  294 (356)
                      ........++..|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+..        .....   ..
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            3333344678889999998764 478999999999999999999999976432211000000        00000   00


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........+..     .............++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         238 AHILRGPHKPPS-----LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHhCCCCCCc-----hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            000000000000     00000111223567889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=299.94  Aligned_cols=245  Identities=24%  Similarity=0.432  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|...  ++.+++|.++.... ..+.+.+|+.+++.++|+||+++++++.+ .+..+++|||+++++
T Consensus        11 ~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~   86 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGS   86 (256)
T ss_pred             eeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCc
Confidence            478999999999999875  67788998876543 45678999999999999999999998875 558999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.++++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+........    ..
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~  159 (256)
T cd05039          87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SG  159 (256)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc----cC
Confidence            9999976555578999999999999999999999   9999999999999999999999999999876532211    23


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||.+..+.++.++|+||||+++||+++ |..||...+..        .........     .          
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~-----~----------  216 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEKG-----Y----------  216 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhcC-----C----------
Confidence            34567999999988889999999999999999997 99998643211        111111100     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ....+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0011223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.3e-42  Score=302.63  Aligned_cols=252  Identities=24%  Similarity=0.452  Sum_probs=198.4

Q ss_pred             CCCcccccCCceEEEEEEcCCC---eEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           73 PGEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..+.||+|+||.||+|.+..++   ..+++|.++.... ...+.+..|+++++.++|||++++.+++.. .+..+++|||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   87 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAMIITEY   87 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcEEEEEc
Confidence            3478999999999999987544   3788888765432 223578899999999999999999998875 4588999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..+..++.|++.|++|||+   .+++|+||||+||+++.++.+|++|||++.........
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          88 MENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            9999999998643 3468999999999999999999999   99999999999999999999999999998765432221


Q ss_pred             cee--cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 EML--EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ...  ....+..|+|||++.+..++.++|+||||+++||+++ |..||...+.       .. ........         
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~-~~~~i~~~---------  226 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE-VMKAINDG---------  226 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH-HHHHHhcC---------
Confidence            111  1122456999999988889999999999999999998 9999865321       11 11111100         


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                              ...+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 --------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01112234456788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.6e-42  Score=314.32  Aligned_cols=241  Identities=19%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHH---hccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELL---GCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      +.||+|+||.||+|.+..++..+|+|+++....   ...+.+..|.+++   +.++||||+++++++.. .+..++||||
T Consensus         5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~E~   83 (324)
T cd05589           5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCFVMEY   83 (324)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEEEEcC
Confidence            679999999999999998999999999875421   1223566665554   56789999999998885 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|...++.   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ..
T Consensus        84 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~  156 (324)
T cd05589          84 AAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD  156 (324)
T ss_pred             CCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence            999999988853   468999999999999999999999   99999999999999999999999999998653221 12


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.+..       .... ......           
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~-~i~~~~-----------  217 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFD-SIVNDE-----------  217 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhCC-----------
Confidence            223456889999999999889999999999999999999999999754221       1111 111000           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                             ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       218 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 -------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                   012223456678999999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.6e-42  Score=304.28  Aligned_cols=251  Identities=21%  Similarity=0.354  Sum_probs=197.0

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .++||+|+||.||++...     .++..+++|.++.........+.+|+++++.++||||+++++++.. .+..++++||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   88 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLLMVFEY   88 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceEEEEec
Confidence            478999999999999753     3466788888876555555689999999999999999999998885 4478999999


Q ss_pred             ccCCChhHhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          149 YKRGNLAQCIRGGSG-------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      +++++|.+++.....             ..+++..++.++.|++.|++|||+   .+++||||||+||++++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECC
Confidence            999999999864321             347889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          216 FGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       216 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......       ..... .
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~-~  237 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EAIEC-I  237 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HHHHH-H
Confidence            9998654322111 1122234677999999998899999999999999999998 89998643211       11111 0


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      ....                 ....+..++..+.+++.+||+.||++||++.++.+.|++
T Consensus       238 ~~~~-----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 TQGR-----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HcCc-----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            0000                 001122344568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.4e-42  Score=302.98  Aligned_cols=251  Identities=20%  Similarity=0.359  Sum_probs=198.1

Q ss_pred             CCcccccCCceEEEEEEcCC---CeEEEEEEecccc-ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVC-TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+...   ...+++|...... ....+.+.+|+.+++.++||||+++++++.+  +..+++|||+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~   88 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELA   88 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcC
Confidence            47899999999999987543   3467888776543 2334578999999999999999999998874  3678999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++++|||++..........
T Consensus        89 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  164 (270)
T cd05056          89 PLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK  164 (270)
T ss_pred             CCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence            999999999743 3358999999999999999999999   999999999999999999999999999987654332222


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....++..|+|||.+....++.++|+||||+++||+++ |..||...+...       ... ......           
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~-~~~~~~-----------  225 (270)
T cd05056         165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIG-RIENGE-----------  225 (270)
T ss_pred             cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHH-HHHcCC-----------
Confidence            222334567999999988889999999999999999986 999997543211       010 000000           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ..+.+..++..+.+++.+||+.+|++|||+.+++..|+++.
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  00122344567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-41  Score=298.81  Aligned_cols=247  Identities=22%  Similarity=0.366  Sum_probs=195.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ++||+|+||.||+|... ++..+++|.++...... ...+.+|+++++.++||||+++++++.. .+..+++|||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCc
Confidence            36999999999999875 57778889876543322 2468899999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+|++|||++..............
T Consensus        79 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          79 FLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            99998643 3457899999999999999999999   9999999999999999999999999999865433222222223


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++.+..++.++|+||||+++||+++ |..||.+....        .........     .          
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~-----~----------  211 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKG-----Y----------  211 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC-----C----------
Confidence            44567999999988889999999999999999998 99999754221        111111100     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                        ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence              00112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-42  Score=319.22  Aligned_cols=247  Identities=19%  Similarity=0.254  Sum_probs=194.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....++..+|+|.++...   ......+.+|+.+++.++||||+++++++.+ ++..++||||++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv~Ey~~  126 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLYMVMEYMP  126 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEEcCCC
Confidence            478999999999999999999999999986432   1223457889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..   ..++......++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus       127 gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~  200 (370)
T cd05596         127 GGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC  200 (370)
T ss_pred             CCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence            9999999864   347788888899999999999999   9999999999999999999999999999876543322223


Q ss_pred             ecccCCCcccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          231 LEASASQGYKAPELIKMK----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ....|++.|+|||++.+.    .++.++|+|||||++|||++|..||.+.+..       . .......... .     .
T Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~~-~-----~  266 (370)
T cd05596         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMDHKN-S-----L  266 (370)
T ss_pred             CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcCCC-c-----C
Confidence            345789999999998653    4789999999999999999999999764321       1 1111111000 0     0


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~  349 (356)
                              ..+.....+..+.+++..||+.+|++  ||++++++.
T Consensus       267 --------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 --------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             --------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                    00111123567789999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3e-41  Score=302.64  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....     +...+++|.+...... ....+.+|+.+++.++||||+++++.|.. ++..++++|
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   83 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLLLIVE   83 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcEEEEE
Confidence            4789999999999998752     3357888887654332 23578899999999999999999998875 457899999


Q ss_pred             cccCCChhHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE
Q 038580          148 FYKRGNLAQCIRGGS----------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL  205 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  205 (356)
                      |+.+++|.+++....                      ...+++..++.++.|++.||+|||+   .+++||||||+||++
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence            999999999985321                      2357889999999999999999999   999999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 038580          206 DRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDF  283 (356)
Q Consensus       206 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~  283 (356)
                      ++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...     
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----  235 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-----  235 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            9999999999999875432221 11122344667999999988889999999999999999998 9999865321     


Q ss_pred             chhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ..........     .            ....+...+..+.+++..||+.+|++||+++++++.|+++.
T Consensus       236 ---~~~~~~~~~~-----~------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ---ERLFNLLKTG-----Y------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ---HHHHHHHhCC-----C------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence               1111111100     0            00112334567889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-43  Score=323.12  Aligned_cols=247  Identities=19%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+|+|+++....   .....+.+|+++++.++||||+++++++.+ ++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~   84 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEEECCCC
Confidence            3789999999999999998999999999875321   222457889999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........  
T Consensus        85 ~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          85 GGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9999999874  3468999999999999999999999   99999999999999999999999999998654221100  


Q ss_pred             -----------------------------------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 038580          229 -----------------------------------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI  273 (356)
Q Consensus       229 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~  273 (356)
                                                         ......||+.|+|||++....++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011235899999999999889999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 038580          274 NENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN---IKQVLW  349 (356)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~il~  349 (356)
                      ...+...       ... ....  ..    ...        ..+.....+..+.+++.+|+. +|.+|++   +.++++
T Consensus       240 ~~~~~~~-------~~~-~i~~--~~----~~~--------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQE-------TYR-KIIN--WK----ETL--------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHH-------HHH-HHHc--CC----Ccc--------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            7543211       001 0000  00    000        000111234567789999996 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-41  Score=306.98  Aligned_cols=256  Identities=22%  Similarity=0.395  Sum_probs=199.0

Q ss_pred             cCCCCcccccCCceEEEEEEc-------CCCeEEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQ-------RSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGE  141 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (356)
                      +..++.||+|+||.||+|.+.       ..+..+++|..+.... ...+++.+|+.+++.+ +||||+++++++.. .+.
T Consensus        17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~   95 (304)
T cd05101          17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGP   95 (304)
T ss_pred             eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-CCc
Confidence            344588999999999999752       2345788998765432 2335789999999999 79999999998885 458


Q ss_pred             eEEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          142 KLIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+   .+++||||||+||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~  172 (304)
T cd05101          96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTE  172 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcC
Confidence            899999999999999996421              2357888899999999999999999   99999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCch
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL  285 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~  285 (356)
                      ++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++||+++ |..||...+.       
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------  245 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-------  245 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------
Confidence            999999999998765432221 1222344567999999988889999999999999999998 7888864321       


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..... .....                 .....+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       246 ~~~~~-~~~~~-----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 EELFK-LLKEG-----------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHH-HHHcC-----------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            11111 11100                 001122345667889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=300.56  Aligned_cols=255  Identities=19%  Similarity=0.315  Sum_probs=202.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+++|.+......   ...++.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e~~~   85 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELAD   85 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEEEEecC
Confidence            37799999999999999888999999977643222   22478899999999999999999998885 458999999999


Q ss_pred             CCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++++|||++........ 
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd08229          86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-
Confidence            9999998863  234568999999999999999999999   9999999999999999999999999999876533221 


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|..||.+....     ...... ....     ...+    
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~-----~~~~----  226 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCK-KIEQ-----CDYP----  226 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhh-hhhc-----CCCC----
Confidence            122346788899999998888999999999999999999999998653221     001000 0000     0000    


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             .......+..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus       227 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 -------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                   0012235667889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=300.10  Aligned_cols=250  Identities=22%  Similarity=0.406  Sum_probs=199.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.++ ++..+++|.+.... ....++.+|+.+++.++||||+++++++.. ....+++|||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   87 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGS   87 (261)
T ss_pred             eeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccCCCC
Confidence            478999999999999986 45668888887533 344679999999999999999999998874 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.+|++|||++..............
T Consensus        88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            9999976555678999999999999999999999   9999999999999999999999999999876543222222222


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||.+.+..++.++|+||||+++||+++ |..||.+....       .... .....    .           
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~-~~~~~----~-----------  221 (261)
T cd05034         165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------EVLE-QVERG----Y-----------  221 (261)
T ss_pred             CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH-HHHcC----C-----------
Confidence            34567999999998889999999999999999999 99999653211       1111 11000    0           


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+...+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence              0011223356788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=300.54  Aligned_cols=247  Identities=17%  Similarity=0.271  Sum_probs=196.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-----chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-----RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ++.||+|+||.||++....++..+++|.+......     ....+.+|++++++++||||+++++++... +..++++||
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   85 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-ETLSIFMEY   85 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-CeEEEEEEE
Confidence            58899999999999999888999999987643221     124688899999999999999999998854 489999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+.+..  ...++......++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        86 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          86 MPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             CCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            999999999873  3457888899999999999999999   99999999999999999999999999998754322111


Q ss_pred             ce--ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 EM--LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ..  ....++..|+|||.+.+..++.++|+||||+++||+++|..||......       .........           
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~-----------  222 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQ-----------  222 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhcc-----------
Confidence            11  2345677899999999888999999999999999999999999653211       000000000           


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                            ......+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 ------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  00111233455678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-42  Score=305.53  Aligned_cols=248  Identities=20%  Similarity=0.256  Sum_probs=196.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+|+|.+.......   ...+..|+.+++.++|+|++.+++.+.+ ++..+++|||++
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~   83 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMN   83 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEEecC
Confidence            377999999999999999999999999886543222   2356789999999999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......  ..
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~  158 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI  158 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cc
Confidence            9999999865445568999999999999999999999   999999999999999999999999999986543221  12


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||++.+..++.++|+||||+++|||++|..||........    ............             
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~~~~~~~-------------  221 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVQ-------------  221 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHhhhhhhh-------------
Confidence            234678899999999988999999999999999999999999975432111    000000000000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                           ...+...+..+.+++..||+.||++|||     ++++++
T Consensus       222 -----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 -----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 0012223456789999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=301.66  Aligned_cols=269  Identities=22%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccc--cccchHHHHHHHHHHhccCCCccccccceeeC----CCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG----PRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~~lv~e  147 (356)
                      .+.||+|+||.|+.+.++.+|+.||+|.+...  .....+...+|+.+|+.++|+||+.+++++..    +....|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            37799999999999999999999998877632  23334678899999999999999999998774    2347899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC-C
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-A  226 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~  226 (356)
                      +|.. +|.+.++  .+..++.....-++.|++.||.|+|+   .+++||||||.|++++.+...||+|||+|+..... .
T Consensus       107 lMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  107 LMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             HHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            9955 9999998  34558888899999999999999999   99999999999999999999999999999987543 1


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ....+....|.+|.|||++.+ ..|+...||||.||++.||++|++.|.+.+.......+..... ...+..+.....+.
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG-tP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG-TPSEEDLQKIRSEK  259 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC-CCCHHHHHHhccHH
Confidence            122345677999999998754 5799999999999999999999999998654332211111110 00000011111000


Q ss_pred             ccc---ccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLL---CSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~---~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...   ..+..+..++   -++......+|+.+||..||.+|+|++|.++
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000   0001111111   1134455779999999999999999999875

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.4e-42  Score=306.94  Aligned_cols=251  Identities=23%  Similarity=0.420  Sum_probs=194.3

Q ss_pred             CCcccccCCceEEEEEEcCCCe--EEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~--~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++.  .+++|.++.... ...+.+.+|+++++++ +||||+++++++.. .+..++++||+
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~   85 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYIAIEYA   85 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceEEEEec
Confidence            4789999999999999876653  467777764322 2335788999999999 79999999998874 45799999999


Q ss_pred             cCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          150 KRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       150 ~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ++++|.+++....              ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~d  162 (297)
T cd05089          86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIAD  162 (297)
T ss_pred             CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECC
Confidence            9999999986421              1357889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ||++......  ........+..|+|||++.+..++.++||||||+++|||++ |..||......       .... ...
T Consensus       163 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~-~~~  232 (297)
T cd05089         163 FGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYE-KLP  232 (297)
T ss_pred             cCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH-HHh
Confidence            9997542211  11111223456999999988889999999999999999998 99999654211       1111 110


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..     .            ....+..++..+.+++.+||+.+|.+||+++++++.|+++.
T Consensus       233 ~~-----~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         233 QG-----Y------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             cC-----C------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00     0            00112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.9e-42  Score=306.31  Aligned_cols=269  Identities=22%  Similarity=0.234  Sum_probs=193.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhcc---CCCccccccceeeCC----CCceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCI---RHPNLVPLLGFYAGP----RGEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~----~~~~~l  144 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++......  ...+.+|+.+++.+   +||||+++++++...    ....++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            367999999999999999999999999887543222  23566777777655   699999999987632    235799


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      ++||+.+ +|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        85 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          85 VFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             EEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            9999985 89988875555568999999999999999999999   9999999999999999999999999999876542


Q ss_pred             CCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|..||.+.........+....... ....+......
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (288)
T cd07863         161 QM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP-PEDDWPRDVTL  237 (288)
T ss_pred             cc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC-ChhhCcccccc
Confidence            21  1223457888999999998889999999999999999999999997543211100000000000 00000000000


Q ss_pred             ccccccCC--CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 DMLLCSNS--NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........  .......++.+..+.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000000  0000111234566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-42  Score=304.03  Aligned_cols=251  Identities=20%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             CCcccccCCceEEEEEEcCC-----CeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRS-----GSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~-----~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+...     +..+++|.+..... .....+.+|+.+++.++||||+++++++... +..+++||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e   89 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QPTLVVME   89 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CCcEEEEe
Confidence            47899999999999988643     37889998764432 2234788999999999999999999988854 58999999


Q ss_pred             cccCCChhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          148 FYKRGNLAQCIRGGS--------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      |+++++|.+++....        ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccc
Confidence            999999999986422        2346888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +....... .......++..|+|||.+.+..++.++|+||||+++||++| |..||.+.+...        .........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~  238 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VLKFVIDGG  238 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------HHHHHhcCC
Confidence            76533221 12223345678999999988889999999999999999998 899986432111        111111000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                                       ....+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 -----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                             001222346678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-42  Score=304.72  Aligned_cols=240  Identities=24%  Similarity=0.381  Sum_probs=184.8

Q ss_pred             cccccCCceEEEEEEcCC------------------------CeEEEEEEeccccccchHHHHHHHHHHhccCCCccccc
Q 038580           76 VIGKSNYGTLYKALLQRS------------------------GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL  131 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~------------------------~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  131 (356)
                      .||+|+||.||+|.+..+                        ...+++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999986321                        23578888865444444678889999999999999999


Q ss_pred             cceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC--
Q 038580          132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY--  209 (356)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~--  209 (356)
                      +++|.. ++..++||||+++|+|..++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++  
T Consensus        82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEe-CCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence            999885 45889999999999999998642 3468889999999999999999999   9999999999999998654  


Q ss_pred             -----CeEEeccccccccCCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCC
Q 038580          210 -----QPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELI-SGKEPINENPTPDED  282 (356)
Q Consensus       210 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~-tg~~p~~~~~~~~~~  282 (356)
                           .+|++|||++......     ....++..|+|||.+.+ ..++.++|+||||+++||++ +|..||........ 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                 3799999987543211     12346677999998865 56899999999999999985 68998875432110 


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                         .....    . .   .               ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus       231 ---~~~~~----~-~---~---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ---ERFYE----K-K---H---------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HHHHH----h-c---c---------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               01000    0 0   0               001112235889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.3e-42  Score=327.11  Aligned_cols=249  Identities=21%  Similarity=0.271  Sum_probs=197.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCC-------ceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-------EKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------~~~l  144 (356)
                      .+.||+|+||+||+|....+++.+|+|.++.....  ....+.+|+..+..++|+|++++...+.....       ..++
T Consensus        37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l  116 (496)
T PTZ00283         37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL  116 (496)
T ss_pred             EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence            47899999999999999989999999998654322  23467889999999999999998876643221       3679


Q ss_pred             EEecccCCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccccc
Q 038580          145 VHPFYKRGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      +|||+++|+|.++++..  ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus       117 V~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~  193 (496)
T PTZ00283        117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMY  193 (496)
T ss_pred             EEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence            99999999999998642  24568899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          223 NPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       223 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|..||...+.       ........ ...    
T Consensus       194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~-~~~----  261 (496)
T PTZ00283        194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTL-AGR----  261 (496)
T ss_pred             cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHh-cCC----
Confidence            43221 122345689999999999999999999999999999999999999975321       11111111 000    


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .             .+.+...+.++.+++..||+.||++||++.+++..
T Consensus       262 ~-------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 Y-------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C-------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0             11233445678899999999999999999998763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-42  Score=317.71  Aligned_cols=248  Identities=17%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....++..+|+|+++....   ...+.+.+|+.+++.++||||+++++++.. .+..++||||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   84 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLVMEYQP   84 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEEECCCC
Confidence            3789999999999999999999999999875432   123468889999999999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...........
T Consensus        85 ~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          85 GGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999743 2468999999999999999999999   9999999999999999999999999999977644333333


Q ss_pred             ecccCCCcccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          231 LEASASQGYKAPELIK------MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~------~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      ....+++.|+|||++.      ...++.++|||||||++|||++|..||...+...       ...........      
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~------  227 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQRF------  227 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCCCc------
Confidence            3456889999999986      4567899999999999999999999997543211       11110000000      


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ...+.....+..+.+|+..||+ +|++||++.++++
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 ---------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                     0001112245567899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.4e-42  Score=324.34  Aligned_cols=265  Identities=19%  Similarity=0.273  Sum_probs=189.4

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-------CCceEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-------RGEKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~~~~l  144 (356)
                      ...+.||+|+||.||+|....+++.+|+|.+...    .....+|+.+++.++||||+++++++...       ....++
T Consensus        69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            3457899999999999999888888999977532    23456799999999999999998876421       124678


Q ss_pred             EEecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccc
Q 038580          145 VHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLL  221 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~  221 (356)
                      +|||+++ +|.+++..  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+++.
T Consensus       145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            9999986 77776642  234578999999999999999999999   9999999999999999664 799999999976


Q ss_pred             cCCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh------
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL------  294 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  294 (356)
                      ....  .......+++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+.........      
T Consensus       221 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        221 LLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             ccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            5432  22234567889999998865 46899999999999999999999999865432111111000000000      


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+..-+..   ........++...+.++.+|+.+||+.||++|||+.++++
T Consensus       299 ~~~~~~~~~~~~---~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        299 NPNYADIKFPDV---KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             chhhhcccCCcc---CchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000000000000   0000001122234567889999999999999999999874

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-41  Score=303.19  Aligned_cols=260  Identities=19%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CCCcccccCCceEEEEEE----cCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~  146 (356)
                      ..+.||+|+||.||++.+    ..++..+++|.++..... ....+.+|+++++.++|||++++++++... ....+++|
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM   87 (284)
T ss_pred             hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence            347899999999999985    346788999988754322 235789999999999999999999988754 34689999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        88 e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          88 EFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            999999999998643 2358999999999999999999999   999999999999999999999999999987654322


Q ss_pred             Cc--ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCchhHHHHHhhhhc
Q 038580          227 GQ--EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE--------DFHLPTFMRNAVLDH  296 (356)
Q Consensus       227 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~  296 (356)
                      ..  ......++..|+|||++.+..++.++|+||||+++||++|+..|+........        ........ ..... 
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-  241 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEE-  241 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHHc-
Confidence            21  11233456679999999888899999999999999999998776532211000        00000000 00000 


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                      ....+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       242 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         242 ----------------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ----------------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                            001111233566789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.2e-42  Score=308.15  Aligned_cols=251  Identities=24%  Similarity=0.417  Sum_probs=193.3

Q ss_pred             CCcccccCCceEEEEEEcCCCe--EEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~--~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.++.++.  .+++|.++.... .....+.+|++++.++ +||||+++++++.. ++..++++||+
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~   90 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA   90 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceEEEEeC
Confidence            3789999999999999876664  456666554322 2335788899999999 89999999998875 45899999999


Q ss_pred             cCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          150 KRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       150 ~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ++++|.++++...              ...+++..++.++.|++.|++|||+   .+++||||||+||+++.++.+||+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~d  167 (303)
T cd05088          91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  167 (303)
T ss_pred             CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCc
Confidence            9999999996321              2357899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ||++.....  .........+..|+|||.+.+..++.++||||||+++||++| |..||...+..       +... ...
T Consensus       168 fg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~-~~~  237 (303)
T cd05088         168 FGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE-KLP  237 (303)
T ss_pred             cccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH-HHh
Confidence            999753211  111112233567999999988889999999999999999998 99998653321       1111 000


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..     .            ....+...+..+.+++.+||+.+|++||+++++++.|+++.
T Consensus       238 ~~-----~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         238 QG-----Y------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             cC-----C------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00     0            00011223456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.4e-41  Score=304.28  Aligned_cols=199  Identities=22%  Similarity=0.360  Sum_probs=161.6

Q ss_pred             CCCcccccCCceEEEEEEc--CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~  149 (356)
                      .+.+||+|+||.||+|...  .++..+|+|.++..  .....+.+|+.+++.++||||+++++++... +...++++||+
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             cccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            3578999999999999975  35678899988643  2335678899999999999999999988643 34678999998


Q ss_pred             cCCChhHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE----cCCCCeEEecccc
Q 038580          150 KRGNLAQCIRGG-------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQPYVSDFGL  218 (356)
Q Consensus       150 ~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~  218 (356)
                      .+ +|.+++...       ....++...+..++.|++.||+|||+   .+++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 888877421       12358888999999999999999999   999999999999999    4567899999999


Q ss_pred             ccccCCCCC--cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          219 HLLLNPTAG--QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       219 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      +........  .......+|+.|+|||++.+ ..++.++||||+||++|||++|..||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            976543221  12234567889999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-41  Score=301.96  Aligned_cols=247  Identities=23%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCC-----CCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGP-----RGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....++..+|+|...... .....+..|+.+++++ +||||+++++++...     ....+++||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e   89 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME   89 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence            367999999999999999899999999986532 3445788999999988 699999999988642     235899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++.......+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.++|+|||++....... 
T Consensus        90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-  165 (272)
T cd06637          90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-  165 (272)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-
Confidence            9999999999986555678999999999999999999999   999999999999999999999999999987653322 


Q ss_pred             cceecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          228 QEMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      .......++..|+|||++.     ...++.++|+|||||++|||++|..||.......      .  .......     .
T Consensus       166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~--~~~~~~~-----~  232 (272)
T cd06637         166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------A--LFLIPRN-----P  232 (272)
T ss_pred             ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------H--HHHHhcC-----C
Confidence            2223456788899999986     3357889999999999999999999996432110      0  0000000     0


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+           .......+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 AP-----------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC-----------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00           0011233456889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.3e-42  Score=305.47  Aligned_cols=247  Identities=19%  Similarity=0.258  Sum_probs=195.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||+||+|.+..+++.+|+|.+.......   ...+.+|+++++.++|+|++.+.+.+.. ++..+++|||+++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~   84 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLTIMNG   84 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEEeccC
Confidence            67999999999999999899999999886543222   2357789999999999999999988875 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|..++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++......  ....
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  159 (285)
T cd05632          85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIR  159 (285)
T ss_pred             ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--Cccc
Confidence            999988865445579999999999999999999999   99999999999999999999999999998654321  1223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||++.+..++.++|+||||+++||+++|..||........    ...+.......               
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~---------------  220 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLET---------------  220 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcc---------------
Confidence            44678999999999888899999999999999999999999975321110    01111111100               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                         ....+...+..+.+++..||+.||++||+     +.+++.
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 ---EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               00112234456789999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-41  Score=300.98  Aligned_cols=240  Identities=21%  Similarity=0.371  Sum_probs=185.9

Q ss_pred             CcccccCCceEEEEEEcCC------------CeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCce
Q 038580           75 EVIGKSNYGTLYKALLQRS------------GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~------------~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  142 (356)
                      +.||+|+||.||+|.+...            ...+++|.+..........+.+|+.+++.++||||+++++++.. +...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence            3589999999999986422            23578888765544444578889999999999999999999885 4478


Q ss_pred             EEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC-------eEEec
Q 038580          143 LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ-------PYVSD  215 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~kl~D  215 (356)
                      +++|||+++++|..++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.       ++++|
T Consensus        80 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999988642 3458999999999999999999999   99999999999999987664       89999


Q ss_pred             cccccccCCCCCcceecccCCCcccCccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIK-MKDASEETDIYSFGVIMLELI-SGKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ||++.....     .....++..|+|||.+. +..++.++||||||+++|||+ +|..||.......    ...     .
T Consensus       156 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~-----~  221 (262)
T cd05077         156 PGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER-----F  221 (262)
T ss_pred             CCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH-----H
Confidence            998765422     12335677899999886 466899999999999999998 5888876432110    000     0


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                      ....        .          .........+.+++.+||+.||++||++.+|+..|
T Consensus       222 ~~~~--------~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 YEGQ--------C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HhcC--------c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0000        0          00111234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-41  Score=302.53  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=195.6

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..     .+..+++|......... ...+..|+.+++.++||||+++++++.+. +..+++||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   89 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-LPRFILLE   89 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCcEEEEe
Confidence            3789999999999999976     67888999876443322 34689999999999999999999988754 47899999


Q ss_pred             cccCCChhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEeccccc
Q 038580          148 FYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~  219 (356)
                      |+++++|.+++....     ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++   .+||+|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccc
Confidence            999999999986432     2358899999999999999999999   9999999999999998754   5899999998


Q ss_pred             cccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...+..       ... ...... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~-~~~~~~-  237 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVM-EFVTGG-  237 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH-HHHHcC-
Confidence            7653222111 112233467999999988889999999999999999997 99998754321       111 111100 


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                                      .....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       238 ----------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         238 ----------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ----------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                            0001123345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-42  Score=313.64  Aligned_cols=238  Identities=22%  Similarity=0.287  Sum_probs=187.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHH-HHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIE-LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||+||+|.+..+++.+|+|++......   ....+..|.. +++.++||||+++++.+.. ++..+++|||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            3699999999999999999999999998643221   1234445544 5678999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (323)
T cd05575          80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT  153 (323)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence            9999999863  4468888999999999999999999   99999999999999999999999999998653221 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||...+.       ..... ......             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~-~i~~~~-------------  212 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYD-NILNKP-------------  212 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHH-HHHcCC-------------
Confidence            345688999999999988999999999999999999999999975321       11111 111000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK  345 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  345 (356)
                           ...+...+..+.+++.+||+.||++||++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                 001122355688999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-43  Score=304.71  Aligned_cols=240  Identities=22%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchH---HHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK---EFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.|-+|.....|+.||+|.+++......+   .+++|+++|+.|+||||+.++.+|+. .+...+||||..+
T Consensus        59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvivMEYaS~  137 (668)
T KOG0611|consen   59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVIVMEYASG  137 (668)
T ss_pred             HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEEEEEecCC
Confidence            7799999999999999999999999999876554444   57899999999999999999999995 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.|.+++.  ....+++.....++.||++|+.|+|.   ++++|||||.+|||+|.++++||+|||++-.+..  ..-..
T Consensus       138 GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kfLq  210 (668)
T KOG0611|consen  138 GELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKFLQ  210 (668)
T ss_pred             ccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc--ccHHH
Confidence            99999997  45679999999999999999999999   9999999999999999999999999999877643  33345


Q ss_pred             cccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      +++|++-|.+||+..+.+| .+..|.||||+++|-++.|..||++.+...        +...+..+...+          
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs~GaYrE----------  272 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQISRGAYRE----------  272 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhhcccccC----------
Confidence            7899999999999999888 578999999999999999999998743211        111111111111          


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               +..+....-||+.||-+||++|-|+.+|..
T Consensus       273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  273 ---------PETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ---------CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                     111223446999999999999999999875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-42  Score=318.09  Aligned_cols=197  Identities=21%  Similarity=0.280  Sum_probs=169.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||++....++..+|+|+++....   .....+..|+.++..++||||+++++.+.+ ....++||||++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv~E~~~   84 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLIMEFLP   84 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEEEcCCC
Confidence            3789999999999999998999999999875322   122467889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC---
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG---  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  227 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........   
T Consensus        85 gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          85 GGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            9999999974  3568999999999999999999999   9999999999999999999999999999875432110   


Q ss_pred             -------------------------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          228 -------------------------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       228 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                                                     .......||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                           0012346899999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-40  Score=294.16  Aligned_cols=254  Identities=21%  Similarity=0.350  Sum_probs=203.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+++|.++.....   ....+.+|++++++++|+|++++++++... +..+++|||++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   85 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIVLELAD   85 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEecCC
Confidence            47899999999999999988999999988643222   235788999999999999999999998854 58899999999


Q ss_pred             CCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|.+++...  ....+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-  161 (267)
T cd08224          86 AGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             CCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-
Confidence            99999998642  24558899999999999999999999   9999999999999999999999999999876533221 


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......++..|+|||.+.+..++.++|+||||+++|++++|..||.....     ........ ....    .       
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~----~-------  224 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK-IEKC----D-------  224 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhh-hhcC----C-------
Confidence            12234577889999999888899999999999999999999999864321     11111111 0000    0       


Q ss_pred             ccCCCCCCCCc-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVS-EERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ..+.+ ...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       225 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 ------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  00112 245567889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.1e-42  Score=318.70  Aligned_cols=249  Identities=19%  Similarity=0.275  Sum_probs=193.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||++....+++.+|+|++....   ......+.+|+.+++.++||||+++++++.+ ++..++||||+
T Consensus        47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~  125 (370)
T cd05621          47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLYMVMEYM  125 (370)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEcCC
Confidence            3478999999999999999999999999986422   1223457889999999999999999998885 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..   ..++...+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++..........
T Consensus       126 ~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         126 PGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            99999999963   357888899999999999999999   999999999999999999999999999987654333223


Q ss_pred             eecccCCCcccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          230 MLEASASQGYKAPELIKMK----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .....||+.|+|||++.+.    .++.++|+|||||++|||++|..||...+..       ... ........       
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~-~~i~~~~~-------  264 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTY-SKIMDHKN-------  264 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHH-HHHHhCCc-------
Confidence            3455789999999998754    3788999999999999999999999754211       111 11110000       


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLWK  350 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~~  350 (356)
                             ....+.....+..+.+++..|++.+|.+  ||++.++++.
T Consensus       265 -------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 -------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                   0000111233556778999999855543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-41  Score=294.96  Aligned_cols=249  Identities=22%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             CcccccCCceEEEEEEcCC---CeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.....   +..+++|.++...... .+.+.+|++.++.++|+|++++++++.. .+..+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            4699999999999999865   8889999987654433 4688999999999999999999998885 568999999999


Q ss_pred             CCChhHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          151 RGNLAQCIRGGS-------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       151 ~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +++|.+++....       ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            999999997532       3678999999999999999999999   999999999999999999999999999987764


Q ss_pred             CCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          224 PTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       224 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .... .......++..|+|||.+....++.++|+||+|++++||++ |..||.....        ..........     
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~-----  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKG-----  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-----
Confidence            3321 22234456778999999988889999999999999999999 6999976421        1111111110     


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                                  .....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       224 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                        011123344678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-41  Score=309.79  Aligned_cols=268  Identities=20%  Similarity=0.268  Sum_probs=194.3

Q ss_pred             Cccccc--CCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKS--NYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G--~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ++||+|  +||+||++..+.+++.+|+|.++.....  ..+.+.+|+++++.++||||++++++|..+ +..++||||++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~   82 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMA   82 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEeccC
Confidence            679999  7889999999999999999998754322  224678899999999999999999999854 58999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      +|+|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+...........  
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            9999999965444568999999999999999999999   99999999999999999999999999865433211110  


Q ss_pred             ----ceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh--------
Q 038580          229 ----EMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL--------  294 (356)
Q Consensus       229 ----~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  294 (356)
                          ......++..|+|||++.+  ..++.++|||||||++|||++|..||........   ..........        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccccch
Confidence                0112245667999999875  4588999999999999999999999975432110   0000000000        


Q ss_pred             ------hcccccccCcccc-------ccc--CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 ------DHRITDLYHPDML-------LCS--NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 ------~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ........+....       ...  ......+........+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                  0000000000000       000  000001122334567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.3e-42  Score=314.74  Aligned_cols=241  Identities=21%  Similarity=0.266  Sum_probs=187.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHH-HHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLI-ELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|++.....   .....+..|. .+++.++||||+++++++.. .+..+++|||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            369999999999999998999999999864321   1223344444 35678899999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+.......++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~  153 (325)
T cd05602          80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTT  153 (325)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCc
Confidence            9999999874  3457788888899999999999999   99999999999999999999999999998653221 1122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||...+..       ..... .....             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~-i~~~~-------------  212 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDN-ILNKP-------------  212 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHH-HHhCC-------------
Confidence            3456899999999999989999999999999999999999999753321       11111 10000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                           .....+.+..+.+++..||+.||.+||++.+.+
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                 011223345678999999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-41  Score=300.63  Aligned_cols=251  Identities=25%  Similarity=0.462  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCe---EEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~---~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++.   .+++|.++.... ....+|..|+.+++.++||||+++++++.. ++..+++|||+
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~   87 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFM   87 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEEEecC
Confidence            4789999999999999876554   689998875422 223579999999999999999999998874 45889999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|.+++... ...+++..+..++.|++.|++|||+   .+++|+||||+||+++.++.+|++|||++..........
T Consensus        88 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          88 ENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             CCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            999999999743 3458899999999999999999999   999999999999999999999999999987654322211


Q ss_pred             e-e-ccc--CCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          230 M-L-EAS--ASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       230 ~-~-~~~--~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      . . ...  .+..|+|||.+.+..++.++||||||+++||+++ |..||......       + ........     .  
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~-~~~~i~~~-----~--  228 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------D-VINAIEQD-----Y--  228 (269)
T ss_pred             ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------H-HHHHHHcC-----C--
Confidence            1 1 111  2346999999998899999999999999999887 99998653211       1 11111100     0  


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                ..+.+.+++..+.+++.+||+.+|++||++.+++..|+++
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      0112234456688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=298.70  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=208.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      .+||+|+||.||+|.++.+|.++|+|.+.  .....+++..|+.+|+....|++|++||.|- ....+++|||||-.||.
T Consensus        39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   39 GKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehhhcCCCcH
Confidence            67999999999999999999999999764  3456689999999999999999999999876 35589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+.++. +++++.+..+..++.+.++||+|||.   ..-+|||||+.|||++.+|.+||+|||++..+... .....+..
T Consensus       116 SDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVI  190 (502)
T KOG0574|consen  116 SDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVI  190 (502)
T ss_pred             HHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCccc
Confidence            999975 45789999999999999999999999   88899999999999999999999999999876543 23345678


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ||+.|||||++..-.|..++||||||+...||..|++||.+.......+-++                       .+..+
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-----------------------T~PPP  247 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-----------------------TKPPP  247 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-----------------------CCCCC
Confidence            9999999999999899999999999999999999999998754433222221                       11222


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ...-++.-++++.+++++||..+|++|-|+-++++.
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            334466678889999999999999999999888763

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-41  Score=299.27  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc-ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++.+..++..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+ ++..++++||++++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   83 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEYCDGG   83 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEeeCCCC
Confidence            378999999999999999889999999886432 2234578889999999999999999998885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.......++......++.|++.||.|||+   .+++|+||||+||++++++.++++|||.+....... .....
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  159 (255)
T cd08219          84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACT  159 (255)
T ss_pred             cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccccc
Confidence            99999875555668899999999999999999999   999999999999999999999999999987654322 11223


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|..||...+.       ..... ......               
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~-~~~~~~---------------  216 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLIL-KVCQGS---------------  216 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHH-HHhcCC---------------
Confidence            4678889999999888899999999999999999999999975321       01111 100000               


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                        ..+.+...+..+.+++.+||+.||++||++.+++..
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 --YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              001223345568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-41  Score=298.36  Aligned_cols=249  Identities=21%  Similarity=0.418  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||++.+. ++..+++|.++... .....+.+|+++++.++|+||+++++++..  ...+++|||+++++
T Consensus        11 ~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~   86 (260)
T cd05073          11 EKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGS   86 (260)
T ss_pred             EeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCc
Confidence            478999999999999876 44557888776432 234578899999999999999999998775  57899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++........++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+..............
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            9999976555668889999999999999999999   9999999999999999999999999999876543222222233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++....++.++|+||||+++++++| |..||...+...        ........     .          
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~-----~----------  220 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERG-----Y----------  220 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCC-----C----------
Confidence            44567999999988889999999999999999999 899997532111        01111000     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        ..+.+...+.++.+++.+||+.+|++||++.++.+.|+++
T Consensus       221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence              0011223455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-42  Score=311.45  Aligned_cols=238  Identities=20%  Similarity=0.272  Sum_probs=188.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCC-ccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHP-NLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|....+++.+|+|+++....   ...+.+..|.++++.++|+ +|+.+++++.. .+..++||||+
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~   83 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYV   83 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEEEcCC
Confidence            3779999999999999998899999999875321   2234677889999988765 57888887775 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ...
T Consensus        84 ~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~  157 (324)
T cd05587          84 NGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKT  157 (324)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCc
Confidence            99999999863  3458889999999999999999999   99999999999999999999999999998643211 122


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....|+..|+|||++.+..++.++|+|||||++|||+||..||.+.+..       . .........            
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~-~~~~i~~~~------------  217 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------E-LFQSIMEHN------------  217 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcCC------------
Confidence            33456899999999999999999999999999999999999999753211       1 111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                            ...+...+..+.+++.+||+.||++||+.
T Consensus       218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                  01122334567899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.8e-42  Score=303.19  Aligned_cols=241  Identities=22%  Similarity=0.381  Sum_probs=186.3

Q ss_pred             CcccccCCceEEEEEEcCCCe-------EEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGS-------VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~-------~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      +.||+|+||.||+|.....+.       .+++|.+........+.+.+|+.+++.++||||+++++++..+ ...+++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEe
Confidence            359999999999998865433       3777776544434446788999999999999999999998854 47899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC--------eEEeccccc
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ--------PYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~~  219 (356)
                      |+++|+|.++++... ..+++...+.++.|++.||+|||+   .+++||||||+||+++.++.        ++++|||++
T Consensus        80 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          80 YVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             cCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999997432 368899999999999999999999   99999999999999987765        589999987


Q ss_pred             cccCCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGK-EPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      .....     .....++..|+|||++.+ ..++.++|+||||+++||+++|. .||...+..       . ... .....
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~-~~~-~~~~~  221 (258)
T cd05078         156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------K-KLQ-FYEDR  221 (258)
T ss_pred             cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------H-HHH-HHHcc
Confidence            65422     122456778999999976 45789999999999999999985 555432110       0 000 00000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                                        ...+.....++.+++.+||+.||++|||++++++.|+
T Consensus       222 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                              0111223356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-41  Score=305.85  Aligned_cols=254  Identities=21%  Similarity=0.383  Sum_probs=196.9

Q ss_pred             CCCcccccCCceEEEEEEc-------CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           73 PGEVIGKSNYGTLYKALLQ-------RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      ..+.||+|+||.||++...       .....+++|.++..... ...++..|+.+++.+ +||||++++++|.. .+..+
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~   94 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLY   94 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-CCceE
Confidence            4588999999999999763       23457888987754322 234688899999999 69999999998875 45899


Q ss_pred             EEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC
Q 038580          144 IVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY  209 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  209 (356)
                      ++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCC
Confidence            9999999999999996422              2357889999999999999999999   9999999999999999999


Q ss_pred             CeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhH
Q 038580          210 QPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       210 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  287 (356)
                      .+||+|||+++........ ......++..|+|||.+.+..++.++|+||||+++||+++ |..||...+.        .
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------~  243 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--------E  243 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence            9999999998765432111 1112233457999999988889999999999999999999 8888865321        1


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..........                 ....+..++.++.+++.+||+.+|++||++.++++.|+++.
T Consensus       244 ~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 ELFKLLREGH-----------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111111100                 00122344567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-41  Score=297.15  Aligned_cols=239  Identities=24%  Similarity=0.380  Sum_probs=188.6

Q ss_pred             CcccccCCceEEEEEEcCCC----------eEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           75 EVIGKSNYGTLYKALLQRSG----------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~----------~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      +.||+|+||.||+|.+..++          ..+++|.++..... ...+.+|+.+++.++||||+++++++..  +..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            46999999999999998665          35677776544332 5788999999999999999999998876  46899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-------CeEEeccc
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-------QPYVSDFG  217 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg  217 (356)
                      ++||+++|+|.+++.... ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++       .+||+|||
T Consensus        78 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999997433 268899999999999999999999   9999999999999999887       79999999


Q ss_pred             cccccCCCCCcceecccCCCcccCccccccC--CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          218 LHLLLNPTAGQEMLEASASQGYKAPELIKMK--DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ++.....     .....++..|+|||++...  .++.++|+||||+++||+++ |..||.......    ......   .
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~~~~---~  221 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KERFYQ---D  221 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHHHHh---c
Confidence            9876432     1223456679999998876  78999999999999999999 577776542111    000000   0


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                      .     ...               +......+.+++.+||+.+|++||++.++++.|+
T Consensus       222 ~-----~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 Q-----HRL---------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C-----CCC---------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0     000               0001157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-41  Score=300.63  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=186.9

Q ss_pred             cccccCCceEEEEEEcC--CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           76 VIGKSNYGTLYKALLQR--SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .||+|+||.||+|.+..  ++..+++|.++..... ....+.+|+.+++.++||||+++++++.+. ...+++|||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCCC
Confidence            59999999999998753  3456788877654332 224788899999999999999999988754 4789999999999


Q ss_pred             ChhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-
Q 038580          153 NLAQCIRGGS---GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       153 sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      +|.++++...   ....++..+..++.|++.|++|||+   .+++|+||||+||+++.++++||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996422   2345677888999999999999999   99999999999999999999999999998654322111 


Q ss_pred             ceecccCCCcccCccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          229 EMLEASASQGYKAPELIKMK-------DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~-------~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |..||.......    .   ..... ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~---~~~~~-~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----V---LTYTV-REQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----H---HHHHh-hcccCC
Confidence            11233456789999998642       35789999999999999997 999996532111    0   00000 000000


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                      ...+.            .....+..+.+++..|| .+|++|||+++|+..|+
T Consensus       230 ~~~~~------------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPR------------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCc------------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111            11123445778999999 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=320.60  Aligned_cols=248  Identities=19%  Similarity=0.260  Sum_probs=190.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....+++.+|+|.+.....   ...+.+.+|+++++.++||||+++++++.+ .+..++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~E~~~   84 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLIMEFLP   84 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEEEeCCC
Confidence            3789999999999999999999999998864321   123467889999999999999999999985 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.+......  
T Consensus        85 gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          85 GGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999973  3568888899999999999999999   99999999999999999999999999998632110000  


Q ss_pred             --------------------------------------------ceecccCCCcccCccccccCCCCCcchhHHHHHHHH
Q 038580          229 --------------------------------------------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIML  264 (356)
Q Consensus       229 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~  264 (356)
                                                                  ......||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001245889999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC---
Q 038580          265 ELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR---  341 (356)
Q Consensus       265 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---  341 (356)
                      ||++|..||...+...       ... ...... .....+             .....+..+.+++.+|++ +|.+|   
T Consensus       240 elltG~~Pf~~~~~~~-------~~~-~i~~~~-~~~~~p-------------~~~~~s~~~~dli~~lL~-~~~~r~~r  296 (377)
T cd05629         240 ECLIGWPPFCSENSHE-------TYR-KIINWR-ETLYFP-------------DDIHLSVEAEDLIRRLIT-NAENRLGR  296 (377)
T ss_pred             hhhcCCCCCCCCCHHH-------HHH-HHHccC-CccCCC-------------CCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence            9999999997533211       011 000000 000000             011234567799999997 67765   


Q ss_pred             CCHHHHHHH
Q 038580          342 PNIKQVLWK  350 (356)
Q Consensus       342 ps~~~il~~  350 (356)
                      +++.+++..
T Consensus       297 ~~~~~~l~h  305 (377)
T cd05629         297 GGAHEIKSH  305 (377)
T ss_pred             CCHHHHhcC
Confidence            599988763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-41  Score=306.47  Aligned_cols=256  Identities=21%  Similarity=0.371  Sum_probs=198.0

Q ss_pred             cCCCCcccccCCceEEEEEEcC-------CCeEEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGE  141 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  141 (356)
                      +..++.||+|+||.||++....       +...+|+|.++.... ....++..|+.+++.+ +||||++++++|.. .+.
T Consensus        20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~   98 (307)
T cd05098          20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGP   98 (307)
T ss_pred             eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCc
Confidence            3446889999999999998642       234688998875422 2235688899999999 79999999998885 458


Q ss_pred             eEEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          142 KLIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .+++|||+++|+|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+||+++.
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~  175 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE  175 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcC
Confidence            999999999999999996432              1347889999999999999999999   99999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCch
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL  285 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~  285 (356)
                      ++.+||+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+.       
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-------  248 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------  248 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-------
Confidence            999999999998654322111 1112233467999999988889999999999999999998 8888864321       


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .. ........                 .....+...+.++.+++.+||+.+|++||++.++++.|+++.
T Consensus       249 ~~-~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 EE-LFKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HH-HHHHHHcC-----------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            11 11111100                 001123344567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-41  Score=312.17  Aligned_cols=266  Identities=23%  Similarity=0.247  Sum_probs=192.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||++.+..++..+|+|.+.....  .....+.+|+.+++.++||||+++++++....     ...+++|
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            4789999999999999998899999999864322  23356788999999999999999999886433     2479999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+.    ..++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus       106 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-  176 (359)
T cd07876         106 ELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-  176 (359)
T ss_pred             eCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccccC-
Confidence            99976 6766664    247888899999999999999999   99999999999999999999999999998754321 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch--------hHHHH---Hhhhh
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL--------PTFMR---NAVLD  295 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~--------~~~~~---~~~~~  295 (356)
                       .......++..|+|||++.+..++.++||||||+++|||++|..||.+.+........        .....   .....
T Consensus       177 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         177 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             -ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence             1223456788999999999889999999999999999999999999864321100000        00000   00000


Q ss_pred             cccccccCc--cccc---ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          296 HRITDLYHP--DMLL---CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       296 ~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........+  ....   .+...............+.+++.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000000  0000   00000000111123456889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-41  Score=308.33  Aligned_cols=238  Identities=21%  Similarity=0.288  Sum_probs=186.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHH-HHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIE-LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+..++..+|+|++.....   .....+..|.. +++.++||||+++++++.+. +..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            369999999999999998999999999864322   12234555544 67889999999999988754 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|...+..  ...++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            9999988863  3467888888999999999999999   999999999999999999999999999986532211 122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|++.|+|||++.+..++.++|||||||++|||++|..||...+.       ..... ......             
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~-~i~~~~-------------  212 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYD-NILHKP-------------  212 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHH-HHhcCC-------------
Confidence            345688999999999988899999999999999999999999975321       11111 111000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK  345 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  345 (356)
                           ...+......+.+++..||+.||.+||++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                 012223345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-41  Score=294.31  Aligned_cols=247  Identities=20%  Similarity=0.280  Sum_probs=202.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|.-|+||++.++.++...|+|++.+......   ...+.|.++|+.+.||.+..||+.+++++ ..|++||||+|
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-~~cl~meyCpG  161 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-YSCLVMEYCPG  161 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-eeEEEEecCCC
Confidence            679999999999999999999999999986644433   35778999999999999999999999654 89999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC------
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT------  225 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~------  225 (356)
                      |+|...++...++.+++..+.-++..++.||+|||.   .|||.|||||+|||+-++|++.|+||.++......      
T Consensus       162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence            999999998888999999999999999999999999   99999999999999999999999999986432100      


Q ss_pred             -------------------------------------------------CCcceecccCCCcccCccccccCCCCCcchh
Q 038580          226 -------------------------------------------------AGQEMLEASASQGYKAPELIKMKDASEETDI  256 (356)
Q Consensus       226 -------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv  256 (356)
                                                                       .+.......||-.|+|||++.+...+.+.|.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW  318 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW  318 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence                                                             0011223456677999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCC
Q 038580          257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSP  336 (356)
Q Consensus       257 wslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  336 (356)
                      |+||+++|||+.|..||.+.+..+...   ..+.+                     ....+...+.+..+.|||+..|.+
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl~---NIv~~---------------------~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETLR---NIVGQ---------------------PLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhHH---HHhcC---------------------CCcCCCCCcchhHHHHHHHHHhcc
Confidence            999999999999999999876544311   11110                     011122235677899999999999


Q ss_pred             CCCCCCC----HHHHHH
Q 038580          337 SPSLRPN----IKQVLW  349 (356)
Q Consensus       337 ~p~~Rps----~~~il~  349 (356)
                      ||++|..    +.||.+
T Consensus       375 dP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ChhhhhccccchHHhhc
Confidence            9999997    777653

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-41  Score=302.61  Aligned_cols=247  Identities=20%  Similarity=0.285  Sum_probs=195.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++|||++++++++.. ++..++++||+++++
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~~~~   88 (282)
T cd06643          10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCAGGA   88 (282)
T ss_pred             HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecCCCc
Confidence            3679999999999999998899999999865544445678899999999999999999998885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..++.. ...++++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ......
T Consensus        89 l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~  163 (282)
T cd06643          89 VDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF  163 (282)
T ss_pred             HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccccc
Confidence            9988764 23468999999999999999999999   999999999999999999999999999986543221 122334


Q ss_pred             cCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          234 SASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       234 ~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .++..|+|||++.     ...++.++|+|||||++|||++|..||...+..       ..... .....     .+    
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~~~~-----~~----  226 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLK-IAKSE-----PP----  226 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHH-HhhcC-----CC----
Confidence            6788899999984     345778999999999999999999998753211       00110 00000     00    


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ....+...+..+.+++..||+.||++||++.++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 ------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00112234567889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-42  Score=313.66  Aligned_cols=239  Identities=21%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             CcccccCCceEEEEEEc---CCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +.||+|+||.||++...   .++..+|+|+++.....  ....+..|++++++++||||+++++++.+ ++..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence            56999999999998763   56788999998754322  22457789999999999999999999885 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ...
T Consensus        81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~  154 (318)
T cd05582          81 RGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKK  154 (318)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCc
Confidence            99999999863  3468999999999999999999999   99999999999999999999999999998764322 122


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|..||...+..       ... .......            
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~-~~i~~~~------------  214 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETM-TMILKAK------------  214 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHH-HHHHcCC------------
Confidence            33456889999999999888999999999999999999999999753210       111 1111000            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ  346 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~  346 (356)
                            ...+...+..+.+++.+||+.||++||++.+
T Consensus       215 ------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                  0122234556789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=304.02  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|....++..+++|.+........+.+.+|+.+++.++||||+++++.+.. ..+.++||||+++++
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~~~~~  103 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGS  103 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecccCCCC
Confidence            3679999999999999988888999998876555556778999999999999999999998885 448999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........ .....
T Consensus       104 L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~  176 (296)
T cd06654         104 LTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  176 (296)
T ss_pred             HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence            9999863   357888999999999999999999   9999999999999999999999999999876432211 12234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||.......      .... .....      .+         
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~-~~~~~------~~---------  234 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYL-IATNG------TP---------  234 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHH-HhcCC------CC---------
Confidence            67788999999988888999999999999999999999997533211      0000 00000      00         


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..+.+...+..+.+++.+||+.+|++||++.+++.
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             01122344566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.2e-41  Score=298.02  Aligned_cols=251  Identities=25%  Similarity=0.448  Sum_probs=197.1

Q ss_pred             CCcccccCCceEEEEEEcCCC---eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++   ..+++|.++..... ..+.+..|+.+++.++||||+++++++.. ++..+++|||+
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   87 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMIVTEYM   87 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEcC
Confidence            478999999999999886433   47888887653322 23578999999999999999999998875 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|.+++... ...+++..+..++.|++.|++|||+   .+++||||||+||+++.++.++++|||++..........
T Consensus        88 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd05066          88 ENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  163 (267)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence            999999999743 2457889999999999999999999   999999999999999999999999999987654322211


Q ss_pred             e--ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 M--LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      .  ....++..|+|||.+.+..++.++|+||||+++||+++ |..||.+.....    .    .....+.     .    
T Consensus       164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~----~~~~~~~-----~----  226 (267)
T cd05066         164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----V----IKAIEEG-----Y----  226 (267)
T ss_pred             eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----H----HHHHhCC-----C----
Confidence            1  11223457999999998889999999999999999887 999987543211    1    1111100     0    


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                              ..+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                    0011223456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-42  Score=319.88  Aligned_cols=197  Identities=18%  Similarity=0.243  Sum_probs=167.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+|+|.+.....   .....+.+|+++++.++||||+++++.+.+ ++..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~E~~~   84 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEEeCCC
Confidence            3789999999999999999999999999865322   123468889999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC---
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG---  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  227 (356)
                      +|+|.+++..  ...++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........   
T Consensus        85 gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          85 GGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999864  3467888899999999999999999   9999999999999999999999999999753210000   


Q ss_pred             -------------------------------------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHH
Q 038580          228 -------------------------------------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIML  264 (356)
Q Consensus       228 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~  264 (356)
                                                                 .......||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                       0011246889999999999889999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 038580          265 ELISGKEPINEN  276 (356)
Q Consensus       265 el~tg~~p~~~~  276 (356)
                      ||++|..||...
T Consensus       240 elltG~~Pf~~~  251 (382)
T cd05625         240 EMLVGQPPFLAQ  251 (382)
T ss_pred             HHHhCCCCCCCC
Confidence            999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.9e-41  Score=302.60  Aligned_cols=258  Identities=19%  Similarity=0.345  Sum_probs=196.6

Q ss_pred             CCcccccCCceEEEEEEcCC----------------CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceee
Q 038580           74 GEVIGKSNYGTLYKALLQRS----------------GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYA  136 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~----------------~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~  136 (356)
                      .+.||+|+||.||+|.+...                +..+++|.+...... ....+.+|+++++.++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            47899999999999987643                356788988754332 3357889999999999999999999887


Q ss_pred             CCCCceEEEEecccCCChhHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          137 GPRGEKLIVHPFYKRGNLAQCIRGGS---------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       137 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .. +..++++||+++++|.+++....         ...+++..++.++.|++.||+|||+   .+++|+||||+||++++
T Consensus        90 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~  165 (296)
T cd05051          90 VD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             cC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecC
Confidence            54 58999999999999999996432         1268899999999999999999999   99999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCc
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS--GKEPINENPTPDEDFH  284 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t--g~~p~~~~~~~~~~~~  284 (356)
                      ++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++||+++  +..||...+..     
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-----  240 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-----  240 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-----
Confidence            999999999998754332211 1223345678999999988889999999999999999998  67777643211     


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                        ....... ..    ......      ....+.+..++.++.+++.+||+.||++|||+.++++.|++
T Consensus       241 --~~~~~~~-~~----~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 --QVIENAG-HF----FRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHH-hc----cccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              1111110 00    000000      00011122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=279.43  Aligned_cols=265  Identities=24%  Similarity=0.320  Sum_probs=204.2

Q ss_pred             hhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC----CCCceE
Q 038580           68 DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG----PRGEKL  143 (356)
Q Consensus        68 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~~  143 (356)
                      +..+...+.+|+|||+.||+++...++..+|+|.+.-......+...+|++..++++|||+++++++...    .....|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            3334445889999999999999888899999988876655566789999999999999999999997642    233689


Q ss_pred             EEEecccCCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          144 IVHPFYKRGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ++++|+..|||.+.+...  .+..+++.+.+.|+.++++||.+||+ ...++.||||||.|||+++++.+++.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999998642  34468999999999999999999999 223499999999999999999999999998865


Q ss_pred             cCCCCCcc--------eecccCCCcccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHH
Q 038580          222 LNPTAGQE--------MLEASASQGYKAPELIKMK---DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR  290 (356)
Q Consensus       222 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  290 (356)
                      ..-.-...        -....-|..|+|||.+.-.   ..+.++|||||||++|+|+.|..||...........+.    
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA----  254 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA----  254 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe----
Confidence            43211110        0122346779999998754   35789999999999999999999997543322211110    


Q ss_pred             HhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                ...+++.        .+-....++.+.+++..|++.||.+||++.+++..++++.
T Consensus       255 ----------v~n~q~s--------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 ----------VQNAQIS--------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------eeccccc--------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      0000110        0011125677889999999999999999999999999875

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-41  Score=297.60  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.||+|+||.||+|.+..++..+|+|.+..... ...+++.+|++++++++||||+++++++... +..++++||+++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~   85 (279)
T cd06619           7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTEFMDGGS   85 (279)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEecCCCCC
Confidence            779999999999999988999999998864322 2235788999999999999999999998854 48899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..+.      .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......   .....
T Consensus        86 l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (279)
T cd06619          86 LDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTY  153 (279)
T ss_pred             hHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCC
Confidence            97552      46788888999999999999999   99999999999999999999999999998764322   12234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||++.+..++.++|+||||+++|+|++|..||................. ......     .+         
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-----~~---------  218 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED-----PP---------  218 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC-----CC---------
Confidence            678899999999988899999999999999999999999975432221111111111 000000     00         


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                        .......+.++.+++.+||+.+|++||++++++..
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 --VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              00011234467899999999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-40  Score=302.16  Aligned_cols=198  Identities=22%  Similarity=0.362  Sum_probs=160.4

Q ss_pred             CCcccccCCceEEEEEEcC--CCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC-CCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQR--SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG-PRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  150 (356)
                      +.+||+|+||.||+|....  ++..+|+|.++...  ....+.+|+++++.++||||+++++++.. .+...++++||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            5789999999999999764  45788888876432  33468889999999999999999998753 3447899999987


Q ss_pred             CCChhHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE----cCCCCeEEeccccc
Q 038580          151 RGNLAQCIRGG-------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQPYVSDFGLH  219 (356)
Q Consensus       151 ~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~  219 (356)
                      + +|.+++...       ....+++..+..++.|++.||.|||+   .+++||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787776421       12357888999999999999999999   999999999999999    56679999999999


Q ss_pred             cccCCCCCc--ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          220 LLLNPTAGQ--EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       220 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      .........  ......++..|+|||++.+ ..++.++|||||||++|||+||..||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            765433221  1234467889999999876 457999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.3e-42  Score=310.86  Aligned_cols=238  Identities=20%  Similarity=0.265  Sum_probs=188.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|....++..+|+|+++.....   ....+..|..++..+ +||+|+.+++++.+ .+..++||||+
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~   83 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFVMEYV   83 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEEEcCC
Confidence            37799999999999999988999999998754221   223466677777776 58999999998875 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ...
T Consensus        84 ~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~  157 (323)
T cd05616          84 NGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVT  157 (323)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCc
Confidence            99999998863  3468889999999999999999999   99999999999999999999999999998653221 122


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....|++.|+|||++.+..++.++|+|||||++|||+||..||.+.+..        ..........            
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~------------  217 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN------------  217 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC------------
Confidence            23456889999999999999999999999999999999999999753211        1111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                            ...+...+.++.+++.+||+.||++|+++
T Consensus       218 ------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  11223345677899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=316.09  Aligned_cols=245  Identities=27%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChh
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      +||+|+||+||.|++..++..+|+|-+........+.+.+|+.+.+.++|.|||+++|.|. +++..-+.||-++||||.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-enGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-ENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-CCCeEEEEeecCCCCcHH
Confidence            6999999999999999999999999887766667788999999999999999999999876 566889999999999999


Q ss_pred             HhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEeccccccccCCCCCcceec
Q 038580          156 QCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       156 ~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +.|+.. =.++  .+.++--+..||++||.|||.   +.|||||||-+|+|++ -.|.+||+|||-++.+..- ..-..+
T Consensus       661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET  735 (1226)
T KOG4279|consen  661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET  735 (1226)
T ss_pred             HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence            999742 2234  677788889999999999999   9999999999999996 4689999999998776432 223346


Q ss_pred             ccCCCcccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          233 ASASQGYKAPELIKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ..||..|||||++..+  .|..++|||||||.+.||.||++||.....+...                       +-..+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----------------------MFkVG  792 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----------------------MFKVG  792 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----------------------hhhhc
Confidence            7899999999999876  4889999999999999999999999865432211                       00111


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....-.+.|.+...+...++.+|+..||.+||++++++.
T Consensus       793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            122234568889999999999999999999999999975

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-41  Score=297.46  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=199.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++....+++.+++|.+.....  ...+.+.+|+++++.++|||++++++.+...++..++++||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            4779999999999999988888899998764322  22356888999999999999999999876555568999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++.++..++.+++.|++|||+   .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        85 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~  160 (257)
T cd08223          85 GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MAS  160 (257)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-ccc
Confidence            999999976556678999999999999999999999   9999999999999999999999999999876543221 223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||++.+..++.++|+||||++++|+++|..||...+.       ...... ......             
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~-~~~~~~-------------  219 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYR-IIEGKL-------------  219 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHH-HHhcCC-------------
Confidence            44577889999999988899999999999999999999999864321       111111 100000             


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                0122345567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-41  Score=299.72  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=195.0

Q ss_pred             CcccccCCceEEEEEEcCCC------eEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSG------SVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~------~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      +.||+|+||.||+|......      ..+++|.+..... .....+.+|+.+++.++||||+++++++.. .+..+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence            35999999999999886433      6788887754332 234578999999999999999999998875 448999999


Q ss_pred             cccCCChhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-----CeEEeccc
Q 038580          148 FYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-----QPYVSDFG  217 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg  217 (356)
                      |+++++|.+++....     ...+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999996422     2347889999999999999999999   9999999999999999887     89999999


Q ss_pred             cccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          218 LHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       218 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      ++........ .......++..|+|||++.++.++.++||||||+++|||+| |..||...+..       +... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~-~~~~  228 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQ-HVTA  228 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHH-HHhc
Confidence            9865432211 11122344678999999998899999999999999999998 99998643211       1000 0000


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                                       ......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       229 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 -----------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                             00111233456778899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-41  Score=308.04  Aligned_cols=239  Identities=22%  Similarity=0.299  Sum_probs=187.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHH-HHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIE-LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|....++..+|+|+++....   .....+..|.. +++.++||||+++++++.. ++..+++|||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            359999999999999999999999999865322   12234555554 5678999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  153 (325)
T cd05604          80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT  153 (325)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence            9999988863  4568899999999999999999999   99999999999999999999999999998653221 1222


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....|+..|+|||++.+..++.++|||||||++|||++|..||...+..       ..... .....        .    
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~-~~~~~--------~----  213 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDN-ILHKP--------L----  213 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHH-HHcCC--------c----
Confidence            3456889999999999999999999999999999999999999754311       11111 11100        0    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ  346 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~  346 (356)
                            ......+..+.+++..|++.+|++||++.+
T Consensus       214 ------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         214 ------VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ------cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                  011123456778999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-42  Score=320.40  Aligned_cols=248  Identities=17%  Similarity=0.224  Sum_probs=190.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....+++.+|+|++.....   .....+.+|+++++.++||||+++++.+.+ ++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~   84 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVMDYIP   84 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEEEeCCC
Confidence            3779999999999999999999999999864321   223468889999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC---
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG---  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  227 (356)
                      +|+|.+++..  ...++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..+.....   
T Consensus        85 ~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          85 GGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999974  3457888888999999999999999   9999999999999999999999999999753210000   


Q ss_pred             ---------------------------------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh
Q 038580          228 ---------------------------------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       228 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  268 (356)
                                                             .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00112468899999999998899999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC---CHH
Q 038580          269 GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP---NIK  345 (356)
Q Consensus       269 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp---s~~  345 (356)
                      |..||.+......        ......  +.    .        ....+...+.+..+.+++.+|+ .+|++|+   ++.
T Consensus       240 G~~Pf~~~~~~~~--------~~~i~~--~~----~--------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         240 GQPPFLADTPAET--------QLKVIN--WE----T--------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             CCCCCCCCCHHHH--------HHHHhc--cC----c--------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            9999976432110        000000  00    0        0000111123445667888766 4999999   888


Q ss_pred             HHHHH
Q 038580          346 QVLWK  350 (356)
Q Consensus       346 ~il~~  350 (356)
                      ++++.
T Consensus       297 ell~h  301 (376)
T cd05598         297 EIKAH  301 (376)
T ss_pred             HHhCC
Confidence            88753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.7e-41  Score=302.24  Aligned_cols=258  Identities=18%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             CCcccccCCceEEEEEEcC----------------CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceee
Q 038580           74 GEVIGKSNYGTLYKALLQR----------------SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYA  136 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~----------------~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~  136 (356)
                      .+.||+|+||.||++....                +...+|+|.++..... ....+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4789999999999986432                3457889988754322 2357899999999999999999999887


Q ss_pred             CCCCceEEEEecccCCChhHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          137 GPRGEKLIVHPFYKRGNLAQCIRGGS---------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       137 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .. +..+++|||+++++|.+++....         ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.
T Consensus        90 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~  165 (296)
T cd05095          90 TS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGK  165 (296)
T ss_pred             cC-CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcC
Confidence            54 47899999999999999986422         1246788899999999999999999   99999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCc
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS--GKEPINENPTPDEDFH  284 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t--g~~p~~~~~~~~~~~~  284 (356)
                      ++.++|+|||++.......... .....++..|+|||....+.++.++|+||||+++|||++  |..||...+....   
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---  242 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---  242 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---
Confidence            9999999999987643322111 122234567999999888889999999999999999998  7788865332111   


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                       .......... ......             .+.+..++..+.+++.+||+.||++||++.+|.+.|++
T Consensus       243 -~~~~~~~~~~-~~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 -IENTGEFFRD-QGRQVY-------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHHHhh-cccccc-------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             0000000000 000000             01122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-41  Score=299.18  Aligned_cols=251  Identities=21%  Similarity=0.397  Sum_probs=197.7

Q ss_pred             CCcccccCCceEEEEEEcCCCe----EEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++.    .+++|..+..... ...++.+|+.+++.++||||++++++|.+  ...++++||
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   89 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLITQL   89 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEEec
Confidence            4789999999999999875553    5788877654332 23578899999999999999999999885  578999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  165 (279)
T cd05057          90 MPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE  165 (279)
T ss_pred             CCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence            9999999999753 2358999999999999999999999   99999999999999999999999999998765432211


Q ss_pred             c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      . .....++..|+|||.+....++.++|+||||+++||+++ |..||.+.+..       + .........         
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~---------  228 (279)
T cd05057         166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------E-IPDLLEKGE---------  228 (279)
T ss_pred             eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------H-HHHHHhCCC---------
Confidence            1 112223567999999988889999999999999999999 99998753211       1 111111100         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ..+.+..+...+.+++.+||..+|++||++.++++.|+++.
T Consensus       229 --------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         229 --------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                    00112223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-41  Score=301.67  Aligned_cols=258  Identities=19%  Similarity=0.314  Sum_probs=193.0

Q ss_pred             CCcccccCCceEEEEEEcCC--------------CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCC
Q 038580           74 GEVIGKSNYGTLYKALLQRS--------------GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGP  138 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~--------------~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (356)
                      .+.||+|+||.||++.....              ...+|+|.++..... ....+.+|++++++++|||++++++++.. 
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-   88 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-   88 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC-
Confidence            47899999999999987532              235788888754322 23468999999999999999999998875 


Q ss_pred             CCceEEEEecccCCChhHhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC
Q 038580          139 RGEKLIVHPFYKRGNLAQCIRGGS----------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN  208 (356)
Q Consensus       139 ~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  208 (356)
                      .+..+++|||+++++|.+++....          ...+++..++.++.|++.||+|||+   .+++|+||||+||+++++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~  165 (295)
T cd05097          89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNH  165 (295)
T ss_pred             CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCC
Confidence            458999999999999999985321          1246888999999999999999999   999999999999999999


Q ss_pred             CCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCch
Q 038580          209 YQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS--GKEPINENPTPDEDFHL  285 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t--g~~p~~~~~~~~~~~~~  285 (356)
                      +.+||+|||++......... ......++..|+|||.+.++.++.++|+||||+++|||++  +..||...+...    .
T Consensus       166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~----~  241 (295)
T cd05097         166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ----V  241 (295)
T ss_pred             CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH----H
Confidence            99999999998754322211 1122334668999999988889999999999999999998  666776432111    1


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                      ......... ........             ..+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       242 ~~~~~~~~~-~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFFR-NQGRQIYL-------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhhh-hccccccC-------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111100000 00000000             0111234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=299.98  Aligned_cols=254  Identities=19%  Similarity=0.290  Sum_probs=205.1

Q ss_pred             CCcccccCCceEEEEEEcCC-----CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRS-----GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~-----~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..++.+|.||.||.|.|++.     .+.+.+|.++...++ ....+..|-.++....|||+.++.+++.......++++.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            35688999999999988632     234445555433222 224578888889999999999999999877778899999


Q ss_pred             cccCCChhHhhh-----c-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          148 FYKRGNLAQCIR-----G-GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       148 ~~~~gsL~~~l~-----~-~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ++.-|+|+.||.     . ...+.++-.+...++.|++.|++|||+   .+++|.||.++||+||+..++||+|-.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999996     1 223456777888999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCCccee-cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          222 LNPTAGQEML-EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       222 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      .-+.++.-.. ....+..||+||.+.+..|+..+|+||||+++|||+| |+.||.+.++.++...+        .     
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--------k-----  512 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--------K-----  512 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--------h-----
Confidence            6655544332 3345778999999999999999999999999999999 99999876554432211        1     


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                  .+.+...|.+|+++++.+|.-||..+|++||++++++.-|.++.
T Consensus       513 ------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  513 ------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                        22233457789999999999999999999999999999998763

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-41  Score=298.34  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---------HHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---------KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ++.||+|+||.||+|....++..+++|.+........         +.+.+|+.+++.++||||+++++++.. .+..++
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   83 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-ADHLNI   83 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCccEE
Confidence            4789999999999999988888899998865433221         457889999999999999999998875 458899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      ++||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          84 FLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            9999999999999974  3568888999999999999999999   9999999999999999999999999999876542


Q ss_pred             CCCc-----ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          225 TAGQ-----EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       225 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      ....     ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..       ...... ..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~-~~----  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKI-GE----  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHH-hc----
Confidence            1111     111234678899999998888999999999999999999999999753210       000000 00    


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..            ....+...+..+.+++.+||+.||++||++.++++
T Consensus       227 -~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 -NA------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -cC------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             00            01123345667889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.2e-41  Score=309.64  Aligned_cols=267  Identities=21%  Similarity=0.273  Sum_probs=193.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||++.+..++..+|+|.+......  ....+.+|+.+++.++||||+++++++....     ...+++|
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            37799999999999999888999999988654322  2356788999999999999999999876432     3579999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+.    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus       102 e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-  172 (355)
T cd07874         102 ELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  172 (355)
T ss_pred             hhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-
Confidence            99976 6777664    247888899999999999999999   99999999999999999999999999998764322 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc--------hhHHHHH---h---
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH--------LPTFMRN---A---  292 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~--------~~~~~~~---~---  292 (356)
                       .......++..|+|||++.+..++.++|+|||||++|||++|..||.+.+.......        .++....   .   
T Consensus       173 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             -cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence             122345678899999999988999999999999999999999999976432111000        0000000   0   


Q ss_pred             hhhc--ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          293 VLDH--RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       293 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ..+.  .......+..............+......+.+++.+||+.||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000  000000000000000000011122234568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.4e-41  Score=295.92  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      ..||+|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++||||+++++++.. ++..++++||+++++|
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L   92 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIFMEQVPGGSL   92 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEEEecCCCCCH
Confidence            579999999999999988899999998876555555689999999999999999999998875 4589999999999999


Q ss_pred             hHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCCCCCccee
Q 038580          155 AQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       155 ~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      .+++.... ..+  +...+..++.|++.||+|||+   .+++||||||+||+++. ++.++|+|||++....... ....
T Consensus        93 ~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~  167 (268)
T cd06624          93 SALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTE  167 (268)
T ss_pred             HHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Cccc
Confidence            99997432 234  788888999999999999999   99999999999999986 6799999999986543211 1122


Q ss_pred             cccCCCcccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          232 EASASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ...++..|+|||++....  ++.++|+||||+++|++++|..||.........     ......                
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~~~----------------  226 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKVGM----------------  226 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhhhh----------------
Confidence            345788899999986543  788999999999999999999998653211100     000000                


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .......+......+.+++.+||+.+|++|||+.+++.
T Consensus       227 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 --FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              00011123345567889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.8e-41  Score=294.95  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=198.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+++|.++....  .+++.+|+++++.++||||+++++++... ...++++||+++++
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~   84 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGS   84 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecCCCCc
Confidence            4779999999999999998888999998865432  56899999999999999999999988854 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........ .....
T Consensus        85 L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  159 (256)
T cd06612          85 VSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV  159 (256)
T ss_pred             HHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence            9999863 23568999999999999999999999   9999999999999999999999999999876543321 22234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++||||||+++|+|++|..||..........       . .. ..              ..
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~-~~-~~--------------~~  216 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------M-IP-NK--------------PP  216 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------h-hc-cC--------------CC
Confidence            46788999999988889999999999999999999999997532211100       0 00 00              00


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+......+.+++.+||+.||++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            011123345567889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-40  Score=296.74  Aligned_cols=260  Identities=21%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             CcccccCCceEEEEEEcC----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQR----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~  148 (356)
                      +.||+|+||.||+|.+..    ++..+|+|.++..... ..+.+.+|+++++.++||||+++++++... ....+++|||
T Consensus        10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   89 (284)
T cd05038          10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY   89 (284)
T ss_pred             eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence            779999999999998753    4788999998765443 356899999999999999999999987642 3368999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        90 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05038          90 LPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY  165 (284)
T ss_pred             CCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc
Confidence            99999999997432 358999999999999999999999   99999999999999999999999999998776422211


Q ss_pred             c--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc-------hhHHHHHhhhhcccc
Q 038580          229 E--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH-------LPTFMRNAVLDHRIT  299 (356)
Q Consensus       229 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  299 (356)
                      .  .....++..|+|||.+.+..++.++|+||||+++|||+||..|+...........       ..........     
T Consensus       166 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  240 (284)
T cd05038         166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-----  240 (284)
T ss_pred             eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-----
Confidence            1  1122345569999999888899999999999999999999999865432221100       0000000000     


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                  .....+.+..++.++.+++.+||+.+|++||++.+++++|+++.
T Consensus       241 ------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         241 ------------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             ------------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence                        00011123344577899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-41  Score=300.84  Aligned_cols=251  Identities=22%  Similarity=0.365  Sum_probs=195.8

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..     ++..+++|.++..... ...++.+|+.+++.++||||+++++++.. +...++++|
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   88 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKPMCLLFE   88 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCccEEEEe
Confidence            4789999999999998742     5678899988754322 23578999999999999999999998875 447899999


Q ss_pred             cccCCChhHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          148 FYKRGNLAQCIRGGS--------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      |+++|+|.+++....                    ...+++..++.++.|++.||+|||+   .+++||||||+||+++.
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~  165 (288)
T cd05050          89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGE  165 (288)
T ss_pred             cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecC
Confidence            999999999996321                    1246788899999999999999999   99999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCch
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL  285 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~  285 (356)
                      ++.++|+|||++......... .......+..|+|||.+.+..++.++|+||||+++|||++ |..||.+....      
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------  239 (288)
T cd05050         166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------  239 (288)
T ss_pred             CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            999999999998654322211 1122234567999999988899999999999999999998 88888643211      


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                       +.. .......        .         .+.+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       240 -~~~-~~~~~~~--------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -EVI-YYVRDGN--------V---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHH-HHHhcCC--------C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             111 1111100        0         01123345678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=314.58  Aligned_cols=197  Identities=25%  Similarity=0.374  Sum_probs=173.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CC-----ccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HP-----NLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .++||+|+||.|.+|.+..+++.||+|+++.. .....+...|+.+|..++ |.     |+|+++++|.. +++.|||+|
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~HlciVfE  268 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLCIVFE  268 (586)
T ss_pred             EEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccceeeeeh
Confidence            47899999999999999999999999999853 233456788999999987 43     89999999884 669999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC--CCeEEeccccccccCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN--YQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~  225 (356)
                      .+.. +|.++++.....+++...+..++.||+.||.+||.   .+|||+||||+|||+.+.  ..+||+|||.++.... 
T Consensus       269 LL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-  343 (586)
T KOG0667|consen  269 LLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-  343 (586)
T ss_pred             hhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCC-
Confidence            9976 99999998888899999999999999999999999   999999999999999643  3799999999987543 


Q ss_pred             CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 038580          226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD  280 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~  280 (356)
                         .......+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+.+..+
T Consensus       344 ---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  344 ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             ---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence               2336677889999999999999999999999999999999998898865433

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-41  Score=293.14  Aligned_cols=248  Identities=23%  Similarity=0.386  Sum_probs=196.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ++||+|+||.||++.+.. +..+++|..+..... ....+.+|+++++.++||||+++++++.. ....++++||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCc
Confidence            369999999999999987 888899987755443 34578999999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce-ec
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM-LE  232 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  232 (356)
                      |.+++... ...+++..+..++.+++.|++|||+   .+++||||+|+||+++.++.++|+|||++........... ..
T Consensus        79 l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          79 LLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            99998643 3467889999999999999999999   9999999999999999999999999999875432111111 11


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+..|+|||.+.++.++.++|+||||+++||++| |..||......        .........               
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~---------------  211 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESG---------------  211 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcC---------------
Confidence            223556999999988889999999999999999999 88888653211        011111000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                        .....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       212 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         212 --YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence              0011233445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6e-41  Score=330.15  Aligned_cols=254  Identities=21%  Similarity=0.272  Sum_probs=196.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .++||+|+||.||+|.+..+++.+|+|.++......   .+.+.+|+++++.++||||+++++++.+ ++..+++|||++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLVMEY~e   85 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYTMPYIE   85 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEEEEcCC
Confidence            378999999999999999889999999987543222   3468899999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          151 RGNLAQCIRGG---------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       151 ~gsL~~~l~~~---------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      +++|.+++...         .....++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCccee
Confidence            99999998631         12345667888999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCC-----------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 038580          222 LNPTAG-----------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH  284 (356)
Q Consensus       222 ~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~  284 (356)
                      ......                 .......||+.|+|||.+.+..++.++|||||||++|||+||..||.........  
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~--  240 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS--  240 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh--
Confidence            521100                 0111245899999999999999999999999999999999999999753221110  


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhh
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-NIKQVLWKLEDL  354 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~il~~L~~~  354 (356)
                           ...    .   ...+..         .....+.+..+.+++.+||+.||++|| +++++.+.|+++
T Consensus       241 -----~~~----~---i~~P~~---------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        241 -----YRD----V---ILSPIE---------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             -----hhh----h---ccChhh---------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 000    0   000000         001123445678999999999999996 677777777764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=288.78  Aligned_cols=245  Identities=21%  Similarity=0.306  Sum_probs=196.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc--cccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|.|+.|++.....+|+.+++|++...  .....+++.+|+.+.+.|+|||||++...+. +.+..++|+|+|.|+
T Consensus        17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ylvFe~m~G~   95 (355)
T KOG0033|consen   17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGG   95 (355)
T ss_pred             HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-ccceeEEEEecccch
Confidence            7799999999999999999988888877533  2334578999999999999999999999887 456899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEeccccccccCCCCCcc
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +|..-+-.+  ...++......++||+++|.|+|.   ++|||||+||.|+++.   +...+||+|||++....  .+..
T Consensus        96 dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~  168 (355)
T KOG0033|consen   96 ELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEA  168 (355)
T ss_pred             HHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC--Cccc
Confidence            998766422  345666777889999999999999   9999999999999994   44568999999998876  3344


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      -....||++|||||++...+|+.++|||+.|++++-++.|..||.+.+.    ..+.+.+...        .+       
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g--------~y-------  229 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAG--------AY-------  229 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhcc--------cc-------
Confidence            4567899999999999999999999999999999999999999987432    1111111110        01       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ....+.-+...++..+|+++||..||.+|.|+.|.++
T Consensus       230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               1111223345566789999999999999999998875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-42  Score=286.37  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc----h----HHHHHHHHHHhcc-CCCccccccceeeCCCCce
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR----D----KEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (356)
                      .+.+.+|+|..++|-++.++.++...++|++.......    .    +.-..|+.+|+++ .||||+.+.++|++ +...
T Consensus        20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~sF~   98 (411)
T KOG0599|consen   20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-DAFV   98 (411)
T ss_pred             ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-cchh
Confidence            34578999999999999999888888888775332221    1    2456789999987 59999999999996 4489


Q ss_pred             EEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccccc
Q 038580          143 LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      ++|+|.|+.|.|.++|.  +.-.+++....+|+.|+.+|++|||.   .+||||||||+|||+|++.++||+|||+++..
T Consensus        99 FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeecc
Confidence            99999999999999997  45578889999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCcceecccCCCcccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKM------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      .  .+......+||++|+|||.+..      ..|+...|+|+.|+++|.++.|.+||....        .-.+...+.++
T Consensus       174 ~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~ImeG  243 (411)
T KOG0599|consen  174 E--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIMEG  243 (411)
T ss_pred             C--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHHhc
Confidence            4  3566778899999999999864      357889999999999999999999986311        01111111111


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .              .--..+...+.++...+|+.+||+.||++|.|+++.++
T Consensus       244 k--------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  244 K--------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             c--------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1              11122345567788999999999999999999999885

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-41  Score=305.48  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=207.9

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccC-CCccccccceeeCCCCceEEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +..++.||+|.||.||++..+.+|..+|+|++.+......   ....+|+.+|+.+. |||||.+.+.|.++. ..++||
T Consensus        37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~lvm  115 (382)
T KOG0032|consen   37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVYLVM  115 (382)
T ss_pred             EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEEEEE
Confidence            3445889999999999999999999999999976544333   48999999999998 999999999999655 899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC----CCeEEecccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN----YQPYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~  222 (356)
                      |++.||.|.+.+...   .+++.....++.|++.++.|||+   .+++||||||+|+|+...    +.+|++|||++...
T Consensus       116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999754   39999999999999999999999   999999999999999643    47999999999887


Q ss_pred             CCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ..  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+......        .+....+    
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~----  255 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF----  255 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC----
Confidence            65  556678899999999999999999999999999999999999999998754322111        1111111    


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                .-..+.-......+.++++.|+..||..|+++.++++
T Consensus       256 ----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                      1112233445777889999999999999999999986

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.9e-41  Score=304.60  Aligned_cols=268  Identities=17%  Similarity=0.235  Sum_probs=194.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ....+.+|+.++++++||||+++++++.. ++..+++|||+++ 
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-   88 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFEYLDK-   88 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEeCCCC-
Confidence            47899999999999999988999999988754332 23467889999999999999999999885 4589999999986 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... .....
T Consensus        89 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  163 (309)
T cd07872          89 DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSN  163 (309)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc-ccccc
Confidence            888887643 3457888899999999999999999   999999999999999999999999999986543221 11223


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc---cc
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM---LL  308 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  308 (356)
                      ..++..|+|||.+.+ ..++.++||||||+++|||+||..||...+..+....+..... ......+........   ..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhhhcchhhhhhhh
Confidence            456788999998864 4688999999999999999999999976443211100000000 000000000000000   00


Q ss_pred             ccCCCCC--CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHE--NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .......  .......+.++.+++.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000  0011224556789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-41  Score=305.62  Aligned_cols=258  Identities=20%  Similarity=0.364  Sum_probs=198.6

Q ss_pred             hhcCCCCcccccCCceEEEEEEcC-------CCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCC
Q 038580           69 ILDAPGEVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPR  139 (356)
Q Consensus        69 ~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  139 (356)
                      ..+..++.||+|+||.||++.+..       .+..+++|.++..... ..+++.+|+++++++ +||||++++++|.. .
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-C
Confidence            334456889999999999998642       2346889987643222 235789999999999 79999999998875 4


Q ss_pred             CceEEEEecccCCChhHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGG--------------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL  205 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  205 (356)
                      +..++++||+++|+|.+++...              ....+++..+..++.|++.||+|||+   .+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence            5899999999999999998642              12357888999999999999999999   999999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 038580          206 DRNYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDF  283 (356)
Q Consensus       206 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~  283 (356)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.+.     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            99999999999998765332211 1122233467999999998889999999999999999998 8888865321     


Q ss_pred             chhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ..... ......                 ....+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       243 --~~~~~-~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 --EELFK-LLKEGH-----------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --HHHHH-HHHcCC-----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence              11111 111000                 00112234567889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=326.75  Aligned_cols=254  Identities=22%  Similarity=0.391  Sum_probs=206.0

Q ss_pred             CCCcccccCCceEEEEEEc---C----CCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           73 PGEVIGKSNYGTLYKALLQ---R----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~---~----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      .++.||+|.||.|++|...   .    ....||+|.++..... ..+.+..|+++|+.+ +||||+.++|.|.. ++..+
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~~  378 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPLY  378 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCceE
Confidence            3468999999999999764   1    1467899988765444 346899999999988 59999999999886 67999


Q ss_pred             EEEecccCCChhHhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC
Q 038580          144 IVHPFYKRGNLAQCIRGGS------------G--EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY  209 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  209 (356)
                      +++||+..|+|.++|+...            .  ..++....+.++.|||.|++||++   .+++||||.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence            9999999999999997533            1  138889999999999999999999   9999999999999999999


Q ss_pred             CeEEeccccccccCCCCCcceeccc--CCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchh
Q 038580          210 QPYVSDFGLHLLLNPTAGQEMLEAS--ASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP  286 (356)
Q Consensus       210 ~~kl~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~  286 (356)
                      .+||+|||+++...+..........  -+..|||||.+....|+.+|||||||+++||++| |..||.+...       .
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-------~  528 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-------T  528 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-------H
Confidence            9999999999865544333322222  4567999999999999999999999999999999 9999976221       1


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ..+...+.                 .+.+...|..|..+++++|+.||+.+|++||++.++.+.|++.
T Consensus       529 ~~l~~~l~-----------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 EELLEFLK-----------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHh-----------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11111111                 2233445777889999999999999999999999999999873

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.1e-41  Score=302.52  Aligned_cols=251  Identities=23%  Similarity=0.444  Sum_probs=195.5

Q ss_pred             CCcccccCCceEEEEEEcCCCe----EEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++.    .+++|.+....... ..++.+|+.+++.++||||++++|+|..+  ..+++++|
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~v~e~   89 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TIQLVTQL   89 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cceeeehh
Confidence            3789999999999999876664    46888776543222 23688999999999999999999988743  46789999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.........
T Consensus        90 ~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          90 MPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             cCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            9999999998643 3358889999999999999999999   99999999999999999999999999998765432221


Q ss_pred             -ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 -EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+....    .......    ...         
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~---------  228 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLLE----KGE---------  228 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----CCC---------
Confidence             1122334668999999988889999999999999999998 89998753210    0111111    000         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ..+.+..++..+.+++..||..+|++||+++++++.|.++.
T Consensus       229 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         229 --------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    00111223456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-40  Score=295.95  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.||+|+||.||+|.+..++..+|+|.++.... ...+.+.+|+++++.++||||+++++++.. ++..++|+||+++++
T Consensus        10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   88 (277)
T cd06642          10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYLGGGS   88 (277)
T ss_pred             HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEccCCCc
Confidence            679999999999999988899999998874432 223578999999999999999999998885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++++|||++........ .....
T Consensus        89 L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~  161 (277)
T cd06642          89 ALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF  161 (277)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcc
Confidence            9998863   468889999999999999999999   9999999999999999999999999999876543211 12234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++|+||||+++||+++|..||........    ..    ....     ...          
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~----~~~~-----~~~----------  218 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----LF----LIPK-----NSP----------  218 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----Hh----hhhc-----CCC----------
Confidence            567889999999988899999999999999999999999875322110    00    0000     000          


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .......+..+.+++.+||+.+|++||++.++++
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         219 --PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              0112234567889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.7e-41  Score=297.99  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=185.1

Q ss_pred             cccccCCceEEEEEEcC--CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           76 VIGKSNYGTLYKALLQR--SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .||+|+||.||+|....  ....+++|.+...... ....+.+|+..++.++||||+++++.+.. .+..+++|||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCCC
Confidence            59999999999997643  3456778876543322 23468889999999999999999998875 45899999999999


Q ss_pred             ChhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-
Q 038580          153 NLAQCIRGGS---GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       153 sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      +|.+++....   ....++.....++.|++.|++|||+   .+++||||||+||+++.++++||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999996432   2335677888999999999999999   99999999999999999999999999998653222111 


Q ss_pred             ceecccCCCcccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          229 EMLEASASQGYKAPELIKM-------KDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......       ......... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~-~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVRE-QDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhc-cCcc
Confidence            1122334667999998743       356789999999999999999 78888653211       001111110 0000


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                      ...            ...+...+..+.+++..|| .||++||++++|++.|.
T Consensus       230 ~~~------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPK------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            001            1112234556778899999 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-40  Score=298.70  Aligned_cols=252  Identities=19%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             CCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|..+.     .+..+|+|.++..... ....+.+|+.+++.++||||+++++++... +..+++||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   89 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-QPTLVVME   89 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEe
Confidence            4789999999999997652     3557889987644322 224678899999999999999999988754 48899999


Q ss_pred             cccCCChhHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          148 FYKRGNLAQCIRGGS--------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      |+++|+|.++++...        ....++..+..++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++
T Consensus        90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~  166 (288)
T cd05061          90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT  166 (288)
T ss_pred             CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence            999999999996421        1335677888999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +........ ......++..|+|||.+.++.++.++|+|||||++|||++ |..||.+...       .+ .........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~-~~~~~~~~~  238 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQ-VLKFVMDGG  238 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcCC
Confidence            754322211 1122234567999999988889999999999999999998 7888865321       11 111111000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                       ....+...+..+.+++..||+.||++|||+.++++.|++.
T Consensus       239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         239 -----------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                             0011223356788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-40  Score=312.65  Aligned_cols=265  Identities=15%  Similarity=0.195  Sum_probs=191.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+|+|...      ...+.+|++++++++|||||++++++.. ++..+++||++. ++
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~~~-~~  245 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPKYR-SD  245 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEccC-CC
Confidence            467999999999999999888889998532      2356789999999999999999998875 458899999995 68


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-ceec
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-EMLE  232 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  232 (356)
                      |..++... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........ ....
T Consensus       246 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        246 LYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            98888642 3468999999999999999999999   99999999999999999999999999998765332221 1224


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc--cccc---Ccccc
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI--TDLY---HPDML  307 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~  307 (356)
                      ..||..|+|||++.+..++.++|||||||++|||++|..|+...............+...+.....  ....   ...+.
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            568999999999999899999999999999999999887654322211111111111111111000  0000   00000


Q ss_pred             ----cc--cCCC---CCCCCc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 ----LC--SNSN---HENPVS--EERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ----~~--~~~~---~~~~~~--~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                          ..  ....   ....+.  ......+.+|+..||+.||++|||+.|+++.
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                00  0000   000000  0123467899999999999999999999864

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.8e-41  Score=300.58  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|....++..+++|.+........+.+.+|+.+++.++||||+++++++.. .+..+++|||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~  102 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGS  102 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecccCCCC
Confidence            4779999999999999988889999998876555555678899999999999999999998885 448999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........ .....
T Consensus       103 L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~  175 (297)
T cd06656         103 LTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  175 (297)
T ss_pred             HHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcc
Confidence            9999863   357888999999999999999999   9999999999999999999999999999876533221 12234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++|+||||+++|++++|..||...+........   ..                    ...
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~--------------------~~~  232 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT--------------------NGT  232 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---cc--------------------CCC
Confidence            5778899999999888999999999999999999999999753321110000   00                    000


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+...+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011123344566789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-41  Score=314.23  Aligned_cols=248  Identities=18%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+|+|++.....   .....+.+|+.+++.++||||+++++.+.+ ++..+++|||++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~  126 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMP  126 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCC
Confidence            4789999999999999999999999999864221   223457889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.++++.   ..++...+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus       127 gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~  200 (371)
T cd05622         127 GGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC  200 (371)
T ss_pred             CCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence            9999999863   347888888999999999999999   9999999999999999999999999999877644333333


Q ss_pred             ecccCCCcccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          231 LEASASQGYKAPELIKMK----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ....||+.|+|||++...    .++.++|||||||++|||++|..||...+..       .... .+.... .   .  .
T Consensus       201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~-~i~~~~-~---~--~  266 (371)
T cd05622         201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYS-KIMNHK-N---S--L  266 (371)
T ss_pred             cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHH-HHHcCC-C---c--c
Confidence            456789999999998754    3789999999999999999999999753321       0011 110000 0   0  0


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLWK  350 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~~  350 (356)
                              ..+.....+..+.+++..|++.++.+  ||+++++++.
T Consensus       267 --------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 --------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             --------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                    00111234556778999999844433  7789988764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.2e-41  Score=320.77  Aligned_cols=195  Identities=21%  Similarity=0.315  Sum_probs=160.8

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCC------CccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH------PNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||+||+|.+..++..+|+|+++... ....++..|+++++.++|      ++++.+++++....++.++||
T Consensus       133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~  211 (467)
T PTZ00284        133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM  211 (467)
T ss_pred             EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence            3468999999999999999889999999986432 223456677777777654      458888898887667889999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----------------C
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----------------Q  210 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----------------~  210 (356)
                      +++ +++|.+++..  ...+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++                .
T Consensus       212 ~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        212 PKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             ecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            988 6688888863  35689999999999999999999971  4999999999999998765                4


Q ss_pred             eEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          211 PYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       211 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      +||+|||.+....    .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus       287 vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        287 VRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             EEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999875432    12234578999999999999999999999999999999999999997644

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-40  Score=299.72  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++.+..++..+++|.++..... ....+.+|+++++.++||||++++++|.. ++..++++||++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ey~~~~   84 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGG   84 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEeeccCCC
Confidence            37799999999999999988999999988653222 23468899999999999999999999885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.++++.  ...+++..+..++.|+++||+|||+.  .+++|+||||+||+++.++.+||+|||++.......   ...
T Consensus        85 ~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~  157 (308)
T cd06615          85 SLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS  157 (308)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence            99999974  35688999999999999999999972  489999999999999999999999999986543221   123


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc-------cCc-
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL-------YHP-  304 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~-  304 (356)
                      ..++..|+|||.+.+..++.++|+||||+++||+++|..||...+...    .................       ... 
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCCCc
Confidence            467888999999988889999999999999999999999986432111    00000000000000000       000 


Q ss_pred             -c-------cc-cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          305 -D-------ML-LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       305 -~-------~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                       .       .. ......+.. .....+.++.+++.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0       00 000000000 011245568899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-41  Score=298.60  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchH--HHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK--EFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||++....++..+|+|.+.........  ....|+.+++.++||||+++++++.. ....+++|||+++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~~   82 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEETT
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-ccccccccccccc
Confidence            37899999999999999999999999998765433332  34558999999999999999999885 5588999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.  ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+.... .......
T Consensus        83 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~  156 (260)
T PF00069_consen   83 GSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN  156 (260)
T ss_dssp             EBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred             cccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccccc
Confidence            99999997  34568999999999999999999999   999999999999999999999999999987541 1223334


Q ss_pred             cccCCCcccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIK-MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||++. ...++.++|+||+|+++|+|++|..||.......    ..................        
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~--------  224 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD----QLEIIEKILKRPLPSSSQ--------  224 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH----HHHHHHHHHHTHHHHHTT--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchh----hhhhhhhccccccccccc--------
Confidence            566788999999998 7888999999999999999999999998641101    011111111000000000        


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ........+.+++..||+.||++||++.++++
T Consensus       225 -------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00111267889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=294.26  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.||+|+||.||+|....++..+++|.++.........+.+|+.+++.++||||+++++.+.. .+..++++||+++++|
T Consensus        15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L   93 (267)
T cd06645          15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEFCGGGSL   93 (267)
T ss_pred             HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEeccCCCcH
Confidence            779999999999999998899999999876544444568889999999999999999998875 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+++..  ...+++..+..++.|++.|+.|||+   .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus        94 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  167 (267)
T cd06645          94 QDIYHV--TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFI  167 (267)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccccccc
Confidence            999863  3468899999999999999999999   999999999999999999999999999986653221 1223446


Q ss_pred             CCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          235 ASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       235 ~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ++..|+|||++.   ...++.++|+|||||++|||++|..||.........   ..     .....    ..+..     
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---~~-----~~~~~----~~~~~-----  230 (267)
T cd06645         168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FL-----MTKSN----FQPPK-----  230 (267)
T ss_pred             CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---Hh-----hhccC----CCCCc-----
Confidence            788999999874   456889999999999999999999998653321110   00     00000    00000     


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          .......+..+.+++.+||+.+|++||+++++++
T Consensus       231 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 ----LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ----ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                0000112345779999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-40  Score=308.12  Aligned_cols=265  Identities=23%  Similarity=0.273  Sum_probs=192.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||++.+...+..+|+|.+.....  .....+.+|+.+++.++||||+++++++....     ...++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            4789999999999999998899999998865322  22356888999999999999999999876432     3579999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+.    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       109 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         109 ELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  180 (364)
T ss_pred             eCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence            99976 7777764    247888899999999999999999   999999999999999999999999999987653321


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch--------hHHHHH---hh--
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL--------PTFMRN---AV--  293 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~--------~~~~~~---~~--  293 (356)
                        ......++..|+|||++.+..++.++|||||||++|||++|..||.+.+.......+        +.....   ..  
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         181 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             --cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence              223456788999999999989999999999999999999999999764321110000        000000   00  


Q ss_pred             -hhcccccccCcccc-cccC--CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          294 -LDHRITDLYHPDML-LCSN--SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       294 -~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ...+. ........ ....  ..............+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         259 YVENRP-KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhCC-CcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             00000 00000000 0000  00000111123456889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.5e-41  Score=301.27  Aligned_cols=244  Identities=20%  Similarity=0.328  Sum_probs=197.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.||.|+||.||+|....+++.+++|.+........+.+.+|+.+++.++|||++++++++.. .+..++++||+++++|
T Consensus        25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L  103 (296)
T cd06655          25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGSL  103 (296)
T ss_pred             EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEecCCCcH
Confidence            679999999999999988899999998876555555678999999999999999999999885 4489999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      ..++..   ..+++..+..++.|++.|++|||+   .+++|+||+|+||+++.++.+||+|||++........ ......
T Consensus       104 ~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~  176 (296)
T cd06655         104 TDVVTE---TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMV  176 (296)
T ss_pred             HHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcC
Confidence            998863   358899999999999999999999   9999999999999999999999999999876543221 122345


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||.+.+..++.++|+||||+++|++++|..||...+...      . .. ......     .          .
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~-~~-~~~~~~-----~----------~  233 (296)
T cd06655         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------A-LY-LIATNG-----T----------P  233 (296)
T ss_pred             CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HH-HHHhcC-----C----------c
Confidence            7788999999988889999999999999999999999997532210      0 00 000000     0          0


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....+...+..+.+++.+||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            01122334567889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.7e-41  Score=299.60  Aligned_cols=247  Identities=22%  Similarity=0.309  Sum_probs=195.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+++|.+........+.+..|+.+++.++||||+++++.+.. ++..+++|||+++++
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   95 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEFCPGGA   95 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEecCCCCc
Confidence            3779999999999999998899999999876544445678899999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..++... ...+++..+..++.|++.|++|||+   .+++||||||+||+++.++.++|+|||++....... ......
T Consensus        96 l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~  170 (292)
T cd06644          96 VDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF  170 (292)
T ss_pred             HHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccccee
Confidence            98887532 3468999999999999999999999   999999999999999999999999999876543221 122234


Q ss_pred             cCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          234 SASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       234 ~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .++..|+|||++.     ...++.++|+||||+++|||++|..||...+..       ..... ....     ..+    
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~-~~~~-----~~~----  233 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLK-IAKS-----EPP----  233 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHH-HhcC-----CCc----
Confidence            5678899999985     345688999999999999999999998653211       00110 0000     000    


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ....+...+..+.+++.+||+.+|++||+++++++
T Consensus       234 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  01112234456889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-40  Score=293.06  Aligned_cols=244  Identities=24%  Similarity=0.345  Sum_probs=198.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++.... .....+.+|+.+++.++||||+++++.+.+ ++..+++|||++++
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   87 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEecCCCC
Confidence            3779999999999999988899999998875432 234578899999999999999999998885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++..   ..+++.....++.|++.|++|||+   .+++|+||+|+||+++.++.++++|||++....... .....
T Consensus        88 ~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~  160 (277)
T cd06640          88 SALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNT  160 (277)
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccccc
Confidence            99999863   357888899999999999999999   999999999999999999999999999986654322 12223


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||++.+..++.++|+||||+++|||+||..||...+.....    .    ...                 .
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~----~~~-----------------~  215 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----F----LIP-----------------K  215 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----h----hhh-----------------c
Confidence            45677899999998888999999999999999999999999754321110    0    000                 0


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ..........+..+.+++.+||+.+|++||++.++++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            00112344567788999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-40  Score=292.11  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=198.6

Q ss_pred             CCcccccCCceEEEEEEcCCC----eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSG----SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||++.+...+    ..+++|.++..... ..+.+..|+++++.++||||+++++++... +..+++|||
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e~   82 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIVMEY   82 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEEEec
Confidence            377999999999999998765    88999998765443 456899999999999999999999988854 589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++.......+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999975433338999999999999999999999   99999999999999999999999999998765433222


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+.+..++.++|+||+|++++||++ |..||...+.       ..... ......          
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~-~~~~~~----------  221 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLE-YLKKGY----------  221 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHhcCC----------
Confidence            2212336678999999988889999999999999999998 7888765211       11111 111000          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                             ....+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0011223566788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-40  Score=298.00  Aligned_cols=269  Identities=20%  Similarity=0.258  Sum_probs=193.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|....++..+++|.++.....  ....+.+|+.+++.++||||+++++++.. ++..++||||++ 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-   82 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLS-   82 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEecCC-
Confidence            36799999999999999988999999988654322  23578899999999999999999999885 458999999997 


Q ss_pred             CChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ++|.+++.... ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~  158 (285)
T cd07861          83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY  158 (285)
T ss_pred             CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence            58988886433 3568999999999999999999999   999999999999999999999999999987543221 111


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc---Cccc
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY---HPDM  306 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  306 (356)
                      ....++..|+|||.+.+. .++.++|+||||+++|||+||..||.+.+.............. .....+....   +...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC-CChhhhhcchhhHHHHh
Confidence            233557889999988654 5788999999999999999999999764321110000000000 0000000000   0000


Q ss_pred             cc-ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LL-CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .. ..............+.++.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00 00000000011124556789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-40  Score=303.11  Aligned_cols=190  Identities=19%  Similarity=0.276  Sum_probs=160.5

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +...+.||+|+||.||+|....++..+|+|+...      .....|+.++++++||||+++++++... +..++++|++.
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVLPHYS  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEEEccC
Confidence            3445789999999999999998888999997542      2345689999999999999999998854 47899999995


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                       ++|.+++.. ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++......  ...
T Consensus       141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~  213 (357)
T PHA03209        141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF  213 (357)
T ss_pred             -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence             588888864 34568999999999999999999999   99999999999999999999999999998653221  122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN  274 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~  274 (356)
                      ....|+..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            34568899999999998899999999999999999999655543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-40  Score=291.86  Aligned_cols=248  Identities=19%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||.+....++..+++|.+....  ....+++.+|++++++++|+||+++++++.. .+..+++|||+++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e~~~~   83 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEMEYANG   83 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEEecCC
Confidence            378999999999999999889889999876432  2233578899999999999999999999885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.+||+|||++........ ...
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~  159 (256)
T cd08221          84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE  159 (256)
T ss_pred             CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence            999999976545678999999999999999999999   9999999999999999999999999999876543322 223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|..||.....       .+..... .....             
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~-------------  218 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKI-VQGNY-------------  218 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH-HcCCC-------------
Confidence            44678889999999888889999999999999999999999864321       1111110 10000             


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                          .+.+...+..+.+++.+||+.+|++||++.++++.+
T Consensus       219 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 ----TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                011233456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8e-40  Score=290.02  Aligned_cols=252  Identities=17%  Similarity=0.328  Sum_probs=184.7

Q ss_pred             cccccCCceEEEEEEcCC--CeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           76 VIGKSNYGTLYKALLQRS--GSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~--~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .||+|+||.||+|....+  ...+++|.++.... ...+.+.+|+.+++.++||||+++++.|.. ....+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence            599999999999976533  23456676654332 234579999999999999999999999885 45889999999999


Q ss_pred             ChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Ccc
Q 038580          153 NLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQE  229 (356)
Q Consensus       153 sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  229 (356)
                      +|.++++...  ....+...+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997432  2346777788999999999999999   999999999999999999999999999875422111 111


Q ss_pred             eecccCCCcccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          230 MLEASASQGYKAPELIKM-------KDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||...+.       .+....... ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~-~~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIK-DQQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHh-hccccc
Confidence            223456788999998753       245789999999999999997 5667754321       111111111 111111


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                      .++.+            .......+.+++..|| .+|++||+++++++.|.
T Consensus       230 ~~~~~------------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQL------------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCcc------------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111            1123356778999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=312.65  Aligned_cols=241  Identities=23%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||.|+||.||.|.+..+.++||+|...-....   ..+++..|+..|+.++|||+|.+-|+|.. +...|||||||-|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVMEYClG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEYCLG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHHHHhc
Confidence            6799999999999999999999999987644333   23578999999999999999999998884 4588999999976


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       |-.+++.- -.+++....+..|+.+.+.||+|||+   .+.||||||+.|||+++.|.|||+|||.+....+     ..
T Consensus       111 -SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----An  180 (948)
T KOG0577|consen  111 -SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----AN  180 (948)
T ss_pred             -cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-----hh
Confidence             66666642 24578888899999999999999999   9999999999999999999999999999876533     34


Q ss_pred             cccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          232 EASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .+.||+.|||||++.   .+.|+-++||||||+++.|+...++|+..++......++.   .          .-.|.+  
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---Q----------NesPtL--  245 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---Q----------NESPTL--  245 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---h----------cCCCCC--
Confidence            679999999999985   5789999999999999999999999977654322111110   0          111111  


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                               .+.+-+..+..++..||+.-|.+|||.++++..
T Consensus       246 ---------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 ---------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ---------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                     133446678899999999999999999998763

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-40  Score=294.78  Aligned_cols=267  Identities=19%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.++.++..+++|.+......  ..+.+.+|+.+++.++|||++++++++... ...+++|||+++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~   84 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVFEYCDH   84 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEEeccCc
Confidence            36799999999999999988999999987643222  235678999999999999999999998854 488999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|..+...  ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........ ...
T Consensus        85 ~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (286)
T cd07847          85 TVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT  158 (286)
T ss_pred             cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence            888887653  3458999999999999999999999   9999999999999999999999999999876543221 122


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc-
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC-  309 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  309 (356)
                      ...++..|+|||.+.+ ..++.++|+||||+++|||++|..||.+....+....+.........  ......+...... 
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  236 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP--RHQQIFSTNQFFKG  236 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh--HHhhhccccccccc
Confidence            3356778999999875 45789999999999999999999999865432111000000000000  0000000000000 


Q ss_pred             -cCCCCCCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 -SNSNHENP-----VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 -~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ........     .....+..+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00000000     01123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=295.53  Aligned_cols=244  Identities=24%  Similarity=0.371  Sum_probs=197.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc-ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+++++.++|||++++++++.+. ...++++||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~   84 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYCGGG   84 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEeeCCC
Confidence            367999999999999999899999999987543 22335788999999999999999999988854 5899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++...   .+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||++....... .....
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~  157 (274)
T cd06609          85 SCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNT  157 (274)
T ss_pred             cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccccc
Confidence            999998742   78999999999999999999999   999999999999999999999999999987764332 22234


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||.+.+..++.++|+||||+++|||+||..||...+...        ........     ..+..      
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~-----~~~~~------  218 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKN-----NPPSL------  218 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhc-----CCCCC------
Confidence            457778999999998889999999999999999999999997543111        00000000     00000      


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           .....+..+.+++.+||..+|++||+++++++
T Consensus       219 -----~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 -----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 00114556889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-40  Score=295.29  Aligned_cols=251  Identities=21%  Similarity=0.364  Sum_probs=195.8

Q ss_pred             CcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..||+|+||.||+|..+.     +...+++|.+...... ..+++.+|++++++++||||+++++++.. .+..+++|||
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   89 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPHYMILEY   89 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcceEEEEe
Confidence            679999999999999753     3467888887654332 23579999999999999999999998874 4578999999


Q ss_pred             ccCCChhHhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          149 YKRGNLAQCIRGGSG-------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      +++|+|.+++.....       ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||++..
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            999999999964331       258999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      .............++..|+|||.+.+..++.++|+||||+++|++++ |..||.+....       .... ........ 
T Consensus       167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~-~~~~~~~~-  237 (275)
T cd05046         167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLN-RLQAGKLE-  237 (275)
T ss_pred             cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHH-HHHcCCcC-
Confidence            43222222223345667999999988888999999999999999999 78888643211       1111 11100000 


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                                     ...+...+..+.+++.+||+.+|++||++.++++.|.+
T Consensus       238 ---------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 ---------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                           00122345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.3e-41  Score=300.38  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      ..||+|+||.||++....++..+++|.+........+.+.+|+..++.++||||+++++.+.. .+..+++|||+++++|
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~~~~L  106 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGGAL  106 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCCCCcH
Confidence            669999999999999988889999998865544455678899999999999999999998875 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........ ......
T Consensus       107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~  179 (292)
T cd06658         107 TDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV  179 (292)
T ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence            998853   357889999999999999999999   9999999999999999999999999999865432221 222345


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||.+.+..++.++|+||||+++||+++|..||...+..       ..... ...     ...+.         
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~~-----~~~~~---------  237 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRR-IRD-----NLPPR---------  237 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHh-----cCCCc---------
Confidence            788899999998888999999999999999999999998753211       00110 000     00000         


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                       .......+..+.+++..||+.||++|||++++++.
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 -VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             00111234567799999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-40  Score=295.67  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=193.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeC-----CCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAG-----PRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~~lv~e~  148 (356)
                      +.||+|+||.||+|.+..++..+++|...... ....++..|+.+++++ +||||+++++++..     .....+++|||
T Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            77999999999999999899999999875432 2335688899999888 69999999998752     23478999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++.......+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus       101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-  176 (282)
T cd06636         101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-  176 (282)
T ss_pred             CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-
Confidence            999999999976555668888899999999999999999   9999999999999999999999999999875432211 


Q ss_pred             ceecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          229 EMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ......++..|+|||.+.     ...++.++|+||||+++|||++|..||...........        ...     ...
T Consensus       177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--------~~~-----~~~  243 (282)
T cd06636         177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--------IPR-----NPP  243 (282)
T ss_pred             CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--------Hhh-----CCC
Confidence            123345788899999886     34578899999999999999999999975322111000        000     000


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +           .......+..+.+++.+||+.||.+||++.++++
T Consensus       244 ~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         244 P-----------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             C-----------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0           0011234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-40  Score=294.44  Aligned_cols=255  Identities=21%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.||+|+||+||++....++..+++|++..... ...+.+.+|+++++.++||||+++++++... +..++++||+++++
T Consensus        11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   89 (284)
T cd06620          11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEFMDCGS   89 (284)
T ss_pred             HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEecCCCCC
Confidence            779999999999999998899999998765432 2235789999999999999999999998864 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..++..  ...+++.....++.+++.||.|||+.  .+++|+||+|+||++++++.++|+|||++.......   ....
T Consensus        90 L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~  162 (284)
T cd06620          90 LDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTF  162 (284)
T ss_pred             HHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCcc
Confidence            9998863  34689999999999999999999962  579999999999999999999999999976542211   1234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||++.+..++.++|+|||||++|+++||..||...................... .... ..+.        
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~--------  232 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQE-PPPR--------  232 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-Hhhc-cCCC--------
Confidence            67889999999988889999999999999999999999998654332211111111110000 0000 0000        


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ......+..+.+++.+||+.||++||++.++++.
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         233 ---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             ---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               0112255678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-40  Score=292.54  Aligned_cols=247  Identities=19%  Similarity=0.296  Sum_probs=192.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-----chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-----RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|....++..+++|.++.....     ....+.+|+.+++.++||||+++++++... ++..++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            458899999999999999888889999987643211     124688899999999999999999987643 35678999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++..  ...+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        86 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          86 EYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            99999999999874  3357888899999999999999999   999999999999999999999999999986543211


Q ss_pred             --CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          227 --GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       227 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                        ........++..|+|||.+.+..++.++|+||||+++||+++|..||.....       ..........     .   
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~-----~---  225 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQ-----P---  225 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcC-----C---
Confidence              1111234577889999999888899999999999999999999999975321       0111100000     0   


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               .....+......+.+++ +||..+|++||++++++.
T Consensus       226 ---------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ---------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                     01112334455667777 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-40  Score=290.98  Aligned_cols=247  Identities=22%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+.. +..+++|.++.. .....++.+|+++++.++|||++++++++.. ....++++||+++++
T Consensus         9 ~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~   85 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLE-KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFMEHGC   85 (256)
T ss_pred             EeeecCcccceEEEEEEeC-CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcCCCCc
Confidence            3779999999999998864 556788877643 2234579999999999999999999998874 458899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..+++..+..++.|++.|++|||+   .+++|+||||+||+++.++.++|+|||++..............
T Consensus        86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          86 LSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            999986432 357889999999999999999999   9999999999999999999999999999875433222222223


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+.++.++.++|+||||+++||+++ |..||......       . ........  ....          
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~--~~~~----------  221 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------E-VVETINAG--FRLY----------  221 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------H-HHHHHhCC--CCCC----------
Confidence            34567999999988889999999999999999998 99998643211       1 11111000  0000          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                           .+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       222 -----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 -----KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 11113467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.2e-40  Score=296.26  Aligned_cols=249  Identities=25%  Similarity=0.390  Sum_probs=193.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeC----CCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAG----PRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||++....++..+++|+++.. ......+.+|+.+++.+ +||||+++++++..    .++..+++|||
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  101 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL  101 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence            37799999999999999988999999987642 22345788899999999 69999999998742    33468999999


Q ss_pred             ccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          149 YKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       149 ~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +++++|.++++.  .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  178 (286)
T cd06638         102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  178 (286)
T ss_pred             cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence            999999998753  234568888999999999999999999   999999999999999999999999999987654322


Q ss_pred             CcceecccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      . ......++..|+|||++..     ..++.++|+|||||++|||++|..||........       ... ....     
T Consensus       179 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~~-~~~~-----  244 (286)
T cd06638         179 L-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFK-IPRN-----  244 (286)
T ss_pred             C-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hhh-cccc-----
Confidence            1 2223467889999999853     4478899999999999999999999875432110       000 0000     


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ..+          ....+......+.+++.+||+.||++|||+.++++.
T Consensus       245 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         245 PPP----------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCC----------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            000          000111234568899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-40  Score=295.36  Aligned_cols=248  Identities=23%  Similarity=0.378  Sum_probs=194.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++.+..++..+|+|.++.... .....+.+|++++++++||||+++++.+.. ++..+++|||++++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~   84 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCMEYMDAG   84 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEeecCCC
Confidence            3779999999999999998899999998865322 223578899999999999999999998885 45899999999999


Q ss_pred             ChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          153 NLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       153 sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +|..++.... ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......   ..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~  159 (286)
T cd06622          85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AK  159 (286)
T ss_pred             CHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---cc
Confidence            9999986432 34689999999999999999999962  589999999999999999999999999986643221   12


Q ss_pred             cccCCCcccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          232 EASASQGYKAPELIKMK------DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ...++..|+|||.+.+.      .++.++|+|||||++|||++|..||.......    ....... ...          
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~~----------  224 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSA-IVD----------  224 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHH-Hhh----------
Confidence            34567789999998543      35789999999999999999999996432111    1111000 000          


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ......+.+.+.++.+++.+||+.+|++||++.+++.
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 -------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                   0011233446677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.9e-41  Score=300.23  Aligned_cols=244  Identities=20%  Similarity=0.294  Sum_probs=196.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      ..||+|+||.||++....++..+++|.+........+.+.+|+.+++.++||||+++++++.. ++..++++||+++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~~L  105 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCCCH
Confidence            569999999999999988889999999876555555678899999999999999999998885 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      ..++..   ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++....... .......
T Consensus       106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~  178 (297)
T cd06659         106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV  178 (297)
T ss_pred             HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccccee
Confidence            998753   458899999999999999999999   999999999999999999999999999986543322 1223456


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||++.+..++.++|+||||+++|||++|..||......       .... .....     ..+..        
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~-~~~~~-----~~~~~--------  237 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMK-RLRDS-----PPPKL--------  237 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHhcc-----CCCCc--------
Confidence            788999999998888999999999999999999999998743211       0010 00000     00000        


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ......+..+.+++.+||+.+|++||++.++++
T Consensus       238 --~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 --KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             --cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence              011123456789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=290.91  Aligned_cols=249  Identities=23%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|....++..+++|.+........+.+..|+++++.++||||+++++++.. ++..+++|||+++++
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~~~~~~   86 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEYCGGGS   86 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeCCCCCc
Confidence            3779999999999999988888999999876555555789999999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...++...+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+....... ......
T Consensus        87 l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~  161 (262)
T cd06613          87 LQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSF  161 (262)
T ss_pred             HHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hccccc
Confidence            99988642 2568899999999999999999999   999999999999999999999999999987654321 122334


Q ss_pred             cCCCcccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          234 SASQGYKAPELIKMK---DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~---~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      .++..|+|||.+...   .++.++|+||||+++|||+||..||...+...       .... ....   ....+      
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~-~~~~---~~~~~------  224 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFL-ISKS---NFPPP------  224 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhc---cCCCc------
Confidence            567789999998766   78899999999999999999999997533111       0000 0000   00000      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ........+..+.+++.+||+.+|++|||+++++.
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 ----KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                01123345667899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-41  Score=313.20  Aligned_cols=196  Identities=20%  Similarity=0.298  Sum_probs=168.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....++..+|+|+++...   ......+..|+.++..++||||+++++.+.+ ++..++||||+++
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~E~~~g   85 (360)
T cd05627           7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLIMEFLPG   85 (360)
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCC
Confidence            77999999999999999999999999986432   1223467889999999999999999998885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC----
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG----  227 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----  227 (356)
                      |+|.+++..  ...++...+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........    
T Consensus        86 g~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          86 GDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999873  3468899999999999999999999   9999999999999999999999999999864421100    


Q ss_pred             ------------------------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          228 ------------------------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       228 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                                                    .......||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                          0012346889999999999999999999999999999999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-40  Score=303.61  Aligned_cols=238  Identities=20%  Similarity=0.271  Sum_probs=188.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|....++..+|+|+++....   ...+.+..|..+++.+. |++|+++++++.+ .+..++||||+
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~Ey~   83 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFVMEYV   83 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEEEcCC
Confidence            3789999999999999999999999999875321   22245777888888876 5678888887775 44899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ...
T Consensus        84 ~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~  157 (323)
T cd05615          84 NGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVT  157 (323)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC-Ccc
Confidence            99999999863  3468999999999999999999999   99999999999999999999999999998753221 122


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....|+..|+|||++.+..++.++|+||||+++|||++|..||.+.+..        ..........            
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~------------  217 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHN------------  217 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC------------
Confidence            23456889999999999889999999999999999999999999764211        1111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                            ...+...+..+.+++.+||+.+|++|++.
T Consensus       218 ------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  01122344567899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-40  Score=296.66  Aligned_cols=267  Identities=21%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+......  ..+.+.+|+++++.++||||+++++++.. ++..++++||+++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   84 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDH   84 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCc
Confidence            37899999999999999888899999987654332  23568899999999999999999999875 5589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|..+...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....... ....
T Consensus        85 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~  158 (286)
T cd07846          85 TVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT  158 (286)
T ss_pred             cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence            998887653  3358999999999999999999999   999999999999999999999999999987653322 2222


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|..||...........+.......  ........+.......
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  236 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL--IPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC--chhhHHHhccchHhhc
Confidence            3456788999999865 347889999999999999999999886533211000000000000  0000000000000000


Q ss_pred             CCCCC-------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHE-------NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....       .....+.+..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000       0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=297.42  Aligned_cols=247  Identities=22%  Similarity=0.321  Sum_probs=196.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.||+|+||.||+|.+..++..+++|..+.......+.+..|++++++++||||+++++++.. ++..+++|||+++++|
T Consensus        11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L   89 (280)
T cd06611          11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFCDGGAL   89 (280)
T ss_pred             HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeeccCCCcH
Confidence            679999999999999988899999999876544455678999999999999999999999885 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        90 ~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  164 (280)
T cd06611          90 DSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFI  164 (280)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceee
Confidence            9998642 3468999999999999999999999   9999999999999999999999999998765432211 222345


Q ss_pred             CCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          235 ASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       235 ~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ++..|+|||.+.     ...++.++|+||||+++|||++|..||......       ..... .....     .+     
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~-~~~~~-----~~-----  226 (280)
T cd06611         165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLK-ILKSE-----PP-----  226 (280)
T ss_pred             cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHH-HhcCC-----CC-----
Confidence            788899999975     345678999999999999999999999753211       11111 00000     00     


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                           ....+...+..+.+++..||+.+|++||++.++++.
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 -----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 011122345578899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.3e-40  Score=297.44  Aligned_cols=265  Identities=17%  Similarity=0.245  Sum_probs=193.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ....+.+|+.+++.++||||+++++++.. ++..++++||+. +
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e~~~-~   88 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLD-K   88 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEeccc-c
Confidence            37799999999999999988999999988754332 23467889999999999999999999885 458999999997 4


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus        89 ~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~  163 (301)
T cd07873          89 DLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSN  163 (301)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccc
Confidence            999888643 3458889999999999999999999   9999999999999999999999999999865432211 1123


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhh---hhcccccccCccccc
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV---LDHRITDLYHPDMLL  308 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  308 (356)
                      ..++..|+|||.+.+ ..++.++||||||+++|||+||..||...+....    ........   ....+..........
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCChhhchhhhcccccc
Confidence            356788999998865 4578899999999999999999999976432110    00000000   000011100000000


Q ss_pred             ccC-CCCC----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSN-SNHE----NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~-~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ... ....    .......+..+.+++.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000 0000    0011223556789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=304.64  Aligned_cols=198  Identities=21%  Similarity=0.300  Sum_probs=167.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....++..+|+|+++...   ....+.+.+|+.++..++||||+++++++.+ +++.++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   84 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEEEecCC
Confidence            377999999999999999899999999986422   1223458889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus        85 g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          85 GGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             CCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999642 3468888999999999999999999   9999999999999999999999999999876543332222


Q ss_pred             ecccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          231 LEASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      ....|++.|+|||++..     ..++.++|||||||++|||++|..||...
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            33468999999999863     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.9e-40  Score=289.47  Aligned_cols=250  Identities=20%  Similarity=0.353  Sum_probs=197.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .++.||+|+||.||+|....++..+++|.++.....      ..+.+..|+.++++++||||+++++++.. .+..++++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~   82 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFNLFV   82 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEEEEE
Confidence            357899999999999999888999999988643311      23578899999999999999999999885 44899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPT  225 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~  225 (356)
                      ||+++++|.+++..  ..++++.....++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||.+......
T Consensus        83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          83 EWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             eccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999999974  3468889999999999999999999   9999999999999998775 5999999998765433


Q ss_pred             CCcc---eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          226 AGQE---MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       226 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ....   .....++..|+|||.+.+..++.++|+||+|+++|++++|..||.......    ..........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--------  225 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIAS--------  225 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhc--------
Confidence            1111   123356788999999988889999999999999999999999996432211    1111100000        


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               .......+......+.+++.+||+.+|++||++.++++
T Consensus       226 ---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ---------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                     00111234456677889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=312.62  Aligned_cols=246  Identities=22%  Similarity=0.302  Sum_probs=200.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      -.||.|+||.||+|..+.++..+|-|++...+....+++.-|+++|+...||+||++++.|.. ++.++++.|||.||-.
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCGGGAV  116 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecCCchH
Confidence            348999999999999999999999999987777777899999999999999999999997663 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      +..+-. -+..++..++.-++.|++.||.|||+   .+|+|||||+.|||++-+|.++|+|||++..... .......+.
T Consensus       117 DaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFI  191 (1187)
T KOG0579|consen  117 DAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFI  191 (1187)
T ss_pred             hHHHHH-hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcccc
Confidence            988753 46689999999999999999999999   9999999999999999999999999999765332 233345789


Q ss_pred             CCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          235 ASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       235 ~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ||+.|||||+..     ..+|++++||||||+.+.||..+.+|..+.+......        .+.......+.       
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll--------KiaKSePPTLl-------  256 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--------KIAKSEPPTLL-------  256 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH--------HHhhcCCCccc-------
Confidence            999999999875     4589999999999999999999999987644311110        00000000011       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              .|..-...+.|++..||..||..||+++++++
T Consensus       257 --------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 --------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                    12223445779999999999999999999986

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=295.29  Aligned_cols=270  Identities=19%  Similarity=0.273  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.....  ..+.+.+|+++++.++||||+++++++.. ++..++++||+++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~   84 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVER   84 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCC
Confidence            47799999999999999988999999988654322  23578999999999999999999999885 5589999999998


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +.+..+...  ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++............
T Consensus        85 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          85 TLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            777665542  3458899999999999999999999   99999999999999999999999999998776543322233


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc-c
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL-C  309 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  309 (356)
                      ...++..|+|||++.+. .++.++|+||||+++|++++|..||.............................++.... .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            44567889999999877 789999999999999999999999975432111000000000000000000000000000 0


Q ss_pred             cCCCC-----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNH-----ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....     ....+...+.++.+++.+||+.+|++||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000     00112223677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-40  Score=290.72  Aligned_cols=242  Identities=25%  Similarity=0.440  Sum_probs=193.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||++..  ++..+++|..+..  .....+.+|+.+++.++|||++++++++.. + ..+++|||+++++
T Consensus        11 ~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~-~~~~v~e~~~~~~   84 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-N-GLYIVMELMSKGN   84 (254)
T ss_pred             eeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C-CcEEEEECCCCCC
Confidence            48899999999999975  5667888887643  234578999999999999999999998864 3 5799999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||++.......    ...
T Consensus        85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~  157 (254)
T cd05083          85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS  157 (254)
T ss_pred             HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence            9999976555568999999999999999999999   999999999999999999999999999986543211    122


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..||......       .. .......     .          
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~-~~~~~~~-----~----------  214 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EV-KECVEKG-----Y----------  214 (254)
T ss_pred             CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HH-HHHHhCC-----C----------
Confidence            33567999999988899999999999999999998 99998753211       11 1111100     0          


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                        ....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 --RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              001122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.5e-40  Score=294.37  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=197.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||++....++..+++|.+........+.+.+|+.+++.++|||++++++++... +..++++||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~  102 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVMEYLAGGS  102 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEecCCCCc
Confidence            37799999999999998888888999988655455556789999999999999999999998854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus       103 L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~  175 (293)
T cd06647         103 LTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM  175 (293)
T ss_pred             HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccc
Confidence            9999863   357888999999999999999999   9999999999999999999999999998866543222 12234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+....++.++|+||||+++|++++|..||...+.........       ..                ..
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-------~~----------------~~  232 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TN----------------GT  232 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------cC----------------CC
Confidence            57788999999988889999999999999999999999997543211100000       00                00


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111223345578899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=302.80  Aligned_cols=263  Identities=19%  Similarity=0.255  Sum_probs=189.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++.....  ..+.+.+|+.+++.++||||+++++++....     ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            47899999999999999888999999988643222  2346778999999999999999999875321     3578899


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +++ +++|.+++.   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus       100 ~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  171 (343)
T cd07878         100 NLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-  171 (343)
T ss_pred             ecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence            987 679988875   3468999999999999999999999   99999999999999999999999999998765332 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH-------HHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF-------MRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  298 (356)
                         .....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+...       ..........
T Consensus       172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence               224467889999999876 56889999999999999999999999754321100000000       0000000000


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .... ..+........ ..........+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         249 RKYI-QSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHh-hccccccchhH-HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000 00000000000 0000012235779999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.6e-40  Score=292.41  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=193.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||+||++....+++.+++|.+.....   .....+..|+++++.++||||+++++.+.. .+..+++|||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            6899999999999998999999998864321   223456789999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.+.....  .......
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR  154 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence            9999975444578999999999999999999999   9999999999999999999999999999876432  1222234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||++.+..++.++|+||||+++|+|++|..||........    ...+......                  
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~------------------  212 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLE------------------  212 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcccc------------------
Confidence            567789999999888899999999999999999999999975432111    0111100000                  


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                      .....+...+..+.+++.+||+.||++||     ++.+++.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            00112233456788999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.4e-40  Score=291.70  Aligned_cols=254  Identities=24%  Similarity=0.406  Sum_probs=195.0

Q ss_pred             CCcccccCCceEEEEEEcC---CCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC--C---ceE
Q 038580           74 GEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR--G---EKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~---~~~  143 (356)
                      .+.||+|+||.||+|.+..   ++..+|+|.++.....  ..+++.+|+++++.++||||+++++++....  +   ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            4779999999999998753   4688999988654322  2356889999999999999999999876432  1   247


Q ss_pred             EEEecccCCChhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          144 IVHPFYKRGNLAQCIRGG----SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      ++++|+++|+|..++...    ....+++.....++.|++.||+|||+   .+++||||||+||+++.++.+|++|||++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccccc
Confidence            889999999999887421    12357888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ........ .......++..|++||.+.+..++.++||||||+++|||++ |..||...+..       . .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~-~~~~~~~~~  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------E-IYNYLIKGN  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------H-HHHHHHcCC
Confidence            76532221 11123344567999999988889999999999999999999 88888653221       0 011110000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                       ....+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       233 -----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         233 -----------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                             00112234567889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.1e-40  Score=288.70  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=195.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-----cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-----TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ++.||+|+||.||+|....++..+++|.+.....     ...+.+.+|+++++.++||||+++++++.. ....++++||
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~   83 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIFLEL   83 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEEEEEe
Confidence            4789999999999999988888999998764332     133578899999999999999999998875 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++..  ...+++..+..++.|++.|++|||+   .+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          84 VPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            999999999974  3458899999999999999999999   999999999999999999999999999987653322  


Q ss_pred             ceecccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+.... ++.++|+||||+++|++++|..||.....       ...........           
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~-----------  218 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSK-----------  218 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcc-----------
Confidence            223455788899999987766 89999999999999999999999975321       00010000000           


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            .....+......+.+++.+||+.+|++||++.+++.
T Consensus       219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  001122334567789999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-39  Score=303.41  Aligned_cols=266  Identities=18%  Similarity=0.250  Sum_probs=193.5

Q ss_pred             CCCCcccccCCceEEEEEEc--CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ...+.||+|+||.||++...  ..+..+++|.+...     ....+|+++++.++||||+++++++.. .+..+++||++
T Consensus        95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~e~~  168 (392)
T PHA03207         95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVMPKY  168 (392)
T ss_pred             EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEehhc
Confidence            34478999999999999764  34577888876532     346789999999999999999998874 45899999998


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-c
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-Q  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  228 (356)
                      . ++|.+++.  ....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++........ .
T Consensus       169 ~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        169 K-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             C-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            6 58888884  34578999999999999999999999   9999999999999999999999999999876543222 1


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccc--cccCcc-
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT--DLYHPD-  305 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-  305 (356)
                      ......||..|+|||++....++.++|||||||++|||++|..||.+.........+...... .......  ...... 
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGSTNL  321 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccchhH
Confidence            223456899999999999889999999999999999999999999875543321111111111 0000000  000000 


Q ss_pred             ---cc-cccCCCCCCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          306 ---ML-LCSNSNHENPVS-----EERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       306 ---~~-~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         .. ...........+     .....++.+++..||+.||++||++.+++..
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               00 000000000000     1123467789999999999999999999863

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.2e-40  Score=290.14  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||+||+|....++..+++|++..... .....+.+|++.++.++|||++++++.+.. ++..++++|+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~   84 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMPYLSGG   84 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEeccCCC
Confidence            4789999999999999988889999999865432 234678999999999999999999998875 45899999999999


Q ss_pred             ChhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc---
Q 038580          153 NLAQCIRGGSG-EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ---  228 (356)
Q Consensus       153 sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  228 (356)
                      +|.+++..... ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........   
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          85 SLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             cHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            99999975332 568999999999999999999999   99999999999999999999999999998765433222   


Q ss_pred             ceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||.+... .++.++|+||||+++|||++|..||...+....       ........      .+   
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~------~~---  225 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------LMLTLQND------PP---  225 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-------HHHHhcCC------CC---
Confidence            12334578889999998776 789999999999999999999999975433210       00000000      00   


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ...........+..+.+++.+||+.||++||++.++++
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 ----SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ----CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00000011244567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-40  Score=292.35  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=193.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc----------hHHHHHHHHHHhccCCCccccccceeeCCCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR----------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  143 (356)
                      ++.||+|+||.||+|....++..+++|.++......          .+.+..|+.+++.++|||++++++++.. .+..+
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-EEYLS   84 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-CCceE
Confidence            478999999999999998889999999875321111          1357889999999999999999998875 45899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +++||+++++|.++++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++++|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999743  468889999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCc-ceecccCCCcccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          224 PTAGQ-EMLEASASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       224 ~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      ..... ......++..|+|||.+....  ++.++|+||||+++||+++|..||......       ...... .......
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~~  231 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKL-GNKRSAP  231 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHh-hccccCC
Confidence            22111 123345778899999987654  789999999999999999999998642211       000000 0000000


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...            .......+..+.+++..||+.+|++||++.++++
T Consensus       232 ~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIP------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCC------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000            0112234567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-41  Score=305.53  Aligned_cols=241  Identities=18%  Similarity=0.203  Sum_probs=184.3

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhcc---CCCccccccceeeCCCCceEEEEeccc
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCI---RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ||+|+||+||+|....++..+|+|++........   ..+..|..++.+.   +||||+++++++.. .+..+++|||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            7999999999999998999999999864322111   2344566666554   69999999998885 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        80 ~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~  153 (330)
T cd05586          80 GGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTT  153 (330)
T ss_pred             CChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCc
Confidence            9999998863  4568899999999999999999999   99999999999999999999999999998653221 1222


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....|+..|+|||++.+. .++.++|||||||++|||++|..||...+..       . .........   ...      
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~-~~~~i~~~~---~~~------  216 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------Q-MYRNIAFGK---VRF------  216 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------H-HHHHHHcCC---CCC------
Confidence            345689999999998754 4789999999999999999999999753211       1 111111000   000      


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRP----NIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp----s~~~il~  349 (356)
                              .....+..+.+++.+||+.||++||    ++.++++
T Consensus       217 --------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 --------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                    0112345677999999999999998    4666554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-39  Score=287.34  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=196.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|....++..+++|.++.....  ..+.+..|+++++.++|+||+++++++.. .+..++++||+++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSG   83 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEecCCC
Confidence            47899999999999999888999999998765443  34678999999999999999999998774 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce-
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM-  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-  230 (356)
                      ++|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........... 
T Consensus        84 ~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          84 GTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            999999974  3457888899999999999999999   9999999999999999999999999999876543322211 


Q ss_pred             --ecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 --LEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 --~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                        ....++..|+|||++....   ++.++||||||+++||+++|..||......        +........    .    
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--------~~~~~~~~~----~----  222 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--------FQIMFHVGA----G----  222 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--------HHHHHHHhc----C----
Confidence              1345678899999998766   889999999999999999999999753210        000000000    0    


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            .....+.....+..+.+++..||+.+|++||++.+++.
T Consensus       223 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 ------HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ------CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  00001111223566789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-40  Score=297.21  Aligned_cols=248  Identities=20%  Similarity=0.273  Sum_probs=197.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+++|.+......   ..+.+..|+++++.++||||+++++.+.. ....+++|||+.
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~   84 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLVMDYCP   84 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEEEEecC
Confidence            37799999999999999988999999988754333   23568899999999999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      +++|.+++.......+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........  
T Consensus        85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            9999999976555678999999999999999999999   99999999999999999999999999998654321110  


Q ss_pred             --------------------------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 038580          229 --------------------------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED  282 (356)
Q Consensus       229 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~  282 (356)
                                                ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+...  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--  239 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--  239 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--
Confidence                                      0112356778999999988889999999999999999999999997543211  


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN----IKQVLW  349 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps----~~~il~  349 (356)
                           ...... ...        .        ..+.....+..+.+++.+||+.||++||+    +++++.
T Consensus       240 -----~~~~~~-~~~--------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         240 -----TFSNIL-KKE--------V--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -----HHHHHh-cCC--------c--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence                 000000 000        0        00111124667889999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.2e-40  Score=287.63  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=196.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++....++..+++|.+.....  ...+.+.+|+++++.++|||++++++.+.. ++..++++||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEYAPG   83 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEecCCC
Confidence            3779999999999999988899999998865422  223578899999999999999999998874 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ++|.+++.......+++..+..++.+++.|++|||+   .+++|+||+|+||++++++ .+|++|||++.......  ..
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~  158 (256)
T cd08220          84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KA  158 (256)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cc
Confidence            999999976555668999999999999999999999   9999999999999998654 57999999987654321  12


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||.+....++.++|+||||+++|+|++|..||...+.       ......... ..             
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~-~~-------------  217 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMS-GT-------------  217 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHh-cC-------------
Confidence            234577889999999888889999999999999999999999865321       111111100 00             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ..+.+...+..+.+++.+||+.+|++|||+.++++
T Consensus       218 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 ----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                00112234567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.4e-40  Score=289.35  Aligned_cols=246  Identities=19%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-----chHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-----RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e  147 (356)
                      ++.||+|+||.||+|.+..++..+++|.++.....     ..+.+.+|++++++++||||+++++++.++. ...+++||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            47899999999999999988999999987532211     1246788999999999999999999876543 46789999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++...  ..+++...+.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          87 HMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            99999999998632  357888899999999999999999   9999999999999999999999999999875432111


Q ss_pred             --cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          228 --QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       228 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                        .......++..|+|||.+.+..++.++|+||||+++||+++|..||...+..       .........          
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~----------  224 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQ----------  224 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcC----------
Confidence              1122345778899999998888999999999999999999999999643110       001100000          


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ......+......+.+++.+||. +|++||+++++++
T Consensus       225 -------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 -------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   00112344556678899999995 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-40  Score=303.70  Aligned_cols=251  Identities=18%  Similarity=0.216  Sum_probs=191.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.++.++..+|+|++.....   .....+..|+.++..++|+||+++++.+.+ .+..++||||++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ey~~   84 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLVMDYYV   84 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEEEeccC
Confidence            3779999999999999999999999999864221   122357889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.++++.. ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus        85 ~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          85 GGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             CCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999742 3468888999999999999999999   9999999999999999999999999999876433322223


Q ss_pred             ecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 LEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ....|++.|+|||++.     ...++.++|||||||++|||++|..||...+.       ...... ...... ...   
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~-i~~~~~-~~~---  228 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGK-IMNHKE-RFQ---  228 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHH-HhCCCc-ccc---
Confidence            3456899999999986     34678999999999999999999999975321       111111 100000 000   


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLWK  350 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~~  350 (356)
                               ........+..+.+++.+|+..+|.+  |++++++++.
T Consensus       229 ---------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ---------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                     00011234566788999988654444  6889888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-40  Score=289.36  Aligned_cols=246  Identities=21%  Similarity=0.335  Sum_probs=198.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++....+++.+++|.+....  .....++.+|+.++++++||||+++++++.. .+..++++||+++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDYCEG   83 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEecCCC
Confidence            378999999999999999889999999876432  2233578999999999999999999998875 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++...+.++.|++.|++|||+   .+++|+||+|+||+++.++.++++|||++........ ...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~  159 (256)
T cd08218          84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LAR  159 (256)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhh
Confidence            999999875445568899999999999999999999   9999999999999999999999999999876543221 122


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||++.+..++.++|+||||++++++++|..||....       ........... .              
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~-~--------------  217 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKIIRG-S--------------  217 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHHhcC-C--------------
Confidence            3356778999999988889999999999999999999999986421       11111111100 0              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ..+.+...+..+.+++.+||+.+|++||++.++++
T Consensus       218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 ---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               01123344667889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-40  Score=325.96  Aligned_cols=249  Identities=20%  Similarity=0.287  Sum_probs=192.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||++.+..++..+++|.+......  ....+..|+.+++.++|||||+++++|... ....++||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            37899999999999999999999999998754322  235688999999999999999999987543 346899999999


Q ss_pred             CCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCceecCCCCCCeeEcC-----------------
Q 038580          151 RGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGF----HRPIIHGNLKSKNILLDR-----------------  207 (356)
Q Consensus       151 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----~~~ivH~dlk~~Nill~~-----------------  207 (356)
                      +|+|.+++...  ....+++..++.|+.||+.||+|||+..    ..+|+||||||+|||++.                 
T Consensus        98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            99999998642  2356899999999999999999999821    134999999999999964                 


Q ss_pred             CCCeEEeccccccccCCCCCcceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL  285 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~  285 (356)
                      .+.+||+|||++.......  ......+++.|+|||++..  ..++.++|||||||++|||+||..||...+.      .
T Consensus       178 ~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~------~  249 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN------F  249 (1021)
T ss_pred             CCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc------H
Confidence            3358999999987653221  1234468999999999854  4588999999999999999999999975321      1


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+. .+...       +.+           .....+..+.+|+..||+.+|.+||++.+++.
T Consensus       250 ~qli~-~lk~~-------p~l-----------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        250 SQLIS-ELKRG-------PDL-----------PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHH-HHhcC-------CCC-----------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            11111 11100       000           01122456889999999999999999999984

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.6e-40  Score=294.18  Aligned_cols=244  Identities=20%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.||+|++|.||++....++..+++|.++.......+.+.+|+.+++.++||||+++++++.. .++.++++||+++++|
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~~~~L  103 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLEGGAL  103 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccCCCCH
Confidence            689999999999999988888999998865444445678899999999999999999998875 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+++..   ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||.+....... .......
T Consensus       104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~  176 (285)
T cd06648         104 TDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLV  176 (285)
T ss_pred             HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccccc
Confidence            999874   458888999999999999999999   999999999999999999999999999876543221 1222345


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||.+.+..++.++|+||||+++|||++|..||...+.       ...... ....     ..+..        
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~-~~~~-----~~~~~--------  235 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKR-IRDN-----LPPKL--------  235 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHH-HHhc-----CCCCC--------
Confidence            78889999999888899999999999999999999999865321       011110 1000     00000        


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       236 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              011224467889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.7e-40  Score=289.89  Aligned_cols=247  Identities=22%  Similarity=0.342  Sum_probs=192.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc------hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .++.||+|+||.||+|... ++..+|+|.++......      ...+.+|+++++.++|+||+++++++... +..++++
T Consensus         4 ~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~   81 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISIFM   81 (265)
T ss_pred             ccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEEEE
Confidence            3578999999999999875 67778888876432211      14588899999999999999999998854 5899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999963  3467888999999999999999999   999999999999999999999999999986542211


Q ss_pred             -----CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          227 -----GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       227 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                           ........++..|+|||++.+..++.++|+||||+++|++++|..||...+...      .....  ....   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~--~~~~---~  225 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYI--GAHR---G  225 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHh--hhcc---C
Confidence                 111123457788999999998889999999999999999999999997532110      00000  0000   0


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .            ....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       226 ~------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 L------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0            00122234566889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-39  Score=288.99  Aligned_cols=251  Identities=20%  Similarity=0.354  Sum_probs=194.5

Q ss_pred             CCcccccCCceEEEEEEcC-CCeEEEEEEeccccc----------cchHHHHHHHHHHhc-cCCCccccccceeeCCCCc
Q 038580           74 GEVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVCT----------TRDKEFGDLIELLGC-IRHPNLVPLLGFYAGPRGE  141 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~----------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~  141 (356)
                      .+.||+|+||.||+|.+.. ++..+++|.+.....          ....++..|+.++.+ ++||||+++++++.. ++.
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~   83 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-NDR   83 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-CCe
Confidence            3779999999999999987 678889888753221          112346678887764 799999999998885 558


Q ss_pred             eEEEEecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          142 KLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      .+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999998743  2345688899999999999999999952  67999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      .......  ......++..|+|||.+.+..++.++|+||||+++||+++|..||.....       ..... ...+... 
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~-~~~~~~~-  230 (269)
T cd08528         162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLAT-KIVEAVY-  230 (269)
T ss_pred             eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHH-HHhhccC-
Confidence            7654332  22345678889999999988899999999999999999999999864321       11111 1111000 


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                         .+            ......+..+.+++.+||+.||++||++.++.+++++
T Consensus       231 ---~~------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 ---EP------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ---Cc------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence               00            0011234568899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.1e-40  Score=302.51  Aligned_cols=250  Identities=16%  Similarity=0.206  Sum_probs=191.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+|+|++....   ......+.+|..++..++|+||+++++++.+ ++..++||||++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv~Ey~~   84 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLVMDYYV   84 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCC
Confidence            378999999999999999899999999986422   1122457889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus        85 gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          85 GGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             CCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999742 3468888899999999999999999   9999999999999999999999999999876544333233


Q ss_pred             ecccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 LEASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ....|++.|+|||++.+     +.++.++|+||||+++|||++|..||...+..       .... ......      ..
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~-~i~~~~------~~  226 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYG-KIMNHE------ER  226 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHH-HHHcCC------Cc
Confidence            34568999999999875     46788999999999999999999999753211       1111 000000      00


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~  349 (356)
                      ..       -.....+.+..+.+++.+|+..++++  |++++++++
T Consensus       227 ~~-------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 FQ-------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cc-------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            00       00011123566888999999866544  457887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7e-40  Score=292.72  Aligned_cols=270  Identities=22%  Similarity=0.259  Sum_probs=193.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|....++..+++|.++.....  ....+.+|++++++++||||+++++++.+ .+..+++|||+. 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-   82 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLH-   82 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEeeccc-
Confidence            36799999999999999888999999988654322  22468899999999999999999999875 458999999996 


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++....... ....
T Consensus        83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~  158 (284)
T cd07860          83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT  158 (284)
T ss_pred             cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccc
Confidence            589999876556678999999999999999999999   999999999999999999999999999987543221 1122


Q ss_pred             cccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh--cccccccCccccc
Q 038580          232 EASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD--HRITDLYHPDMLL  308 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  308 (356)
                      ...++..|+|||.+.+.. ++.++|+||||+++|||+||..||...+..................  .............
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            334577899999886544 5889999999999999999999997543211100000000000000  0000000000000


Q ss_pred             c-cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 C-SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      . +....-..........+.+++.+||+.||++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0 0000000001123455779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-39  Score=293.08  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=195.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-----chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-----RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.....     ....+..|+++++.++||||+++++++.+ .+..++||||
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~   83 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVFEF   83 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEEcc
Confidence            36799999999999999888889999998755433     22457789999999999999999999886 5589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      + +++|.+++.... ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus        84 ~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  157 (298)
T cd07841          84 M-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R  157 (298)
T ss_pred             c-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence            9 889999997533 368999999999999999999999   999999999999999999999999999987654322 1


Q ss_pred             ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccccc-C
Q 038580          229 EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLY-H  303 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~  303 (356)
                      ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||.+.....    ...........   ..+.... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID----QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH----HHHHHHHHcCCCchhhhhhcccc
Confidence            1223345678999998854 457899999999999999999977776533211    00001000000   0000000 0


Q ss_pred             ccccc--ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          304 PDMLL--CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       304 ~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      +....  ..............+..+.+++.+||+.||++|||+.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000  000000001122345678899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-39  Score=290.63  Aligned_cols=266  Identities=18%  Similarity=0.227  Sum_probs=196.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+++|.+.....  .....+.+|+.+++.++||||+++++++.. ....++|+||+ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~-~   82 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEYM-P   82 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEeccc-C
Confidence            3779999999999999988899999998875442  223578999999999999999999998885 45889999999 9


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++............
T Consensus        83 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          83 SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99999986433 568999999999999999999999   99999999999999999999999999998766443322233


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---ccccccCccc-
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---RITDLYHPDM-  306 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-  306 (356)
                      ...++..|+|||.+.+. .++.++||||+|++++||++|..||.......    ............   .+....+... 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhccCcchh
Confidence            45678889999998654 46899999999999999999987776533211    001111000000   0000000000 


Q ss_pred             -ccccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 -LLCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 -~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..........   ....+....+.+++.+||+.+|++||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             0000000000   011133478899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-39  Score=287.14  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=196.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~g  152 (356)
                      +.||.|++|.||++.+..++..+++|.+..... .....+.+|++++++++||||++++++|... .+..+++|||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            679999999999999998899999998875433 2345789999999999999999999988643 34789999999999


Q ss_pred             ChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          153 NLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       153 sL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|.+++..  .....++......++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........   
T Consensus        87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---  160 (287)
T cd06621          87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---  160 (287)
T ss_pred             CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc---
Confidence            99988753  234557888999999999999999999   9999999999999999999999999999765432211   


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........  ...+.. ........     +.+.   
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-~~~~~~~~-----~~~~---  229 (287)
T cd06621         161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--GPIELL-SYIVNMPN-----PELK---  229 (287)
T ss_pred             ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC--ChHHHH-HHHhcCCc-----hhhc---
Confidence            133567789999999888899999999999999999999999975432110  111111 11110000     0000   


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..  .......+..+.+++.+||+.+|++|||+.++++
T Consensus       230 -~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 -DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             00  0000123567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.3e-40  Score=294.16  Aligned_cols=247  Identities=26%  Similarity=0.422  Sum_probs=192.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCC----CceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPR----GEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----~~~~lv~e~~  149 (356)
                      +.||+|+||.||++....++..+++|.+.... .....+.+|+.+++++ +|||++++++++...+    +..++++||+
T Consensus        28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~  106 (291)
T cd06639          28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC  106 (291)
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence            67999999999999999899999999886432 2345678899999998 7999999999886433    3689999999


Q ss_pred             cCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          150 KRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       150 ~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      ++++|.++++.  .....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       107 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  183 (291)
T cd06639         107 NGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  183 (291)
T ss_pred             CCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence            99999998853  234568899999999999999999999   9999999999999999999999999999876533221


Q ss_pred             cceecccCCCcccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          228 QEMLEASASQGYKAPELIKMK-----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      . .....++..|+|||++...     .++.++|+||||+++|||++|..||........       ... .....     
T Consensus       184 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-------~~~-~~~~~-----  249 (291)
T cd06639         184 R-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------LFK-IPRNP-----  249 (291)
T ss_pred             c-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-------HHH-HhcCC-----
Confidence            1 2234577889999998643     368899999999999999999999975422110       000 00000     


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+          ....+......+.+++.+||+.+|++||++.++++
T Consensus       250 ~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PP----------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CC----------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00          00112233456889999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.8e-40  Score=292.44  Aligned_cols=265  Identities=19%  Similarity=0.240  Sum_probs=191.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||.||+|.+..+|..+++|.++.....  ....+.+|+++++.++||||+++++++.+ .+..++++||+.+ 
T Consensus         6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~-   83 (284)
T cd07839           6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFEYCDQ-   83 (284)
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEecCCC-
Confidence            6799999999999999988999999988653222  22467889999999999999999999885 4489999999975 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... .....
T Consensus        84 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~  158 (284)
T cd07839          84 DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSA  158 (284)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCC
Confidence            888877632 3458999999999999999999999   999999999999999999999999999987643221 11223


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---c---ccccccCcc
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---H---RITDLYHPD  305 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~  305 (356)
                      ..++..|+|||++.+. .++.++|+||||+++|||+||..|+........  .+. ........   .   ......+..
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLK-RIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHH-HHHHHhCCCChHHhHHhhhccccc
Confidence            4567889999998764 478999999999999999999988653222110  000 00000000   0   000000000


Q ss_pred             -cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 -MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 -~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .................+.++.+++.+||+.||++|||+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             00000000000112234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=287.48  Aligned_cols=244  Identities=21%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccC---CCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.... ....++.+|+.+++.++   |||++++++++.. +...+++|||+
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv~e~~   84 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWIIMEYA   84 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEEEecC
Confidence            3779999999999999988999999998865432 23357889999999986   9999999998874 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|.++++.   ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        85 ~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06917          85 EGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K  157 (277)
T ss_pred             CCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence            99999999864   368899999999999999999999   9999999999999999999999999999876543322 2


Q ss_pred             eecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....++..|+|||.+.++ .++.++|+||||+++|+|++|..||.........       . ...     ....+..  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~-~~~-----~~~~~~~--  222 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------M-LIP-----KSKPPRL--  222 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------h-ccc-----cCCCCCC--
Confidence            2344678889999988654 4688999999999999999999999754321100       0 000     0000000  


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               .....+.++.+++.+||+.||++||++.+++.
T Consensus       223 ---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 ---------EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                     01114557889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=296.73  Aligned_cols=245  Identities=20%  Similarity=0.272  Sum_probs=201.9

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..-++||+|+||.||-++.+.+|+.+|.|.+.+....   ...-..+|-.+|.+++.+.||.+-..|++++ .+|+|+..
T Consensus       188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-~LClVLtl  266 (591)
T KOG0986|consen  188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-ALCLVLTL  266 (591)
T ss_pred             eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-ceEEEEEe
Confidence            3348999999999999999999999998887543222   2235788899999999999999988788655 89999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |.||+|.-++.+-....+++..+.-++.+|+.||++||.   .+||.||+||+|||+|++|+++|+|+|+|.-+..  +.
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g~  341 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--GK  341 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC--CC
Confidence            999999999976666789999999999999999999999   9999999999999999999999999999987643  44


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||.+|||||++.++.|+.+.|.||+||++|||+.|+.||...........+.+    ...              
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----r~~--------------  403 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----RTL--------------  403 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH----HHh--------------
Confidence            55566999999999999999999999999999999999999999975322221111111    111              


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                          ......++..+++..+|.+..|+.||++|..+
T Consensus       404 ----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 ----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             ----cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence                11123567778888999999999999999753

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-39  Score=284.37  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~  150 (356)
                      .+.||.|+||.||++....++..+++|.++....  ...+.+..|+++++.++||||+++++++... +...++++||++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~   84 (265)
T cd08217           5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE   84 (265)
T ss_pred             eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence            3679999999999999998899999998864322  2234688899999999999999999977643 346799999999


Q ss_pred             CCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          151 RGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLH-----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       151 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +++|.+++...  ....+++..++.++.|++.||+|||     +   .+++|+||+|+||++++++.+||+|||++....
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            99999998642  2457899999999999999999999     7   899999999999999999999999999987764


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.       .. .........      
T Consensus       162 ~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~------  226 (265)
T cd08217         162 HDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQ-LASKIKEGK------  226 (265)
T ss_pred             CCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HH-HHHHHhcCC------
Confidence            3322 12234678889999999888899999999999999999999999975321       11 111111100      


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                 ....+...+..+.+++.+||+.+|++||++.+|++
T Consensus       227 -----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 -----------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             -----------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                       01123345677889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-39  Score=287.20  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=195.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|........ ....+.+|+.++++++||||+++++++.. ++..++|+||++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~   87 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGG   87 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEeCCCC
Confidence            47799999999999999888999999987644322 23578899999999999999999998885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++..   ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++++|||++....... .....
T Consensus        88 ~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~  160 (277)
T cd06641          88 SALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT  160 (277)
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcc
Confidence            99999863   358899999999999999999999   999999999999999999999999999986653321 11223


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||.+.+..++.++|+||||+++|++++|..||.......        .........               
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~---------------  217 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNN---------------  217 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCC---------------
Confidence            456778999999988888999999999999999999999986532110        000000000               


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                        ....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              001223345668899999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.5e-39  Score=282.72  Aligned_cols=243  Identities=21%  Similarity=0.264  Sum_probs=195.3

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||.|+||.||++.+..++..+++|.+.....   ...+.+.+|+.+++.++||||+++++.+.+ +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            6999999999999998889999999865432   233578999999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..  ...++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        80 L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          80 LWTILRD--RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            9999974  3458889999999999999999999   999999999999999999999999999987654322  22334


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|++||.+.+..++.++|+||||+++|++++|..||......     ........ ..                ..
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~----------------~~  210 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDI-LK----------------GN  210 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHH-hc----------------cC
Confidence            6778899999998888999999999999999999999999764321     11111111 00                00


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                      .....+...+..+.+++.+||+.+|++||+     ++++++
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            011223334667899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=289.04  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=194.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||.|++|.||+|.++.++..+++|.+......  ....+.+|+++++.++|||++++++++.+ ++..++++||+. 
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~~~-   81 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEFLD-   81 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEeccC-
Confidence            37799999999999999988999999988654322  23568889999999999999999999885 458999999995 


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~  157 (283)
T cd07835          82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT  157 (283)
T ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence            599999875444568999999999999999999999   9999999999999999999999999999875432211 112


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc--cccc-ccCcccc
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH--RITD-LYHPDML  307 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~  307 (356)
                      ...++..|+|||++.+. .++.++|+||||+++|||++|..||...+....   ............  .+.. ...+...
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchhhh
Confidence            23457789999987654 578899999999999999999999975432111   011000000000  0000 0000000


Q ss_pred             --cc-cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 --LC-SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 --~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .. .............+..+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00 0000000111223457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=293.72  Aligned_cols=245  Identities=18%  Similarity=0.288  Sum_probs=206.7

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch--HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..++.||+|.|..|-+|++--+|+.||+|++.+...+..  ..+..|++.|+.++|||||++|.+..+. ..+||++|.-
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-TKlyLiLELG   99 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-TKLYLILELG   99 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-ceEEEEEEec
Confidence            345789999999999999999999999999986544433  4688999999999999999999987754 4799999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE-cCCCCeEEeccccccccCCCCCc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL-DRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      .+|+|.+|+... .+.+.+....+++.||+.|+.|+|.   .++|||||||+|+.+ .+-|-+||.|||++-.+.  .+.
T Consensus       100 D~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--PG~  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--PGK  173 (864)
T ss_pred             CCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC--Ccc
Confidence            999999999643 3568888999999999999999999   999999999999766 567899999999987664  356


Q ss_pred             ceecccCCCcccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDAS-EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .....+|+..|-|||++.+..|+ ++.|||||||++|.+++|+.||...+..+...-+   +.                 
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---mD-----------------  233 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---MD-----------------  233 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---hc-----------------
Confidence            67788999999999999999886 5789999999999999999999876654432111   11                 


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            .....|.-...++.+||..||..||.+|-+.++|+.
T Consensus       234 ------CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  234 ------CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ------ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                  112356677888999999999999999999999874

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-39  Score=289.16  Aligned_cols=266  Identities=17%  Similarity=0.239  Sum_probs=190.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|..+.++..+++|.++..... ....+.+|+++++.++||||+++++++.+ ++..++||||+.+ 
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~-   87 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFEYLDT-   87 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEecCCC-
Confidence            37899999999999999888999999998654322 23457789999999999999999999885 4589999999985 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.... ..+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++........ ....
T Consensus        88 ~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~  162 (291)
T cd07844          88 DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSN  162 (291)
T ss_pred             CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccc
Confidence            9999886433 368899999999999999999999   9999999999999999999999999999865432111 1112


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh---hcccccccC-----
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL---DHRITDLYH-----  303 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-----  303 (356)
                      ..++..|+|||++.+ ..++.++||||+|+++|||++|..||.+......   ..........   ...+.....     
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED---QLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHhcCCCChhhhhhhhhccccc
Confidence            245678999998865 4578999999999999999999999975432110   0000000000   000000000     


Q ss_pred             -cccccccCCCC-CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 -PDMLLCSNSNH-ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 -~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ........... ...........+.+++..||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             00000000000 00000011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.6e-40  Score=295.28  Aligned_cols=249  Identities=16%  Similarity=0.215  Sum_probs=193.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||++....+++.+++|.+.....   .....+.+|+++++.++||||+++++.+.. +++.+++|||+++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g   85 (305)
T cd05609           7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVMEYVEG   85 (305)
T ss_pred             eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEecCCC
Confidence            779999999999999998899999998865432   123467889999999999999999998875 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc---
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ---  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  228 (356)
                      ++|.+++..  ...+++.....++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++........   
T Consensus        86 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          86 GDCATLLKN--IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999964  3468899999999999999999999   99999999999999999999999999987642111000   


Q ss_pred             -----------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          229 -----------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       229 -----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                                 ......++..|+|||.+.+..++.++|+||||+++||+++|..||.+...       ....... ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~-~~~~  232 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQV-ISDD  232 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH-Hhcc
Confidence                       01123467789999999888899999999999999999999999975321       1111111 0000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                         ...+            ......+..+.+++.+||+.||++||++.++.+.|+
T Consensus       233 ---~~~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         233 ---IEWP------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---cCCC------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence               0000            001134556789999999999999999665555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=289.00  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCC-----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPR-----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....++..+++|.+..... ....+.+|+.+++++ +||||+++++++....     ...+++||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e   89 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME   89 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence            4789999999999999988888999998865432 346789999999998 6999999999886432     35899999


Q ss_pred             cccCCChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          148 FYKRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            999999999886432  4578999999999999999999999   99999999999999999999999999998664332


Q ss_pred             CCcceecccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          226 AGQEMLEASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      . .......++..|+|||++..     ..++.++||||||++++++++|..||.......       .... ....    
T Consensus       167 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~-~~~~----  233 (275)
T cd06608         167 L-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFK-IPRN----  233 (275)
T ss_pred             h-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHH-hhcc----
Confidence            2 22234457888999998753     346789999999999999999999996432110       0000 0000    


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..+          ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       234 -~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 -PPP----------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -CCC----------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             000          11122335667889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-39  Score=285.59  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|..+.++..+++|.+.....  ...+.+.+|+++++.++||||+++++.+.. .+..++++||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~   83 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDG   83 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEecCCC
Confidence            3779999999999999998888999998865321  233568899999999999999999998875 5589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ++|.+++.......+++..+..++.|++.||+|||+   .+++|+||+|+||++++++ .+|++|||.+....... ...
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (257)
T cd08225          84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELA  159 (257)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccc
Confidence            999999975555568999999999999999999999   9999999999999999885 46999999987654322 122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||.+.+..++.++|+||||+++||+++|..||...+.       ........ ..    ...       
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~-~~----~~~-------  220 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKIC-QG----YFA-------  220 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHh-cc----cCC-------
Confidence            234578889999999888899999999999999999999999864321       11111111 00    000       


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 ------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  111223456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-39  Score=289.70  Aligned_cols=256  Identities=15%  Similarity=0.171  Sum_probs=181.6

Q ss_pred             CCCcccccCCceEEEEEEcCC---CeEEEEEEeccccccchH-----------HHHHHHHHHhccCCCccccccceeeCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTTRDK-----------EFGDLIELLGCIRHPNLVPLLGFYAGP  138 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (356)
                      ..+.||+|+||.||+|.+..+   +..+++|+..........           ....+...+..+.|+|++++++.+...
T Consensus        16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   95 (294)
T PHA02882         16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK   95 (294)
T ss_pred             EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence            347899999999999998876   667777764432221111           112233345567899999999865533


Q ss_pred             CC---ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          139 RG---EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       139 ~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ..   ..+++++++.. ++.+.+..  ....++..+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|
T Consensus        96 ~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         96 RCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             cCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEEE
Confidence            32   34667777644 66666653  2235778889999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCC------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH
Q 038580          216 FGLHLLLNPTAG------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM  289 (356)
Q Consensus       216 fg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  289 (356)
                      ||+++.......      .......||+.|+|||+..+..++.++|||||||++|||++|..||..........   ...
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~---~~~  246 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI---HAA  246 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH---HHh
Confidence            999876532211      11123468899999999999999999999999999999999999998653222111   100


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                      .......    ......           ...+++..+.+++..||+.+|++||++.++++.|+
T Consensus       247 ~~~~~~~----~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        247 KCDFIKR----LHEGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHH----hhhhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1000000    000000           01223567889999999999999999999998764

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-39  Score=283.03  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.||+|+||.||++.++.++..+++|.+..... .....+.+|+++++.++||||+++++.+... +..++++||+++++
T Consensus         7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   85 (265)
T cd06605           7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEYMDGGS   85 (265)
T ss_pred             HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEecCCCc
Confidence            679999999999999998899999998875433 2335788999999999999999999988854 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..++......++.|++.|++|||+.  .+++|+||+|+||++++++.++|+|||.+.........   ..
T Consensus        86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~~  159 (265)
T cd06605          86 LDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TF  159 (265)
T ss_pred             HHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---cc
Confidence            999997433 5788899999999999999999984  68999999999999999999999999998654322111   25


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++|+||||+++|++++|..||.......  ..............                 
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-----------------  220 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIVNEP-----------------  220 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHhcCC-----------------
Confidence            67788999999988899999999999999999999999997543211  11111111111000                 


Q ss_pred             CCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEE-RILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ....+.. .+..+.+++.+||..||++|||+.+++.
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             0011122 5667889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.2e-39  Score=293.77  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=193.0

Q ss_pred             Cccccc--CCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKS--NYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G--~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..||+|  +||+||++.+..++..+|+|+.......  ..+.+.+|+.+++.++||||++++++|... +..++++||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEeccc
Confidence            446666  9999999999989999999998754322  235688899999999999999999999864 48899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      +++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+.......... 
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999999976555568899999999999999999999   999999999999999999999999998653322111110 


Q ss_pred             -----eecccCCCcccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH-----------
Q 038580          230 -----MLEASASQGYKAPELIKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN-----------  291 (356)
Q Consensus       230 -----~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------  291 (356)
                           .....++..|+|||++.+.  .++.++|||||||++|||++|..||.........   ......           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML---LQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH---HHHhcCCCCCCcccccc
Confidence                 0112245569999998763  4789999999999999999999999754321100   000000           


Q ss_pred             -----hhhh--cccccccCccc-c-----cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          292 -----AVLD--HRITDLYHPDM-L-----LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       292 -----~~~~--~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ....  ........... .     .........+.+..+...+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                 0000  00000000000 0     000000111223456778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.1e-39  Score=287.67  Aligned_cols=240  Identities=20%  Similarity=0.292  Sum_probs=194.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+++|.++....   .....+.+|++++++++||||+++++++.. .+..+++|||++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~   84 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVMEYVP   84 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEEEecCC
Confidence            3779999999999999998899999998864322   223568889999999999999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...++...+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......    .
T Consensus        85 ~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~  155 (290)
T cd05580          85 GGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T  155 (290)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence            9999999874  3568899999999999999999999   99999999999999999999999999998765432    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.        ...........             
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-------------  214 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGK-------------  214 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-------------
Confidence            344678889999999888889999999999999999999999975331        11111111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       215 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 -----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 012223356788999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.7e-39  Score=287.45  Aligned_cols=243  Identities=19%  Similarity=0.257  Sum_probs=186.8

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHH---hccCCCccccccceeeCCCCceEEEEecc
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELL---GCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .||+|+||.||++....++..+|+|.++......   ...+.+|..++   ...+||||+.+++++.. ++..+++|||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            4899999999999999889999999886543221   12334444333   34479999999998875 44899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||++......   .
T Consensus        80 ~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~  151 (279)
T cd05633          80 NGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K  151 (279)
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---C
Confidence            99999998863  3468999999999999999999999   99999999999999999999999999998654322   1


Q ss_pred             eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....++..|+|||.+.+ ..++.++|+||||+++|||++|..||........     .........             
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-------------  213 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLT-------------  213 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhhc-------------
Confidence            123467889999999864 5578999999999999999999999975432111     111110000             


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLWK  350 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~~  350 (356)
                           .....+...+..+.+++.+||+.||++||     +++++++.
T Consensus       214 -----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 -----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                 00112334566788999999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-39  Score=286.57  Aligned_cols=244  Identities=20%  Similarity=0.267  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+++|.+.....   ...+.+.+|++++++++||||+++++.+.. +...++++||+.
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   83 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVVDLLL   83 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEEeCCC
Confidence            3779999999999999988899999998865432   234678999999999999999999998875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++...  ..++...+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        84 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  156 (258)
T cd05578          84 GGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT  156 (258)
T ss_pred             CCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence            99999999743  578899999999999999999999   999999999999999999999999999987654322  22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||.+.+..++.++|+||||+++|++++|..||...+..     ...........               
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~---------------  216 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET---------------  216 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc---------------
Confidence            3445777899999998888999999999999999999999999754321     11111111110               


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNI--KQVL  348 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~--~~il  348 (356)
                         .....+...+..+.+++.+||+.||.+||++  ++++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               0111233445778899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.2e-39  Score=290.84  Aligned_cols=267  Identities=20%  Similarity=0.281  Sum_probs=191.1

Q ss_pred             ccccc--CCceEEEEEEcCCCeEEEEEEeccc--cccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           76 VIGKS--NYGTLYKALLQRSGSVRLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        76 ~ig~G--~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +||+|  ++|.||.++...++..+|+|.++..  .......+..|+++++.++||||+++++++.. .+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCC
Confidence            34554  5566677776778899999998654  22333579999999999999999999998885 4588999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC----
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG----  227 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----  227 (356)
                      ++|.+++.......+++.....++.|++.||+|||+   .+++||||||+||+++.++.+|++|||.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999999976555568899999999999999999999   9999999999999999999999999998765432111    


Q ss_pred             --cceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh----hcccc
Q 038580          228 --QEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL----DHRIT  299 (356)
Q Consensus       228 --~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~  299 (356)
                        .......++..|+|||++..  ..++.++|+||||+++|||++|..||...+....   ..+.......    .....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchh
Confidence              01122345667999999875  3588999999999999999999999976432111   0000000000    00000


Q ss_pred             c----ccC---cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          300 D----LYH---PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       300 ~----~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .    ...   .....................++.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0    000   0000000001111223345667899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-39  Score=290.58  Aligned_cols=241  Identities=23%  Similarity=0.327  Sum_probs=190.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+++|.+......   ..+++.+|+++++.++||||+++.++|.. ++..++++||+.
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVMEYCL   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEHHhhC
Confidence            37799999999999999888999999987643322   22468899999999999999999999885 447899999997


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                       |+|.+.+... ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......     
T Consensus        99 -g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----  168 (307)
T cd06607          99 -GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----  168 (307)
T ss_pred             -CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence             4777776532 3468999999999999999999999   99999999999999999999999999998654322     


Q ss_pred             ecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....++..|+|||++.   ...++.++||||||+++|||+||..||...+...       ... .....     ..+.  
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~-~~~~~-----~~~~--  233 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQN-----DSPT--  233 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHH-HHhcC-----CCCC--
Confidence            2345677899999874   3568899999999999999999999986532111       000 00000     0000  


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ......+..+.+++.+||+.+|++||++.+++.
T Consensus       234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 ---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ---------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                     012234567899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-39  Score=290.13  Aligned_cols=269  Identities=19%  Similarity=0.240  Sum_probs=193.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.++.++..+++|.++......  ...+.+|+.++++++||||+++++++..+. +..++++||+.
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~   89 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE   89 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence            377999999999999999889999999887543222  235678999999999999999999887542 58999999997


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      + +|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        90 ~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~  163 (293)
T cd07843          90 H-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPY  163 (293)
T ss_pred             c-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-ccc
Confidence            5 9998886432 368999999999999999999999   999999999999999999999999999987654322 112


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccc---cccC---
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT---DLYH---  303 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---  303 (356)
                      ....++..|+|||.+.+. .++.++|+||||+++|||++|..||...+.......+....... ....+.   ....   
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  242 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP-TEKIWPGFSELPGAKK  242 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chHHHHHhhccchhcc
Confidence            234567789999988654 46899999999999999999999997543211100000000000 000000   0000   


Q ss_pred             cccccccCCCCCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEE-RILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..............++.. ....+.+++.+||+.+|++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000000000000111111 3566889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=283.55  Aligned_cols=267  Identities=22%  Similarity=0.285  Sum_probs=195.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||+|....++..+++|.++...  ......+.+|+++++.++|||++++++++... .+..++++||+++
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07840           5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH   84 (287)
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence            67999999999999999889999999987653  22335788999999999999999999998865 2689999999985


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+++... ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++............
T Consensus        85 -~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          85 -DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             -cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence             898888643 2468999999999999999999999   99999999999999999999999999998766443322223


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||.+.+ ..++.++||||||+++|||+||..||...+.......+..... ......+....+.  ....
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~  236 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG-SPTDENWPGVSKL--PWFE  236 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchhhccccccc--hhhh
Confidence            3455778999997764 4578999999999999999999999975442111000000000 0000000000000  0000


Q ss_pred             CCCCCCC--------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENP--------VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .......        ....++..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000        01112567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.9e-39  Score=289.14  Aligned_cols=244  Identities=21%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      .+||+|+||.||++....++..+++|.+..........+.+|+.+++.++|||++++++.+.. .+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCcH
Confidence            569999999999999998999999998765444445678999999999999999999998885 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+++..   ..+++.....++.|++.|++|||+   .+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus       105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  177 (292)
T cd06657         105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV  177 (292)
T ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence            998753   357889999999999999999999   999999999999999999999999999876543221 1123345


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||.+.+..++.++|+||||+++||+++|..||......       +... ..... .    .+.         
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~-~~~~~-~----~~~---------  235 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMK-MIRDN-L----PPK---------  235 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhh-C----Ccc---------
Confidence            778899999998888899999999999999999999998753211       0000 00000 0    000         


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             0011123446778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-40  Score=300.35  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=194.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccc--cc--cchHHHHHHHHHHhccCCCccccccceeeCCCC-ceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-EKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e~  148 (356)
                      ..+||+|+|-+||+|.+..+|..||.-.++..  ..  ...+.|..|+.+|+.|+|||||++|.++.+..+ ..-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            37799999999999999988888874333221  11  122579999999999999999999998886543 57789999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEeccccccccCCCCC
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |..|+|..|++  +.+..+...+.+|+.||++||.|||+ ..++|+|||||.+||||+ ..|.|||+|+|+|........
T Consensus       125 ~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  125 FTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             ccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            99999999997  45568888999999999999999998 457999999999999997 458999999999988765433


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .   ...|||.|||||+.. ..|+...||||||..++||+|+..||+....+..   +-+-+........+....|    
T Consensus       202 k---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---IYKKV~SGiKP~sl~kV~d----  270 (632)
T KOG0584|consen  202 K---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---IYKKVTSGIKPAALSKVKD----  270 (632)
T ss_pred             c---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---HHHHHHcCCCHHHhhccCC----
Confidence            3   368999999999987 7899999999999999999999999987543221   1111111111111111222    


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                      .++.++|..|+.. .++|||+.|+|+
T Consensus       271 ----------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 ----------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                            2577999999999 999999999986

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.8e-39  Score=286.26  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=190.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||.||++.+..++..+|+|.+...... ....+.+|+.++.++. ||||+++++++.. ++..+++|||+.. 
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e~~~~-   87 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICMELMDI-   87 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEecccC-
Confidence            6799999999999999989999999988654332 3346888999999986 9999999998875 4578999999865 


Q ss_pred             ChhHhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          153 NLAQCI---RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++.++.   .......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||++.......  .
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~  163 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--A  163 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--c
Confidence            655543   222346789999999999999999999972  489999999999999999999999999986543321  1


Q ss_pred             eecccCCCcccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 MLEASASQGYKAPELIKMK---DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      .....++..|+|||.+...   .++.++|+||||+++|||++|..||....      ...........      ...+.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~------~~~~~~  231 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK------GDPPIL  231 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC------CCCCcC
Confidence            1233577889999998766   68899999999999999999999997532      01111110000      000000


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                              ........+..+.+++.+||+.+|++|||+.++++.
T Consensus       232 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 --------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    001122356678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-38  Score=281.19  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=192.5

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||.||++.+..++..+++|.+.....   .....+.+|++++++++||||+++++.+.. +...++++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999998899999999865433   233578889999999999999999998875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC------
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG------  227 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------  227 (356)
                      |.+++...  ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........      
T Consensus        80 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          80 LASLLENV--GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99999743  368999999999999999999999   9999999999999999999999999999765432211      


Q ss_pred             -cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          228 -QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       228 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       .......++..|+|||......++.++|+||||+++||+++|..||.....       ..... ......         
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~-~~~~~~---------  217 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQ-NILNGK---------  217 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHhcCC---------
Confidence             122234567789999999888899999999999999999999999975321       01111 110000         


Q ss_pred             ccccCCCCCCCCcHH--HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          307 LLCSNSNHENPVSEE--RILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                               ...+..  .+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       218 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 ---------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                     001111  256788999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=273.81  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=207.1

Q ss_pred             cchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeC---CC
Q 038580           64 LTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAG---PR  139 (356)
Q Consensus        64 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~  139 (356)
                      ..+.+.+.....+||-|-.|.|..+..+.+|+..|+|++..     ....++|+++--.. .|||||+++++|..   ..
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            33444443445889999999999999999999999999873     35678888875443 69999999998863   23


Q ss_pred             CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEecc
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDF  216 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Df  216 (356)
                      ..+++|||+|+||.|.+.+.++....+++.++-+|+.||+.|+.|||+   .+|.||||||+|+|.+   .|..+||+||
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence            467889999999999999998888899999999999999999999999   9999999999999996   4567999999


Q ss_pred             ccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          217 GLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       217 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      |+++....  .....+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||.....    ..++..+...+...
T Consensus       209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~g  282 (400)
T KOG0604|consen  209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTG  282 (400)
T ss_pred             ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhcc
Confidence            99986432  2334566789999999999999999999999999999999999999986544    33444444333221


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..              .-..+.....++...++++.+|..+|++|.|+.+++.
T Consensus       283 qy--------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QY--------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             Cc--------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            10              0011223456778899999999999999999999864

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.4e-39  Score=287.96  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.... ....+.+|+++++.++|+|++++++.+... +..++++||+++++
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~  101 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGS  101 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCCCc
Confidence            3779999999999999988888899999875443 456789999999999999999999988854 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus       102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~  176 (286)
T cd06614         102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSV  176 (286)
T ss_pred             HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccc
Confidence            999997533 478999999999999999999999   9999999999999999999999999998765432211 12233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++|+||||+++|++++|..||...+..       ..... ......               
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~-~~~~~~---------------  233 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFL-ITTKGI---------------  233 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHhcCC---------------
Confidence            5677899999998888999999999999999999999998643211       00000 000000               


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            000112224567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.3e-39  Score=280.35  Aligned_cols=246  Identities=28%  Similarity=0.413  Sum_probs=199.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|++|.||++....++..+++|.+..........+.+|++.++.++|||++++++++... +..++++||+++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~   83 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCCc
Confidence            47799999999999999888899999998765554557899999999999999999999988754 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.... ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||.+........  ....
T Consensus        84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~  157 (253)
T cd05122          84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM  157 (253)
T ss_pred             HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence            999987432 578999999999999999999999   9999999999999999999999999999876543321  2345


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+....++.++|+||||++++++++|..||...+..       ...... ......              
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~--------------  215 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKI-ATNGPP--------------  215 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHH-HhcCCC--------------
Confidence            6778899999998888899999999999999999999998753210       000000 000000              


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 -GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00111112567889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-38  Score=284.83  Aligned_cols=266  Identities=20%  Similarity=0.232  Sum_probs=189.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|....++..+++|.++...... ...+.+|+.+++.++|+||+++++++.. ++..++++||+. +
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~-~   87 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEEeccc-C
Confidence            377999999999999998888899999986543222 2467889999999999999999998885 458999999996 5


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus        88 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~  162 (291)
T cd07870          88 DLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSS  162 (291)
T ss_pred             CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCC
Confidence            887776532 2457788888999999999999999   9999999999999999999999999999865432211 1223


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---------cccccc
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---------RITDLY  302 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~  302 (356)
                      ..++..|+|||.+.+. .++.++|+||||+++|||++|..||........  .+.. ........         ......
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEK-IWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHH-HHHHcCCCChhhhhhhhhccccc
Confidence            3467889999998754 578899999999999999999999975432100  0000 00000000         000000


Q ss_pred             CcccccccCCCCCC-CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHEN-PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ......+....... .........+.+++.+|++.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000 000011456779999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-38  Score=288.79  Aligned_cols=266  Identities=22%  Similarity=0.242  Sum_probs=192.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++......  ...+.+|+.+++.++|+||+++++++.... +..+++|||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            377999999999999999889999999886543222  235678999999999999999999887543 46899999997


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      + +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++....... ...
T Consensus        92 ~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~  165 (309)
T cd07845          92 Q-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPM  165 (309)
T ss_pred             C-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCC
Confidence            5 888888643 3568999999999999999999999   999999999999999999999999999987654322 112


Q ss_pred             ecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---cccccccCccc
Q 038580          231 LEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLYHPDM  306 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  306 (356)
                      ....++..|+|||.+.+ ..++.++|+||||+++|||++|..||...+....    ...+......   ..+........
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ----LDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCChhhchhhhcccc
Confidence            23344677999999865 4578999999999999999999999975432111    0101100000   00000000000


Q ss_pred             -ccccCCCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 -LLCSNSNHENP----VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 -~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ...........    .....+..+.+++..||+.||++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00000000000    00113556789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.8e-39  Score=285.77  Aligned_cols=245  Identities=24%  Similarity=0.410  Sum_probs=187.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHH-HhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIEL-LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||.||++.+..++..+|+|.++..... ...++..|+.. ++..+||||+++++++.. ++..+++|||++ |
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e~~~-~   84 (283)
T cd06617           7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICMEVMD-T   84 (283)
T ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEhhhhc-c
Confidence            6799999999999999989999999988754322 23455556654 666789999999998875 458999999997 5


Q ss_pred             ChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          153 NLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +|.+++...  ....+++..++.++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++.......  .
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (283)
T cd06617          85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A  159 (283)
T ss_pred             cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence            888887532  23568999999999999999999998   6 89999999999999999999999999987653221  1


Q ss_pred             eecccCCCcccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          230 MLEASASQGYKAPELIKM----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .....++..|+|||.+.+    ..++.++|+||||+++|||++|..||......     . ........ .     ..+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~-~~~~~~~~-~-----~~~~  227 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----F-QQLKQVVE-E-----PSPQ  227 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----H-HHHHHHHh-c-----CCCC
Confidence            122456788999998864    45688999999999999999999998642211     0 10110000 0     0000


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .           .....+..+.+++..||+.+|++||++.++++
T Consensus       228 ~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 L-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0           01124567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-38  Score=291.57  Aligned_cols=264  Identities=21%  Similarity=0.247  Sum_probs=192.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|....++..+|+|.+.....  .....+.+|+.++++++||||+++++++....     ...+++|
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            3779999999999999998999999998864322  22346778999999999999999999876432     3579999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+..    .++...+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       101 e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850         101 ELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             eccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence            99965 88888753    28888899999999999999999   999999999999999999999999999987654322


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch--------hHHHHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL--------PTFMRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~  298 (356)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+        ..+... . ....
T Consensus       173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~  248 (353)
T cd07850         173 M--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR-L-QPTV  248 (353)
T ss_pred             C--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH-h-hhhh
Confidence            1  22345678899999999889999999999999999999999999754321100000        000000 0 0000


Q ss_pred             ccccCccc--------ccc---cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDM--------LLC---SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........        ...   .........+...+..+.+++.+||+.||++|||+.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000000        000   0000000112234667889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-38  Score=287.38  Aligned_cols=243  Identities=23%  Similarity=0.320  Sum_probs=190.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+++|.+......   ....+..|+++++.++|||++++++++.. +...+++|||+.
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~  108 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVMEYCL  108 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEeCCC
Confidence            37799999999999999888999999988643222   22468889999999999999999998885 447899999997


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      + +|.+.+... ..++++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++.....     .
T Consensus       109 g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~  178 (317)
T cd06635         109 G-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----A  178 (317)
T ss_pred             C-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-----c
Confidence            5 787777532 4468999999999999999999999   9999999999999999999999999998765432     1


Q ss_pred             ecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....++..|+|||.+.   .+.++.++|+||||+++|||++|..||.......        ..........     +   
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~-----~---  242 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNES-----P---  242 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccC-----C---
Confidence            2345778899999874   4568899999999999999999999986532110        0000000000     0   


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                              .......+..+.+++.+||+.+|++||++.++++.+
T Consensus       243 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 --------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             --------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                    001223455688999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.1e-38  Score=279.86  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|++|.||+|....++..+++|.+..... .....+.+|+..+++++|||++++++++..+ +..++++||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~   84 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEecCCC
Confidence            3789999999999999998899999998876543 3346899999999999999999999988854 5899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++...  ..++....+.++.|++.|++|||+.  .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        85 ~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~  159 (264)
T cd06623          85 SLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT  159 (264)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence            999999743  5689999999999999999999975  78999999999999999999999999998765432221 123


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..++..|+|||.+....++.++|+||||+++|+++||..||......    ........ ....                
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~-~~~~----------------  218 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQA-ICDG----------------  218 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHH-HhcC----------------
Confidence            45678899999998888999999999999999999999999764320    11111111 0000                


Q ss_pred             CCCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          313 NHENPVSEE-RILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       313 ~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                       .....+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 -PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             00111222 45678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-38  Score=281.94  Aligned_cols=242  Identities=19%  Similarity=0.267  Sum_probs=186.6

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHH---HHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIE---LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .||+|+||.||+|....+++.+|+|.+.......   ...+..|..   +++...||||+.+++.+... +..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence            4899999999999998889999999886543221   122334433   44456799999999988854 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++|..++..  ...+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.++|+|||++.......   
T Consensus        80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            99999998863  3568999999999999999999999   999999999999999999999999999987543221   


Q ss_pred             eecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....++..|+|||.+.++ .++.++|+||+|+++|||++|..||.........    . .......             
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~-~~~~~~~-------------  213 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----E-IDRMTLT-------------  213 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----H-HHHHhhc-------------
Confidence            1234678899999998754 6889999999999999999999999764322110    0 0000000             


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           .....+...+..+.+++.+||+.+|++||     ++.++++
T Consensus       214 -----~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 -----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -----cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                 00112223356788999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9e-39  Score=287.13  Aligned_cols=270  Identities=18%  Similarity=0.204  Sum_probs=191.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccC-CCccccccceeeCCCC----ceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRG----EKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|..+.....  ....+.+|+.+++.++ ||||+++++++...+.    ..+++|
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            47899999999999999989999999987654322  2357888999999995 6999999998774332    379999


Q ss_pred             ecccCCChhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEecccccccc
Q 038580          147 PFYKRGNLAQCIRGGS---GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~  222 (356)
                      ||+++ +|.+++....   ...+++..+..++.||+.||.|||+   .+++||||+|+||+++. ++.+||+|||++...
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99986 8988885322   3468999999999999999999999   99999999999999998 889999999998765


Q ss_pred             CCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ..... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..||.+.+.......+...... .....+...
T Consensus       162 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  239 (295)
T cd07837         162 SIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVWPGV  239 (295)
T ss_pred             CCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhCcch
Confidence            33211 1122345778999998864 45789999999999999999999999764321110000000000 000000000


Q ss_pred             cCcc--cccccCC-CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPD--MLLCSNS-NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~--~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....  ...+... .......+..+..+.+++.+||+.||++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000  0000000 0000011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-39  Score=293.78  Aligned_cols=266  Identities=21%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ....+.+|+.+++.++||||+++++++....    ...++++||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            47899999999999999988999999988643222 2356888999999999999999999865322    357999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +.+ +|.+.+.   ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  162 (336)
T cd07849          90 MET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH  162 (336)
T ss_pred             ccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence            975 8888875   3468999999999999999999999   99999999999999999999999999998765332211


Q ss_pred             --ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccccc
Q 038580          229 --EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLY  302 (356)
Q Consensus       229 --~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  302 (356)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+...    ....+......   .......
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCHHHHHHhh
Confidence              1123457888999998754 568899999999999999999999997543211    00000000000   0000000


Q ss_pred             CcccccccC---CCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          303 HPDMLLCSN---SNHENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       303 ~~~~~~~~~---~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .........   .....+   ..++.+..+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000   000000   011235668899999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.7e-38  Score=284.97  Aligned_cols=267  Identities=21%  Similarity=0.232  Sum_probs=192.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC---------Cce
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR---------GEK  142 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------~~~  142 (356)
                      .+.||+|+||.||+|.++.++..+++|.++....  .....+.+|+++++.++||||+++++++.+..         +..
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            4789999999999999998899999999875432  22346788999999999999999999886433         378


Q ss_pred             EEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccccc
Q 038580          143 LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      ++++||+++ ++...+... ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        92 ~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  166 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLY  166 (302)
T ss_pred             EEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence            999999986 777777643 3468999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---c
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---I  298 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  298 (356)
                      ............++..|+|||.+.+ ..++.++||||||+++|||++|..||.......    ....+........   +
T Consensus       167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLELISRLCGSPCPAVW  242 (302)
T ss_pred             cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhhc
Confidence            4332222222345677999998764 457889999999999999999999997532211    0000111000000   0


Q ss_pred             ccccCcccc-----cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDML-----LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........     ...............+..+.+++.+||+.||++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000     000000000001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=287.75  Aligned_cols=200  Identities=24%  Similarity=0.338  Sum_probs=165.1

Q ss_pred             CcccccCCceEEEEEEcC--CCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQR--SGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~--~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~  148 (356)
                      +.||+|+||.||+|....  ++..+|+|.+....   ......+.+|+.+++.++||||+++++++.... ...++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            679999999999999987  78999999987633   333457788999999999999999999988652 478999999


Q ss_pred             ccCCChhHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC----CCCeEEeccccccc
Q 038580          149 YKRGNLAQCIRGG---SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR----NYQPYVSDFGLHLL  221 (356)
Q Consensus       149 ~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~~~~  221 (356)
                      +++ +|.+.+...   ....++...+..++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            976 777766421   22368889999999999999999999   99999999999999999    99999999999876


Q ss_pred             cCCCCC--cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 038580          222 LNPTAG--QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPT  278 (356)
Q Consensus       222 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~  278 (356)
                      ......  .......++..|+|||++.+. .++.++|+||||++++||++|..||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            543222  112234567889999987654 578999999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-38  Score=282.73  Aligned_cols=263  Identities=18%  Similarity=0.225  Sum_probs=190.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccC-CCccccccceeeCCC-CceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIR-HPNLVPLLGFYAGPR-GEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||+|....++..+|+|.++..... .......|+..++++. |||++++++++.+.. +..++++||+.+
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM   84 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc
Confidence            6799999999999999988999999988754322 2234557888888885 999999999887542 588999999974


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+.+... ...+++..+..++.|++.||+|||+   .+++||||+|+||+++. +.+||+|||++........  ..
T Consensus        85 -~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~  156 (282)
T cd07831          85 -NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YT  156 (282)
T ss_pred             -cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC--cC
Confidence             888888643 2468999999999999999999999   99999999999999999 9999999999876533221  12


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchh-------HHHHHhhhhcccccccC
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP-------TFMRNAVLDHRITDLYH  303 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~  303 (356)
                      ...++..|+|||.+.. ..++.++|+|||||++|||++|..||.+.+..+......       .................
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3456788999997654 557889999999999999999999997643211100000       00000000000000000


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +...    ...-.......+..+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         237 PSKK----GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccc----cccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000    00000011245678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=291.44  Aligned_cols=267  Identities=23%  Similarity=0.302  Sum_probs=198.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....++..+++|.+....  ....+.+.+|+.+++.++||||+++++++....    +..+++|+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            478999999999999998888899999887543  223457899999999999999999999887543    47899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++ +|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||||.||+++.++.++|+|||++........
T Consensus        85 ~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          85 LMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             chhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9985 89988864  3378999999999999999999999   9999999999999999999999999999877544321


Q ss_pred             --cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---cccccc
Q 038580          228 --QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDL  301 (356)
Q Consensus       228 --~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  301 (356)
                        .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.....    .........   ..+...
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL----NLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH----HHHHHhcCCCChhHhhhc
Confidence              112334567889999999877 7899999999999999999999999765421110    000000000   000000


Q ss_pred             cCcccccc-cCCCCC-----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          302 YHPDMLLC-SNSNHE-----NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       302 ~~~~~~~~-~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ........ ......     .....+.+..+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000000 000000     00112245678899999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=322.70  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=201.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.+||.|.||.||-|...++|+..|+|-++.....  ....+.+|..++..++|||+|+++|+=. .+...+|.||||.+
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-HRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-HREKVYIFMEYCEG 1318 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-cHHHHHHHHHHhcc
Confidence            57899999999999999999999999987654333  2357899999999999999999999755 34578999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC---Cc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA---GQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~  228 (356)
                      |+|.+.+..  +...++....-+..|++.|++|||.   .|||||||||.||+++.+|.+|++|||.|....+..   ..
T Consensus      1319 GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1319 GSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             CcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            999999974  3346666677788999999999999   999999999999999999999999999998765432   12


Q ss_pred             ceecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 EMLEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ......||+.|||||++.+..   -..+.||||+|||+.||+||+.||...+.   .+.+...+                
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V---------------- 1454 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHV---------------- 1454 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHH----------------
Confidence            234668999999999997543   45789999999999999999999986543   11121111                


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                           ..++..+.|...+++=.+++..||+.||++|.++.|+++.
T Consensus      1455 -----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 -----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 1233445677788888999999999999999999988763

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.5e-39  Score=292.13  Aligned_cols=266  Identities=20%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCC---CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGP---RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|....++..+++|.+.....  .....+.+|+.+++.++||||+++++++..+   ....++++||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            4779999999999999998999999998875432  2235678899999999999999999987632   2468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +. ++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          90 ME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             hh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            96 589998863  3458999999999999999999999   99999999999999999999999999998765332221


Q ss_pred             c---eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh---hcccccc
Q 038580          229 E---MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL---DHRITDL  301 (356)
Q Consensus       229 ~---~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  301 (356)
                      .   .....++..|+|||.+.+ ..++.++|+||||+++|||++|..||.+.+....   + ........   .......
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~-~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---L-KLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---H-HHHHHHhCCChhHhhhhh
Confidence            1   123467788999999865 4688999999999999999999999976432110   0 00000000   0000000


Q ss_pred             cCccccccc---CCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCS---NSNHENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~---~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........   ......+   .....+..+.+++.+||+.+|++||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000000   0000000   11234677899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=279.74  Aligned_cols=247  Identities=18%  Similarity=0.282  Sum_probs=193.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc-----ccchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-----TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+..++..+++|.+....     ......+.+|++++++++||||+++++++.+.. +..++++
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            3588999999999999998889999999874321     112246889999999999999999999876543 4678999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++..  ...+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          86 EYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            99999999999863  3357888899999999999999999   999999999999999999999999999987643211


Q ss_pred             --CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          227 --GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       227 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                        ........++..|+|||.+.+..++.++|+||||+++||+++|..||......       .........         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~---------  224 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQ---------  224 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcC---------
Confidence              11112345778899999998888899999999999999999999999753211       111110000         


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              ......+......+.+++.+||+ +|..||++.+++.
T Consensus       225 --------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 --------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    00111344556778899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.4e-38  Score=278.70  Aligned_cols=235  Identities=17%  Similarity=0.279  Sum_probs=183.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCCChh
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      ||+|+||.||++..+.++..+++|.........   .  |+.....+ +||||+++++.+..+ +..+++|||+++++|.
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~-~~~~iv~e~~~~~~L~   97 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL-KGHVLIMDYIKDGDLF   97 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC-CeeEEEEEcCCCCcHH
Confidence            699999999999999899999999986432211   1  22222222 699999999998854 4899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcceeccc
Q 038580          156 QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       156 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      ++++..  ..+++..+..++.|+++||.|||+   .+++||||+|+||+++.++ .++|+|||++......     ....
T Consensus        98 ~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~  167 (267)
T PHA03390         98 DLLKKE--GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD  167 (267)
T ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence            999743  378999999999999999999999   9999999999999999998 9999999998764322     1235


Q ss_pred             CCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCC
Q 038580          235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH  314 (356)
Q Consensus       235 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (356)
                      ++..|+|||++.+..++.++|+||||+++|||++|..||........  ....+.... . .                  
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~-~-~------------------  225 (267)
T PHA03390        168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ-Q-K------------------  225 (267)
T ss_pred             CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh-c-c------------------
Confidence            77889999999988899999999999999999999999985432211  111111100 0 0                  


Q ss_pred             CCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 038580          315 ENPVSEERILKFFQLAMACCSPSPSLRPN-IKQVLW  349 (356)
Q Consensus       315 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~il~  349 (356)
                      ..+.....+..+.+++.+||+.+|++||+ ++++++
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00122245567889999999999999996 588874

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-38  Score=292.13  Aligned_cols=266  Identities=20%  Similarity=0.250  Sum_probs=194.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|....++..+++|.++....  .....+.+|+.+++.++||||+++++++....    ...++++|
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            3679999999999999998999999998865322  22346778999999999999999999876432    35899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+. ++|.+++..  ...+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  162 (337)
T cd07858          90 LMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-  162 (337)
T ss_pred             CCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence            996 589888863  3568999999999999999999999   999999999999999999999999999987654322 


Q ss_pred             cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh---hcccccccC
Q 038580          228 QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL---DHRITDLYH  303 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  303 (356)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....    .........   ........+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ----LKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH----HHHHHHHhCCCChHHhhhcCc
Confidence            22233456788999998765 4688999999999999999999999975431110    000000000   000000000


Q ss_pred             cccccc---cCCCCC---CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          304 PDMLLC---SNSNHE---NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       304 ~~~~~~---~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ......   ......   .....+.+..+.+++.+||+.+|++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000   000000   00112356678899999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-38  Score=290.14  Aligned_cols=263  Identities=19%  Similarity=0.237  Sum_probs=191.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------------hHHHHHHHHHHhccCCCccccccceeeCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------------DKEFGDLIELLGCIRHPNLVPLLGFYAGPR  139 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++......              ...+.+|+++++.++||||+++++++.. +
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~   92 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-G   92 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec-C
Confidence            477999999999999998889999999886543222              1247789999999999999999999885 4


Q ss_pred             CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      +..+++|||+. |+|.+++..  ...+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccce
Confidence            58999999997 599999863  3458889999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCC-------------CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch
Q 038580          220 LLLNPTA-------------GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL  285 (356)
Q Consensus       220 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~  285 (356)
                      .......             ........++..|+|||.+.+. .++.++|+||||+++|||++|..||...+....    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~----  242 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ----  242 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence            7653110             1111223456789999998754 468999999999999999999999976542111    


Q ss_pred             hHHHHHhhhhc---ccccccCcccccccCCCCCC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          286 PTFMRNAVLDH---RITDLYHPDMLLCSNSNHEN-----PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       286 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+.......   .+.....  ...........     ......+..+.+++..||+.+|++||++++++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKK--LPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhh--cccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            00011000000   0000000  00000000000     001123566889999999999999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-39  Score=308.00  Aligned_cols=270  Identities=16%  Similarity=0.202  Sum_probs=179.9

Q ss_pred             CCCcccccCCceEEEEEEcCCC-eEEEEE--------------Ee-cc--ccccchHHHHHHHHHHhccCCCccccccce
Q 038580           73 PGEVIGKSNYGTLYKALLQRSG-SVRLLR--------------FL-RP--VCTTRDKEFGDLIELLGCIRHPNLVPLLGF  134 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~-~~~a~k--------------~~-~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  134 (356)
                      ..+.||+|+||+||++.++... ...++|              .+ +.  ........+.+|+++++.++||||++++++
T Consensus       152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  231 (501)
T PHA03210        152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI  231 (501)
T ss_pred             EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence            3478999999999998765322 111111              01 00  011123468899999999999999999999


Q ss_pred             eeCCCCceEEEEecccCCChhHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCe
Q 038580          135 YAGPRGEKLIVHPFYKRGNLAQCIRGGS---GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP  211 (356)
Q Consensus       135 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  211 (356)
                      +... +..+++++++.+ +|..++....   ...........++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus       232 ~~~~-~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~v  306 (501)
T PHA03210        232 LRSE-ANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKI  306 (501)
T ss_pred             EEEC-CeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence            8854 478999999864 7777764322   1223456677899999999999999   999999999999999999999


Q ss_pred             EEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH
Q 038580          212 YVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN  291 (356)
Q Consensus       212 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  291 (356)
                      ||+|||++...............|+..|+|||++.+..++.++|||||||++|||++|..++...........+.+.+..
T Consensus       307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~  386 (501)
T PHA03210        307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS  386 (501)
T ss_pred             EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence            99999999876543333333457899999999999999999999999999999999987654322211111111111110


Q ss_pred             hhhhcccccccCcccc---c----ccCCC-CCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          292 AVLDHRITDLYHPDML---L----CSNSN-HENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       292 ~~~~~~~~~~~~~~~~---~----~~~~~-~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      . . ....+..++...   .    ..... ...+   .....+..+.+++.+||+.||++|||+.|++.
T Consensus       387 ~-~-~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        387 L-S-VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             c-c-cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0 0 000000000000   0    00000 0000   00012345678899999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.5e-38  Score=278.02  Aligned_cols=246  Identities=24%  Similarity=0.394  Sum_probs=199.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++.+..++..+++|.+.....  .....+..|+++++.++|||++++.+.+... +..++++||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e~~~~   83 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVMEYADG   83 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEEecCC
Confidence            3679999999999999998889999998875433  3345788999999999999999999988754 689999999999


Q ss_pred             CChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          152 GNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       152 gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|.+++....  ...+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~  159 (258)
T cd08215          84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL  159 (258)
T ss_pred             CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence            99999997543  4678999999999999999999999   999999999999999999999999999987654332 12


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....++..|+|||.+....++.++|+||+|+++|+|++|..||.....       ....... ....    .       
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~-~~~~----~-------  220 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKI-LKGQ----Y-------  220 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHH-hcCC----C-------
Confidence            2334677889999999888899999999999999999999999864321       1111111 1100    0       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            .+.+...+..+.+++.+||+.+|++||++.++++
T Consensus       221 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 ------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-39  Score=281.69  Aligned_cols=243  Identities=19%  Similarity=0.233  Sum_probs=186.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHH-HhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIEL-LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|....++..+|+|.++......   ...+..|..+ ....+|||++++++++.. ++..++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            46999999999999998889999999986432211   1234445444 345589999999998885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.++++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....     .
T Consensus        81 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          81 GGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            9999999973  3468888999999999999999999   9999999999999999999999999998765432     1


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||.+.+..++.++|+||||+++||+++|..||...+..       . ...........           
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~-----------  211 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------A-VFDNILSRRIN-----------  211 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcccC-----------
Confidence            2345677899999998888899999999999999999999999653211       1 11111100000           


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ........++..+.+++.+||+.+|++||++.++.+.
T Consensus       212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence               0001122345678899999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.2e-38  Score=284.57  Aligned_cols=269  Identities=22%  Similarity=0.260  Sum_probs=190.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+++|.++.....  ....+.+|+++++.++||||+++++++.. .+..++||||++ 
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-   84 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVFEYLD-   84 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEEeccc-
Confidence            36799999999999999988999999988654322  23568899999999999999999999885 458999999996 


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ++|.+++........++..+..++.|++.||+|||+   .+++|+||+|+||+++. ++.+||+|||++....... ...
T Consensus        85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~  160 (294)
T PLN00009         85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTF  160 (294)
T ss_pred             ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-ccc
Confidence            488888865444456888889999999999999999   99999999999999985 5579999999986543221 111


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC-ccccc
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH-PDMLL  308 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  308 (356)
                      ....++..|+|||++.+. .++.++|+||||+++|+|+||..||...+.............. .....+..... +....
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSLPDYKS  239 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccchhhhh
Confidence            233457789999988653 5789999999999999999999999754321110000000000 00000000000 00000


Q ss_pred             ---ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 ---CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ............+.+..+.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00000000011223456789999999999999999999885

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=281.65  Aligned_cols=267  Identities=23%  Similarity=0.276  Sum_probs=193.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhcc---CCCccccccceeeCCCC----ceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCI---RHPNLVPLLGFYAGPRG----EKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----~~~l  144 (356)
                      .+.||+|+||.||+|.++.++..+++|.++......  ...+.+|+.+++++   +|||++++++++...+.    ..++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            367999999999999998888999999987543322  23566777776655   69999999999875442    3899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      +|||+.+ +|.+++.......+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             Eehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999975 89998875444568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      ..  ......++..|+|||++.+..++.++|+||||+++|||++|..||.+......   +...................
T Consensus       160 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         160 EM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             Cc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcCCCc
Confidence            21  11233467789999999988899999999999999999999999875432111   11111100000000000000


Q ss_pred             c-cccccCCCCC---CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 D-MLLCSNSNHE---NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~-~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      . ..........   .....+....+.+++.+||+.||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0 0000000000   1112234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=278.99  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=197.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|++|.||+|....++..+++|.++.....  ....+..|++++++++||||+++++++..+ +..++++||+++ 
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~-   82 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEFMDT-   82 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEeccCC-
Confidence            6799999999999999888999999988754333  335788899999999999999999988754 589999999976 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~  157 (283)
T cd05118          83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH  157 (283)
T ss_pred             CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence            8888886432 578999999999999999999999   999999999999999999999999999987664432 12223


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---cccccccC--ccc
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLYH--PDM  306 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~  306 (356)
                      ..++..|+|||.+.+. .++.++|+||||+++|+++||+.||...+..+.    ..........   ..+.....  ...
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCchHhcccchhhhhhh
Confidence            4567789999998776 789999999999999999999999976432111    0000000000   00000000  000


Q ss_pred             -ccccCCC--CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 -LLCSNSN--HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 -~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .......  .......+.+.++.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             0000000  000122345778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-38  Score=280.81  Aligned_cols=264  Identities=20%  Similarity=0.298  Sum_probs=193.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|....+++.+++|.+....... .....+|+..+++++ |||++++++++.. ++..+++|||+ +
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~   81 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-E   81 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-C
Confidence            377999999999999998888999999876543322 224566889999999 9999999998885 55899999999 7


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+++.......+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........  ..
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  156 (283)
T cd07830          82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YT  156 (283)
T ss_pred             CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cC
Confidence            799999875544578999999999999999999999   9999999999999999999999999999876533211  12


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH---------HHHHhhhhcccccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT---------FMRNAVLDHRITDL  301 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~  301 (356)
                      ...++..|+|||++.. ..++.++|+||||+++||+++|..||..............         +..........   
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL---  233 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc---
Confidence            3456778999998754 4578999999999999999999999975432111000000         00000000000   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ........... ........+..+.+++.+||+.+|++||++.+++.
T Consensus       234 -~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 -GFRFPQFAPTS-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             -ccccccccccc-HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             00000000000 00001112467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=293.92  Aligned_cols=273  Identities=19%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|+.+.+|+.+|+|.++.....+. +...+|+++|++++|||||+++++=.+..     ....++||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            3789999999999999999999999999987665444 46889999999999999999999654322     35689999


Q ss_pred             cccCCChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCC--CeEEecccccccc
Q 038580          148 FYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNY--QPYVSDFGLHLLL  222 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~~~~~  222 (356)
                      ||.+|||...|+... ...+++..++.++.+++.||.|||.   ++|+||||||.||++-  .+|  ..||+|||.|+-.
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999997644 4579999999999999999999999   9999999999999983  333  4689999999887


Q ss_pred             CCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc--cc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR--IT  299 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~  299 (356)
                      ..  +.......||..|++||+... ..|+..+|.|||||++||++||..||-....+...   .+.+........  ..
T Consensus       175 ~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~---~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  175 DD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN---KEIMWHIITKKPSGVA  249 (732)
T ss_pred             CC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc---chhhhhhhccCCCcee
Confidence            54  335667899999999999984 78999999999999999999999999643322211   111111111000  00


Q ss_pred             cccC--cccccccCC--CCCCCCcHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHhhh
Q 038580          300 DLYH--PDMLLCSNS--NHENPVSEERILKFFQLAMACCSPSPSLRP--NIKQVLWKLEDL  354 (356)
Q Consensus       300 ~~~~--~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp--s~~~il~~L~~~  354 (356)
                      ....  .+-...+..  ......+......+..++..+|..+|++|-  .+.+..+.+.++
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            0000  000000000  001112333445566777888899999998  666666665554

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.4e-38  Score=285.94  Aligned_cols=268  Identities=21%  Similarity=0.281  Sum_probs=192.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhcc-CCCccccccceeeCCC-CceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPR-GEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++..+++|.+....  ......+..|+.+++.+ +||||++++++|...+ ...+++|||+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            378999999999999998888889988775321  22334677899999999 9999999999886433 3689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      .+ +|.+++...   .+++.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus        92 ~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          92 ET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             cc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            74 999988642   67888899999999999999999   99999999999999999999999999998765432211 


Q ss_pred             ---ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH-------HHhhhhcc
Q 038580          229 ---EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM-------RNAVLDHR  297 (356)
Q Consensus       229 ---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~  297 (356)
                         ......++..|+|||.+.+ ..++.++|+||||+++|||+||..||.+..............       ........
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF  244 (337)
T ss_pred             cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence               2223457888999998764 457889999999999999999999996543211100000000       00000000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ...... .... ...........+.+..+.+++..||+.||++|||+.+++..
T Consensus       245 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         245 AATMLD-SLPS-RPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhh-hccc-ccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000 0000 00000001111246678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-37  Score=272.22  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~~~  150 (356)
                      .+.||+|++|.||+|....++..+++|.+.....  ...+.+.+|++.+++++||||+++++.+.... ...++++||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            4789999999999999998899999998875543  23467899999999999999999999887541 57899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-c
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-E  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~  229 (356)
                      +++|.+++....  .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999997433  78999999999999999999999   99999999999999999999999999998776443221 1


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....++..|+|||.+....++.++|+||||++++++++|..||.....      ....... ...              
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~--------------  218 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYK-IGS--------------  218 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHh-ccc--------------
Confidence            2344677889999999888899999999999999999999999976430      0010000 000              


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .......+...+..+.+++.+||+.+|++||++.+++.
T Consensus       219 --~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 --SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              00011123344678899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4e-38  Score=282.01  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=193.5

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      .+.||+|+||.||++...   .++..+++|.++....    ...+.+.+|++++.++ +||||+++++.+.. +...++|
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   83 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTKLHLI   83 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCEEEEE
Confidence            377999999999999864   3567889998864321    1234678899999999 59999999998874 4578999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          84 LDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            999999999999863  3468888999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCcceecccCCCcccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          226 AGQEMLEASASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      .........++..|+|||.+.+..  .+.++|+||||+++|||++|..||.......   .... ........       
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-~~~~~~~~-------  227 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSE-ISRRILKS-------  227 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHH-HHHHHHcc-------
Confidence            332233445788899999987654  6889999999999999999999996432111   1111 11111100       


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED  353 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~  353 (356)
                                 ..+.+...+..+.+++.+||+.||++|||+.++...|+.
T Consensus       228 -----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                       011222344568899999999999999998888766653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-38  Score=276.13  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||++....++..+++|.+.....  ....++.+|+++++.++||||+++.+++.+. ...++++||+++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~   83 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVMEYAPF   83 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEehhcCC
Confidence            3779999999999999988888999998865432  2234678899999999999999999988754 589999999999


Q ss_pred             CChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          152 GNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       152 gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|.+++...  ....+++..+..++.|++.||+|||+   .+++|+||+|.||++++++.+|++|||++......   .
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~  157 (256)
T cd08530          84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M  157 (256)
T ss_pred             CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence            9999998642  23568899999999999999999999   99999999999999999999999999998776443   2


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....++..|++||.+.+..++.++|+||||+++||+++|..||...+..       . ........             
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~-------------  216 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------D-LRYKVQRG-------------  216 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhcC-------------
Confidence            22345678899999998888999999999999999999999999753311       1 11111110             


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          .....+...+.++.+++.+||+.+|++||++.++++
T Consensus       217 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         217 ----KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                011233456678999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.9e-38  Score=280.73  Aligned_cols=267  Identities=18%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|++|.||+|.+..++..+++|.++..... ....+.+|+++++.++||||+++++++.+. +..+++|||+++ 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~-   82 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEYMDK-   82 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEecCCc-
Confidence            37799999999999999989999999988754332 335678899999999999999999998854 588999999985 


Q ss_pred             ChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          153 NLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       153 sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +|.+++.... ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++++|||++........ ...
T Consensus        83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (284)
T cd07836          83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFS  158 (284)
T ss_pred             cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccc
Confidence            8888876432 3468999999999999999999999   9999999999999999999999999999875432211 112


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|++||++.+. .++.++|+||||+++|++++|..||.+.+..+....+...... .....+.......  ...
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~  235 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT-PTESTWPGISQLP--EYK  235 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CChhhHHHHhcCc--hhc
Confidence            33457789999988654 5788999999999999999999999765432111111000000 0000000000000  000


Q ss_pred             CCCC------CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNH------ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+      .....+..+..+.+++..||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000      00011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=286.95  Aligned_cols=259  Identities=17%  Similarity=0.274  Sum_probs=193.1

Q ss_pred             cccchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEecccc-ccchHHHHHHHHHHhccC-CCccccccceeeCCC
Q 038580           62 EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-TTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPR  139 (356)
Q Consensus        62 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  139 (356)
                      +.+.+++-.+...+.||+||.+.||++...+.+..+++|+..... .....-|.+|+.+|.+|+ |.+||++++|=.. +
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d  432 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-D  432 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-C
Confidence            345555555555688999999999999887656656666543322 222357999999999996 9999999996554 6


Q ss_pred             CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      +.+|+||||-.. +|.++|+.+......| .+..+..|++.++.++|.   .||||.||||.|+|+-+ |.+||+|||+|
T Consensus       433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechh
Confidence            699999998765 9999998766655556 677888999999999999   99999999999999875 48999999999


Q ss_pred             cccCCCCCc-ceecccCCCcccCccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH
Q 038580          220 LLLNPTAGQ-EMLEASASQGYKAPELIKMKD-----------ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       220 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----------~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  287 (356)
                      ......... .....+||+.||+||.+....           .+++|||||+||++|+|+.|+.||...         ..
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n  577 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------IN  577 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HH
Confidence            877544322 235678999999999986432           457899999999999999999999742         11


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...      ++..+.+|+-.+-.+.     .+.  ..++.++|+.||+.||.+||++.++|+
T Consensus       578 ~~a------Kl~aI~~P~~~Iefp~-----~~~--~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 QIA------KLHAITDPNHEIEFPD-----IPE--NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHH------HHHhhcCCCccccccC-----CCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            111      1111222221110000     011  112889999999999999999999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.3e-38  Score=286.30  Aligned_cols=266  Identities=21%  Similarity=0.311  Sum_probs=191.9

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..+.||+|+||.||+|....++..+++|.+.....  ...+.+..|+++++.++||||+++++++.......++++||+.
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~   93 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG   93 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc
Confidence            34789999999999999998999999998754322  2345788899999999999999999988765668899999984


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                       ++|..+++.   ..++......++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||.+......    .
T Consensus        94 -~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~  162 (328)
T cd07856          94 -TDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----M  162 (328)
T ss_pred             -cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC----c
Confidence             589888863   357888888999999999999999   99999999999999999999999999998754321    1


Q ss_pred             ecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc-ccc
Q 038580          231 LEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD-MLL  308 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  308 (356)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+++||..||...........+.+.... ..+.......+.. ...
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT-PPDDVINTICSENTLRF  241 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHHHhccchhhHHH
Confidence            23356778999998765 56899999999999999999999999754321000000000000 0000000000000 000


Q ss_pred             ccCCCCCCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          309 CSNSNHENPVS-----EERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       309 ~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ........+.+     ...+..+.+++.+||+.+|++||++++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000011     1234678899999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.7e-38  Score=280.47  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=190.8

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      .+.||+|+||.||++...   .+|..+|+|+++....    ...+.+.+|+.+++.+ +||||+++++.+.. ++..+++
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv   83 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTKLHLI   83 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCeEEEE
Confidence            377999999999999874   3678899999875322    1235678899999999 59999999998874 4578999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      +||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          84 LDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            999999999999974  3468888999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCcceecccCCCcccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          226 AGQEMLEASASQGYKAPELIKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      .........++..|+|||.+...  .++.++|+||||+++|++++|..||.......   ............        
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~--------  227 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS--------  227 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhcc--------
Confidence            22233345678889999998753  46789999999999999999999986422111   111111110000        


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                                 ..+.+......+.+++.+||+.||++||     ++.+++.
T Consensus       228 -----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                       0112233456778999999999999997     6677654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=274.58  Aligned_cols=244  Identities=27%  Similarity=0.459  Sum_probs=198.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|++|.||++....++..+++|.+.....  .....+.+|++++++++|||++++++++... +..++++||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~   83 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILEYAEN   83 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEecCCC
Confidence            4789999999999999988888999999876543  2335789999999999999999999988754 589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++...  ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        84 ~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~  157 (254)
T cd06627          84 GSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA  157 (254)
T ss_pred             CcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence            9999998743  578999999999999999999999   99999999999999999999999999998765433221 23


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...++..|+|||...+..++.++|+||+|+++|++++|..||.....      ........ ..                
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~~----------------  214 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIV-QD----------------  214 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cc----------------
Confidence            34577889999999877789999999999999999999999864321      11100000 00                


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .....+...+..+.+++.+||+.+|++||++.+++.
T Consensus       215 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 --DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              001123344567889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-37  Score=281.60  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=188.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|+...++..+++|.+.......   ...+..|+++++.++|||++++++++.+. ...+++|||+.
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVMEYCL  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEecCC
Confidence            367999999999999998889999999886433222   24678899999999999999999998854 47899999996


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                       |+|.+++... ...+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.+||+|||++....     ..
T Consensus       105 -~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~  174 (313)
T cd06633         105 -GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PA  174 (313)
T ss_pred             -CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CC
Confidence             4787777532 3468999999999999999999999   999999999999999999999999999875432     12


Q ss_pred             ecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....++..|+|||++.   ...++.++|+||||+++|||++|..||...+....       .... ....     .+.  
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~~~~-~~~~-----~~~--  239 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHI-AQND-----SPT--  239 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHH-HhcC-----CCC--
Confidence            2346778899999984   45688899999999999999999999875422110       0000 0000     000  


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ......+..+.+++.+||+.+|++||++.+++.
T Consensus       240 ---------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         240 ---------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     011123346789999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-37  Score=281.54  Aligned_cols=270  Identities=19%  Similarity=0.254  Sum_probs=189.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCC-------CceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPR-------GEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------~~~~l  144 (356)
                      .+.||+|+||.||+|....++..+|+|.+.......  ...+.+|+.++++++||||++++++|...+       ...++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            377999999999999999899999999876433222  235678999999999999999999886433       34699


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      +|||+.+ +|.+.+... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus        97 v~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  171 (310)
T cd07865          97 VFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL  171 (310)
T ss_pred             EEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence            9999975 888887642 3468999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCc---ceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          225 TAGQ---EMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       225 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                      ....   ......++..|+|||.+.+. .++.++|+||||+++|||++|..||...+...... ....+...........
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  250 (310)
T cd07865         172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEVWPG  250 (310)
T ss_pred             CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhccc
Confidence            2221   11233467789999988654 47889999999999999999999987543211000 0000000000000000


Q ss_pred             ccCcccc--cccCCCCCCCC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 LYHPDML--LCSNSNHENPV-----SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 ~~~~~~~--~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .......  ...........     +......+.+++.+||+.||++|||++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000  00000000000     0012345679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=271.48  Aligned_cols=235  Identities=21%  Similarity=0.273  Sum_probs=195.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchH---HHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK---EFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ++||+|.||+|.+++-+.+++.+|+|++++...-...   .-..|-++|+..+||.+..+-..|++. +++|.||||..|
T Consensus       174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-drlCFVMeyanG  252 (516)
T KOG0690|consen  174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-DRLCFVMEYANG  252 (516)
T ss_pred             HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-ceEEEEEEEccC
Confidence            7899999999999999999999999999876443333   346678899999999999998888864 499999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.|.-+|.+  .+.+++....-+-..|++||.|||+   .+||.||||.+|.|+|++|++||+|||+|+--- ..+....
T Consensus       253 GeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~k  326 (516)
T KOG0690|consen  253 GELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTTK  326 (516)
T ss_pred             ceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-cccceec
Confidence            999998873  4567787888889999999999999   999999999999999999999999999997532 3345566


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+||+.|+|||++....|..+.|.|.+|+++|||++|+.||...+.    ..+.+.+...                   
T Consensus       327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl~e-------------------  383 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELILME-------------------  383 (516)
T ss_pred             cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHHHHhh-------------------
Confidence            88999999999999999999999999999999999999999975332    1222222111                   


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRP  342 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  342 (356)
                         +..+|.....+...|+...|..||.+|.
T Consensus       384 ---d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 ---DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ---hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence               1124555566777899999999999996

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.4e-38  Score=283.43  Aligned_cols=241  Identities=22%  Similarity=0.328  Sum_probs=188.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||+|....++..+++|.+.....   ...+++.+|+++++.++|||++++++++... ...++|+||+. 
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-   98 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-   98 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEEEEccC-
Confidence            679999999999999998888999998764322   2234678899999999999999999988854 57899999997 


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+.+... ...+++..+..++.|++.|+.|||+   .+++||||+|+||+++.++.++|+|||++......     .
T Consensus        99 ~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~  169 (308)
T cd06634          99 GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N  169 (308)
T ss_pred             CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----c
Confidence            5888777532 3458889999999999999999999   99999999999999999999999999998654321     2


Q ss_pred             cccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          232 EASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ...++..|+|||.+.   .+.++.++||||||+++|||++|..||.......       .. .......     .+.   
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~-~~~~~~~-----~~~---  233 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------AL-YHIAQNE-----SPA---  233 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HH-HHHhhcC-----CCC---
Confidence            345678899999874   3567889999999999999999999986532110       00 0000000     000   


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                              ......+..+.+++.+||+.+|++||++.+++..
T Consensus       234 --------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             --------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                    0122345668899999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.3e-38  Score=278.78  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|....++..+++|++....   ......+..|.+++++++ ||||+++++++.. ++..+++|||+
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~   84 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYA   84 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEEEEcCC
Confidence            467999999999999999899999999986532   122356888999999998 9999999998875 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC--
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG--  227 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--  227 (356)
                      ++++|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++++|||++........  
T Consensus        85 ~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          85 PNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99999999974  3469999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             -----------------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHH
Q 038580          228 -----------------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR  290 (356)
Q Consensus       228 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  290 (356)
                                       .......++..|+|||......++.++|+||||++++++++|..||.....    .   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~---~~~~  232 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----Y---LTFQ  232 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----H---HHHH
Confidence                             112233467789999999888899999999999999999999999975431    0   0000


Q ss_pred             HhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 038580          291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI----KQVLW  349 (356)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~----~~il~  349 (356)
                       .....                  ....+...+..+.+++.+||+.+|++||++    +++++
T Consensus       233 -~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 -KILKL------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHhc------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             00000                  011223345678899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-37  Score=277.35  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=186.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ...++..|+.++.+.. ||||++++++|.+ ....+++|||+.+
T Consensus        20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~   98 (296)
T cd06618          20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICMELMST   98 (296)
T ss_pred             eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEeeccCc
Confidence            47899999999999999988999999998754322 2345666777666664 9999999999885 4489999999854


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+.+... ...+++..+..++.|++.||+|||+.  .+++||||+|+||++++++.+||+|||++........  ..
T Consensus        99 -~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~~  172 (296)
T cd06618          99 -CLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KT  172 (296)
T ss_pred             -CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--cc
Confidence             777776532 34789999999999999999999962  4899999999999999999999999999876533221  12


Q ss_pred             cccCCCcccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          232 EASASQGYKAPELIKMKD----ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~----~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ...++..|+|||.+.+..    ++.++|+||||+++|||++|..||......      ...... ......     +   
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~~~-----~---  237 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTK-ILQEEP-----P---  237 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHH-HhcCCC-----C---
Confidence            334677899999987543    788999999999999999999998642110      011111 110000     0   


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                             ..+.....+.++.+++.+||+.||++||++.+++..
T Consensus       238 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 -------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   000111234568899999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-38  Score=289.71  Aligned_cols=243  Identities=23%  Similarity=0.331  Sum_probs=201.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch--HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ....||+|.|++|.+|++..++..||+|.+++......  +.+.+|+++|..++|||||+++.+..++. .+|+||||+.
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-~lylV~eya~  138 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-TLYLVMEYAS  138 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-eeEEEEEecc
Confidence            34789999999999999999999999999986544332  56899999999999999999999888655 8999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|.+.+++..  ...........+..|+++|++|||+   +.|||||||++|+|++.+.++||+|||++..+..  ....
T Consensus       139 ~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~~l  211 (596)
T KOG0586|consen  139 GGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GLML  211 (596)
T ss_pred             CchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--cccc
Confidence            9999999973  2334446778889999999999999   9999999999999999999999999999988763  4445


Q ss_pred             ecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .+.+|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||.+.+..+....        ....             
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------vl~g-------------  270 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------VLRG-------------  270 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------heee-------------
Confidence            67899999999999998776 5789999999999999999999987543322111        0000             


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ..+.+.-...++.++++.++..+|.+|++++++.+
T Consensus       271 -----k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 -----KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -----eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                 11123334556779999999999999999999875

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=278.15  Aligned_cols=266  Identities=24%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||.||+|....++..+++|.+....  ....+.+..|+.+++.++|||++++++++.+. +..++++||+++ 
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~-   82 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEYCDM-   82 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecCcCc-
Confidence            67999999999999999889999999987653  22335788899999999999999999988854 589999999985 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........ ....
T Consensus        83 ~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~  157 (282)
T cd07829          83 DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH  157 (282)
T ss_pred             CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence            9999997432 468999999999999999999999   9999999999999999999999999999876543221 2223


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc-----cCccc
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL-----YHPDM  306 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  306 (356)
                      ..++..|+|||.+.+. .++.++|+||||+++||+++|..||...+.......+....... ....+...     .+...
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP-TEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC-cHHHHHhhcccccccccc
Confidence            3456779999998766 78999999999999999999999997643211100000000000 00000000     00000


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........ ....+..+..+.+++.+||+.||++||++.+++.
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000 0011122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=263.04  Aligned_cols=247  Identities=20%  Similarity=0.318  Sum_probs=190.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..||.|+.|.||++..+.+|.+.|+|..+...... .+.+...++++.+- ..|.||+.+|+|..+. ..++.||.|.. 
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~IcMelMs~-  175 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFICMELMST-  175 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHHHHHHHH-
Confidence            46999999999999999999999999987543322 23455666655444 4799999999998644 78889999854 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      .++..++. ...++++..+-++...+.+||.||-..  ++++|||+||+|||+|+.|++|+||||++-.+..+  .....
T Consensus       176 C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtr  250 (391)
T KOG0983|consen  176 CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTR  250 (391)
T ss_pred             HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--ccccc
Confidence            67766653 356788888889999999999999874  88999999999999999999999999998766433  33345


Q ss_pred             ccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          233 ASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       233 ~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ..|.+.|||||-+.   ...|+..+||||||+.++|+.||+.||.+.+..   +.....+.+...         |.    
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkvln~eP---------P~----  314 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKVLNEEP---------PL----  314 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHHHhcCC---------CC----
Confidence            67889999999986   346899999999999999999999999875432   211111111100         11    


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                            .+.....+..+.+++..||+.|+.+||...++++.
T Consensus       315 ------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  315 ------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                  11112245667799999999999999999998863

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-37  Score=280.83  Aligned_cols=269  Identities=19%  Similarity=0.256  Sum_probs=188.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCC-------CceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPR-------GEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------~~~~l  144 (356)
                      .+.||+|+||.||+|.+..++..+++|.+.......  ...+.+|+++++.++||||+++++++....       ...++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            377999999999999999888889999876433222  246788999999999999999999775333       24799


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      +++|+.+ +|...+.. ....+++..+..++.|+++||+|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus        93 v~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  167 (311)
T cd07866          93 VTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDG  167 (311)
T ss_pred             EEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence            9999975 77777753 23468999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCcc----------eecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          225 TAGQE----------MLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       225 ~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      .....          .....++..|+|||.+.+. .++.++||||||+++|||++|..||.+.+.......+..... ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~-~~  246 (311)
T cd07866         168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG-TP  246 (311)
T ss_pred             CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CC
Confidence            21111          1122456779999987654 578999999999999999999999975433211000000000 00


Q ss_pred             hhccc------ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          294 LDHRI------TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       294 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....      ................. .........+.+++.+||+.||++|||+.+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000      00000000000000000 000112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=268.94  Aligned_cols=237  Identities=22%  Similarity=0.276  Sum_probs=191.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ||+|+||.||++....++..+++|.++.....   ....+..|+++++.++||||+++++.+.. ++..+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            69999999999999888899999988754332   23478899999999999999999998874 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++...  ..+++.....++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        80 L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          80 LFSHLSKE--GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            99999743  368999999999999999999999   999999999999999999999999999987653321 122344


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|++||...+...+.++|+||||+++|++++|..||...+.       ..... .....                 
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~-~~~~~-----------------  208 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYE-KILKD-----------------  208 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH-HHhcC-----------------
Confidence            567789999999888889999999999999999999999965322       01111 11000                 


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQ  346 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~  346 (356)
                       ....+...+..+.+++.+||..||++||++.+
T Consensus       209 -~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 -PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             11123334667889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-37  Score=284.62  Aligned_cols=266  Identities=15%  Similarity=0.241  Sum_probs=189.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCC-------------C
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-------------G  140 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------------~  140 (356)
                      .+.||+|+||.||+|....++..+++|.+........+.+.+|+++++.++||||+++++++....             .
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN   89 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence            478999999999999999889999999887655555567889999999999999999998765432             2


Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEeccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLH  219 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~  219 (356)
                      ..++++||+. ++|.+++..   ..+++..+..++.|++.||.|||+   .+++||||||+||+++ .++.+|++|||++
T Consensus        90 ~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg~~  162 (342)
T cd07854          90 SVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLA  162 (342)
T ss_pred             eEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence            4789999997 489888853   358889999999999999999999   9999999999999997 4567899999998


Q ss_pred             cccCCCCCcc--eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh--
Q 038580          220 LLLNPTAGQE--MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL--  294 (356)
Q Consensus       220 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  294 (356)
                      ..........  .....++..|+|||.+.. ..++.++|+|||||++|||++|..||...+.....   .........  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~  239 (342)
T cd07854         163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM---QLILESVPVVR  239 (342)
T ss_pred             eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCC
Confidence            7654322111  122346778999998654 46788999999999999999999999754321110   000000000  


Q ss_pred             hcccccccCccccccc--CCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 DHRITDLYHPDMLLCS--NSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..............+.  ......   ........++.+++.+||+.||++|||+++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000000000000000  000000   011123456889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-37  Score=273.18  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=190.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-----cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-----TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||++.+...+...++|+++....     .....+..|+.+++.++||||+++++++.+. ...++++||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCIITEY   83 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEEEEEe
Confidence            4779999999999999987666666666654221     1223577889999999999999999988754 478999999


Q ss_pred             ccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          149 YKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       149 ~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +++++|.+++..  .....+++..++.++.|++.||.|||+   .+++|+||+|+||++++ +.++|+|||++.......
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999998853  234568999999999999999999999   99999999999999986 469999999987653322


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       .......++..|+|||.+.+..++.++|+||||+++|++++|..||....       ........ ...          
T Consensus       160 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~-~~~----------  220 (260)
T cd08222         160 -DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRI-VEG----------  220 (260)
T ss_pred             -ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH-HcC----------
Confidence             12223456788999999988888999999999999999999999986421       11111110 000          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             .....+...+..+.+++.+||+.+|++||++.++++
T Consensus       221 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 -------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   001123455678889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=246.23  Aligned_cols=268  Identities=20%  Similarity=0.241  Sum_probs=198.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ++||+|+||+||+|+.+++++.||+|..+......  .....+|+-+++.++|.|||+++++..+ +..+-+|+|||.. 
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe~cdq-   85 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ-   85 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHHhhH-
Confidence            67999999999999999999999999987654332  3578999999999999999999998774 4488999999976 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|..+... -+..++.....+++.|+++||.|+|+   +++.|||+||+|.+++.+|..|++|||+++.+.-+.. --..
T Consensus        86 dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa  160 (292)
T KOG0662|consen   86 DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA  160 (292)
T ss_pred             HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence            99998863 35568888999999999999999999   9999999999999999999999999999987653321 1223


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ..-|..|.+|.++.+. -|++..|+||.||++.|+.. |.+.|.+.+..+....+.........+.+......|+-...+
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            4567889999998765 58999999999999999998 777687755433332332222211111111111111111111


Q ss_pred             CCCCC---CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHE---NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....   .+.-++....=.+++...+..+|.+|.+++..++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11000   0111222333468999999999999999998765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=306.28  Aligned_cols=246  Identities=19%  Similarity=0.259  Sum_probs=199.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ++||+|+||.|..++++.++.++|+|++.+...-   ...-|..|-++|..-+.+.|+++.-.|++++ ++|+|||||+|
T Consensus        81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~-~LYlVMdY~pG  159 (1317)
T KOG0612|consen   81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER-YLYLVMDYMPG  159 (1317)
T ss_pred             HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-ceEEEEecccC
Confidence            7899999999999999999999999999874332   3346899999999999999999998899654 99999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|...+....  .++...+.-++..|+.||+-||+   .|+|||||||+|||+|.+|++||+|||.|..+..++.-...
T Consensus       160 GDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~  234 (1317)
T KOG0612|consen  160 GDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS  234 (1317)
T ss_pred             chHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence            99999997432  78888899999999999999999   99999999999999999999999999999888877777777


Q ss_pred             cccCCCcccCccccc----c-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          232 EASASQGYKAPELIK----M-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~----~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ...|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||...+.-+..        ..+..+.       ..
T Consensus       235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--------~KIm~hk-------~~  299 (1317)
T KOG0612|consen  235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--------GKIMNHK-------ES  299 (1317)
T ss_pred             cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH--------HHHhchh-------hh
Confidence            889999999999995    2 57899999999999999999999999753221111        1111110       00


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN---IKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~il~  349 (356)
                             ...|.....+.+..+||.+.+. +|+.|..   ++++..
T Consensus       300 -------l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  300 -------LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             -------cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                   0011113356677788887665 6778876   776653

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.9e-38  Score=264.14  Aligned_cols=198  Identities=22%  Similarity=0.361  Sum_probs=166.4

Q ss_pred             CcccccCCceEEEEEEcCCC----eEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRSG----SVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..||+|+||.||+|.-.++.    +.+|+|.++....  .-.....+|+.+++.++|||++++..++...+...++++||
T Consensus        30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY  109 (438)
T KOG0666|consen   30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY  109 (438)
T ss_pred             ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence            56999999999999665432    3678888876533  23367899999999999999999999998767789999999


Q ss_pred             ccCCChhHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC----CCeEEeccccccc
Q 038580          149 YKRGNLAQCIRG---GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN----YQPYVSDFGLHLL  221 (356)
Q Consensus       149 ~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  221 (356)
                      .+. +|.+.++-   ...+.++.....+|+.||+.|+.|||+   +=++||||||.|||+..+    |.+||+|+|+++.
T Consensus       110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~  185 (438)
T KOG0666|consen  110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLARL  185 (438)
T ss_pred             hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence            988 99988852   234568889999999999999999999   889999999999999877    9999999999998


Q ss_pred             cCCCCCc--ceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          222 LNPTAGQ--EMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       222 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      +.++...  ......-|..|+|||++.+. .|+.+.|||+.||++.||+|-++.|.+.
T Consensus       186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            7654322  23345668899999998865 6999999999999999999998888764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.7e-37  Score=265.35  Aligned_cols=220  Identities=20%  Similarity=0.189  Sum_probs=175.7

Q ss_pred             cCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChhHhhh
Q 038580           80 SNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR  159 (356)
Q Consensus        80 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  159 (356)
                      |.||.||++.+..++..+|+|.++...     .+..|...+....||||+++++++.. .+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987532     33445555555679999999998885 458999999999999999986


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcc
Q 038580          160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY  239 (356)
Q Consensus       160 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y  239 (356)
                      .  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+......    .....++..|
T Consensus        78 ~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y  148 (237)
T cd05576          78 K--FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY  148 (237)
T ss_pred             H--hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence            3  3458999999999999999999999   99999999999999999999999999987554321    1223456679


Q ss_pred             cCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCc
Q 038580          240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVS  319 (356)
Q Consensus       240 ~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (356)
                      +|||.+....++.++|+||+|+++||+++|..|+.........                  .            .....+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~------------------~------------~~~~~~  198 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------------H------------TTLNIP  198 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc------------------c------------cccCCc
Confidence            9999998888899999999999999999999887532211000                  0            000112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          320 EERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       320 ~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                      ...+..+.+++.+||+.||++||++
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            2344568899999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=278.10  Aligned_cols=260  Identities=20%  Similarity=0.306  Sum_probs=187.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++....  .....+.+|+.+++.++||||+++++++....     ...++++
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            4789999999999999988889999998864322  12346889999999999999999999876432     2468999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.. +|..+..    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....  
T Consensus       100 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--  169 (342)
T cd07879         100 PYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--  169 (342)
T ss_pred             ccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence            99975 7776652    358889999999999999999999   9999999999999999999999999999865422  


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHH----------Hhhhh
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR----------NAVLD  295 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~~  295 (356)
                        ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.+....   +.....          .....
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcc
Confidence              1123356778999999876 4688999999999999999999999976432110   000000          00000


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ........ ....+... ............+.+++.+||+.||++||++++++..
T Consensus       245 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         245 KAAKSYIK-SLPKYPRK-DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             cchHHHHh-hcCCcccc-hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000 00000000 0000011234567899999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-36  Score=277.88  Aligned_cols=268  Identities=19%  Similarity=0.269  Sum_probs=187.9

Q ss_pred             CcccccCCceEEEEEEcCC--CeEEEEEEecccccc--chHHHHHHHHHHhcc-CCCccccccceeeC---CCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRS--GSVRLLRFLRPVCTT--RDKEFGDLIELLGCI-RHPNLVPLLGFYAG---PRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~--~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~~~lv~  146 (356)
                      +.||+|+||.||++.....  +..+|+|.++.....  ..+.+.+|+++++++ +||||+++++.+..   .....++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~   85 (332)
T cd07857           6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE   85 (332)
T ss_pred             EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence            6799999999999999877  888999987643222  235678899999999 59999999986532   223578888


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +|+. ++|.+.+..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        86 e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          86 ELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             eccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            8886 589998863  4568999999999999999999999   999999999999999999999999999987654322


Q ss_pred             Cc---ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          227 GQ---EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       227 ~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ..   ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+............. ...........
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-TPDEETLSRIG  238 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-CCCHHHHHhhh
Confidence            11   1223467888999998765 4689999999999999999999999975332110000000000 00000000000


Q ss_pred             Ccccc---cccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDML---LCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~---~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+...   .........   .........+.+++.+||+.||++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000   000000000   011122457889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=279.17  Aligned_cols=262  Identities=21%  Similarity=0.271  Sum_probs=187.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|....++..+|+|.++.....  ..+.+.+|+.++++++||||+++++++....     ...++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            36799999999999999888999999988653222  2356788999999999999999999876322     3467888


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +++ +++|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.....  
T Consensus       102 ~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--  172 (345)
T cd07877         102 HLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--  172 (345)
T ss_pred             hhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccccc--
Confidence            776 7799888763   358899999999999999999999   9999999999999999999999999999875432  


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhh--hhcccccccC
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV--LDHRITDLYH  303 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  303 (356)
                        ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||...+....   +........  .........+
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHhhccc
Confidence              1223456788999998865 4678899999999999999999999965332110   000000000  0000000000


Q ss_pred             cc---cccccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PD---MLLCSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~---~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..   ............+   ....+..+.+++.+||+.||++||++.+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00   0000000000000   0113456789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-36  Score=279.24  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=189.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|....++..+|+|.+......  ....+.+|+++++.++||||+++++++....     ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            37799999999999999988999999988643222  2246889999999999999999999887433     2458999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+ +++|..++..   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||++...... 
T Consensus       100 e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-  171 (343)
T cd07880         100 PFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-  171 (343)
T ss_pred             ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence            998 6799888753   468999999999999999999999   99999999999999999999999999998754321 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch-------hHHHHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL-------PTFMRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~  298 (356)
                         .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+.......+       +............
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence               123456788999999875 45789999999999999999999999754321100000       0000000000000


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..... ...... ...-.....+....+.+++.+|++.||++|||+.+++.
T Consensus       249 ~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         249 KNYVK-KLPRFR-KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHH-hccccC-cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000 000000 00000011233456889999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=289.51  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=208.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceee----CCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYA----GPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~----~~~~~~~lv~e~  148 (356)
                      .++||.|.+|.||+++...++..+|+|+.... .+.+++++.|..+++.. .|||++.++|++.    ..++.+||||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf  102 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF  102 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence            37899999999999999999999999987654 44557888999999887 5999999999875    234589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |.+||..+++++-.+..+.|..+.-|+..++.|+.|||.   ..++|||+|-.|||++.++.+|++|||++...+.+.. 
T Consensus       103 C~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g-  178 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG-  178 (953)
T ss_pred             cCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecccc-
Confidence            999999999988778889999999999999999999999   9999999999999999999999999999988765443 


Q ss_pred             ceecccCCCcccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          229 EMLEASASQGYKAPELIKMK-----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ...+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+.++......+.++.                
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR----------------  242 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----------------  242 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC----------------
Confidence            34567899999999999643     467899999999999999999999988755333322221                


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             +..+....+..-.+++.+++..||..|-++||++.++++
T Consensus       243 -------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 -------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                   112222345667788999999999999999999998875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-37  Score=281.01  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=190.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+++|.+.....  .....+.+|+.+++.++|||++++++++...+     ...++++
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            3779999999999999998899999998764322  22356778999999999999999999776433     2489999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+ +++|.+++..   ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++...... 
T Consensus       100 e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851         100 HLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence            998 5699998863   468999999999999999999999   99999999999999999999999999998765322 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                         .....++..|+|||.+.+ ..++.++|+||||+++||+++|..||...........+..... ...+..........
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~  247 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEELLQKISSES  247 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHHHHhhccchh
Confidence               223456778999999865 3678999999999999999999999975432110000000000 00000000000000


Q ss_pred             cc---cccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 ML---LCSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~---~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..   ..........+   ....+..+.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00   00000000000   0123567889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=265.64  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=190.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHH-hccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELL-GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..||.|.||+|++-.++..|+..|+|.++..... ..+.+..|.+.. +.-+.||||++||.+-. ++..|+.||.|.- 
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELMDI-  147 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHHhh-
Confidence            5699999999999999999999999999876553 335678888764 44579999999998764 5589999999975 


Q ss_pred             ChhHhhh---cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          153 NLAQCIR---GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l~---~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ||+.+.+   .-....+++..+-.|..-.+.||.||-..  ..|+|||+||+|||+|..|.+||||||++..+..+..  
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            8876653   22345688888888888889999999985  7899999999999999999999999999876543221  


Q ss_pred             eecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 MLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ...-.|...|||||-+..  ..|+.+||+||||++++|+.||..||.+-+      ...+.+...+..       +|...
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~g-------dpp~l  290 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVIG-------DPPIL  290 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHcC-------CCCee
Confidence            223467788999999863  348999999999999999999999997521      122222221111       11111


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...      .-..+....+.+++..||.+|-++||+..++++
T Consensus       291 ~~~------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFD------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCc------ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            000      011224566889999999999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-38  Score=260.78  Aligned_cols=270  Identities=19%  Similarity=0.270  Sum_probs=193.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc--cccchHHHHHHHHHHhccCCCccccccceeeC---CC----CceEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG---PR----GEKLIV  145 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~----~~~~lv  145 (356)
                      .+||+|.||.||+|..+++++.|++|..-..  ...-.....+|+++|..++|+|++.++..|.+   +.    ..+++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            6799999999999999988888776654322  22334578899999999999999999988763   22    348999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |.+|+. +|.-.|.+ ....++...+.+++.++..||.|+|.   ..|+|||+||+|+||+.++.+||+|||+++.+...
T Consensus       103 f~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             HHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            999988 99998874 34678899999999999999999999   99999999999999999999999999999765432


Q ss_pred             CCcc---eecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          226 AGQE---MLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       226 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ....   -....-|..|++||.+.+. .|+++.|+|..||++.||+|+.+-+++.+.......+ ..+-.......|...
T Consensus       178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I-s~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI-SQLCGSITKEVWPNV  256 (376)
T ss_pred             cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH-HHHhccCCcccCCCc
Confidence            2211   1233447889999988764 6999999999999999999999998876543322111 111111111111111


Q ss_pred             cCccc-cc---ccCCCCCCCCcHHHH------HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          302 YHPDM-LL---CSNSNHENPVSEERI------LKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       302 ~~~~~-~~---~~~~~~~~~~~~~~~------~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      ..-.+ ..   .+-.....+.-++..      ++..+|+..++..||.+|+++++++..
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            00000 00   000000001111111      256789999999999999999998753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=267.82  Aligned_cols=265  Identities=19%  Similarity=0.257  Sum_probs=197.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCC--C----ccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH--P----NLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..+|+|+||.|-.+.++..+..+|+|+++.....+ +...-|++++.++.+  |    -+|.+.++|. -.++.|+|+|.
T Consensus        95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd-yrghiCivfel  172 (415)
T KOG0671|consen   95 DLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFD-YRGHICIVFEL  172 (415)
T ss_pred             hhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhh-ccCceEEEEec
Confidence            67999999999999999889999999998654322 457788999999842  3    3667777676 46799999998


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC--------------------C
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR--------------------N  208 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------------------~  208 (356)
                      + |.|+.+++..+...+++...+..|+.|++++++|||+   .+++|.||||+|||+.+                    +
T Consensus       173 l-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks  248 (415)
T KOG0671|consen  173 L-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS  248 (415)
T ss_pred             c-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence            8 4499999998888899999999999999999999999   99999999999999842                    3


Q ss_pred             CCeEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-------
Q 038580          209 YQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE-------  281 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~-------  281 (356)
                      ..++++|||.+......    ......|..|.|||++.+-.++.++||||+||+|.|++||...|...+..+.       
T Consensus       249 ~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI  324 (415)
T KOG0671|consen  249 TAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI  324 (415)
T ss_pred             cceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence            45899999998775332    2456778999999999999999999999999999999999999987664331       


Q ss_pred             CCchhHHHHHhh------hhccccc--cc-Cccccc----ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          282 DFHLPTFMRNAV------LDHRITD--LY-HPDMLL----CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       282 ~~~~~~~~~~~~------~~~~~~~--~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                      ...+|..+....      ...++.+  .. ..++..    |.....--.....+..++++|++.||..||.+|+|+.|++
T Consensus       325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL  404 (415)
T KOG0671|consen  325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL  404 (415)
T ss_pred             hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence            112222221111      0000000  00 000000    0000000112334566799999999999999999999987


Q ss_pred             H
Q 038580          349 W  349 (356)
Q Consensus       349 ~  349 (356)
                      .
T Consensus       405 ~  405 (415)
T KOG0671|consen  405 S  405 (415)
T ss_pred             c
Confidence            5

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=256.53  Aligned_cols=262  Identities=20%  Similarity=0.275  Sum_probs=202.4

Q ss_pred             hhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEE
Q 038580           68 DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        68 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +.+.-+++.||+|+|+.|--+....++..+|+|++.+..........+|++++...+ |+||+.++.+|++ +.+.||||
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FYLVf  155 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFYLVF  155 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEEEEE
Confidence            334445689999999999999998999999999998876666678899999988775 9999999999995 45899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEeccccccccC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGLHLLLN  223 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~  223 (356)
                      |-|.||+|..++.  ....+++..+.++..+|+.||.|||.   +||.|||+||+|||.....   -+||+||.+..-..
T Consensus       156 EKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             ecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999999999997  35578999999999999999999999   9999999999999997544   47999998864321


Q ss_pred             --C----CCCcceecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch-------
Q 038580          224 --P----TAGQEMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL-------  285 (356)
Q Consensus       224 --~----~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~-------  285 (356)
                        .    .......+.+|+..|||||+..     ..-|+.++|.||||+++|-|++|..||.+.-..+-.+.-       
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence              1    1122234567788899999864     235889999999999999999999999987654433211       


Q ss_pred             hHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+.+-..++++.. ++.+             .-....+++..+++...+..|+.+|.++.+++.
T Consensus       311 Q~~LFesIQEGkY-eFPd-------------kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  311 QNKLFESIQEGKY-EFPD-------------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHhccCC-cCCh-------------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1111111221110 0000             112346777889999999999999999988765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-36  Score=295.49  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=179.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeC----------------
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAG----------------  137 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------------  137 (356)
                      +.||+||||.||+++.+-+|+.+|+|.+..... .....+.+|+.++++|+|||||+++..+..                
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            689999999999999999999999999876542 223578999999999999999998732110                


Q ss_pred             ---------------------------------------C----------------------------------------
Q 038580          138 ---------------------------------------P----------------------------------------  138 (356)
Q Consensus       138 ---------------------------------------~----------------------------------------  138 (356)
                                                             .                                        
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                   0                                        


Q ss_pred             ---------------C--------CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 038580          139 ---------------R--------GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH  195 (356)
Q Consensus       139 ---------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH  195 (356)
                                     +        ..+|+-||||+...|.++++++... -.....+++..+|++||+|+|+   .++||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~---~giIH  720 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD---QGIIH  720 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh---Cceee
Confidence                           0        1247788999887777777643221 1456788999999999999999   99999


Q ss_pred             cCCCCCCeeEcCCCCeEEeccccccccC--------------C---CCCcceecccCCCcccCccccccCC---CCCcch
Q 038580          196 GNLKSKNILLDRNYQPYVSDFGLHLLLN--------------P---TAGQEMLEASASQGYKAPELIKMKD---ASEETD  255 (356)
Q Consensus       196 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~--------------~---~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sD  255 (356)
                      |||||.||++|.+..|||+|||++....              .   ......+...||.-|+|||++.+..   |+.|+|
T Consensus       721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD  800 (1351)
T KOG1035|consen  721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID  800 (1351)
T ss_pred             ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence            9999999999999999999999997611              0   0111234567888999999997654   999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccC
Q 038580          256 IYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCS  335 (356)
Q Consensus       256 vwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  335 (356)
                      |||+|++++||+.   ||...    +.   ...+...+....+...              ..+..+....=..+++.+++
T Consensus       801 mYSLGIVlFEM~y---PF~Ts----ME---Ra~iL~~LR~g~iP~~--------------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  801 MYSLGIVLFEMLY---PFGTS----ME---RASILTNLRKGSIPEP--------------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             hHHHHHHHHHHhc---cCCch----HH---HHHHHHhcccCCCCCC--------------cccccccchHHHHHHHHHhc
Confidence            9999999999986   45421    10   0001111111111111              01122223334579999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038580          336 PSPSLRPNIKQVLW  349 (356)
Q Consensus       336 ~~p~~Rps~~~il~  349 (356)
                      +||++||||.+++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=278.44  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +++||+|.||+||-|+++.+|+.||+|++.+..-  .....+++|+.+|+.+.||.||.+-..|++++ +.++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-rvFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-RVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-eEEEEehhhcc
Confidence            5899999999999999999999999999976533  33457999999999999999999999999766 89999999966


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~  228 (356)
                       +..+.+-..+..+++.....-+..||+.||.|||.   ++|+|+||||+|||+...   -++||||||.++......  
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence             55555544566779988888899999999999999   999999999999999643   479999999999875322  


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      -.....||+.|+|||++.+..|...-|+||.|+++|--++|..||..+....+..+...++.+                 
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP-----------------  784 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP-----------------  784 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC-----------------
Confidence            234678999999999999999999999999999999999999999875432222221111111                 


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         .    ....+......+||...|+..-++|-+..+-+.
T Consensus       785 ---p----~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 ---P----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---C----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               0    112234455678999999999999998876553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=276.12  Aligned_cols=234  Identities=21%  Similarity=0.298  Sum_probs=188.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ...+|.|+|+.|-.+.+..+....++|++...    ..+..+|+.++... +||||+++.+.+.+. .+.++|||.+.++
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-~~~~~v~e~l~g~  401 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-KEIYLVMELLDGG  401 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCC-ceeeeeehhcccc
Confidence            35699999999999999988888999998754    23345566555444 799999999999854 4899999999998


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE-cCCCCeEEeccccccccCCCCCccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL-DRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      -|.+.+...   +.....+..|+.+|+.|+.|||+   +|++||||||.|||+ ++.++++|+|||.++..+..    ..
T Consensus       402 ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~  471 (612)
T KOG0603|consen  402 ELLRRIRSK---PEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD  471 (612)
T ss_pred             HHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence            887777532   22226777899999999999999   999999999999999 69999999999998776543    23


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+-|..|.|||++....|+.++|+||||++||+|++|+.||...+..       ..+...+.                 
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~-----------------  527 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQ-----------------  527 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhc-----------------
Confidence            446678899999999999999999999999999999999999865443       11111111                 


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ..+++...+....+|+..||+.||.+||++.++..
T Consensus       528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ---CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence               12234667778899999999999999999999864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.7e-35  Score=289.69  Aligned_cols=141  Identities=18%  Similarity=0.266  Sum_probs=124.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++......   ...+..|+.+++.++||||+++++++.. .+..++||||+.
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmEy~~   87 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLVMEYLI   87 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEEEeCCC
Confidence            378999999999999999899999999987543222   2568889999999999999999988875 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      +++|.+++..  ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        88 g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999863  3457888899999999999999999   999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=259.07  Aligned_cols=237  Identities=22%  Similarity=0.305  Sum_probs=190.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      -.+||+|+||.|.+|..+.+.+.+|+|++++...-..   +--..|-++|+.. +-|.++++...|++.+ ++|.||||+
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-RLyFVMEyv  432 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-RLYFVMEYV  432 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-heeeEEEEe
Confidence            4789999999999999999999999999986533222   2234566666655 5789999999888655 999999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      .||+|--.+++  -..+.++.+.-++..|+-||-|||+   ++|+.||||.+|||+|.+|++||+|||+++-- -.....
T Consensus       433 nGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-i~~~~T  506 (683)
T KOG0696|consen  433 NGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IFDGVT  506 (683)
T ss_pred             cCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc-ccCCcc
Confidence            99999988874  3346667788899999999999999   99999999999999999999999999998752 233455


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ..+.+||+.|+|||++..++|+.+.|.||||+++|||+.|+.||.+.+..+    +..    .+.++.            
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----lF~----aI~ehn------------  566 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQ----AIMEHN------------  566 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHH----HHHHcc------------
Confidence            668899999999999999999999999999999999999999998754322    111    111111            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPN  343 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  343 (356)
                            -.+|...+.+..++....+...|.+|..
T Consensus       567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  1245556667778888999999999853

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-34  Score=250.45  Aligned_cols=239  Identities=23%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             CCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChhHhhh
Q 038580           81 NYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR  159 (356)
Q Consensus        81 ~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  159 (356)
                      +||.||+|....++..+++|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            58999999999888999999987655444 5789999999999999999999998875 458999999999999999987


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcc
Q 038580          160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY  239 (356)
Q Consensus       160 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y  239 (356)
                      ...  .+++..+..++.+++.++.|||+   .+++|+||+|+||++++++.++++|||.+.......  ......++..|
T Consensus        80 ~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       80 KRG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             hcc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            432  38889999999999999999999   999999999999999999999999999987754332  22344567789


Q ss_pred             cCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCc
Q 038580          240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVS  319 (356)
Q Consensus       240 ~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (356)
                      ++||.+....++.++|+||||+++|++++|..||......   ........    ...    ..           .....
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~----~~~----~~-----------~~~~~  210 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIG----KPK----PP-----------FPPPE  210 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHh----ccC----CC-----------Ccccc
Confidence            9999998888899999999999999999999998653110   00111100    000    00           00000


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          320 EERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       320 ~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+.++.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            014567889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.3e-35  Score=281.55  Aligned_cols=263  Identities=19%  Similarity=0.148  Sum_probs=163.5

Q ss_pred             CCCcccccCCceEEEEEEcCC----CeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceee-----CCCCceE
Q 038580           73 PGEVIGKSNYGTLYKALLQRS----GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA-----GPRGEKL  143 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~----~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----~~~~~~~  143 (356)
                      ..+.||+|+||.||+|.+..+    +..+|+|.+.....  .+.+..+  .++...+.+++.++..+.     ..+...+
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            358899999999999999888    88888887653211  1111111  122222333333322211     2345789


Q ss_pred             EEEecccCCChhHhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE
Q 038580          144 IVHPFYKRGNLAQCIRGGSGE------------------AHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL  205 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  205 (356)
                      +++||+.+++|.+++......                  ......+..++.|++.||+|||+   .+|+||||||+|||+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl  288 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIF  288 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEE
Confidence            999999999999998642210                  01123456789999999999999   999999999999999


Q ss_pred             cC-CCCeEEeccccccccCCCCCcceecccCCCcccCccccccC----------------------CCCCcchhHHHHHH
Q 038580          206 DR-NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK----------------------DASEETDIYSFGVI  262 (356)
Q Consensus       206 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDvwslG~~  262 (356)
                      +. ++.+||+|||+++..............+++.|+|||.+...                      .++.++|||||||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            85 57999999999976543333333456778899999965322                      23446799999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCchhHHHHHh-hhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 038580          263 MLELISGKEPINENPTPDEDFHLPTFMRNA-VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR  341 (356)
Q Consensus       263 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  341 (356)
                      +|||+++..|+...     ...+...+... .....+.....+...  ..................+|+.+||+.||++|
T Consensus       369 L~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        369 FLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRAS--PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccc--hhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999976654321     00000000000 000000000000000  00000000001112245689999999999999


Q ss_pred             CCHHHHHH
Q 038580          342 PNIKQVLW  349 (356)
Q Consensus       342 ps~~~il~  349 (356)
                      ||+.++++
T Consensus       442 ~ta~e~L~  449 (566)
T PLN03225        442 ISAKAALA  449 (566)
T ss_pred             CCHHHHhC
Confidence            99999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.5e-34  Score=268.26  Aligned_cols=261  Identities=16%  Similarity=0.213  Sum_probs=174.9

Q ss_pred             CCCcccccCCceEEEEEEc----------------CCCeEEEEEEeccccccchHH--------------HHHHHHHHhc
Q 038580           73 PGEVIGKSNYGTLYKALLQ----------------RSGSVRLLRFLRPVCTTRDKE--------------FGDLIELLGC  122 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~----------------~~~~~~a~k~~~~~~~~~~~~--------------~~~e~~~l~~  122 (356)
                      ..++||+|+||+||+|.+.                ..++.||+|.++.......++              +..|+.++.+
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~  228 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK  228 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence            3488999999999999752                234678888876433222223              3346667777


Q ss_pred             cCCCcc-----ccccceeeC-------CCCceEEEEecccCCChhHhhhcCC----------------------CCCCCH
Q 038580          123 IRHPNL-----VPLLGFYAG-------PRGEKLIVHPFYKRGNLAQCIRGGS----------------------GEAHKW  168 (356)
Q Consensus       123 l~h~ni-----v~~~~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~  168 (356)
                      ++|.|+     ++++++|..       .++..++|+||+++++|.++++...                      ...+++
T Consensus       229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence            766554     677787653       1346899999999999999986421                      112467


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccccC
Q 038580          169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK  248 (356)
Q Consensus       169 ~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  248 (356)
                      ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...............+++.|+|||.+...
T Consensus       309 ~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            7888999999999999999   9999999999999999999999999999865433222222223447889999987543


Q ss_pred             C--------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          249 D--------------------A--SEETDIYSFGVIMLELISGKE-PINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       249 ~--------------------~--~~~sDvwslG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .                    |  ..+.|+||+||++++|++|.. ||...................+     ....   
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~-----r~~~---  457 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW-----RMYK---  457 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH-----Hhhc---
Confidence            2                    1  124799999999999999875 6653221111000000000000     0000   


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSP---SLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~Rps~~~il~  349 (356)
                           .................+|+..+|..+|   .+|+|++++++
T Consensus       458 -----~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 -----GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -----ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                 0001111223345678899999999766   68999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=231.19  Aligned_cols=206  Identities=22%  Similarity=0.352  Sum_probs=167.8

Q ss_pred             cchhhhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-HHHHHHHHHHh-ccCCCccccccceeeCCCCc
Q 038580           64 LTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLG-CIRHPNLVPLLGFYAGPRGE  141 (356)
Q Consensus        64 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~  141 (356)
                      +.+.+........||+|+||.|=+-++..+|.+.|+|.++....... +....|+++.. ....|.+|.|+|.+-. .+.
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-ccc
Confidence            55555555556789999999999999999999999999876543332 45677777654 4579999999997653 458


Q ss_pred             eEEEEecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          142 KLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      .++.||.|.. ||+.+-+.  ..+...++..+-+|+..+.+||.|||+.  ..++|||+||.|||++.+|++|+||||++
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccc
Confidence            9999999976 89887653  2456788889999999999999999995  78999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCCcccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIKM----KDASEETDIYSFGVIMLELISGKEPINE  275 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~tg~~p~~~  275 (356)
                      -.+.++-..  .-..|...|||||.+..    ..|+.+|||||||+.+.||.+++.||..
T Consensus       197 G~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  197 GYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            776443222  22457778999998853    3689999999999999999999999863

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=265.64  Aligned_cols=237  Identities=18%  Similarity=0.244  Sum_probs=195.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc---cccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV---CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ..||-|+||.|=++..+......|+|++++.   .+...+....|-.+|...+.|.||++|-.|.+++ +.|++||-|-|
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-yvYmLmEaClG  504 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-YVYMLMEACLG  504 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-hhhhhHHhhcC
Confidence            5699999999999988765555788887654   2333456788999999999999999999998654 89999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.|-..|+  ....++..+..-++..+++|++|||+   ++|+.|||||+|+++|.+|-+||.|||+++....  +....
T Consensus       505 GElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g~KTw  577 (732)
T KOG0614|consen  505 GELWTILR--DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--GRKTW  577 (732)
T ss_pred             chhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc--CCcee
Confidence            99999997  35568888888899999999999999   9999999999999999999999999999988754  55667


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      +.+||+.|.|||++.+...+.++|.||||++++|+++|.+||++.+.......+.+.+..                    
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------------------  637 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------------------  637 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--------------------
Confidence            899999999999999999999999999999999999999999986543322222221111                    


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPN  343 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  343 (356)
                          -.+|........+|++.....+|.+|..
T Consensus       638 ----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 ----IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                0133444556678999999999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=275.19  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=183.2

Q ss_pred             hhhcCCCCcccccCCce-EEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEE
Q 038580           68 DILDAPGEVIGKSNYGT-LYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        68 ~~~~~~~~~ig~G~~g~-V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      .++...++++|.|+.|+ ||+|...  ++.||+|.+-.   ....-..+|++.|+.- .|||||++++.=. .+...|+.
T Consensus       508 k~~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIa  581 (903)
T KOG1027|consen  508 KLFFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIA  581 (903)
T ss_pred             eeeeccHHHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEE
Confidence            45566678999999988 6999985  77888887643   2234568899998876 5999999987444 45589999


Q ss_pred             EecccCCChhHhhhcC-CCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---C--CCeEEecccc
Q 038580          146 HPFYKRGNLAQCIRGG-SGEA-HKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---N--YQPYVSDFGL  218 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~-~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~  218 (356)
                      .|.|.. +|.+++... .... ..--....+..|+++||+|||+   .+||||||||+||||+.   +  .+++|+|||+
T Consensus       582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            999976 999999753 1111 1112346778899999999999   99999999999999976   3  4689999999


Q ss_pred             ccccCCCCC--cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          219 HLLLNPTAG--QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       219 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      |+.+.....  .......||-+|+|||.+....-+.+.||||+||++|+.++ |..||.+....+...          ..
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI----------l~  727 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI----------LT  727 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh----------hc
Confidence            988754322  22445678999999999998888899999999999999998 599998643322110          00


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +.    ..-.         ......++  +..+||.+|++.+|..||+|.+++.
T Consensus       728 ~~----~~L~---------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  728 GN----YTLV---------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             Cc----ccee---------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00    0000         00011122  6779999999999999999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=255.95  Aligned_cols=251  Identities=20%  Similarity=0.302  Sum_probs=194.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccch-------HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-------KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+||+|||+.||+|.+...++.||+|+-.....-++       +...+|.++-+.|.||.||++|+++.-+.+.+|-|+|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            579999999999999998999999998653322111       2467789999999999999999999866778999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~  224 (356)
                      ||+|.+|+-+|+.  .+...+..+..|+.||+.||.||.. .+.+|+|-||||.|||+.+   .|.+||.|||+++.+..
T Consensus       549 YceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd  625 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD  625 (775)
T ss_pred             ecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence            9999999999974  4568888999999999999999986 6689999999999999954   46799999999998765


Q ss_pred             CCCc------ceecccCCCcccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          225 TAGQ------EMLEASASQGYKAPELIKMK----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       225 ~~~~------~~~~~~~~~~y~aPE~~~~~----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ....      -.....||.+|++||.+..+    ..+.|.||||.||++|.++.|+.||...-........     +.+.
T Consensus       626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-----NTIl  700 (775)
T KOG1151|consen  626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-----NTIL  700 (775)
T ss_pred             CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-----hchh
Confidence            4333      23456789999999988644    3578999999999999999999999754322111000     0000


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                      ...  +             -..+..+-...+..++|++||++.-++|.+..++.
T Consensus       701 kAt--E-------------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  701 KAT--E-------------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             cce--e-------------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            000  0             01122233455677899999999999999887765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-33  Score=258.27  Aligned_cols=209  Identities=17%  Similarity=0.266  Sum_probs=174.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||-|+||.|.++...++..++|+|.+++...-..   .....|.++|+.-..+.||+||-.|++ ++.+|+||+|.+
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVMdYIP  712 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMDYIP  712 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEEeccC
Confidence            4679999999999999988899999999876533222   257889999999999999999999996 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      ||++-.+|-  ....+++..+.-++..++.|+++.|.   .|+|||||||+|||||.+|++||.|||+|.-+....... 
T Consensus       713 GGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  713 GGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             CccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999885  34568888888899999999999999   999999999999999999999999999986432110000 


Q ss_pred             ----------------------------------------eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhC
Q 038580          230 ----------------------------------------MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG  269 (356)
Q Consensus       230 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg  269 (356)
                                                              .....||+.|+|||++....|+..+|.||.||+|+||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence                                                    0123578889999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCchhHH
Q 038580          270 KEPINENPTPDEDFHLPTF  288 (356)
Q Consensus       270 ~~p~~~~~~~~~~~~~~~~  288 (356)
                      +.||-..+..+....+..|
T Consensus       868 ~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             CCCccCCCCCcceeeeeeh
Confidence            9999987776665555444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=238.35  Aligned_cols=245  Identities=19%  Similarity=0.316  Sum_probs=189.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHH---HHHHHHHHhc-cCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---FGDLIELLGC-IRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~---~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      -++||+|+|.+|..+.+..+.+.+|+|++++..-...++   .+.|-.+... -+||.+|.+..+|++ ++++++|.||+
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlffvieyv  333 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLFFVIEYV  333 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEEEEEEEe
Confidence            378999999999999999999999999998764443332   3445444443 479999999998885 55999999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|--+++  ..+.+++..+.-+...|..||.|||+   .||+.||||.+|+|+|..|++|+.|+|+++--- ..+..
T Consensus       334 ~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l-~~gd~  407 (593)
T KOG0695|consen  334 NGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPGDT  407 (593)
T ss_pred             cCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC-CCCcc
Confidence            9999977775  34568888888899999999999999   999999999999999999999999999987532 23444


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ..+.+||+.|.|||++.+..|..+.|.|++|++++||+.|+.||+-.............+-..+.+..+.          
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----------  477 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----------  477 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----------
Confidence            5688999999999999999999999999999999999999999974332222222222222222221111          


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPN  343 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps  343 (356)
                              .|...+-....+++.-|++||.+|..
T Consensus       478 --------iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 --------IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                    12222223446788899999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-32  Score=241.85  Aligned_cols=130  Identities=25%  Similarity=0.321  Sum_probs=110.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-----C---CccccccceeeC--C-CCc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-----H---PNLVPLLGFYAG--P-RGE  141 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~--~-~~~  141 (356)
                      ..++||=|.|++||++.+.++.+.||+|+.+... ...+....||++|++++     |   .+||+|++.|..  + +.+
T Consensus        82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H  160 (590)
T KOG1290|consen   82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH  160 (590)
T ss_pred             EEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence            3578999999999999999999999999987542 23356788999999874     3   379999998863  2 238


Q ss_pred             eEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      .|+|+|++ |-+|..++.....+.++...+.+|+.||+.||.|||..  .+|+|.||||+|||+.
T Consensus       161 VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  161 VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence            89999998 45999999877778899999999999999999999997  6899999999999973

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.4e-33  Score=227.07  Aligned_cols=258  Identities=19%  Similarity=0.293  Sum_probs=189.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCC-ceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRG-EKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-~~~lv~e~~~~g  152 (356)
                      +++|+|.|+.||.|..-.+.+.+++|++++.   ..+.+.+|+.+|..++ ||||++++++..++.+ ...|++||..+.
T Consensus        44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~  120 (338)
T KOG0668|consen   44 RKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT  120 (338)
T ss_pred             HHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence            7899999999999998888899999999865   4568999999999997 9999999998886654 578999999998


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCCCCCccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +.....     ..++-..+..++.++++||.|+||   .||.|||+||.|+++|. .-..+|+|+|++.++.+...  -.
T Consensus       121 Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--Yn  190 (338)
T KOG0668|consen  121 DFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YN  190 (338)
T ss_pred             cHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCce--ee
Confidence            877664     246666788899999999999999   99999999999999985 44689999999988764322  22


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCC-CCCCCCCCchhHHHHHhhhh---cccccccCccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINE-NPTPDEDFHLPTFMRNAVLD---HRITDLYHPDM  306 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  306 (356)
                      -...+..|--||.+-. +.|+.+-|+|||||++..|+..+.||.. .+..+....+...+......   ....-..+|..
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            3345667889998865 4689999999999999999999999754 33322222222222111000   00111122221


Q ss_pred             cc------------ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LL------------CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..            +.+.....    -...+..+++...|..|-++|||+.|.+.
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11            11111111    12345678999999999999999998764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.8e-34  Score=237.26  Aligned_cols=268  Identities=23%  Similarity=0.308  Sum_probs=195.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~  146 (356)
                      +.+.||-|.||.||...+..+|+.++.|.+.....  ...+.+.+|+.+|.-++|.|+++.++..+.+.    .++|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            35889999999999999999999998887654322  22357889999999999999999999776433    1467888


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      |.|.. +|...+-  +.+.++...+.-+..||++||.|||+   .+|.||||||.|.|++.+...||||||+++......
T Consensus       137 ELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  137 ELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            88865 8888875  45667777888899999999999999   999999999999999999999999999999876665


Q ss_pred             CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH--------HHh---hh
Q 038580          227 GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM--------RNA---VL  294 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~---~~  294 (356)
                      ...+....-|..|.|||++.+. .|+...||||.||++.|++..+..|......+...-+.+.+        +..   ..
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            5566666778889999999875 69999999999999999999888887543322111111111        000   00


Q ss_pred             hcccccc-cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          295 DHRITDL-YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       295 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .+.++.. ..|+.....    ....+...-.+-.++...++..||.+|.+..+.+..
T Consensus       291 ~H~LR~~~k~Ps~~vLY----tlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLY----KIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhhccCCCCCCcccee----eecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            0111100 011110000    001122233345577888999999999998887654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8e-31  Score=222.54  Aligned_cols=211  Identities=31%  Similarity=0.496  Sum_probs=180.4

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChh
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      ||+|++|.||++....++..+++|.+...... ....+.+|++.++.++|++++++++++... ...++++|++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence            68999999999999887889999998754332 236799999999999999999999988854 5899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCCCCCcceeccc
Q 038580          156 QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       156 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      +++.... ..+++..+..++.+++.++.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            9987432 468899999999999999999999   99999999999999999 89999999999876543321 122345


Q ss_pred             CCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          235 ASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       235 ~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      +...|++||.+... .++.++|+|++|++++++                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            67779999998877 788999999999999998                                               


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                                ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                      135589999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=251.29  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=198.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      .++|+|+||.||++++..+++.+|+|+++........-.+.|+-+++..+|||||.++|.|.. +...++.||||.+|+|
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicMEycgggsl   99 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICMEYCGGGSL   99 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEEecCCCcc
Confidence            669999999999999999999999999998888787888999999999999999999998874 4589999999999999


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceeccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS  234 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  234 (356)
                      .+.-+  -..++.+.++.-++.....|++|||+   .+-+|||||-.||++++.|.+|++|||.+..+...- .....+.
T Consensus       100 Qdiy~--~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krksfi  173 (829)
T KOG0576|consen  100 QDIYH--VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFI  173 (829)
T ss_pred             cceee--ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-hhhhccc
Confidence            99876  45678888888999999999999999   999999999999999999999999999987665432 2334678


Q ss_pred             CCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          235 ASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       235 ~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ||+.|||||+..   .+.|...+|+|+.|+...|+..-+.|-.+....    +....+...        .++|.      
T Consensus       174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----r~l~LmTkS--------~~qpp------  235 (829)
T KOG0576|consen  174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----RALFLMTKS--------GFQPP------  235 (829)
T ss_pred             CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----HHHHHhhcc--------CCCCC------
Confidence            999999999863   567899999999999999998877774432211    111111110        11100      


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ...-...-.+.+.++++.|+..+|.+||++..++.
T Consensus       236 ---~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 ---TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               00111223456789999999999999999998765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=242.77  Aligned_cols=194  Identities=18%  Similarity=0.285  Sum_probs=164.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--------cchHHHHHHHHHHhccC---CCccccccceeeCCCC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--------TRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRG  140 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  140 (356)
                      .+-..+|+|+||.|++|.++.+...|++|.+.+..-        .+.-..-.|+++|+.++   |+||++++++|++. +
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd-d  642 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD-D  642 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-C
Confidence            344789999999999999999888999999875421        11123567999999997   99999999999964 4


Q ss_pred             ceEEEEecc-cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          141 EKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       141 ~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      +.||+||-. ++-+|.+++.  ....+++.....|..|++.|+++||+   .+|||||||-+|+.++.+|-+||+|||.+
T Consensus       643 ~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccch
Confidence            889999865 5669999997  34568888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPIN  274 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~  274 (356)
                      .+...   .+-....||..|.|||++.+..| ...-|||++|+++|.++....||.
T Consensus       718 a~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            76432   22335789999999999999887 567899999999999999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=226.12  Aligned_cols=262  Identities=23%  Similarity=0.249  Sum_probs=190.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccc--cccchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~e  147 (356)
                      ..+|.|.- .|.-+.+.-.++.|++|.....  .....+...+|..++..++|+||++++.++...+     ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            56788877 6777777666667776655432  2223356788999999999999999999887433     25799999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.. +|.+.+.    -.++-.++..+..|++.|+.|||+   .+|+||||||+||++..+.++||.|||++......  
T Consensus       102 ~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  102 LMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             hhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--
Confidence            9965 9998886    357777889999999999999999   99999999999999999999999999998765432  


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH--------HHhhhhcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM--------RNAVLDHRIT  299 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  299 (356)
                      ........+..|.|||++.+-.|...+||||.||++.||++|...|.+.+..+....+.+..        ......  ..
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~--~r  249 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT--VR  249 (369)
T ss_pred             cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH--HH
Confidence            34556778889999999988889999999999999999999999998765433222221111        111000  00


Q ss_pred             cccCcccc--------cccCC--CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          300 DLYHPDML--------LCSNS--NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       300 ~~~~~~~~--------~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+......        .++..  ......+.-......+++.+||..||++|.++++++.
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            00000000        00000  0011112223455789999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.7e-30  Score=218.77  Aligned_cols=197  Identities=29%  Similarity=0.461  Sum_probs=168.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|++|.||++....++..+++|.+...... ..+.+.+|++.+++++|+|++++++++.. ....++++|+++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~~~~   82 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYCEGG   82 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEeccCCC
Confidence            36799999999999999887888999998765444 45688999999999999999999998875 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++..... .+++.....++.+++.++.|||+   .+++|+|++|.||+++.++.++|+|||.+.............
T Consensus        83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            99999974322 17889999999999999999999   899999999999999999999999999987764432112233


Q ss_pred             ccCCCcccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 038580          233 ASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGKEPINE  275 (356)
Q Consensus       233 ~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~tg~~p~~~  275 (356)
                      ..++..|++||.+ ....++.++|+|+||++++|+++|..||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4566789999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=220.96  Aligned_cols=247  Identities=19%  Similarity=0.350  Sum_probs=191.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEec--cccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLR--PVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+|.+...|..|+|+|+.+.  ++.|++.  .......++|..|.-.|+.+.||||.+++|.|.++. ++.++..||+.|
T Consensus       196 tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq~mp~g  272 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQYMPFG  272 (448)
T ss_pred             hhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeeeeccch
Confidence            56888999999999998443  3444443  333444578999999999999999999999999765 789999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      ||.+.|++..+-..+..+..+++.+++.|++|||+ .++-|..--|.+..+++|++.+++|+--. .++     +.+...
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad-~kf-----sfqe~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMAD-TKF-----SFQEVG  345 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheeccc-cee-----eeeccc
Confidence            99999998888788889999999999999999998 33334445789999999999998874211 111     111123


Q ss_pred             ccCCCcccCccccccCCC---CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          233 ASASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~---~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+.||+||.+...+.   -.++|+|||++++||+.|...||.+.+..+....+.      +                
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------l----------------  403 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------L----------------  403 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------h----------------
Confidence            345778999999986654   357999999999999999999999866544322111      0                


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ++.+...|+.....+..||.-|++.||.+||.+..|+-.||++.
T Consensus       404 --eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 --EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              11222345566677889999999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.9e-31  Score=238.26  Aligned_cols=266  Identities=18%  Similarity=0.192  Sum_probs=196.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC------CCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR------HPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ...|+|-|++|..|.+...+..||+|+++.... -.+.=..|+++|++|+      --|+++++-.|.. .+++|||+|.
T Consensus       438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knHLClVFE~  515 (752)
T KOG0670|consen  438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNHLCLVFEP  515 (752)
T ss_pred             eccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cceeEEEehh
Confidence            347899999999999998888999999986432 3355678999999996      2388999988874 5599999998


Q ss_pred             ccCCChhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEeccccccccCCCC
Q 038580          149 YKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       149 ~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~  226 (356)
                      +.- +|.+.|+. +.+..+....+..++.|+..||..|-.   .+++|.||||+|||+++. ...||||||.|.....  
T Consensus       516 Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e--  589 (752)
T KOG0670|consen  516 LSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSASFASE--  589 (752)
T ss_pred             hhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCcccccccc--
Confidence            754 99999963 345668888899999999999999999   899999999999999865 4689999999876543  


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-------chhHHHHH--hhhhcc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-------HLPTFMRN--AVLDHR  297 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~~~--~~~~~~  297 (356)
                       ....+..-+..|.|||++.+-+|+...|+||.||.|||+.||+..|.+.+...+.-       .++.-+..  .+.+..
T Consensus       590 -neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH  668 (752)
T KOG0670|consen  590 -NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH  668 (752)
T ss_pred             -ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence             22334555778999999999999999999999999999999999999876654321       11111110  011100


Q ss_pred             cccc-------cCc---c--cccccCCCC------------C-CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDL-------YHP---D--MLLCSNSNH------------E-NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~-------~~~---~--~~~~~~~~~------------~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +...       .|+   .  .....+..+            . ..-......++.+|+..|+..||++|.|..+.|+
T Consensus       669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            0000       000   0  000000000            0 1123356778999999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=209.22  Aligned_cols=248  Identities=19%  Similarity=0.254  Sum_probs=178.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccce-eeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGF-YAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~~lv~e~~~~  151 (356)
                      ++.+|+|.||.+-++.++.++..+++|.+... .....+|.+|..---.| .|.||+.-|++ |++. +....++||++.
T Consensus        29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-d~YvF~qE~aP~  106 (378)
T KOG1345|consen   29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-DAYVFVQEFAPR  106 (378)
T ss_pred             HHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-ceEEEeeccCcc
Confidence            47799999999999999999999999988643 33456888887654344 48999998875 5544 478889999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCCCeEEeccccccccCCCCCcc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      |+|.+-+.   ...+-+....+++.|+++|+.|||+   .++||||||.+|||+-  +..++|+||||..+...    ..
T Consensus       107 gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g----~t  176 (378)
T KOG1345|consen  107 GDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG----TT  176 (378)
T ss_pred             chhhhhcC---cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC----ce
Confidence            99998775   3456677788999999999999999   9999999999999993  44589999999876532    22


Q ss_pred             eecccCCCcccCcccccc---C--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          230 MLEASASQGYKAPELIKM---K--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~---~--~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      .........|.+||+...   +  ...+.+|+|.||++++.++||..||....  .+.....+|..-...  ...  ..|
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~w~~r--k~~--~~P  250 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQWLKR--KNP--ALP  250 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHHHhcc--cCc--cCc
Confidence            222233455899997753   2  24678999999999999999999998432  233333333321110  000  000


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                      +.            -....+.+.++.++-+..+|++|-..-+..++-
T Consensus       251 ~~------------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  251 KK------------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hh------------hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            00            011234566888999999999996555555443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.5e-28  Score=216.29  Aligned_cols=267  Identities=22%  Similarity=0.324  Sum_probs=191.3

Q ss_pred             CCCCcccccCCceEEEEEEcC---CCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...++||+|+|++||++.+..   .++.+|+|.+...+  ....+.+|+++|..+. +.||+++.+.+. .++..++|+|
T Consensus        39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~v~ivlp  115 (418)
T KOG1167|consen   39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR-NNDQVAIVLP  115 (418)
T ss_pred             hhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc-cCCeeEEEec
Confidence            335889999999999999876   77889999887543  4456899999999885 899999999776 4568999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEecccccccc----
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLL----  222 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~----  222 (356)
                      |++.-+..++..     .++...+..++..+..||+++|.   .||+||||||.|+|.+.. +.-.|.|||++...    
T Consensus       116 ~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  116 YFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             ccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            999999888875     46678889999999999999999   999999999999999854 46679999997611    


Q ss_pred             -------------CC----------------CC----------CcceecccCCCcccCcccccc-CCCCCcchhHHHHHH
Q 038580          223 -------------NP----------------TA----------GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVI  262 (356)
Q Consensus       223 -------------~~----------------~~----------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~  262 (356)
                                   ..                +.          ........||++|.|||++.. +..++++||||.|++
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                         00                00          000113358899999999864 457889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCC-CchhHH-----HHH-hhhhcc--ccc--c--cCcc---------cccccCCCC----CC
Q 038580          263 MLELISGKEPINENPTPDED-FHLPTF-----MRN-AVLDHR--ITD--L--YHPD---------MLLCSNSNH----EN  316 (356)
Q Consensus       263 l~el~tg~~p~~~~~~~~~~-~~~~~~-----~~~-~~~~~~--~~~--~--~~~~---------~~~~~~~~~----~~  316 (356)
                      ++-++++..||......... .++...     ++. ....++  +.+  .  ..+.         ...|.....    ..
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999998764433211 111111     111 111111  000  0  0000         011111111    11


Q ss_pred             CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          317 PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       317 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+-.+..+++++.+|+..||.+|.|+++.++
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            223334557899999999999999999999886

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=8.7e-28  Score=199.22  Aligned_cols=167  Identities=23%  Similarity=0.302  Sum_probs=125.5

Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |||.++++.. +..+++..++.++.|++.||+|||+   .+      ||+||+++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence            6899999742 4569999999999999999999999   65      999999999999999  9998765432      


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+++.|||||++.+..++.++|||||||++|||+||..||......      .......... ....  .+       
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~-~~~~--~~-------  126 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNG-MPAD--DP-------  126 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHH-hccC--Cc-------
Confidence            125788999999999999999999999999999999999999653221      1111111100 0000  00       


Q ss_pred             CCCCCCCcHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          312 SNHENPVSEERIL--KFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       312 ~~~~~~~~~~~~~--~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        .....+.....  .+.+++.+||+.+|++||++.++++.+..+
T Consensus       127 --~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      127 --RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             --cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence              00011223333  689999999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.2e-28  Score=248.85  Aligned_cols=197  Identities=16%  Similarity=0.168  Sum_probs=137.5

Q ss_pred             hccCC-CccccccceeeC------CCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 038580          121 GCIRH-PNLVPLLGFYAG------PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI  193 (356)
Q Consensus       121 ~~l~h-~niv~~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i  193 (356)
                      +.++| +||.+++++|..      ....++.++||+ +++|.++++.. ...+++..++.++.||++||+|||+   .+|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            34556 688888887721      113567778887 45999999743 4568999999999999999999999   999


Q ss_pred             eecCCCCCCeeEcCC-------------------CCeEEeccccccccCCCC---------------CcceecccCCCcc
Q 038580          194 IHGNLKSKNILLDRN-------------------YQPYVSDFGLHLLLNPTA---------------GQEMLEASASQGY  239 (356)
Q Consensus       194 vH~dlk~~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~---------------~~~~~~~~~~~~y  239 (356)
                      +||||||+|||++..                   +.+|++|||+++......               ........+|+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   445666666654321000               0001123467889


Q ss_pred             cCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCc
Q 038580          240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVS  319 (356)
Q Consensus       240 ~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (356)
                      ||||++.+..|+.++|||||||++|||++|..|+....         ..... ....    ...+.             .
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~-~~~~----~~~~~-------------~  234 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSS-LRHR----VLPPQ-------------I  234 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHH-HHHh----hcChh-------------h
Confidence            99999999999999999999999999999888764210         00000 0000    00000             0


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          320 EERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       320 ~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........+++..||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            011233557889999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-25  Score=200.29  Aligned_cols=257  Identities=17%  Similarity=0.202  Sum_probs=189.4

Q ss_pred             CCCcccccCCceEEEEEEcCCC-eEEEEEEeccccccchHHHHHHHHHHhccCC----CccccccceeeCCCCceEEEEe
Q 038580           73 PGEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEFGDLIELLGCIRH----PNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..+.||+|+||.||++....++ ..+|+|+...........+..|+.++..+..    +++..+++.....+...++||+
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~  101 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS  101 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence            3588999999999999987664 6788888765544444478889999888873    5777777766334557899998


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-----CCeEEecccccc--
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-----YQPYVSDFGLHL--  220 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~~~--  220 (356)
                      .+ |.||.++........++..+.+.++.|++.+|.+||+   .|++||||||.|++++..     ..+.+.|||+++  
T Consensus       102 l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen  102 LL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             cc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            77 6699998865556789999999999999999999999   999999999999999865     468999999998  


Q ss_pred             ccCCCCCc------c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          221 LLNPTAGQ------E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       221 ~~~~~~~~------~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      .+......      . .....||..|+++.+..+...+.+.|+||++.++.|+..|..||....................
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~  257 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL  257 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence            32222111      1 1234589999999999999999999999999999999999999976443222111111111000


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      .        ..             .....+..+.++...+-..+..++|+...+...|.+.
T Consensus       258 ~--------~~-------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  258 T--------DR-------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             c--------cc-------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            0        00             0111234455566666668999999999998887654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=203.96  Aligned_cols=159  Identities=19%  Similarity=0.174  Sum_probs=121.8

Q ss_pred             CCCcccccCCceEEEEEEcC-CCeEEEEEEeccccc-----cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVCT-----TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||+||+|.+.. ++.++|+|.......     .....+.+|+++|+.++|+|+++.+..+    +..+++|
T Consensus        22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVm   97 (365)
T PRK09188         22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVR   97 (365)
T ss_pred             EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEE
Confidence            35889999999999998875 677788887653211     1234689999999999999998633211    3679999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeEcCCCCeEEeccccccccCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNL-KSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      ||+++++|... .  ..   .   ...++.++++||+|||+   .+++|||| ||+|||++.++.+||+|||+++.....
T Consensus        98 E~~~G~~L~~~-~--~~---~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188         98 GWTEGVPLHLA-R--PH---G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             EccCCCCHHHh-C--cc---c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            99999999632 1  11   1   14577899999999999   99999999 999999999999999999999876432


Q ss_pred             CCcc-------eecccCCCcccCcccccc
Q 038580          226 AGQE-------MLEASASQGYKAPELIKM  247 (356)
Q Consensus       226 ~~~~-------~~~~~~~~~y~aPE~~~~  247 (356)
                      ....       .....+++.|+|||.+.-
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            2111       134456778999999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.3e-25  Score=214.77  Aligned_cols=254  Identities=20%  Similarity=0.228  Sum_probs=183.9

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccc--cccch----HHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTTRD----KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ..++++|.|.+|.|+.............|..+..  .....    ..+..|.-+-..+.|||++..+..+..... ..-.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence            4568899999998888877655554444443310  11111    125556666778899999888877664443 3333


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      ||||++ +|..++...  ..+....+-.+..|+..|+.|||+   .|+.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       400 mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            999999 999998743  356667788899999999999999   99999999999999999999999999998776443


Q ss_pred             CC---cceecccCCCcccCccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          226 AG---QEMLEASASQGYKAPELIKMKDASE-ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       226 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ..   .......|+..|+|||++....|.+ ..||||.|+++..|.+|+.||.-....+...  .. ..   ....... 
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~-~~---~~~~~~~-  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT-NN---YSDQRNI-  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh-hc---ccccccc-
Confidence            33   2345667888999999999988865 6999999999999999999997654433321  00 00   0000000 


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                .....+.....+.+...++.++|+.||.+|.|+++|++
T Consensus       547 ----------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 ----------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ----------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                      00011223345667778999999999999999999986

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-23  Score=177.22  Aligned_cols=261  Identities=13%  Similarity=0.151  Sum_probs=192.5

Q ss_pred             hhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEE
Q 038580           68 DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        68 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ...+..+++||+|+||..+.|+..-+++.||+|.-..  .++.-++..|.+..+.|. .+.|-..+-+-. .+.+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGq-eG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-EGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeecc-ccchhhhhh
Confidence            3445567999999999999999888899999997432  334457888888888775 577777765433 444778999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-----CeEEeccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-----QPYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~~~~  221 (356)
                      |.+ |-||.++.. ..++.++..+...+|.|+..-++|+|+   +.+|.|||||+|+||...+     .+.++|||+++.
T Consensus       104 dLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            987 559998875 245679999999999999999999999   9999999999999997543     478999999998


Q ss_pred             cCCCCCcce------ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          222 LNPTAGQEM------LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       222 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      +..+.....      ....||.+||+--...+.+.+...|+=|+|.+++..+-|..||.+...+.......+.-......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            766544432      35578999999999888899999999999999999999999999865433221111111000000


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                              +          .....++.|.++..-+.-.=..+-.+-|+.+-+..-+.++
T Consensus       259 --------~----------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  259 --------P----------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             --------C----------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                    0          0012334555666666666666777778877776665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.9e-22  Score=182.67  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=189.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCC-ccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHP-NLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..||.|+||.||++.+.   ..+++|.+.......   ...+.+|+.+++.+.|+ |++++++.+.. .+..+++++++.
T Consensus         6 ~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~   81 (384)
T COG0515           6 RKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVD   81 (384)
T ss_pred             EeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEecCC
Confidence            67999999999999987   667788776554433   46799999999999988 79999998853 435799999999


Q ss_pred             CCChhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRGGSG-EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  228 (356)
                      ++++.+++..... ..++......+..|++.++.|+|+   .+++|||+||+||+++..+ .++++|||.+.........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999977753221 268888899999999999999999   9999999999999999988 6999999998755433222


Q ss_pred             -----ceecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          229 -----EMLEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       229 -----~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                           ......++..|+|||.+..   ..++...|+||+|++++++++|..||...............+......     
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence                 2356678999999999987   578899999999999999999999966543220001111111111000     


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ......        ...........+.+++..|+..+|..|.+..+...
T Consensus       234 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         234 SLASPL--------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccc--------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            000000        00000223356778999999999999998887654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.90  E-value=2e-23  Score=192.88  Aligned_cols=217  Identities=26%  Similarity=0.402  Sum_probs=160.1

Q ss_pred             HhccCCCccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 038580          120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK  199 (356)
Q Consensus       120 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  199 (356)
                      |+.+.|.|+.+++|.+.++ +..+.|.+||..|+|.+.+.. ....+++.....+..+++.||+|||++  +-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            4567899999999999865 589999999999999999985 355689999999999999999999994  223999999


Q ss_pred             CCCeeEcCCCCeEEeccccccccCCC-CCcceecccCCCcccCccccccCC-------CCCcchhHHHHHHHHHHHhCCC
Q 038580          200 SKNILLDRNYQPYVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKD-------ASEETDIYSFGVIMLELISGKE  271 (356)
Q Consensus       200 ~~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwslG~~l~el~tg~~  271 (356)
                      +.||++|..+.+|++|||+....... ............-|.|||.+....       .+.+.|+||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999997665320 001111112234599999997641       4678999999999999999999


Q ss_pred             CCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          272 PINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       272 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                      ||...........+...+..     .......|.+.          ...+....+..++.+||..+|++||+++++-..+
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~----------~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIE----------LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchh----------hhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            99865443332111111111     11112222221          0113444788999999999999999999999888


Q ss_pred             hhhc
Q 038580          352 EDLG  355 (356)
Q Consensus       352 ~~~~  355 (356)
                      +.+.
T Consensus       222 ~~~~  225 (484)
T KOG1023|consen  222 LTIN  225 (484)
T ss_pred             hhhc
Confidence            7653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=5.4e-23  Score=169.02  Aligned_cols=251  Identities=14%  Similarity=0.207  Sum_probs=180.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC-ccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP-NLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ++||+|+||.+|.|..-.+|+.||+|+-+.  ..+...+..|..+.+.++|- .|..+. ++.+++.+-.+||+.. |-|
T Consensus        21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~-~y~~e~~ynvlVMdLL-GPs   96 (341)
T KOG1163|consen   21 RKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIR-HYGTEKDYNVLVMDLL-GPS   96 (341)
T ss_pred             EeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhh-hhccccccceeeeecc-Ccc
Confidence            789999999999999999999999998543  33445678888888888753 333333 3444566889999987 559


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEeccccccccCCCCCc--
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      |.+.+.- ..+.++..+.+-++-|++.-++|+|.   .+++||||||+|.|..-+   ..+.++|||+++.+......  
T Consensus        97 LEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   97 LEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             HHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence            9888752 34568899999999999999999999   999999999999999744   35779999999876443222  


Q ss_pred             ----ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          229 ----EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       229 ----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                          ......||.+|.+--...+-..+...|+=|+|.++..+--|..||.+...................        -+
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s--------~~  244 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS--------TP  244 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC--------CC
Confidence                234557889999888777777789999999999999999999999986544332222221111111        00


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                      ...          .....|.++.-.+.-|-..--++-|+...+-+.+
T Consensus       245 ie~----------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  245 IEV----------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHH----------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            011          1222345555666677766666777665554443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=169.66  Aligned_cols=138  Identities=12%  Similarity=0.115  Sum_probs=107.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccch---------HH-----------------HHHHHHHHhccCCCcc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---------KE-----------------FGDLIELLGCIRHPNL  128 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---------~~-----------------~~~e~~~l~~l~h~ni  128 (356)
                      ..||+|+||.||+|... +|+.+|+|+++.......         ..                 ...|++.+.++.++++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            67999999999999987 789999999875422110         11                 2348899999988876


Q ss_pred             ccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCeeEcC
Q 038580          129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL-HTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       129 v~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .....+..  . ..++||||++++++.....  ....++......++.|++.+|.|+ |+   .+++||||||+||++++
T Consensus        82 ~~p~~~~~--~-~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPILL--K-SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEEe--c-CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEEC
Confidence            44333222  2 3489999999887765432  134688889999999999999999 68   89999999999999984


Q ss_pred             CCCeEEecccccccc
Q 038580          208 NYQPYVSDFGLHLLL  222 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~  222 (356)
                       +.++|+|||++...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             78999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=7.9e-22  Score=171.73  Aligned_cols=230  Identities=17%  Similarity=0.310  Sum_probs=146.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCC---C--------ccccc-----cc-
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRH---P--------NLVPL-----LG-  133 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h---~--------niv~~-----~~-  133 (356)
                      ++.||.|+++.||.+.+..+++..++|++.......   .+++++|.-....+.+   |        -++++     -+ 
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999999999999999986443222   2456666554444322   1        11111     11 


Q ss_pred             --eeeC-CC-C-----ceEEEEecccCCChhHhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 038580          134 --FYAG-PR-G-----EKLIVHPFYKRGNLAQCIR-----GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK  199 (356)
Q Consensus       134 --~~~~-~~-~-----~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  199 (356)
                        ++.. .+ +     ..+++|+-+. +||.+++.     ......+....++.+..|+++.+++||+   .|++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence              1111 10 1     2366777775 48888763     1122234455667778999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccccC--------CCCCcchhHHHHHHHHHHHhCCC
Q 038580          200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK--------DASEETDIYSFGVIMLELISGKE  271 (356)
Q Consensus       200 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~sDvwslG~~l~el~tg~~  271 (356)
                      |+|++++.+|.++|+||+.....+    ........+..|.+||.....        .++.+.|.|++|+++|.|+++..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAG----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETT----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecC----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999998765432    122223445679999977432        46889999999999999999999


Q ss_pred             CCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 038580          272 PINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR  341 (356)
Q Consensus       272 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  341 (356)
                      ||...........                    +..         .+. +.++.+.+|+..+|+.||++|
T Consensus       249 Pf~~~~~~~~~~~--------------------~f~---------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW--------------------DFS---------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG--------------------GGT---------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc--------------------cch---------hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9986432211100                    111         123 678889999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2e-22  Score=170.43  Aligned_cols=166  Identities=13%  Similarity=0.154  Sum_probs=125.9

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHH---------HHHHHHHHhccCCCccccccceeeCC-----
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---------FGDLIELLGCIRHPNLVPLLGFYAGP-----  138 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~-----  138 (356)
                      ..+++|+|+||.||+...  ++..+|+|++++........         +++|+..+.+++||+|.....++...     
T Consensus        35 ~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~  112 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL  112 (232)
T ss_pred             EEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence            347899999999999755  35568999998655444332         68899999999999999998875532     


Q ss_pred             --CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecc
Q 038580          139 --RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDF  216 (356)
Q Consensus       139 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  216 (356)
                        .+..+++|||++|.+|.+...      ++.    ....+++.++..+|+   .+++|||++|.|++++.++ ++++||
T Consensus       113 ~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        113 RYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEEC
Confidence              236899999999999988732      222    245589999999999   9999999999999999988 999999


Q ss_pred             ccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHH
Q 038580          217 GLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELI  267 (356)
Q Consensus       217 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~  267 (356)
                      |...........             ..+.....|..++|+||||+.+.-..
T Consensus       179 g~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            986543211110             11334455678999999999776543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.5e-21  Score=163.26  Aligned_cols=136  Identities=16%  Similarity=0.139  Sum_probs=105.8

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-----CCCccccccceeeCCCC--ceE-E
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-----RHPNLVPLLGFYAGPRG--EKL-I  144 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~--~~~-l  144 (356)
                      ....||+|+||.||.  +..+... ++|+.........+.+.+|+.+++.+     .||||++++|++.++.+  ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            347899999999996  5445554 57777654444567899999999999     57999999999987643  433 7


Q ss_pred             EEec--ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCeeEcC----CCCeEEeccc
Q 038580          145 VHPF--YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL-DYLHTGFHRPIIHGNLKSKNILLDR----NYQPYVSDFG  217 (356)
Q Consensus       145 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg  217 (356)
                      |+||  +++++|.+++.+.   .++..  ..++.+++.++ +|||+   .+|+||||||+|||++.    ++.++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  6689999999742   35544  35577788777 99999   99999999999999974    3479999955


Q ss_pred             cc
Q 038580          218 LH  219 (356)
Q Consensus       218 ~~  219 (356)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=6.8e-21  Score=159.63  Aligned_cols=139  Identities=13%  Similarity=0.130  Sum_probs=108.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------------------------hHHHHHHHHHHhccCCCcc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------------------------DKEFGDLIELLGCIRHPNL  128 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni  128 (356)
                      ..||+|+||.||+|.+. +|+.+|+|+.+......                          ...+..|.+.+.++.|+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            67999999999999987 78999999987642210                          0123578889999999987


Q ss_pred             ccccceeeCCCCceEEEEecccCCChhHh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQC-IRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       129 v~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .....+...   ..++||||++++++... +.   ...++......++.|++.++.++|+.  .+++||||||+||+++ 
T Consensus        82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK---KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec---CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-
Confidence            544433322   24899999998765443 33   23567788899999999999999974  6899999999999999 


Q ss_pred             CCCeEEeccccccccC
Q 038580          208 NYQPYVSDFGLHLLLN  223 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~  223 (356)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.3e-20  Score=154.64  Aligned_cols=184  Identities=16%  Similarity=0.076  Sum_probs=132.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch----HHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD----KEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ...|++|+||+||.+..  ++..++.+.+.....-..    .-+.+|+++|++++ |+++.+++++     +..+++|+|
T Consensus         7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmey   79 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSY   79 (218)
T ss_pred             ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEee
Confidence            47799999999996654  566666666654332111    24789999999995 5788888874     257999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNL-KSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +.|.+|.+.+..   .      ...+..|++.+|.++|+   .|++|||| ||.|||++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~---~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR---G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh---h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999998754321   1      13467789999999999   99999999 79999999999999999999986543221


Q ss_pred             c------ce------ecccCCCcccCccccccC-CCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          228 Q------EM------LEASASQGYKAPELIKMK-DAS-EETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       228 ~------~~------~~~~~~~~y~aPE~~~~~-~~~-~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      .      .+      .....++.|++|+-..-. ..+ ...+.++-|+-+|.++|+..|+.++
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0      00      111245556666643221 233 3467778899999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-21  Score=188.39  Aligned_cols=241  Identities=19%  Similarity=0.224  Sum_probs=162.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc-ccchHHHHHHHHH--HhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-TTRDKEFGDLIEL--LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||++.|=+|.+|++++ |. +++|++-... .-..+.|.+.++-  ...++|||.+++.-+-.+.+ .-|+|-+|..
T Consensus        28 ~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~k-AAylvRqyvk  104 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDK-AAYLVRQYVK  104 (1431)
T ss_pred             ecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhH-HHHHHHHHHh
Confidence            3779999999999999874 44 5666654332 3334455554433  45568999999987655433 5678888887


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      + +|.+.+.-+  .-+..-...=|+.|++.|+..+|.   .+|+|+|||.+|||++.=..+.|+||..-+...-+...+ 
T Consensus       105 h-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  105 H-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             h-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            7 999998622  224444555588999999999999   999999999999999988899999997654321111111 


Q ss_pred             e-----ecccCCCcccCccccccC----------C-CCCcchhHHHHHHHHHHHh-CCCCCCCCC---CCCCCCchhHHH
Q 038580          230 M-----LEASASQGYKAPELIKMK----------D-ASEETDIYSFGVIMLELIS-GKEPINENP---TPDEDFHLPTFM  289 (356)
Q Consensus       230 ~-----~~~~~~~~y~aPE~~~~~----------~-~~~~sDvwslG~~l~el~t-g~~p~~~~~---~~~~~~~~~~~~  289 (356)
                      .     .+...-.+|.|||-+-..          . .+++-||||+||++.|+++ |.+||.-..   -.......++..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            1     011223459999977431          1 4678999999999999998 788875210   000001111111


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                      .        +...|+                    .+..++..|++.||++|.+|++.++.-
T Consensus       259 L--------e~Ied~--------------------~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  259 L--------EKIEDV--------------------SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             H--------HhCcCc--------------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence            1        111111                    356899999999999999999998863

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2e-20  Score=164.22  Aligned_cols=195  Identities=20%  Similarity=0.251  Sum_probs=136.3

Q ss_pred             CCCccccccceeeC--------------------------CCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHH
Q 038580          124 RHPNLVPLLGFYAG--------------------------PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG  177 (356)
Q Consensus       124 ~h~niv~~~~~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  177 (356)
                      +|||||+++++|.+                          .+..+|+||.-++. +|..++-.   ...+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence            59999999987653                          12356889988876 99999862   23344455568889


Q ss_pred             HHHHHHHHhcCCCCCceecCCCCCCeeE--cCCC--CeEEeccccccccCC-----CCCcceecccCCCcccCccccccC
Q 038580          178 IAGGLDYLHTGFHRPIIHGNLKSKNILL--DRNY--QPYVSDFGLHLLLNP-----TAGQEMLEASASQGYKAPELIKMK  248 (356)
Q Consensus       178 i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~  248 (356)
                      +++|+.|||.   +++.|||+|++|||+  |+|+  ...++|||+|..-..     +.........|....||||+...-
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999   999999999999998  4444  356899998753221     111222345667779999998643


Q ss_pred             C------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHH
Q 038580          249 D------ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEER  322 (356)
Q Consensus       249 ~------~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (356)
                      +      --.|+|.|+.|.+.||+++...||.+..  ++...... .+         +...            ...+..+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~-Yq---------e~qL------------Palp~~v  482 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRT-YQ---------ESQL------------PALPSRV  482 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhh-hh---------hhhC------------CCCcccC
Confidence            2      1358999999999999999999998621  11111111 00         0111            1235556


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          323 ILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       323 ~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +..+.+++...|+.||++|++..=...
T Consensus       483 pp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  483 PPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ChHHHHHHHHHhcCCccccCCccHHHh
Confidence            677889999999999999998654333

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.6e-21  Score=180.55  Aligned_cols=226  Identities=23%  Similarity=0.288  Sum_probs=173.6

Q ss_pred             cccccCCceEEEEEE---cCCCeEEEEEEeccccccch--HHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecc
Q 038580           76 VIGKSNYGTLYKALL---QRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~---~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ++|+|.||.|+++.-   ...+..+++|++++......  .....|..++...+ ||.+|++...+++ ++..+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            379999999997532   24567788888765432221  14556777888887 9999999887774 55899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      .+|+|...+..  ...++......+...++-+++++|+   .+++|||+|++||+++.+|++++.|||+++..-...-  
T Consensus        80 rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   80 RGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             ccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99999888763  3346666667778889999999999   9999999999999999999999999999876533221  


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                         .+|+.-|||||++.  .....+|.||||++.+||+||..||..           +.+.. +.               
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~-Il---------------  200 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKR-IL---------------  200 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHH-Hh---------------
Confidence               18899999999987  557889999999999999999999975           11111 10               


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                         ......|.+......+++..++..+|.+|--.
T Consensus       201 ---~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  201 ---KAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ---hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence               01123456666677788888888889888644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.7e-19  Score=176.67  Aligned_cols=189  Identities=19%  Similarity=0.304  Sum_probs=149.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC---CCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ....||+|+||+||+|...+ |+.+|+|+-++..   .-+|---.+++.+|+   -+-|..+...+.- .+.-++|++|.
T Consensus       702 I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~~S~lv~ey~  776 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVF-QNASVLVSEYS  776 (974)
T ss_pred             EEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHcc-CCcceeeeecc
Confidence            34789999999999999986 9999999977543   234444455666666   1233333333332 23568999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-------CCCCeEEecccccccc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-------RNYQPYVSDFGLHLLL  222 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfg~~~~~  222 (356)
                      +.|+|.+++.  ..+..++.....++.|++.-+++||.   .+|||+||||+|+||.       +...++|+|||.+..+
T Consensus       777 ~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  777 PYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             ccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999998  56678999999999999999999999   9999999999999994       2446899999998655


Q ss_pred             CCC-CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 038580          223 NPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKE  271 (356)
Q Consensus       223 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~  271 (356)
                      ..- .+..-....+|-.+-++|+..+.++++..|.|.++.+++-|+.|+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            322 2334455667888999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=6.2e-19  Score=152.28  Aligned_cols=141  Identities=18%  Similarity=0.173  Sum_probs=106.5

Q ss_pred             CCCcccccCCceEEEEE-EcCCCeEEEEEEeccccccc------------------------hHHHHHHHHHHhccCCCc
Q 038580           73 PGEVIGKSNYGTLYKAL-LQRSGSVRLLRFLRPVCTTR------------------------DKEFGDLIELLGCIRHPN  127 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~-~~~~~~~~a~k~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~n  127 (356)
                      ..+.||+|+||.||+|. ...+|..+|+|+++......                        ...+..|++.++++.+.+
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            35789999999999998 55678899999987542110                        012567999999987532


Q ss_pred             cccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeEc
Q 038580          128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP-IIHGNLKSKNILLD  206 (356)
Q Consensus       128 iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~  206 (356)
                       +.+...+..  +..++||||+++.+|......  ...........++.|++.++.+||+   .+ ++||||||+||+++
T Consensus       112 -i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~  183 (237)
T smart00090      112 -VPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH  183 (237)
T ss_pred             -CCCCeeeEe--cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE
Confidence             222222221  235899999999888765421  2245555677899999999999999   99 99999999999999


Q ss_pred             CCCCeEEecccccccc
Q 038580          207 RNYQPYVSDFGLHLLL  222 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~  222 (356)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             789999999987653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.4e-18  Score=148.21  Aligned_cols=134  Identities=19%  Similarity=0.303  Sum_probs=107.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +.||+|++|.||+|.+  .+..+++|.........        ...+.+|++++..++|+|+.....++... +..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEE
Confidence            5699999999999987  34556677655332211        13577899999999999987766666543 4788999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ||++|++|.+.+....     . ....++.+++.+|.++|+   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999986321     1 678899999999999999   9999999999999999 78999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=1.9e-19  Score=163.81  Aligned_cols=122  Identities=28%  Similarity=0.443  Sum_probs=107.4

Q ss_pred             ceEEEEecccCCChhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      ++++.|++|...+|.+++.+ ......++...+.+..|++.|++|      ++.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999963 446678888999999999999999      46899999999999999999999999998


Q ss_pred             cccCCCC-----CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh
Q 038580          220 LLLNPTA-----GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       220 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  268 (356)
                      .......     ........||..||+||.+.++.|+.++||||||++++|+++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7654433     334456688999999999999999999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=3e-18  Score=165.89  Aligned_cols=134  Identities=22%  Similarity=0.289  Sum_probs=105.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||+||+|.+......+.++..+.....      ..+.+.+|+++++.++|+|++....++..+ ...+++|
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-EEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-CCCEEEE
Confidence            358899999999999988644433322222211111      124588999999999999998877666543 3678999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ||+++++|.+++.          ....++.+++.+|.|||+   .+++|||+||+||++ +++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999875          356788999999999999   999999999999999 567999999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=4.5e-18  Score=143.78  Aligned_cols=130  Identities=22%  Similarity=0.310  Sum_probs=100.9

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccc--------hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .||+|+||.||+|.+.  +..+++|.........        ...+.+|+++++.++|+++.....++.. .+..+++||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEE
Confidence            4899999999999864  4566777654322111        1456789999999998876544444443 336789999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      |+++++|.+.+.....         .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999988753211         788899999999999   9999999999999999 78999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.2e-18  Score=143.80  Aligned_cols=136  Identities=19%  Similarity=0.180  Sum_probs=104.8

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc----------------------chHHHHHHHHHHhccCCCc-
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT----------------------RDKEFGDLIELLGCIRHPN-  127 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-  127 (356)
                      +...+.||+|+||.||++... +++.+|+|+++.....                      .......|..++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            444688999999999999875 6888999987643210                      0113567888888888774 


Q ss_pred             -cccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          128 -LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       128 -iv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                       +...++     .+..+++|||+++++|......        .....++.+++.++.++|+   .+++|+||+|.||+++
T Consensus        96 ~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID-----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee-----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence             333332     2356899999999998765421        2355788899999999999   9999999999999999


Q ss_pred             CCCCeEEeccccccccC
Q 038580          207 RNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~~  223 (356)
                      +++.++|+|||++....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            99999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=3.3e-19  Score=173.32  Aligned_cols=204  Identities=19%  Similarity=0.264  Sum_probs=138.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.+.|-.|+||.||...++.+....|+|+-+..            .++     +||..+-+       ..+.|      |
T Consensus        87 ~IklisngAygavylvrh~~trqrfa~kiNkq~------------lil-----Rnilt~a~-------npfvv------g  136 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LIL-----RNILTFAG-------NPFVV------G  136 (1205)
T ss_pred             eeEeeccCCCCceeeeeccccccchhhcccccc------------hhh-----hccccccC-------Cccee------c
Confidence            347899999999999999887777777653321            111     12322221       12222      4


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC------
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA------  226 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~------  226 (356)
                      +-...+++..  +++.        +++.+++|||+   .+|+|||+||+|.+|+.-|++|+.|||+++.--...      
T Consensus       137 Dc~tllk~~g--~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  137 DCATLLKNIG--PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             hhhhhcccCC--CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence            4444454322  2332        12788999999   999999999999999999999999999975421110      


Q ss_pred             --------CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          227 --------GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       227 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                              .......+||+.|.|||++..+.|....|.|++|+++||.+.|..||.+++..+....       .+.+.. 
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~-------visd~i-  275 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ-------VISDDI-  275 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh-------hhhhhc-
Confidence                    1112355899999999999999999999999999999999999999998654321111       111100 


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP  342 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  342 (356)
                      .          |.+     -.+..+.+..+++.+.|+.+|..|-
T Consensus       276 ~----------wpE-----~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  276 E----------WPE-----EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             c----------ccc-----cCcCCCHHHHHHHHHHHHhChHhhc
Confidence            0          000     0122344677899999999999995

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=6.9e-16  Score=133.54  Aligned_cols=138  Identities=19%  Similarity=0.161  Sum_probs=103.4

Q ss_pred             CCCCccc-ccCCceEEEEEEcCCCeEEEEEEecccc-------------ccchHHHHHHHHHHhccCCCcc--cccccee
Q 038580           72 APGEVIG-KSNYGTLYKALLQRSGSVRLLRFLRPVC-------------TTRDKEFGDLIELLGCIRHPNL--VPLLGFY  135 (356)
Q Consensus        72 ~~~~~ig-~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~  135 (356)
                      ..+..|| .|+.|+||.+...  +..+++|.++...             ......+.+|++++..++|+++  ...+++.
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~  111 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR  111 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence            3457898 8999999999875  4456666653210             0122457889999999998875  5666654


Q ss_pred             eCCCCc---eEEEEecccC-CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCe
Q 038580          136 AGPRGE---KLIVHPFYKR-GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP  211 (356)
Q Consensus       136 ~~~~~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  211 (356)
                      ....+.   .++|+|++++ .+|.+++..   .+++..    .+.+++.++.+||+   .||+||||||.|||++.++.+
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence            432222   3599999997 699988863   234443    35679999999999   999999999999999998899


Q ss_pred             EEeccccccc
Q 038580          212 YVSDFGLHLL  221 (356)
Q Consensus       212 kl~Dfg~~~~  221 (356)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=4.9e-16  Score=129.96  Aligned_cols=136  Identities=17%  Similarity=0.199  Sum_probs=93.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchH--HH----------------------HHHHHHHhccCCCc--c
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK--EF----------------------GDLIELLGCIRHPN--L  128 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~--~~----------------------~~e~~~l~~l~h~n--i  128 (356)
                      +.||+|+||.||+|.+. +++.+|+|+++........  ..                      ..|...+..+.+..  +
T Consensus         3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            67999999999999987 7888999988754221111  11                      23444444443332  2


Q ss_pred             ccccceeeCCCCceEEEEecccCCChhHh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQC-IRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       129 v~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      .+.++.     ...+++|||++++++... +....   .. .....++.+++.++.++|+.  .+++|+||||+||+++ 
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence            222221     246899999999543321 11100   11 45778899999999999975  7899999999999999 


Q ss_pred             CCCeEEeccccccccC
Q 038580          208 NYQPYVSDFGLHLLLN  223 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~  223 (356)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=8.3e-16  Score=123.49  Aligned_cols=133  Identities=14%  Similarity=0.081  Sum_probs=108.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCC--CccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH--PNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|.++.||++...+  ..+++|..+....  ...+..|...++.++|  .++.+++++... .+..++++||++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~   78 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGE   78 (155)
T ss_pred             eecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCe
Confidence            679999999999999854  5678888765332  4578999999999976  488888886664 35789999999987


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ++..+         +......++.+++.+++++|.....+++|+|++|.|+++++++.+++.|||.+..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543         5556677889999999999984334799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=2.1e-17  Score=159.81  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=177.0

Q ss_pred             CcccccCCceEEEEEEcC-CCeEEEEEEecccc--ccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|.|+.|-...... ....++.|.+....  .........|..+-+.+. |+|++.+++....++ ..++..+|..
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~~~~~s~  104 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYLLSLSYSD  104 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-ccccccCccc
Confidence            559999999998877643 34455666554432  112234455677666676 999999999777544 7889999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCC--CC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNP--TA  226 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~--~~  226 (356)
                      ++++...+........+......+..|+..++.|+| .   .++.|||+||+|.+++..+ ..+++|||++..+..  ..
T Consensus       105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~  181 (601)
T KOG0590|consen  105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA  181 (601)
T ss_pred             ccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence            999998883112213444556678889999999999 7   8999999999999999999 999999999987755  22


Q ss_pred             CcceecccC-CCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          227 GQEMLEASA-SQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       227 ~~~~~~~~~-~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      .......+| ++.|+|||...+. ......|+||.|+++.-+++|..|+........  ....|......          
T Consensus       182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~----------  249 (601)
T KOG0590|consen  182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNKGR----------  249 (601)
T ss_pred             ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccccc----------
Confidence            333445567 8999999998874 456789999999999999999999876443331  11111111100          


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                               ..............++...++..+|+.|.+.+++.
T Consensus       250 ---------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 ---------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ---------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence                     00011222334456788889999999999887764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=3.2e-15  Score=128.77  Aligned_cols=152  Identities=24%  Similarity=0.361  Sum_probs=114.3

Q ss_pred             HhccCCCccccccceeeCCC----CceEEEEecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 038580          120 LGCIRHPNLVPLLGFYAGPR----GEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI  193 (356)
Q Consensus       120 l~~l~h~niv~~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i  193 (356)
                      +-.+-|.|||++..++.+.+    .+..++.|||..|+|.++|++  .....+......+|+.||..||.|||+ |.+++
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            33456999999999876433    367889999999999999974  224567777888999999999999999 77899


Q ss_pred             eecCCCCCCeeEcCCCCeEEecccccccc---CCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCC
Q 038580          194 IHGNLKSKNILLDRNYQPYVSDFGLHLLL---NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGK  270 (356)
Q Consensus       194 vH~dlk~~Nill~~~~~~kl~Dfg~~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~  270 (356)
                      +|+++..+.|++..+|-+|++----....   ............+-++|.+||.-.....+.++|||+||....||..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999988887432211110   000111112234557799999877667788999999999999998876


Q ss_pred             CC
Q 038580          271 EP  272 (356)
Q Consensus       271 ~p  272 (356)
                      .-
T Consensus       280 iq  281 (458)
T KOG1266|consen  280 IQ  281 (458)
T ss_pred             ec
Confidence            54

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=2.9e-14  Score=133.92  Aligned_cols=142  Identities=14%  Similarity=0.135  Sum_probs=99.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch----------------------------------------HHH
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD----------------------------------------KEF  113 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~----------------------------------------~~~  113 (356)
                      .+.||+|++|.||+|+++ +|+.||+|+.++.....-                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999987 678899999875321100                                        024


Q ss_pred             HHHHHHHhcc----CCCccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 038580          114 GDLIELLGCI----RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG-GLDYLHTG  188 (356)
Q Consensus       114 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~  188 (356)
                      .+|...+.++    +|.+-+.+-.++.+..+..+++|||++|++|.+....... ..+   ...++..++. .+..+|. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh-
Confidence            4455544444    2333344444443333467999999999999887642111 122   3445566655 4678898 


Q ss_pred             CCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       189 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                        .|++|+|++|.||+++.++.++++|||++...+
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=9.4e-13  Score=123.86  Aligned_cols=171  Identities=15%  Similarity=0.197  Sum_probs=123.7

Q ss_pred             EEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCC
Q 038580           87 KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH  166 (356)
Q Consensus        87 ~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~  166 (356)
                      .|..+.++..+.+...+...........+-++.|+.++||||++++..+.. ++..|+|+|.+.  .|..+++.-.    
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~l~----  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKELG----  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHHhH----
Confidence            466666777777777765444334557788899999999999999997775 458999999884  5666765322    


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccc
Q 038580          167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK  246 (356)
Q Consensus       167 ~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  246 (356)
                       .....-.+.||+.||.|||..  .+++|+++.-+.|+++..|..||++|.++........ .......-..|..|+.+.
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence             223444678999999999864  7799999999999999999999999998755432211 011111122356666543


Q ss_pred             cCCCCCcchhHHHHHHHHHHHhCC
Q 038580          247 MKDASEETDIYSFGVIMLELISGK  270 (356)
Q Consensus       247 ~~~~~~~sDvwslG~~l~el~tg~  270 (356)
                      ...  ...|.|-|||++||++.|.
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCcc
Confidence            222  4579999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=1.7e-13  Score=127.47  Aligned_cols=245  Identities=19%  Similarity=0.159  Sum_probs=171.1

Q ss_pred             CCCcccc--cCCceEEEEEE--cCCCeEEEEEEeccccc--cchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEE
Q 038580           73 PGEVIGK--SNYGTLYKALL--QRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        73 ~~~~ig~--G~~g~V~~~~~--~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ....+|.  |.+|.||.+..  ..++..+|+|.-+....  .....-.+|+...++++ |+|.++....+.+ .+..++-
T Consensus       118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~lfiq  196 (524)
T KOG0601|consen  118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGILFIQ  196 (524)
T ss_pred             cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcceee
Confidence            3467999  99999999988  77788888887443222  22223345565555664 9999998877774 5588888


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEecccccc
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG----GLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHL  220 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~  220 (356)
                      +|.+. .+|..+-.. ....++....+....+...    |+.++|+   .+++|-|+||.||+...+ ..++++|||+..
T Consensus       197 tE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  197 TELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcceeE
Confidence            99886 588777653 2334666677778888888    9999999   999999999999999999 889999999987


Q ss_pred             ccCCCCCcc----eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          221 LLNPTAGQE----MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       221 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      .+.......    .....+...|++||++. +.++..+|+|++|.++.+..++..++..... ....++..         
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~---------  340 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQ---------  340 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccc---------
Confidence            665433111    12235666799999976 6678999999999999999988776543210 00000100         


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          .+.+           .++...-..++...+.+++..+|-.|++++.+.+
T Consensus       341 ----~~ip-----------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 ----GYIP-----------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----ccCc-----------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                0010           0111122334555888999999999999887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=2.2e-12  Score=105.98  Aligned_cols=128  Identities=16%  Similarity=0.130  Sum_probs=93.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +.++.|.++.||++...  +..+++|....... ....+..|...++.+.+.++++-+-.+. . ...++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~-~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-P-ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-C-CCCeEEEEecCCCcc
Confidence            56889999999999864  66788888654321 2345788999998887666554332232 2 245899999999887


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP-----IIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ...-      ..    ......+++.+|+.||+   .+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~------~~----~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED------FS----DPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc------cc----CHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430      01    12345689999999999   65     59999999999999 56899999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=2.6e-12  Score=122.35  Aligned_cols=143  Identities=13%  Similarity=0.128  Sum_probs=91.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc----------------------------------hH------HHH
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR----------------------------------DK------EFG  114 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----------------------------------~~------~~~  114 (356)
                      +.||+|++|.||+|.++++|+.||+|+.++.....                                  .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            67999999999999998779999999998542110                                  01      233


Q ss_pred             HHHHHHhcc----CCCccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 038580          115 DLIELLGCI----RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG-GLDYLHTGF  189 (356)
Q Consensus       115 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~~  189 (356)
                      +|...+.++    .+.+.+.+-.++.+-.+..++||||+.|+++.+.-.-. ....+...   ++...+. -+.-+..  
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~---la~~~v~~~~~Qif~--  278 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKL---LAERGVEVFFTQVFR--  278 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHH---HHHHHHHHHHHHHHh--
Confidence            444333333    24444444444443334678999999999998742110 11222211   1111111 1222334  


Q ss_pred             CCCceecCCCCCCeeEcCCC----CeEEeccccccccCC
Q 038580          190 HRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLLLNP  224 (356)
Q Consensus       190 ~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~  224 (356)
                       .|++|+|++|.||+++.++    .+++.|||++...+.
T Consensus       279 -~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        279 -DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             8899999999999999988    999999999876543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=1.3e-10  Score=96.45  Aligned_cols=137  Identities=9%  Similarity=0.077  Sum_probs=94.8

Q ss_pred             CcccccCCceEEEEEEcC------CCeEEEEEEeccccc---------------------cc-hHHH----HHHHHHHhc
Q 038580           75 EVIGKSNYGTLYKALLQR------SGSVRLLRFLRPVCT---------------------TR-DKEF----GDLIELLGC  122 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~---------------------~~-~~~~----~~e~~~l~~  122 (356)
                      -.||.|.-+.||.|....      .+..+|+|+.+....                     .. .+.+    +.|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      246889999863210                     00 1122    378888887


Q ss_pred             cCC--CccccccceeeCCCCceEEEEecccCCChhH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCC
Q 038580          123 IRH--PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQ-CIRGGSGEAHKWSIIYRISIGIAGGLDYL-HTGFHRPIIHGNL  198 (356)
Q Consensus       123 l~h--~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dl  198 (356)
                      +..  -++...+++     ...++||||+.+..+.. .+++   ..++......+..+++.+|..| |.   .+++|+||
T Consensus        83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            752  344444442     25689999997654422 2221   2344455667788999999999 88   89999999


Q ss_pred             CCCCeeEcCCCCeEEeccccccccC
Q 038580          199 KSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       199 k~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      ++.||++++ +.+.|+|||-+....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999974 579999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=2.6e-10  Score=97.77  Aligned_cols=143  Identities=16%  Similarity=0.153  Sum_probs=105.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCC--ccccccceeeCCC--CceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHP--NLVPLLGFYAGPR--GEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~--~~~~lv~e~~  149 (356)
                      +.|+.|.++.||++...+ |..+++|+....... ....+..|.++++.+++.  ++.+++.+.....  +..+++|||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998753 567888886543321 345789999999998753  4556666554321  3568999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG-----------------------------------------  188 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------  188 (356)
                      ++.++...+..   ..++......++.+++.+|..||+.                                         
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888765431   3466667777888888888888851                                         


Q ss_pred             ------------CCCCceecCCCCCCeeEcC--CCCeEEeccccccc
Q 038580          189 ------------FHRPIIHGNLKSKNILLDR--NYQPYVSDFGLHLL  221 (356)
Q Consensus       189 ------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~  221 (356)
                                  ....++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        1245799999999999998  56688999997654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=3.1e-11  Score=112.51  Aligned_cols=238  Identities=17%  Similarity=0.171  Sum_probs=160.1

Q ss_pred             CcccccCCceEEEEEEc-CCCeEEEEEEeccccccchH--HHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDK--EFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..||.|.|+.|+....+ .++..++.|-+.........  .-..|+-+...+ .|.++++++..+...+ ..++-.|||.
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~~~ip~e~~~  349 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-QGYIPLEFCE  349 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-cccCchhhhc
Confidence            56999999999998766 66777777766544333322  234455555555 4899998877666433 6778899999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEeccccccccCCCCCcc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++++.....  ....++....+.+..|++.++.++|+   +.++|+|++|.||++..+ +..+++|||+...+.-    .
T Consensus       350 ~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~----~  420 (524)
T KOG0601|consen  350 GGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF----S  420 (524)
T ss_pred             CcchhhhhH--HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccce----e
Confidence            998876652  34456666788899999999999999   999999999999999886 7888999998754211    1


Q ss_pred             eecccCCCccc--CccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 MLEASASQGYK--APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 ~~~~~~~~~y~--aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .....+.-++.  ++.......+..+.|++|||.-+.|..++...-...   .....+.                     
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~---------------------  476 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIR---------------------  476 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeee---------------------
Confidence            11112222333  555556677889999999999999988876432110   0000000                     


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL  351 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L  351 (356)
                        .+.   .+.......++..+...+...++..||.+.++....
T Consensus       477 --~~~---~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  477 --SGD---TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             --ccc---ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence              000   001111224555677888899999999988776543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.11  E-value=1.8e-11  Score=120.22  Aligned_cols=242  Identities=18%  Similarity=0.189  Sum_probs=157.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +-+-+|.++.++.+.-...+...+.|+.....   ..+.+....+-.++-..+||-++.....+. .....+|+++|..+
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPLVGHYLNG  888 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcchhhHHhcc
Confidence            46788999999988776666444444433221   111222222323332334566666554422 34578999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC---C---C
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN---P---T  225 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~---~---~  225 (356)
                      ++|...|+...  ..+..-.......+..+++|||+   ..+.|+|++|.|.+...++..+++|||......   +   .
T Consensus       889 ~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  889 GDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             CCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            99999987533  23322334455567889999999   778999999999999999999999998321110   0   0


Q ss_pred             ---------------C-----C----cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 038580          226 ---------------A-----G----QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE  281 (356)
Q Consensus       226 ---------------~-----~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~  281 (356)
                                     .     .    .......+|+.|.+||.+.+......+|.|++|++++|.++|..||........
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence                           0     0    012234578889999999999999999999999999999999999986543322


Q ss_pred             CCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038580          282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK  345 (356)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  345 (356)
                      -    +.+.+    ..               ......+........+++...+..+|.+|-.+.
T Consensus      1044 f----~ni~~----~~---------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 F----ENILN----RD---------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             h----hcccc----CC---------------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            1    11100    00               000112223344556788888999999997654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=2e-09  Score=86.74  Aligned_cols=130  Identities=19%  Similarity=0.262  Sum_probs=89.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccch---------HHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---------KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ..+++|+-+.+|.+.+.  +..+++|.--+. ..+.         ..-.+|..++++++---|..-+=+..+ .+...++
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K-~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPK-RYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCc-ccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEE
Confidence            45889999999999774  333555543221 1111         235667888877653222111112232 3367899


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      |||.+|-.|.+.+...         ...++..+=.-+.-||.   .+|+|+||.++|++++.+. +.++|||++..
T Consensus        78 me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999888643         13455566677788999   9999999999999998774 99999999765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.06  E-value=2.5e-08  Score=89.79  Aligned_cols=268  Identities=15%  Similarity=0.181  Sum_probs=158.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccce-----eeCCCC-ceEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGF-----YAGPRG-EKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-----~~~~~~-~~~l  144 (356)
                      ..++.||+|+-+.+|-.-.-  +.-|| |+.........   ...+..|... .||-+-.-+.+     +-..++ ..-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhh-eeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34688999999999964221  12233 44332211111   1223334433 46644331222     111122 2556


Q ss_pred             EEecccCC-ChhHhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          145 VHPFYKRG-NLAQCIR----GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       145 v~e~~~~g-sL~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      +|+...+. ....+++    +......+|...+..+..++.+.+-||.   .|.+-+|+.++|+|+++++.+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence            77776653 2333332    1223347899999999999999999999   99999999999999999999999875432


Q ss_pred             cccCCCCCcceecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCchhHHHHHhh
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISG-KEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ...  ..+.......|...|++||.-.     +-..+..+|-|.+|+++++++.| ..||++.......-.   -....+
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~---p~E~~I  239 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN---PLETDI  239 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC---cchhhh
Confidence            221  2233334556778899999754     23456789999999999998875 999998643322110   011111


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHhhhc
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSP--SPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~~il~~L~~~~  355 (356)
                      ...+.....+...-  ....+....-...+..+-.|..+|+..  ++.-|||++..+..|..+.
T Consensus       240 a~g~f~ya~~~~~g--~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         240 AHGRFAYASDQRRG--LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hcceeeechhccCC--CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            11111111111100  000111112233456677888899854  4678999999999888764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=3.2e-09  Score=85.17  Aligned_cols=142  Identities=19%  Similarity=0.205  Sum_probs=94.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+-||+-+.|+++.+.  |+.+++|.--......        .+...+|++.+.+++--.|.--.-++.+. ..-.++|
T Consensus        13 ~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-~~~~i~M   89 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-YGGQIYM   89 (229)
T ss_pred             eeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-CCCeEEE
Confidence            67889999999999885  6665555421111100        12456788888876522221111123322 2567899


Q ss_pred             ecccC-CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEecccccccc
Q 038580          147 PFYKR-GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~  222 (356)
                      ||.++ .++.+++...............++..|-+.+.-||.   .+++|+||..+||++..++   .+.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99987 478888754332222223336788888899999999   9999999999999996554   3479999997653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=7.6e-09  Score=95.19  Aligned_cols=170  Identities=19%  Similarity=0.257  Sum_probs=126.7

Q ss_pred             CCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEEecccC-CChhH
Q 038580           81 NYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFYKR-GNLAQ  156 (356)
Q Consensus        81 ~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~~~-gsL~~  156 (356)
                      ...+.|++....+|..+++|.+.............-++..+++.|+|+|++-.++.+   .+..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            445789999999999999999854444444455666889999999999999887762   23468999999986 57766


Q ss_pred             hhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          157 CIRGG-------------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       157 ~l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      .--..             .+...++..++.++.|+..||.++|+   .|+..+-|.+.+|+++.+.+++|+.-|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54211             12235678899999999999999999   999999999999999999888887777644332


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKE  271 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~  271 (356)
                      .+..               +-+.   --.+-|.-.||.++.-|.||..
T Consensus       445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            2210               1111   1245688889999999999854

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=1.2e-08  Score=89.43  Aligned_cols=143  Identities=13%  Similarity=0.049  Sum_probs=96.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-----------chHHHHHHHHHHhccCCCcc--ccccceeeCC--
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-----------RDKEFGDLIELLGCIRHPNL--VPLLGFYAGP--  138 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~--  138 (356)
                      ++.+-......|++..+  +|+.+.+|........           ....+.+|...+.++...+|  ...+++....  
T Consensus        27 ~e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN  104 (268)
T ss_pred             CcEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence            45555444455777665  3566777755322210           01147788888777642222  2333433321  


Q ss_pred             --CCceEEEEecccCC-ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-------C
Q 038580          139 --RGEKLIVHPFYKRG-NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-------N  208 (356)
Q Consensus       139 --~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~  208 (356)
                        ...-++|+|++++. +|.+++......+.+......++.+++..+.-||.   .|++|+|+++.|||++.       +
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence              23578999999986 89998864323445566777899999999999999   99999999999999985       4


Q ss_pred             CCeEEeccccccc
Q 038580          209 YQPYVSDFGLHLL  221 (356)
Q Consensus       209 ~~~kl~Dfg~~~~  221 (356)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6789999998643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=2.4e-10  Score=108.33  Aligned_cols=148  Identities=18%  Similarity=0.301  Sum_probs=101.5

Q ss_pred             HHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc--ee------cccCCCcccCccccccC
Q 038580          177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--ML------EASASQGYKAPELIKMK  248 (356)
Q Consensus       177 ~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~------~~~~~~~y~aPE~~~~~  248 (356)
                      +++.|+.|+|.+  .++||++|.|++|.++.++.+||+.|+.+..........  ..      .......|.|||++...
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            355999999986  789999999999999999999999999876543311110  00      11123459999999988


Q ss_pred             CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHH
Q 038580          249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFF  327 (356)
Q Consensus       249 ~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  327 (356)
                      ..+.++|+||+|++++.+.. |+.-+....... .........                     .......+.+.++++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~---------------------~~~~~~~s~~~p~el~  242 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLL---------------------NAGAFGYSNNLPSELR  242 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhccc---------------------ccccccccccCcHHHH
Confidence            88999999999999999985 444443321111 100000000                     0011123456678888


Q ss_pred             HHHhhccCCCCCCCCCHHHHH
Q 038580          328 QLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       328 ~l~~~cl~~~p~~Rps~~~il  348 (356)
                      +-+.+++..++..||++..+.
T Consensus       243 ~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  243 ESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHHHhcCCcccCcchhhhh
Confidence            999999999999999777664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=5.1e-08  Score=83.35  Aligned_cols=136  Identities=20%  Similarity=0.169  Sum_probs=93.6

Q ss_pred             hhcCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc----------------------chHHHHHHHHHHhccCCC
Q 038580           69 ILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT----------------------RDKEFGDLIELLGCIRHP  126 (356)
Q Consensus        69 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~  126 (356)
                      +..+.++.||-|.-+.||.|... .|..+|+|+-+.-.++                      .....++|.+.|.+|...
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             hHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            34456789999999999999987 6777888876421110                      012357788888887644


Q ss_pred             --ccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 038580          127 --NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNIL  204 (356)
Q Consensus       127 --niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  204 (356)
                        .+.+-++     .++..++||+..+-.|...-       ++....-.++..|++-+.-.-.   .|+||+|+++-||+
T Consensus       170 G~~VP~P~~-----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIl  234 (304)
T COG0478         170 GVKVPKPIA-----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNIL  234 (304)
T ss_pred             CCCCCCccc-----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence              4554444     24789999999986654331       1222233344445544444445   89999999999999


Q ss_pred             EcCCCCeEEecccccc
Q 038580          205 LDRNYQPYVSDFGLHL  220 (356)
Q Consensus       205 l~~~~~~kl~Dfg~~~  220 (356)
                      ++++|.+.++||--+.
T Consensus       235 V~~dg~~~vIDwPQ~v  250 (304)
T COG0478         235 VTEDGDIVVIDWPQAV  250 (304)
T ss_pred             EecCCCEEEEeCcccc
Confidence            9999999999996543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=6.5e-08  Score=80.10  Aligned_cols=125  Identities=19%  Similarity=0.184  Sum_probs=77.2

Q ss_pred             eEEEEEEcCCCeEEEEEEecccccc---------------------ch-----HHHHHHHHHHhccCCC--cccccccee
Q 038580           84 TLYKALLQRSGSVRLLRFLRPVCTT---------------------RD-----KEFGDLIELLGCIRHP--NLVPLLGFY  135 (356)
Q Consensus        84 ~V~~~~~~~~~~~~a~k~~~~~~~~---------------------~~-----~~~~~e~~~l~~l~h~--niv~~~~~~  135 (356)
                      .||.|... ++..+|+|+.+.....                     ..     ....+|.+.|.++...  ++.+.+++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38888875 5678899987632100                     00     1357789999988755  34445442 


Q ss_pred             eCCCCceEEEEeccc--CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCeeEcCCCCeE
Q 038580          136 AGPRGEKLIVHPFYK--RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY-LHTGFHRPIIHGNLKSKNILLDRNYQPY  212 (356)
Q Consensus       136 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~k  212 (356)
                      .    ...+||||+.  +..+...... .   ++......++.+++..+.. +|.   .+++|+|+.+.||+++++ .+.
T Consensus        79 ~----~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 N----RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             E----TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred             e----CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence            2    4579999998  6555443321 1   1122345566677775655 468   999999999999999988 999


Q ss_pred             Eecccccccc
Q 038580          213 VSDFGLHLLL  222 (356)
Q Consensus       213 l~Dfg~~~~~  222 (356)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=9.3e-07  Score=73.82  Aligned_cols=139  Identities=7%  Similarity=-0.017  Sum_probs=96.8

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEec-ccc-----ccchHHHHHHHHHHhccCCC--ccccccceee---CC-CCceEE
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLR-PVC-----TTRDKEFGDLIELLGCIRHP--NLVPLLGFYA---GP-RGEKLI  144 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~-~~~-----~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~-~~~~~l  144 (356)
                      -|+||-+.|+.-..... . +-+|.-. ...     .-....|.+|...+..+..-  .+.+.. ++.   .+ .-+-+|
T Consensus        26 ~~rgG~SgV~r~~~~g~-~-~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-K-LYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeCCc-E-EEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46688888998776532 3 4444332 111     11234789999998887522  233333 222   11 124678


Q ss_pred             EEecccC-CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC--eEEeccccccc
Q 038580          145 VHPFYKR-GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ--PYVSDFGLHLL  221 (356)
Q Consensus       145 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~  221 (356)
                      |+|-+.+ -||.+++.+....+.+......+..+++..++-||+   .++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8987764 589998875555566777778899999999999999   99999999999999986667  89999986543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.61  E-value=1.5e-08  Score=95.52  Aligned_cols=183  Identities=21%  Similarity=0.115  Sum_probs=132.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc-cccccceeeCCCCceEEEEecccCC-
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN-LVPLLGFYAGPRGEKLIVHPFYKRG-  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~e~~~~g-  152 (356)
                      .-.++|++++++|.+...+.... .+++..     ..+..-++++|.+++||| .+..++-++ .+...++.++++.++ 
T Consensus       248 h~fvK~altknpKkRptaeklL~-h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee-ceeecc-----chhhHHHHHHHHHccCCCCcccccccCC-cccccchhhhhhcCCc
Confidence            34788999999998876544443 554432     256677899999999999 676666565 445788999999876 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +-.... ......+...+...++..-+++++++|+   ..=+|+|    ||+.++ +..+..||+....++...  ....
T Consensus       321 s~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t  389 (829)
T KOG0576|consen  321 SSALEM-TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT  389 (829)
T ss_pred             cccccC-ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence            221111 1122334445556667777899999999   4458888    777665 578999999887665432  3456


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE  275 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~  275 (356)
                      ..+++.|+|||+...+.+..+.|+|++|+-.-++.-|..|-..
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            6788999999999999999999999999877777777766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=5.3e-07  Score=76.41  Aligned_cols=105  Identities=16%  Similarity=0.139  Sum_probs=77.2

Q ss_pred             HHHHHHHHHhccCCC--ccccccceeeCCC---CceEEEEecccCC-ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 038580          112 EFGDLIELLGCIRHP--NLVPLLGFYAGPR---GEKLIVHPFYKRG-NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL  185 (356)
Q Consensus       112 ~~~~e~~~l~~l~h~--niv~~~~~~~~~~---~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L  185 (356)
                      ...+|...+..+...  .+.+.+++.....   ..-++++|++++. +|.+++.....  .+......++.+++..++-|
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence            566777766655322  2333344433211   2458999999874 89999874222  55556778899999999999


Q ss_pred             hcCCCCCceecCCCCCCeeEcCCC---CeEEeccccccc
Q 038580          186 HTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGLHLL  221 (356)
Q Consensus       186 h~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~  221 (356)
                      |.   .|++|+|+++.|||++.+.   .+.++||+-+..
T Consensus       135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99   9999999999999999887   789999997655

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=9.7e-07  Score=84.00  Aligned_cols=151  Identities=15%  Similarity=0.141  Sum_probs=95.0

Q ss_pred             chhhhhcCCC-CcccccCCceEEEEEEcCCCeEEEEEEeccccccch---------------------------------
Q 038580           65 TICDILDAPG-EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---------------------------------  110 (356)
Q Consensus        65 ~~~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---------------------------------  110 (356)
                      .+.+.+...+ +.|+.++-|.||+|.+++ |+.||+|+.++.-...-                                 
T Consensus       120 ~iee~F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~  198 (517)
T COG0661         120 PIEELFSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF  198 (517)
T ss_pred             CHHHHHHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence            4555565554 789999999999999984 88899999875321110                                 


Q ss_pred             -------HHHHHHHHHHhcc----CCCccccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHH
Q 038580          111 -------KEFGDLIELLGCI----RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA  179 (356)
Q Consensus       111 -------~~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~  179 (356)
                             -++.+|..-+.++    +...=+.+=.+|.+-.+...++|||+.|-.+.+...-.. ...+...   ++..++
T Consensus       199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~  274 (517)
T COG0661         199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLV  274 (517)
T ss_pred             HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHH
Confidence                   0123333333332    121112232334333346799999999988888743212 3444333   333332


Q ss_pred             HH-HHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          180 GG-LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       180 ~~-l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      .+ +..+-.   .|+.|.|..|.||+++.++.+.+.|||+....+
T Consensus       275 ~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         275 RAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            22 222223   679999999999999999999999999976553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=7.6e-06  Score=70.30  Aligned_cols=139  Identities=10%  Similarity=0.141  Sum_probs=79.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCcc--ccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL--VPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..||+|..+.||+.    .+...++|.....  .......+|.+.++.+..-.+  .+.+++... .+...++||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCc
Confidence            56999999999984    2334667876542  233467889998888753333  344554443 44678899999986


Q ss_pred             C-hhHhh---------------------hcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCceecC
Q 038580          153 N-LAQCI---------------------RGGSGEAHKWSIIYR-ISI----------GIAG-GLDYLHT-GFHRPIIHGN  197 (356)
Q Consensus       153 s-L~~~l---------------------~~~~~~~~~~~~~~~-i~~----------~i~~-~l~~Lh~-~~~~~ivH~d  197 (356)
                      + +...+                     +.-.....+...... +-.          .+.. ...+|.. .....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111                     110000111111100 000          0111 1122221 1124579999


Q ss_pred             CCCCCeeEcCCCCeEEeccccccc
Q 038580          198 LKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       198 lk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      +.|.|+++++++ +.++||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999887 99999997643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.20  E-value=6.2e-06  Score=68.55  Aligned_cols=103  Identities=16%  Similarity=0.147  Sum_probs=80.8

Q ss_pred             HHHHHHHhccCC-CccccccceeeCCCCceEEEEecccCCChhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 038580          114 GDLIELLGCIRH-PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGLDYLHTGFHR  191 (356)
Q Consensus       114 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~  191 (356)
                      ..|.-+++.+++ +++.+++|+|-     .+++.||...+++...-.. ..-...+|..+.+|+.++++.+.+++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            457788888876 69999999884     3678899987766422000 0112478999999999999999999986655


Q ss_pred             CceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       192 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .+.-.|++++|+-+++++++|+.|......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            577799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=2.8e-05  Score=74.08  Aligned_cols=154  Identities=14%  Similarity=0.118  Sum_probs=93.7

Q ss_pred             ccchhhhhcCC-CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------------------------------
Q 038580           63 DLTICDILDAP-GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------------------------------  109 (356)
Q Consensus        63 ~~~~~~~~~~~-~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------------------------------  109 (356)
                      .-.+.+++... .+.||.-+.|.||+|++++ |+.||+|+-++.....                                
T Consensus       154 G~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~  232 (538)
T KOG1235|consen  154 GAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIA  232 (538)
T ss_pred             CCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHH
Confidence            34444555443 3779999999999999985 8889999976422111                                


Q ss_pred             -----hHHHHHHHHHH----hccCCCcc---ccccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHH
Q 038580          110 -----DKEFGDLIELL----GCIRHPNL---VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG  177 (356)
Q Consensus       110 -----~~~~~~e~~~l----~~l~h~ni---v~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  177 (356)
                           +-+|..|.+-.    +.+.|-+.   |.+=.++.+-.....|+||||+|..+.+.-.-. ...++...   ++..
T Consensus       233 ~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~---i~~~  308 (538)
T KOG1235|consen  233 KSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHD---ILNK  308 (538)
T ss_pred             hhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHH---HHHH
Confidence                 01233443322    23345551   223333443344789999999997666653211 22344333   3333


Q ss_pred             HHHHHHHHhcCCCCCceecCCCCCCeeEcC----CCCeEEeccccccccC
Q 038580          178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDR----NYQPYVSDFGLHLLLN  223 (356)
Q Consensus       178 i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~~~~~~  223 (356)
                      +.++...+=  +..|++|.|=.|-||+++.    ++.+.+-|||+.....
T Consensus       309 l~~~~~~qI--f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  309 LVEAYLEQI--FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHHHHHH--HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            333322221  1167999999999999983    6789999999976543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.12  E-value=2.9e-05  Score=65.25  Aligned_cols=128  Identities=14%  Similarity=0.108  Sum_probs=77.5

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccchHHH---------HHHHHHHhccCC---CccccccceeeCC----CC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEF---------GDLIELLGCIRH---PNLVPLLGFYAGP----RG  140 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~~~~~~----~~  140 (356)
                      +-......|.+-.  -++..+++|..+.......+.|         .+++..+.+++.   -..+.++.+..-.    ..
T Consensus        39 ~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~  116 (229)
T PF06176_consen   39 FKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS  116 (229)
T ss_pred             ecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence            3333334444433  3567788888775443322222         233333333322   2233333322211    12


Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      ..+++|||++|..|.+...      ++.    .+...+.+++.-+|.   .|+.|+|..|.|++++++ .++++||+..+
T Consensus       117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            4568999999988876532      222    244567788999999   999999999999999966 49999998643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.09  E-value=2.6e-05  Score=67.14  Aligned_cols=142  Identities=16%  Similarity=0.172  Sum_probs=80.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc--cccccceeeC--CCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN--LVPLLGFYAG--PRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~--~~~~~~lv~e~~~  150 (356)
                      +.++.|..+.||+....+ + .+++|.....  .....+..|..+++.+....  +.+++..+..  .....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            468999999999999875 4 6777876543  33457788888888775332  3445543322  1234689999999


Q ss_pred             CCChhH----------------hh---hcC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 038580          151 RGNLAQ----------------CI---RGG--SGEAHKWSI---------IYRI------------SIGIAG-GLDYLHT  187 (356)
Q Consensus       151 ~gsL~~----------------~l---~~~--~~~~~~~~~---------~~~i------------~~~i~~-~l~~Lh~  187 (356)
                      +.++..                .+   +..  ...+.....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987777                11   111  111111110         0000            011222 2333332


Q ss_pred             ----CCCCCceecCCCCCCeeEc-CCCCeEEecccccc
Q 038580          188 ----GFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHL  220 (356)
Q Consensus       188 ----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~  220 (356)
                          .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1236799999999999999 55666799998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=6.6e-05  Score=76.81  Aligned_cols=79  Identities=10%  Similarity=0.160  Sum_probs=54.4

Q ss_pred             CcccccCCceEEEEEEcCCC--eEEEEEEecccc-ccchHHHHHHHHHHhccC-CCcc--ccccceeeCCC--CceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSG--SVRLLRFLRPVC-TTRDKEFGDLIELLGCIR-HPNL--VPLLGFYAGPR--GEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~--~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~--~~~~lv~  146 (356)
                      +.++.|.++.+|+.....++  ..+++|...... ......+.+|.++++.+. |+++  .+++++|.++.  +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            56889999999998775432  345555543222 123357889999999985 6664  66777776432  4678999


Q ss_pred             ecccCCC
Q 038580          147 PFYKRGN  153 (356)
Q Consensus       147 e~~~~gs  153 (356)
                      ||+++..
T Consensus       124 E~v~G~~  130 (822)
T PLN02876        124 EYLEGRI  130 (822)
T ss_pred             EecCCcc
Confidence            9998854

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.01  E-value=6.7e-05  Score=60.45  Aligned_cols=127  Identities=19%  Similarity=0.286  Sum_probs=84.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      ..||+|++|.||+|.+.  +..+|+|+-+.  ......+..|.++|..+.-.++.+=+-.+.    .-++.|||..|-+|
T Consensus        28 ~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          28 KELAKGTTSVVYLGEWR--GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhcccccEEEEeecc--CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            67999999999999996  44677777654  234467899999999888766655433232    23455999999888


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC-CCeeEcCCCCeEEeccccccc
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKS-KNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~-~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .+.-...     +......    +++. +|.-+.  .||-|..|.- ...++.+++.+.|+||.-++.
T Consensus       100 ~~~~~~~-----~rk~l~~----vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG-----DRKHLLR----VLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc-----cHHHHHH----HHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7765421     3333333    4444 333332  7888888864 334444445899999998764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.99  E-value=1.9e-05  Score=79.95  Aligned_cols=196  Identities=17%  Similarity=0.174  Sum_probs=129.4

Q ss_pred             HHHHHHHHhccCCCccccccceeeCCCC---ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 038580          113 FGDLIELLGCIRHPNLVPLLGFYAGPRG---EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF  189 (356)
Q Consensus       113 ~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~  189 (356)
                      .+.|...+.+..|+|++.++.|-.....   ...+..+++..-++...+.  .-...+..+.+.+..+..+|++|+|+  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~--  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHS--  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHH--
Confidence            4556677888899999999887543221   1233456777778877776  34567888888899999999999999  


Q ss_pred             CCCceecCCCCC---CeeEcCCCCeEEe--ccccccccCCCCCcceecccCCCcccCccccccCCCCC--cchhHHHHHH
Q 038580          190 HRPIIHGNLKSK---NILLDRNYQPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE--ETDIYSFGVI  262 (356)
Q Consensus       190 ~~~ivH~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~sDvwslG~~  262 (356)
                       ....|.-+..+   +--.+..+...++  ||+.+.........  .....+..|-+||......+..  ..|+|.+|..
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence             66666555555   4444556666666  88876655432221  1223344578888877665544  4799999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 038580          263 MLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP  342 (356)
Q Consensus       263 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp  342 (356)
                      ...+..|..+-...       ..+....                            +........+....|+..++++|+
T Consensus       382 ~~~~~~~~~i~~~~-------~~~~~~l----------------------------~~~~~~~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKS-------AVPVSLL----------------------------DVLSTSELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             HhhhhhcCcccccc-------cchhhhh----------------------------ccccchhhhhhhhhhcchhhhhcc
Confidence            99988876542211       0000000                            011111455788899999999999


Q ss_pred             CHHHHHHH
Q 038580          343 NIKQVLWK  350 (356)
Q Consensus       343 s~~~il~~  350 (356)
                      ++.+++..
T Consensus       427 ~~~~ll~~  434 (1351)
T KOG1035|consen  427 SALELLTH  434 (1351)
T ss_pred             chhhhhhc
Confidence            99998764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.95  E-value=0.00012  Score=62.47  Aligned_cols=135  Identities=16%  Similarity=0.212  Sum_probs=81.1

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccchH-------------------H-----HHHHHHHHhccC--CCccc
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-------------------E-----FGDLIELLGCIR--HPNLV  129 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~-------------------~-----~~~e~~~l~~l~--h~niv  129 (356)
                      .|.+|.-+.||+|... ++..+|+|+.+.......+                   +     ...|..-|+++.  +=.+.
T Consensus        55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            4677888889998763 5788999998743221111                   0     123444444432  11122


Q ss_pred             cccceeeCCCCceEEEEecccCCCh-hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC
Q 038580          130 PLLGFYAGPRGEKLIVHPFYKRGNL-AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN  208 (356)
Q Consensus       130 ~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  208 (356)
                      +-+++.     ...|+|||+..... .-.|++   -+++......+..++++.+.-|-..  .++||+||+.-|||+. +
T Consensus       134 ~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFR-----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             Cceeec-----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence            222211     34789999865311 111211   1122224555666777777666653  6899999999999999 7


Q ss_pred             CCeEEecccccccc
Q 038580          209 YQPYVSDFGLHLLL  222 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~  222 (356)
                      +.+.|+|+|-+...
T Consensus       203 ~~p~iID~~QaV~~  216 (268)
T COG1718         203 GEPYIIDVSQAVTI  216 (268)
T ss_pred             CeEEEEECcccccc
Confidence            79999999976544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.95  E-value=0.00011  Score=63.89  Aligned_cols=138  Identities=12%  Similarity=0.020  Sum_probs=78.6

Q ss_pred             ccccCC-ceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCCCh
Q 038580           77 IGKSNY-GTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        77 ig~G~~-g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      |-.|.+ ..||+....  +..+++|......   ..+...|+++++.+. +--+.+++++... .+..++||++++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccH
Confidence            444555 788998754  3567777765332   345777888887774 3223445555543 3467899999998777


Q ss_pred             hHhh-------------------hcCC--CCCCC--HHHHHHHHHH--------------------HHHHHHHHhc----
Q 038580          155 AQCI-------------------RGGS--GEAHK--WSIIYRISIG--------------------IAGGLDYLHT----  187 (356)
Q Consensus       155 ~~~l-------------------~~~~--~~~~~--~~~~~~i~~~--------------------i~~~l~~Lh~----  187 (356)
                      ....                   +.-.  ..+..  ..........                    +...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6431                   1111  00111  0000000000                    1111122211    


Q ss_pred             CCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       188 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      .....++|+|+.|.|++++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            112569999999999999998778899999754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.94  E-value=0.00023  Score=59.48  Aligned_cols=131  Identities=15%  Similarity=0.210  Sum_probs=87.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc----------------ccchHHHHHHHHHHhccC------CCccccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC----------------TTRDKEFGDLIELLGCIR------HPNLVPL  131 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~  131 (356)
                      ...||+|+.-.||.--..   .-.++|+.+...                ....++..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            478999999999976433   235677776554                222456677766555544      8899999


Q ss_pred             cceeeCCCCceEEEEecccC------CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE
Q 038580          132 LGFYAGPRGEKLIVHPFYKR------GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL  205 (356)
Q Consensus       132 ~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  205 (356)
                      +|+.+++.+ .-+|+|...+      -+|.+++..   ..++. ...+   .+-+-..||-.   .+|+.+|++|.||++
T Consensus        83 ~G~veT~~G-~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLG-LGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCc-eEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEE
Confidence            999887664 5677776543      367777753   23443 2322   33344567777   889999999999999


Q ss_pred             cCCC----CeEEec-ccc
Q 038580          206 DRNY----QPYVSD-FGL  218 (356)
Q Consensus       206 ~~~~----~~kl~D-fg~  218 (356)
                      ....    .+.|+| ||.
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            6432    466777 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.77  E-value=0.00024  Score=61.46  Aligned_cols=31  Identities=29%  Similarity=0.392  Sum_probs=26.1

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ..++|+|+.+.|++++++...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999999776567999998643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.0012  Score=59.23  Aligned_cols=76  Identities=12%  Similarity=0.144  Sum_probs=53.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCC---CccccccceeeCC--CCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH---PNLVPLLGFYAGP--RGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--~~~~~lv~e~~  149 (356)
                      +.||.|..+.||.....+ + .+++|+.+.  ......+..|.+.|+.+.-   -.+.+++++|...  .+..++|||++
T Consensus        20 ~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         20 ECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            569999999999986543 3 355666432  1133578999999888753   3566677766532  35689999999


Q ss_pred             cCCCh
Q 038580          150 KRGNL  154 (356)
Q Consensus       150 ~~gsL  154 (356)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98755

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.66  E-value=0.00045  Score=60.60  Aligned_cols=137  Identities=10%  Similarity=0.101  Sum_probs=75.9

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCcccc-ccceeeCCCCceEEEEecccCCChh
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP-LLGFYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      +..|-.+.+|+..  .++..+++|..........-+..+|..+++.+....+++ +++.+  +   -++|+||++|..+.
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~---~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E---HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C---CEEEEEeccCcccc
Confidence            5568888999886  345567778754322221124677888888776433332 23222  1   36899999986654


Q ss_pred             Hh-----------------hhcCC--CCCCCHHH-HHHHHHHH---------HHHHHHHhc-----CCCCCceecCCCCC
Q 038580          156 QC-----------------IRGGS--GEAHKWSI-IYRISIGI---------AGGLDYLHT-----GFHRPIIHGNLKSK  201 (356)
Q Consensus       156 ~~-----------------l~~~~--~~~~~~~~-~~~i~~~i---------~~~l~~Lh~-----~~~~~ivH~dlk~~  201 (356)
                      ..                 ++...  ..+++... +..+..++         ..-+..+-.     .....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 12111  11222211 11111111         111222211     11246899999999


Q ss_pred             CeeEcCCCCeEEeccccccc
Q 038580          202 NILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       202 Nill~~~~~~kl~Dfg~~~~  221 (356)
                      |+++++++ +.++||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999987654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.54  E-value=0.0011  Score=55.06  Aligned_cols=120  Identities=20%  Similarity=0.276  Sum_probs=82.7

Q ss_pred             CcccccCC-ceEEEEEEcCCCeEEEEEEecccc---c------------------cchHHHHHHHHHHhccC---CCcc-
Q 038580           75 EVIGKSNY-GTLYKALLQRSGSVRLLRFLRPVC---T------------------TRDKEFGDLIELLGCIR---HPNL-  128 (356)
Q Consensus        75 ~~ig~G~~-g~V~~~~~~~~~~~~a~k~~~~~~---~------------------~~~~~~~~e~~~l~~l~---h~ni-  128 (356)
                      +.||.|.- |.||++...  |..+|+|+++...   .                  .....|..|.+...+|+   +.++ 
T Consensus        43 efLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~  120 (207)
T PF13095_consen   43 EFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLW  120 (207)
T ss_pred             eecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCce
Confidence            78999999 999999985  7799999943210   0                  01135788888887775   4455 


Q ss_pred             -ccccceee-C----------------CCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 038580          129 -VPLLGFYA-G----------------PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH  190 (356)
Q Consensus       129 -v~~~~~~~-~----------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~  190 (356)
                       |+.+||.. +                ......||.||.+...           .+....    +.++.+-+..+|.   
T Consensus       121 Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~k---  182 (207)
T PF13095_consen  121 AVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILHK---  182 (207)
T ss_pred             EEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHHH---
Confidence             88888752 1                0112356777665432           222223    3457777889999   


Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      .+|+-+|+++.|..     .-||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999986     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.48  E-value=0.0015  Score=56.36  Aligned_cols=74  Identities=14%  Similarity=0.105  Sum_probs=45.6

Q ss_pred             CcccccCCceEEEEEEcC-CCeEEEEEEeccccccchHHHHHHHHHHhccCCCcccc-ccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP-LLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.|..|-.+.+|+....+ ++..+++|+.... .....+..+|..+++.+....+++ +++.+  .+   .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~---~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATF--QN---GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC---cEEEEeeCCC
Confidence            457788889999987653 2456778876532 222234457888888775433333 33322  22   3799999987


Q ss_pred             Ch
Q 038580          153 NL  154 (356)
Q Consensus       153 sL  154 (356)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.27  E-value=0.0024  Score=57.29  Aligned_cols=142  Identities=17%  Similarity=0.157  Sum_probs=81.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc--ccccccee-----eCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN--LVPLLGFY-----AGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv~e  147 (356)
                      +.+..|....+|+....  +..+++|+...   ........|++++..+.+.+  +.+.+...     ..-.+..+++++
T Consensus        20 ~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          20 EGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             ecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            55777888899987653  33577787653   23345667777777764322  33443321     112345689999


Q ss_pred             cccCCChhH----h----------hhc---CCC------CCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 038580          148 FYKRGNLAQ----C----------IRG---GSG------EAHKWSIIY----------RISIGIAGGLDYLHT----GFH  190 (356)
Q Consensus       148 ~~~~gsL~~----~----------l~~---~~~------~~~~~~~~~----------~i~~~i~~~l~~Lh~----~~~  190 (356)
                      |++|.++..    .          ++.   ...      ....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999866532    0          010   000      111221110          011112333444442    223


Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987778999997643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.20  E-value=0.0036  Score=56.35  Aligned_cols=141  Identities=18%  Similarity=0.175  Sum_probs=79.9

Q ss_pred             CcccccCCceEEEEEEcC------CCeEEEEEEeccccccchHHHHHHHHHHhccCCCccc-cccceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQR------SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV-PLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e  147 (356)
                      +.+..|-...+|+.....      .+..+++|+..... ....+..+|.++++.+....+. ++++++.  +   ..|++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cchhh
Confidence            345667778899887643      24678888865432 2234567777777776533333 3444332  2   25789


Q ss_pred             cccCCChhHh-----------------hhcCCCC-------CC--CHHHHHH--------------------------HH
Q 038580          148 FYKRGNLAQC-----------------IRGGSGE-------AH--KWSIIYR--------------------------IS  175 (356)
Q Consensus       148 ~~~~gsL~~~-----------------l~~~~~~-------~~--~~~~~~~--------------------------i~  175 (356)
                      |++|.++...                 ++.....       ..  -+..+..                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9888665431                 1111100       01  1111111                          11


Q ss_pred             HHHHHHHHHHhc------CCCCCceecCCCCCCeeEcCC----CCeEEeccccccc
Q 038580          176 IGIAGGLDYLHT------GFHRPIIHGNLKSKNILLDRN----YQPYVSDFGLHLL  221 (356)
Q Consensus       176 ~~i~~~l~~Lh~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  221 (356)
                      ..+..-+.++..      .....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            122222334431      234679999999999999985    7899999997643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.14  E-value=0.016  Score=53.89  Aligned_cols=75  Identities=11%  Similarity=0.028  Sum_probs=49.0

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc-------ccchHHHHHHHHHHhccC---CCccccccceeeCCCCceEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-------TTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~l  144 (356)
                      +.||.|.++.||++...++++.+++|.-.+..       ......+..|.+.|+.+.   ..++.+++.+.   ....++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D---~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD---EELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---CCCCEE
Confidence            56999999999999987554567777643221       112345677777777653   23455565532   235789


Q ss_pred             EEecccCC
Q 038580          145 VHPFYKRG  152 (356)
Q Consensus       145 v~e~~~~g  152 (356)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.89  E-value=0.00072  Score=63.35  Aligned_cols=53  Identities=21%  Similarity=0.380  Sum_probs=42.0

Q ss_pred             cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChhHhhhcC
Q 038580          108 TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGG  161 (356)
Q Consensus       108 ~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  161 (356)
                      .......--.+.++.+.|+|...++.+..+...+..+|+|++.. ||.+.+..+
T Consensus        24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~   76 (725)
T KOG1093|consen   24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG   76 (725)
T ss_pred             CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc
Confidence            34455666678888999999999999887766678889999854 999998643

>PRK05231 homoserine kinase; Provisional

Probab=96.88  E-value=0.017  Score=52.31  Aligned_cols=32  Identities=25%  Similarity=0.327  Sum_probs=27.1

Q ss_pred             CCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       190 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ..++||+|+.+.||+++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            46899999999999999776568999998654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.88  E-value=0.0021  Score=57.03  Aligned_cols=135  Identities=18%  Similarity=0.237  Sum_probs=87.4

Q ss_pred             hhcCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------------------c----hHHHHHHHHHHhccC-C
Q 038580           69 ILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------------------R----DKEFGDLIELLGCIR-H  125 (356)
Q Consensus        69 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------------------~----~~~~~~e~~~l~~l~-h  125 (356)
                      ...+.++.||-|.-+.||.+... .|...++|+-+.-...                  +    .-....|...|+.+. |
T Consensus        92 ~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~  170 (465)
T KOG2268|consen   92 SVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER  170 (465)
T ss_pred             hhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence            34556899999999999999876 4666677764321110                  0    012455666666664 3


Q ss_pred             Ccccc-ccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 038580          126 PNLVP-LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNIL  204 (356)
Q Consensus       126 ~niv~-~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  204 (356)
                      -.-|+ -++     .++.++|||+..+..|.+.-+     ..+..++..   .+..-+--|..   .|+||+|..-=||+
T Consensus       171 gfpVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~---~lm~~Iv~la~---~GlIHgDFNEFNim  234 (465)
T KOG2268|consen  171 GFPVPKPID-----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYD---DLMGLIVRLAN---HGLIHGDFNEFNIM  234 (465)
T ss_pred             CCCCCCccc-----ccceeeHHHhhcccceeeeee-----cCChHHHHH---HHHHHHHHHHH---cCceecccchheeE
Confidence            22222 222     347899999999988876532     223333332   33333444556   89999999999999


Q ss_pred             EcCCCCeEEecccccc
Q 038580          205 LDRNYQPYVSDFGLHL  220 (356)
Q Consensus       205 l~~~~~~kl~Dfg~~~  220 (356)
                      +++++.++++||--+.
T Consensus       235 v~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQMV  250 (465)
T ss_pred             EecCCCEEEeechHhh
Confidence            9999999999996443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.83  E-value=0.034  Score=50.18  Aligned_cols=143  Identities=17%  Similarity=0.226  Sum_probs=79.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC--cccccccee-----eCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP--NLVPLLGFY-----AGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~-----~~~~~~~~lv~e  147 (356)
                      ..++.|....+|+.... ++ .+++|+.+...  ...+...|.+++..|...  .+.+.+...     ....+..+++++
T Consensus        28 ~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             cccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            55777877899987643 34 46677665321  234455666666665322  233333321     122346789999


Q ss_pred             cccCCChhH-----------h---hhc---CCCC-------CCCHHHHHH------------HHHHHHHHHHHHhc----
Q 038580          148 FYKRGNLAQ-----------C---IRG---GSGE-------AHKWSIIYR------------ISIGIAGGLDYLHT----  187 (356)
Q Consensus       148 ~~~~gsL~~-----------~---l~~---~~~~-------~~~~~~~~~------------i~~~i~~~l~~Lh~----  187 (356)
                      |++|.++..           .   ++.   ....       ...|.....            ....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321           0   111   0000       011211110            01123334555532    


Q ss_pred             CCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       188 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ....+++|+|+.+.|+++++++...|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2347899999999999999987778999998643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.54  E-value=0.00046  Score=72.21  Aligned_cols=159  Identities=14%  Similarity=-0.005  Sum_probs=106.6

Q ss_pred             HHHHHHHhccCCCccccccceeeC-CCCceEEEEecccCCChhHhhhcCCCCC--CCHHHHHHHHHHHHHHHHHHhcC--
Q 038580          114 GDLIELLGCIRHPNLVPLLGFYAG-PRGEKLIVHPFYKRGNLAQCIRGGSGEA--HKWSIIYRISIGIAGGLDYLHTG--  188 (356)
Q Consensus       114 ~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~i~~~i~~~l~~Lh~~--  188 (356)
                      ..|.+.++...|+++.....=..+ ...+.+..++++.+|.+.+.+-.+..+.  ++..-....-.+.+.+..-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            334445556689988776553221 2235688899999999999986544332  33222322223335555555542  


Q ss_pred             CCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh
Q 038580          189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       189 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  268 (356)
                      ...--+|+++|+.|.+|+.+..+|++++|+.+..++... ......+++-|+.|+....-.++.++|+|+.|+.+++..-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            224478999999999999999999999999884332211 1223345666888888776678888999999999999877


Q ss_pred             CCCCC
Q 038580          269 GKEPI  273 (356)
Q Consensus       269 g~~p~  273 (356)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            77665

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.44  E-value=0.059  Score=48.49  Aligned_cols=32  Identities=25%  Similarity=0.426  Sum_probs=28.3

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEecccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      ..++|+|..+.|++++++.-+-+.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            46999999999999999888889999987653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.40  E-value=0.044  Score=48.62  Aligned_cols=31  Identities=23%  Similarity=0.438  Sum_probs=25.6

Q ss_pred             CCceecCCCCCCeeEcCCCC-eEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQ-PYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~  221 (356)
                      ..++|+|+.+.|+++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.08  E-value=0.12  Score=47.24  Aligned_cols=74  Identities=14%  Similarity=0.094  Sum_probs=43.3

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccc-------cchHHHHHHHHHHhccC--CCccccccceeeCCCCceEEEE
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-------TRDKEFGDLIELLGCIR--HPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .||.|....||++....++..+++|.-.+...       -.......|.+.|+...  -|..|+-+-+|.  +....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence            47999999999999864445677776532211       11123455666665543  344444322233  33567899


Q ss_pred             ecccC
Q 038580          147 PFYKR  151 (356)
Q Consensus       147 e~~~~  151 (356)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.06  E-value=0.14  Score=46.59  Aligned_cols=140  Identities=21%  Similarity=0.278  Sum_probs=78.7

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC---CCcccc---ccc----eeeCCCCceEEE
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVP---LLG----FYAGPRGEKLIV  145 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---~~~----~~~~~~~~~~lv  145 (356)
                      .|.+ .-..+|+....+++ . ++|+.+..  ....+...|...+..+.   .|=.++   +=|    ....+ .+.+-+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~-~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGR-Y-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEecCCC-e-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEE
Confidence            3444 55678888876443 3 88987764  34456666666666553   221122   211    12222 377889


Q ss_pred             EecccCCChhH-h-----------h-------hcCC------CCCCCHHH-------------HHHHHHHHHHHHHHHhc
Q 038580          146 HPFYKRGNLAQ-C-----------I-------RGGS------GEAHKWSI-------------IYRISIGIAGGLDYLHT  187 (356)
Q Consensus       146 ~e~~~~gsL~~-~-----------l-------~~~~------~~~~~~~~-------------~~~i~~~i~~~l~~Lh~  187 (356)
                      ++|++|..+.. .           +       ++..      .....|..             -.....++...++.+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999987772 1           0       1110      11223320             00122334444444443


Q ss_pred             C----CCCC---ceecCCCCCCeeEcCCCC-eEEeccccccc
Q 038580          188 G----FHRP---IIHGNLKSKNILLDRNYQ-PYVSDFGLHLL  221 (356)
Q Consensus       188 ~----~~~~---ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~  221 (356)
                      .    ....   +||+|+.|.||+++.+.. +.+.||+.+..
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            1    1223   999999999999998874 88999997643

>PRK06148 hypothetical protein; Provisional

Probab=95.76  E-value=0.19  Score=52.89  Aligned_cols=143  Identities=18%  Similarity=0.263  Sum_probs=76.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-------CCCccccccc-----eeeCCCC--
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-------RHPNLVPLLG-----FYAGPRG--  140 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~-----~~~~~~~--  140 (356)
                      +.|+ |..-.+|+.... ++..+++|+.+...  .......|...|..+       .-|.+++-.+     ....+++  
T Consensus        31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            3454 456778888754 45568999987643  223344444455433       2344444321     1112222  


Q ss_pred             ceEEEEecccCCChhHhh-----------------h----c----CCCCCCCHHH-----------------HHHHHHHH
Q 038580          141 EKLIVHPFYKRGNLAQCI-----------------R----G----GSGEAHKWSI-----------------IYRISIGI  178 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l-----------------~----~----~~~~~~~~~~-----------------~~~i~~~i  178 (356)
                      +.+.+++|.+|..+.+..                 +    .    .....+.|..                 ...++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            456789999997775410                 0    0    0111223321                 11222223


Q ss_pred             HHHHH----HHhcCCCCCceecCCCCCCeeEcCCC--CeE-Eeccccccc
Q 038580          179 AGGLD----YLHTGFHRPIIHGNLKSKNILLDRNY--QPY-VSDFGLHLL  221 (356)
Q Consensus       179 ~~~l~----~Lh~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfg~~~~  221 (356)
                      .....    ........++||.|+.+.||+++.++  .+. |+|||.+..
T Consensus       187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22221    11122346799999999999999875  454 999998654

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=95.69  E-value=0.005  Score=47.95  Aligned_cols=30  Identities=33%  Similarity=0.547  Sum_probs=22.3

Q ss_pred             CcchhHHHHHHHHHHHHHHHhheeeecCCC
Q 038580            1 MLKLVLGLALATLLIILILIFFFYRKRLPK   30 (356)
Q Consensus         1 ~~~iv~~~~~~~~~~~~~~~~~~~rr~~~~   30 (356)
                      ||++++|+++++++++++++|+||+|+++.
T Consensus        51 VIGvVVGVGg~ill~il~lvf~~c~r~kkt   80 (154)
T PF04478_consen   51 VIGVVVGVGGPILLGILALVFIFCIRRKKT   80 (154)
T ss_pred             EEEEEecccHHHHHHHHHhheeEEEecccC
Confidence            467788888888877777777777776554

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>PLN02236 choline kinase

Probab=95.49  E-value=0.18  Score=46.36  Aligned_cols=141  Identities=15%  Similarity=0.182  Sum_probs=78.7

Q ss_pred             CcccccCCceEEEEEEcC----CCeEEEEEEeccccccchHHHHHHHHHHhccCCCccc-cccceeeCCCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQR----SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV-PLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+-.|-...+|+.....    ++..+++|+..... ...-+-.+|..+++.+...++. ++++.+.  ++   .+.+|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~--~g---~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFP--NG---RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEEC--Cc---eEEEee
Confidence            345568888899987542    23567888765432 2222446778887777544443 3344442  32   578888


Q ss_pred             cCCChhHh-----------------hhcCC----CCCCCHHHHHHHHHHH-----------------HHHHHH----Hhc
Q 038580          150 KRGNLAQC-----------------IRGGS----GEAHKWSIIYRISIGI-----------------AGGLDY----LHT  187 (356)
Q Consensus       150 ~~gsL~~~-----------------l~~~~----~~~~~~~~~~~i~~~i-----------------~~~l~~----Lh~  187 (356)
                      ++.+|...                 ++...    .....+..+..+..++                 ...+..    +..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665421                 11111    1112233333332211                 111111    221


Q ss_pred             -CCCCCceecCCCCCCeeEcC-CCCeEEeccccccc
Q 038580          188 -GFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLL  221 (356)
Q Consensus       188 -~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  221 (356)
                       .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             12356899999999999986 46899999987653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.47  E-value=0.15  Score=46.46  Aligned_cols=141  Identities=18%  Similarity=0.248  Sum_probs=77.2

Q ss_pred             CcccccCCceEEEEEEcCC---CeEEEEEEeccccccchHHHHHHHHHHhccCCCccc-cccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV-PLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.|..|-...+|+......   +..+++|+.... ....-+-.+|..+++.+..-++. ++++++  +.+   ++.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~-t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN-TDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCC-cCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc---Eeehhhc
Confidence            4455578888998865432   236778876543 22233456778887777644443 344443  232   4888887


Q ss_pred             CCChhH-------h----------hhcCC----CCCCCHHHHHHHHHHH-------------------------HHHHH-
Q 038580          151 RGNLAQ-------C----------IRGGS----GEAHKWSIIYRISIGI-------------------------AGGLD-  183 (356)
Q Consensus       151 ~gsL~~-------~----------l~~~~----~~~~~~~~~~~i~~~i-------------------------~~~l~-  183 (356)
                      +..|..       .          ++...    ..+..|..+..+..++                         +..+. 
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765432       0          12111    1111233332222221                         11111 


Q ss_pred             HHhc-CCCCCceecCCCCCCeeEcC-CCCeEEeccccccc
Q 038580          184 YLHT-GFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLL  221 (356)
Q Consensus       184 ~Lh~-~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  221 (356)
                      ++.+ ....-.+|.|+.+.||++++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1211 11234899999999999974 56899999997654

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.45  E-value=0.082  Score=48.98  Aligned_cols=74  Identities=12%  Similarity=0.129  Sum_probs=43.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc------cchHHHHHHHHHHhccC--CCcccc-ccceeeCCCCceEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT------TRDKEFGDLIELLGCIR--HPNLVP-LLGFYAGPRGEKLIV  145 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~-~~~~~~~~~~~~~lv  145 (356)
                      +.||.|.-..||++.+..++..+++|.-.+...      -.......|.+.|+...  -|..|+ ++. |.  +....++
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~D--~e~~~~v  111 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-FD--SVMNCCV  111 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-EC--cHHhhHH
Confidence            568999999999999854345566665432211      11234556666666543  354444 443 33  3356778


Q ss_pred             EecccC
Q 038580          146 HPFYKR  151 (356)
Q Consensus       146 ~e~~~~  151 (356)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.39  E-value=0.11  Score=46.23  Aligned_cols=72  Identities=11%  Similarity=0.188  Sum_probs=42.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC---CCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.++.|....+|+..  .++..+.+|+-.   ......|..|.+-|+.|.   --.+.+.+++.... +..++++||++.
T Consensus        23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-~~~fLlle~l~~   96 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-DDAFLLLEFLEM   96 (288)
T ss_dssp             EEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-SCCEEEEE----
T ss_pred             EecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-CCceEEEEeecC
Confidence            568889999999877  456677777654   223356888888888773   33456677766543 356999999876


Q ss_pred             C
Q 038580          152 G  152 (356)
Q Consensus       152 g  152 (356)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            5

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.39  E-value=0.094  Score=44.34  Aligned_cols=151  Identities=14%  Similarity=0.113  Sum_probs=86.4

Q ss_pred             cCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCChhHhhh
Q 038580           80 SNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR  159 (356)
Q Consensus        80 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  159 (356)
                      ++.++.-.++.+- |....+|+......-...-|..+.++++++.  .|+++..   +.....-++.|.|-.-.      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIK------  140 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCcc------
Confidence            4444555554432 4455555544333324556778888888764  3455442   22224567788774311      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcc
Q 038580          160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY  239 (356)
Q Consensus       160 ~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y  239 (356)
                           ..+    ..++..=.++|.-.|++ ..+.+|+|..|+|||-|+.|-+||.|-+.-..     .        +.-|
T Consensus       141 -----i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-----~--------~V~~  197 (308)
T PF07387_consen  141 -----INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-----N--------QVNM  197 (308)
T ss_pred             -----cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-----h--------eeeE
Confidence                 111    11111124667778863 36899999999999999999999999875211     0        0112


Q ss_pred             cCccccccCCCCCcchhHHHHHHHHHHHh
Q 038580          240 KAPELIKMKDASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       240 ~aPE~~~~~~~~~~sDvwslG~~l~el~t  268 (356)
                      .--|+   ...+.++++-+|=.-++++..
T Consensus       198 vN~~Y---~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  198 VNIEY---ESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             Eeeec---cccChHHHHHHHHHHHHHHHH
Confidence            22111   334677777777666666665

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.93  E-value=0.09  Score=47.77  Aligned_cols=72  Identities=22%  Similarity=0.116  Sum_probs=54.3

Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      +.|++|++- |+++..      .+...+.+.+.++.+.+.-++-+...  .+.=|||+.-.||+|+ .|++.|+||-+++
T Consensus       300 y~yl~~kdh-gt~is~------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         300 YLYLHFKDH-GTPISI------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEEecC-Cceeee------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence            445556554 334422      23456788889988888877777764  6688999999999999 8999999999988


Q ss_pred             cc
Q 038580          221 LL  222 (356)
Q Consensus       221 ~~  222 (356)
                      ..
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            53

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.89  E-value=0.59  Score=43.66  Aligned_cols=72  Identities=14%  Similarity=0.096  Sum_probs=42.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-------cchHHHHHHHHHHhccC---CCccccccceeeCCCCceEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-------TRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~l  144 (356)
                      +.||.|....||+.... ++ .+++|.-.....       .....-..|.+.|+.+.   ..++.+++.++.   +..++
T Consensus        38 ~eiggGn~N~VyrV~~~-~~-svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de---d~~vl  112 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SG-SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR---TMALI  112 (418)
T ss_pred             EEcCCCceeeEEEEEcC-Cc-cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC---CCCEE
Confidence            56899999999998763 33 466666441111       01122233355554442   246666777665   24678


Q ss_pred             EEecccC
Q 038580          145 VHPFYKR  151 (356)
Q Consensus       145 v~e~~~~  151 (356)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=94.74  E-value=0.029  Score=32.44  Aligned_cols=28  Identities=11%  Similarity=0.383  Sum_probs=15.0

Q ss_pred             cchhHHHHHHHHHHHHHHH-hheeeecCC
Q 038580            2 LKLVLGLALATLLIILILI-FFFYRKRLP   29 (356)
Q Consensus         2 ~~iv~~~~~~~~~~~~~~~-~~~~rr~~~   29 (356)
                      ++++++++++++++++.++ +.+++||.+
T Consensus         6 IaIIv~V~vg~~iiii~~~~YaCcykk~~   34 (38)
T PF02439_consen    6 IAIIVAVVVGMAIIIICMFYYACCYKKHR   34 (38)
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence            5666666666554444444 345555543

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.51  E-value=0.017  Score=34.06  Aligned_cols=22  Identities=23%  Similarity=0.557  Sum_probs=10.3

Q ss_pred             HHHHHHHHHHHHHHhheeeecC
Q 038580            7 GLALATLLIILILIFFFYRKRL   28 (356)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~rr~~   28 (356)
                      ++-++++++++++++|++|||+
T Consensus        18 vVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen   18 VVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             EechHHHHHHHHHHhheEEecc
Confidence            3333444444445555555543

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.43  E-value=0.46  Score=43.45  Aligned_cols=137  Identities=13%  Similarity=0.144  Sum_probs=82.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---------------------cchHH-----HHHHHHHHhccCCCc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---------------------TRDKE-----FGDLIELLGCIRHPN  127 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---------------------~~~~~-----~~~e~~~l~~l~h~n  127 (356)
                      +-.|..|.-+-||.+.-. +|..+|+|+.+....                     ...+.     .+.|++-|.+++...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            356777888899998876 566689998763211                     11111     234555555554333


Q ss_pred             cccccceeeCCCCceEEEEecccCCCh-hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          128 LVPLLGFYAGPRGEKLIVHPFYKRGNL-AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       128 iv~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      |..---...   ....|||+|+....- .-.|+   ...++...+..+-.+++.-|.-|-..  .++||.||+--|+|+.
T Consensus       228 IP~PePIlL---k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  228 IPCPEPILL---KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCceee---ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence            211100011   135789999853211 11122   23455556666666777777777664  5699999999999986


Q ss_pred             CCCCeEEecccccc
Q 038580          207 RNYQPYVSDFGLHL  220 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~  220 (356)
                      + |.+.|+|.+-+.
T Consensus       300 d-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  300 D-GKLYIIDVSQSV  312 (520)
T ss_pred             C-CEEEEEEccccc
Confidence            5 488999987554

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.34  E-value=0.26  Score=45.63  Aligned_cols=62  Identities=10%  Similarity=0.184  Sum_probs=42.4

Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR  207 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~  207 (356)
                      ...++-+|+.+-++..+++.   ...++....+++.--+.|+.-+--.  .+.+|.|+.|.||++-.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence            34677788999999999863   3344444555555555555433321  57999999999999953

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=94.02  E-value=0.029  Score=42.49  Aligned_cols=28  Identities=25%  Similarity=0.449  Sum_probs=13.0

Q ss_pred             chhHHHHHHHHHHHHHHHhheeeecCCCC
Q 038580            3 KLVLGLALATLLIILILIFFFYRKRLPKE   31 (356)
Q Consensus         3 ~iv~~~~~~~~~~~~~~~~~~~rr~~~~~   31 (356)
                      .|++|+.+++++++ ++++|++||+++|.
T Consensus        68 ~Ii~gv~aGvIg~I-lli~y~irR~~Kk~   95 (122)
T PF01102_consen   68 GIIFGVMAGVIGII-LLISYCIRRLRKKS   95 (122)
T ss_dssp             HHHHHHHHHHHHHH-HHHHHHHHHHS---
T ss_pred             ehhHHHHHHHHHHH-HHHHHHHHHHhccC
Confidence            34555554454444 45555556555543

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PTZ00384 choline kinase; Provisional

Probab=92.99  E-value=1.5  Score=40.84  Aligned_cols=75  Identities=8%  Similarity=0.143  Sum_probs=43.7

Q ss_pred             CcccccCCceEEEEEEcCCC------eEEEEEEeccccccchHHHHHHHHHHhccCCCccccc-cceeeCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSG------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL-LGFYAGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~~lv~e  147 (356)
                      +.|..|-.+.+|++....+.      +.|+++.. .......-+-.+|.++++.+...++.+- ++.+.     -.++.|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~-----~g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG-----DFTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-----CEEEEE
Confidence            44656888999998764331      12334332 1222222244667888888876655544 33332     258999


Q ss_pred             cccCCChh
Q 038580          148 FYKRGNLA  155 (356)
Q Consensus       148 ~~~~gsL~  155 (356)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.83  E-value=0.71  Score=39.42  Aligned_cols=73  Identities=10%  Similarity=0.151  Sum_probs=43.5

Q ss_pred             ccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC---ccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP---NLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +-.|.--..|...  .+...+-+|+-.   ......|..|+.-|..+.-.   ++.+++.+-. ..++.|+|+||++.+.
T Consensus        24 v~gG~inea~~v~--dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~-~~~~sylVle~L~~~~   97 (286)
T COG3001          24 VSGGDINEAWRLR--DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGA-SRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cCCccccceeEee--cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecC-CCCeeEEEEeeccCCC
Confidence            3334434444443  345567777633   22335688888777666433   3444554433 4568999999999876


Q ss_pred             hh
Q 038580          154 LA  155 (356)
Q Consensus       154 L~  155 (356)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            66

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	356
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-30
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-27
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 142/283 (50%), Gaps = 12/283 (4%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           ++G+  +G +YK  L     V + R         + +F   +E++    H NL+ L GF 
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
             P  E+L+V+P+   G++A C+R    S     W    RI++G A GL YLH      I
Sbjct: 97  MTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++K+ NILLD  ++  V DFGL  L++              G+ APE +    +SE+
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK 215
Query: 254 TDIYSFGVIMLELISGKEPIN-ENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           TD++ +GV++LELI+G+   +      D+D  L  +++  + + ++  L   D+      
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL----QG 271
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG 355
           N+++    E + +  Q+A+ C   SP  RP + +V+  LE  G
Sbjct: 272 NYKD----EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 12/283 (4%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           ++G+  +G +YK  L     V + R         + +F   +E++    H NL+ L GF 
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
             P  E+L+V+P+   G++A C+R    S     W    RI++G A GL YLH      I
Sbjct: 105 MTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 163
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++K+ NILLD  ++  V DFGL  L++            + G+ APE +    +SE+
Sbjct: 164 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK 223
Query: 254 TDIYSFGVIMLELISGKEPIN-ENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           TD++ +GV++LELI+G+   +      D+D  L  +++  + + ++  L   D+      
Sbjct: 224 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL------ 277
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG 355
             +    +E + +  Q+A+ C   SP  RP + +V+  LE  G
Sbjct: 278 --QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/281 (32%), Positives = 143/281 (50%), Gaps = 19/281 (6%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +IG   +G +YK +L R G+   L+   P  +   +EF   IE L   RHP+LV L+GF 
Sbjct: 46  LIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF- 103
Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
              R E ++++ + + GNL + + G      +  W     I IG A GL YLHT   R I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAI 160
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE--ASASQGYKAPELIKMKDAS 251
           IH ++KS NILLD N+ P ++DFG+        GQ  L      + GY  PE       +
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS-KKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN 311
           E++D+YSFGV++ E++  +  I ++  P E  +L  +   +  + ++  +  P++     
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNLAEWAVESHNNGQLEQIVDPNL----- 273
Query: 312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
               + +  E + KF   A+ C + S   RP++  VLWKLE
Sbjct: 274 ---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 144/285 (50%), Gaps = 27/285 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +IG   +G +YK +L R G+   L+   P  +   +EF   IE L   RHP+LV L+GF 
Sbjct: 46  LIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF- 103
Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
              R E ++++ + + GNL + + G      +  W     I IG A GL YLHT   R I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAI 160
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE------ASASQGYKAPELIKM 247
           IH ++KS NILLD N+ P ++DFG+        G E+ +         + GY  PE    
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGI-----SKKGTELDQTHLXXVVKGTLGYIDPEYFIK 215
Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
              +E++D+YSFGV++ E++  +  I ++  P E  +L  +   +  + ++  +  P++ 
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNLAEWAVESHNNGQLEQIVDPNL- 273
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
                   + +  E + KF   A+ C + S   RP++  VLWKLE
Sbjct: 274 -------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/235 (32%), Positives = 126/235 (53%), Gaps = 15/235 (6%)
Query: 52  TEDLVTFRG---GEDLTI--CDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC 106
           TE+L  F+G   G+D+ I  CD+     E IG  ++GT+++A    S     +   +   
Sbjct: 18  TENLY-FQGAMDGDDMDIPWCDL--NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH 74
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
             R  EF   + ++  +RHPN+V  +G    P     IV  +  RG+L + +   SG   
Sbjct: 75  AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHK-SGARE 132
Query: 167 KWSIIYRISIG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP 224
           +     R+S+   +A G++YLH   + PI+H NLKS N+L+D+ Y   V DFGL  L   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NENPT 278
           T       A+ +  + APE+++ + ++E++D+YSFGVI+ EL + ++P  N NP 
Sbjct: 192 TFLSSK-SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 126/238 (52%), Gaps = 21/238 (8%)
Query: 52  TEDLVTFRG---GEDLTI--CDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC 106
           TE+L  F+G   G+D+ I  CD+     E IG  ++GT+++A    S     +   +   
Sbjct: 18  TENLY-FQGAMDGDDMDIPWCDL--NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH 74
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
             R  EF   + ++  +RHPN+V  +G    P     IV  +  RG+L + +   SG   
Sbjct: 75  AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHK-SGARE 132
Query: 167 KWSIIYRISIG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP 224
           +     R+S+   +A G++YLH   + PI+H +LKS N+L+D+ Y   V DFGL  L   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--- 188
Query: 225 TAGQEMLEASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NENPT 278
                 L +  + G   + APE+++ + ++E++D+YSFGVI+ EL + ++P  N NP 
Sbjct: 189 -KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 26/288 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           G  +G+  +G +YK  +  +  +V+ L  +  + T   K+ F   I+++   +H NLV L
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLA---QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           LGF +   G+ L +V+ +   G+L     C+ G    +  W +  +I+ G A G+++LH 
Sbjct: 96  LGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLS--WHMRCKIAQGAANGINFLHE 151
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE-ASASQGYKAPELIK 246
             H   IH ++KS NILLD  +   +SDFGL       A   M      +  Y APE ++
Sbjct: 152 NHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR 208
Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
             + + ++DIYSFGV++LE+I+G   ++E+  P     L         +  I D     M
Sbjct: 209 -GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM 265
Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                    N      +   + +A  C     + RP+IK+V   L+++
Sbjct: 266 ---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 26/288 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           G  +G+  +G +YK  +  +  +V+ L  +  + T   K+ F   I+++   +H NLV L
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLA---QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           LGF +   G+ L +V+ +   G+L     C+ G    +  W +  +I+ G A G+++LH 
Sbjct: 96  LGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLS--WHMRCKIAQGAANGINFLHE 151
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASASQGYKAPELIK 246
             H   IH ++KS NILLD  +   +SDFGL       A   M      +  Y APE ++
Sbjct: 152 NHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR 208
Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
             + + ++DIYSFGV++LE+I+G   ++E+  P     L         +  I D     M
Sbjct: 209 -GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM 265
Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                    N      +   + +A  C     + RP+IK+V   L+++
Sbjct: 266 ---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 26/288 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           G  +G+  +G +YK  +  +  +V+ L  +  + T   K+ F   I+++   +H NLV L
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLA---QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           LGF +   G+ L +V+ +   G+L     C+ G    +  W +  +I+ G A G+++LH 
Sbjct: 90  LGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLS--WHMRCKIAQGAANGINFLHE 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASASQGYKAPELIK 246
             H   IH ++KS NILLD  +   +SDFGL       A   M      +  Y APE ++
Sbjct: 146 NHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR 202
Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
             + + ++DIYSFGV++LE+I+G   ++E+  P     L         +  I D     M
Sbjct: 203 -GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM 259
Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                    N      +   + +A  C     + RP+IK+V   L+++
Sbjct: 260 ---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 11/215 (5%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 5   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLR 63
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
             RH N++  +G+   P  +  IV  + +  +L   +     +     +I  I+   A G
Sbjct: 64  KTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLI-DIARQTARG 120
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYK 240
           +DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E  S S  + 
Sbjct: 121 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 241 APELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
           APE+I+M+D+   S ++D+Y+FG+++ EL++G+ P
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 41/294 (13%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           GEV+GK  +G   K   + +G V +++ L        + F   ++++ C+ HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                +    I    Y +G   + I       + WS     +  IA G+ YLH+     I
Sbjct: 75  VLYKDKRLNFITE--YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLL-----NPTAGQEMLEASASQGYK-------- 240
           IH +L S N L+  N    V+DFGL  L+      P   + + +    + Y         
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE+I  +   E+ D++SFG+++ E+I        N  PD   +LP  M   +      D
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG-----RVNADPD---YLPRTMDFGLNVRGFLD 241
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            Y P    C  S             FF + + CC   P  RP+  ++   LE L
Sbjct: 242 RYCPPN--CPPS-------------FFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 60  KTRHVNILLFMGYSTAP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 109 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 11/217 (5%)
Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL 119
             +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGV 73
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA 179
           L   RH N++  +G+   P  +  IV  + +  +L   +     +     +I  I+   A
Sbjct: 74  LRKTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLI-DIARQTA 130
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQG 238
            G+DYLH    + IIH +LKS NI L  +    + DFGL    +  +G    E  S S  
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 239 YKAPELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
           + APE+I+M+D+   S ++D+Y+FG+++ EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 28  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 86
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 87  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 135
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 136 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 244

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL 119
             +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGV 59
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYR 173
           L   RH N++  +G+   P           +   + Q   G S   H      K+ +I  
Sbjct: 60  LRKTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL 108
Query: 174 ISIG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           I I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    
Sbjct: 109 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 232 EA-SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
           E  S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 219

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 64
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 65  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 113
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 114 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 87
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 88  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 136
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 137 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 60  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 109 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 64
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 65  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 113
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL  + +  +G    E 
Sbjct: 114 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 113/214 (52%), Gaps = 17/214 (7%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           G   G+  +G +YK  +  +  +V+ L  +  + T   K+ F   I++    +H NLV L
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLA---QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           LGF +   G+ L +V+ +   G+L     C+ G    +  W    +I+ G A G+++LH 
Sbjct: 87  LGFSSD--GDDLCLVYVYXPNGSLLDRLSCLDGTPPLS--WHXRCKIAQGAANGINFLHE 142
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--ASQGYKAPELI 245
             H   IH ++KS NILLD  +   +SDFGL       A Q +  +    +  Y APE +
Sbjct: 143 NHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA-QXVXXSRIVGTTAYXAPEAL 198
Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTP 279
           +  + + ++DIYSFGV++LE+I+G   ++E+  P
Sbjct: 199 R-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 231

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 11/215 (5%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 17  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLR 75
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
             RH N++  +G+   P  +  IV  + +  +L   +     +     +I  I+   A G
Sbjct: 76  KTRHVNILLFMGYSTKP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLI-DIARQTARG 132
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYK 240
           +DYLH    + IIH +LKS NI L  +    + DFGL    +  +G    E  S S  + 
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 241 APELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
           APE+I+M+D+   S ++D+Y+FG+++ EL++G+ P
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 87
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P   +L +        + Q   G S   H      K+ +I  I 
Sbjct: 88  KTRHVNILLFMGYSTKP---QLAI--------VTQWCEGSSLYHHLHIIETKFEMIKLID 136
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL    +  +G    E 
Sbjct: 137 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +L 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYRIS 175
             RH N++  +G+   P           +   + Q   G S   H      K+ +I  I 
Sbjct: 60  KTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108
Query: 176 IG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           I    A G+DYLH    + IIH +LKS NI L  +    + DFGL    +  +G    E 
Sbjct: 109 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165
Query: 234 -SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
            S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 60  GGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL 119
             +D  I D     G+ IG  ++GT+YK       +V++L    P    + + F + + +
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGV 77
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH------KWSIIYR 173
           L   RH N++  +G+   P           +   + Q   G S   H      K+ +I  
Sbjct: 78  LRKTRHVNILLFMGYSTKP-----------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL 126
Query: 174 ISIG--IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           I I    A G+DYLH    + IIH +LKS NI L  +    + DFGL    +  +G    
Sbjct: 127 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 232 EA-SASQGYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDE 281
           E  S S  + APE+I+M+D    S ++D+Y+FG+++ EL++G+ P +     D+
Sbjct: 184 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 237

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 108/200 (54%), Gaps = 11/200 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG  ++GT+YK       +V++L+ + P    + + F + + +L   RH N++  +G+  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
             +    IV  + +  +L + +     +   + +I  I+   A G+DYLH    + IIH 
Sbjct: 103 --KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI-DIARQTAQGMDYLHA---KNIIHR 156
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMKDA---SE 252
           ++KS NI L       + DFGL  + +  +G + +E  + S  + APE+I+M+D    S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 253 ETDIYSFGVIMLELISGKEP 272
           ++D+YS+G+++ EL++G+ P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 150 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 257
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 258 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 258
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 259 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 149 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 256
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 257 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 150 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 257
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 258 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 255
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 256 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 169 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 276
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 277 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 170 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 277
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 278 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 258
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 259 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 253
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 254 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ YL 
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 143 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 250
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 251 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 152 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 259
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 260 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 152 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 259
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 260 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 149 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 256
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 257 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 258
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 259 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 151 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 258
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 259 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 317
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 318 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 51/295 (17%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL--GCI----RHPNL 128
           EVIG+ ++G +Y   L  +   ++   ++ +   R  + G++ + L  G I     HPN+
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDYLH 186
           + LLG      G  L+V P+ K G+L   IR    E H  ++   I  G  +A G+ +L 
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP---- 242
           +   +  +H +L ++N +LD  +   V+DFG   L      +E        G K P    
Sbjct: 156 S---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 243 --ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED-FHLPTFMRNAVLDHRIT 299
             E ++ +  + ++D++SFGV++ EL++   P    P PD + F +  ++        + 
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQG--RRLLQ 263
Query: 300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             Y PD L                   +++ + C  P   +RP+  +++ ++  +
Sbjct: 264 PEYCPDPL-------------------YEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 23/231 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVR----LLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
           +VIG   +G +YK +L+ S   +     ++ L+   T + + +F     ++G   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHT 187
            L G  +  +   +I+  + + G L + +R   GE   +S++  + +  GIA G+ YL  
Sbjct: 110 RLEGVISKYK-PMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLAN 165
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
             +   +H +L ++NIL++ N    VSDFGL  +L  +P A            + APE I
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINE------NPTPDEDFHLPTFM 289
             +  +  +D++SFG++M E+++ G+ P  E          ++ F LPT M
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 26/230 (11%)
Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           EVIG   +G + +  L+  G   S   ++ L+   T R + EF     ++G   HPN++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G         +I+  F + G L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 82  LEGVVTNSM-PVMILTEFMENGALDSFLRLNDGQ---FTVIQLVGMLRGIASGMRYLAEM 137
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----YKAPE 243
            +   +H +L ++NIL++ N    VSDFGL   L   +  +  E S+  G     + APE
Sbjct: 138 SY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENS-SDPTETSSLGGKIPIRWTAPE 193
Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLP 286
            I  +  +  +D +S+G++M E++S G+ P  +    D      +D+ LP
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 243

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 75  EVIGKSNYGTLYKAL-LQRSGSVRLLRFLRPVCTTRDKEFGDLIE-------LLGCIRHP 126
           E+IG   +G +Y+A  +    +V+  R         D++    IE       L   ++HP
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARH------DPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N++ L G         L++  F + G L + +   SG+     I+   ++ IA G++YLH
Sbjct: 67  NIIALRGVCLKEPNLCLVME-FARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQP--------YVSDFGLHLLLNPTAGQEMLEASASQG 238
                PIIH +LKS NIL+ +  +          ++DFGL    + T     + A+ +  
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYA 179
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           + APE+I+    S+ +D++S+GV++ EL++G+ P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 24/229 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           EVIG   +G + +  L+  G   S   ++ L+   T R + EF     ++G   HPN++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G         +I+  F + G L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 80  LEGVVTNSM-PVMILTEFMENGALDSFLRLNDGQ---FTVIQLVGMLRGIASGMRYLAEM 135
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----YKAPEL 244
            +   +H +L ++NIL++ N    VSDFGL   L   +      +S        + APE 
Sbjct: 136 SY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLP 286
           I  +  +  +D +S+G++M E++S G+ P  +    D      +D+ LP
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 241

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 24/230 (10%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPL 131
           VIG   +G +    L+  G   L   ++ L+   T + + +F     ++G   HPN++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-TG 188
            G     +   +IV  + + G+L   ++   G+   +++I  + +  GI+ G+ YL   G
Sbjct: 89  EGVVTKSK-PVMIVTEYMENGSLDTFLKKNDGQ---FTVIQLVGMLRGISAGMKYLSDMG 144
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
           +    +H +L ++NIL++ N    VSDFGL  +L  +P A            + APE I 
Sbjct: 145 Y----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200
Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFM 289
            +  +  +D++S+G++M E++S G+ P  E    D      E + LP+ M
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPM 250

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 43/285 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 326 REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-- 375
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH NL ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 376 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 434
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 435 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 472
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            +   E P  E    K ++L  AC   +PS RP+  ++    E +
Sbjct: 473 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 43/285 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 287 REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 336
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH NL ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 337 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 396 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 433
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            +   E P  E    K ++L  AC   +PS RP+  ++    E +
Sbjct: 434 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 85  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK 193
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 194 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 231
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 232 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
                 +I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  IH 
Sbjct: 81  REPPFYIIIE-FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 136
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L ++N L+  N+   V+DFGL  L+          A     + APE +     S ++D+
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN 316
           ++FGV++ E+ +       +P P  D               ++ +Y    LL  +   E 
Sbjct: 197 WAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLEKDYRMER 234
Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           P  E    K ++L  AC   +PS RP+  ++
Sbjct: 235 P--EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 27/249 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           ++IG  + G +    L+  G   +   ++ L+   T R + +F     ++G   HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHT 187
           L G     RG   +IV  + + G+L   +R   G+   ++I+  + +  G+  G+ YL  
Sbjct: 115 LEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSD 169
Query: 188 -GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPEL 244
            G+    +H +L ++N+L+D N    VSDFGL  +L  +P A            + APE 
Sbjct: 170 LGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFMRNAVLDHR 297
           I  +  S  +D++SFGV+M E+++ G+ P       D      E + LP  M      H+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285
Query: 298 IT-DLYHPD 305
           +  D +H D
Sbjct: 286 LMLDCWHKD 294

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 85  REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 194 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 231
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 232 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 80  REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 189 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 226
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 227 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 93  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 141
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 142 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 201
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 202 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 239
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 240 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 84  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 132
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 193 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 230
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 231 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 82  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 190
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 191 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 228
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 229 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 80  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 189 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 226
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 227 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 80  REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 189 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 226
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 227 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 85  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 194 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 231
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 232 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 82  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 190
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 191 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 228
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 229 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 85  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 194 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 231
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 232 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 27/249 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           ++IG  + G +    L+  G   +   ++ L+   T R + +F     ++G   HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHT 187
           L G     RG   +IV  + + G+L   +R   G+   ++I+  + +  G+  G+ YL  
Sbjct: 115 LEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSD 169
Query: 188 -GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPEL 244
            G+    +H +L ++N+L+D N    VSDFGL  +L  +P A            + APE 
Sbjct: 170 LGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFMRNAVLDHR 297
           I  +  S  +D++SFGV+M E+++ G+ P       D      E + LP  M      H+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285
Query: 298 IT-DLYHPD 305
           +  D +H D
Sbjct: 286 LMLDCWHKD 294

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
                 +I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  IH 
Sbjct: 80  REPPFYIIIE-FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L ++N L+  N+   V+DFGL  L+          A     + APE +     S ++D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN 316
           ++FGV++ E+ +       +P P  D               ++ +Y    LL  +   E 
Sbjct: 196 WAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLEKDYRMER 233
Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           P  E    K ++L  AC   +PS RP+  ++
Sbjct: 234 P--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 80  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 189 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 226
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 227 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
                 +I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  IH 
Sbjct: 80  REPPFYIIIE-FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L ++N L+  N+   V+DFGL  L+          A     + APE +     S ++D+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN 316
           ++FGV++ E+ +       +P P  D               ++ +Y    LL  +   E 
Sbjct: 196 WAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLEKDYRMER 233
Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           P  E    K ++L  AC   +PS RP+  ++
Sbjct: 234 P--EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 82  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 130
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 131 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNK 190
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 191 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 228
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 229 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
                 +I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  IH 
Sbjct: 85  REPPFYIIIE-FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 140
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L ++N L+  N+   V+DFGL  L+          A     + APE +     S ++D+
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN 316
           ++FGV++ E+ +       +P P  D               ++ +Y    LL  +   E 
Sbjct: 201 WAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLEKDYRMER 238
Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           P  E    K ++L  AC   +PS RP+  ++
Sbjct: 239 P--EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 81  REPPFY--------IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 129
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 130 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNK 189
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D               ++ +Y    LL 
Sbjct: 190 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------LSQVYE---LLE 227
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 228 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 110/230 (47%), Gaps = 26/230 (11%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIRHPNLVP 130
           +VIG   +G +    L+  G   +   ++ + +     + ++F     ++G   HPN++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G         +I+  F + G+L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 99  LEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLADM 154
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL-----NPTAGQEMLEASASQGYKAPE 243
            +   +H +L ++NIL++ N    VSDFGL   L     +PT     L       + APE
Sbjct: 155 NY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY-TSALGGKIPIRWTAPE 210
Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLP 286
            I+ +  +  +D++S+G++M E++S G+ P  +    D      +D+ LP
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 78  REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNK 186
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D                + +Y    LL 
Sbjct: 187 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------PSQVYE---LLE 224
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 225 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
                 +I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  IH 
Sbjct: 78  REPPFYIIIE-FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L ++N L+  N+   V+DFGL  L+          A     + APE +     S ++D+
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 257 YSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHEN 316
           ++FGV++ E+ +       +P P  D   P+         ++ +L   D  +      E 
Sbjct: 194 WAFGVLLWEIAT----YGMSPYPGID---PS---------QVYELLEKDYRM------ER 231
Query: 317 PVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           P  E    K ++L  AC   +PS RP+  ++
Sbjct: 232 P--EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFL-------RPVCTTRDKEFGDLIELLGCIRHPNLV 129
           IGK  +G ++K  L +  SV  ++ L             + +EF   + ++  + HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHT 187
            L G    P     +V  F   G+L   +     +AH  KWS+  R+ + IA G++Y+  
Sbjct: 87  KLYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 188 GFHRPIIHGNLKSKNIL---LDRNYQ--PYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
             + PI+H +L+S NI    LD N      V+DFG       T+ Q +   S   G   +
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-------TSQQSVHSVSGLLGNFQW 192
Query: 240 KAPELIKMKDAS--EETDIYSFGVIMLELISGKEPINE 275
            APE I  ++ S  E+ D YSF +I+  +++G+ P +E
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 26/230 (11%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIRHPNLVP 130
           +VIG   +G +    L+  G   +   ++ + +     + ++F     ++G   HPN++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G         +I+  F + G+L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 73  LEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLADM 128
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL-----NPTAGQEMLEASASQGYKAPE 243
            +   +H  L ++NIL++ N    VSDFGL   L     +PT     L       + APE
Sbjct: 129 NY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY-TSALGGKIPIRWTAPE 184
Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLP 286
            I+ +  +  +D++S+G++M E++S G+ P  +    D      +D+ LP
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 234

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFL-------RPVCTTRDKEFGDLIELLGCIRHPNLV 129
           IGK  +G ++K  L +  SV  ++ L             + +EF   + ++  + HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHT 187
            L G    P     +V  F   G+L   +     +AH  KWS+  R+ + IA G++Y+  
Sbjct: 87  KLYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 188 GFHRPIIHGNLKSKNIL---LDRNYQ--PYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
             + PI+H +L+S NI    LD N      V+DFGL       + Q +   S   G   +
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------SQQSVHSVSGLLGNFQW 192
Query: 240 KAPELIKMKDAS--EETDIYSFGVIMLELISGKEPINE 275
            APE I  ++ S  E+ D YSF +I+  +++G+ P +E
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   YG +Y  + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        IV  +   GNL   +R  + E     ++  ++  I+  ++YL    
Sbjct: 99  LEPPFY--------IVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--- 147
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 148 KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D        + V D           LL 
Sbjct: 208 FSIKSDVWAFGVLLWEIAT----YGMSPYPGIDL-------SQVYD-----------LLE 245
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
                E P  E    K ++L  AC   SP+ RP+  + 
Sbjct: 246 KGYRMEQP--EGCPPKVYELMRACWKWSPADRPSFAET 281

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 43/278 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG--- 133
           +G   +G +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 134 ----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               FY        I+  F   GNL   +R  + +     ++  ++  I+  ++YL    
Sbjct: 78  REPPFY--------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  IH +L ++N L+  N+   V+DFGL  L+          A     + APE +    
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+++FGV++ E+ +       +P P  D                + +Y    LL 
Sbjct: 187 FSIKSDVWAFGVLLWEIAT----YGMSPYPGID---------------PSQVYE---LLE 224
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
            +   E P  E    K ++L  AC   +PS RP+  ++
Sbjct: 225 KDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 76  VIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           VIG   +G +    L+    R  +V +          + ++F     ++G   HPN+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 132 LGFYAGPRGEK-LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYL-HT 187
            G     RG+  +IV  F + G L   +R   G+   +++I  + +  GIA G+ YL   
Sbjct: 110 EGVVT--RGKPVMIVIEFMENGALDAFLRKHDGQ---FTVIQLVGMLRGIAAGMRYLADM 164
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  ++  +P A            + APE I
Sbjct: 165 GY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFM 289
           + +  +  +D++S+G++M E++S G+ P  +    D      E + LP  M
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPM 271

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 113/239 (47%), Gaps = 22/239 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV-CTTRDKEFGDLIE---LLGCIRHPNLVP 130
           +VIG   +G +    L+  G   +   ++ +     DK+  D +    ++G   HPN++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G     +   +I+  + + G+L   +R   G   ++++I  + +  GI  G+ YL   
Sbjct: 80  LEGVVTKCK-PVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
            +   +H +L ++NIL++ N    VSDFG+  +L  +P A            + APE I 
Sbjct: 136 SY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFMRNAVLDHRI 298
            +  +  +D++S+G++M E++S G+ P  +    D      E + LP  M   +  H++
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQL 251

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 113/239 (47%), Gaps = 22/239 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV-CTTRDKEFGDLIE---LLGCIRHPNLVP 130
           +VIG   +G +    L+  G   +   ++ +     DK+  D +    ++G   HPN++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G     +   +I+  + + G+L   +R   G   ++++I  + +  GI  G+ YL   
Sbjct: 74  LEGVVTKCK-PVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
            +   +H +L ++NIL++ N    VSDFG+  +L  +P A            + APE I 
Sbjct: 130 SY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFMRNAVLDHRI 298
            +  +  +D++S+G++M E++S G+ P  +    D      E + LP  M   +  H++
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQL 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 112/239 (46%), Gaps = 22/239 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPV-CTTRDKEFGDLIE---LLGCIRHPNLVP 130
           +VIG   +G +    L+  G   +   ++ +     DK+  D +    ++G   HPN++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G     +   +I+  + + G+L   +R   G   ++++I  + +  GI  G+ YL   
Sbjct: 95  LEGVVTKCK-PVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIGSGMKYLS-- 148
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
                +H +L ++NIL++ N    VSDFG+  +L  +P A            + APE I 
Sbjct: 149 -DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPD------EDFHLPTFMRNAVLDHRI 298
            +  +  +D++S+G++M E++S G+ P  +    D      E + LP  M   +  H++
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQL 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +RH NLV LLG     +G   IV  +  +G+L   +R           + + S+ +   +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---- 238
           +YL        +H +L ++N+L+  +    VSDFGL             EAS++Q     
Sbjct: 116 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----------TKEASSTQDTGKL 161
Query: 239 ---YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
              + APE ++ K  S ++D++SFG+++ E+ S G+ P    P  D
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           I+ L   RHP+++ L    + P  +  +V  +   G L   I        K S   R+  
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKNGRLDEKES--RRLFQ 123
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
            I  G+DY H      ++H +LK +N+LLD +    ++DFGL  ++  + G+ +  +  S
Sbjct: 124 QILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGS 178
Query: 237 QGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTP-------DEDFHLPTF 288
             Y APE+I  +  A  E DI+S GVI+  L+ G  P +++  P       D  F+ P +
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY 238
Query: 289 MRNAVL 294
           +  +V+
Sbjct: 239 LNPSVI 244

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 36/233 (15%)
Query: 75  EVIGKSNYGTLYKA-LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           EV  +  +G ++KA LL    +V++     P+   +  +    +  L  ++H N++  +G
Sbjct: 30  EVKARGRFGCVWKAQLLNEYVAVKIF----PIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 134 FYAGPRGEKL-----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             A  RG  +     ++  F+++G+L+  ++        W+ +  I+  +A GL YLH  
Sbjct: 86  --AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHED 140
Query: 189 F------HRPII-HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--- 238
                  H+P I H ++KSKN+LL  N    ++DFGL L     AG+   +     G   
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE--AGKSAGDTHGQVGTRR 198
Query: 239 YKAPELIK-----MKDASEETDIYSFGVIMLELIS----GKEPINENPTPDED 282
           Y APE+++      +DA    D+Y+ G+++ EL S       P++E   P E+
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +RH NLV LLG     +G   IV  +  +G+L   +R           + + S+ +   +
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
           +YL        +H +L ++N+L+  +    VSDFGL    + T     L       + AP
Sbjct: 131 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAP 183
Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           E ++ K  S ++D++SFG+++ E+ S G+ P    P  D
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +RH NLV LLG     +G   IV  +  +G+L   +R           + + S+ +   +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
           +YL        +H +L ++N+L+  +    VSDFGL    + T     L       + AP
Sbjct: 303 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAP 355
Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           E ++ K  S ++D++SFG+++ E+ S G+ P    P  D
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-TTRDKEFGDLIE---LLGCIRHPNLVPL 131
           VIGK ++G +Y          R+   ++ +   T  ++    +    L+  + HPN++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +G    P G   ++ P+   G+L Q IR          +I    + +A G++YL     +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-SFGLQVARGMEYLA---EQ 143
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLH---LLLNPTAGQEMLEASASQGYKAPELIKMK 248
             +H +L ++N +LD ++   V+DFGL    L     + Q+   A     + A E ++  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
             + ++D++SFGV++ EL++   P   +  P   F L  F+       R+     P    
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQG---RRL-----PQPEY 252
Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           C +S              +Q+   C    P++RP  + ++ ++E +
Sbjct: 253 CPDS-------------LYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           EV+G+  +G + KA   R+  V + +       +  K F   +  L  + HPN+V L G 
Sbjct: 15  EVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGF 189
              P     +V  + + G+L   + G         AH  S   + S G+A    YLH+  
Sbjct: 71  CLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA----YLHSMQ 123
Query: 190 HRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
            + +IH +LK  N+LL        + DFG    +       M     S  + APE+ +  
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEGS 179
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
           + SE+ D++S+G+I+ E+I+ ++P +E   P   F +   + N      I +L  P    
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHNGTRPPLIKNLPKP---- 233
Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                               L   C S  PS RP++++++
Sbjct: 234 -----------------IESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 44/280 (15%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           EV+G+  +G + KA   R+  V + +       +  K F   +  L  + HPN+V L G 
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGF 189
              P     +V  + + G+L   + G         AH  S   + S G+A    YLH+  
Sbjct: 70  CLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA----YLHSMQ 122
Query: 190 HRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
            + +IH +LK  N+LL        + DFG    +       M     S  + APE+ +  
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEGS 178
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
           + SE+ D++S+G+I+ E+I+ ++P +E   P   F +   + N      I +L  P    
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHNGTRPPLIKNLPKP---- 232
Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                               L   C S  PS RP++++++
Sbjct: 233 -----------------IESLMTRCWSKDPSQRPSMEEIV 255

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFL-------RPVCTTRDKEFGDLIELLGCIRHPNLV 129
           IGK  +G ++K  L +  SV  ++ L             + +EF   + ++  + HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHT 187
            L G    P     +V  F   G+L   +     +AH  KWS+  R+ + IA G++Y+  
Sbjct: 87  KLYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 188 GFHRPIIHGNLKSKNIL---LDRNYQ--PYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
             + PI+H +L+S NI    LD N      V+DF L       + Q +   S   G   +
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL-------SQQSVHSVSGLLGNFQW 192
Query: 240 KAPELIKMKDAS--EETDIYSFGVIMLELISGKEPINE 275
            APE I  ++ S  E+ D YSF +I+  +++G+ P +E
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           GF    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 25/290 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLG 133
           E++G   YG +YK    ++G +  ++ +  V    ++E    I +L     H N+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 134 FY-----AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            +      G   +  +V  F   G++   I+   G   K   I  I   I  GL +LH  
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 146
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
               +IH ++K +N+LL  N +  + DFG+   L+ T G+       +  + APE+I   
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 204
Query: 249 DASEET-----DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           +  + T     D++S G+  +E+  G  P+ +       F +P      +   + +  + 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 264
Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
             +  C   NH    + E+++K          P    +PN +QV  +L+D
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKH---------PFIRDQPNERQVRIQLKD 305

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  F   G+L + +     + HK  I    + + +  I  G++YL 
Sbjct: 81  GVCYSAGRRNLKLIME-FLPYGSLREYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 135 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 227

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
           +RH NLV LLG     +G   IV  +  +G+L   +R           + + S+ +   +
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
           +YL        +H +L ++N+L+  +    VSDFGL    + T     L       + AP
Sbjct: 122 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAP 174
Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           E ++    S ++D++SFG+++ E+ S G+ P    P  D
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 137
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++KS NILL  +    ++DFG    + P   +   E   +  + APE++  K    +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-EMVGTPYWMAPEVVTRKAYGPK 196
Query: 254 TDIYSFGVIMLELISGKEP-INENP 277
            DI+S G++ +E+I G+ P +NENP
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP 221

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 109 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 164
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 165 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 255
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 256 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +  RG + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 78  LYGYFHDATRVYLILE-YAPRGEVYKELQKLSKFDEQRTATYITEL--ANALSYCHS--- 131
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L  +    Y  PE+I+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLD--YLPPEMIEGRMH 188
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV  + + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           G  + AG R  KLI+  +   G+L   ++  +       ++   S  I  G++YL T   
Sbjct: 81  GVCYSAGRRNLKLIME-YLPYGSLRDYLQAHAERIDHIKLLQYTS-QICKGMEYLGT--- 135
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPELIKMK 248
           +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE +   
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
             S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 196 KFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 227

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 112/250 (44%), Gaps = 39/250 (15%)
Query: 111 KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI 170
           ++F     ++G   HPN++ L G     +   +IV  + + G+L   +R    +   +++
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTV 134
Query: 171 IYRISI--GIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPT 225
           I  + +  GIA G+ YL   G+    +H +L ++NIL++ N    VSDFGL  +L  +P 
Sbjct: 135 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 190
Query: 226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH 284
           A            + +PE I  +  +  +D++S+G+++ E++S G+ P  E         
Sbjct: 191 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--------- 241
Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
                           + + D++   +  +  P   +     +QL + C     + RP  
Sbjct: 242 ----------------MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 285
Query: 345 KQVLWKLEDL 354
           +Q++  L+ L
Sbjct: 286 EQIVSILDKL 295

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +  RG + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 78  LYGYFHDATRVYLILE-YAPRGEVYKELQKLSKFDEQRTATYITEL--ANALSYCHS--- 131
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 188
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 87  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 138
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMKDA 250
           IH N+KS NILL  +    ++DFG    + P    E  + S   G   + APE++  K  
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 251 SEETDIYSFGVIMLELISGKEP-INENP 277
             + DI+S G++ +E+I G+ P +NENP
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENP 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 79  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH NL ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 133 T---KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 225

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 112/250 (44%), Gaps = 39/250 (15%)
Query: 111 KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI 170
           ++F     ++G   HPN++ L G     +   +IV  + + G+L   +R    +   +++
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTV 117
Query: 171 IYRISI--GIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPT 225
           I  + +  GIA G+ YL   G+    +H +L ++NIL++ N    VSDFGL  +L  +P 
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH 284
           A            + +PE I  +  +  +D++S+G+++ E++S G+ P  E         
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--------- 224
Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
                           + + D++   +  +  P   +     +QL + C     + RP  
Sbjct: 225 ----------------MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 268
Query: 345 KQVLWKLEDL 354
           +Q++  L+ L
Sbjct: 269 EQIVSILDKL 278

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 148
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q    A   +  Y +PEL+  K
Sbjct: 149 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEF---GDLIELLGCIRHPNLVPLL 132
            +G  ++G ++    + +G    ++ L+     R K+     D   +L  + HP ++ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G +   + +  ++  + + G L   +R      +  +  Y   + +A  L+YLH+   + 
Sbjct: 73  GTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHS---KD 126
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           II+ +LK +NILLD+N    ++DFG    + P     +     +  Y APE++  K  ++
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYXL---CGTPDYIAPEVVSTKPYNK 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPT 278
             D +SFG+++ E+++G  P  ++ T
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 83  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 137 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 81  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 135 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E+IG   +G ++KA  +  G   ++R ++      ++E    ++ L  + H N+V   G 
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 73
Query: 135 YAG------------------PRGEK----------LIVHPFYKRGNLAQCIRGGSGEAH 166
           + G                  P   K           I   F  +G L Q I    GE  
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              +   +   I  G+DY+H+   + +IH +LK  NI L    Q  + DFGL   L    
Sbjct: 134 DKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELI 267
            +    +  +  Y +PE I  +D  +E D+Y+ G+I+ EL+
Sbjct: 191 KR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 63  DLTICDILDAPG----EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFG 114
           D TI  +LD       +VIG+ N+G + KA +++ G +R+   ++ ++   +  D ++F 
Sbjct: 12  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFA 70
Query: 115 DLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL--------------AQCIR 159
             +E+L  +  HPN++ LLG     RG   +   +   GNL              A  I 
Sbjct: 71  GELEVLCKLGHHPNIINLLGA-CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
             +        +   +  +A G+DYL     +  IH NL ++NIL+  NY   ++DFGL 
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGL- 185
Query: 220 LLLNPTAGQEMLEASASQG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
                + GQE+     + G     + A E +     +  +D++S+GV++ E++S
Sbjct: 186 -----SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 85  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 139 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 231

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 84  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 138 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 77  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 131 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q    +   +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            AS+ +D+++ G I+ +L++G  P 
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 76  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 130 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 222

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 82  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 136 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 96  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 150 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 242

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 78  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 224

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 78  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 109 GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 255

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 96  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--YKAPEL 244
           T   +  IH +L ++NIL++   +  + DFGL  +L        ++        + APE 
Sbjct: 150 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEF 242

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVC--TTRDKE-------FGDLIELLGCIR 124
           +V+G   +GT++K +    G S+++     PVC     DK          D +  +G + 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKI-----PVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           H ++V LLG   G   +  +V  +   G+L   +R   G A    ++    + IA G+ Y
Sbjct: 92  HAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYY 148
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASASQGYKAPE 243
           L       ++H NL ++N+LL    Q  V+DFG+  LL P   Q +  EA     + A E
Sbjct: 149 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEP 272
            I     + ++D++S+GV + EL++ G EP
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVC--TTRDKE-------FGDLIELLGCIR 124
           +V+G   +GT++K +    G S+++     PVC     DK          D +  +G + 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKI-----PVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           H ++V LLG   G   +  +V  +   G+L   +R   G A    ++    + IA G+ Y
Sbjct: 74  HAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYY 130
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASASQGYKAPE 243
           L       ++H NL ++N+LL    Q  V+DFG+  LL P   Q +  EA     + A E
Sbjct: 131 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEP 272
            I     + ++D++S+GV + EL++ G EP
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 125/290 (43%), Gaps = 43/290 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLH-T 187
           L G     +   +IV    + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELI 245
           G+    +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
             +  +  +D++S+G+++ E++S G+ P  E                         + + 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQ 257
Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           D++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/289 (21%), Positives = 123/289 (42%), Gaps = 41/289 (14%)
Query: 75  EVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +V+G   +G +    L+    +  SV +          + ++F     ++G   HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTG 188
           L G     +   +IV    + G+L   +R    +   +++I  + +  GIA G+ YL   
Sbjct: 111 LEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLS-- 164
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
                +H +L ++NIL++ N    VSDFGL  +L  +P A            + +PE I 
Sbjct: 165 -DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
            +  +  +D++S+G+++ E++S G+ P  E                         + + D
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWE-------------------------MSNQD 258
Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           ++   +  +  P   +     +QL + C     + RP  +Q++  L+ L
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 31/257 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVP 130
           A G+VI    +G + K    R+ +V++L+       +  +     +++L  I  H N+V 
Sbjct: 39  AFGQVIEADAFG-IDKTATXRTVAVKMLK--EGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYR----------ISIGIAG 180
           LLG    P G  +++  F K GNL+  +R    E   +  +Y+           S  +A 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAK 155
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQG 238
           G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A     
Sbjct: 156 GMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARLPLK 211
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFMRNA 292
           + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    R  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGTRMR 267
Query: 293 VLDHRITDLYHPDMLLC 309
             D+   ++Y   ML C
Sbjct: 268 APDYTTPEMYQ-TMLDC 283

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 31/257 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVP 130
           A G+VI    +G + K    R+ +V++L+       +  +     +++L  I  H N+V 
Sbjct: 39  AFGQVIEADAFG-IDKTATXRTVAVKMLK--EGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYR----------ISIGIAG 180
           LLG    P G  +++  F K GNL+  +R    E   +  +Y+           S  +A 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAK 155
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQG 238
           G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A     
Sbjct: 156 GMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG-DARLPLK 211
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFMRNA 292
           + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    R  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFXRRLKEGTRMR 267
Query: 293 VLDHRITDLYHPDMLLC 309
             D+   ++Y   ML C
Sbjct: 268 APDYTTPEMYQ-TMLDC 283

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 137
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMKDA 250
           IH ++KS NILL  +    ++DFG    + P    E  + S   G   + APE++  K  
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 251 SEETDIYSFGVIMLELISGKEP-INENP 277
             + DI+S G++ +E+I G+ P +NENP
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENP 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 94  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 147
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q    +   +  Y +PEL+  K
Sbjct: 148 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 111/250 (44%), Gaps = 39/250 (15%)
Query: 111 KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI 170
           ++F     ++G   HPN++ L G     +   +IV    + G+L   +R    +   +++
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSK-PVMIVTEXMENGSLDSFLRKHDAQ---FTV 117
Query: 171 IYRISI--GIAGGLDYLH-TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPT 225
           I  + +  GIA G+ YL   G+    +H +L ++NIL++ N    VSDFGL  +L  +P 
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH 284
           A            + +PE I  +  +  +D++S+G+++ E++S G+ P  E         
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--------- 224
Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
                           + + D++   +  +  P   +     +QL + C     + RP  
Sbjct: 225 ----------------MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 268
Query: 345 KQVLWKLEDL 354
           +Q++  L+ L
Sbjct: 269 EQIVSILDKL 278

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 137
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++KS NILL  +    ++DFG    + P   +       +  + APE++  K    +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 196
Query: 254 TDIYSFGVIMLELISGKEP-INENP 277
            DI+S G++ +E+I G+ P +NENP
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 98  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 151
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q    +   +  Y +PEL+  K
Sbjct: 152 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           Y    G++L +V  +   G+L   +     +  + + + R  +     L++LH+     +
Sbjct: 87  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSN---QV 138
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++KS NILL  +    ++DFG    + P   +       +  + APE++  K    +
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-XMVGTPYWMAPEVVTRKAYGPK 197
Query: 254 TDIYSFGVIMLELISGKEP-INENP 277
            DI+S G++ +E+I G+ P +NENP
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENP 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 72  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 125
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 126 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 249 DASEETDIYSFGVIMLELISGKEPIN 274
            A + +D+++ G I+ +L++G  P  
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFR 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 73  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 126
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 249 DASEETDIYSFGVIMLELISGKEPIN 274
            A + +D+++ G I+ +L++G  P  
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFR 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 15  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 75  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 129 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 249 DASEETDIYSFGVIMLELISGKEPIN 274
            A + +D+++ G I+ +L++G  P  
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFR 213

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 79  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 132
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 133 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 14  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 74  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 127
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 128 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 249 DASEETDIYSFGVIMLELISGKEPIN 274
            A + +D+++ G I+ +L++G  P  
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFR 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  + S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDSTRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAAL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   D        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARD 235

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 38/188 (20%)
Query: 123 IRHPNLVPLLGFYAGPRGEKL-----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           ++H NL+  +   A  RG  L     ++  F+ +G+L   ++G       W+ +  ++  
Sbjct: 66  MKHENLLQFIA--AEKRGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAET 120
Query: 178 IAGGLDYLHTGF-------HRP-IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP----- 224
           ++ GL YLH          H+P I H + KSKN+LL  +    ++DFGL +   P     
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
Query: 225 -TAGQEMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELIS----GKEPIN 274
            T GQ       ++ Y APE+++      +DA    D+Y+ G+++ EL+S       P++
Sbjct: 181 DTHGQ-----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235
Query: 275 ENPTPDED 282
           E   P E+
Sbjct: 236 EYMLPFEE 243

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQ--CIRGGSGEAHKWSIIYRI 174
           I+ L   RHP+++ L    + P  +  +V  +   G L    C  G   E        R+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEA----RRL 116
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
              I   +DY H      ++H +LK +N+LLD +    ++DFGL  ++  + G+ + ++ 
Sbjct: 117 FQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSC 171
Query: 235 ASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHLP 286
            S  Y APE+I  +  A  E DI+S GVI+  L+ G  P ++   P          F++P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231
Query: 287 TFMRNAV 293
            ++  +V
Sbjct: 232 EYLNRSV 238

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 74  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 127
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ ++ L    +  Y  PE+I+ +  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDTL--CGTLDYLPPEMIEGRMH 184
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 137/312 (43%), Gaps = 56/312 (17%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E +GK  YG +++ L    S +V++          R+ E  + + L    RH N+   LG
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNI---LG 66
Query: 134 FYAGPRGEK-------LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           F A     +       LI H +++ G+L   ++  + E H   +  R+++  A GL +LH
Sbjct: 67  FIASDMTSRNSSTQLWLITH-YHEHGSLYDFLQRQTLEPH---LALRLAVSAACGLAHLH 122
Query: 187 -----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-----AS 236
                T     I H + KS+N+L+  N Q  ++D GL ++   + G + L+        +
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM--HSQGSDYLDIGNNPRVGT 180
Query: 237 QGYKAPELIKMK------DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR 290
           + Y APE++  +      ++ + TDI++FG+++ E I+ +  +N      ED+  P +  
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE-IARRTIVN---GIVEDYRPPFY-- 234
Query: 291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILK------FFQLAMACCSPSPSLRPN- 343
               D    D    DM      + + P    R+          Q+   C  P+PS R   
Sbjct: 235 ----DVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTA 290
Query: 344 --IKQVLWKLED 353
             IK+ L K+ +
Sbjct: 291 LRIKKTLQKISN 302

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G V  ++ L+       ++F   IE+L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLH 186
           G  + AG R  KLI+  +   G+L   +     + HK  I    + + +  I  G++YL 
Sbjct: 78  GVCYSAGRRNLKLIME-YLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPE 243
           T   +  IH +L ++NIL++   +  + DFGL  +L P   +        +    + APE
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPE 187
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
            +     S  +D++SFGV++ EL +    I ++ +P  +F
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTY---IEKSKSPPAEF 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 94  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 147
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 148 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 102 L--YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 155
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 156 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 148
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 149 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 74  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 127
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG      P++ +  L  S +  Y  PE+I+ +  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTL--SGTLDYLPPEMIEGRMH 184
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 95  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 148
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 149 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 63  DLTICDILDAPG----EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFG 114
           D TI  +LD       +VIG+ N+G + KA +++ G +R+   ++ ++   +  D ++F 
Sbjct: 5   DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFA 63
Query: 115 DLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL--------------AQCIR 159
             +E+L  +  HPN++ LLG     RG   +   +   GNL              A  I 
Sbjct: 64  GELEVLCKLGHHPNIINLLGA-CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
             +        +   +  +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL 
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL- 178
Query: 220 LLLNPTAGQEMLEASASQG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
                + GQE+     + G     + A E +     +  +D++S+GV++ E++S
Sbjct: 179 -----SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 98  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 151
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 152 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E+IG   +G ++KA  +  G   +++ ++      ++E    ++ L  + H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 135 YAG------------PRGEK---LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA 179
           + G             R +     I   F  +G L Q I    GE     +   +   I 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            G+DY+H+   + +I+ +LK  NI L    Q  + DFGL   L     +    +  +  Y
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX--RSKGTLRY 187
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELI 267
            +PE I  +D  +E D+Y+ G+I+ EL+
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 75  EVIGKSNYGTLYK-ALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL- 132
           E+IG+  YG +YK +L +R  +V++  F        +K     I  +  + H N+   + 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKN----IYRVPLMEHDNIARFIV 74
Query: 133 ---GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                 A  R E L+V  +Y  G+L + +   S     W    R++  +  GL YLHT  
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 190 HR------PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA----GQEMLEASASQG- 238
            R       I H +L S+N+L+  +    +SDFGL + L        G+E   A +  G 
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 239 --YKAPEL----IKMKD---ASEETDIYSFGVIMLELI 267
             Y APE+    + ++D   A ++ D+Y+ G+I  E+ 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 63  DLTICDILDAPG----EVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRD-KEFG 114
           D TI  +LD       +VIG+ N+G + KA +++ G +R+   ++ ++   +  D ++F 
Sbjct: 15  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFA 73
Query: 115 DLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL--------------AQCIR 159
             +E+L  +  HPN++ LLG     RG   +   +   GNL              A  I 
Sbjct: 74  GELEVLCKLGHHPNIINLLGA-CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
             +        +   +  +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL 
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL- 188
Query: 220 LLLNPTAGQEMLEASASQG-----YKAPELIKMKDASEETDIYSFGVIMLELIS 268
                + GQE+     + G     + A E +     +  +D++S+GV++ E++S
Sbjct: 189 -----SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 97  L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 150
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 151 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +    +   E+     +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL---CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A      R  ++++L     +   +        +++  + HP  V 
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 131 LLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L  ++     EKL     Y K G L + IR         +  Y  +  I   L+YLH   
Sbjct: 100 L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHG-- 153
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SASQGYKAPELIKMK 248
            + IIH +LK +NILL+ +    ++DFG   +L+P + Q        +  Y +PEL+  K
Sbjct: 154 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
            A + +D+++ G I+ +L++G  P 
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 89
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 90  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 143
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTTL--CGTLDYLPPEMIEGRMH 200
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 252

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +VR++   +   ++  K F + + ++  + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++ E   S  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 20/187 (10%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQ--CIRGGSGEAHKWSIIYRI 174
           I+ L   RHP+++ L    + P  +  +V  +   G L    C  G   E        R+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEA----RRL 116
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
              I   +DY H      ++H +LK +N+LLD +    ++DFGL  ++  + G+ +  + 
Sbjct: 117 FQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSC 171
Query: 235 ASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHLP 286
            S  Y APE+I  +  A  E DI+S GVI+  L+ G  P ++   P          F++P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231
Query: 287 TFMRNAV 293
            ++  +V
Sbjct: 232 EYLNRSV 238

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 74
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 75  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 128
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXL--CGTLDYLPPEMIEGRMH 185
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 98
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 99  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 152
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTTL--CGTLDYLPPEMIEGRMH 209
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 98
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 99  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 152
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ ++ L    +  Y  PE+I+ +  
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRDDL--CGTLDYLPPEMIEGRMH 209
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 118 ELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY-KRGNLAQCIRGGSGEAHKWSIIYRISI 176
           +++  + HP  V L  ++     EKL     Y K G L + IR         +  Y  + 
Sbjct: 82  DVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TA 137
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA-SA 235
            I   L+YLH    + IIH +LK +NILL+ +    ++DFG   +L+P + Q        
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           +  Y +PEL+  K A + +D+++ G I+ +L++G  P 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 78  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 131
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 188
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAAL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ ++ L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 71
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 72  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 125
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 182
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 234

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAAL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           HP+++ L+  Y        +V    ++G L   +      + K +    I   +   + +
Sbjct: 159 HPHIITLIDSYESS-SFMFLVFDLMRKGELFDYLTEKVALSEKET--RSIMRSLLEAVSF 215
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH      I+H +LK +NILLD N Q  +SDFG    L P  G+++ E   + GY APE+
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYLAPEI 270
Query: 245 IK--MKDA----SEETDIYSFGVIMLELISGKEPI 273
           +K  M +      +E D+++ GVI+  L++G  P 
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR--PVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG +     + +   R ++ +R   V T+ + +  + + +L  + HPN++ L  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           +   R   L++   YK G L   I  R    E     II ++      G+ YLH      
Sbjct: 105 FEDKRNYYLVMEC-YKGGELFDEIIHRMKFNEVDAAVIIKQV----LSGVTYLH---KHN 156
Query: 193 IIHGNLKSKNILLDRNYQPY---VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           I+H +LK +N+LL+   +     + DFGL  +      ++M E   +  Y APE+++ K 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLR-KK 213
Query: 250 ASEETDIYSFGVIMLELISGKEP 272
             E+ D++S GVI+  L++G  P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 105/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 78  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 131
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE I+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEXIEGRXH 188
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 77  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 130
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 187
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 239

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 76
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  +S  IA G+ Y+    +   +
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEET 254
           H +L++ NIL+  N    V+DFGL  L+          A     + APE       + ++
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 255 DIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           D++SFG+++ EL + G+ P             P  +   VLD        P    C  S 
Sbjct: 194 DVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPPECPESL 241
Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
           H+             L   C    P  RP  + +   LED
Sbjct: 242 HD-------------LMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 31/258 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 41  AFGQVIEADAFG-IDKTATXRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 98
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE--AHKWSIIYR----------ISIGIA 179
           LG    P G  +++  F K GNL+  +R    E   +K   +Y+           S  +A
Sbjct: 99  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVA 158
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQ 237
            G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A    
Sbjct: 159 KGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLPL 214
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFMRN 291
            + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    R 
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 292 AVLDHRITDLYHPDMLLC 309
              D+   ++Y   ML C
Sbjct: 271 RAPDYTTPEMYQ-TMLDC 287

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 23  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 76
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  +S  IA G+ Y+    +   +
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 187
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 235
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 236 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTR----DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK +    G +V++   ++ +  T     + EF D   ++  + HP+LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG    P  +  +V      G L + +           ++    + IA G+ YL    
Sbjct: 81  RLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGS-QLLLNWCVQIAKGMMYLE--- 134
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----YKAPEL 244
            R ++H +L ++N+L+       ++DFGL  LL    G E  E +A  G     + A E 
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---GDEK-EYNADGGKMPIKWMALEC 190
Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPT 278
           I  +  + ++D++S+GV + EL++ G +P +  PT
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEF--GDLIELLGCIRHPNLVPL 131
           E +G+ ++G +  A   ++     L+F+ R +    D        I  L  +RHP+++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCI----RGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
                 P    +++   Y  G L   I    R    E        R    I   ++Y H 
Sbjct: 75  YDVITTPTDIVMVIE--YAGGELFDYIVEKKRMTEDEGR------RFFQQIICAIEYCH- 125
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
                I+H +LK +N+LLD N    ++DFGL  ++  T G  +  +  S  Y APE+I  
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVING 181
Query: 248 K-DASEETDIYSFGVIMLELISGKEPINENPTPD 280
           K  A  E D++S G+++  ++ G+ P ++   P+
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 74  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 127
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR------- 173
           H N+V LLG    P G  +++  F K GNL+  +R    E   + +    +Y+       
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 174 ---ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
               S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   +
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF- 283
           +  +A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F 
Sbjct: 198 KG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFC 252
Query: 284 -HLPTFMRNAVLDHRITDLYHPDMLLC 309
             L    R    D+   ++Y   ML C
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQ-TMLDC 278

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 78  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 131
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEMIEGRMH 188
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 73  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDYLPPEMIEGRMH 183
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 16  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 69
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 126
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDN------EXTARQGAKFPIKWTAPEAALYG 180
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 228
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 229 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG--- 140
           Y A+L+R+ +++ L   RP    T   + + +L+ L+  + H N++ LL  +   +    
Sbjct: 44  YDAILERNVAIKKLS--RPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEE 100
Query: 141 -EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
            + + +       NL+Q I+          ++Y++ +GI     +LH+     IIH +LK
Sbjct: 101 FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHSA---GIIHRDLK 153
Query: 200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIY 257
             NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+
Sbjct: 154 PSNIVVKSDATLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209
Query: 258 SFGVIMLELISG 269
           S GVIM E+I G
Sbjct: 210 SVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG--- 140
           Y A+L+R+ +++ L   RP    T   + + +L+ L+  + H N++ LL  +   +    
Sbjct: 44  YDAILERNVAIKKLS--RPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEE 100
Query: 141 -EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
            + + +       NL+Q I+          ++Y++ +GI     +LH+     IIH +LK
Sbjct: 101 FQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHSA---GIIHRDLK 153
Query: 200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIY 257
             NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+
Sbjct: 154 PSNIVVKSDATLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209
Query: 258 SFGVIMLELISG 269
           S GVIM E+I G
Sbjct: 210 SVGVIMGEMIKG 221

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR------- 173
           H N+V LLG    P G  +++  F K GNL+  +R    E   + +    +Y+       
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 174 ---ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
               S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   +
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF- 283
           +  +A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F 
Sbjct: 198 KG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFC 252
Query: 284 -HLPTFMRNAVLDHRITDLYHPDMLLC 309
             L    R    D+   ++Y   ML C
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQ-TMLDC 278

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 77  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS--- 130
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL  N +  ++DFG  +   P++ ++ L    +  Y  PE+I+ +  
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTL--CGTLDYLPPEMIEGRMH 187
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + G  P   +   +        +F  P F+     D
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTR----DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK +    G +V++   ++ +  T     + EF D   ++  + HP+LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG    P  +  +V      G L + +           ++    + IA G+ YL    
Sbjct: 104 RLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGS-QLLLNWCVQIAKGMMYLE--- 157
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----YKAPEL 244
            R ++H +L ++N+L+       ++DFGL  LL    G E  E +A  G     + A E 
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---GDEK-EYNADGGKMPIKWMALEC 213
Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPT 278
           I  +  + ++D++S+GV + EL++ G +P +  PT
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 248

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 33/260 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 39  AFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 96
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR----------ISIG 177
           LG    P G  +++  F K GNL+  +R    E   + +    +Y+           S  
Sbjct: 97  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASA 235
           +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A  
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG-DARL 212
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFM 289
              + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGT 268
Query: 290 RNAVLDHRITDLYHPDMLLC 309
           R    D+   ++Y   ML C
Sbjct: 269 RMRAPDYTTPEMYQ-TMLDC 287

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           EV+G   +  ++    + +G +  L+ ++     RD    + I +L  I+H N+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y       L++      G L   I  RG   E     +I ++       + YLH      
Sbjct: 75  YESTTHYYLVMQ-LVSGGELFDRILERGVYTEKDASLVIQQV----LSAVKYLH---ENG 126
Query: 193 IIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           I+H +LK +N+L    + N +  ++DFGL  +        M  A  + GY APE++  K 
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 250 ASEETDIYSFGVIMLELISGKEPINE 275
            S+  D +S GVI   L+ G  P  E
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 33/260 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 39  AFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 96
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR----------ISIG 177
           LG    P G  +++  F K GNL+  +R    E   + +    +Y+           S  
Sbjct: 97  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASA 235
           +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A  
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARL 212
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFM 289
              + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGT 268
Query: 290 RNAVLDHRITDLYHPDMLLC 309
           R    D+   ++Y   ML C
Sbjct: 269 RMRAPDYTTPEMYQ-TMLDC 287

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 46  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 104
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 105 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 157
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M+    ++ Y+APE+I      E  DI+S 
Sbjct: 158 NIVVKSDCTLKILDFGLAR----TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSV 213
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 214 GCIMGEMIKG 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL+Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDATLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR------- 173
           H N+V LLG    P G  +++  F K GNL+  +R    E   + +    +Y+       
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 174 ---ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
               S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   +
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF- 283
           +  +A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F 
Sbjct: 198 KG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFC 252
Query: 284 -HLPTFMRNAVLDHRITDLYHPDMLLC 309
             L    R    D+   ++Y   ML C
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQ-TMLDC 278

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR------- 173
           H N+V LLG    P G  +++  F K GNL+  +R    E   + +    +Y+       
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 174 ---ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
               S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   +
Sbjct: 141 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF- 283
           +  +A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F 
Sbjct: 198 KG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFC 252
Query: 284 -HLPTFMRNAVLDHRITDLYHPDMLLC 309
             L    R    D+   ++Y   ML C
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQ-TMLDC 278

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL+Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLG 133
           +G   YG +     + +G+ R ++ ++    T     G L++ +  ++   HPN++ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           F+   R   L++   Y+ G L   I  R    E     I+ ++      G  YLH     
Sbjct: 72  FFEDKRNYYLVME-VYRGGELFDEIILRQKFSEVDAAVIMKQV----LSGTTYLH---KH 123
Query: 192 PIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
            I+H +LK +N+LL+   R+    + DFGL        G +M E   +  Y APE+++ K
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLR-K 180
Query: 249 DASEETDIYSFGVIMLELISGKEP 272
              E+ D++S GVI+  L+ G  P
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E +GK  YG +++   Q  + +V++          R+ E  + + L    RH N+   LG
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LG 66
Query: 134 FYAGPRGEK-------LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           F A     +       LI H +++ G+L   ++  + +        RI + IA GL +LH
Sbjct: 67  FIASDMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLH 122
Query: 187 -----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--- 238
                T     I H +LKSKNIL+ +N Q  ++D GL ++ + +  Q  +  +   G   
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 239 YKAPEL------IKMKDASEETDIYSFGVIMLEL 266
           Y APE+      +   D+ +  DI++FG+++ E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGLAR----TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 68  DILDAPGEVI------GKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           D+ + P E +      G   +G ++      +  V + + L+P  T   + F +  +++ 
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAI-KTLKP-GTMSPESFLEEAQIMK 59
Query: 122 CIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
            ++H  LV L   YA    E + IV  +  +G+L   ++ G G A K   +  ++  +A 
Sbjct: 60  KLKHDKLVQL---YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 116
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ Y+    +   IH +L+S NIL+       ++DFGL  L+         E +A QG K
Sbjct: 117 GMAYIERMNY---IHRDLRSANILVGNGLICKIADFGLARLIEDN------EXTARQGAK 167
Query: 241 ------APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                 APE       + ++D++SFG+++ EL++ G+ P
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 76  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 129
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  +++FG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 186
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E +GK  YG +++   Q  + +V++          R+ E  + + L    RH N+   LG
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LG 66
Query: 134 FYAGPRGEK-------LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           F A     +       LI H +++ G+L   ++  + +        RI + IA GL +LH
Sbjct: 67  FIASDMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLH 122
Query: 187 -----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--- 238
                T     I H +LKSKNIL+ +N Q  ++D GL ++ + +  Q  +  +   G   
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 239 YKAPEL------IKMKDASEETDIYSFGVIMLEL 266
           Y APE+      +   D+ +  DI++FG+++ E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 33/260 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 39  AFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 96
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR----------ISIG 177
           LG    P G  +++  F K GNL+  +R    E   + +    +Y+           S  
Sbjct: 97  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASA 235
           +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A  
Sbjct: 157 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DARL 212
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFM 289
              + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGT 268
Query: 290 RNAVLDHRITDLYHPDMLLC 309
           R    D+   ++Y   ML C
Sbjct: 269 RMRAPDYTTPEMYQ-TMLDC 287

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 19  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 72
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 129
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 183
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 231
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 232 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 264

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 74
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 75  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 128
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  +++FG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 185
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 237

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 45  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 103
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 156
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 157 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 213 GCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  IRH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 105/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++   +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 69
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 70  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 180
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + GK P   N   +        +F  P F+     D
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 232

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +VR++   +   ++  K F + + ++  + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 58  FRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL 116
           ++  ED  I DI D   +V+G   +  +  A  +R+  +  ++ + +     ++    + 
Sbjct: 10  WKQAED--IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRI 174
           I +L  I+HPN+V L   Y    G   ++      G L   I  +G   E     +I+++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNIL---LDRNYQPYVSDFGLHLLLNPTAGQEML 231
                  + YLH      I+H +LK +N+L   LD + +  +SDFGL  + +P  G  + 
Sbjct: 126 ----LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLS 176
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NEN 276
            A  + GY APE++  K  S+  D +S GVI   L+ G  P  +EN
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E +GK  YG +++   Q  + +V++          R+ E  + + L    RH N+   LG
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LG 95
Query: 134 FYAGPRGEK-------LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           F A     +       LI H +++ G+L   ++  + +        RI + IA GL +LH
Sbjct: 96  FIASDMTSRHSSTQLWLITH-YHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLH 151
Query: 187 -----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--- 238
                T     I H +LKSKNIL+ +N Q  ++D GL ++ + +  Q  +  +   G   
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 239 YKAPEL------IKMKDASEETDIYSFGVIMLEL 266
           Y APE+      +   D+ +  DI++FG+++ E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 58  FRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL 116
           ++  ED  I DI D   +V+G   +  +  A  +R+  +  ++ + +     ++    + 
Sbjct: 10  WKQAED--IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRI 174
           I +L  I+HPN+V L   Y    G   ++      G L   I  +G   E     +I+++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNIL---LDRNYQPYVSDFGLHLLLNPTAGQEML 231
                  + YLH      I+H +LK +N+L   LD + +  +SDFGL  + +P  G  + 
Sbjct: 126 ----LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLS 176
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NEN 276
            A  + GY APE++  K  S+  D +S GVI   L+ G  P  +EN
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 58  FRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL 116
           ++  ED  I DI D   +V+G   +  +  A  +R+  +  ++ + +     ++    + 
Sbjct: 10  WKQAED--IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRI 174
           I +L  I+HPN+V L   Y    G   ++      G L   I  +G   E     +I+++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNIL---LDRNYQPYVSDFGLHLLLNPTAGQEML 231
                  + YLH      I+H +LK +N+L   LD + +  +SDFGL  + +P  G  + 
Sbjct: 126 ----LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLS 176
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NEN 276
            A  + GY APE++  K  S+  D +S GVI   L+ G  P  +EN
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYR------- 173
           H N+V LLG    P G  +++  F K GNL+  +R    E   + +    +Y+       
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 174 ---ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQ 228
               S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   +
Sbjct: 187 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF- 283
           +  +A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F 
Sbjct: 244 KG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFC 298
Query: 284 -HLPTFMRNAVLDHRITDLYHPDMLLC 309
             L    R    D+   ++Y   ML C
Sbjct: 299 RRLKEGTRMRAPDYTTPEMYQ-TMLDC 324

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           IG   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 148
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 149 A---DIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 201
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 58  FRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL 116
           ++  ED  I DI D   +V+G   +  +  A  +R+  +  ++ + +     ++    + 
Sbjct: 10  WKQAED--IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRI 174
           I +L  I+HPN+V L   Y    G   ++      G L   I  +G   E     +I+++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNIL---LDRNYQPYVSDFGLHLLLNPTAGQEML 231
                  + YLH      I+H +LK +N+L   LD + +  +SDFGL  + +P  G  + 
Sbjct: 126 ----LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLS 176
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI-NEN 276
            A  + GY APE++  K  S+  D +S GVI   L+ G  P  +EN
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 275 LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 328
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+        +
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 487
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 488 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 520

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 245
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+        +
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 404
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 405 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 32/259 (12%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 40  AFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 97
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI---IYR----------ISIGI 178
           LG    P G  +++  F K GNL+  +R    E   +     +Y+           S  +
Sbjct: 98  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQV 157
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASAS 236
           A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A   
Sbjct: 158 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG-DARLP 213
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPTFMR 290
             + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L    R
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKEGTR 269
Query: 291 NAVLDHRITDLYHPDMLLC 309
               D+   ++Y   ML C
Sbjct: 270 MRAPDYTTPEMYQ-TMLDC 287

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 245
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+        +
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 404
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 405 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 150
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 151 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAPEIMLN 203
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 192 LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 245
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+        +
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI------EDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 404
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 405 ECPESLHD-------------LMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 150
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 151 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAPEIMLN 203
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  R  +V+++   +   T+  K F + + ++  + HPN+V L
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVKL 79
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  +
Sbjct: 80  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKY 134
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 135 ---IVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +   + +    +E+   +RHPN++ 
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++       LI+  +   G + + ++  S    + +  Y   +  A  L Y H+   
Sbjct: 77  LYGYFHDATRVYLILE-YAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS--- 130
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL  N +  ++DFG  +   P++ +  L    +  Y  PE+I+ +  
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTL--CGTLDYLPPEMIEGRMH 187
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE-------DFHLPTFMRNAVLD 295
            E+ D++S GV+  E + G  P   +   +        +F  P F+     D
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 148
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 149 A---DIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 201
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLG 133
           +G   YG +     + +G+ R ++ ++    T     G L++ +  ++   HPN++ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           F+   R   L++   Y+ G L   I  R    E     I+ ++      G  YLH     
Sbjct: 89  FFEDKRNYYLVME-VYRGGELFDEIILRQKFSEVDAAVIMKQV----LSGTTYLH---KH 140
Query: 192 PIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
            I+H +LK +N+LL+   R+    + DFGL        G +M E   +  Y APE+++ K
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLR-K 197
Query: 249 DASEETDIYSFGVIMLELISGKEP 272
              E+ D++S GVI+  L+ G  P
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 150
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 151 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAPEIMLN 203
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 149
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 150 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 202
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQFLIYQI----LRGLKYIHS 139
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 163
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 164 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMXGXVATRWYRAPEIMLN 216
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGXVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 149
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 150 A---DIIHRDLKPSNLAVNEDSELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 202
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 149
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 150 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 202
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 154
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 155 A---DIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 207
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK ++G ++K +  R+  V  ++ +         ++    I +L     P +    G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+     
Sbjct: 93  SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS---EK 144
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            IH ++K+ N+LL  + +  ++DFG+   L  T  +       +  + APE+IK      
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 203
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           + DI+S G+  +EL  G+ P +E       F +P   +N           +P  L     
Sbjct: 204 KADIWSLGITAIELARGEPPHSELHPMKVLFLIP---KN-----------NPPTL---EG 246
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           N+  P+ E           AC +  PS RP  K++L
Sbjct: 247 NYSKPLKE--------FVEACLNKEPSFRPTAKELL 274

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 146 A---DIIHRDLKPSNLAVNEDSELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 198
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 149
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 150 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 202
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK ++G ++K +  R+  V  ++ +         ++    I +L     P +    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+     
Sbjct: 73  SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS---EK 124
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            IH ++K+ N+LL  + +  ++DFG+   L  T  +       +  + APE+IK      
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDS 183
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           + DI+S G+  +EL  G+ P +E       F +P   +N           +P  L     
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLIP---KN-----------NPPTL---EG 226
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           N+  P+ E           AC +  PS RP  K++L
Sbjct: 227 NYSKPLKE--------FVEACLNKEPSFRPTAKELL 254

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 148
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 149 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 201
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 146 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 198
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 17  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 70
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 127
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 181
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 229
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 230 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 262

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK ++G ++K +  R+  V  ++ +         ++    I +L     P +    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+     
Sbjct: 73  SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS---EK 124
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            IH ++K+ N+LL  + +  ++DFG+   L  T  +       +  + APE+IK      
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 183
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           + DI+S G+  +EL  G+ P +E       F +P   +N           +P  L     
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLIP---KN-----------NPPTL---EG 226
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           N+  P+ E           AC +  PS RP  K++L
Sbjct: 227 NYSKPLKE--------FVEACLNKEPSFRPTAKELL 254

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 141 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 193
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 150
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 151 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 203
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMAGFVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 153
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 154 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 206
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 146 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 198
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK ++G ++K +  R+  V  ++ +         ++    I +L     P +    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+     
Sbjct: 88  SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS---EK 139
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            IH ++K+ N+LL  + +  ++DFG+   L  T  +       +  + APE+IK      
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDS 198
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           + DI+S G+  +EL  G+ P +E       F +P   +N           +P  L     
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIP---KN-----------NPPTL---EG 241
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           N+  P+ E           AC +  PS RP  K++L
Sbjct: 242 NYSKPLKE--------FVEACLNKEPSFRPTAKELL 269

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 148
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 149 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 201
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMAGFVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 15  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 68
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 125
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 179
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 227
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 228 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 260

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPV---CTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           +GK  YG ++K++ +R+G V  ++ +       T   + F +++ L     H N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE-AHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                    + +   Y   +L   IR    E  HK  ++Y++       + YLH+G    
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL----IKVIKYLHSG---G 129
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGL------------HLLLNPTAGQE--------MLE 232
           ++H ++K  NILL+      V+DFGL            ++ L+     E        + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 233 ASASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
             A++ Y+APE L+     ++  D++S G I+ E++ GK
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 142
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 143 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 195
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 154
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 155 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 207
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 162
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 163 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 215
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 141 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 193
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 163
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 164 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 216
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EXTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 167 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMXGYVATRWYRAPEIMLN 219
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 162
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 163 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 215
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 163
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 164 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 216
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 139
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 155
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 156 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 208
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 155
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 156 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 208
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 166
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 167 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 219
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 139
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +V+++   +   ++  K F + + ++  + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 139
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMAGFVATRWYRAPEIMLN 192
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 141
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 142 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 194
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 146 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 198
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +V+++   +   ++  K F + + ++  + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE-MLEASA-SQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG   M+E    ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVCHK 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+  + H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL+Q I+          ++Y++ +GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDATLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLG- 133
           +G+ ++G +++   +++G      F   V   R + F  + EL+ C  +  P +VPL G 
Sbjct: 82  VGRGSFGEVHRMKDKQTG------FQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGA 134
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA-GGLDYLHTGFHRP 192
              GP     I     + G+L Q I+         ++ Y   +G A  GL+YLHT   R 
Sbjct: 135 VREGPWVN--IFMELLEGGSLGQLIKQMGCLPEDRALYY---LGQALEGLEYLHT---RR 186
Query: 193 IIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA-GQEMLEAS---ASQGYKAPELIKM 247
           I+HG++K+ N+LL  +  +  + DFG  L L P   G+ +L       ++ + APE++  
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 248 KDASEETDIYSFGVIMLELISGKEPINE 275
           K    + DI+S   +ML +++G  P  +
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLG- 133
           +G+ ++G +++   +++G      F   V   R + F  + EL+ C  +  P +VPL G 
Sbjct: 66  VGRGSFGEVHRMKDKQTG------FQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGA 118
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA-GGLDYLHTGFHRP 192
              GP     I     + G+L Q I+         ++ Y   +G A  GL+YLHT   R 
Sbjct: 119 VREGPWVN--IFMELLEGGSLGQLIKQMGCLPEDRALYY---LGQALEGLEYLHT---RR 170
Query: 193 IIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA-GQEMLEAS---ASQGYKAPELIKM 247
           I+HG++K+ N+LL  +  +  + DFG  L L P   G+ +L       ++ + APE++  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 248 KDASEETDIYSFGVIMLELISGKEPINE 275
           K    + DI+S   +ML +++G  P  +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIR 124
           P   IG   YGT+YKA    SG    L+ +R        P+ T R+     L+  L    
Sbjct: 8   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVA---LLRRLEAFE 64
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPF---YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           HPN+V L+   A  R ++ I       +   +L   +            I  +      G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           LD+LH      I+H +LK +NIL+       ++DFGL  +   +    +     +  Y+A
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVVTLWYRA 179
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGK 270
           PE++     +   D++S G I  E+   K
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG 133
           +G   YG++  A+ +RSG  V + +  RP  +     + + +L+ LL  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLD 90
Query: 134 FYAGPRGEK-----LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            +      +      +V PF  + +L + +     E     ++Y++      GL Y+H+ 
Sbjct: 91  VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQM----LKGLKYIHSA 145
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KM 247
               ++H +LK  N+ ++ + +  + DFGL       A  EM     ++ Y+APE+I   
Sbjct: 146 ---GVVHRDLKPGNLAVNEDCELKILDFGL----ARHADAEMTGYVVTRWYRAPEVILSW 198
Query: 248 KDASEETDIYSFGVIMLELISGK 270
              ++  DI+S G IM E+++GK
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG 133
           +G   YG++  A+ +RSG  V + +  RP  +     + + +L+ LL  ++H N++ LL 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLD 108
Query: 134 FYAGPRGEK-----LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            +      +      +V PF  + +L + +     E     ++Y++      GL Y+H+ 
Sbjct: 109 VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQYLVYQM----LKGLKYIHSA 163
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KM 247
               ++H +LK  N+ ++ + +  + DFGL       A  EM     ++ Y+APE+I   
Sbjct: 164 ---GVVHRDLKPGNLAVNEDCELKILDFGL----ARHADAEMTGYVVTRWYRAPEVILSW 216
Query: 248 KDASEETDIYSFGVIMLELISGK 270
              ++  DI+S G IM E+++GK
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK ++G ++K +  R+  V  ++ +         ++    I +L       +    G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
            Y   +G KL I+  +   G+    +R G  +  + + + +    I  GLDYLH+     
Sbjct: 89  SYL--KGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHS---EK 140
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            IH ++K+ N+LL       ++DFG+   L  T  +       +  + APE+I+      
Sbjct: 141 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 199
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
           + DI+S G+  +EL  G EP      P+ D H    MR               +L     
Sbjct: 200 KADIWSLGITAIELAKG-EP------PNSDMHP---MR---------------VLFLIPK 234
Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           N+   +  +    F +   AC +  PS RP  K++L
Sbjct: 235 NNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI---------ELLGCIRHPN 127
           +G   YG++  A   ++G       LR       K F  +I          LL  ++H N
Sbjct: 42  VGSGAYGSVCAAFDTKTG-------LRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 128 LVPLLGFYAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           ++ LL  +   R  +      L+ H       N+ +C +    + H   +IY+I      
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LR 148
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           GL Y+H+     IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+
Sbjct: 149 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYR 201
Query: 241 APE-LIKMKDASEETDIYSFGVIMLELISGK 270
           APE ++     ++  DI+S G IM EL++G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +V+++   +   ++  K F + + ++  + HPN+V L
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 71
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 72  FEVIETEKTLYLVME--YASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQYCHQKF 126
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLG 133
           +G   YG +  A+  R+G+ V + +  RP  +     + + +L  LL  +RH N++ LL 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL-RLLKHMRHENVIGLLD 91
Query: 134 FYAGPRG-----EKLIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHT 187
            +          +  +V PF    +L + ++    GE     ++Y++      GL Y+H 
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQM----LKGLRYIHA 146
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
                IIH +LK  N+ ++ + +  + DFGL       A  EM     ++ Y+APE+I  
Sbjct: 147 A---GIIHRDLKPGNLAVNEDCELKILDFGL----ARQADSEMXGXVVTRWYRAPEVILN 199
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM E+I+GK
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 111/257 (43%), Gaps = 24/257 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  +++  +  L+ L      ++    +    IE+   +RHPN++ 
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 79
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           +  ++   R    ++  F  RG L + ++       + S  +   +      D LH    
Sbjct: 80  MYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA-----DALHYCHE 133
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +IH ++K +N+L+    +  ++DFG  +       + M     +  Y  PE+I+ K  
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM---CGTLDYLPPEMIEGKTH 190
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDE--------DFHLPTFMRNAVLDHRITDL- 301
            E+ D++  GV+  E + G  P + +P+  E        D   P F+ +   D  I+ L 
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHRRIVNVDLKFPPFLSDGSKD-LISKLL 248
Query: 302 -YHPDMLLCSNSNHENP 317
            YHP   L      E+P
Sbjct: 249 RYHPPQRLPLKGVMEHP 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLG- 133
           +G+ ++G +++   +++G      F   V   R + F  + EL+ C  +  P +VPL G 
Sbjct: 80  LGRGSFGEVHRMKDKQTG------FQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGA 132
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA-GGLDYLHTGFHRP 192
              GP     I     + G+L Q I+         ++ Y   +G A  GL+YLHT   R 
Sbjct: 133 VREGPWVN--IFMELLEGGSLGQLIKQMGCLPEDRALYY---LGQALEGLEYLHT---RR 184
Query: 193 IIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA-GQEMLEAS---ASQGYKAPELIKM 247
           I+HG++K+ N+LL  +  +  + DFG  L L P   G+ +L       ++ + APE++  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 248 KDASEETDIYSFGVIMLELISGKEPINE 275
           K    + DI+S   +ML +++G  P  +
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 128/307 (41%), Gaps = 61/307 (19%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC 122
           D T  D+ D  GE IG+  YG++ K + + SG +  ++ +R   T  +KE   L+  L  
Sbjct: 18  DFTAEDLKDL-GE-IGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDV 73
Query: 123 IRHPNLVP-LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKW------------- 168
           +   +  P ++ FY             ++ G+   C+   S    K+             
Sbjct: 74  VMRSSDCPYIVQFYGA----------LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 169 -SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
             I+ +I++     L++L       IIH ++K  NILLDR+    + DFG+   L  +  
Sbjct: 124 EEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 228 QEMLEASASQGYKAPELIKMKDASE----ETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +     +  + Y APE I    + +     +D++S G+ + EL +G+            F
Sbjct: 182 KT--RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR------------F 227
Query: 284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERIL--KFFQLAMACCSPSPSLR 341
             P +  N+V D ++T +   D    SN       SEER     F      C +   S R
Sbjct: 228 PYPKW--NSVFD-QLTQVVKGDPPQLSN-------SEEREFSPSFINFVNLCLTKDESKR 277
Query: 342 PNIKQVL 348
           P  K++L
Sbjct: 278 PKYKELL 284

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           +++F +  E++  + HP LV L G     +    +V  F + G L+  +R   G     +
Sbjct: 44  EEDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET 102
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +       
Sbjct: 103 LL-GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158
Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
                    + +PE+      S ++D++SFGV+M E+ S GK P       +    + T 
Sbjct: 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218
Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R          LY P +     S H            +Q+   C    P  RP   ++L
Sbjct: 219 FR----------LYKPRL----ASTH-----------VYQIMNHCWKERPEDRPAFSRLL 253
Query: 349 WKLEDLGK 356
            +L ++ +
Sbjct: 254 RQLAEIAE 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L + NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 72  APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           A G+VI    +G + K    R+ +V++L+        R     +L  L+    H N+V L
Sbjct: 41  AFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIHIGHHLNVVNL 98
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS----------------IIYRIS 175
           LG    P G  +++  F K GNL+  +R    E   +                 I Y  S
Sbjct: 99  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY--S 156
Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEA 233
             +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +A
Sbjct: 157 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-DA 212
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLPT 287
                + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L  
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLKE 268
Query: 288 FMRNAVLDHRITDLYHPDMLLC 309
             R    D+   ++Y   ML C
Sbjct: 269 GTRMRAPDYTTPEMYQ-TMLDC 289

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G + K   + SG +  R L  L      R++   +L  L  C    N   ++GF
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC----NSPYIVGF 79
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIR---GGS-----GEAHKW--SIIYRISIGIAGGLDY 184
           Y            FY  G ++ C+    GGS      EA +    I+ ++SI +  GL Y
Sbjct: 80  YGA----------FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 129
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           L       I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y APE 
Sbjct: 130 LREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMAPER 184
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV 293
           ++    S ++DI+S G+ ++EL  G+ PI   P PD       F R  V
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPI---PPPDAKELEAIFGRPVV 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +V+++   +   ++  K F + + ++  + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L++   Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVME--YASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     +  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  R  +++++   +   T+  K F + + ++  + HPN+V L
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVKL 76
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   LI+   Y  G       +  G  +  +    +R    I   + Y H   
Sbjct: 77  FEVIETEKTLYLIME--YASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCH--- 128
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            + I+H +LK++N+LLD +    ++DFG       T G ++     S  Y APEL + K 
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 125 HPNLVPLLGFYAGPRG---EKLIVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIA 179
           HPN++ L+ +    RG   E  ++ PF+KRG L   I      G       I  + +GI 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG------LHLLLNPTA--GQEML 231
            GL+ +H    +   H +LK  NILL    QP + D G      +H+  +  A   Q+  
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 232 EASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPIN 274
               +  Y+APEL  ++      E TD++S G ++  ++ G+ P +
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + D+GL          EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDYGL----ARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P  T   + F    +++  +RH  LV L   Y
Sbjct: 26  LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL---Y 79
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G L   ++G  G+  +   +  ++  IA G+ Y+    +   +
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+         E +A QG K      APE     
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYG 190
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 238
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 239 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/245 (20%), Positives = 105/245 (42%), Gaps = 8/245 (3%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++ A   +   V  ++ ++P   + +    +   ++  ++H  LV L     
Sbjct: 23  LGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAE-ANVMKTLQHDKLVKLHAVVT 80
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
             +    I+  F  +G+L   ++   G       +   S  IA G+ ++     R  IH 
Sbjct: 81  --KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 135
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L++ NIL+  +    ++DFGL  ++          A     + APE I     + ++D+
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 257 YSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE 315
           +SFG++++E+++ G+ P      P+    L    R    ++   +LY+  M    N   E
Sbjct: 196 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEE 255
Query: 316 NPVSE 320
            P  E
Sbjct: 256 RPTFE 260

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           +++F +  E++  + HP LV L G     +    +V  F + G L+  +R   G     +
Sbjct: 46  EEDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET 104
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +       
Sbjct: 105 LL-GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160
Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
                    + +PE+      S ++D++SFGV+M E+ S GK P       +    + T 
Sbjct: 161 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220
Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R          LY P +     S H            +Q+   C    P  RP   ++L
Sbjct: 221 FR----------LYKPRL----ASTH-----------VYQIMNHCWKERPEDRPAFSRLL 255
Query: 349 WKLEDLGK 356
            +L ++ +
Sbjct: 256 RQLAEIAE 263

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIR 124
           P   IG   YGT+YKA    SG    L+ +R        P+ T R+     L+  L    
Sbjct: 8   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVA---LLRRLEAFE 64
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPF---YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           HPN+V L+   A  R ++ I       +   +L   +            I  +      G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           LD+LH      I+H +LK +NIL+       ++DFGL  +   +    +     +  Y+A
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVVTLWYRA 179
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGK 270
           PE++     +   D++S G I  E+   K
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           +++F +  E++  + HP LV L G     +    +V  F + G L+  +R   G     +
Sbjct: 47  EEDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET 105
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +       
Sbjct: 106 LL-GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161
Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
                    + +PE+      S ++D++SFGV+M E+ S GK P       +    + T 
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R          LY P +     S H            +Q+   C    P  RP   ++L
Sbjct: 222 FR----------LYKPRL----ASTH-----------VYQIMNHCWRERPEDRPAFSRLL 256
Query: 349 WKLEDLGK 356
            +L ++ +
Sbjct: 257 RQLAEIAE 264

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE-MLEASA-SQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG   M+E    ++ Y+APE+I      E  D++S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVCHK 222

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + +G+ ++G +  A    +G    L+ +      +    G +   I  L  +RHP+++ L
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 132 LGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
              Y   + +  I+      GN     + Q  +    EA       R    I   ++Y H
Sbjct: 80  ---YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR------RFFQQIISAVEYCH 130
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                 I+H +LK +N+LLD +    ++DFGL  ++  T G  +  +  S  Y APE+I 
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVIS 185
Query: 247 MK-DASEETDIYSFGVIMLELISGKEPINENPTP 279
            K  A  E D++S GVI+  ++  + P ++   P
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/245 (20%), Positives = 105/245 (42%), Gaps = 8/245 (3%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++ A   +   V  ++ ++P   + +    +   ++  ++H  LV L     
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAE-ANVMKTLQHDKLVKLHAVVT 253
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
             +    I+  F  +G+L   ++   G       +   S  IA G+ ++     R  IH 
Sbjct: 254 --KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L++ NIL+  +    ++DFGL  ++          A     + APE I     + ++D+
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 257 YSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE 315
           +SFG++++E+++ G+ P      P+    L    R    ++   +LY+  M    N   E
Sbjct: 369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEE 428
Query: 316 NPVSE 320
            P  E
Sbjct: 429 RPTFE 433

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E +G+  YG +YKA     G +  L+ +R        P    R+      I LL  + HP
Sbjct: 27  EKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIRE------ISLLKELHHP 79
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKWSIIYRISIGIAGGLD 183
           N+V L+      R   L+    +   +L + +   + G  ++     +Y++  G+A    
Sbjct: 80  NIVSLIDVIHSERCLTLVFE--FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA---- 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
             H   HR I+H +LK +N+L++ +    ++DFGL             E   +  Y+AP+
Sbjct: 134 --HCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-VTLWYRAPD 189
Query: 244 -LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
            L+  K  S   DI+S G I  E+I+GK P+    T D+  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQL 229

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           +++F +  E++  + HP LV L G     +    +V  F + G L+  +R   G     +
Sbjct: 49  EEDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET 107
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +       
Sbjct: 108 LL-GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163
Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
                    + +PE+      S ++D++SFGV+M E+ S GK P       +    + T 
Sbjct: 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223
Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R          LY P +     S H            +Q+   C    P  RP   ++L
Sbjct: 224 FR----------LYKPRL----ASTH-----------VYQIMNHCWRERPEDRPAFSRLL 258
Query: 349 WKLEDLGK 356
            +L ++ +
Sbjct: 259 RQLAEIAE 266

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 38  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 96
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 97  DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 149
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  D++S 
Sbjct: 150 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSV 205
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 206 GCIMGEMVCHK 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E +G+  YG +YKA     G +  L+ +R        P    R+      I LL  + HP
Sbjct: 27  EKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIRE------ISLLKELHHP 79
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKWSIIYRISIGIAGGLD 183
           N+V L+      R   L+    +   +L + +   + G  ++     +Y++  G+A    
Sbjct: 80  NIVSLIDVIHSERCLTLVFE--FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA---- 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
             H   HR I+H +LK +N+L++ +    ++DFGL             E   +  Y+AP+
Sbjct: 134 --HCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-VTLWYRAPD 189
Query: 244 -LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
            L+  K  S   DI+S G I  E+I+GK P+    T D+  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQL 229

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIR 124
           P   IG   YGT+YKA    SG    L+ +R        P+ T R+     L+  L    
Sbjct: 8   PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVA---LLRRLEAFE 64
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPF---YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           HPN+V L+   A  R ++ I       +   +L   +            I  +      G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL------HLLLNPTAGQEMLEASA 235
           LD+LH      I+H +LK +NIL+       ++DFGL       + L+P           
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV--------V 173
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGK 270
           +  Y+APE++     +   D++S G I  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 49  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQ 107
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 108 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 160
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  D++S 
Sbjct: 161 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSV 216
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 217 GCIMGEMVCHK 227

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + +G+ ++G +  A    +G    L+ +      +    G +   I  L  +RHP+++ L
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 132 LGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
              Y   + +  I+      GN     + Q  +    EA       R    I   ++Y H
Sbjct: 74  ---YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR------RFFQQIISAVEYCH 124
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                 I+H +LK +N+LLD +    ++DFGL  ++  T G  +  +  S  Y APE+I 
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVIS 179
Query: 247 MK-DASEETDIYSFGVIMLELISGKEPINENPTP 279
            K  A  E D++S GVI+  ++  + P ++   P
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 96
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 152
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 209
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPI---PPPD 234

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + +G+ ++G +  A    +G    L+ +      +    G +   I  L  +RHP+++ L
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 132 LGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
              Y   + +  I+      GN     + Q  +    EA       R    I   ++Y H
Sbjct: 70  ---YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR------RFFQQIISAVEYCH 120
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                 I+H +LK +N+LLD +    ++DFGL  ++  T G  +  +  S  Y APE+I 
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVIS 175
Query: 247 MK-DASEETDIYSFGVIMLELISGKEPINENPTP 279
            K  A  E D++S GVI+  ++  + P ++   P
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + +G+ ++G +  A    +G    L+ +      +    G +   I  L  +RHP+++ L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
              Y   + +  I+      GN     + Q  +    EA       R    I   ++Y H
Sbjct: 79  ---YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR------RFFQQIISAVEYCH 129
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                 I+H +LK +N+LLD +    ++DFGL  ++  T G  +  +  S  Y APE+I 
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVIS 184
Query: 247 MK-DASEETDIYSFGVIMLELISGKEPINENPTP 279
            K  A  E D++S GVI+  ++  + P ++   P
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H      +L   ++     + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTH--LMGADLNNIVKXQKLTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDXELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 102/251 (40%), Gaps = 31/251 (12%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + +F +  E++  + HP LV L G     +    +V  F + G L+  +R   G   
Sbjct: 63  SMSEDDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA 121
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
             +++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +    
Sbjct: 122 AETLL-GMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 177
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
                       + +PE+      S ++D++SFGV+M E+ S GK P       +    +
Sbjct: 178 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237
Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
            T  R          LY P +     S H            +Q+   C    P  RP   
Sbjct: 238 STGFR----------LYKPRL----ASTH-----------VYQIMNHCWKERPEDRPAFS 272
Query: 346 QVLWKLEDLGK 356
           ++L +L ++ +
Sbjct: 273 RLLRQLAEIAE 283

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 110/254 (43%), Gaps = 24/254 (9%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLG 133
           +GK  +G +Y A  +++  +  L+ L      ++    +    IE+   +RHPN++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           ++   R    ++  F  RG L + ++       + S  +   +      D LH    R +
Sbjct: 82  YFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA-----DALHYCHERKV 135
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH ++K +N+L+    +  ++DFG  +       + M     +  Y  PE+I+ K   E+
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM---CGTLDYLPPEMIEGKTHDEK 192
Query: 254 TDIYSFGVIMLELISGKEPINENPTPDE--------DFHLPTFMRNAVLDHRITDL--YH 303
            D++  GV+  E + G  P + +P+  E        D   P F+ +   D  I+ L  YH
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFD-SPSHTETHRRIVNVDLKFPPFLSDGSKD-LISKLLRYH 250
Query: 304 PDMLLCSNSNHENP 317
           P   L      E+P
Sbjct: 251 PPQRLPLKGVMEHP 264

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 69
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 125
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI---PPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 69
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 125
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI---PPPD 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++   +L  L  C    N   ++GF
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC----NSPYIVGF 69
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 125
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI---PPPD 207

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDXTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G++  ++ L+     + ++F   I++L  +    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 133 GFYAGP-RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           G   GP R E  +V  +   G L   ++         S +   S  I  G++YL +   R
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA-SRLLLYSSQICKGMEYLGS---R 130
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMK 248
             +H +L ++NIL++      ++DFGL  LL P      +     Q    + APE +   
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDF--------HLPTFMRNAVLDHRITD 300
             S ++D++SFGV++ EL +     +++ +P  +F         +P   R   L      
Sbjct: 190 IFSRQSDVWSFGVVLYELFTY---CDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 246
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           L  P    C    HE             L   C +PSP  RP+   +
Sbjct: 247 LPAPPA--CPAEVHE-------------LMKLCWAPSPQDRPSFSAL 278

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  R  +++++   +   T+  K F + + ++  + HPN+V L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVKL 79
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   LI+   Y  G       +  G  +  +    +R    I   + Y H   
Sbjct: 80  FEVIETEKTLYLIME--YASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCH--- 131
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            + I+H +LK++N+LLD +    ++DFG       T G ++     +  Y APEL + K 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L+R+ +++ L       T   + + +L+ L+  + H N++ LL  +   +     +
Sbjct: 44  YDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVFTPQKSLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL+Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDATLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISG 269
           G IM E+I G
Sbjct: 212 GCIMGEMIKG 221

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++   +L  L  C    N   ++GF
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC----NSPYIVGF 69
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 125
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI---PPPD 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H      +L   ++     + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTH--LMGADLNNIVKSQKLTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDSELKILDFG----LCRHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 69
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 125
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 182
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI---PPPD 207

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 37  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 96  DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA---GIIHRDLKPS 148
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 149 NIVVKSDXTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 205 GCIMGEMVRHK 215

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 38  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 96
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 97  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 149
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 150 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 206 GCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++   +L  L  C    N   ++GF
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC----NSPYIVGF 131
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL    H+ 
Sbjct: 132 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLREK-HK- 187
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 244
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPD 280
           ++DI+S G+ ++E+  G+ PI   P PD
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPI---PPPD 269

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 13/129 (10%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL + L   AGQ   +  A +
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
            G+ APEL+  ++     D ++ GV + E+I+ + P        E+  L    +  VL+ 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQ 408
Query: 297 RITDLYHPD 305
            +T   +PD
Sbjct: 409 AVT---YPD 414

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 37  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 96  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 148
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 149 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 205 GCIMGEMVRHK 215

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 16/156 (10%)
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           HPN++ L   Y        +V    K+G L   +        K ++  + +  I   L  
Sbjct: 70  HPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRALLE 122
Query: 185 LHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           +    H+  I+H +LK +NILLD +    ++DFG    L+P  G+++ E   +  Y APE
Sbjct: 123 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPE 180
Query: 244 LIK--MKD----ASEETDIYSFGVIMLELISGKEPI 273
           +I+  M D      +E D++S GVIM  L++G  P 
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H      +L   ++     + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTH--LMGADLNNIVKXQKLTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 45  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 103
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 104 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 156
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 157 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 213 GCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 82  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 193
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 194 NIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 113/233 (48%), Gaps = 31/233 (13%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALL-QRSGS-----VRLLRFLRPVCTTRDKEFGD 115
           ED+ I +     G ++GK  +G++ +A L Q  GS     V++L+    +  + D E  +
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK--ADIIASSDIE--E 71
Query: 116 LIELLGCIR---HPNLVPLLGFYAGPRGE-----KLIVHPFYKRGNLAQCIRGGSGEAHK 167
            +    C++   HP++  L+G     R +      +++ PF K G+L   +       + 
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 168 WSI----IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN 223
           +++    + R  + IA G++YL +   R  IH +L ++N +L  +    V+DFGL   + 
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKI- 187
Query: 224 PTAGQEMLEASASQ---GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             +G    +  AS+    + A E +     +  +D+++FGV M E+++ G+ P
Sbjct: 188 -YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 43  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 101
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 102 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 154
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 155 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 210
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 211 GCIMGEMVRHK 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 44  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 45  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 103
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 104 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 156
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 157 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 213 GCIMGEMVRHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 38  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 96
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 97  DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 149
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 150 NIVVKSDCTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 206 GCIMGEMVRHK 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 100/247 (40%), Gaps = 31/247 (12%)
Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
           +++F +  E++  + HP LV L G     +    +V  F + G L+  +R   G     +
Sbjct: 46  EEDFIEEAEVMMKLSHPKLVQLYGV-CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAET 104
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++  + + +  G+ YL       +IH +L ++N L+  N    VSDFG+   +       
Sbjct: 105 LL-GMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160
Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
                    + +PE+      S ++D++SFGV+M E+ S GK P       +    + T 
Sbjct: 161 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220
Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R          LY P +     S H            +Q+   C    P  RP   ++L
Sbjct: 221 FR----------LYKPRL----ASTH-----------VYQIMNHCWKERPEDRPAFSRLL 255
Query: 349 WKLEDLG 355
            +L  + 
Sbjct: 256 RQLAAIA 262

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 51/87 (58%), Gaps = 8/87 (9%)
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK--MKD- 249
           I+H +LK +NILLD +    ++DFG    L+P  G+++ E   +  Y APE+I+  M D 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 250 ---ASEETDIYSFGVIMLELISGKEPI 273
                +E D++S GVIM  L++G  P 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 49/286 (17%)
Query: 77  IGKSNYGTLYKALLQRSGSVRL-LRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +G+  +G ++      +G+ R+ ++ L+P      + F    +++  +RH  LV L   Y
Sbjct: 193 LGQGCFGEVWMGTW--NGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQL---Y 246
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           A    E + IV  +  +G+L   ++G  G+  +   +  ++  IA G+ Y+        +
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIKMK 248
           H +L++ NIL+  N    V+DFGL  L+      E  E +A QG K      APE     
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI------EDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
             + ++D++SFG+++ EL + G+ P             P  +   VLD        P   
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCPP 405
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
            C  S H+             L   C    P  RP  + +   LED
Sbjct: 406 ECPESLHD-------------LMCQCWRKDPEERPTFEYLQAFLED 438

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 13/129 (10%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL + L   AGQ   +  A +
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
            G+ APEL+  ++     D ++ GV + E+I+ + P        E+  L    +  VL+ 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQ 408
Query: 297 RITDLYHPD 305
            +T   +PD
Sbjct: 409 AVT---YPD 414

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH---PNLVPL 131
           E +G+ +YG++YKA+ + +G +  ++ + PV    + +  ++I+ +  ++    P++V  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-PV----ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
            G Y     +  IV  +   G+++  IR  +    +   I  I      GL+YLH  F R
Sbjct: 90  YGSYFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIATILQSTLKGLEYLH--FMR 145
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            I H ++K+ NILL+      ++DFG+   L     +       +  + APE+I+    +
Sbjct: 146 KI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX-VIGTPFWMAPEVIQEIGYN 203
Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
              DI+S G+  +E+  GK P  +       F +PT
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++    +I  L  +   N   ++GF
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGF 88
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 144
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S 
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSV 201
Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN 291
           ++DI+S G+ ++E+  G+ PI         F L  ++ N
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+ C+ H N++ LL  +   +     +
Sbjct: 82  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPS 193
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 194 NIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 250 GCIMGEMVRHK 260

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           + +L  ++HPN+V     +    G   IV  + + G+L + I    G   +   I    +
Sbjct: 74  VAVLANMKHPNIVQYRESFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-A 235
            I   L ++H    R I+H ++KS+NI L ++    + DFG+  +LN T   E+  A   
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIG 187
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGK 270
           +  Y +PE+ + K  + ++DI++ G ++ EL + K
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR-----------PVCTTRDKEFGDLIELLG 121
           P   IG   YGT+YKA    SG    L+ +R           P+ T R+     L+  L 
Sbjct: 13  PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA---LLRRLE 69
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPF---YKRGNLAQCIRGGSGEAHKWSIIYRISIGI 178
              HPN+V L+   A  R ++ I       +   +L   +            I  +    
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
             GLD+LH      I+H +LK +NIL+       ++DFGL  +   +    +     +  
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTLW 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGK 270
           Y+APE++     +   D++S G I  E+   K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 13/129 (10%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL + L   AGQ   +  A +
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
            G+ APEL+  ++     D ++ GV + E+I+ + P        E+  L    +  VL+ 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQ 408
Query: 297 RITDLYHPD 305
            +T   +PD
Sbjct: 409 AVT---YPD 414

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 13/129 (10%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL + L   AGQ   +  A +
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
            G+ APEL+  ++     D ++ GV + E+I+ + P        E+  L    +  VL+ 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQ 408
Query: 297 RITDLYHPD 305
            +T   +PD
Sbjct: 409 AVT---YPD 414

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DF     L      EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDF----YLARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 82  RLLGICLTSTVQLIMQLMPF---GXLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 132
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 185
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 104/230 (45%), Gaps = 16/230 (6%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-----RHPNLVP 130
           VIG+ +Y  +    L+++  +  +R ++      D++  D ++    +      HP LV 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVG 117
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +         V  +   G+L   ++       + +  Y   I +A  L+YLH    
Sbjct: 118 LHSCFQ-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH---E 171
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           R II+ +LK  N+LLD      ++D+G+    L P  G        +  Y APE+++ +D
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGED 229
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDE-DFHLPTFMRNAVLDHRI 298
                D ++ GV+M E+++G+ P +   + D  D +   ++   +L+ +I
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 36/274 (13%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           IGK ++G +YK +   +  V  ++ +         ++    I +L     P +    G Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 136 AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
              +  KL I+  +   G+    ++ G  E    + I R    I  GLDYLH+      I
Sbjct: 87  L--KSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLHS---ERKI 138
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEET 254
           H ++K+ N+LL       ++DFG+   L  T  +       +  + APE+IK      + 
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDFKA 197
Query: 255 DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH 314
           DI+S G+  +EL  G EP      P+ D H            R+  L   +        H
Sbjct: 198 DIWSLGITAIELAKG-EP------PNSDLH----------PMRVLFLIPKNSPPTLEGQH 240
Query: 315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             P        F +   AC +  P  RP  K++L
Sbjct: 241 SKP--------FKEFVEACLNKDPRFRPTAKELL 266

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
           V+GK ++G +     + +G    ++ +  R V    DKE     ++LL  + HPN++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            F+   +G   +V   Y  G L   I  R    E     II ++  GI     Y+H    
Sbjct: 93  EFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMHKN-- 145
Query: 191 RPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I+H +LK +N+LL+   ++    + DFGL       A ++M +   +  Y APE++  
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH- 201
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
               E+ D++S GVI+  L+SG  P N
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLL 132
           GE IG+ N+G ++   L+   ++  ++  R       K +F     +L    HPN+V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G     +    IV    + G+    +R   G   +   + ++    A G++YL +   + 
Sbjct: 179 GV-CTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--------YKAPEL 244
            IH +L ++N L+       +SDFG+       + +E     A+ G        + APE 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGM-------SREEADGVXAASGGLRQVPVKWTAPEA 286
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
           +     S E+D++SFG+++ E  S    +  +P P+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS----LGASPYPN 318

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSGS-----VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G      V ++          +KE  D   ++  + +P++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 115 RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 165
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 166 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 218
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 75  EVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           + IGK N+  +  A   L  +  +V+++   +   ++  K F + + +   + HPN+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIXKVLNHPNIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                  +   L+    Y  G       +  G  +  +    +R    I   + Y H  F
Sbjct: 79  FEVIETEKTLYLVXE--YASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCHQKF 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK++N+LLD +    ++DFG       T G ++     +  Y APEL + K 
Sbjct: 134 ---IVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 250 AS-EETDIYSFGVIMLELISGKEPIN 274
               E D++S GVI+  L+SG  P +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +G   YG++  A    L Q+    +L R  + +   R + + +L  LL  ++H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR-RTYREL-RLLKHLKHENVIGLL 93
Query: 133 GFYAGPRG-----EKLIVHPFYKR--GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
             +          E  +V         N+ +C      + H   ++Y++      GL Y+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQL----LRGLKYI 147
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H+     IIH +LK  N+ ++ + +  + DFG    L   A +EM    A++ Y+APE +
Sbjct: 148 HSA---GIIHRDLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVATRWYRAPEIM 200
Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     ++  DI+S G IM EL+ GK
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTP 181
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 235
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 236 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 266

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 82  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 132
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 185
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTP 181
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 235
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 236 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 266

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +G   YG++  A    L Q+    +L R  + +   R + + +L  LL  ++H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR-RTYREL-RLLKHLKHENVIGLL 85
Query: 133 GFYAGPRG-----EKLIVHPFY--KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
             +          E  +V         N+ +C      + H   ++Y++      GL Y+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQL----LRGLKYI 139
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H+     IIH +LK  N+ ++ + +  + DFG    L   A +EM    A++ Y+APE +
Sbjct: 140 HSA---GIIHRDLKPSNVAVNEDCELRILDFG----LARQADEEMTGYVATRWYRAPEIM 192
Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     ++  DI+S G IM EL+ GK
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  +  FGL          EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILGFGL----ARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 84  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 134
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 187
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + D GL          EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDAGL----ARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 130 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTP 185
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 239
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 240 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 270

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 30/280 (10%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           EVIG      +  A    +   V + R     C T   E    I+ +    HPN+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIG-----IAGGLDYLH 186
            +   + E  +V      G++   I+     GE HK  ++   +I      +  GL+YLH
Sbjct: 81  SFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLH 138
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL----NPTAGQEMLEASASQGYKAP 242
                  IH ++K+ NILL  +    ++DFG+   L    + T  +       +  + AP
Sbjct: 139 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL-----PTFMRNAVLDH 296
           E++ +++    + DI+SFG+  +EL +G  P ++ P P +   L     P  +   V D 
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGVQDK 254
Query: 297 RITDLYHPD----MLLCSNSNHENPVSEERIL--KFFQLA 330
            +   Y       + LC   + E   +   +L  KFFQ A
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 83  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 186
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 71
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 72  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 128
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 129 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGX 185
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
           V+GK ++G +     + +G    ++ +  R V    DKE     ++LL  + HPN++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            F+   +G   +V   Y  G L   I  R    E     II ++  GI     Y+H    
Sbjct: 116 EFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMHKN-- 168
Query: 191 RPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I+H +LK +N+LL+   ++    + DFGL       A ++M +   +  Y APE++  
Sbjct: 169 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH- 224
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
               E+ D++S GVI+  L+SG  P N
Sbjct: 225 GTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 68
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 69  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 125
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 126 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 182
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 30/280 (10%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           EVIG      +  A    +   V + R     C T   E    I+ +    HPN+V    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIG-----IAGGLDYLH 186
            +   + E  +V      G++   I+     GE HK  ++   +I      +  GL+YLH
Sbjct: 76  SFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLH 133
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL----NPTAGQEMLEASASQGYKAP 242
                  IH ++K+ NILL  +    ++DFG+   L    + T  +       +  + AP
Sbjct: 134 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL-----PTFMRNAVLDH 296
           E++ +++    + DI+SFG+  +EL +G  P ++ P P +   L     P  +   V D 
Sbjct: 191 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGVQDK 249
Query: 297 RITDLYHPD----MLLCSNSNHENPVSEERIL--KFFQLA 330
            +   Y       + LC   + E   +   +L  KFFQ A
Sbjct: 250 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%)
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           LD +       I+H ++K +NIL+D N    + DFG+   L+ T+  +      +  Y +
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           PE  K +   E TDIYS G+++ E++ G+ P N
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
           V+GK ++G +     + +G    ++ +  R V    DKE     ++LL  + HPN++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            F+   +G   +V   Y  G L   I  R    E     II ++  GI     Y+H    
Sbjct: 117 EFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMH---K 168
Query: 191 RPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I+H +LK +N+LL+   ++    + DFGL       A ++M +   +  Y APE++  
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH- 225
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
               E+ D++S GVI+  L+SG  P N
Sbjct: 226 GTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGX 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTP 179
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 233
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 234 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 264

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           GE+IGK  +G +Y        ++RL+   R     + K F   +      RH N+V  +G
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIAGGLDYLHTGFHR 191
               P     I+    K   L   +R      + +K     +I+  I  G+ YLH    +
Sbjct: 97  ACMSP-PHLAIITSLCKGRTLYSVVRDAKIVLDVNK---TRQIAQEIVKGMGYLHA---K 149
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP-TAGQEMLEASASQGY---KAPELIKM 247
            I+H +LKSKN+  D N +  ++DFGL  +     AG+   +     G+    APE+I+ 
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 248 KDA---------SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR 290
                       S+ +D+++ G I  EL + + P    P     + + T M+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLL 132
           GE IG+ N+G ++   L+   ++  ++  R       K +F     +L    HPN+V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G     +    IV    + G+    +R   G   +   + ++    A G++YL +   + 
Sbjct: 179 GV-CTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--------YKAPEL 244
            IH +L ++N L+       +SDFG+       + +E     A+ G        + APE 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGM-------SREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
           +     S E+D++SFG+++ E  S    +  +P P+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS----LGASPYPN 318

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 71
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 72  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 128
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 129 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 185
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 56  VTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGD 115
           V  + G      DIL    E +G   +G +++ + + +G V + +F+            +
Sbjct: 42  VEVKQGSVYDYYDIL----EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 97
Query: 116 LIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRIS 175
            I ++  + HP L+ L   +   + E +++  F   G L   I     +  +  +I  + 
Sbjct: 98  EISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS--DFGLHLLLNPTAGQEMLEA 233
               G L ++H      I+H ++K +NI+ +      V   DFGL   LNP    ++  A
Sbjct: 157 QACEG-LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           +A   + APE++  +     TD+++ GV+   L+SG  P 
Sbjct: 213 TAE--FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 85  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 135
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 188
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLITQLMPF---GXLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YG +YKA  + +G V  L+ +R        P    R+      I LL  + HP
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE------ISLLKELNHP 62
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N+V LL          L+    +   +L + +   +       +I      +  GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LI 245
           +  HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+
Sbjct: 121 S--HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 176
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
             K  S   DI+S G I  E+++ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 66
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 67  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 123
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 124 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 180
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + D GL          EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDRGL----ARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 66
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 67  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 123
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 124 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 180
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 65
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 66  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 122
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 123 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 179
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 148 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTP 203
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 257
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 258 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
           K  S   DI+S G I  E+++ +     +   D+ F +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 65
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 122
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 123 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 179
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G++  ++ L+     + ++F   I++L  +    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           G   GP  + L +V  +   G L   ++         S +   S  I  G++YL +   R
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA-SRLLLYSSQICKGMEYLGS---R 134
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMK 248
             +H +L ++NIL++      ++DFGL  LL P      +     Q    + APE +   
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDF--------HLPTFMRNAVLDHRITD 300
             S ++D++SFGV++ EL +     +++ +P  +F         +P   R   L      
Sbjct: 194 IFSRQSDVWSFGVVLYELFTY---CDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 250
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           L  P    C    HE             L   C +PSP  RP+   +
Sbjct: 251 LPAPPA--CPAEVHE-------------LMKLCWAPSPQDRPSFSAL 282

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 68
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 125
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 126 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 182
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 65
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L + +   +       +I      +  GL + H+ 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQ--DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 122
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 123 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 179
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 66
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 67  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 123
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 124 -HR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 180
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 30/171 (17%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +    G+       + 
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTP 205
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
            Y APE++  K  S E D++S G IM  L+ GK P   +   +      T++R    ++ 
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEYS 259
Query: 298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           I               H NPV+   I K  Q         P+ RP I ++L
Sbjct: 260 I-------------PKHINPVAASLIQKMLQT-------DPTARPTINELL 290

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           + +++ G L+K   Q +  V  +  +R   T + ++F +    L    HPN++P+LG   
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 137 GPRG--EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
            P      LI H +   G+L   +  G+      S   + ++ +A G+ +LHT    P+I
Sbjct: 78  SPPAPHPTLITH-WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT--LEPLI 134
Query: 195 -HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS-- 251
               L S+++++D +    +S   +      + G+    A     + APE ++ K     
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQ-SPGRMYAPA-----WVAPEALQKKPEDTN 188
Query: 252 -EETDIYSFGVIMLELISGKEPINE 275
               D++SF V++ EL++ + P  +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFAD 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 91  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 141
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 142 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 194
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 75  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 125
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 178
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 106 RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 156
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 157 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 209
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 87  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 137
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 138 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 190
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 31/249 (12%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF    + +  + HP LV   G          IV  +   G L   +R   G+  
Sbjct: 44  SMSEDEFFQEAQTMMKLSHPKLVKFYGV-CSKEYPIYIVTEYISNGCLLNYLRS-HGKGL 101
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
           + S +  +   +  G+ +L +      IH +L ++N L+DR+    VSDFG+   +    
Sbjct: 102 EPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               +       + APE+      S ++D+++FG++M E+ S GK P +     +     
Sbjct: 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----- 213
Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
              +      HR   LY P   L S++              +Q+  +C    P  RP  +
Sbjct: 214 --VVLKVSQGHR---LYRPH--LASDT-------------IYQIMYSCWHELPEKRPTFQ 253
Query: 346 QVLWKLEDL 354
           Q+L  +E L
Sbjct: 254 QLLSSIEPL 262

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
           V+GK ++G +     + +G    ++ +  R V    DKE     ++LL  + HPN++ L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            F+   +G   +V   Y  G L   I  R    E     II ++  GI     Y+H    
Sbjct: 99  EFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMHKN-- 151
Query: 191 RPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I+H +LK +N+LL+   ++    + DFGL       A ++M +   +  Y APE++  
Sbjct: 152 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH- 207
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
               E+ D++S GVI+  L+SG  P N
Sbjct: 208 GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFG-DLIE--LLGCIRHPNLVPLL 132
           V+GK ++G +  A  + +  +  ++ L+     +D +    ++E  +L  +  P  +  L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                       V  +   G+L   I+         ++ Y   I I  GL +LH    R 
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI--GLFFLHK---RG 140
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           II+ +LK  N++LD      ++DFG+   H++     G    E   +  Y APE+I  + 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM----DGVTTREFCGTPDYIAPEIIAYQP 196
Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV 293
             +  D +++GV++ E+++G+ P +     DED    + M + V
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDGE---DEDELFQSIMEHNV 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 84  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 134
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 187
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 65
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 66  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 122
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 123 -HR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 179
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 84  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 134
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 187
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G++  ++ L+     + ++F   I++L  +    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           G   GP  + L +V  +   G L   ++         S +   S  I  G++YL +   R
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA-SRLLLYSSQICKGMEYLGS---R 133
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMK 248
             +H +L ++NIL++      ++DFGL  LL P      +     Q    + APE +   
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDF--------HLPTFMRNAVLDHRITD 300
             S ++D++SFGV++ EL +     +++ +P  +F         +P   R   L      
Sbjct: 193 IFSRQSDVWSFGVVLYELFTY---CDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQR 249
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           L  P    C    HE             L   C +PSP  RP+   +
Sbjct: 250 LPAPPA--CPAEVHE-------------LMKLCWAPSPQDRPSFSAL 281

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 84  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 134
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 187
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPV-CTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  A   ++G  V + +  RP       K     + LL  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +   R  +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 143
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + D GL          EM    A++ Y+APE ++ 
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDGGL----ARHTDDEMTGYVATRWYRAPEIMLN 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               ++  DI+S G IM EL++G+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 83  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 186
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 88  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 138
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 191
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L   +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQ--DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +G   YG++  A    L Q+    +L R  + +   R + + +L  LL  ++H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR-RTYREL-RLLKHLKHENVIGLL 93
Query: 133 GFYAGPRG-----EKLIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLH 186
             +          E  +V       +L   ++  +  + H   ++Y++      GL Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQL----LRGLKYIH 148
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LI 245
           +     IIH +LK  N+ ++ + +  + DFG    L   A +EM    A++ Y+APE ++
Sbjct: 149 SA---GIIHRDLKPSNVAVNEDSELRILDFG----LARQADEEMTGYVATRWYRAPEIML 201
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
                ++  DI+S G IM EL+ GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 77  IGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           +GK N+G++    Y  L   +G++  ++ L+     + ++F   I++L  +    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           G   GP  + L +V  +   G L   ++         S +   S  I  G++YL +   R
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA-SRLLLYSSQICKGMEYLGS---R 146
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIKMK 248
             +H +L ++NIL++      ++DFGL  LL P      +     Q    + APE +   
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
             S ++D++SFGV++ EL +     +++ +P  +F
Sbjct: 206 IFSRQSDVWSFGVVLYELFTY---CDKSCSPSAEF 237

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 78  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAEGMN 128
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 129 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 181
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 57  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 113
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH NL++ NIL+       ++DFGL  L+          A    
Sbjct: 114 IAEGMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 170
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 230
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 231 CPEELYQL-MRLCWKERPED 249

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 71  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 75  EVIGKSNYGTLY---KALLQRSGSVRLLRFLRPVC-TTRDKEFGDL-IELLGCIRHPNLV 129
           +V+G+ ++G ++   K     SG +  ++ L+      RD+    +  ++L  + HP +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L  +     G+  ++  F + G+L   +        +    Y   + +  GLD+LH+  
Sbjct: 94  KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL--GLDHLHS-- 148
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIK 246
              II+ +LK +NILLD      ++DFGL    +  A     +A +  G   Y APE++ 
Sbjct: 149 -LGIIYRDLKPENILLDEEGHIKLTDFGL----SKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 247 MKDASEETDIYSFGVIMLELISGKEPIN 274
            +  S   D +S+GV+M E+++G  P  
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRI 174
           I LL  + HPN++ L   +   +   L+   FY+ G L + I  R    E    +I+ +I
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVT-EFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLLLNPTAGQEML 231
             GI     YLH      I+H ++K +NILL+         + DFGL      +   ++ 
Sbjct: 156 LSGIC----YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLR 206
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           +   +  Y APE++K K  +E+ D++S GVIM  L+ G  P 
Sbjct: 207 DRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFE--FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 68/305 (22%)
Query: 78  GKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG 137
           GK      Y    ++   +  ++ L+       K+F    ELL  ++H ++V   G    
Sbjct: 27  GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV- 85
Query: 138 PRGEKLI-VHPFYKRGNLAQCIRGGSGEAH-----------KWSIIYRISIGIAGGLDYL 185
             G+ LI V  + K G+L + +R    +A              S +  I+  IA G+ YL
Sbjct: 86  -EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL 144
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASASQGYK 240
            +   +  +H +L ++N L+  N    + DFG+   +  T      G  ML       + 
Sbjct: 145 AS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WM 197
Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRIT 299
            PE I  +  + E+D++S GV++ E+ + GK+P  +                        
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ------------------------ 233
Query: 300 DLYHPDMLLCSNSNHENPVSEERILK--------FFQLAMACCSPSPSLRPNIKQVLWKL 351
                     SN+     +++ R+L+         ++L + C    P +R NIK +   L
Sbjct: 234 ---------LSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284
Query: 352 EDLGK 356
           ++L K
Sbjct: 285 QNLAK 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    ++  +L   +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQ--DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 76  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 128
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 38/240 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A   R+  V  ++ +       ++++ D+I+    L  +RHPN +   G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  ++ G   GL YLH+  
Sbjct: 122 CYLREHTAWLVME--YCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLAYLHS-- 172
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              +IH ++K+ NILL       + DFG   ++ P           +  + APE+I   D
Sbjct: 173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMD 226
Query: 250 ASE---ETDIYSFGVIMLELISGKEP------------INENPTPD-EDFHLPTFMRNAV 293
             +   + D++S G+  +EL   K P            I +N +P  +  H   + RN V
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++      S  V  ++ L+P  T   + F +   L+  ++H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKV-AVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
             R E + I+  +  +G+L   ++   G       +   S  IA G+ Y+     +  IH
Sbjct: 79  --REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            +L++ N+L+  +    ++DFGL  ++          A     + APE I     + ++D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 256 IYSFGVIMLELIS-GKEP 272
           ++SFG+++ E+++ GK P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-----RHPNLVP 130
           VIG+ +Y  +    L+++  +  ++ ++      D++  D ++    +      HP LV 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVG 74
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +         V  +   G+L   ++       + +  Y   I +A  L+YLH    
Sbjct: 75  LHSCFQ-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH---E 128
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           R II+ +LK  N+LLD      ++D+G+    L P  G        +  Y APE+++ +D
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSXFCGTPNYIAPEILRGED 186
Query: 250 ASEETDIYSFGVIMLELISGKEP---INENPTPDED 282
                D ++ GV+M E+++G+ P   +  +  PD++
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-----RHPNLVP 130
           VIG+ +Y  +    L+++  +  ++ ++      D++  D ++    +      HP LV 
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVG 85
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +         V  +   G+L   ++       + +  Y   I +A  L+YLH    
Sbjct: 86  LHSCFQ-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH---E 139
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           R II+ +LK  N+LLD      ++D+G+    L P  G        +  Y APE+++ +D
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSXFCGTPNYIAPEILRGED 197
Query: 250 ASEETDIYSFGVIMLELISGKEP---INENPTPDED 282
                D ++ GV+M E+++G+ P   +  +  PD++
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 233

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 65
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 66  VKLLDVIHTENKLYLVFE--FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 122
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 123 -HR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 179
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L   +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK--MKD- 249
           I+H +LK +NILLD +    ++DFG    L+P  G+++     +  Y APE+I+  M D 
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 250 ---ASEETDIYSFGVIMLELISGKEPI 273
                +E D++S GVIM  L++G  P 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 38/240 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE---LLGCIRHPNLVPLLG 133
           IG  ++G +Y A   R+  V  ++ +       ++++ D+I+    L  +RHPN +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIAGGLDYLHTGF 189
            Y       L++   Y  G+ +  +     E HK  +    I  ++ G   GL YLH+  
Sbjct: 83  CYLREHTAWLVME--YCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              +IH ++K+ NILL       + DFG   ++ P           +  + APE+I   D
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMD 187
Query: 250 ASE---ETDIYSFGVIMLELISGKEP------------INENPTPD-EDFHLPTFMRNAV 293
             +   + D++S G+  +EL   K P            I +N +P  +  H   + RN V
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 71  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 74  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 127 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L   +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFE--FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-----RHPNLVP 130
           VIG+ +Y  +    L+++  +  ++ ++      D++  D ++    +      HP LV 
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDI-DWVQTEKHVFEQASNHPFLVG 70
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +         V  +   G+L   ++       + +  Y   I +A  L+YLH    
Sbjct: 71  LHSCFQ-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH---E 124
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           R II+ +LK  N+LLD      ++D+G+    L P  G        +  Y APE+++ +D
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSXFCGTPNYIAPEILRGED 182
Query: 250 ASEETDIYSFGVIMLELISGKEP---INENPTPDED 282
                D ++ GV+M E+++G+ P   +  +  PD++
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 71  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 71  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKXFCGTPEYLAPEVLEDNDY 182
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIE--LLGCIRHPNLVPL 131
           +++GK  +G +     + +G    ++ LR  V   +D+    + E  +L   RHP L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
              YA    ++L  V  +   G L   +        + +  Y     I   L+YLH+   
Sbjct: 71  K--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHS--- 123
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL      + G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D +  GV+M E++ G+ P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 66
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L   +   +       +I      +  GL + H+ 
Sbjct: 67  VKLLDVIHTENKLYLVFE--FLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 123
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 124 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 180
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/308 (21%), Positives = 133/308 (43%), Gaps = 43/308 (13%)
Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIEL 119
           ED+ I   L   G+++G+  +G++ +  L++     L   ++ +    +  +E  + +  
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 120 LGCIR---HPNLVPLLGFYAGPRGE----KLIVHPFYKRGNLAQCI---RGGSGEAH-KW 168
             C++   HPN++ LLG       +     +++ PF K G+L   +   R  +G  H   
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAG 227
             + +  + IA G++YL    +R  +H +L ++N +L  +    V+DFGL   + +    
Sbjct: 147 QTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
           ++   A     + A E +  +  + ++D+++FGV M E+ +        P P        
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR----GMTPYP-------- 251
Query: 288 FMRNAVLDHRITD-LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
                V +H + D L H          H     E+ + + +++  +C    P  RP    
Sbjct: 252 ----GVQNHEMYDYLLH---------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298
Query: 347 VLWKLEDL 354
           +  +LE L
Sbjct: 299 LRLQLEKL 306

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L  +R       V +T  +E    I LL  + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 64
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 65  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 121
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 122 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 178
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L  +R       V +T  +E    I LL  + HPN+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 63
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 64  VKLLDVIHTENKLYLVFE--FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 121 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR------PVCTTRDKEFGDLIELLGCIRHPNL 128
           E IG+  YG +YKA  + +G V  L+ +R       V +T  +E    I LL  + HPN+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 67
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LL          L+    +   +L + +   +       +I      +  GL + H+ 
Sbjct: 68  VKLLDVIHTENKLYLVFE--HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 124
Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKM 247
            HR ++H +LK +N+L++      ++DFGL             E   +  Y+APE L+  
Sbjct: 125 -HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILLGC 181
Query: 248 KDASEETDIYSFGVIMLELISGK 270
           K  S   DI+S G I  E+++ +
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 70/281 (24%)
Query: 104 PVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSG 163
           P    R K+F    ELL  ++H ++V   G   G     ++V  + K G+L + +R    
Sbjct: 56  PTLAAR-KDFQREAELLTNLQHEHIVKFYGV-CGDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 164 EAH--------------KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY 209
           +A                 S +  I+  IA G+ YL +   +  +H +L ++N L+  N 
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL 170
Query: 210 QPYVSDFGLHLLLNPT-----AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIML 264
              + DFG+   +  T      G  ML       +  PE I  +  + E+D++SFGVI+ 
Sbjct: 171 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILW 226
Query: 265 ELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERI 323
           E+ + GK+P          F L                        SN+     +++ R+
Sbjct: 227 EIFTYGKQPW---------FQL------------------------SNTEVIECITQGRV 253
Query: 324 L--------KFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
           L        + + + + C    P  R NIK++   L  LGK
Sbjct: 254 LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 77  IGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G  N G ++K   + SG V  R L  L      R++   +L  L  C    N   ++GF
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC----NSPYIVGF 72
Query: 135 YAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y      GE  I       G+L Q ++       +  I+ ++SI +  GL YL       
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE--KHK 128
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           I+H ++K  NIL++   +  + DFG+   L      E +    ++ Y +PE ++    S 
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV---GTRSYMSPERLQGTHYSV 185
Query: 253 ETDIYSFGVIMLELISGKEP 272
           ++DI+S G+ ++E+  G+ P
Sbjct: 186 QSDIWSMGLSLVEMAVGRYP 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++      S  V + + L+P  T   + F +   L+  ++H  LV L   YA
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAV-KTLKP-GTMSVQAFLEEANLMKTLQHDKLVRL---YA 74
Query: 137 GPRGEK--LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
               E+   I+  F  +G+L   ++   G       +   S  IA G+ Y+     +  I
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEET 254
           H +L++ N+L+  +    ++DFGL  ++          A     + APE I     + ++
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 255 DIYSFGVIMLELIS-GKEP 272
           +++SFG+++ E+++ GK P
Sbjct: 192 NVWSFGILLYEIVTYGKIP 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 61/117 (52%), Gaps = 7/117 (5%)
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
           G +G     ++ Y  +  I  GL+ LH      I++ +LK +NILLD +    +SD GL 
Sbjct: 279 GQAGFPEARAVFY--AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 220 LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN 276
           + +    GQ +     + GY APE++K +  +   D ++ G ++ E+I+G+ P  + 
Sbjct: 334 VHV--PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFG-DLIE---LLGCIRHPNLVP 130
           +++GK ++G ++ A  +++     ++ L+      D +    ++E   L     HP L  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           +   +   +     V  +   G+L   I+         +  Y   I +  GL +LH+   
Sbjct: 84  MFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL--GLQFLHS--- 137
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + I++ +LK  NILLD++    ++DFG+    N     +  E   +  Y APE++  +  
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGM-CKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 251 SEETDIYSFGVIMLELISGKEPIN 274
           +   D +SFGV++ E++ G+ P +
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFH 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E +G   +  +  A  + +G +  ++ + +     ++    + I +L  I+H N+V L  
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALED 87
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
            Y  P    L++      G L   I  +G   E    ++I ++       LD ++     
Sbjct: 88  IYESPNHLYLVMQ-LVSGGELFDRIVEKGFYTEKDASTLIRQV-------LDAVYYLHRM 139
Query: 192 PIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
            I+H +LK +N+L    D   +  +SDFGL  +     G  M  A  + GY APE++  K
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQK 197
Query: 249 DASEETDIYSFGVIMLELISGKEPI-NENPT 278
             S+  D +S GVI   L+ G  P  +EN +
Sbjct: 198 PYSKAVDCWSIGVIAYILLCGYPPFYDENDS 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 77  IGKSNYGTLYKAL-LQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPN 127
           IG+  YG ++KA  L+  G    L+ +R        P+ T R+     ++  L    HPN
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA---VLRHLETFEHPN 75
Query: 128 LVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L       R +   KL +   +   +L   +            I  +   +  GLD+
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH+  HR ++H +LK +NIL+  + Q  ++DFGL  + +      +     +  Y+APE+
Sbjct: 136 LHS--HR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     +   D++S G I  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E +G   +G +++   + +G+    +F+     +  +     I+ +  +RHP LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTGFHRP 192
           +     E ++++ F   G L + +   + E +K S    +     +  GL ++H   +  
Sbjct: 117 FED-DNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHENNY-- 170
Query: 193 IIHGNLKSKNILL--DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
            +H +LK +NI+    R+ +  + DFGL   L+P    ++   +A   + APE+ + K  
Sbjct: 171 -VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE--FAAPEVAEGKPV 227
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
              TD++S GV+   L+SG  P 
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSPF 250

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +++A L  S  V + + L+      DK F +  ++++  ++HPN+V L  
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS------IIYRISIGIAGGLDYLHT 187
           F+     +K  V        + + +   S    K        +I      +   L Y+H+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD       + DFG   +L   AG+  +    S+ Y+APELI 
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSXICSRYYRAPELIF 214
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              + +   DI+S G +M EL+ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 61/116 (52%), Gaps = 7/116 (6%)
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH 219
           G +G     ++ Y  +  I  GL+ LH      I++ +LK +NILLD +    +SD GL 
Sbjct: 279 GQAGFPEARAVFY--AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 220 LLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE 275
           + +    GQ +     + GY APE++K +  +   D ++ G ++ E+I+G+ P  +
Sbjct: 334 VHV--PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 62  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 118
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 119 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 175
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 176 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 235
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 236 CPEELYQL-MRLCWKERPED 254

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 61  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 235 CPEELYQL-MRLCWKERPED 253

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 70  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 126
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 127 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 183
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 184 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 243
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 244 CPEELYQL-MRLCWKERPED 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 67  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 124 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 180
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 241 CPEELYQL-MRLCWKERPED 259

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 63  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 119
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 120 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 176
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 177 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 236
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 237 CPEELYQL-MRLCWKERPED 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 61  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI 174
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 235 CPEELYQL-MRLCWKERPED 253

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 61  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 235 CPEELYQL-MRLCWKERPED 253

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YG +YKA     G    L+ +R        P  T R+      I +L  ++H 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIRE------ISILKELKHS 60
Query: 127 NLVPLLGFYAGPRGEKLIV-HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V L       +   L+  H       L     GG       S + ++  GIA    Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YC 116
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H    R ++H +LK +N+L++R  +  ++DFGL         +   E   +  Y+AP+ L
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-VTLWYRAPDVL 172
Query: 245 IKMKDASEETDIYSFGVIMLELISG 269
           +  K  S   DI+S G I  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YG +YKA     G    L+ +R        P  T R+      I +L  ++H 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIRE------ISILKELKHS 60
Query: 127 NLVPLLGFYAGPRGEKLIV-HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V L       +   L+  H       L     GG       S + ++  GIA    Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YC 116
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H    R ++H +LK +N+L++R  +  ++DFGL         +   E   +  Y+AP+ L
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV-VTLWYRAPDVL 172
Query: 245 IKMKDASEETDIYSFGVIMLELISG 269
           +  K  S   DI+S G I  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 118 ELLGC--IRHPNLVPLLG-FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           EL+ C  +  P +VPL G    GP     I     + G+L Q ++         ++ Y  
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVN--IFMELLEGGSLGQLVKEQGCLPEDRALYY-- 171
Query: 175 SIGIA-GGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA-GQEML 231
            +G A  GL+YLH+   R I+HG++K+ N+LL  +     + DFG  + L P   G+++L
Sbjct: 172 -LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 232 EAS---ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE 275
                  ++ + APE++  +    + D++S   +ML +++G  P  +
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 85  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 135
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 188
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 77  IGKSNYGTLYKAL-LQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPN 127
           IG+  YG ++KA  L+  G    L+ +R        P+ T R+     ++  L    HPN
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA---VLRHLETFEHPN 75
Query: 128 LVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L       R +   KL +   +   +L   +            I  +   +  GLD+
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH+  HR ++H +LK +NIL+  + Q  ++DFGL  + +      +     +  Y+APE+
Sbjct: 136 LHS--HR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     +   D++S G I  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+    +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 88  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 138
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 191
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E +G   +G +++   + +G+    +F+     +  +     I+ +  +RHP LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI--GIAGGLDYLHTGFHRP 192
           +     E ++++ F   G L + +   + E +K S    +     +  GL ++H   +  
Sbjct: 223 FED-DNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHENNY-- 276
Query: 193 IIHGNLKSKNILL--DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
            +H +LK +NI+    R+ +  + DFGL   L+P    ++   +A   + APE+ + K  
Sbjct: 277 -VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE--FAAPEVAEGKPV 333
Query: 251 SEETDIYSFGVIMLELISGKEPI 273
              TD++S GV+   L+SG  P 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 69  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 125
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 126 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 182
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 183 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 242
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 243 CPEELYQL-MRLCWKERPED 261

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL---------RPVCTTRDKEFGDLIELLGCIR 124
           GE +G   +  + K   + +G     +F+         R VC    +E    + +L  + 
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR---EEIEREVSILRQVL 73
Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGL 182
           HPN++ L   Y   R + +++      G L   +  +    E    S I +I      G+
Sbjct: 74  HPNIITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGV 128
Query: 183 DYLHTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQG 238
           +YLHT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPE 183
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           + APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 260 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 316
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
            Y APE+++  D     D +  GV+M E++ G+ P 
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 83  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 186
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + ++ + PF   G L   +R      GS     W +       IA G++
Sbjct: 83  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 186
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 313
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
            Y APE+++  D     D +  GV+M E++ G+ P 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 77  IGKSNYGTLYKAL-LQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHPN 127
           IG+  YG ++KA  L+  G    L+ +R        P+ T R+     ++  L    HPN
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA---VLRHLETFEHPN 75
Query: 128 LVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L       R +   KL +   +   +L   +            I  +   +  GLD+
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH+  HR ++H +LK +NIL+  + Q  ++DFGL  + +      +     +  Y+APE+
Sbjct: 136 LHS--HR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEV 190
Query: 245 IKMKDASEETDIYSFGVIMLELISGK 270
           +     +   D++S G I  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 61  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 235 CPEELYQL-MRLCWKERPED 253

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 14/167 (8%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----EKLIVHPFYKRGNLAQCIRGGS 162
           T   + + +L+ LL C+ H N++ LL  +   +     + + +       NL Q I    
Sbjct: 63  THAKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMEL 121
Query: 163 GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL 222
                  ++Y++  GI     +LH+     IIH +LK  NI++  +    + DFGL    
Sbjct: 122 DHERMSYLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL--AR 172
Query: 223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG 269
             +    M     ++ Y+APE+I      E  DI+S G IM EL+ G
Sbjct: 173 TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 66  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 122
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 123 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 179
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 180 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 239
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 240 CPEELYQL-MRLCWKERPED 258

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/245 (20%), Positives = 104/245 (42%), Gaps = 18/245 (7%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G   +G ++ A   +   V  ++ ++P   + +    +   ++  ++H  LV L     
Sbjct: 190 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAE-ANVMKTLQHDKLVKLHAVVT 247
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG 196
             +    I+  F  +G+L   ++   G       +   S  IA G+ ++     R  IH 
Sbjct: 248 --KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 302
Query: 197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDI 256
           +L++ NIL+  +    ++DFGL            + A     + APE I     + ++D+
Sbjct: 303 DLRAANILVSASLVCKIADFGL----------ARVGAKFPIKWTAPEAINFGSFTIKSDV 352
Query: 257 YSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE 315
           +SFG++++E+++ G+ P      P+    L    R    ++   +LY+  M    N   E
Sbjct: 353 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEE 412
Query: 316 NPVSE 320
            P  E
Sbjct: 413 RPTFE 417

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 67  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 124 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 180
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 240
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 241 CPEELYQL-MRLCWKERPED 259

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLHTGF-------HRPIIHGNLKSKNILLDRNYQPY 212
            G G  HK+ +  R  I ++   + LH           +  +H NL ++N+LL   +   
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476
Query: 213 VSDFGLHLLLNPTAGQEMLEASASQGYK--APELIKMKDASEETDIYSFGVIMLELIS-G 269
           +SDFGL   L          ++     K  APE I  +  S  +D++S+GV M E +S G
Sbjct: 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 270 KEPINENPTPD 280
           ++P  +   P+
Sbjct: 537 QKPYKKMKGPE 547

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 117 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKXFCGTP 173
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
            Y APE+++  D     D +  GV+M E++ G+ P 
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YG +YKA     G    L+ +R        P  T R+      I +L  ++H 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIRE------ISILKELKHS 60
Query: 127 NLVPLLGFYAGPRGEKLIV-HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V L       +   L+  H       L     GG       S + ++  GIA    Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YC 116
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-L 244
           H    R ++H +LK +N+L++R  +  ++DFGL         +   E   +  Y+AP+ L
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-VTLWYRAPDVL 172
Query: 245 IKMKDASEETDIYSFGVIMLELISG 269
           +  K  S   DI+S G I  E+++G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 119 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKXFCGTP 175
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
            Y APE+++  D     D +  GV+M E++ G+ P 
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 56  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 112
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 113 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 169
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 170 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 229
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 230 CPEELYQL-MRLCWKERPED 248

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL        G  M     + 
Sbjct: 118 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKXFCGTP 174
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
            Y APE+++  D     D +  GV+M E++ G+ P 
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 118 ELLGC--IRHPNLVPLLG-FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           EL+ C  +  P +VPL G    GP     I     + G+L Q ++         ++ Y  
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVN--IFMELLEGGSLGQLVKEQGCLPEDRALYY-- 190
Query: 175 SIGIA-GGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA-GQEML 231
            +G A  GL+YLH+   R I+HG++K+ N+LL  +     + DFG  + L P   G+ +L
Sbjct: 191 -LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 232 EAS---ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINE 275
                  ++ + APE++  +    + D++S   +ML +++G  P  +
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 77  IGKSNYGTLYKAL-LQRSGSVRLLRFL-RPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           IG+ ++ T+YK L  + +  V       R +  +  + F +  E L  ++HPN+V     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 135 YAGP-RGEKLIV--HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +    +G+K IV        G L   ++    +  K  ++      I  GL +LHT    
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLK--RFKVXKIKVLRSWCRQILKGLQFLHTRTP- 150
Query: 192 PIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           PIIH +LK  NI +        + D GL  L   +  + ++    +  + APE  + K  
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFXAPEXYEEK-Y 206
Query: 251 SEETDIYSFGVIMLELISGKEPINE 275
            E  D+Y+FG   LE  + + P +E
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSE 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 24/234 (10%)
Query: 49  EGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTL----YKALLQRSGSVRLLRFLRP 104
           EG  + L    G +DL +        E +G  ++G +    + A   ++ SV  ++ L+P
Sbjct: 5   EGPLQSLTCLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKP 56
Query: 105 VCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGG 161
              ++ +   D I  +  +    H NL+ L G    P  +  +V      G+L   +R  
Sbjct: 57  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKH 114
Query: 162 SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL 221
            G       + R ++ +A G+ YL +   +  IH +L ++N+LL       + DFGL   
Sbjct: 115 QGH-FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 222 LNPTAGQEMLEA--SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           L       +++        + APE +K +  S  +D + FGV + E+ + G+EP
Sbjct: 171 LPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+    +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 77  IGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGF 134
           +G   YG++  +   +SG  + + +  RP  +    K     + LL  ++H N++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 135 YAGPRGEK------LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +      +      L+ H       N+ +C +    + H   +IY+I      GL Y+H+
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI----LRGLKYIHS 172
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
                IIH +LK  N+ ++ + +  + DFG    L      EM    A++ Y+APE ++ 
Sbjct: 173 A---DIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 225
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
               +   DI+S G IM EL++G+
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+    +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 88  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 138
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G     
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGGKVPIK 191
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 81  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 131
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 184
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 83  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 133
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 186
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG--- 140
           Y A+L R+ +++ L   RP    T   + + +L+ L+  + H N++ LL  +   +    
Sbjct: 44  YDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVFTPQKTLEE 100
Query: 141 -EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
            + + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK
Sbjct: 101 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLK 153
Query: 200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIY 257
             NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+
Sbjct: 154 PSNIVVKSDXTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209
Query: 258 SFGVIMLELISGK 270
           S G IM E++  K
Sbjct: 210 SVGCIMGEMVRHK 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK L    G  V++   ++ LR   + + +KE  D   ++  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 130 PLLGFYAGPRGEKLI-VHPFYKRGNLAQCIRG-----GSGEAHKWSIIYRISIGIAGGLD 183
            LLG       + +  + PF   G L   +R      GS     W +       IA G++
Sbjct: 88  RLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQYLLNWCV------QIAKGMN 138
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG----- 238
           YL     R ++H +L ++N+L+       ++DFG   LL    G E  E  A  G     
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL----GAEEKEYHAEGGKVPIK 191
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPD 280
           + A E I  +  + ++D++S+GV + EL++ G +P +  P  +
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIITLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 76  VIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
           ++GK ++G + K    + Q+  +V+++       + ++K+   +   +ELL  + HPN++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN----KASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNL-AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            L            IV   Y  G L  + I+      H  +   RI   +  G+ Y+H  
Sbjct: 85  KLFEILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMH-- 138
Query: 189 FHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
               I+H +LK +NILL+   ++    + DFGL          +M +   +  Y APE++
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVL 195
Query: 246 KMKDASEETDIYSFGVIMLELISGKEP 272
           +     E+ D++S GVI+  L+SG  P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG 177
           L+  ++H  LV L   YA    E + I+  + + G+L   ++  SG     + +  ++  
Sbjct: 71  LMKQLQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 127
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ ++     R  IH +L++ NIL+       ++DFGL  L+          A    
Sbjct: 128 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 184
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH 296
            + APE I     + ++D++SFG+++ E+++ G+ P      P+   +L    R    D+
Sbjct: 185 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 244
Query: 297 RITDLYHPDMLLCSNSNHEN 316
              +LY   M LC     E+
Sbjct: 245 CPEELYQL-MRLCWKERPED 263

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 86  YKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG--- 140
           Y A+L R+ +++ L   RP    T   + + +L+ L+  + H N++ LL  +   +    
Sbjct: 44  YDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVFTPQKTLEE 100
Query: 141 -EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK 199
            + + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK
Sbjct: 101 FQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLK 153
Query: 200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIY 257
             NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+
Sbjct: 154 PSNIVVKSDXTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209
Query: 258 SFGVIMLELISGK 270
           S G IM E++  K
Sbjct: 210 SVGCIMGEMVRHK 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 41/188 (21%)
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL  N    + DFGL   +  NP   ++  +
Sbjct: 205 SFQVARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG-D 260
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
                 + APE I  K  S ++D++S+GV++ E+ S    +  +P P    DEDF   L 
Sbjct: 261 TRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS----LGGSPYPGVQMDEDFCSRLR 316
Query: 287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
             MR    ++   ++Y                         Q+ + C    P  RP   +
Sbjct: 317 EGMRMRAPEYSTPEIY-------------------------QIMLDCWHRDPKERPRFAE 351
Query: 347 VLWKLEDL 354
           ++ KL DL
Sbjct: 352 LVEKLGDL 359

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 88  V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 139
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 198
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPP 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G+  YG + K     SG +  ++ +R    +++++   L++L   +R  +    + FY 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYG 73
Query: 137 GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKW-------------SIIYRISIGIAGGLD 183
                       ++ G++  C+        K+              I+ +I++ I   L+
Sbjct: 74  A----------LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           +LH+     +IH ++K  N+L++   Q  + DFG+   L     +++   +  + Y APE
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPE 179
Query: 244 LIK----MKDASEETDIYSFGVIMLELISGKEPINENPTP 279
            I      K  S ++DI+S G+ M+EL   + P +   TP
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 30/168 (17%)
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ YLH      +IH +LK  N+ L+ +    + DFGL   +    G+   +   +  Y 
Sbjct: 138 GVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGTPNYI 193
Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE++  K  S E DI+S G I+  L+ GK P   +   +      T++R    ++ +  
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE------TYIRIKKNEYSV-- 245
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                        H NPV+   I +            P+LRP++ ++L
Sbjct: 246 -----------PRHINPVASALIRRMLH-------ADPTLRPSVAELL 275

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVAYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 97  V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 148
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 207
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPP 230

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 24/234 (10%)
Query: 49  EGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTL----YKALLQRSGSVRLLRFLRP 104
           EG  + L    G +DL +        E +G  ++G +    + A   ++ SV  ++ L+P
Sbjct: 5   EGPLQSLTCLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKP 56
Query: 105 VCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGG 161
              ++ +   D I  +  +    H NL+ L G    P  +  +V      G+L   +R  
Sbjct: 57  DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKH 114
Query: 162 SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL 221
            G       + R ++ +A G+ YL +   +  IH +L ++N+LL       + DFGL   
Sbjct: 115 QGH-FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 222 LNPTAGQEMLEA--SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           L       +++        + APE +K +  S  +D + FGV + E+ + G+EP
Sbjct: 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 86  YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----E 141
           Y A+L R+ +++ L       T   + + +L+ L+  + H N++ LL  +   +     +
Sbjct: 44  YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVFTPQKTLEEFQ 102
Query: 142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSK 201
            + +       NL Q I+          ++Y++  GI     +LH+     IIH +LK  
Sbjct: 103 DVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA---GIIHRDLKPS 155
Query: 202 NILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASASQGYKAPELIKMKDASEETDIYSF 259
           NI++  +    + DFGL      TAG    M     ++ Y+APE+I      E  DI+S 
Sbjct: 156 NIVVKSDXTLKILDFGL----ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 260 GVIMLELISGK 270
           G IM E++  K
Sbjct: 212 GCIMGEMVRHK 222

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIY 172
           I++L   RH N++ +      P  E++    IV    +               H    +Y
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--M 230
           +I      GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       +
Sbjct: 134 QI----LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 231 LEASASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
            E  A++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIY 172
           I++L   RH N++ +      P  E++    IV    +               H    +Y
Sbjct: 74  IKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--M 230
           +I      GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       +
Sbjct: 134 QI----LRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFL 186
Query: 231 LEASASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
            E  A++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC 122
           DL   ++ +  GE +G   +G +YKA  + +G++   + +        +++   IE+L  
Sbjct: 14  DLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT 72
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR---GGSGEAHKWSI--------I 171
             HP +V LLG Y             Y  G L   I    GG+ +A    +        I
Sbjct: 73  CDHPYIVKLLGAY-------------YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
             +   +   L++LH+   + IIH +LK+ N+L+       ++DFG+    N    Q+  
Sbjct: 120 QVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRD 175
Query: 232 EASASQGYKAPELI---KMKDA--SEETDIYSFGVIMLELISGKEPINE-NP 277
               +  + APE++    MKD     + DI+S G+ ++E+   + P +E NP
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---FGDLIELLGCIRHPNLVPL 131
           +VIG+  +G +     + +  V  ++ L      +  +   F +  +++     P +V L
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT-GFH 190
             FYA      L +   Y  G     +        KW+  Y   + +A  LD +H+ GF 
Sbjct: 140 --FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA--LDAIHSMGF- 194
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K  N+LLD++    ++DFG  + +N         A  +  Y +PE++K +  
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 251 S----EETDIYSFGVIMLELISGKEPI 273
                 E D +S GV + E++ G  P 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC 122
           DL   ++ +  GE +G   +G +YKA  + +G++   + +        +++   IE+L  
Sbjct: 6   DLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT 64
Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR---GGSGEAHKWSI--------I 171
             HP +V LLG Y             Y  G L   I    GG+ +A    +        I
Sbjct: 65  CDHPYIVKLLGAY-------------YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 111
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
             +   +   L++LH+   + IIH +LK+ N+L+       ++DFG+    N    Q+  
Sbjct: 112 QVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRD 167
Query: 232 EASASQGYKAPELI---KMKDA--SEETDIYSFGVIMLELISGKEPINE-NP 277
               +  + APE++    MKD     + DI+S G+ ++E+   + P +E NP
Sbjct: 168 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 92  V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 143
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 202
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPP 225

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---FGDLIELLGCIRHPNLVPL 131
           +VIG+  +G +     + +  V  ++ L      +  +   F +  +++     P +V L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT-GFH 190
             FYA      L +   Y  G     +        KW+  Y   + +A  LD +H+ GF 
Sbjct: 135 --FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA--LDAIHSMGF- 189
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K  N+LLD++    ++DFG  + +N         A  +  Y +PE++K +  
Sbjct: 190 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 251 S----EETDIYSFGVIMLELISGKEPI 273
                 E D +S GV + E++ G  P 
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 56  VTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKE 112
           VTF  G++  I        E IG   YG +  A  + +G   +++ +     V T   + 
Sbjct: 48  VTFDVGDEYEII-------ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 100
Query: 113 FGDLIELLGCIRHPNLVPLLGFY--AGPRGEKLIVHPFYK--RGNLAQCIRGGSGEA--H 166
             +L ++L   +H N++ +        P GE   V+        +L Q I         H
Sbjct: 101 LREL-KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH--LLLNP 224
               +Y++      GL Y+H+     +IH +LK  N+L++ N +  + DFG+   L  +P
Sbjct: 160 VRYFLYQL----LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212
Query: 225 TAGQE-MLEASASQGYKAPEL-IKMKDASEETDIYSFGVIMLELISGKE 271
              Q  M E  A++ Y+APEL + + + ++  D++S G I  E+++ ++
Sbjct: 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           + +++ G L+K   Q +  V  +  +R   T + ++F +    L    HPN++P+LG   
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 137 GPRG--EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
            P      LI H +   G+L   +  G+      S   + ++  A G  +LHT    P+I
Sbjct: 78  SPPAPHPTLITH-WXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT--LEPLI 134
Query: 195 -HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS-- 251
               L S+++ +D +    +S   +      + G+    A     + APE ++ K     
Sbjct: 135 PRHALNSRSVXIDEDXTARISXADVKFSFQ-SPGRXYAPA-----WVAPEALQKKPEDTN 188
Query: 252 -EETDIYSFGVIMLELISGKEPINE 275
               D +SF V++ EL++ + P  +
Sbjct: 189 RRSADXWSFAVLLWELVTREVPFAD 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           +G+  YG + K     SG +  ++ +R    +++++   L++L   +R  +    + FY 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYG 117
Query: 137 GPRGEKLIVHPFYKRGNLAQCIR-------------GGSGEAHKWSIIYRISIGIAGGLD 183
                       ++ G++  C+                 G+     I+ +I++ I   L+
Sbjct: 118 A----------LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           +LH+     +IH ++K  N+L++   Q  + DFG+   L  +  + +   +  + Y APE
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTI--DAGCKPYMAPE 223
Query: 244 LIK----MKDASEETDIYSFGVIMLELISGKEPINENPTP 279
            I      K  S ++DI+S G+ M+EL   + P +   TP
Sbjct: 224 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 263

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 99  V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 150
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 209
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPP 232

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---FGDLIELLGCIRHPNLVPL 131
           +VIG+  +G +     + +  V  ++ L      +  +   F +  +++     P +V L
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT-GFH 190
             FYA      L +   Y  G     +        KW+  Y   + +A  LD +H+ GF 
Sbjct: 140 --FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA--LDAIHSMGF- 194
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
              IH ++K  N+LLD++    ++DFG  + +N         A  +  Y +PE++K +  
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 251 S----EETDIYSFGVIMLELISGKEPI 273
                 E D +S GV + E++ G  P 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 30/168 (17%)
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ YLH      +IH +LK  N+ L+ +    + DFGL   +    G+   +   +  Y 
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGTPNYI 209
Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE++  K  S E DI+S G I+  L+ GK P   +   +      T++R    ++ +  
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE------TYIRIKKNEYSV-- 261
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                        H NPV+   I +            P+LRP++ ++L
Sbjct: 262 -----------PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRD----KEFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F+  R + ++R     +E    + +L  IRHPN
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   +   + + +++      G L   +     E+       +    I  G+ YLH+
Sbjct: 77  IITLHDIFEN-KTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 188 GFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPE 243
              + I H +LK +NI LLD+N   P +   DFG+   +   AG E      +  + APE
Sbjct: 134 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPE 188
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++  +    E D++S GVI   L+SG  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 68  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 126
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLTARNVLVTENNVM 183
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 184 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 243
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 244 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 278
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 279 MRDCWHAVPSQRPTFKQL---VEDLDR 302

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 RIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRD----KEFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F+  R + ++R     +E    + +L  IRHPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   +   + + +++      G L   +     E+       +    I  G+ YLH+
Sbjct: 70  IITLHDIFEN-KTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 188 GFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPE 243
              + I H +LK +NI LLD+N   P +   DFG+   +   AG E      +  + APE
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPE 181
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++  +    E D++S GVI   L+SG  P
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 242
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 303 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 337
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 338 MRDCWHAVPSQRPTFKQL---VEDLDR 361

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 73  EKDLSDLVSEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLRARRPPG 131
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 188
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 189 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 248
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 249 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 283
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 284 MRDCWHAVPSQRPTFKQL---VEDLDR 307

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 70  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 128
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 185
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 186 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 245
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 246 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 280
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 281 MRDCWHAVPSQRPTFKQL---VEDLDR 304

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 75  EVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
           +VIG+  +G +    +KA  Q+  +++LL     +  +    F +  +++     P +V 
Sbjct: 81  KVIGRGAFGEVQLVRHKAS-QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 139
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +   +   +++   Y  G     +        KW+  Y   + +A  LD +H+   
Sbjct: 140 LFCAFQDDKYLYMVME--YMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA--LDAIHS--- 192
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
             +IH ++K  N+LLD++    ++DFG  + ++ T       A  +  Y +PE++K +  
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 251 S----EETDIYSFGVIMLELISGKEPI 273
                 E D +S GV + E++ G  P 
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 76  VIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
           ++GK ++G + K    + Q+  +V+++       + ++K+   +   +ELL  + HPN++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN----KASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNL-AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            L            IV   Y  G L  + I+      H  +   RI   +  G+ Y+H  
Sbjct: 85  KLFEILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMH-- 138
Query: 189 FHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
               I+H +LK +NILL+   ++    + DFGL          +M +   +  Y APE++
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVL 195
Query: 246 KMKDASEETDIYSFGVIMLELISGKEP 272
           +     E+ D++S GVI+  L+SG  P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 117 IELLGCIRHPNLVPLLGFYA--GPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYR 173
           IE+L  + H N+V   G     G  G KLI+  F   G+L + +     + + K  + Y 
Sbjct: 62  IEILRNLYHENIVKYKGICTEDGGNGIKLIME-FLPSGSLKEYLPKNKNKINLKQQLKY- 119
Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-- 231
            ++ I  G+DYL +   R  +H +L ++N+L++  +Q  + DFGL   +        +  
Sbjct: 120 -AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS 268
           +  +   + APE +        +D++SFGV + EL++
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIIHLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 76  VIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
           ++GK ++G + K    + Q+  +V+++       + ++K+   +   +ELL  + HPN++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN----KASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNL-AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            L            IV   Y  G L  + I+      H  +   RI   +  G+ Y+H  
Sbjct: 85  KLFEILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMH-- 138
Query: 189 FHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
               I+H +LK +NILL+   ++    + DFGL          +M +   +  Y APE++
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVL 195
Query: 246 KMKDASEETDIYSFGVIMLELISGKEP 272
           +     E+ D++S GVI+  L+SG  P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 117 IELLGCIRHPNLVPLLGFYA--GPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYR 173
           IE+L  + H N+V   G     G  G KLI+  F   G+L + +     + + K  + Y 
Sbjct: 74  IEILRNLYHENIVKYKGICTEDGGNGIKLIME-FLPSGSLKEYLPKNKNKINLKQQLKY- 131
Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-- 231
            ++ I  G+DYL +   R  +H +L ++N+L++  +Q  + DFGL   +        +  
Sbjct: 132 -AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS 268
           +  +   + APE +        +D++SFGV + EL++
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH--LLLNPTAGQE-MLEASASQ 237
           GL Y+H+     +IH +LK  N+L++ N +  + DFG+   L  +P   Q  M E  A++
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 238 GYKAPEL-IKMKDASEETDIYSFGVIMLELISGKE 271
            Y+APEL + + + ++  D++S G I  E+++ ++
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--A 235
           +A  LD+LH+     II+ +LK +NILLD      ++DFGL      +   E    S   
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFCG 188
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           +  Y APE++  +  ++  D +SFGV+M E+++G  P  
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGS--- 162
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 163 -----------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
                       E   +  +   +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFG-DLIE---LLGCIRHPNLVP 130
           +++GK ++G ++ A  +++     ++ L+      D +    ++E   L     HP L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           +   +   +     V  +   G+L   I+         +  Y   I +  GL +LH+   
Sbjct: 83  MFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL--GLQFLHS--- 136
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + I++ +LK  NILLD++    ++DFG+    N     +      +  Y APE++  +  
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGM-CKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 251 SEETDIYSFGVIMLELISGKEPIN 274
           +   D +SFGV++ E++ G+ P +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFH 219

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--A 235
           +A  LD+LH+     II+ +LK +NILLD      ++DFGL      +   E    S   
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFCG 189
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           +  Y APE++  +  ++  D +SFGV+M E+++G  P  
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 77  IGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           +G+  +G ++ A     L ++   +  ++ L+    +  ++F    ELL  ++H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS-------------IIYRISIGI 178
            G     R   L+V  + + G+L + +R    +A   +              +  ++  +
Sbjct: 86  FGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEA 233
           A G+ YL  G H   +H +L ++N L+ +     + DFG+   +  T      G+ ML  
Sbjct: 145 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                +  PE I  +  + E+D++SFGV++ E+ + GK+P
Sbjct: 202 R----WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--A 235
           +A  LD+LH+     II+ +LK +NILLD      ++DFGL      +   E    S   
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHEKKAYSFCG 188
Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           +  Y APE++  +  ++  D +SFGV+M E+++G  P  
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 139 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 130 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGS--GEAHKWSIIYRI 174
           IE+L  + HPN++ +   +        IV    + G L + I      G+A     +  +
Sbjct: 71  IEVLKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQEM 230
              +   L Y H+   + ++H +LK +NIL  ++  P+    + DFGL  L    + +  
Sbjct: 130 MKQMMNALAYFHS---QHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFK--SDEHS 183
Query: 231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
             A+ +  Y APE+ K +D + + DI+S GV+M  L++G  P  
Sbjct: 184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 142 V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 193
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 252
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPP 275

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 77  IGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           +G+  +G ++ A     L ++   +  ++ L+    +  ++F    ELL  ++H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS-------------IIYRISIGI 178
            G     R   L+V  + + G+L + +R    +A   +              +  ++  +
Sbjct: 80  FGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEA 233
           A G+ YL  G H   +H +L ++N L+ +     + DFG+   +  T      G+ ML  
Sbjct: 139 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                +  PE I  +  + E+D++SFGV++ E+ + GK+P
Sbjct: 196 R----WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 141 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+LL+      + DFGL  + +P       + E  A
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A ++ SG +  ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              G++L +V  F + G L   +        +   I  + + +   L  LH    + +IH
Sbjct: 219 V--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IAAVCLAVLQALSVLHA---QGVIH 270
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APELI       E D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-XLVGTPYWMAPELISRLPYGPEVD 329
Query: 256 IYSFGVIMLELISGKEP-INENP 277
           I+S G++++E++ G+ P  NE P
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPP 352

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 118/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     +          + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 10/207 (4%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLR--PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            IG  +YG   K   +  G + + + L    +     +     + LL  ++HPN+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKW--SIIYRISIGIAGGLDYLHT--- 187
                    L IV  + + G+LA  I  G+ E        + R+   +   L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
           G H  ++H +LK  N+ LD      + DFGL  +LN        E   +  Y +PE +  
Sbjct: 133 GGH-TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK-EFVGTPYYMSPEQMNR 190
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
              +E++DI+S G ++ EL +   P  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVGYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 14/167 (8%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----EKLIVHPFYKRGNLAQCIRGGS 162
           T   + + +L+ LL C+ H N++ LL  +   +     + + +       NL Q I    
Sbjct: 65  THAKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMEL 123
Query: 163 GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL 222
                  ++Y++  GI     +LH+     IIH +LK  NI++  +    + DFGL    
Sbjct: 124 DHERMSYLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL--AR 174
Query: 223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG 269
                  M     ++ Y+APE+I     +   DI+S G IM EL+ G
Sbjct: 175 TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 16/210 (7%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLR--PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            IG  +YG   K   +  G + + + L    +     +     + LL  ++HPN+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKW--SIIYRISIGIAGGLDYLHT--- 187
                    L IV  + + G+LA  I  G+ E        + R+   +   L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
           G H  ++H +LK  N+ LD      + DFGL  +LN     +   A A  G   Y +PE 
Sbjct: 133 GGH-TVLHRDLKPANVFLDGKQNVKLGDFGLARILN----HDTSFAKAFVGTPYYMSPEQ 187
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPIN 274
           +     +E++DI+S G ++ EL +   P  
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
           V+GK ++G +     + +G    ++ +  R V    DKE     ++LL  + HPN+  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            F+   +G   +V   Y  G L   I  R    E     II ++  GI     Y H    
Sbjct: 93  EFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGIT----YXHKN-- 145
Query: 191 RPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I+H +LK +N+LL+   ++    + DFGL       A ++  +   +  Y APE++  
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKXKDKIGTAYYIAPEVLHG 202
Query: 248 KDASEETDIYSFGVIMLELISGKEPIN 274
               E+ D++S GVI+  L+SG  P N
Sbjct: 203 T-YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ YLH      +IH +LK  N+ L+ +    + DFGL   +    G+       +  Y 
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKTLCGTPNYI 209
Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE++  K  S E DI+S G I+  L+ GK P   +   +      T++R    ++ +  
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE------TYIRIKKNEYSV-- 261
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                        H NPV+   I +            P+LRP++ ++L
Sbjct: 262 -----------PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 10/131 (7%)
Query: 160 GGSGEAHKWSIIYRISIGIAGGLDYLH---TGF----HRPIIHGNLKSKNILLDRNYQPY 212
            G G  HK+ +  R  I ++   + LH    G      +  +H +L ++N+LL   +   
Sbjct: 91  AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 150
Query: 213 VSDFGLHLLLNPTAGQEMLEASASQGYK--APELIKMKDASEETDIYSFGVIMLELIS-G 269
           +SDFGL   L          ++     K  APE I  +  S  +D++S+GV M E +S G
Sbjct: 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 270 KEPINENPTPD 280
           ++P  +   P+
Sbjct: 211 QKPYKKMKGPE 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 77  IGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           +G+  +G ++ A     L ++   +  ++ L+    +  ++F    ELL  ++H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWS-------------IIYRISIGI 178
            G     R   L+V  + + G+L + +R    +A   +              +  ++  +
Sbjct: 109 FGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEA 233
           A G+ YL  G H   +H +L ++N L+ +     + DFG+   +  T      G+ ML  
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                +  PE I  +  + E+D++SFGV++ E+ + GK+P
Sbjct: 225 R----WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           G+ YLH      +IH +LK  N+ L+ +    + DFGL   +    G+       +  Y 
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKXLCGTPNYI 209
Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           APE++  K  S E DI+S G I+  L+ GK P   +   +      T++R    ++ +  
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE------TYIRIKKNEYSV-- 261
Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                        H NPV+   I +            P+LRP++ ++L
Sbjct: 262 -----------PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRD----KEFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F+  R + ++R     +E    + +L  IRHPN
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPN 90
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   +   + + +++      G L   +     E+       +    I  G+ YLH+
Sbjct: 91  IITLHDIFEN-KTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 188 GFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPE 243
              + I H +LK +NI LLD+N   P +   DFG+   +   AG E      +  + APE
Sbjct: 148 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPE 202
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++  +    E D++S GVI   L+SG  P
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--MLEASA 235
           I  GL Y+H+     ++H +LK  N+L++      + DFGL  + +P       + E  A
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 236 SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
           ++ Y+APE ++  K  ++  DI+S G I+ E++S +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IEL 119
           DL   D  +  GE +G   +G +YKA   ++    +L   + + T  ++E  D    I++
Sbjct: 32  DLNPEDFWEIIGE-LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII-------- 171
           L    HPN+V LL               FY   NL   I   +G A    ++        
Sbjct: 88  LASCDHPNIVKLLD-------------AFYYENNLWILIEFCAGGAVDAVMLELERPLTE 134
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
            +I +     LD L+      IIH +LK+ NIL   +    ++DFG+    N    Q   
Sbjct: 135 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRTIQRRD 193
Query: 232 EASASQGYKAPELIKMKDASE-----ETDIYSFGVIMLELISGKEPINE-NP 277
               +  + APE++  + + +     + D++S G+ ++E+   + P +E NP
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 27/279 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      ++    +    IE+   + HPN++ 
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILR 87
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L  ++   R   LI+  +  RG L + ++       + +    I   +A  L Y H    
Sbjct: 88  LYNYFYDRRRIYLILE-YAPRGELYKELQKSCTFDEQRTAT--IMEELADALMYCHG--- 141
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +       + M     +  Y  PE+I+ +  
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTM---CGTLDYLPPEMIEGRMH 198
Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI-TDLYHPDMLLC 309
           +E+ D++  GV+  EL+ G      NP  +   H  T+ R   +D +    +      L 
Sbjct: 199 NEKVDLWCIGVLCYELLVG------NPPFESASHNETYRRIVKVDLKFPASVPTGAQDLI 252
Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           S     NP          +L +A  S  P +R N ++VL
Sbjct: 253 SKLLRHNPSE--------RLPLAQVSAHPWVRANSRRVL 283

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLR----PVCTTRD-KEFGDLIELLGCIRHP 126
           EVIGK  +  + + + + +G   +V+++   +    P  +T D K    +  +L   +HP
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML---KHP 86
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDY 184
           ++V LL  Y+   G   +V  F    +L   I  R  +G  +  ++       I   L Y
Sbjct: 87  HIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 185 LHTGFHRPIIHGNLKSKNILL--DRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQG--- 238
            H      IIH ++K +N+LL    N  P  + DFG+ + L    G+  L A    G   
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL----GESGLVAGGRVGTPH 198
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           + APE++K +   +  D++  GVI+  L+SG  P 
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IEL 119
           DL   D  +  GE +G   +G +YKA   ++    +L   + + T  ++E  D    I++
Sbjct: 32  DLNPEDFWEIIGE-LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII-------- 171
           L    HPN+V LL               FY   NL   I   +G A    ++        
Sbjct: 88  LASCDHPNIVKLLD-------------AFYYENNLWILIEFCAGGAVDAVMLELERPLTE 134
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
            +I +     LD L+      IIH +LK+ NIL   +    ++DFG+    N    Q   
Sbjct: 135 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRD 193
Query: 232 EASASQGYKAPELIKMKDASE-----ETDIYSFGVIMLELISGKEPINE-NP 277
               +  + APE++  + + +     + D++S G+ ++E+   + P +E NP
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPN 127
           E +G  ++G +    + A   ++ SV + + L+P   ++ +   D I  +  +    H N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAV-KCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           L+ L G    P  +  +V      G+L   +R   G       + R ++ +A G+ YL +
Sbjct: 73  LIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA--SASQGYKAPELI 245
              +  IH +L ++N+LL       + DFGL   L       +++        + APE +
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEP 272
           K +  S  +D + FGV + E+ + G+EP
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRL--LRFL-RPVCTTRD--KEFGDLIELLGCIRHPNLVP 130
            IGK ++G +   ++Q++ + ++  ++++ +  C  R+  +     ++++  + HP LV 
Sbjct: 22  AIGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-------KWSIIYRISIGIAGGLD 183
           L  +Y+    E + +        +   + GG    H       K   +      +   LD
Sbjct: 80  L--WYSFQDEEDMFM--------VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           YL    ++ IIH ++K  NILLD +   +++DF +  +L P   Q +   + ++ Y APE
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQ-ITTMAGTKPYMAPE 184
Query: 244 LIKMKDA---SEETDIYSFGVIMLELISGKEP 272
           +   +     S   D +S GV   EL+ G+ P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 106/229 (46%), Gaps = 18/229 (7%)
Query: 76  VIGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTTRDKEFGDL----IELLGCIRHPNLVP 130
           ++G+ +YG + K   + +G  V + +FL    +  DK    +    I+LL  +RH NLV 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           LL      +    +V  F     L       +G    + ++ +    I  G+ + H+   
Sbjct: 89  LLEV-CKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHS--- 142
Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
             IIH ++K +NIL+ ++    + DFG    L    G+   +  A++ Y+APEL+ + D 
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELL-VGDV 200
Query: 251 S--EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR 297
              +  D+++ G ++ E+  G+     +   D+ +H+   + N +  H+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPAF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 15/215 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           E +G   +G + + + Q +G    ++  R   + +++E   L I+++  + HPN+V    
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 134 FYAG-----PRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIGIAGGLDYLHT 187
              G     P    L+   + + G+L + +         K   I  +   I+  L YLH 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVS---DFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
                IIH +LK +NI+L    Q  +    D G    L+   G+   E   +  Y APEL
Sbjct: 141 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPEL 195
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTP 279
           ++ K  +   D +SFG +  E I+G  P   N  P
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 230

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 63  DLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IEL 119
           DL   D  +  GE +G   +G +YKA   ++    +L   + + T  ++E  D    I++
Sbjct: 32  DLNPEDFWEIIGE-LGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 120 LGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII-------- 171
           L    HPN+V LL               FY   NL   I   +G A    ++        
Sbjct: 88  LASCDHPNIVKLLD-------------AFYYENNLWILIEFCAGGAVDAVMLELERPLTE 134
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
            +I +     LD L+      IIH +LK+ NIL   +    ++DFG+    N    Q   
Sbjct: 135 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRD 193
Query: 232 EASASQGYKAPELIKMKDASE-----ETDIYSFGVIMLELISGKEPINE-NP 277
               +  + APE++  + + +     + D++S G+ ++E+   + P +E NP
Sbjct: 194 XFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 15/215 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           E +G   +G + + + Q +G    ++  R   + +++E   L I+++  + HPN+V    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 134 FYAG-----PRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIGIAGGLDYLHT 187
              G     P    L+   + + G+L + +         K   I  +   I+  L YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVS---DFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
                IIH +LK +NI+L    Q  +    D G    L+   G+   E   +  Y APEL
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAPEL 194
Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTP 279
           ++ K  +   D +SFG +  E I+G  P   N  P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 125 HPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           H N+V +   Y    G++L +V  F + G L   +        +   I  + + +   L 
Sbjct: 101 HDNVVDMYSSYLV--GDELWVVMEFLEGGALTDIVTHTRMNEEQ---IATVCLSVLRALS 155
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           YLH   ++ +IH ++KS +ILL  + +  +SDFG    ++    +       +  + APE
Sbjct: 156 YLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-XLVGTPYWMAPE 211
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           +I       E DI+S G++++E+I G+ P  NE P
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 246

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL------LGCIRHPNL 128
           E +GK  +  + + + + +G    L F   +  T+     D  +L         ++HPN+
Sbjct: 12  EELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 129 VPL-----------LGF---YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           V L           L F     G   E ++   FY   + + CI+               
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------------- 113
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEML 231
              I   + Y H+     I+H NLK +N+LL    +     ++DFGL + +N +      
Sbjct: 114 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
             + + GY +PE++K    S+  DI++ GVI+  L+ G  P       DED H
Sbjct: 168 --AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW-----DEDQH 213

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL------LGCIRHPNL 128
           E +GK  +  + + + + +G    L F   +  T+     D  +L         ++HPN+
Sbjct: 11  EELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 129 VPL-----------LGF---YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           V L           L F     G   E ++   FY   + + CI+               
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------------- 112
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEML 231
              I   + Y H+     I+H NLK +N+LL    +     ++DFGL + +N +      
Sbjct: 113 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
             + + GY +PE++K    S+  DI++ GVI+  L+ G  P       DED H
Sbjct: 167 --AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW-----DEDQH 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 12/208 (5%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLR--PVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            IG  +YG   K   +  G + + + L    +     +     + LL  ++HPN+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 134 FYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKW--SIIYRISIGIAGGLDYLHT--- 187
                    L IV  + + G+LA  I  G+ E        + R+   +   L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN-PTAGQEMLEASASQGYKAPELIK 246
           G H  ++H +LK  N+ LD      + DFGL  +LN  T+  +    +    Y +PE + 
Sbjct: 133 GGH-TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY--YMSPEQMN 189
Query: 247 MKDASEETDIYSFGVIMLELISGKEPIN 274
               +E++DI+S G ++ EL +   P  
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL------LGCIRHPNL 128
           E +GK  +  + + + + +G    L F   +  T+     D  +L         ++HPN+
Sbjct: 12  EELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 129 VPL-----------LGF---YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           V L           L F     G   E ++   FY   + + CI+               
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------------- 113
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEML 231
              I   + Y H+     I+H NLK +N+LL    +     ++DFGL + +N +      
Sbjct: 114 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
             + + GY +PE++K    S+  DI++ GVI+  L+ G  P       DED H
Sbjct: 168 --AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW-----DEDQH 213

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 119/267 (44%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +++  DL+   E++  I +H N++ LLG      G   ++  +  +GNL + +R      
Sbjct: 81  EEDLSDLVSEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 166 HKWSI-IYRI-------------SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S  I R+             +  +A G++YL +   +  IH +L ++N+L+  N   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   +N     ++         + APE +  +  + ++D++SFGV+M E+ + G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 257 GSPYPGIPV-EELFKL---LKEG---HRMDKPAN-----CTN-------------ELYMM 291
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 292 MRDCWHAVPSQRPTFKQL---VEDLDR 315

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILIGELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPN 127
           E +G  ++G +    + A   ++ SV  ++ L+P   ++ +   D I  +  +    H N
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           L+ L G    P  +  +V      G+L   +R   G       + R ++ +A G+ YL +
Sbjct: 77  LIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 133
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA--SASQGYKAPELI 245
              +  IH +L ++N+LL       + DFGL   L       +++        + APE +
Sbjct: 134 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEP 272
           K +  S  +D + FGV + E+ + G+EP
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPN 127
           E +G  ++G +    + A   ++ SV  ++ L+P   ++ +   D I  +  +    H N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           L+ L G    P  +  +V      G+L   +R   G       + R ++ +A G+ YL +
Sbjct: 73  LIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA--SASQGYKAPELI 245
              +  IH +L ++N+LL       + DFGL   L       +++        + APE +
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEP 272
           K +  S  +D + FGV + E+ + G+EP
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 54/233 (23%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL------LGCIRHPNL 128
           E +GK  +  + + + + +G    L F   +  T+     D  +L         ++HPN+
Sbjct: 35  EELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 129 VPL-----------LGF---YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRI 174
           V L           L F     G   E ++   FY   + + CI+               
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------------- 136
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQEML 231
              I   + Y H+     I+H NLK +N+LL    +     ++DFGL + +N +      
Sbjct: 137 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
             + + GY +PE++K    S+  DI++ GVI+  L+ G  P       DED H
Sbjct: 191 --AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF-----WDEDQH 236

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 75  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 127
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 182
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 134 FYAGPRGEKLIVHPF----YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+     +K +V+      Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 195
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 75  EVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPN 127
           E +G  ++G +    + A   ++ SV  ++ L+P   ++ +   D I  +  +    H N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           L+ L G    P  +  +V      G+L   +R   G       + R ++ +A G+ YL +
Sbjct: 73  LIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA--SASQGYKAPELI 245
              +  IH +L ++N+LL       + DFGL   L       +++        + APE +
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEP 272
           K +  S  +D + FGV + E+ + G+EP
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 21/221 (9%)
Query: 68  DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDLIELLGCIRHP 126
           D+     E++G+  Y  +  A+  ++G    ++ + +    +R + F ++  L  C  + 
Sbjct: 12  DMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNK 71
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N++ L+ F+       L+         LA   +       + S + R    +A  LD+LH
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR---DVAAALDFLH 128
Query: 187 TGFHRPIIHGNLKSKNILLD--RNYQPY-VSDF--GLHLLLN----PTAGQEMLEASASQ 237
           T   + I H +LK +NIL +      P  + DF  G  + LN    P    E+     S 
Sbjct: 129 T---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 238 GYKAPELIKM-KDAS----EETDIYSFGVIMLELISGKEPI 273
            Y APE++++  D +    +  D++S GV++  ++SG  P 
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 75  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 127
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 182
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 9/125 (7%)
Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
           ++ Y   I I  GL +L +   + II+ +LK  N++LD      ++DFG+    N   G 
Sbjct: 444 AVFYAAEIAI--GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGV 497
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
                  +  Y APE+I  +   +  D ++FGV++ E+++G+ P       DED    + 
Sbjct: 498 TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSI 554
Query: 289 MRNAV 293
           M + V
Sbjct: 555 MEHNV 559

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 52  TEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTL----YKALLQRSGSVRLLRFLRPVCT 107
           ++ L    G +DL +        E +G  ++G +    + A   ++ SV  ++ L+P   
Sbjct: 2   SQSLTCLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVL 53
Query: 108 TRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE 164
           ++ +   D I  +  +    H NL+ L G    P  +  +V      G+L   +R   G 
Sbjct: 54  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQGH 111
Query: 165 AHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP 224
                 + R ++ +A G+ YL +   +  IH +L ++N+LL       + DFGL   L  
Sbjct: 112 -FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 167
Query: 225 TAGQEMLEA--SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
                +++        + APE +K +  S  +D + FGV + E+ + G+EP
Sbjct: 168 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   Y   + + +++      G L   +     E+            I  G+ YLH+
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 188 GFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPE 243
                I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  + APE
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPE 187
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++  +    E D++S GVI   L+SG  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   Y   + + +++      G L   +        + +  +   I    G+ YLH+
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLHS 132
Query: 188 GFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGYKAPE 243
                I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  + APE
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPE 187
Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++  +    E D++S GVI   L+SG  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           +HPN++ L   Y   +   L+         L + +R       + S +      I   ++
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT---IGKTVE 135
Query: 184 YLHTGFHRPIIHGNLKSKNIL-LDRNYQP---YVSDFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+   + ++H +LK  NIL +D +  P    + DFG    L    G  ++    +  +
Sbjct: 136 YLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL-LMTPCYTANF 191
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP--TPDE 281
            APE++K +   E  DI+S G+++  +++G  P    P  TP+E
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 16/161 (9%)
Query: 117 IELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKWSI 170
           I LL    HPN++ L   +     P   KL +     R +LAQ I   R      H    
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +Y I +G       LH      ++H +L   NILL  N    + DF   L    TA    
Sbjct: 140 MYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFN--LAREDTADANK 190
Query: 231 LEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
                 + Y+APEL+ + K  ++  D++S G +M E+ + K
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+++H  F   +++ +LK  NILLD +    +SD GL    +         +  + 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 238 GYKAPELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
           GY APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+++H  F   +++ +LK  NILLD +    +SD GL    +         +  + 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 238 GYKAPELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
           GY APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 16/161 (9%)
Query: 117 IELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKWSI 170
           I LL    HPN++ L   +     P   KL +     R +LAQ I   R      H    
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +Y I +G       LH      ++H +L   NILL  N    + DF   L    TA    
Sbjct: 140 MYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFN--LAREDTADANK 190
Query: 231 LEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
                 + Y+APEL+ + K  ++  D++S G +M E+ + K
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YGT++KA  + +  +  L+ +R        P    R+      I LL  ++H 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE------ICLLKELKHK 61
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N+V L       +   L+    +   +L +     +G+     I+      +  GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFE--FCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCH 118
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LI 245
           +   R ++H +LK +N+L++RN +  ++DFGL             E   +  Y+ P+ L 
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV-VTLWYRPPDVLF 174
Query: 246 KMKDASEETDIYSFGVIMLELISGKEPI 273
             K  S   D++S G I  EL +   P+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+++H  F   +++ +LK  NILLD +    +SD GL    +         +  + 
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 353
Query: 238 GYKAPELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
           GY APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
           ++ Y   I I  GL +L +   + II+ +LK  N++LD      ++DFG+    N   G 
Sbjct: 123 AVFYAAEIAI--GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGV 176
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
                  +  Y APE+I  +   +  D ++FGV++ E+++G+ P  E    DE F     
Sbjct: 177 TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQ---- 231
Query: 289 MRNAVLDHRIT 299
              ++++H + 
Sbjct: 232 ---SIMEHNVA 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+++H  F   +++ +LK  NILLD +    +SD GL    +         +  + 
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 238 GYKAPELIKMKDASEET-DIYSFGVIMLELISGKEPINENPTPDE 281
           GY APE+++   A + + D +S G ++ +L+ G  P  ++ T D+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 112 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 195
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           +HPN++ L   Y   +   L+         L + +R       + S +      I   ++
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT---IGKTVE 135
Query: 184 YLHTGFHRPIIHGNLKSKNIL-LDRNYQP---YVSDFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+   + ++H +LK  NIL +D +  P    + DFG    L    G  ++    +  +
Sbjct: 136 YLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL-LMTPCYTANF 191
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP--TPDE 281
            APE++K +   E  DI+S G+++  +++G  P    P  TP+E
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 99
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 160 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 214
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 142 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 196
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 195
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 84
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 145 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 199
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 88
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 149 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 203
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 113 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 173 RISIG-IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
           +I +G I   L++LH      II+ ++K +NILLD N    ++DFGL         +   
Sbjct: 162 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 232 EASASQGYKAPELIKMKDASEE--TDIYSFGVIMLELISGKEPIN 274
           +   +  Y AP++++  D+  +   D +S GV+M EL++G  P  
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 153 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 207
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLRPVCTTRDKEFG-DLIELLGCIRHPNLVPLLGF 134
           IG+ +YG ++K   + +G  V + +FL        K+     I +L  ++HPNLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           +   R   L+   +     L +  R   G      ++  I+      +++ H       I
Sbjct: 71  FRRKRRLHLVFE-YCDHTVLHELDRYQRGVPE--HLVKSITWQTLQAVNFCHK---HNCI 124
Query: 195 HGNLKSKNILLDRNYQPYVSDFGL-HLLLNPTAGQEMLEASASQGYKAPE-LIKMKDASE 252
           H ++K +NIL+ ++    + DFG   LL  P+   +  +  A++ Y++PE L+       
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD--DEVATRWYRSPELLVGDTQYGP 182
Query: 253 ETDIYSFGVIMLELISG 269
             D+++ G +  EL+SG
Sbjct: 183 PVDVWAIGCVFAELLSG 199

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 153 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 207
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 57/100 (57%), Gaps = 5/100 (5%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML-EASAS 236
           +  G+ YLH G    I H ++K +N+LLD      +SDFGL  +      + +L +   +
Sbjct: 114 LMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE 275
             Y APEL+K ++  +E  D++S G+++  +++G+ P ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIF 229
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 93
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 154 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 208
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 74  GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPN 127
           GE +G   +  + K   + +G   + + ++  R   + R     D+   + +L  I+HPN
Sbjct: 16  GEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI----GIAGGLD 183
           ++ L   Y   + + +++      G L   +      A K S+    +      I  G+ 
Sbjct: 76  VITLHEVYEN-KTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGVY 128
Query: 184 YLHTGFHRPIIHGNLKSKNI-LLDRNY-QPYVS--DFGLHLLLNPTAGQEMLEASASQGY 239
           YLH+     I H +LK +NI LLDRN  +P +   DFGL   ++   G E      +  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEF 183
Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++  +    E D++S GVI   L+SG  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 195
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 59/123 (47%), Gaps = 12/123 (9%)
Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           I+ ++++ I   L YL       +IH ++K  NILLD   Q  + DFG+   L     ++
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182
Query: 230 MLEASASQGYKAPELIKMKDASE-----ETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
              ++    Y APE I   D ++       D++S G+ ++EL +G+ P     T   DF 
Sbjct: 183 --RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFE 237
Query: 285 LPT 287
           + T
Sbjct: 238 VLT 240

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  G+ YLH+     I+H +L   N+LL RN    ++DFGL   L     ++      + 
Sbjct: 121 IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYTLCGTP 176
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHLPTFM 289
            Y +PE+        E+D++S G +   L+ G+ P + +   +        D+ +P+F+
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 108
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 169 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 223
Query: 246 KMKDASEETDIYSFGVIMLELISGKEPI 273
              D +   D++S G ++ EL+ G +PI
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLG-QPI 250

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E++G   +G ++K     +G     + ++       +E  + I ++  + H NL+ L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           +   + + ++V  +   G L   I   S    +   I  +   I  G+ ++H  +   I+
Sbjct: 155 FES-KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQMY---IL 209
Query: 195 HGNLKSKNIL-LDRNY-QPYVSDFGLHLLLNPTAGQEMLEAS-ASQGYKAPELIKMKDAS 251
           H +LK +NIL ++R+  Q  + DFGL     P   +E L+ +  +  + APE++     S
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 252 EETDIYSFGVIMLELISGKEP 272
             TD++S GVI   L+SG  P
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP 287

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK------EFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +      E    + +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           ++ L   Y   R + +++      G L   +  +    E    S I +I      G++YL
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYL 131
Query: 186 HTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQGYKA 241
           HT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  + A
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVA 186
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +    E D++S GVI   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 229
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           E +G   Y T+YK L + +G    L+ ++       P    R+      I L+  ++H N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE------ISLMKELKHEN 64
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR----GGSGEAHKWSIIYRISIGIAGGLD 183
           +V L           L+    +   +L + +     G +    + +++      +  GL 
Sbjct: 65  IVRLYDVIHTENKLTLVFE--FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           + H      I+H +LK +N+L+++  Q  + DFGL             E   +  Y+AP+
Sbjct: 123 FCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-VTLWYRAPD 178
Query: 244 -LIKMKDASEETDIYSFGVIMLELISGK 270
            L+  +  S   DI+S G I+ E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK------EFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +      E    + +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           ++ L   Y   R + +++      G L   +  +    E    S I +I      G++YL
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYL 131
Query: 186 HTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQGYKA 241
           HT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  + A
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVA 186
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +    E D++S GVI   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK------EFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +      E    + +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           ++ L   Y   R + +++      G L   +  +    E    S I +I      G++YL
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYL 131
Query: 186 HTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQGYKA 241
           HT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  + A
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVA 186
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +    E D++S GVI   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 116
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 177 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 231
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK------EFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +      E    + +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           ++ L   Y   R + +++      G L   +  +    E    S I +I      G++YL
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYL 131
Query: 186 HTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQGYKA 241
           HT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  + A
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVA 186
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +    E D++S GVI   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 85
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 146 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 200
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK------EFGDLIELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +      E    + +L  + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           ++ L   Y   R + +++      G L   +  +    E    S I +I      G++YL
Sbjct: 77  VITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI----LDGVNYL 131
Query: 186 HTGFHRPIIHGNLKSKNI-LLDRNYQ-PYVS--DFGLHLLLNPTAGQEMLEASASQGYKA 241
           HT   + I H +LK +NI LLD+N   P++   DFGL   +    G E      +  + A
Sbjct: 132 HT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVA 186
Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +    E D++S GVI   L+SG  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML----EA 233
           I  G+ YLH+  +   IH NL ++N+LLD +    + DFGL   +    G E      + 
Sbjct: 126 ICEGMAYLHSQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDG 180
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPT 278
            +   + APE +K       +D++SFGV + EL++  +     PT
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 118
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 179 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 233
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +VIG  ++G +Y+A L  SG +  ++ +      +++E    ++++  + H N+V L  F
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYF 81
Query: 135 Y--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHTG 188
           +  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+ 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 189 FHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
               I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI  
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRYYRAPELIFG 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
             D +   D++S G ++ EL+ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 17/109 (15%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY---VSDFGLH--LLLN----PTAGQ 228
           +A  LD+LH   ++ I H +LK +NIL +   Q     + DFGL   + LN    P +  
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 229 EMLEASASQGYKAPELIKM--KDAS---EETDIYSFGVIMLELISGKEP 272
           E+L    S  Y APE+++   ++AS   +  D++S GVI+  L+SG  P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLLG 133
           +VIG  ++G +Y+A L  SG +  ++ +      +DK F +  ++++  + H N+V L  
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRY 159
Query: 134 FY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHT 187
           F+  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI- 245
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 220 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIF 274
Query: 246 KMKDASEETDIYSFGVIMLELISGK 270
              D +   D++S G ++ EL+ G+
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYA 136
           IG+ + G +  A  + SG    ++ +      R +   + + ++   +H N+V +   Y 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 137 GPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
              GE+L ++  F + G L   +        +   I  +   +   L YLH    + +IH
Sbjct: 113 V--GEELWVLMEFLQGGALTDIVSQVRLNEEQ---IATVCEAVLQALAYLHA---QGVIH 164
Query: 196 GNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETD 255
            ++KS +ILL  + +  +SDFG    ++    +       +  + APE+I     + E D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-XLVGTPYWMAPEVISRSLYATEVD 223
Query: 256 IYSFGVIMLELISGKEP 272
           I+S G++++E++ G+ P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML----EA 233
           I  G+ YLH   +   IH NL ++N+LLD +    + DFGL   +    G E      + 
Sbjct: 126 ICEGMAYLHAQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDG 180
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPT 278
            +   + APE +K       +D++SFGV + EL++  +     PT
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 225

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-----IELLGCIRHPNLV 129
           + +G+  + T+YKA  + +  +  ++ ++    +  K+  +      I+LL  + HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LL  +       L+    +   +L   I+  S      S I    +    GL+YLH  +
Sbjct: 76  GLLDAFGHKSNISLVFD--FMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQHW 132
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KMK 248
              I+H +LK  N+LLD N    ++DFGL      +  +       ++ Y+APEL+   +
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRWYRAPELLFGAR 188
Query: 249 DASEETDIYSFGVIMLELI 267
                 D+++ G I+ EL+
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 76  VIGKSNYGTLY---KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNL 128
           V+GK  YG ++   K     +G +  ++ L+     R+ +     +    +L  ++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           V L+  YA   G KL ++  +   G L   +          +  Y   I +A  L +LH 
Sbjct: 84  VDLI--YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA--LGHLH- 138
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
              + II+ +LK +NI+L+      ++DFGL    +   G        +  Y APE++  
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHXFCGTIEYMAPEILMR 195
Query: 248 KDASEETDIYSFGVIMLELISGKEPI---NENPTPDE----DFHLPTFMRNAVLD 295
              +   D +S G +M ++++G  P    N   T D+      +LP ++     D
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 76  VIGKSNYGTLY---KALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNL 128
           V+GK  YG ++   K     +G +  ++ L+     R+ +     +    +L  ++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           V L+  YA   G KL ++  +   G L   +          +  Y   I +A  L +LH 
Sbjct: 84  VDLI--YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA--LGHLH- 138
Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
              + II+ +LK +NI+L+      ++DFGL    +   G        +  Y APE++  
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHTFCGTIEYMAPEILMR 195
Query: 248 KDASEETDIYSFGVIMLELISGKEPI---NENPTPDE----DFHLPTFMRNAVLD 295
              +   D +S G +M ++++G  P    N   T D+      +LP ++     D
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGF 134
           V+GK  YG +Y A    S  VR+     P   +R  +   + I L   ++H N+V  LG 
Sbjct: 29  VLGKGTYGIVY-AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 135 YAGPRGEKLIVHPFYKR---GNLAQCIRGGSGE-AHKWSIIYRISIGIAGGLDYLHTGFH 190
           ++    E   +  F ++   G+L+  +R   G        I   +  I  GL YLH    
Sbjct: 88  FS----ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---D 140
Query: 191 RPIIHGNLKSKNILLDRNYQPY--VSDFGLHLLL---NPTAGQEMLEASASQGYKAPELI 245
             I+H ++K  N+L++  Y     +SDFG    L   NP         + +  Y APE+I
Sbjct: 141 NQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET----FTGTLQYMAPEII 195
Query: 246 KM--KDASEETDIYSFGVIMLELISGKEPINENPTP 279
               +   +  DI+S G  ++E+ +GK P  E   P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 70  LDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
           LD   + +G+ ++    K + ++S     ++ +        ++  ++  L  C  HPN+V
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK--EITALKLCEGHPNIV 69
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIGIAGGLDYLHTG 188
            L   +   +    +V      G L + I+     +  + S I R    +   + ++H  
Sbjct: 70  KLHEVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR---KLVSAVSHMHD- 124
Query: 189 FHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
               ++H +LK +N+L    + N +  + DFG    L P   Q +     +  Y APEL+
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGF-ARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 246 KMKDASEETDIYSFGVIMLELISGKEPI 273
                 E  D++S GVI+  ++SG+ P 
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI---ELLGCIR-HPNLVPL 131
           V+GK ++G +  A ++ +G +  ++ L+     +D +    +    +L   R HP L  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
              +  P      V  F   G+L   I+         +  Y  +  I   L +LH    +
Sbjct: 90  FCCFQTP-DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEIISALMFLHD---K 143
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            II+ +LK  N+LLD      ++DFG+        G        +  Y APE+++     
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGM-CKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 252 EETDIYSFGVIMLELISGKEPI 273
              D ++ GV++ E++ G  P 
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPF 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 10/84 (11%)
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-------GQE--MLEASASQGYKAPE 243
           +IH +LK  N+L++ N    V DFGL  +++ +A       GQ+  M+E  A++ Y+APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 244 -LIKMKDASEETDIYSFGVIMLEL 266
            ++     S   D++S G I+ EL
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 17/143 (11%)
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +
Sbjct: 199 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-D 254
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK 310
Query: 287 TFMRNAVLDHRITDLYHPDMLLC 309
              R    D+   ++Y   ML C
Sbjct: 311 EGTRMRAPDYTTPEMYQ-TMLDC 332

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 120 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 17/143 (11%)
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +
Sbjct: 197 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-D 252
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 253 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK 308
Query: 287 TFMRNAVLDHRITDLYHPDMLLC 309
              R    D+   ++Y   ML C
Sbjct: 309 EGTRMRAPDYTTPEMYQT-MLDC 330

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 163 GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL 222
           G+     I+ +I++ I   L++LH+     +IH ++K  N+L++   Q    DFG+   L
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL 187
Query: 223 NPTAGQEMLEASASQGYKAPELI----KMKDASEETDIYSFGVIMLELISGKEPINENPT 278
                +++   +  + Y APE I      K  S ++DI+S G+  +EL   + P +   T
Sbjct: 188 VDDVAKDI--DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGT 245
Query: 279 P 279
           P
Sbjct: 246 P 246

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 17/143 (11%)
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +
Sbjct: 204 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-D 259
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 260 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK 315
Query: 287 TFMRNAVLDHRITDLYHPDMLLC 309
              R    D+   ++Y   ML C
Sbjct: 316 EGTRMRAPDYTTPEMYQT-MLDC 337

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGF 134
           V+GK  YG +Y A    S  VR+     P   +R  +   + I L   ++H N+V  LG 
Sbjct: 15  VLGKGTYGIVY-AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 135 YAGPRGEKLIVHPFYKR---GNLAQCIRGGSGE-AHKWSIIYRISIGIAGGLDYLHTGFH 190
           ++    E   +  F ++   G+L+  +R   G        I   +  I  GL YLH    
Sbjct: 74  FS----ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--- 126
Query: 191 RPIIHGNLKSKNILLDRNYQPY--VSDFGLHLLL---NPTAGQEMLEASASQGYKAPELI 245
             I+H ++K  N+L++  Y     +SDFG    L   NP         + +  Y APE+I
Sbjct: 127 NQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET----FTGTLQYMAPEII 181
Query: 246 KM--KDASEETDIYSFGVIMLELISGKEPINENPTP 279
               +   +  DI+S G  ++E+ +GK P  E   P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 217

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 17/143 (11%)
Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLE 232
           S  +A G+++L +   R  IH +L ++NILL       + DFGL   +  +P   ++  +
Sbjct: 206 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-D 261
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP----DEDF--HLP 286
           A     + APE I  +  + ++D++SFGV++ E+ S    +  +P P    DE+F   L 
Sbjct: 262 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK 317
Query: 287 TFMRNAVLDHRITDLYHPDMLLC 309
              R    D+   ++Y   ML C
Sbjct: 318 EGTRMRAPDYTTPEMYQT-MLDC 339

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 22/208 (10%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YGT++KA  + +  +  L+ +R        P    R+      I LL  ++H 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE------ICLLKELKHK 61
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N+V L       +   L+    +   +L +     +G+     I+      +  GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFE--FCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCH 118
Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LI 245
           +   R ++H +LK +N+L++RN +  +++FGL             E   +  Y+ P+ L 
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV-VTLWYRPPDVLF 174
Query: 246 KMKDASEETDIYSFGVIMLELISGKEPI 273
             K  S   D++S G I  EL +   P+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 10/84 (11%)
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-------GQE--MLEASASQGYKAPE 243
           +IH +LK  N+L++ N    V DFGL  +++ +A       GQ+  M E  A++ Y+APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 244 -LIKMKDASEETDIYSFGVIMLEL 266
            ++     S   D++S G I+ EL
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 120 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 114 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 136 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 136 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 134 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 126 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 75  EVIGKSNYGTLYKALL------QRSGSVRLLRFLRPVCTTRDKEFGDLIE-------LLG 121
           E +G+  +G +YK  L      +++ +V        + T +DK  G L E       L  
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAV-------AIKTLKDKAEGPLREEFRHEAMLRA 84
Query: 122 CIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI----------- 170
            ++HPN+V LLG     +   +I   +   G+L + +   S  +   S            
Sbjct: 85  RLQHPNVVCLLGVVTKDQPLSMIF-SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 143
Query: 171 ---IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
                 +   IA G++YL +     ++H +L ++N+L+       +SD GL   +     
Sbjct: 144 PPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 228 QEMLEASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
            ++L  S     + APE I     S ++DI+S+GV++ E+ S G +P
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 478 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +VIG  ++G +Y+A L  SG +  ++ +      +++E    ++++  + H N+V L  F
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYF 81
Query: 135 Y--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHTG 188
           +  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+ 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 189 FHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
               I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI  
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFG 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
             D +   D++S G ++ EL+ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           ++ G+ YL        +H +L ++N+LL   +   +SDFGL   L         +     
Sbjct: 479 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 238 GYK--APELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
             K  APE I     S ++D++SFGV+M E  S G++P
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 10/84 (11%)
Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-------GQE--MLEASASQGYKAPE 243
           +IH +LK  N+L++ N    V DFGL  +++ +A       GQ+  M E  A++ Y+APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 244 -LIKMKDASEETDIYSFGVIMLEL 266
            ++     S   D++S G I+ EL
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           ++G+  +G +Y+ +       ++   ++  +  CT  +KE F     ++  + HP++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +G          I+   Y  G L   +          +++   S+ I   + YL +    
Sbjct: 75  IGIIE--EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLES---I 128
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYKAPELIKMK 248
             +H ++  +NIL+       + DFGL   +     ++  +AS ++    + +PE I  +
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFR 185
Query: 249 DASEETDIYSFGVIMLELIS-GKEP 272
             +  +D++ F V M E++S GK+P
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           +VIG  ++G +Y+A L  SG +  ++ +      +++E    ++++  + H N+V L  F
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRYF 81
Query: 135 Y--AGPRGEKLIVHPF--YKRGNLAQCIRGGSGEAHKWSIIYR--ISIGIAGGLDYLHTG 188
           +  +G + +++ ++    Y    + +  R  S       +IY       +   L Y+H+ 
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 189 FHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
               I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI  
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFG 196
Query: 247 MKDASEETDIYSFGVIMLELISGK 270
             D +   D++S G ++ EL+ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/185 (21%), Positives = 79/185 (42%), Gaps = 6/185 (3%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 40  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRHRFQ 98
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 99  TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
Query: 286 PTFMR 290
              +R
Sbjct: 215 AQGLR 219

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 75  EVIGKSNYGTLYKALLQRSG-SVRL---LRFLRPVCTTR-DKEFGDLIELLGCIRHPNLV 129
           +V+G   +GT+YK +    G +V++   ++ LR   + + +KE  D   ++  +  P + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG       +  +V      G L   +R   G      ++    + IA G+ YL    
Sbjct: 83  RLLGICLTSTVQ--LVTQLMPYGCLLDHVRENRGRLGSQDLL-NWCMQIAKGMSYLE--- 136
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE-ASASQGYKAPELIKMK 248
              ++H +L ++N+L+       ++DFGL  LL+    +   +       + A E I  +
Sbjct: 137 DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 249 DASEETDIYSFGVIMLELIS-GKEPINENPT 278
             + ++D++S+GV + EL++ G +P +  P 
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           ++G+  +G +Y+ +       ++   ++  +  CT  +KE F     ++  + HP++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +G          I+   Y  G L   +          +++   S+ I   + YL +    
Sbjct: 91  IGIIE--EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMAYLES---I 144
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYKAPELIKMK 248
             +H ++  +NIL+       + DFGL   +     ++  +AS ++    + +PE I  +
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFR 201
Query: 249 DASEETDIYSFGVIMLELIS-GKEP 272
             +  +D++ F V M E++S GK+P
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/205 (20%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 76  VIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPL 131
           ++G+  +G +Y+ +       ++   ++  +  CT  +KE F     ++  + HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +G          I+   Y  G L   +          +++   S+ I   + YL +    
Sbjct: 79  IGIIE--EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAMAYLES---I 132
Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ---GYKAPELIKMK 248
             +H ++  +NIL+       + DFGL   +     ++  +AS ++    + +PE I  +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFR 189
Query: 249 DASEETDIYSFGVIMLELIS-GKEP 272
             +  +D++ F V M E++S GK+P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 62
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 119
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGY 239
               T     I H +LKSKNIL+ +N    ++D GL   H     T          ++ Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 230

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE-------LLGCIRHPN 127
           E +G+  +G +YK  L         + +  + T +DK  G L E       L   ++HPN
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------IYR 173
           +V LLG     +   +I   +   G+L + +   S  +   S                  
Sbjct: 74  VVCLLGVVTKDQPLSMIF-SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
           +   IA G++YL +     ++H +L ++N+L+       +SD GL   +      ++L  
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 234 SA-SQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEP 272
           S     + APE I     S ++DI+S+GV++ E+ S G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 61
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 118
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGY 239
               T     I H +LKSKNIL+ +N    ++D GL   H     T          ++ Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 229

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/185 (21%), Positives = 79/185 (42%), Gaps = 6/185 (3%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 45  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 103
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 104 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 160 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219
Query: 286 PTFMR 290
              +R
Sbjct: 220 AQGLR 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/185 (21%), Positives = 79/185 (42%), Gaps = 6/185 (3%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 44  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 102
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 103 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 158
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 159 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 218
Query: 286 PTFMR 290
              +R
Sbjct: 219 AQGLR 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGG 181
           +HPN++ L   Y   +    +V    K G L   I  +    E    ++++ I+  +   
Sbjct: 74  QHPNIITLKDVYDDGK-YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV--- 129
Query: 182 LDYLHTGFHRPIIHGNLKSKNIL-LDRNYQP---YVSDFGLHLLLNPTAGQEMLEASASQ 237
            +YLH    + ++H +LK  NIL +D +  P    + DFG    L    G  ++    + 
Sbjct: 130 -EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPCYTA 184
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP--TPDE 281
            + APE+++ +      DI+S GV++  +++G  P    P  TP+E
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 31/249 (12%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 51  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 109
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 110 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 165
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 166 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 225
Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
              +R          LY P +            SE    K + +  +C       RP  K
Sbjct: 226 AQGLR----------LYRPHL-----------ASE----KVYTIMYSCWHEKADERPTFK 260
Query: 346 QVLWKLEDL 354
            +L  + D+
Sbjct: 261 ILLSNILDV 269

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 31/249 (12%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 119 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 175 ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
              +R          LY P +            SE    K + +  +C       RP  K
Sbjct: 235 AQGLR----------LYRPHL-----------ASE----KVYTIMYSCWHEKADERPTFK 269
Query: 346 QVLWKLEDL 354
            +L  + D+
Sbjct: 270 ILLSNILDV 278

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 67
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 124
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGY 239
               T     I H +LKSKNIL+ +N    ++D GL   H     T          ++ Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 235

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 64
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 121
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGY 239
               T     I H +LKSKNIL+ +N    ++D GL   H     T          ++ Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 232

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 249 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 301
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 85  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H NL ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 143 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 197
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 85  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-----GQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  TA     G+ +L     
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR-- 197
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 87
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 144
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
               T     I H +LKSKNIL+ +N    ++D GL +  +       +  +   G   Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 255

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 75  EVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           E IGK  +G +++   +    +V++          R+ E    + L    RH N+   LG
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENI---LG 100
Query: 134 FYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
           F A      G   +  +V  +++ G+L   +   +        + ++++  A GL +LH 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG---MIKLALSTASGLAHLHM 157
Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---HLLLNPTAGQEMLEASASQGY 239
               T     I H +LKSKNIL+ +N    ++D GL   H     T          ++ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 240 KAPEL----IKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF 288
            APE+    I MK  ++ +  DIY+ G++  E I+ +  I       ED+ LP +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG---GIHEDYQLPYY 268

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 86  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H NL ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 144 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 198
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 199 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 263 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 315
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 363

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLG-ACTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 133 LEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 189
Query: 212 YVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 190 KIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 250 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 284
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 285 MRDCWHAVPSQRPTFKQL---VEDLDR 308

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 31/249 (12%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 119 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
               + +     +  PE++     S ++DI++FGV+M E+ S GK P       +   H+
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
Query: 286 PTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
              +R          LY P +            SE    K + +  +C       RP  K
Sbjct: 235 AQGLR----------LYRPHL-----------ASE----KVYTIMYSCWHEKADERPTFK 269
Query: 346 QVLWKLEDL 354
            +L  + D+
Sbjct: 270 ILLSNILDV 278

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-----MK 248
           +H ++K  N+LLD N    ++DFG  L +N     +   A  +  Y +PE+++     M 
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
               E D +S GV M E++ G+ P 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           P + +G+  +G +++A  +       ++ +R P      ++    ++ L  + HP +V  
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 132 LGFY-----------AGPRGEKLIVHPFYKRGNLAQCIRGG-SGEAHKWSIIYRISIGIA 179
              +           + P+    I     ++ NL   + G  + E  + S+   I + IA
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL----------HLLLNPT-AGQ 228
             +++LH+   + ++H +LK  NI    +    V DFGL            +L P  A  
Sbjct: 129 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELI 267
                  ++ Y +PE I     S + DI+S G+I+ EL+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/255 (21%), Positives = 102/255 (40%), Gaps = 43/255 (16%)
Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH 166
           +  + EF +  +++  + H  LV L G     R    I+  +   G L   +R       
Sbjct: 45  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQ 103
Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
              ++  +   +   ++YL +   +  +H +L ++N L++      VSDFGL   +    
Sbjct: 104 TQQLL-EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD- 158
Query: 227 GQEMLEASASQG------YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTP 279
                E ++S+G      +  PE++     S ++DI++FGV+M E+ S GK P       
Sbjct: 159 -----EYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 213
Query: 280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPS 339
           +   H+   +R          LY P +            SE    K + +  +C      
Sbjct: 214 ETAEHIAQGLR----------LYRPHL-----------ASE----KVYTIMYSCWHEKAD 248
Query: 340 LRPNIKQVLWKLEDL 354
            RP  K +L  + D+
Sbjct: 249 ERPTFKILLSNILDV 263

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK-----MK 248
           +H ++K  N+LLD N    ++DFG  L +N     +   A  +  Y +PE+++     M 
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 249 DASEETDIYSFGVIMLELISGKEPI 273
               E D +S GV M E++ G+ P 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 17/109 (15%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY---VSDF--GLHLLLN----PTAGQ 228
           +A  LD+LH   ++ I H +LK +NIL +   Q     + DF  G  + LN    P +  
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 229 EMLEASASQGYKAPELIKM--KDAS---EETDIYSFGVIMLELISGKEP 272
           E+L    S  Y APE+++   ++AS   +  D++S GVI+  L+SG  P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 124 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 123 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 175
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 124 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 124 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML----EA 233
           I  G+ YLH   +   IH +L ++N+LLD +    + DFGL   +    G E      + 
Sbjct: 143 ICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEXYRVREDG 197
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPT 278
            +   + APE +K       +D++SFGV + EL++  +     PT
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           IE+L  + HP ++ +  F+     +  IV    + G L   + G          +Y   +
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP---YVSDFGLHLLLNPTAGQEMLEA 233
            +A  + YLH      IIH +LK +N+LL    +     ++DFG   +L  T+    L  
Sbjct: 130 LLA--VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 182
Query: 234 SASQGYKAPE-LIKMKDA--SEETDIYSFGVIMLELISGKEPINENPT 278
             +  Y APE L+ +  A  +   D +S GVI+   +SG  P +E+ T
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 230

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 82  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 194
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 195 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 85  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 197
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NIL+       V DFG+   +   +G  + + +A  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA-DSGNSVXQTAAVI 180
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y +PE  +       +D+YS G ++ E+++G+ P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 115/280 (41%), Gaps = 40/280 (14%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI---ELLGCIRHPNLVPLLG 133
           IG+  +  +Y+A     G    L+ ++       K   D I   +LL  + HPN++    
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI---K 96
Query: 134 FYAG--PRGEKLIVHPFYKRGNLAQCIRGGSGEAH--KWSIIYRISIGIAGGLDYLHTGF 189
           +YA      E  IV      G+L++ I+    +        +++  + +   L+++H+  
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-- 154
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP--TAGQEMLEASASQGYKAPELIKM 247
            R ++H ++K  N+ +       + D GL    +   TA   ++    +  Y +PE I  
Sbjct: 155 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 210
Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
              + ++DI+S G ++ E+ + + P   +            M    L  +I    +P + 
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKIEQCDYPPL- 258
Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
               S+H    SEE      QL   C +P P  RP++  V
Sbjct: 259 ---PSDH---YSEE----LRQLVNMCINPDPEKRPDVTYV 288

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 85  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 197
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 45/220 (20%)
Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
           +VIGK ++G +  A  +       ++ L+     + KE   ++     LL  ++HP LV 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 131 L-LGFYAGPR---------GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           L   F    +         G +L  H   +R  L    R  + E             IA 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------------IAS 150
Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
            L YLH+     I++ +LK +NILLD      ++DFGL         +E +E +++    
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL--------CKENIEHNSTTSTF 199
Query: 239 -----YKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
                Y APE++  +      D +  G ++ E++ G  P 
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQAREPPG 132
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 189
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 250 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 284
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 285 MRDCWHAVPSQRPTFKQL---VEDLDR 308

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NI++       V DFG+   +   +G  + + +A  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 180
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
           G   Y +PE  +       +D+YS G ++ E+++G+ P   + +PD
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPD 225

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 67  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 125
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 126 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 182
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 183 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 242
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 243 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 277
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 278 MRDCWHAVPSQRPTFKQL---VEDLDR 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 189
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 250 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 284
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 285 MRDCWHAVPSQRPTFKQL---VEDLDR 308

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 35/183 (19%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML----EA 233
           I  G+ YLH   +   IH  L ++N+LLD +    + DFGL   +    G E      + 
Sbjct: 120 ICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDG 174
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-----HLP-- 286
            +   + APE +K       +D++SFGV + EL++     + N +P   F     H    
Sbjct: 175 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTY---CDSNQSPHTKFTELIGHTQGQ 231
Query: 287 -TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
            T +R   L  R   L  PD   C               + + L   C     S RP  +
Sbjct: 232 MTVLRLTELLERGERLPRPDRCPC---------------EIYHLMKNCWETEASFRPTFQ 276
Query: 346 QVL 348
            ++
Sbjct: 277 NLV 279

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 115 EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 230
Query: 212 YVSDFGLHLLLNPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 291 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 325
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 326 MRDCWHAVPSQRPTFKQL---VEDLDR 349

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 35/183 (19%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML----EA 233
           I  G+ YLH   +   IH  L ++N+LLD +    + DFGL   +    G E      + 
Sbjct: 121 ICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDG 175
Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-----HLP-- 286
            +   + APE +K       +D++SFGV + EL++     + N +P   F     H    
Sbjct: 176 DSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTY---CDSNQSPHTKFTELIGHTQGQ 232
Query: 287 -TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
            T +R   L  R   L  PD   C               + + L   C     S RP  +
Sbjct: 233 MTVLRLTELLERGERLPRPDRCPC---------------EIYHLMKNCWETEASFRPTFQ 277
Query: 346 QVL 348
            ++
Sbjct: 278 NLV 280

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 87  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 199
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 200 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 255
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 256 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 285

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 121
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 122 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 178
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 179 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 238
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 239 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 273
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 274 MRDCWHAVPSQRPTFKQL---VEDLDR 297

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 117/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEA 165
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 66  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 124
Query: 166 HKWSI--------------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
            ++S               +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 125 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 181
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 182 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 241
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 242 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 276
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 277 MRDCWHAVPSQRPTFKQL---VEDLDR 300

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI--RHPNLVPLLGF 134
           IGK  YG ++     R   V +  F     TT +  +    E+   +  RH N+   LGF
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFF----TTEEASWFRETEIYQTVLMRHENI---LGF 96
Query: 135 YA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            A      G   +  ++  +++ G+L   ++  + +A     + +++     GL +LHT 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS---MLKLAYSSVSGLCHLHTE 153
Query: 189 FHR-----PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YK 240
                    I H +LKSKNIL+ +N    ++D GL +       +  +  +   G   Y 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 241 APELIKMK------DASEETDIYSFGVIMLEL 266
            PE++          +    D+YSFG+I+ E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  +G ++KA  +++G  V L + L        P+   R+      I++L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------IKILQLLKHENV 79
Query: 129 VPLLGF-------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--IYRISIGIA 179
           V L+         Y   +G   +V  F +  +LA  +   S    K+++  I R+   + 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLL 135
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL---LLNPTAGQEMLEASAS 236
            GL Y+H      I+H ++K+ N+L+ R+    ++DFGL     L   +          +
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 237 QGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
             Y+ PE L+  +D     D++  G IM E+ + + PI +  T      L
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NI++       V DFG+   +   +G  + + +A  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 180
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y +PE  +       +D+YS G ++ E+++G+ P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  +G ++KA  +++G  V L + L        P+   R+      I++L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------IKILQLLKHENV 79
Query: 129 VPLLGF-------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--IYRISIGIA 179
           V L+         Y   +G   +V  F +  +LA  +   S    K+++  I R+   + 
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLL 135
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL---LLNPTAGQEMLEASAS 236
            GL Y+H      I+H ++K+ N+L+ R+    ++DFGL     L   +          +
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 237 QGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
             Y+ PE L+  +D     D++  G IM E+ + + PI +  T      L
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NI++       V DFG+   +   +G  + + +A  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 180
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEPIN 274
           G   Y +PE  +       +D+YS G ++ E+++G+ P  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NI++       V DFG+   +   +G  + + +A  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 180
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y +PE  +       +D+YS G ++ E+++G+ P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA     L+      IIH ++K  NI++       V DFG+   +   +G  + + +A  
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 197
Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y +PE  +       +D+YS G ++ E+++G+ P
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  +G ++KA  +++G  V L + L        P+   R+      I++L  ++H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------IKILQLLKHENV 78
Query: 129 VPLLGF-------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--IYRISIGIA 179
           V L+         Y   +G   +V  F +  +LA  +   S    K+++  I R+   + 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLL 134
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL---LLNPTAGQEMLEASAS 236
            GL Y+H      I+H ++K+ N+L+ R+    ++DFGL     L   +          +
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 237 QGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
             Y+ PE L+  +D     D++  G IM E+ + + PI +  T      L
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 240

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 22/224 (9%)
Query: 66  ICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH 125
           + D+ +  G  +G+  YG +YKA  +     +     +   T         I LL  ++H
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH 77
Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR-GGSGEAHKWSI------IYRISIGI 178
           PN++ L   +      K+ +   Y   +L   I+   + +A+K  +      +  +   I
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQPYVSDFGLHLLLN----PTAGQEM 230
             G+ YLH  +   ++H +LK  NIL+        +  ++D G   L N    P A  ++
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA--DL 192
Query: 231 LEASASQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPI 273
                +  Y+APE L+  +  ++  DI++ G I  EL++  EPI
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 77  IGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNLV 129
           +G+  Y T+YK   + + ++  L+ +R       P    R+      + LL  ++H N+V
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE------VSLLKDLKHANIV 63
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L       +   L+    Y   +L Q +    G       +      +  GL Y H   
Sbjct: 64  TLHDIIHTEKSLTLVFE--YLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN-PTAGQEMLEASASQGYKAPE-LIKM 247
            + ++H +LK +N+L++   +  ++DFGL    + PT   +      +  Y+ P+ L+  
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD--NEVVTLWYRPPDILLGS 175
Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
            D S + D++  G I  E+ +G+ P+    T +E  H 
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHF 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP 126
            E +G+  +  ++K + +  G       +  LL+ L        + F +   ++  + H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 127 NLVPLLGF-YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLD 183
           +LV   G  + G   E ++V  F K G+L   ++         +I++++ +   +A  + 
Sbjct: 73  HLVLNYGVCFCG--DENILVQEFVKFGSLDTYLKKNKNCI---NILWKLEVAKQLAWAMH 127
Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQ------PYV--SDFGLHLLLNPTAGQEMLEASA 235
           +L       +IHGN+ +KNILL R         P++  SD G+ + + P   +++L+   
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERI 181
Query: 236 SQGYKAPELIKM-KDASEETDIYSFGVIMLELISG 269
              +  PE I+  K+ +  TD +SFG  + E+ SG
Sbjct: 182 P--WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 85  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 197
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 198 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 84  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 142 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 196
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 197 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 252
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 253 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 282

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE- 252
           +H ++K  NIL+D N    ++DFG  L L      +   A  +  Y +PE+++  +  + 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 253 ----ETDIYSFGVIMLELISGKEPI 273
               E D +S GV M E++ G+ P 
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 87  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 199
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 200 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 255
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 256 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 285

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  +   ++    CT+   R+K   + + +     HP++
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 74  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA----YL 127
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 128 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI 184
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 77  IGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y+     +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIAGG 181
           LLG  +  +G+  L+V      G+L   +R    EA             + +++  IA G
Sbjct: 84  LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+    +  +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 142 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 196
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKE 271
             + APE +K    +  +D++SFGV++ E+ S  E
Sbjct: 197 --WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 229

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 12/129 (9%)
Query: 156 QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY--QPYV 213
           Q I G +G   K S + ++ I +   L+Y+H       +HG++K+ N+LL      Q Y+
Sbjct: 139 QKISGQNGTFKK-STVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYL 194
Query: 214 SDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA------SEETDIYSFGVIMLELI 267
           +D+GL     P    +  + +  +G+         DA      S  +D+   G  ML  +
Sbjct: 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254
Query: 268 SGKEPINEN 276
            GK P  +N
Sbjct: 255 CGKLPWEQN 263

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/297 (19%), Positives = 129/297 (43%), Gaps = 53/297 (17%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 115 LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 173 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 227
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 228 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 283
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
                  PDML                   F+L   C   +P +RP+  +++  +++
Sbjct: 284 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 21/121 (17%)
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL----HLLLN---- 223
           +R+   I   L Y+H+   + IIH NLK  NI +D +    + DFGL    H  L+    
Sbjct: 119 WRLFRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 224 -----PTAGQEMLEASASQGYKAPELIK-MKDASEETDIYSFGVIMLELI----SGKEPI 273
                P +   +  A  +  Y A E++      +E+ D YS G+I  E I    +G E +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERV 235
Query: 274 N 274
           N
Sbjct: 236 N 236

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 86  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 198
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 199 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 254
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 255 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 80  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 138 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 192
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 193 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 248
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 249 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 278

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLR----PVCTTRD-KEFGDLIELLGCIRHP 126
           EVIGK  +  + + + + +G   +V+++   +    P  +T D K    +  +L   +HP
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML---KHP 86
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDY 184
           ++V LL  Y+   G   +V  F    +L   I  R  +G  +  ++       I   L Y
Sbjct: 87  HIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 185 LHTGFHRPIIHGNLKSKNILL--DRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQG--- 238
            H      IIH ++K   +LL    N  P  +  FG+ + L    G+  L A    G   
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL----GESGLVAGGRVGTPH 198
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           + APE++K +   +  D++  GVI+  L+SG  P 
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 93  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 206 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 261
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 262 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 291

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 70
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 71  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 124
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 74  GEVIGKSNYGTLYKALLQRSG-------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP 126
            E +G+  +  ++K + +  G       +  LL+ L        + F +   ++  + H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG--IAGGLDY 184
           +LV   G       E ++V  F K G+L   ++         +I++++ +   +A  + +
Sbjct: 73  HLVLNYGVCVCG-DENILVQEFVKFGSLDTYLKKNKNCI---NILWKLEVAKQLAAAMHF 128
Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQ------PYV--SDFGLHLLLNPTAGQEMLEASAS 236
           L       +IHGN+ +KNILL R         P++  SD G+ + + P   +++L+    
Sbjct: 129 LE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIP 182
Query: 237 QGYKAPELIKM-KDASEETDIYSFGVIMLELISG 269
             +  PE I+  K+ +  TD +SFG  + E+ SG
Sbjct: 183 --WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 86  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 198
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 199 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 254
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDML                   F+L   C   +P +RP+  +++
Sbjct: 255 PDN---CPDML-------------------FELMRMCWQYNPKMRPSFLEII 284

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/292 (19%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 77  IGKSNYGTLY----KALLQRSGSVRL-LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVP 130
           +G+ ++G +Y    K +++     R+ ++ +    + R++ EF +   ++      ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 131 LLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAH--------KWSIIYRISIGIAGG 181
           LLG  +  +G+  L++     RG+L   +R    E            S + +++  IA G
Sbjct: 78  LLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT-----AGQEMLEASAS 236
           + YL+       +H +L ++N ++  ++   + DFG+   +  T      G+ +L     
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 190
Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       M   +LD 
Sbjct: 191 --WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLLDK 246
Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  PDMLL                   +L   C   +P +RP+  +++
Sbjct: 247 PDN---CPDMLL-------------------ELMRMCWQYNPKMRPSFLEII 276

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 74  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 127
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 128 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 75
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 76  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 129
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 130 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 186
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGG 181
           +HPN++ L   Y   +    +V    K G L   I  +    E    ++++ I+  +   
Sbjct: 74  QHPNIITLKDVYDDGK-YVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTV--- 129
Query: 182 LDYLHTGFHRPIIHGNLKSKNIL-LDRNYQP---YVSDFGLHLLLNPTAGQEMLEASASQ 237
            +YLH    + ++H +LK  NIL +D +  P    + DFG    L    G  +     + 
Sbjct: 130 -EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LXTPCYTA 184
Query: 238 GYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP--TPDE 281
            + APE+++ +      DI+S GV++   ++G  P    P  TP+E
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEE 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 98/241 (40%), Gaps = 17/241 (7%)
Query: 42  QSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRF 101
           ++ +  E  + ED  T     D  I       G  IG+  +G +++ +     +  +   
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 102 LRPV--CTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQC 157
           ++    CT+       L E L      HP++V L+G          I+      G L   
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSF 480
Query: 158 IRGGSGEAHKWSII---YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS 214
           ++         S+I   Y++S  +A    YL +   +  +H ++ ++N+L+  N    + 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALA----YLES---KRFVHRDIAARNVLVSSNDCVKLG 533
Query: 215 DFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLE-LISGKEPI 273
           DFGL   +  +   +  +      + APE I  +  +  +D++ FGV M E L+ G +P 
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 274 N 274
Sbjct: 594 Q 594

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 21/121 (17%)
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL----HLLLN---- 223
           +R+   I   L Y+H+   + IIH +LK  NI +D +    + DFGL    H  L+    
Sbjct: 119 WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 224 -----PTAGQEMLEASASQGYKAPELIK-MKDASEETDIYSFGVIMLELI----SGKEPI 273
                P +   +  A  +  Y A E++      +E+ D+YS G+I  E+I    +G E +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 274 N 274
           N
Sbjct: 236 N 236

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 101
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 102 VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 155
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 156 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 212
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 76
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 77  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 130
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 131 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 187
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 21/121 (17%)
Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL----HLLLN---- 223
           +R+   I   L Y+H+   + IIH +LK  NI +D +    + DFGL    H  L+    
Sbjct: 119 WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 224 -----PTAGQEMLEASASQGYKAPELIK-MKDASEETDIYSFGVIMLELI----SGKEPI 273
                P +   +  A  +  Y A E++      +E+ D+YS G+I  E+I    +G E +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 274 N 274
           N
Sbjct: 236 N 236

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 75  EVIGKSNYGTLYKALLQRSG---SVRLLRFLR----PVCTTRD-KEFGDLIELLGCIRHP 126
           EVIGK  +  + + + + +G   +V+++   +    P  +T D K    +  +L   +HP
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML---KHP 88
Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDY 184
           ++V LL  Y+   G   +V  F    +L   I  R  +G  +  ++       I   L Y
Sbjct: 89  HIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 185 LHTGFHRPIIHGNLKSKNILL--DRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQG--- 238
            H      IIH ++K   +LL    N  P  +  FG+ + L    G+  L A    G   
Sbjct: 148 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL----GESGLVAGGRVGTPH 200
Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPI 273
           + APE++K +   +  D++  GVI+  L+SG  P 
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 15/144 (10%)
Query: 136 AGPRGEKLIVHPFYKRGNLAQCI-RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           + P+    I     ++ NL   + R  S E  +  +   I I IA  +++LH+   + ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLM 186
Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM----LEASASQG-------YKAPE 243
           H +LK  NI    +    V DFGL   ++    ++     + A A+         Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 244 LIKMKDASEETDIYSFGVIMLELI 267
            I   + S + DI+S G+I+ EL+
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  L   ++    CT+   R+K   + + +     HP++
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 78
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 79  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 132
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 133 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG----- 160
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 161 ---------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
                       E      +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 118 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 174
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 235 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 269
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 270 MRDCWHAVPSQRPTFKQL---VEDLDR 293

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 9/119 (7%)
Query: 153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP- 211
           NL + I+    +     ++ + +  I   LD LH      IIH +LK +NILL +  +  
Sbjct: 184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG 240
Query: 212 -YVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG 269
             V DFG     +    Q +     S+ Y+APE+I         D++S G I+ EL++G
Sbjct: 241 IKVIDFGSSCYEH----QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/235 (21%), Positives = 98/235 (41%), Gaps = 40/235 (17%)
Query: 124 RHPNLVPLLGF--YAGPRGEKLIVHPFYKRGNLAQCIRGGS--------GEAHKWSIIYR 173
           +H N+V LLG   + GP    L++  +   G+L   +R  +        G   +   +  
Sbjct: 108 QHENIVNLLGACTHGGPV---LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL-LLNPTAGQEMLE 232
            S  +A G+ +L +   +  IH ++ ++N+LL   +   + DFGL   ++N +       
Sbjct: 165 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA 292
           A     + APE I     + ++D++S+G+++ E+ S    +  NP        P  + N+
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNP-------YPGILVNS 270
Query: 293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
                + D Y       +  N             + +  AC +  P+ RP  +Q+
Sbjct: 271 KFYKLVKDGYQMAQPAFAPKN------------IYSIMQACWALEPTHRPTFQQI 313

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 9/119 (7%)
Query: 153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP- 211
           NL + I+    +     ++ + +  I   LD LH      IIH +LK +NILL +  +  
Sbjct: 184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG 240
Query: 212 -YVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG 269
             V DFG     +    Q +     S+ Y+APE+I         D++S G I+ EL++G
Sbjct: 241 IKVIDFGSSCYEH----QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 9/119 (7%)
Query: 153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP- 211
           NL + I+    +     ++ + +  I   LD LH      IIH +LK +NILL +  +  
Sbjct: 184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG 240
Query: 212 -YVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISG 269
             V DFG     +    Q +     S+ Y+APE+I         D++S G I+ EL++G
Sbjct: 241 IKVIDFGSSCYEH----QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 52/267 (19%)
Query: 110 DKEFGDLI---ELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG----- 160
           +K+  DLI   E++  I +H N++ LLG      G   ++  +  +GNL + ++      
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPG 132
Query: 161 ---------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP 211
                       E      +   +  +A G++YL +   +  IH +L ++N+L+  +   
Sbjct: 133 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 189
Query: 212 YVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-G 269
            ++DFGL   ++     ++         + APE +  +  + ++D++SFGV++ E+ + G
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P    P  +E F L   ++     HR+    +     C+N             + + +
Sbjct: 250 GSPYPGVPV-EELFKL---LKEG---HRMDKPSN-----CTN-------------ELYMM 284
Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
              C    PS RP  KQ+   +EDL +
Sbjct: 285 MRDCWHAVPSQRPTFKQL---VEDLDR 308

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 74  GEVIGKSNYGTLYKAL----LQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
           G+++G+ +YG + + L    L R     L +         +      I+LL  +RH N++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L+        +K+ +   Y    + + +     +       +     +  GL+YLH+  
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-ASQGYKAPELIKMK 248
            + I+H ++K  N+LL       +S  G+   L+P A  +    S  S  ++ PE+    
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 249 D--ASEETDIYSFGVIMLELISGKEPI 273
           D  +  + DI+S GV +  + +G  P 
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV--CTT---RDKEFGDLIELLGCIRHPNL 128
           G  IG+  +G +++ +     +  +   ++    CT+   R+K   + + +     HP++
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ-FDHPHI 73
Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII---YRISIGIAGGLDYL 185
           V L+G          I+      G L   ++         S+I   Y++S  +A    YL
Sbjct: 74  VKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA----YL 127
Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI 245
            +   +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I
Sbjct: 128 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 246 KMKDASEETDIYSFGVIMLE-LISGKEPIN 274
             +  +  +D++ FGV M E L+ G +P  
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/235 (21%), Positives = 98/235 (41%), Gaps = 40/235 (17%)
Query: 124 RHPNLVPLLGF--YAGPRGEKLIVHPFYKRGNLAQCIRGGS--------GEAHKWSIIYR 173
           +H N+V LLG   + GP    L++  +   G+L   +R  +        G   +   +  
Sbjct: 100 QHENIVNLLGACTHGGPV---LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL-LLNPTAGQEMLE 232
            S  +A G+ +L +   +  IH ++ ++N+LL   +   + DFGL   ++N +       
Sbjct: 157 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA 292
           A     + APE I     + ++D++S+G+++ E+ S    +  NP        P  + N+
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNP-------YPGILVNS 262
Query: 293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
                + D Y       +  N             + +  AC +  P+ RP  +Q+
Sbjct: 263 KFYKLVKDGYQMAQPAFAPKN------------IYSIMQACWALEPTHRPTFQQI 305

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 7/94 (7%)
Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM------ 247
           +H ++K  NILLDR     ++DFG  L L        L A  +  Y +PE+++       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 248 -KDASEETDIYSFGVIMLELISGKEPINENPTPD 280
                 E D ++ GV   E+  G+ P   + T +
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 77  IGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPNL 128
           IG+  +G ++KA  +++G  V L + L        P+   R+      I++L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------IKILQLLKHENV 79
Query: 129 VPLLGF-------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--IYRISIGIA 179
           V L+         Y   +    +V  F +  +LA  +   S    K+++  I R+   + 
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLL 135
Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL---LLNPTAGQEMLEASAS 236
            GL Y+H      I+H ++K+ N+L+ R+    ++DFGL     L   +          +
Sbjct: 136 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 237 QGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
             Y+ PE L+  +D     D++  G IM E+ + + PI +  T      L
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLAL 241

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 43/179 (24%)
Query: 123 IRHPNLVPL------LGFY--------AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKW 168
           ++HPN+V L       GF+         G   E ++   +Y   + + CI          
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ-------- 138
Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPT 225
                    I   ++++H      I+H +LK +N+LL    +     ++DFGL + +   
Sbjct: 139 ---------ILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
             Q     + + GY +PE+++     +  DI++ GVI+  L+ G  P       DED H
Sbjct: 187 Q-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFW-----DEDQH 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 34/132 (25%)
Query: 164 EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN 223
           E H  +++Y + +G+     Y+H+     I+H +LK  N L++++    V DFGL   ++
Sbjct: 155 ELHIKTLLYNLLVGVK----YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 224 -PTAGQEMLEAS-------------------------ASQGYKAPELIKMKDA-SEETDI 256
            P  G   L  S                          ++ Y+APELI +++  +E  D+
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267
Query: 257 YSFGVIMLELIS 268
           +S G I  EL++
Sbjct: 268 WSIGCIFAELLN 279

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	356
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-54
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-52
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-17
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-15
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-14
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-13
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-13
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-13
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-13
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-13
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-11
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-11
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-11
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-10
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-10
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-09
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-08
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-07
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-07
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-06
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-04
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-04
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-04
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  180 bits (460), Expect = 2e-54
 Identities = 82/292 (28%), Positives = 142/292 (48%), Gaps = 36/292 (12%)

Query: 76  VIGKSNYGTLYKALLQRSGSV----RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
           ++G+  +G +YK  L   G++    RL           + +F   +E++    H NL+ L
Sbjct: 37  ILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRL 92

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK--WSIIYRISIGIAGGLDYLHTGF 189
            GF   P  E+L+V+P+   G++A C+R          W    RI++G A GL YLH   
Sbjct: 93  RGFCMTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT--------AGQEMLEASASQGYKA 241
              IIH ++K+ NILLD  ++  V DFGL  L++           G        + G+ A
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG--------TIGHIA 203

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINEN-PTPDEDFHLPTFMRNAVLDHRITD 300
           PE +    +SE+TD++ +GV++LELI+G+   +      D+D  L  +++  + + ++  
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263

Query: 301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE 352
           L   D+        +    +E + +  Q+A+ C   SP  RP + +V+  LE
Sbjct: 264 LVDVDL--------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  175 bits (446), Expect = 2e-52
 Identities = 86/286 (30%), Positives = 139/286 (48%), Gaps = 27/286 (9%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFY 135
           +IG   +G +YK +L R G+   L+   P  +   +EF   IE L   RHP+LV L+G +
Sbjct: 46  LIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG-F 103

Query: 136 AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK--WSIIYRISIGIAGGLDYLHTGFHRPI 193
              R E ++++ + + GNL + + G         W     I IG A GL YLHT     I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AI 160

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE------MLEASASQGYKAPELIKM 247
           IH ++KS NILLD N+ P ++DFG+         Q             + GY  PE    
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGI-SKKGTELDQTHLSTVVK----GTLGYIDPEYFIK 215

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
              +E++D+YSFGV++ E++  +  I ++  P E  +L  +   +  + ++  +  P++ 
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVNLAEWAVESHNNGQLEQIVDPNL- 273

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
                   + +  E + KF   A+ C + S   RP++  VLWKLE 
Sbjct: 274 -------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  152 bits (386), Expect = 1e-43
 Identities = 66/253 (26%), Positives = 116/253 (45%), Gaps = 30/253 (11%)

Query: 110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KW 168
            ++F   I+++   +H NLV LLGF +    +  +V+ +   G+L   +    G     W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
            +  +I+ G A G+++LH       IH ++KS NILLD  +   +SDFGL         Q
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS-EKFAQ 188

Query: 229 EMLEASAS------QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED 282
            ++    +        Y APE ++ +  + ++DIYSFGV++LE+I+G   ++E+    E 
Sbjct: 189 TVM----TSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 240

Query: 283 FHLPTFMRNAVLDHR-ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR 341
             L         + + I D     M         N      +   + +A  C     + R
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM---------NDADSTSVEAMYSVASQCLHEKKNKR 291

Query: 342 PNIKQVLWKLEDL 354
           P+IK+V   L+++
Sbjct: 292 PDIKKVQQLLQEM 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  149 bits (378), Expect = 1e-42
 Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 50/307 (16%)

Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
            DL         GEV+GK  +G   K   + +G V +++ L        + F   ++++ 
Sbjct: 10  SDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62

Query: 122 CIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
           C+ HPN++  +G     + ++L  +  + K G L   I+      + WS     +  IA 
Sbjct: 63  CLEHPNVLKFIG--VLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIAS 119

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-------------HLLLNPTAG 227
           G+ YLH+     IIH +L S N L+  N    V+DFGL                L     
Sbjct: 120 GMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
           ++      +  + APE+I  +   E+ D++SFG+++ E+I           PD       
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN-----ADPDYL----- 226

Query: 288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
             R       +          C  +             FF + + CC   P  RP+  ++
Sbjct: 227 -PRTMDFGLNVRGFLDRY---CPPNCPP---------SFFPITVRCCDLDPEKRPSFVKL 273

Query: 348 LWKLEDL 354
              LE L
Sbjct: 274 EHWLETL 280

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  146 bits (370), Expect = 2e-41
 Identities = 58/308 (18%), Positives = 112/308 (36%), Gaps = 47/308 (15%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            EV  +  +G ++KA L        V++           + E    +  L  ++H N++ 
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYE----VYSLPGMKHENILQ 82

Query: 131 LLGFYAGPRG---EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            +G          +  ++  F+++G+L+  ++        W+ +  I+  +A GL YLH 
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE 139

Query: 188 GFHR-------PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGY 239
                       I H ++KSKN+LL  N    ++DFGL L                ++ Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 240 KAPELI-----KMKDASEETDIYSFGVIMLELISGKEPINEN------PTPDEDFHLPTF 288
            APE++       +DA    D+Y+ G+++ EL S     +        P  +E    P+ 
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259

Query: 289 --MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
             M+  V+  +       D                 +    +    C       R +   
Sbjct: 260 EDMQEVVVHKKK-RPVLRD----------YWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

Query: 347 VLWKLEDL 354
           V  ++  +
Sbjct: 309 VGERITQM 316

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  133 bits (336), Expect = 6e-37
 Identities = 51/289 (17%), Positives = 105/289 (36%), Gaps = 43/289 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLL 132
              + +++ G L+K   Q +  + +        +TR  ++F +    L    HPN++P+L
Sbjct: 15  LTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           G    P      ++  +   G+L   +  G+      S   + ++ +A G+ +LHT    
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            I    L S+++++D +    +S   +                 +  + APE ++ K   
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------MYAPAWVAPEALQKKPED 186

Query: 252 EET---DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYHPD 305
                 D++SF V++ EL++ + P         D           L+     I     P 
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPF-------ADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +                     +L   C +  P+ RP    ++  LE +
Sbjct: 240 VS--------------------KLMKICMNEDPAKRPKFDMIVPILEKM 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  132 bits (334), Expect = 2e-36
 Identities = 69/288 (23%), Positives = 131/288 (45%), Gaps = 33/288 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLL 132
           G+ IG  ++GT+YK      G V +        T +  + F + + +L   RH N++  +
Sbjct: 29  GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G+   P+    IV  + +  +L   +   S    +   +  I+   A G+DYLH    + 
Sbjct: 87  GYSTAPQ--LAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHA---KS 140

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPELIKMKDA- 250
           IIH +LKS NI L  +    + DFGL    +  +G    E  + S  + APE+I+M+D+ 
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 251 --SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
             S ++D+Y+FG+++ EL++G+ P   N    +           +++        PD+  
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPY-SNINNRD----------QIIEMVGRGSLSPDLSK 249

Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
             ++  +         +  +L   C       RP+  ++L ++E+L +
Sbjct: 250 VRSNCPK---------RMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  132 bits (334), Expect = 2e-36
 Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 42/286 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            EV+G+  +G + KA   R+  V + +       +  K F   +  L  + HPN+V L G
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAH-KWSIIYRISIGIAGGLDYLHTGFHRP 192
               P     +V  + + G+L   + G     +   +      +  + G+ YLH+   + 
Sbjct: 69  ACLNPV---CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 193 IIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
           +IH +LK  N+LL        + DFG    +       M     S  + APE+ +  + S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEGSNYS 181

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYHPDMLL 308
           E+ D++S+G+I+ E+I+ ++P +E   P            AV +     +       +  
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW------AVHNGTRPPLIKNLPKPIE- 234

Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                               L   C S  PS RP++++++  +  L
Sbjct: 235 -------------------SLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  131 bits (330), Expect = 2e-35
 Identities = 64/318 (20%), Positives = 110/318 (34%), Gaps = 56/318 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            E+IG+  YG +YK  L        V++  F        +K     I  +  + H N+  
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKN----IYRVPLMEHDNIAR 71

Query: 131 LLG----FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
            +       A  R E L+V  +Y  G+L + +         W    R++  +  GL YLH
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLH 128

Query: 187 T------GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ--- 237
           T       +   I H +L S+N+L+  +    +SDFGL + L         E   +    
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 238 ----GYKAPELIK-------MKDASEETDIYSFGVIMLELISGKEPINEN--------PT 278
                Y APE+++        + A ++ D+Y+ G+I  E+      +             
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 279 PDEDFHLPTF--MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSP 336
             E  + PTF  M+  V   +      P        N              +    C   
Sbjct: 249 QTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVR------SLKETIEDCWDQ 298

Query: 337 SPSLRPNIKQVLWKLEDL 354
               R   +    ++ +L
Sbjct: 299 DAEARLTAQXAEERMAEL 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  129 bits (327), Expect = 3e-35
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 34/285 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPL 131
            E IG  ++GT+++A     GS   ++ L       +   EF   + ++  +RHPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           +G  A  +   L IV  +  RG+L + +   G+ E         ++  +A G++YLH   
Sbjct: 100 MG--AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
           + PI+H NLKS N+L+D+ Y   V DFGL  L   T       A+ +  + APE+++ + 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEP 215

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
           ++E++D+YSFGVI+ EL + ++P         + +    +               ++   
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVGFKC-----KRLEI--- 260

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             + +          +   +   C +  P  RP+   ++  L  L
Sbjct: 261 PRNLNP---------QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (324), Expect = 5e-35
 Identities = 67/301 (22%), Positives = 122/301 (40%), Gaps = 57/301 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFL----RPVCTTRDKEFGDLIELLGCIRHP 126
            + IGK  +G ++K  L +  S   ++ L             + +EF   + ++  + HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           N+V L G    P     +V  F   G+L   +        KWS+  R+ + IA G++Y+ 
Sbjct: 84  NIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPY-----VSDFGLHLLLNPTAGQEMLEASASQG--- 238
              + PI+H +L+S NI L    +       V+DFGL       + Q +   S   G   
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------SQQSVHSVSGLLGNFQ 191

Query: 239 YKAPELIKMKDA--SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
           + APE I  ++   +E+ D YSF +I+  +++G+ P          F             
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----------FD------------ 229

Query: 297 RITDLYHPDMLLCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
              +  +  +   +    E     + E+   +   +   C S  P  RP+   ++ +L +
Sbjct: 230 ---EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286

Query: 354 L 354
           L
Sbjct: 287 L 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  127 bits (322), Expect = 7e-35
 Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 45/293 (15%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSV---RLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            E+IG   +G +Y+A       V             +   +      +L   ++HPN++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 131 LLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
           L G     +   L +V  F + G L + + G   +     I+   ++ IA G++YLH   
Sbjct: 71  LRG--VCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 190 HRPIIHGNLKSKNILLDRNYQPY--------VSDFGLHLLLNPTAGQEMLEASASQGYKA 241
             PIIH +LKS NIL+ +  +          ++DFGL    + T     + A+ +  + A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMA 182

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           PE+I+    S+ +D++S+GV++ EL++G+ P                +   V  ++    
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-------RGID-GLAVAYGVAMNK---- 230

Query: 302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                          P+       F +L   C +P P  RP+   +L +L  +
Sbjct: 231 LAL------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 8e-35
 Identities = 67/310 (21%), Positives = 116/310 (37%), Gaps = 55/310 (17%)

Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG 121
           E L I       GE+IGK  +G +Y        ++RL+   R       K F   +    
Sbjct: 33  EQLEI-------GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQL-KAFKREVMAYR 84

Query: 122 CIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
             RH N+V  +G  A      L I+    K   L   +R         +   +I+  I  
Sbjct: 85  QTRHENVVLFMG--ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVK 141

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL----HLLLNPTAGQEMLEASAS 236
           G+ YLH    + I+H +LKSKN+  D N +  ++DFGL     +L       ++   +  
Sbjct: 142 GMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 237 QGYKAPELIKMKDA---------SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
             + APE+I+             S+ +D+++ G I  EL + + P    P          
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------AE 249

Query: 288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFF-QLAMACCSPSPSLRPNIKQ 346
            +   +                  +  +  +S+  + K    + + C +     RP   +
Sbjct: 250 AIIWQM-----------------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTK 292

Query: 347 VLWKLEDLGK 356
           ++  LE L K
Sbjct: 293 LMDMLEKLPK 302

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  124 bits (312), Expect = 3e-33
 Identities = 66/312 (21%), Positives = 121/312 (38%), Gaps = 55/312 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            E +GK  YG +++   Q  G    V++          R+ E    +     +RH N++ 
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETE----LYNTVMLRHENILG 66

Query: 131 LLG---FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            +           +  ++  +++ G+L   ++  +          RI + IA GL +LH 
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHI 123

Query: 188 GFHR-----PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
                     I H +LKSKNIL+ +N Q  ++D GL ++ + +  Q  +  +   G   Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 240 KAPELIK------MKDASEETDIYSFGVIMLELISGKEPINEN-----PTPDEDFHLPTF 288
            APE++         D+ +  DI++FG+++ E+               P  D   + P+F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 289 --MRNAVLDHR----ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP 342
             MR  V   +    I + +  D  L S                 +L   C   +PS R 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTS---------------LAKLMKECWYQNPSARL 288

Query: 343 NIKQVLWKLEDL 354
              ++   L  +
Sbjct: 289 TALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  122 bits (308), Expect = 3e-32
 Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 53/311 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            + IGK  YG ++    +  G    V++          R+ E    I     +RH N++ 
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETE----IYQTVLMRHENIL- 94

Query: 131 LLGFYA------GPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
             GF A      G   +  ++  +++ G+L   ++           + +++     GL +
Sbjct: 95  --GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCH 149

Query: 185 LHTGFHR-----PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG- 238
           LHT          I H +LKSKNIL+ +N    ++D GL +       +  +  +   G 
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 239 --YKAPELI------KMKDASEETDIYSFGVIMLELISGKEPIN-----ENPTPDEDFHL 285
             Y  PE++          +    D+YSFG+I+ E+             + P  D     
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 286 PTF--MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN 343
           P++  MR  V   ++     P      +S+           +  +L   C + +P+ R  
Sbjct: 270 PSYEDMREIVCIKKLR----PSFPNRWSSDECLR-------QMGKLMTECWAHNPASRLT 318

Query: 344 IKQVLWKLEDL 354
             +V   L  +
Sbjct: 319 ALRVKKTLAKM 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  122 bits (307), Expect = 4e-32
 Identities = 59/310 (19%), Positives = 115/310 (37%), Gaps = 47/310 (15%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
            E IGK  +G +++   +  G    V++          R+ E    I     +RH N++ 
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAE----IYQTVMLRHENILG 100

Query: 131 LLG---FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH- 186
            +       G   +  +V  +++ G+L   +            + ++++  A GL +LH 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 157

Query: 187 ----TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---Y 239
               T     I H +LKSKNIL+ +N    ++D GL +  +       +  +   G   Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 240 KAPELI------KMKDASEETDIYSFGVIMLELISGKEPIN-----ENPTPDEDFHLPTF 288
            APE++      K  ++ +  DIY+ G++  E+             + P  D     P+ 
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 289 --MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
             MR  V + +      P++    N                ++   C   + + R    +
Sbjct: 278 EEMRKVVCEQK----LRPNI---PNRWQSCEALRV----MAKIMRECWYANGAARLTALR 326

Query: 347 VLWKLEDLGK 356
           +   L  L +
Sbjct: 327 IKKTLSQLSQ 336

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.0 bits (247), Expect = 8e-24
 Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 42/254 (16%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEK---LIVHPFYKRGNLAQCIRGGSGEAHKWS--II 171
            ++     HPN++ L+ +    RG K    ++ PF+KRG L   I     + +  +   I
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH--LLLNPTAGQE 229
             + +GI  GL+ +H    +   H +LK  NILL    QP + D G      ++    ++
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193

Query: 230 ML---EASASQG---YKAPELIKMK---DASEETDIYSFGVIMLELISGKEPINENPTPD 280
            L   + +A +    Y+APEL  ++      E TD++S G ++  ++ G+ P        
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-------- 245

Query: 281 EDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL 340
             + +     ++V       L  P              S       +QL  +  +  P  
Sbjct: 246 --YDMVFQKGDSVALAVQNQLSIPQ---------SPRHSSA----LWQLLNSMMTVDPHQ 290

Query: 341 RPNIKQVLWKLEDL 354
           RP+I  +L +LE L
Sbjct: 291 RPHIPLLLSQLEAL 304

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 96.6 bits (241), Expect = 3e-23
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 44/285 (15%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
              IG+ ++ T+YK L   +        ++  +  +       +E     E+L  ++HPN
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEE----AEMLKGLQHPN 86

Query: 128 LVPLLGFYAGPRGEKL---IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V     +      K    +V      G L   ++    +  K  ++      I  GL +
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQF 144

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           LHT    PIIH +LK  NI +        + D GL  L   +  + ++    +  + APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPE 200

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           + + K   E  D+Y+FG+ MLE+ + + P +E                A +  R+T    
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNA------------AQIYRRVTSGVK 247

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           P            P  +E I         C   +   R +IK +L
Sbjct: 248 PASF----DKVAIPEVKEIIEG-------CIRQNKDERYSIKDLL 281

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 57/284 (20%), Positives = 111/284 (39%), Gaps = 40/284 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            + IG+  +  +Y+A     G    L+ ++       K   D    I+LL  + HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96

Query: 131 LLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLHT 187
               +      +L IV      G+L++ I+             +++  + +   L+++H+
Sbjct: 97  YYASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
              R ++H ++K  N+ +       + D GL    +         A +  G   Y +PE 
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA----AHSLVGTPYYMSPER 207

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
           I     + ++DI+S G ++ E+ + + P          F+    M    L  +I    +P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP----------FYGDK-MNLYSLCKKIEQCDYP 256

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            +         +  SEE      QL   C +P P  RP++  V 
Sbjct: 257 PLP-------SDHYSEE----LRQLVNMCINPDPEKRPDVTYVY 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 42/282 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            + IG+ ++G          G   +++ +  +     KE  +    + +L  ++HPN+V 
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 131 LLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
               +       L IV  + + G+L + I    G   +   I    + I   L ++H   
Sbjct: 88  YRESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-- 143

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIK 246
            R I+H ++KS+NI L ++    + DFG+  +LN T       A A  G   Y +PE+ +
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL----ARACIGTPYYLSPEICE 198

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
            K  + ++DI++ G ++ EL + K            F   +      L  +I     P +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA----------FEAGSMKN---LVLKIISGSFPPV 245

Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                       S +       L       +P  RP++  +L
Sbjct: 246 --------SLHYSYD----LRSLVSQLFKRNPRDRPSVNSIL 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 41/285 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
             IG  +YG   K   +  G + + + L     T + E   L   + LL  ++HPN+V  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWS--IIYRISIGIAGGLDYLHT- 187
                      L IV  + + G+LA  I  G+ E        + R+   +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 188 -GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPE 243
                 ++H +LK  N+ LD      + DFGL  +LN         A    G   Y +PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKTFVGTPYYMSPE 186

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
            +     +E++DI+S G ++ EL +   P       +             L  +I +   
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------------LAGKIREGKF 233

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             +            S+E      ++     +     RP+++++L
Sbjct: 234 RRI--------PYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 266

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 57/294 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G+  +G ++      +  V + + L+P   + +  F    +++  +RH  LV L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAI-KTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 246

Query: 134 ------FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
                  Y        IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+  
Sbjct: 247 VVSEEPIY--------IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
                 +H +L++ NIL+  N    V+DFGL  L+         E +A QG K      A
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTA 349

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           PE       + ++D++SFG+++ EL +        P P         M N  +  ++   
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT----KGRVPYPG--------MVNREVLDQVERG 397

Query: 302 YH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           Y  P    C  S                L   C    P  RP  + +   LED 
Sbjct: 398 YRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 64/294 (21%), Positives = 114/294 (38%), Gaps = 57/294 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G+  +G ++      +  V + + L+P   + +  F    +++  +RH  LV L  
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAI-KTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 329

Query: 134 ------FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
                  Y        IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+  
Sbjct: 330 VVSEEPIY--------IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
                 +H +L++ NIL+  N    V+DFGL  L+         E +A QG K      A
Sbjct: 381 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTA 432

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           PE       + ++D++SFG+++ EL +        P P         M N  +  ++   
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTT----KGRVPYPG--------MVNREVLDQVERG 480

Query: 302 YH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           Y  P    C  S                L   C    P  RP  + +   LED 
Sbjct: 481 YRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 63/288 (21%), Positives = 104/288 (36%), Gaps = 62/288 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
              +G+ ++G +++   +++G       VRL  F       R +E    +     +  P 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEE----LVACAGLSSPR 111

Query: 128 LVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDY 184
           +VPL G      G  + I     + G+L Q I+  G   E                GL+Y
Sbjct: 112 IVPLYGAVR--EGPWVNIFMELLEGGSLGQLIKQMGCLPE----DRALYYLGQALEGLEY 165

Query: 185 LHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQEMLEASAS-QG---Y 239
           LHT   R I+HG++K+ N+LL  +  +  + DFG  L L P    + L       G   +
Sbjct: 166 LHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP------------INENPTPDE------ 281
            APE++  K    + DI+S   +ML +++G  P            I   P P        
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282

Query: 282 -----DFHLPTFMRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEE 321
                        +     HR +           L      ++P   E
Sbjct: 283 APLTAQAIQEGLRKEP--VHRASAMELRRKVGKALQEVGGLKSPWKGE 328

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 60/293 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E+IG   +G ++KA  +  G   +++ ++      ++E    ++ L  + H N+V   G
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNG 71

Query: 134 FY--------------AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGI 178
            +              +  + + L I   F  +G L Q I    GE     +   +   I
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
             G+DY+H+   + +I+ +LK  NI L    Q  + DFGL   L         + + S+G
Sbjct: 132 TKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-----KRTRSKG 183

Query: 239 ---YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD 295
              Y +PE I  +D  +E D+Y+ G+I+ EL+                   T    +   
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC---------------DTAFETSKFF 228

Query: 296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             + D    D+             ++       L     S  P  RPN  ++L
Sbjct: 229 TDLRDGIISDI-----------FDKK----EKTLLQKLLSKKPEDRPNTSEIL 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 59/295 (20%), Positives = 115/295 (38%), Gaps = 59/295 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + +G   +G ++ A   +   V  ++ ++P   + +  F     ++  ++H  LV L  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA 250

Query: 134 ------FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
                  Y        I+  F  +G+L   ++   G       +   S  IA G+ ++  
Sbjct: 251 VVTKEPIY--------IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
              R  IH +L++ NIL+  +    ++DFGL  ++         E +A +G K      A
Sbjct: 302 --QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTA 353

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE I     + ++D++SFG++++E+++ G+ P      P         M N  +   +  
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PG--------MSNPEVIRALER 400

Query: 301 LYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            Y  P    C                 + + M C    P  RP  + +   L+D 
Sbjct: 401 GYRMPRPENCPEE-------------LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 51/307 (16%), Positives = 105/307 (34%), Gaps = 59/307 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNL 128
             V+ +  +  +Y+A    SG      RLL           +E    +  +  +  HPN+
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE----VCFMKKLSGHPNI 88

Query: 129 VPLLGFYAGPR------GEKLIVHPFYKRGNLAQCI-RGGSGEAHKWSIIYRISIGIAGG 181
           V      +  +        + ++     +G L + + +  S        + +I       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQG- 238
           + ++H     PIIH +LK +N+LL       + DFG    +   P         +  +  
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 239 --------YKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT 287
                   Y+ PE+I +       E+ DI++ G I+  L   + P  +            
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG----------- 256

Query: 288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
             +  +++ + +   H                      F  L  A    +P  R +I +V
Sbjct: 257 -AKLRIVNGKYSIPPHD------------TQYTV----FHSLIRAMLQVNPEERLSIAEV 299

Query: 348 LWKLEDL 354
           + +L+++
Sbjct: 300 VHQLQEI 306

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.1 bits (211), Expect = 8e-19
 Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 39/297 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
              +GK N+G++        G           L+     + ++F   I++L  +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              G   GP  + L +V  +   G L   ++          ++   S  I  G++YL + 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICKGMEYLGS- 145

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             R  +H +L ++NIL++      ++DFGL  LL      +       +  +      AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLL----PLDKDYYVVREPGQSPIFWYAP 199

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEP-INENPTPDEDFHLPTFMRNAVLDHRITD 300
           E +     S ++D++SFGV++ EL +   +                     + L   + +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 301 ---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              L  P    C    HE             L   C +PSP  RP+   +  +L+ L
Sbjct: 260 GQRLPAPPA--CPAEVHE-------------LMKLCWAPSPQDRPSFSALGPQLDML 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 53/296 (17%), Positives = 107/296 (36%), Gaps = 36/296 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
              +G+ ++G +        G     +     L+P        +    IE+L  + H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           V   G      G  + ++  F   G+L + +     + +    +   ++ I  G+DYL +
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGMDYLGS 144

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
              R  +H +L ++N+L++  +Q  + DFGL   +      +    +            A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI----ETDKEYYTVKDDRDSPVFWYA 197

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP-TFMRNAVLDHRIT 299
           PE +        +D++SFGV + EL++      +      +        M    L + + 
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 300 DLYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +    P    C +  +             QL   C    PS R + + ++   E L
Sbjct: 258 EGKRLPCPPNCPDEVY-------------QLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 45/210 (21%), Positives = 77/210 (36%), Gaps = 42/210 (20%)

Query: 151 RGNLAQCI-RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY 209
           + NL   + R  S E  +  +   I I IA  +++LH    + ++H +LK  NI    + 
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD 201

Query: 210 QPYVSDFGL--------HLLLNPTAGQEMLEASASQG---YKAPELIKMKDASEETDIYS 258
              V DFGL              T        +   G   Y +PE I   + S + DI+S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261

Query: 259 FGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPV 318
            G+I+ EL+       E              R  ++   + +L  P             +
Sbjct: 262 LGLILFELLYSFSTQME--------------RVRIIT-DVRNLKFP------------LL 294

Query: 319 SEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             ++  +   +     SPSP+ RP    ++
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDII 324

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 55/308 (17%), Positives = 106/308 (34%), Gaps = 40/308 (12%)

Query: 75  EVIGK--SNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
            VIGK   +  T+  A  + +G    +R +  +    ++    L   + +     HPN+V
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           P    +      +L +V  F   G+    I     +      I  I  G+   LDY+H  
Sbjct: 90  PYRATFI--ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH-- 145

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
            H   +H ++K+ +IL+  + + Y+S    +L +     ++ +     +         +P
Sbjct: 146 -HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 243 ELIKMKDA--SEETDIYSFGVIMLELISGKEP------------INENPTP--------D 280
           E+++        ++DIYS G+   EL +G  P                  P         
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264

Query: 281 EDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL 340
            +    +  R+         L        +  +  +P        F      C   +P  
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324

Query: 341 RPNIKQVL 348
           RP+   +L
Sbjct: 325 RPSASTLL 332

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 82.8 bits (205), Expect = 3e-18
 Identities = 55/302 (18%), Positives = 108/302 (35%), Gaps = 58/302 (19%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
           P + +G+  +G +++A  +       ++ +R     R+     +   ++ L  + HP +V
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEHPGIV 66

Query: 130 PLLG-FYAGPRGEKLIVHPFYK----------RGNLAQCIRGGSGEAHK-WSIIYRISIG 177
                +      EKL                 + NL   + G      +  S+   I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA  +++LH+   + ++H +LK  NI    +    V DFGL   ++    ++ +      
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 238 G-----------YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP 286
                       Y +PE I     S + DI+S G+I+ EL+               +   
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------------YPFS 228

Query: 287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQ 346
           T M        + +L  P            P+  ++    + +     SPSP  RP    
Sbjct: 229 TQMERVRTLTDVRNLKFP------------PLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276

Query: 347 VL 348
           ++
Sbjct: 277 II 278

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 81.5 bits (202), Expect = 6e-18
 Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 51/291 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + IG   +G ++         V  ++ +R    + + +F +  E++  + HP LV L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYG 70

Query: 134 --FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
                 P     +V  F + G L+  +R   G     +++  + + +  G+ YL      
Sbjct: 71  VCLEQAPI---CLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCEGMAYLEE---A 123

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELI 245
            +IH +L ++N L+  N    VSDFG+   +         + ++S G K      +PE+ 
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSSTGTKFPVKWASPEVF 177

Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH- 303
                S ++D++SFGV+M E+ S GK P       +          N+ +   I+  +  
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-----EN--------RSNSEVVEDISTGFRL 224

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
               L S   +             Q+   C    P  RP   ++L +L ++
Sbjct: 225 YKPRLASTHVY-------------QIMNHCWRERPEDRPAFSRLLRQLAEI 262

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 45/281 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKE--FGDLIELLGCIRHPNLVP 130
              +G  +YG ++K   +  G +  ++    P    +D+     ++       +HP  V 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGS-GEAHKWSIIYRISIGIAGGLDYLHT 187
           L   +    G  L +       +L Q     G S  EA  W  +    +     L +LH+
Sbjct: 122 LEQAWE--EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHS 175

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
              + ++H ++K  NI L    +  + DFGL + L      E+ E      Y APEL+  
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP--RYMAPELL-Q 229

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
                  D++S G+ +LE+    E     P   E +     +R   L    T        
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMEL----PHGGEGWQ---QLRQGYLPPEFTAGL----- 277

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                      S E       + +    P P LR   + +L
Sbjct: 278 -----------SSE----LRSVLVMMLEPDPKLRATAEALL 303

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 47/290 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G   YG +Y+ + ++      ++ L+      + EF     ++  I+HPNLV LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283

Query: 134 --FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
                 P     I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +
Sbjct: 284 VCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 337

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELI 245
             IH NL ++N L+  N+   V+DFGL  L+           +A  G K      APE +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESL 391

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH-P 304
                S ++D+++FGV++ E+ +       +P P         +  + +   +   Y   
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPG--------IDLSQVYELLEKDYRME 439

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
               C                 ++L  AC   +PS RP+  ++    E +
Sbjct: 440 RPEGCPEK-------------VYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 26/309 (8%), Positives = 65/309 (21%), Gaps = 58/309 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSG------------------------SVRLLRFLR---PVC 106
            E +   +   ++                                +      L    P  
Sbjct: 67  VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 107 TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR-----GG 161
               +      + +     P    L            ++       +L            
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 162 SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL 221
                    ++ ++  +      L     + ++HG+    N+ +  + +  + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242

Query: 222 LNPTAGQEMLEASASQGYKAPELIKMKDA--SEETDIYSFGVIMLELISGKEPINENPTP 279
                G     +S    Y   E +    A  +   + +  G+ +  +     P       
Sbjct: 243 ---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP------- 292

Query: 280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPS 339
              F L T             +   D L         P+ +        L     +    
Sbjct: 293 ---FGLVTPGIKGSWKRPSLRVPGTDSL---AFGSCTPLPDF----VKTLIGRFLNFDRR 342

Query: 340 LRPNIKQVL 348
            R    + +
Sbjct: 343 RRLLPLEAM 351

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 51/307 (16%), Positives = 106/307 (34%), Gaps = 67/307 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
             V+G+  +G + KA          ++ +R      +++   +   + LL  + H  +V 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIR----HTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 131 LLGFYAGPRGEKLIVHP------------FYKRGNLAQCIRGGSG---EAHKWSIIYRIS 175
               +   R     +              + + G L   I   +        W +  +I 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI- 125

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
                 L Y+H+   + IIH +LK  NI +D +    + DFGL   ++ +     L++  
Sbjct: 126 ---LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 236 SQG-------------YKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDE 281
             G             Y A E++      +E+ D+YS G+I  E+I          T  E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS------TGME 233

Query: 282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR 341
             ++   +R+  ++                 + ++   +       ++        P+ R
Sbjct: 234 RVNILKKLRSVSIEF--------------PPDFDDNKMKV----EKKIIRLLIDHDPNKR 275

Query: 342 PNIKQVL 348
           P  + +L
Sbjct: 276 PGARTLL 282

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 56/307 (18%), Positives = 106/307 (34%), Gaps = 73/307 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKEFGDLIE---LLGCIRHPN 127
            E +G  ++G + +          +   ++ L+P   ++ +   D I     +  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 128 LVPLLG------FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
           L+ L G                +V      G+L   +R   G     ++    ++ +A G
Sbjct: 83  LIRLYGVVLTPPMK--------MVTELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVAEG 133

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK- 240
           + YL +   +  IH +L ++N+LL       + DFGL   L              +  K 
Sbjct: 134 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD----HYVMQEHRKV 186

Query: 241 -----APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA-V 293
                APE +K +  S  +D + FGV + E+ + G+EP                +  + +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------------LNGSQI 233

Query: 294 LD------HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV 347
           L        R   L  P+   C                 + + + C +  P  RP    +
Sbjct: 234 LHKIDKEGER---LPRPE--DCPQD-------------IYNVMVQCWAHKPEDRPTFVAL 275

Query: 348 LWKLEDL 354
              L + 
Sbjct: 276 RDFLLEA 282

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 29/219 (13%), Positives = 74/219 (33%), Gaps = 24/219 (10%)

Query: 74  GEVIGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL 128
             ++G+  +  +Y+A        ++    +L+  +P           L+E L        
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKWSIIYRISIGIAGGLDYL 185
           +     +       ++V   Y  G L   I   +    +     ++   ++ +   ++ +
Sbjct: 130 MKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPY-----------VSDFGLHLLLNPTAGQEMLEAS 234
           H      IIHG++K  N +L   +              + D G  + +       +  A 
Sbjct: 189 HD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 235 A-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
             + G++  E++  K  + + D +     +  ++ G   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 50/298 (16%), Positives = 99/298 (33%), Gaps = 42/298 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
              +G+ ++G +       +            L+     +    +   I++L  + H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSI--IYRISIGIAGGLDYL 185
           +   G         L +V  +   G+L   +       H   +  +   +  I  G+ YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYL 150

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK----- 240
           H    +  IH +L ++N+LLD +    + DFGL   +     +        +        
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFW 203

Query: 241 -APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP-TFMRNAVLDHR 297
            APE +K       +D++SFGV + EL++      +      E   +    M    L   
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

Query: 298 ITDLYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +      P    C                 + L   C     S RP  + ++  L+ +
Sbjct: 264 LERGERLPRPDKCPAE-------------VYHLMKNCWETEASFRPTFENLIPILKTV 308

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 59/292 (20%), Positives = 116/292 (39%), Gaps = 57/292 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
            + IGK  +G +     + +  +V+ ++          + F     ++  +RH NLV LL
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLL 80

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G     +G   IV  +  +G+L   +R           + + S+ +   ++YL       
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NN 137

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIK 246
            +H +L ++N+L+  +    VSDFGL         +    +S     K      APE ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGL-------TKEA---SSTQDTGKLPVKWTAPEALR 187

Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD---LY 302
            K  S ++D++SFG+++ E+ S G       P P         +    +  R+     + 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFG-----RVPYPR--------IPLKDVVPRVEKGYKMD 234

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            PD   C  +              +++   C     ++RP+  Q+  +LE +
Sbjct: 235 APD--GCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 59/295 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E +G   +G ++         V + + L+    + D  F     L+  ++H  LV L  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAV-KSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYA 75

Query: 134 ------FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
                  Y        I+  + + G+L   ++  SG     + +  ++  IA G+ ++  
Sbjct: 76  VVTQEPIY--------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
              R  IH +L++ NIL+       ++DFGL  L+         E +A +G K      A
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EYTAREGAKFPIKWTA 178

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE I     + ++D++SFG+++ E+++ G+ P      P         M N  +   +  
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----PG--------MTNPEVIQNLER 225

Query: 301 LYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            Y       C                 +QL   C    P  RP    +   LED 
Sbjct: 226 GYRMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 47/231 (20%), Positives = 88/231 (38%), Gaps = 52/231 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
             +G    G ++K   +++G V  ++ +R   +   +E   ++     +L     P +V 
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHDCPYIV- 87

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKW--------SIIYRISIGIAG 180
               +            F    ++   +   G   E  K          I+ ++++ I  
Sbjct: 88  --QCFGT----------FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS---- 236
            L YL       +IH ++K  NILLD   Q  + DFG+       +G+  L    +    
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGI-------SGR--LVDDKAKDRS 184

Query: 237 ---QGYKAPELIKMKDASEET-----DIYSFGVIMLELISGKEPINENPTP 279
                Y APE I   D ++       D++S G+ ++EL +G+ P     T 
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 55/307 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
             +G  N G ++K   + SG V   + +      +      +   +++L     P +V  
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNSPYIVGF 96

Query: 132 LG-FYAGPRGEKLIVHPFYKRGNLAQCIR--GGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
            G FY+   GE  I       G+L Q ++  G   E     I+ ++SI +  GL YL   
Sbjct: 97  YGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIAVIKGLTYLREK 150

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS------QGYKAP 242
               I+H ++K  NIL++   +  + DFG+       +GQ  L  S +      + Y +P
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGV-------SGQ--LIDSMANSFVGTRSYMSP 199

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY 302
           E ++    S ++DI+S G+ ++E+  G+ PI   P PD       F      D   T   
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI---PPPDAKELELMFGCQVEGDAAETPPR 256

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAM---------------------ACCSPSPSLR 341
                   N    +      I +     +                      C   +P+ R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316

Query: 342 PNIKQVL 348
            ++KQ++
Sbjct: 317 ADLKQLM 323

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 56/292 (19%), Positives = 105/292 (35%), Gaps = 53/292 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + +G   +G +     +    V + + ++    + D EF +  +++  + H  LV L G
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAI-KMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYG 86

Query: 134 --FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL-HTGFH 190
                 P     I+  +   G L   +R          ++  +   +   ++YL    F 
Sbjct: 87  VCTKQRPI---FIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQF- 141

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APEL 244
              +H +L ++N L++      VSDFGL   +         E ++S G K       PE+
Sbjct: 142 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EYTSSVGSKFPVRWSPPEV 192

Query: 245 IKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           +     S ++DI++FGV+M E+ S G     + P             N+     I     
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLG-----KMPYER--------FTNSETAEHIAQGLR 239

Query: 304 -PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                L S                + +  +C       RP  K +L  + D+
Sbjct: 240 LYRPHLASEK-------------VYTIMYSCWHEKADERPTFKILLSNILDV 278

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 57/286 (19%), Positives = 98/286 (34%), Gaps = 41/286 (14%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
           P +V+G    GT+    +  +  V + R L    +  D+E   L E      HPN++   
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIRYF 84

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                 + + + +        L + +      AH       +      GL +LH      
Sbjct: 85  CTEKDRQFQYIAIE--LCAATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 193 IIHGNLKSKNILL-----DRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQGYKAPELI 245
           I+H +LK  NIL+         +  +SDFGL   L +   +         ++G+ APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 246 K---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY 302
                ++ +   DI+S G +   +IS        P           +  A          
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH----PFGKSLQRQANILLGA---------C 245

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             D L     + E            +L     +  P  RP+ K VL
Sbjct: 246 SLDCL-----HPEKHEDVI----ARELIEKMIAMDPQKRPSAKHVL 282

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 63/295 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV------CTTRDKEFGDLIELLGCIRHPN 127
            + IGK  +G +     +             V           + F     ++  +RH N
Sbjct: 198 LQTIGKGEFGDVMLGDYRG----------NKVAVKCIKNDATAQAFLAEASVMTQLRHSN 247

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           LV LLG     +G   IV  +  +G+L   +R           + + S+ +   ++YL  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 306

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
                 +H +L ++N+L+  +    VSDFGL         +    +S     K      A
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGL-------TKE---ASSTQDTGKLPVKWTA 354

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE ++ K  S ++D++SFG+++ E+ S G+ P      P         +    +  R+  
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PR--------IPLKDVVPRVEK 401

Query: 301 LYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            Y       C  +              + +   C     + RP   Q+  +LE +
Sbjct: 402 GYKMDAPDGCPPA-------------VYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 78.5 bits (194), Expect = 9e-17
 Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 40/298 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
            + +GK N+G++                    L+       ++F   IE+L  ++H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              G         L ++  +   G+L   ++          ++   +  I  G++YL T 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGMEYLGT- 132

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             +  IH +L ++NIL++   +  + DFGL  +L     Q+       +  +      AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVL----PQDKEFFKVKEPGESPIFWYAP 186

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT---FMRNAVLDHRIT 299
           E +     S  +D++SFGV++ EL +  E     P              M    L   + 
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

Query: 300 D---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +   L  PD   C +  +              +   C + + + RP+ + +  +++ +
Sbjct: 247 NNGRLPRPDG--CPDEIYM-------------IMTECWNNNVNQRPSFRDLALRVDQI 289

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 49/295 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
            EVIG+ ++G +Y   L  +   ++   ++ L  +    +  +F     ++    HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG      G  L+V P+ K G+L   IR  +       +I    + +A G+ YL +  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLAS-- 146

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APE 243
            +  +H +L ++N +LD  +   V+DFGL   +     +E        G K      A E
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY---DKEYYSVHNKTGAKLPVKWMALE 202

Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD-- 300
            ++ +  + ++D++SFGV++ EL++ G       P PD        +    +   +    
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPD--------VNTFDITVYLLQGR 249

Query: 301 -LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            L  P+   C +               +++ + C  P   +RP+  +++ ++  +
Sbjct: 250 RLLQPEY--CPD-------------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 59/300 (19%), Positives = 126/300 (42%), Gaps = 59/300 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
            EVIG+ ++G +Y   L  +   ++   ++ L  +    +  +F     ++    HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG      G  L+V P+ K G+L   IR  +       +I    + +A G+ +L +  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLAS-- 210

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK--------- 240
            +  +H +L ++N +LD  +   V+DFGL         ++M +      +          
Sbjct: 211 -KKFVHRDLAARNCMLDEKFTVKVADFGL--------ARDMYDKEFDSVHNKTGAKLPVK 261

Query: 241 --APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR 297
             A E ++ +  + ++D++SFGV++ EL++ G       P PD        +    +   
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPD--------VNTFDITVY 308

Query: 298 ITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +     L  P+   C +               +++ + C  P   +RP+  +++ ++  +
Sbjct: 309 LLQGRRLLQPEY--CPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 65/295 (22%), Positives = 128/295 (43%), Gaps = 51/295 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
            +V+G   +G +    L+      +    + L+   T + + +F     ++G   HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 130 PLLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT- 187
            L G     + +  +IV  + + G+L   +R    +     ++  +  GIA G+ YL   
Sbjct: 110 RLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRGIASGMKYLSDM 166

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
           G+    +H +L ++NIL++ N    VSDFGL  +L      +   A  ++G K      +
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLGRVLE----DDPEAAYTTRGGKIPIRWTS 218

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE I  +  +  +D++S+G+++ E++S G     E P  +        M N  +   + +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYG-----ERPYWE--------MSNQDVIKAVDE 265

Query: 301 LYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            Y  P  + C  + +             QL + C     + RP  +Q++  L+ L
Sbjct: 266 GYRLPPPMDCPAALY-------------QLMLDCWQKDRNNRPKFEQIVSILDKL 307

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 65/296 (21%), Positives = 121/296 (40%), Gaps = 59/296 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
              +G   YG +Y+ + ++      V+ L+      T   +EF     ++  I+HPNLV 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 131 LLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           LLG      P     I+  F   GNL   +R  + +     ++  ++  I+  ++YL   
Sbjct: 74  LLGVCTREPPF---YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 129

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             +  IH +L ++N L+  N+   V+DFGL  L+           +A  G K      AP
Sbjct: 130 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFPIKWTAP 181

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD- 300
           E +     S ++D+++FGV++ E+ + G      +P P         +  + +   +   
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPG--------IDLSQVYELLEKD 228

Query: 301 --LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +  P+   C                 ++L  AC   +PS RP+  ++    E +
Sbjct: 229 YRMERPE--GCPEK-------------VYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 58/291 (19%), Positives = 113/291 (38%), Gaps = 51/291 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + +G   +G +     +    V  ++ ++    + D EF    + +  + HP LV   G
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYG 70

Query: 134 --FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
                 P     IV  +   G L   +R          ++  +   +  G+ +L +    
Sbjct: 71  VCSKEYPI---YIVTEYISNGCLLNYLRSHGKGLEPSQLLE-MCYDVCEGMAFLES---H 123

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELI 245
             IH +L ++N L+DR+    VSDFG+   +         +  +S G K      APE+ 
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPVKWSAPEVF 177

Query: 246 KMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH- 303
                S ++D+++FG++M E+ S G     + P             N+ +  +++  +  
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLG-----KMPYDL--------YTNSEVVLKVSQGHRL 224

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
               L S++              +Q+  +C    P  RP  +Q+L  +E L
Sbjct: 225 YRPHLASDT-------------IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 55/297 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
            ++IG  + G +    L+  G   +    + L+   T R + +F     ++G   HPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 130 PLLGFYAGPRGE-KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT- 187
            L G     RG   +IV  + + G+L   +R   G+     ++  +  G+  G+ YL   
Sbjct: 114 RLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-MLRGVGAGMRYLSDL 170

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
           G+    +H +L ++N+L+D N    VSDFGL  +L      +   A  + G K      A
Sbjct: 171 GY----VHRDLAARNVLVDSNLVCKVSDFGLSRVL----EDDPDAAYTTTGGKIPIRWTA 222

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE I  +  S  +D++SFGV+M E+++ G     E P  +        M N  +   + +
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYG-----ERPYWN--------MTNRDVISSVEE 269

Query: 301 ---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              L  P    C ++ H             QL + C     + RP   Q++  L+ L
Sbjct: 270 GYRLPAPM--GCPHALH-------------QLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 55/297 (18%), Positives = 110/297 (37%), Gaps = 58/297 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
             ++G+  +G +Y+ +       ++   ++  +  CT  +K +F     ++  + HP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 130 PLLG-FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT- 187
            L+G     P     I+   Y  G L   +          +++   S+ I   + YL + 
Sbjct: 77  KLIGIIEEEPT---WIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMAYLESI 132

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
                 +H ++  +NIL+       + DFGL   +         +   +   +      +
Sbjct: 133 NC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLPIKWMS 182

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
           PE I  +  +  +D++ F V M E++S GK+P                + N  +   +  
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW-------------LENKDVIGVLEK 229

Query: 301 ---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              L  PD  LC                 + L   C    PS RP   +++  L D+
Sbjct: 230 GDRLPKPD--LCPPV-------------LYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 40/298 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
            + +GK N+G++                    L+       ++F   IE+L  ++H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 130 PLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              G         L ++  +   G+L   ++          ++   +  I  G++YL T 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGMEYLGT- 163

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             +  IH +L ++NIL++   +  + DFGL  +L     Q+       +  +      AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVL----PQDKEYYKVKEPGESPIFWYAP 217

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT---FMRNAVLDHRIT 299
           E +     S  +D++SFGV++ EL +  E     P              M    L   + 
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

Query: 300 D---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +   L  PD   C +  +              +   C + + + RP+ + +  +++ +
Sbjct: 278 NNGRLPRPDG--CPDEIYM-------------IMTECWNNNVNQRPSFRDLALRVDQI 320

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 58/296 (19%), Positives = 113/296 (38%), Gaps = 54/296 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRDK-EFGDLIELLGCIRHPNL 128
            +V+G   +GT+YK L    G    +      LR   + +   E  D   ++  + +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             LLG          ++      G L   +R          ++    + IA G++YL   
Sbjct: 80  CRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLED- 135

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             R ++H +L ++N+L+       ++DFGL  LL    G E  E  A  G K      A 
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GAEEKEYHAEGG-KVPIKWMAL 188

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD- 300
           E I  +  + ++D++S+GV + EL++ G +P                +  + +   +   
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DG--------IPASEISSILEKG 235

Query: 301 --LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             L  P   +C+                + +   C       RP  ++++ +   +
Sbjct: 236 ERLPQPP--ICTID-------------VYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 59/306 (19%), Positives = 114/306 (37%), Gaps = 57/306 (18%)

Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRL--LRFLRPVCTTRDK-EFGDLIE 118
           ++L I DI       +G  N+G++ + + +         ++ L+      D  E     +
Sbjct: 9   DNLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGI 178
           ++  + +P +V L+G         ++V      G L + + G   E    ++   +   +
Sbjct: 63  IMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQV 119

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
           + G+ YL     +  +H +L ++N+LL   +   +SDFGL   L    G +    +A   
Sbjct: 120 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL----GADDSYYTARSA 172

Query: 239 YK------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRN 291
            K      APE I  +  S  +D++S+GV M E +S G++P  +             M+ 
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-------------MKG 219

Query: 292 AVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
             +   I     +  P    C                 + L   C       RP+   V 
Sbjct: 220 PEVMAFIEQGKRMECPP--ECPPE-------------LYALMSDCWIYKWEDRPDFLTVE 264

Query: 349 WKLEDL 354
            ++   
Sbjct: 265 QRMRAC 270

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 54/297 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF----LRPVCTTRDK-EFGDLIELLGCIRHPNL 128
            +VIG   +G +YK +L+ S   + +      L+   T + + +F     ++G   H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 129 VPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           + L G      P    +I+  + + G L + +R   GE     ++  +  GIA G+ YL 
Sbjct: 109 IRLEGVISKYKPM---MIITEYMENGALDKFLREKDGEFSVLQLVG-MLRGIAAGMKYLA 164

Query: 187 T-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK----- 240
              +    +H +L ++NIL++ N    VSDFGL  +L      +      + G K     
Sbjct: 165 NMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVL----EDDPEATYTTSGGKIPIRW 216

Query: 241 -APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRI 298
            APE I  +  +  +D++SFG++M E+++ G     E P  +        + N  +   I
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYG-----ERPYWE--------LSNHEVMKAI 263

Query: 299 TDLYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            D +  P  + C ++ +             QL M C     + RP    ++  L+ L
Sbjct: 264 NDGFRLPTPMDCPSAIY-------------QLMMQCWQQERARRPKFADIVSILDKL 307

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 51/292 (17%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRL--LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLL 132
            +G  N+G++ + + +         ++ L+      D  E     +++  + +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G         ++V      G L + + G   E    ++   +   ++ G+ YL     + 
Sbjct: 403 GVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEE---KN 456

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APELIK 246
            +H NL ++N+LL   +   +SDFGL   L    G +    +A    K      APE I 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKAL----GADDSYYTARSAGKWPLKWYAPECIN 512

Query: 247 MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD---LY 302
            +  S  +D++S+GV M E +S G++P  +             M+   +   I     + 
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKK-------------MKGPEVMAFIEQGKRME 559

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            P    C                 + L   C       RP+   V  ++   
Sbjct: 560 CPP--ECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 596

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 55/295 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLL 132
           GE IG+ N+G ++   L+   ++  ++  R       K +F     +L    HPN+V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 133 G--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           G      P     IV    + G+    +R   G   +   + ++    A G++YL +   
Sbjct: 179 GVCTQKQPI---YIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLES--- 231

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK-------APE 243
           +  IH +L ++N L+       +SDFG+               +AS G +       APE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG------VYAASGGLRQVPVKWTAPE 285

Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD-- 300
            +     S E+D++SFG+++ E  S G  P      P+        + N      +    
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPY-----PN--------LSNQQTREFVEKGG 332

Query: 301 -LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            L  P+  LC ++              F+L   C +  P  RP+   +  +L+ +
Sbjct: 333 RLPCPE--LCPDA-------------VFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 37/319 (11%), Positives = 90/319 (28%), Gaps = 82/319 (25%)

Query: 74  GEVIGKSNYGTLYKALLQRSG---------------------------SVRLLRFLR-PV 105
           G V+G+ +     +A  Q +G                            +RLLR ++   
Sbjct: 78  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 106 CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI-----RG 160
                  F    +L+   +   ++ +                   + NL           
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 161 GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL 220
            + ++       ++++ +   L  LH   H  ++H  L+  +I+LD+    +++ F   +
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 221 LLNPTAGQEMLEASASQGYKAPELIKMK-----------DASEETDIYSFGVIMLELISG 269
                     + +S S+G++ PEL   +             +   D ++ G+++  +   
Sbjct: 255 RDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQL 329
             P                +  +    R                    + +   ++   L
Sbjct: 310 DLP----------ITKDAALGGSEWIFR----------------SCKNIPQP--VR--AL 339

Query: 330 AMACCSPSPSLRPNIKQVL 348
                      R    Q +
Sbjct: 340 LEGFLRYPKEDRLLPLQAM 358

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 54/296 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
            +V+G   +GT++K +    G    +      +      +  +   D +  +G + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V LLG   G      +V  +   G+L   +R   G      ++    + IA G+ YL   
Sbjct: 78  VRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGMYYLEE- 133

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
               ++H NL ++N+LL    Q  V+DFG+  LL P       +       K      A 
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKTPIKWMAL 186

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD- 300
           E I     + ++D++S+GV + EL++ G EP                +R A +   +   
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-----AG--------LRLAEVPDLLEKG 233

Query: 301 --LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             L  P   +C+                + + + C     ++RP  K++  +   +
Sbjct: 234 ERLAQPQ--ICTID-------------VYMVMVKCWMIDENIRPTFKELANEFTRM 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 53/294 (18%), Positives = 107/294 (36%), Gaps = 52/294 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
           G  IG+  +G +++ +     +  L   ++  +   +   + +F      +    HP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT-G 188
            L+G          I+      G L   ++         S+I   +  ++  L YL +  
Sbjct: 80  KLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESKR 136

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
           F    +H ++ ++N+L+  N    + DFGL   +  +          +   K      AP
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAP 186

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           E I  +  +  +D++ FGV M E++  G       P           ++N  +  RI + 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHG-----VKPFQG--------VKNNDVIGRIENG 233

Query: 302 YH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
              P    C  +              + L   C +  PS RP   ++  +L  +
Sbjct: 234 ERLPMPPNCPPT-------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 61/295 (20%), Positives = 121/295 (41%), Gaps = 49/295 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDKEFGDLI---ELLGCIRHPN 127
             VIGK ++G +Y          R+   ++ L  +   +  E    +    L+  + HPN
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE--AFLREGLLMRGLNHPN 83

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L+G    P G   ++ P+   G+L Q IR          +I    + +A G++YL  
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS-FGLQVARGMEYLAE 142

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------A 241
              +  +H +L ++N +LD ++   V+DFGL   +     +E       +  +      A
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL---DREYYSVQQHRHARLPVKWTA 196

Query: 242 PELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD 300
            E ++    + ++D++SFGV++ EL++ G       P           +    L H +  
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRG-----APPYRH--------IDPFDLTHFLAQ 243

Query: 301 LYH-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
               P    C +S              +Q+   C    P++RP  + ++ ++E +
Sbjct: 244 GRRLPQPEYCPDS-------------LYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 17/219 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
            E +G   +G + + + Q +G    ++  R   + +++E +   I+++  + HPN+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 133 GFYAGPRGEKLIVHPF----Y-KRGNLAQCI-RGGSGEAHKWSIIYRISIGIAGGLDYLH 186
               G +       P     Y + G+L + + +  +    K   I  +   I+  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPY---VSDFGLHLLLNPTAGQEMLEASA-SQGYKAP 242
                 IIH +LK +NI+L    Q     + D G    L+     E+      +  Y AP
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAP 192

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE 281
           EL++ K  +   D +SFG +  E I+G  P   N  P +
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 56/309 (18%), Positives = 103/309 (33%), Gaps = 76/309 (24%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-------LRPVCTTRDKEFGDLIELLGCIRHP 126
            E +G+  +  ++K + +  G    L         L        + F +   ++  + H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 127 NLVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +LV   G           ++V  F K G+L   ++      +    +  ++  +A  + +
Sbjct: 73  HLVLNYGVCVCGDEN---ILVQEFVKFGSLDTYLKKNKNCINILWKLE-VAKQLAAAMHF 128

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPY--------VSDFGLHLLLNPTAGQEMLEASAS 236
           L       +IHGN+ +KNILL R             +SD G+ + + P            
Sbjct: 129 LEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----------K 174

Query: 237 QGYK------APELIK-MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTF 288
              +       PE I+  K+ +  TD +SFG  + E+ S G +P            L   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP------------LSA- 221

Query: 289 MRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK 345
           + +        D   L  P             +          L   C    P  RP+ +
Sbjct: 222 LDSQRKLQFYEDRHQLPAPK--AA-------EL--------ANLINNCMDYEPDHRPSFR 264

Query: 346 QVLWKLEDL 354
            ++  L  L
Sbjct: 265 AIIRDLNSL 273

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 25/207 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLR-FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
           + IG    G +  A            +L R F       R  +E    + L+ C+ H N+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNI 123

Query: 129 VPLLG-FYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           + LL  F      E+     +V       NL Q I+          ++Y++      G+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQM----LCGIK 178

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           +LH+     IIH +LK  NI++  +    + DFGL      +    M     ++ Y+APE
Sbjct: 179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 233

Query: 244 LIKMKDASEETDIYSFGVIMLELISGK 270
           +I      E  DI+S G IM E++  K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y    G++L +V  +   G+L   +      E      I  +       L++LH+     
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRECLQALEFLHS---NQ 136

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGYKAPE 243
           +IH ++KS NILL  +    ++DFG    + P   +          M          APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM----------APE 186

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           ++  K    + DI+S G++ +E+I G+ P +NENP
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 54/296 (18%), Positives = 114/296 (38%), Gaps = 54/296 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLR----FLRPVCTTRDK-EFGDLIELLGCIRHPNL 128
            +V+G   +GT+YK L    G    +      LR   + +   E  D   ++  + +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             LLG          ++      G L   +R          ++    + IA G++YL   
Sbjct: 80  CRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGMNYLED- 135

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
             R ++H +L ++N+L+       ++DFGL  LL         +   ++G K      A 
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMAL 188

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD- 300
           E I  +  + ++D++S+GV + EL++ G +P +              +  + +   +   
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------------IPASEISSILEKG 235

Query: 301 --LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             L  P   +C+                + + + C       RP  ++++ +   +
Sbjct: 236 ERLPQPP--ICTID-------------VYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
             IG+ + G +  A  + SG    ++ +      R +   + + ++   +H N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           Y    GE+L ++  F + G L   +      E      I  +   +   L YLH    + 
Sbjct: 111 YL--VGEELWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHA---QG 161

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGYKAPE 243
           +IH ++KS +ILL  + +  +SDFG    ++    +          M          APE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM----------APE 211

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           +I     + E DI+S G++++E++ G+ P  +++P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKEFGDLIELLGCIRHPNLVPL 131
            + +G   YG +     + +   R ++ +    V T+ + +  + + +L  + HPN++ L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
             F+   R    +V   YK G L   I  R    E     II +    +  G+ YLH   
Sbjct: 102 YDFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ----VLSGVTYLH--- 153

Query: 190 HRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
              I+H +LK +N+LL   +++    + DFGL  +      ++M E   +  Y APE+++
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLR 211

Query: 247 MKDASEETDIYSFGVIMLELISGKEP 272
            K   E+ D++S GVI+  L++G  P
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPP 236

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 28/208 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLR-FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
             +G   YG++  A+ +RSG      +L R F   +   R  +E    + LL  ++H N+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLKHMQHENV 85

Query: 129 VPLLG-FYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           + LL  F             +V PF +  +L + +     E     ++Y++      GL 
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQM----LKGLK 140

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           Y+H+     ++H +LK  N+ ++ + +  + DFGL    +     EM     ++ Y+APE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPE 193

Query: 244 LI-KMKDASEETDIYSFGVIMLELISGK 270
           +I      ++  DI+S G IM E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 34/244 (13%), Positives = 74/244 (30%), Gaps = 55/244 (22%)

Query: 74  GEVIGKSNYG---------------TLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE 118
              + +  +                   K+LL++          +    ++  +F + ++
Sbjct: 36  IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 119 LLGCIRHPNLVPLLGF------------YAGPRGE--KLIVHPFYKRGNLAQCIRGGSGE 164
           ++  I++   +   G             Y        K           L +        
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYM-ENDSILKFDE----YFFVLDKNYTCFIPI 150

Query: 165 AHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-----H 219
                II      +     Y+H    + I H ++K  NIL+D+N +  +SDFG       
Sbjct: 151 QVIKCIIK----SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 220 LLLNPTAGQEMLEASASQGYKAPELI--KMKDASEETDIYSFGVIMLELISGKEPINENP 277
             +  + G        +  +  PE    +      + DI+S G+ +  +     P +   
Sbjct: 205 KKIKGSRG--------TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 278 TPDE 281
           +  E
Sbjct: 257 SLVE 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 25/207 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLR-FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
           + IG    G +  A            +L R F       R  +E    + L+ C+ H N+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNI 86

Query: 129 VPLLG-FYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLD 183
           + LL  F      E+     IV       NL Q I+          ++Y++      G+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQMELDHERMSYLLYQM----LCGIK 141

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
           +LH+     IIH +LK  NI++  +    + DFGL      +    M     ++ Y+APE
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 196

Query: 244 LIKMKDASEETDIYSFGVIMLELISGK 270
           +I      E  DI+S G IM E+I G 
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKEFGDL---IELLGCIRHPNL 128
             V+GK ++G +     + +G    ++ +  R V    DKE   L   ++LL  + HPN+
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPNI 88

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           + L  F+        +V   Y  G L   I  R    E     II +    +  G+ Y+H
Sbjct: 89  MKLYEFFEDKG-YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ----VLSGITYMH 143

Query: 187 TGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
                 I+H +LK +N+LL    ++    + DFGL         ++M +   +  Y APE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPE 198

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEP 272
           ++      E+ D++S GVI+  L+SG  P
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 31/218 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVR---------LLRFLRPVCTTRDKEFGDL----IELL 120
              +G   YG +     +   S +           +          ++F +     I LL
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 121 GCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIG 177
             + HPN++ L   +   +     +V  FY+ G L + I  R    E    +I+ +    
Sbjct: 101 KSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ---- 154

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEAS 234
           I  G+ YLH      I+H ++K +NILL   +      + DFGL    +     ++ +  
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRL 209

Query: 235 ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            +  Y APE++K K  +E+ D++S GVIM  L+ G  P
Sbjct: 210 GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 54/235 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI-EL---LGCIRHPNLVP 130
             +G+  YG + K     SG +  ++ +R   T   +E   L+ +L   +  +  P  V 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPFTV- 69

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIR--GGS-----------GEAHKWSIIYRISIG 177
              FY             ++ G++  C+     S           G+     I+ +I++ 
Sbjct: 70  --TFYGA----------LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS- 236
           I   L++LH+     +IH ++K  N+L++   Q  + DFG+       +G   L    + 
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGI-------SGY--LVDDVAK 166

Query: 237 ------QGYKAPELIKMKDA----SEETDIYSFGVIMLELISGKEPINENPTPDE 281
                 + Y APE I  +      S ++DI+S G+ M+EL   + P +   TP +
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 39/187 (20%), Positives = 81/187 (43%), Gaps = 27/187 (14%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG-----EAHKWSI 170
           +++   ++HP+++ L  ++       + +V      G + + ++         EA     
Sbjct: 62  VKIHCQLKHPSILELYNYFEDS--NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--F 117

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +++I      G+ YLH+     I+H +L   N+LL RN    ++DFGL   L      E 
Sbjct: 118 MHQI----ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEK 168

Query: 231 LEAS-ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------ED 282
                 +  Y +PE+        E+D++S G +   L+ G+ P + +   +        D
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228

Query: 283 FHLPTFM 289
           + +P+F+
Sbjct: 229 YEMPSFL 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 44/222 (19%), Positives = 85/222 (38%), Gaps = 51/222 (22%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            E +G   +G +++   + +G+    +F+    T  + +   +   I+ +  +RHP LV 
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 131 LLGFYAGPR-----------GEKL--IVHPFYKRGNL-----AQCIRGGSGEAHKWSIIY 172
           L   +               GE    +     +   +      + +R             
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ------------ 263

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV--SDFGLHLLLNPTAGQEM 230
                +  GL ++H       +H +LK +NI+        +   DFGL   L+P   Q +
Sbjct: 264 -----VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSV 313

Query: 231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              + +  + APE+ + K     TD++S GV+   L+SG  P
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 37/213 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEFGDL---------IELLGCIR 124
             +G   YG++  A   ++G  V + +  RP        F  +         + LL  ++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--------FQSIIHAKRTYRELRLLKHMK 86

Query: 125 HPNLVPLLG-FYAGPRGEKL----IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGI 178
           H N++ LL  F      E+     +V       +L   ++     + H   +IY+I    
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI---- 141

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
             GL Y+H+     IIH +LK  N+ ++ + +  + DFGL          EM    A++ 
Sbjct: 142 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRW 194

Query: 239 YKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
           Y+APE++      ++  DI+S G IM EL++G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 51/293 (17%), Positives = 107/293 (36%), Gaps = 50/293 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL---LRFLRPVCTTRDK-EFGDLIELLGCIRHPNLV 129
           G  IG+  +G +++ +     +  +   ++  +   +   + +F      +    HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L+G          I+      G L   ++         S+I   +  ++  L YL +  
Sbjct: 455 KLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLES-- 509

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------APE 243
            +  +H ++ ++N+L+  N    + DFGL   +  +          +   K      APE
Sbjct: 510 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPE 562

Query: 244 LIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY 302
            I  +  +  +D++ FGV M E++  G       P           ++N  +  RI +  
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHG-----VKPFQG--------VKNNDVIGRIENGE 609

Query: 303 H-PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             P    C  +              + L   C +  PS RP   ++  +L  +
Sbjct: 610 RLPMPPNCPPT-------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
              +G   +G ++    + SG  R+++ +    +    E   +   IE+L  + HPN++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME--QIEAEIEVLKSLDHPNIIK 84

Query: 131 LLGFYAGPR-----------GEKL--IVHPFYKRGNL-----AQCIRGGSGEAHKWSIIY 172
           +   +               GE L  IV    +   L     A+ ++             
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK------------- 131

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQE 229
                +   L Y H    + ++H +LK +NIL      +    + DFGL  L      + 
Sbjct: 132 ----QMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEH 182

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              A+ +  Y APE+ K +D + + DI+S GV+M  L++G  P
Sbjct: 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 55/296 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS-----VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL 128
            + +G  N+GT+ K   Q         V++L+        +D E      ++  + +P +
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYI 80

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           V ++G         ++V    + G L + ++       K   I  +   ++ G+ YL   
Sbjct: 81  VRMIGICEAES--WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK------AP 242
                +H +L ++N+LL   +   +SDFGL   L      +     A    K      AP
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL----RADENYYKAQTHGKWPVKWYAP 189

Query: 243 ELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITD- 300
           E I     S ++D++SFGV+M E  S G++P                M+ + +   +   
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-------------MKGSEVTAMLEKG 236

Query: 301 --LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +  P    C                 + L   C +     RP    V  +L + 
Sbjct: 237 ERMGCPA--GCPRE-------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 45/230 (19%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E IGK ++G ++K +  R+  V  ++ +  +    D E  D+   I +L     P +   
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAED-EIEDIQQEITVLSQCDSPYVTKY 85

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            G Y   +  KL I+  +   G+    +  G  +  + + I R    I  GLDYLH+   
Sbjct: 86  YGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHS--- 137

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGYKA 241
              IH ++K+ N+LL  + +  ++DFG+   L  T  +          M          A
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM----------A 187

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP------------INENPTP 279
           PE+IK      + DI+S G+  +EL  G+ P            I +N  P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP 237

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 32/188 (17%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYR 173
           IE+   +RHPN++ +  ++   +  ++ ++  F  RG L + ++  G   E    + +  
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-----HLLLNPTAGQ 228
               +A  L Y H    R +IH ++K +N+L+    +  ++DFG       L      G 
Sbjct: 123 ----LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG- 174

Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------E 281
                  +  Y  PE+I+ K   E+ D++  GV+  E + G  P +     +        
Sbjct: 175 -------TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227

Query: 282 DFHLPTFM 289
           D   P F+
Sbjct: 228 DLKFPPFL 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 50/216 (23%), Positives = 79/216 (36%), Gaps = 35/216 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDL---IELLGCIR 124
             V+GK  YG +Y      +        +              +    L   I L   ++
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE---------RDSRYSQPLHEEIALHKHLK 77

Query: 125 HPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKW-SIIYRISIGIAGGL 182
           H N+V  LG +       + I       G+L+  +R   G        I   +  I  GL
Sbjct: 78  HKNIVQYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135

Query: 183 DYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAGQEMLEASASQG--- 238
            YLH      I+H ++K  N+L++  +    +SDFG    L               G   
Sbjct: 136 KYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE----TFTGTLQ 188

Query: 239 YKAPELIKMKD--ASEETDIYSFGVIMLELISGKEP 272
           Y APE+I        +  DI+S G  ++E+ +GK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 58/311 (18%), Positives = 124/311 (39%), Gaps = 73/311 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDKEFGDLI---ELLGCIRHPN 127
           G+++G+  +G++ +  L++     L    + ++   ++  +E  + +     +    HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPN 97

Query: 128 LVPLLG--FYAGPRGEK--LIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGIA 179
           ++ LLG       +G    +++ PF K G+L   +     E     I    + +  + IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            G++YL     R  +H +L ++N +L  +    V+DFGL         +++        Y
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGL--------SKKIYSGDY---Y 203

Query: 240 K------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP 286
           +            A E +  +  + ++D+++FGV M E+ + G       P P       
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM-----TPYPG------ 252

Query: 287 TFMRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN 343
             ++N  +   +     L  P+   C +             + +++  +C    P  RP 
Sbjct: 253 --VQNHEMYDYLLHGHRLKQPED--CLD-------------ELYEIMYSCWRTDPLDRPT 295

Query: 344 IKQVLWKLEDL 354
              +  +LE L
Sbjct: 296 FSVLRLQLEKL 306

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 35/227 (15%), Positives = 81/227 (35%), Gaps = 20/227 (8%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
            +++G+     +++   +++G +  ++    +   R  +      E+L  + H N+V L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCI-RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
                       ++  F   G+L   +    +      S    +   + GG+++L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 191 RPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
             I+H N+K  NI+            ++DFG    L     ++ +    ++ Y  P++ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPDMYE 188

Query: 247 MKDA--------SEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
                           D++S GV      +G  P      P  +  +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 28/237 (11%), Positives = 72/237 (30%), Gaps = 41/237 (17%)

Query: 74  GEVIGKSNYGTLYKA---------------------------LLQRSGSVRLLRFLR-PV 105
           G V+G+ +     +A                           + +    +RLLR ++   
Sbjct: 83  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 106 CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI-----RG 160
                  F    +L+   +   ++ +                   + NL           
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 161 GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL 220
            + ++       ++++ +   L  LH   H  ++H  L+  +I+LD+    +++ F   +
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 221 LLNPTAGQEMLEASASQGYKAPELIKMKDA-----SEETDIYSFGVIMLELISGKEP 272
               +A   +    A     A  ++          +   D ++ G+ +  +     P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 22/184 (11%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCI--RGGSGEAHKWSIIYR 173
           I +   + H ++V   GF+     + + +V    +R +L +    R    E      +  
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR- 148

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
               I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +      E  + 
Sbjct: 149 ---QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKV 200

Query: 234 S-ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHL 285
              +  Y APE++  K  S E D++S G IM  L+ GK P   +   +        ++ +
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260

Query: 286 PTFM 289
           P  +
Sbjct: 261 PKHI 264

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 55/236 (23%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLI-EL---LGCIRHPNLVP 130
             IG+  YG++ K + + SG +  ++ +R   T  +KE   L+ +L   +     P +V 
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSDCPYIV- 84

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCI---RGGSGEAHKW-----------SIIYRISI 176
              FY             ++ G+   C+        + +K+            I+ +I++
Sbjct: 85  --QFYGA----------LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASAS 236
                L++L       IIH ++K  NILLDR+    + DFG+       +GQ  L  S +
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI-------SGQ--LVDSIA 181

Query: 237 -------QGYKAPELIKMKDASEE----TDIYSFGVIMLELISGKEPINENPTPDE 281
                  + Y APE I    + +     +D++S G+ + EL +G+ P  +  +  +
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 22/184 (11%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCI--RGGSGEAHKWSIIYR 173
           I +   + H ++V   GF+     + + +V    +R +L +    R    E      +  
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR- 122

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
               I  G  YLH      +IH +LK  N+ L+ + +  + DFGL   +      E  + 
Sbjct: 123 ---QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKV 174

Query: 234 S-ASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHL 285
              +  Y APE++  K  S E D++S G IM  L+ GK P   +   +        ++ +
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 234

Query: 286 PTFM 289
           P  +
Sbjct: 235 PKHI 238

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 50/225 (22%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVR-----LLRFLRPVCTTRDKEFGDL---IELLGCIRH 125
           GE +G   +  + K   + +G          R  R       +E  ++   + +L  + H
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE--EIEREVSILRQVLH 74

Query: 126 PNLVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSII 171
            N++ L   Y               GE    L              I+            
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----------- 123

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAG 227
                 I  G++YLHT   + I H +LK +NI+L     P     + DFGL   +    G
Sbjct: 124 ------ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--G 172

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            E      +  + APE++  +    E D++S GVI   L+SG  P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 31/140 (22%), Positives = 57/140 (40%), Gaps = 22/140 (15%)

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
            +       L++ H      IIH ++K  NI++       V DFG+   +   +G  + +
Sbjct: 120 EVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQ 175

Query: 233 ASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP-------------INEN 276
            +A  G   Y +PE  +       +D+YS G ++ E+++G+ P             + E+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235

Query: 277 PTP--DEDFHLPTFMRNAVL 294
           P P       L   +   VL
Sbjct: 236 PIPPSARHEGLSADLDAVVL 255

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 34/189 (17%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIR--GGSGEAHKWSIIYR 173
           +E+   +RHPN++ L G++      ++ ++  +   G + + ++      E    + I  
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL-----HLLLNPTAGQ 228
               +A  L Y H+   + +IH ++K +N+LL    +  ++DFG              G 
Sbjct: 118 ----LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG- 169

Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE------- 281
                  +  Y  PE+I+ +   E+ D++S GV+  E + GK P  E  T  E       
Sbjct: 170 -------TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISR 221

Query: 282 -DFHLPTFM 289
            +F  P F+
Sbjct: 222 VEFTFPDFV 230

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 49/223 (21%), Positives = 81/223 (36%), Gaps = 46/223 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL------IELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   +   +           + +L  + HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 128 LVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYR 173
           ++ L   Y               GE    L              I+              
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------------- 123

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQE 229
               I  G++YLHT   + I H +LK +NI+L     P     + DFGL   +    G E
Sbjct: 124 ----ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVE 174

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                 +  + APE++  +    E D++S GVI   L+SG  P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            E +G   +G +++ + + +G V + +F+       DK    +   I ++  + HP L+ 
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY--TVKNEISIMNQLHHPKLIN 112

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGG------SGEAHKWS--IIYRISIGIAGGL 182
           L   +       LI+          + + GG      + E +K S   +         GL
Sbjct: 113 LHDAFEDKYEMVLIL----------EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYV--SDFGLHLLLNPTAGQEMLEASASQGYK 240
            ++H      I+H ++K +NI+ +      V   DFGL   LNP   + +   +A+  + 
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFA 217

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEP 272
           APE++  +     TD+++ GV+   L+SG  P
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 31/103 (30%), Positives = 54/103 (52%), Gaps = 9/103 (8%)

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             +  I  G+ + H      I+H ++K +NIL+D N    + DFG+   L+ T+   + +
Sbjct: 115 NFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS---LTQ 168

Query: 233 ASASQG---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            +   G   Y +PE  K +   E TDIYS G+++ E++ G+ P
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLR-FLRPVCTTRD-KEFGDLIELLGCIRHPNL 128
           + +G   YG +  A+  R+G+     +L R F   +   R  +E    + LL  +RH N+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMRHENV 86

Query: 129 VPLLG-FYAGPRGEKL----IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGL 182
           + LL  F      +      +V PF    +L + ++    GE     ++Y++      GL
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQM----LKGL 141

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
            Y+H      IIH +LK  N+ ++ + +  + DFGL    +     EM     ++ Y+AP
Sbjct: 142 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAP 194

Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGK 270
           E+I      ++  DI+S G IM E+I+GK
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 39/299 (13%), Positives = 96/299 (32%), Gaps = 23/299 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDLIELLGCIRHPNLVPLL 132
            +++G+     +++   +++G +  ++    +   R  +      E+L  + H N+V L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCI-RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
                       ++  F   G+L   +    +      S    +   + GG+++L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 191 RPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
             I+H N+K  NI+            ++DFG    L     ++ +    ++ Y  P++ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPDMYE 188

Query: 247 MKDA--------SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI 298
                           D++S GV      +G  P      P  +  +   +        I
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 299 TDLYHPD---MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           + +   +   +    +      +S    +    +                Q   +  D+
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 25/209 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLV 129
             IG+  YG +  A    +       ++  F       R  +E    I++L   RH N++
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRHENII 88

Query: 130 PLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDY 184
            +      P  E++    IV    +  +L + ++       H    +Y+I      GL Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQI----LRGLKY 143

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--HLLLNPTAGQEMLEASASQGYKAP 242
           +H+     ++H +LK  N+LL+      + DFGL      +      + E  A++ Y+AP
Sbjct: 144 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGK 270
           E++   K  ++  DI+S G I+ E++S +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.6 bits (166), Expect = 4e-13
 Identities = 50/260 (19%), Positives = 97/260 (37%), Gaps = 61/260 (23%)

Query: 34  HNDLEINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRS 93
           H+    +   +N   +G   +                     ++GK ++G + K   + +
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNI---------------VCMLGKGSFGEVLKCKDRIT 46

Query: 94  GSVRLL-RFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPLLGFYAGPR---------- 139
                +    +     +D     +   +ELL  + HPN++ L                  
Sbjct: 47  QQEYAVKVINKASAKNKDTS--TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104

Query: 140 -GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIH 195
            GE   ++I    +   + A+ I+                  +  G+ Y+H      I+H
Sbjct: 105 GGELFDEIIKRKRFSEHDAARIIKQ-----------------VFSGITYMHK---HNIVH 144

Query: 196 GNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
            +LK +NILL   +++    + DFGL          +M +   +  Y APE+++     E
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVLR-GTYDE 201

Query: 253 ETDIYSFGVIMLELISGKEP 272
           + D++S GVI+  L+SG  P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 50/225 (22%), Positives = 82/225 (36%), Gaps = 50/225 (22%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVR-----LLRFLRPVCTTRDKEFGDL---IELLGCIRH 125
           GE +G   +  + K   + +G          R  +       +E  D+   + +L  I+H
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE--DIEREVSILKEIQH 73

Query: 126 PNLVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSII 171
           PN++ L   Y               GE    L            + ++            
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----------- 122

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAG 227
                 I  G+ YLH+     I H +LK +NI+L     P     + DFGL   ++   G
Sbjct: 123 ------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--G 171

Query: 228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            E      +  + APE++  +    E D++S GVI   L+SG  P
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 44/298 (14%), Positives = 103/298 (34%), Gaps = 58/298 (19%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL-RFLRPVCTTRDKEFGDLIE----LLGCIRHPNL 128
            E IG   +G+++K + +  G +  + R  +P+  + D++  + +          +H ++
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHAVLGQHSHV 73

Query: 129 VPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWS--IIYRISIGIAGGLDYL 185
           V     +A    + + I + +   G+LA  I         +    +  + + +  GL Y+
Sbjct: 74  VRYFSAWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-----------EMLEAS 234
           H      ++H ++K  NI + R   P  +          +               +    
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 235 ASQG---YKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR 290
             +G   + A E+++       + DI++  + ++     +      P   + +       
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRNGDQW------- 237

Query: 291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                H I     P +           +S+E    F +L      P P  RP+   ++
Sbjct: 238 -----HEIRQGRLPRI--------PQVLSQE----FTELLKVMIHPDPERRPSAMALV 278

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 67.2 bits (165), Expect = 6e-13
 Identities = 48/223 (21%), Positives = 82/223 (36%), Gaps = 46/223 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL------IELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++    +  +           + +L  IRHPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 128 LVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYR 173
           ++ L   +               GE    L            Q ++              
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------------- 116

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQE 229
               I  G+ YLH+   + I H +LK +NI+L     P     + DFG+   +    G E
Sbjct: 117 ----ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNE 167

Query: 230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                 +  + APE++  +    E D++S GVI   L+SG  P
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 49/214 (22%), Positives = 76/214 (35%), Gaps = 28/214 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE-FGDL---------IELLGCIR 124
             I   +YG +   +      V + R    V   R      D          I LL    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 125 HPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIG 177
           HPN++ L   +       +    +V    +  +LAQ I          H    +Y I   
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI--- 143

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
              GL  LH      ++H +L   NILL  N    + DF L                  +
Sbjct: 144 -LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHR 197

Query: 238 GYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
            Y+APEL+ + K  ++  D++S G +M E+ + K
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 47/219 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
              +G+     +Y+   + +     L+ L+    T DK+   +   I +L  + HPN++ 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKK--IVRTEIGVLLRLSHPNIIK 112

Query: 131 LLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           L   +  P            GE   +++   +Y   + A  ++                 
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ---------------- 156

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
            I   + YLH      I+H +LK +N+L      +    ++DFGL  ++       M   
Sbjct: 157 -ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTV 210

Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
             + GY APE+++      E D++S G+I   L+ G EP
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 58/312 (18%), Positives = 123/312 (39%), Gaps = 74/312 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL---RFLRPVCTTRDKEFGDLI---ELLGCIRHPN 127
           G ++GK  +G++ +A L++     +    + L+        +  + +     +    HP+
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPH 86

Query: 128 LVPLLG--FYAGPRGEK---LIVHPFYKRGNLAQCIRGGSGEAHKWSI----IYRISIGI 178
           +  L+G    +  +G     +++ PF K G+L   +       + +++    + R  + I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG 238
           A G++YL +   R  IH +L ++N +L  +    V+DFGL         +++        
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGL--------SRKIYSGDY--- 192

Query: 239 YK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHL 285
           Y+            A E +     +  +D+++FGV M E+++ G+      P        
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ-----TPYAG----- 242

Query: 286 PTFMRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP 342
              + NA + + +     L  P    C               + + L   C S  P  RP
Sbjct: 243 ---IENAEIYNYLIGGNRLKQPP--ECME-------------EVYDLMYQCWSADPKQRP 284

Query: 343 NIKQVLWKLEDL 354
           +   +  +LE++
Sbjct: 285 SFTCLRMELENI 296

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 44/248 (17%), Positives = 83/248 (33%), Gaps = 52/248 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVR-----LLRFLRPVCTTRDKEFGDLIELLGCIRHPNL 128
              IG+ +YG +  A+  ++ ++R         +R +     +     + L+  + HPN+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 129 VPLLGFYAGP---------------------RGEKLIVHPFYKRGNLAQCIRGGSGEAHK 167
             L   Y                          +               C      E   
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 168 WSIIYRISIG----------------IAGGLDYLHTGFHRPIIHGNLKSKNILL--DRNY 209
              I+                     I   L YLH   ++ I H ++K +N L   ++++
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207

Query: 210 QPYVSDFGL---HLLLNPTAGQEMLEASASQGYKAPELIKMKDAS--EETDIYSFGVIML 264
           +  + DFGL      LN      M   + +  + APE++   + S   + D +S GV++ 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 265 ELISGKEP 272
            L+ G  P
Sbjct: 268 LLLMGAVP 275

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDK-EFGDLIELLGCIRHPNLVPLLG 133
             +G+  Y  +++A+   +    +++ L+PV   + K E   L  L G    PN++ L  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG---GPNIITLAD 98

Query: 134 FYAGPRGEKLI-VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
               P       V       +  Q  +  + +      +Y I       LDY H+     
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQTLT-DYDIRFYMYEILKA----LDYCHS---MG 150

Query: 193 IIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIKMKDA 250
           I+H ++K  N+++D  + +  + D+GL    +P  GQE     AS+ +K PE L+  +  
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQMY 208

Query: 251 SEETDIYSFGVIMLELISGKEPI 273
               D++S G ++  +I  KEP 
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPF 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 47/220 (21%), Positives = 91/220 (41%), Gaps = 46/220 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL---IELLGCIRHPNLV 129
             ++GK ++G + K   + +     ++ + +     +D     +   +ELL  + HPN++
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--TILREVELLKKLDHPNIM 84

Query: 130 PLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRIS 175
            L                   GE   ++I    +   + A+ I+                
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--------------- 129

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             +  G+ Y+H      I+H +LK +NILL   +++    + DFGL          +M +
Sbjct: 130 --VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              +  Y APE+++     E+ D++S GVI+  L+SG  P
Sbjct: 183 RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 41/220 (18%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           E +G+ +YG++YKA+ + +G +  ++ +       + +  ++   I ++     P++V  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPV-----ESDLQEIIKEISIMQQCDSPHVVKY 89

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIGIAGGLDYLHT 187
            G Y   +   L IV  +   G+++  IR  +    E      I  I      GL+YLH 
Sbjct: 90  YGSYF--KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE----IATILQSTLKGLEYLHF 143

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQG 238
                 IH ++K+ NILL+      ++DFG+   L  T  +          M        
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM-------- 192

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
             APE+I+    +   DI+S G+  +E+  GK P  + +P
Sbjct: 193 --APEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 43/232 (18%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDKEFGDL---IELLGCIRH 125
              +G   +G ++ A+ +      +++F     +   C   D + G +   I +L  + H
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGIAG 180
            N++ +L  +        +V   +  G      + +  R     A     I+R    +  
Sbjct: 89  ANIIKVLDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---IFR---QLVS 141

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-ASQGY 239
            + YL     + IIH ++K +NI++  ++   + DFG           ++      +  Y
Sbjct: 142 AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA---AYLERGKLFYTFCGTIEY 195

Query: 240 KAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINE-NPTPDEDFHLPTFM 289
            APE++        E +++S GV +  L+  + P  E   T +   H P  +
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 27/226 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKEFGDL------IELLGCIRH 125
            + +G    G +  A  +++     +R +  R       +E          IE+L  + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLD 183
           P ++ +  F+     +  IV    + G L   +       EA      Y+    +   + 
Sbjct: 200 PCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQ 253

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPY---VSDFGLHLLLNPTAGQEMLEASASQGYK 240
           YLH      IIH +LK +N+LL    +     ++DFG   +L       M     +  Y 
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYL 308

Query: 241 APELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           APE++        +   D +S GVI+   +SG  P +E+ T     
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 64.9 bits (159), Expect = 3e-12
 Identities = 39/219 (17%), Positives = 82/219 (37%), Gaps = 46/219 (21%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
              IG+ ++G +  A+ + +   R  + +        ++       IE++  + HPN++ 
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 131 LLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           L   +               GE   +++    ++  + A+ ++                 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD---------------- 114

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
            +   + Y H      + H +LK +N L      +    + DFGL     P  G+ M   
Sbjct: 115 -VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTK 168

Query: 234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
             +  Y +P++++      E D +S GV+M  L+ G  P
Sbjct: 169 VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 40/220 (18%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---------IELLGCIRH 125
            ++G+  YG +  A  + +G +  ++ + P        F            I++L   +H
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKH 68

Query: 126 PNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAG 180
            N++ +         E      I+    +  +L + I      + H    IY+       
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT----LR 123

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---------HLLLNPTAGQEML 231
            +  LH      +IH +LK  N+L++ N    V DFGL                    M+
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 232 EASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
           E  A++ Y+APE++      S   D++S G I+ EL   +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 35/187 (18%), Positives = 75/187 (40%), Gaps = 26/187 (13%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGS---GEAHKWSIIY 172
           I +L  + HPN+V L+     P  + L +V     +G + +          +A  +   +
Sbjct: 87  IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY---F 143

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
           +    +  G++YLH   ++ IIH ++K  N+L+  +    ++DFG+           +L 
Sbjct: 144 Q---DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLS 195

Query: 233 ASA-SQGYKAPELIKMKDAS---EETDIYSFGVIMLELISGKEPINENPTPD-------E 281
            +  +  + APE +         +  D+++ GV +   + G+ P  +            +
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ 255

Query: 282 DFHLPTF 288
               P  
Sbjct: 256 ALEFPDQ 262

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 11/104 (10%)

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT----AGQ 228
            I   I   LD  H        H ++K +NIL+  +   Y+ DFG+            G 
Sbjct: 138 AIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194

Query: 229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            +     +  Y APE      A+   DIY+   ++ E ++G  P
Sbjct: 195 TV----GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 38/217 (17%), Positives = 86/217 (39%), Gaps = 32/217 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVP 130
           + +G    G ++ A+         ++ +    P       +E    I+++  + H N+V 
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHDNIVK 72

Query: 131 LLGFYAGPRGEKLIVHPFYKRGN------------LAQCIRGGS-GEAHKWSIIYRISIG 177
           +         +           N            LA  +  G   E H    +Y++   
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL--- 129

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGL--HLLLNPTAGQEMLEAS 234
              GL Y+H+     ++H +LK  N+ ++  +    + DFGL   +  + +    + E  
Sbjct: 130 -LRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 235 ASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
            ++ Y++P L+    + ++  D+++ G I  E+++GK
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 45/220 (20%), Positives = 82/220 (37%), Gaps = 36/220 (16%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           EVIG      +  A          ++ +         +  +L   I+ +    HPN+V  
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQCHHPNIVSY 78

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWS------IIYRISIGIAGGLDY 184
              +     ++L +V      G++   I+    +    S       I  I   +  GL+Y
Sbjct: 79  YTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK---- 240
           LH       IH ++K+ NILL  +    ++DFG+       +         ++       
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGV-------SAFLATGGDITRNKVRKTF 186

Query: 241 -------APELIKMKDA-SEETDIYSFGVIMLELISGKEP 272
                  APE+++       + DI+SFG+  +EL +G  P
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 38/222 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
             +G   +G +YKA  + +G++   + +        +++   IE+L    HP +V LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 135 YAGPRGEKL-IVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIGIAGGLDYLHTGFH 190
           Y      KL I+  F   G +   +        E      I  +   +   L++LH+   
Sbjct: 85  YY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----IQVVCRQMLEALNFLHS--- 135

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASASQGYKA 241
           + IIH +LK+ N+L+       ++DFG+      T  +          M          A
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM----------A 185

Query: 242 PELIKMKDASEET-----DIYSFGVIMLELISGKEP-INENP 277
           PE++  +   +       DI+S G+ ++E+   + P    NP
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 56/243 (23%), Positives = 108/243 (44%), Gaps = 22/243 (9%)

Query: 38  EINQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVR 97
            +N    N  ++      V    G+     +I     +VIG  ++G +++A L  S  V 
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVA 68

Query: 98  LLRFLRPVCTTRDKEF-GDLIELLGCIRHPNLVPLLGFY--AGPRGEKL---IVHPFYKR 151
           + + L      +DK F    ++++  ++HPN+V L  F+   G + +++   +V  +   
Sbjct: 69  IKKVL------QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122

Query: 152 GNLAQCIRGGSGEAHKWSIIY--RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY 209
             + +  R  +       ++        +   L Y+H+     I H ++K +N+LLD   
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IG-ICHRDIKPQNLLLDPPS 178

Query: 210 QPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELI 267
               + DFG   +L    G+  +    S+ Y+APELI    + +   DI+S G +M EL+
Sbjct: 179 GVLKLIDFGSAKILIA--GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

Query: 268 SGK 270
            G+
Sbjct: 237 QGQ 239

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 64.1 bits (157), Expect = 7e-12
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 50/221 (22%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            EV+G   +  ++    + +G +  L+ ++     RD    + I +L  I+H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 134 FYAGPR-----------GEKL---IVHPFYKRGNL-----AQCIRGGSGEAHKWSIIYRI 174
            Y               GE L   I+    +RG       +  I+               
Sbjct: 74  IYESTTHYYLVMQLVSGGE-LFDRIL----ERGVYTEKDASLVIQQ-------------- 114

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEML 231
              +   + YLH      I+H +LK +N+L    + N +  ++DFGL  +        M 
Sbjct: 115 ---VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMS 165

Query: 232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            A  + GY APE++  K  S+  D +S GVI   L+ G  P
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 15/121 (12%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-S 236
           I   + Y H    + I+H +LK++N+LLD +    ++DFG             L+A   +
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---GGKLDAFCGA 176

Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTP-------DEDFHLPTF 288
             Y APEL + K     E D++S GVI+  L+SG  P +               + +P +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236

Query: 289 M 289
           M
Sbjct: 237 M 237

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 42/196 (21%), Positives = 75/196 (38%), Gaps = 39/196 (19%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGE-----AHKWSII 171
           I+LL  +RH N++ L+        +K+ +        + +    G  E       K    
Sbjct: 57  IQLLRRLRHKNVIQLVDVLYNEEKQKMYM--------VMEYCVCGMQEMLDSVPEK---- 104

Query: 172 YRISIGIA--------GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN 223
            R  +  A         GL+YLH    + I+H ++K  N+LL       +S  G+   L+
Sbjct: 105 -RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160

Query: 224 PTAGQEMLEAS-ASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPD 280
           P A  +    S  S  ++ PE+    D  +  + DI+S GV +  + +G  P   +    
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220

Query: 281 -------EDFHLPTFM 289
                    + +P   
Sbjct: 221 LFENIGKGSYAIPGDC 236

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/311 (19%), Positives = 103/311 (33%), Gaps = 70/311 (22%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
             +++G  + GT+      +   V + R L   C     E   L E      HPN++   
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRYY 75

Query: 133 GFYAGPR----------GE--KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
                 R               L+        NL         E +  S++      IA 
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL-----QKEYNPISLLR----QIAS 126

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY-------------VSDFGLHLLLNP--- 224
           G+ +LH      IIH +LK +NIL+  + +               +SDFGL   L+    
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 225 TAGQEMLEASASQGYKAPELIK-------MKDASEETDIYSFGVIMLELISGKEPINENP 277
           +    +   S + G++APEL++        +  +   DI+S G +   ++S  +     P
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH----P 239

Query: 278 TPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPS 337
             D+       +R       I  L            H+  +  E       L        
Sbjct: 240 FGDKYSRESNIIRG------IFSLDEMK------CLHDRSLIAEAT----DLISQMIDHD 283

Query: 338 PSLRPNIKQVL 348
           P  RP   +VL
Sbjct: 284 PLKRPTAMKVL 294

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDL---IELLGCIRHPNLV 129
            E +GK  +  + + + + +G     + +     + RD +   L     +   ++HPN+V
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ--KLEREARICRKLQHPNIV 91

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
            L            +V      G L + I  R    EA     I +I       + Y H+
Sbjct: 92  RLHDSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHS 146

Query: 188 GFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
                I+H NLK +N+LL    +     ++DFGL + +N    +     + + GY +PE+
Sbjct: 147 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEV 201

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEP 272
           +K    S+  DI++ GVI+  L+ G  P
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPP 229

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 41/227 (18%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLVP 130
           E++G   YG +YK    ++G +  ++    V      E  ++ +    L     H N+  
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 131 LLGFY----AGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
             G +         ++L +V  F   G++   I+   G   K   I  I   I  GL +L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE---------MLEASAS 236
           H      +IH ++K +N+LL  N +  + DFG+   L+ T G+          M      
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM------ 196

Query: 237 QGYKAPELIKMKDASEET-----DIYSFGVIMLELISGKEP-INENP 277
               APE+I   +  + T     D++S G+  +E+  G  P  + +P
Sbjct: 197 ----APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 37/216 (17%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
             E++G   +G ++K     +G     + +      +DKE  ++   I ++  + H NL+
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDKE--EVKNEISVMNQLDHANLI 149

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGG------SGEAHKWS-----IIYRISIGI 178
            L   +       L++          + + GG        E++  +     +  +    I
Sbjct: 150 QLYDAFESKNDIVLVM----------EYVDGGELFDRIIDESYNLTELDTILFMKQ---I 196

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV--SDFGLHLLLNPTAGQEMLEASAS 236
             G+ ++H      I+H +LK +NIL        +   DFGL     P   +++     +
Sbjct: 197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGT 251

Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
             + APE++     S  TD++S GVI   L+SG  P
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 45/220 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL-RFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
            E +GK  +  + + + + +G             + RD +   L     +   ++HPN+V
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ--KLEREARICRKLQHPNIV 68

Query: 130 PLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRIS 175
            L                   GE    ++   FY   + + CI+                
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------------- 113

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             I   + Y H+     I+H NLK +N+LL    +     ++DFGL + +N    +    
Sbjct: 114 --ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            + + GY +PE++K    S+  DI++ GVI+  L+ G  P
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
             IG  ++G +Y A   R+  V  ++ +       ++++ D+   +  L  +RHPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSG---EAHKWSIIYRISIGIAGGLDYLHT 187
            G Y   R     +V   Y  G+ +  +        E      I  ++ G   GL YLH+
Sbjct: 120 RGCYL--REHTAWLVME-YCLGSASDLLEVHKKPLQEVE----IAAVTHGALQGLAYLHS 172

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPEL 244
                +IH ++K+ NILL       + DFG        A   M  A++  G   + APE+
Sbjct: 173 ---HNMIHRDVKAGNILLSEPGLVKLGDFGS-------ASI-MAPANSFVGTPYWMAPEV 221

Query: 245 IKMKDASE---ETDIYSFGVIMLELISGKEP-INENP 277
           I   D  +   + D++S G+  +EL   K P  N N 
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 29/184 (15%)

Query: 123 IRHPNLVPLL--GFYAGPRGEKLIVHPF----YKRG-NLAQCIRGGSGEAHKWSIIYRIS 175
           + HP++V +     +    G+ +    +    Y  G +L +        A          
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPV---GYIVMEYVGGQSLKRSKGQKLPVAE----AIAYL 188

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
           + I   L YLH      +++ +LK +NI+L    Q  + D G    +N       L  + 
Sbjct: 189 LEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG---YLYGTP 241

Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP-----INENPTPDEDFHLPTFMR 290
             G++APE+++    +  TDIY+ G  +  L           ++  P  D          
Sbjct: 242 --GFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG 298

Query: 291 NAVL 294
             + 
Sbjct: 299 RLLR 302

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 47/196 (23%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPR----------GE--KLIVHPFYKRGNLAQCIRGGSGE 164
           I  L  +RHP+++ L      P           GE    IV    ++  + +       E
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV----EKKRMTE------DE 109

Query: 165 AHK--WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL 222
             +    II          ++Y H      I+H +LK +N+LLD N    ++DFGL  ++
Sbjct: 110 GRRFFQQIIC--------AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

Query: 223 NPTAGQEMLEAS-ASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTP- 279
                   L+ S  S  Y APE+I  K  A  E D++S G+++  ++ G+ P ++   P 
Sbjct: 159 TDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

Query: 280 ------DEDFHLPTFM 289
                    + +P F+
Sbjct: 216 LFKKVNSCVYVMPDFL 231

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 40/222 (18%), Positives = 77/222 (34%), Gaps = 52/222 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            E +G+  +G +++ +   S    + +F++      D+    +   I +L   RH N++ 
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQV--LVKKEISILNIARHRNILH 65

Query: 131 LLGFYAGPR-----------GEKL--IVHPFYKRGNL-----AQCIRGGSGEAHKWSIIY 172
           L   +                +    I         L        +              
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQ------------ 110

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL--DRNYQPYVSDFGLHLLLNPTAGQEM 230
                +   L +LH      I H +++ +NI+    R+    + +FG    L P  G   
Sbjct: 111 -----VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNF 160

Query: 231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                +  Y APE+ +    S  TD++S G ++  L+SG  P
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLR--FLRPVCTTRDKEFGDLIELLGCIRHPNLVPLL 132
            + G+  +GT+     + +G    ++     P    R+ +   +++ L  + HPN+V L 
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHHPNIVQLQ 85

Query: 133 GFYAGPRGEKL------IVHPFYKRGNLAQCIRGGSG------EAHKWSIIYRISIGIAG 180
            ++              +V  +     L +C R                 +++    +  
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ----LIR 140

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            +  LH      + H ++K  N+L++  +    + DFG    L+P   +  +    S+ Y
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVAYICSRYY 197

Query: 240 KAPELI-KMKDASEETDIYSFGVIMLELISGK 270
           +APELI   +  +   DI+S G I  E++ G+
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 62.2 bits (152), Expect = 3e-11
 Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 15/121 (12%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-AS 236
           I   +DY H      ++H +LK +N+LLD +    ++DFGL    N  +  E L  S  S
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS---NMMSDGEFLRTSCGS 173

Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTP-------DEDFHLPTF 288
             Y APE+I  +  A  E DI+S GVI+  L+ G  P ++   P          F++P +
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233

Query: 289 M 289
           +
Sbjct: 234 L 234

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 72/311 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL--LRFLRPVCTTRDK-EFGDLIELLGCI-RHPNLV 129
            +VIG+ N+G + KA +++ G      ++ ++   +  D  +F   +E+L  +  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 130 PLLG--FYAGPRGEKLIVHPFYKRGNL--------------AQCIRGGSGEAHKWSIIYR 173
            LLG   + G      +   +   GNL              A  I   +        +  
Sbjct: 90  NLLGACEHRGYL---YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 174 ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA 233
            +  +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL         +     
Sbjct: 147 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVY 195

Query: 234 SASQGYK------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP 286
                 +      A E +     +  +D++S+GV++ E++S G       P         
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCG------ 244

Query: 287 TFMRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN 343
             M  A L  ++     L  P    C +               + L   C    P  RP+
Sbjct: 245 --MTCAELYEKLPQGYRLEKPLN--CDDE-------------VYDLMRQCWREKPYERPS 287

Query: 344 IKQVLWKLEDL 354
             Q+L  L  +
Sbjct: 288 FAQILVSLNRM 298

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 41/121 (33%), Positives = 62/121 (51%), Gaps = 15/121 (12%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS-AS 236
           I  G+DY H      ++H +LK +N+LLD +    ++DFGL    N  +  E L  S  S
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS---NMMSDGEFLRTSCGS 178

Query: 237 QGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTP-------DEDFHLPTF 288
             Y APE+I  +  A  E DI+S GVI+  L+ G  P +++  P       D  F+ P +
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY 238

Query: 289 M 289
           +
Sbjct: 239 L 239

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 42/220 (19%), Positives = 84/220 (38%), Gaps = 44/220 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL-RFLRPVCTTRDKEFGDL---IELLGCIRHPNLV 129
            E +GK  +  + + +   +G             + RD +   L     +   ++HPN+V
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ--KLEREARICRLLKHPNIV 73

Query: 130 PLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRIS 175
            L    +              GE    ++   +Y   + + CI+                
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ--------------- 118

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             I   + + H      ++H NLK +N+LL    +     ++DFGL + +     Q    
Sbjct: 119 --ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG 172

Query: 233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            + + GY +PE+++     +  D+++ GVI+  L+ G  P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 60/317 (18%), Positives = 105/317 (33%), Gaps = 85/317 (26%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
              +G   +G +Y+  +    +           L  VC+ +D+ +F     ++    H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII-----YRISIGIAG 180
           +V  +G    + PR    I+      G+L   +R       + S +       ++  IA 
Sbjct: 95  IVRCIGVSLQSLPR---FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV---SDFGLHLLLNPTAGQEMLEAS--A 235
           G  YL        IH ++ ++N LL       V    DFG+         +++  AS   
Sbjct: 152 GCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM--------ARDIYRASYYR 200

Query: 236 SQGYK-------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPT 287
             G          PE       + +TD +SFGV++ E+ S G  P               
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------------- 245

Query: 288 FMRNAVLDHRITDLYHPDMLLCSNSNHE--NPVSEERIL--------KFFQLAMACCSPS 337
                          +P       SN E    V+    +          +++   C    
Sbjct: 246 ---------------YPSK-----SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQ 285

Query: 338 PSLRPNIKQVLWKLEDL 354
           P  RPN   +L ++E  
Sbjct: 286 PEDRPNFAIILERIEYC 302

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 58/310 (18%), Positives = 105/310 (33%), Gaps = 71/310 (22%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
              +G   +G +Y+  +    +           L  VC+ +D+ +F     ++    H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNLA---QCIRGGSGEAHKWSI--IYRISIGIAG 180
           +V  +G    + PR    I+      G+L    +  R    +    ++  +  ++  IA 
Sbjct: 136 IVRCIGVSLQSLPR---FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV---SDFGLHLLLNPTAGQEMLEAS--A 235
           G  YL        IH ++ ++N LL       V    DFG+         +++  A    
Sbjct: 193 GCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM--------ARDIYRAGYYR 241

Query: 236 SQGYK-------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPT 287
             G          PE       + +TD +SFGV++ E+ S G  P      P        
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-----PS------- 289

Query: 288 FMRNAVLDHRITD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
              N  +   +T    +  P    C                 +++   C    P  RPN 
Sbjct: 290 -KSNQEVLEFVTSGGRMDPPKN--CPG-------------PVYRIMTQCWQHQPEDRPNF 333

Query: 345 KQVLWKLEDL 354
             +L ++E  
Sbjct: 334 AIILERIEYC 343

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 48/226 (21%), Positives = 86/226 (38%), Gaps = 27/226 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKEFGDL------IELLGCIRH 125
            + +G    G +  A  +++     ++ +  R       +E          IE+L  + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLD 183
           P ++ +  F+     +  IV    + G L   +       EA      Y++       + 
Sbjct: 75  PCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----LLAVQ 128

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPY---VSDFGLHLLLNPTAGQEMLEASASQGYK 240
           YLH      IIH +LK +N+LL    +     ++DFG   +L       M     +  Y 
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYL 183

Query: 241 APELIKMKDA---SEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           APE++        +   D +S GVI+   +SG  P +E+ T     
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 43/248 (17%), Positives = 98/248 (39%), Gaps = 30/248 (12%)

Query: 39  INQQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRL 98
           ++    +        + + F+  E+    +      + +G+  +  + + + + +G    
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMENFN--NFYILTSKELGRGKFAVVRQCISKSTGQEYA 58

Query: 99  LRFLR-PVCTTRDKEFGDL---IELLGCIRH-PNLVPLLGFYAGPRGEKLIVHPFYKRGN 153
            +FL+        +   ++   I +L   +  P ++ L   Y     E +++  +   G 
Sbjct: 59  AKFLKKRRRGQDCRA--EILHEIAVLELAKSCPRVINLHEVYENTS-EIILILEYAAGGE 115

Query: 154 L-AQCIRGGSG-----EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR 207
           + + C+   +      +      + +    I  G+ YLH      I+H +LK +NILL  
Sbjct: 116 IFSLCLPELAEMVSENDV---IRLIKQ---ILEGVYYLHQ---NNIVHLDLKPQNILLSS 166

Query: 208 NYQPY---VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIML 264
            Y      + DFG+   +      E+ E   +  Y APE++     +  TD+++ G+I  
Sbjct: 167 IYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224

Query: 265 ELISGKEP 272
            L++   P
Sbjct: 225 MLLTHTSP 232

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 38/176 (21%), Positives = 75/176 (42%), Gaps = 22/176 (12%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNL----AQCIRGGSGEAHK--WS 169
           I +   + H N+V   G           +   +   G L       I     +A +    
Sbjct: 56  ICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++         G+ YLH      I H ++K +N+LLD      +SDFGL  +      + 
Sbjct: 114 LM--------AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 230 MLEAS-ASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
           +L     +  Y APEL+K ++  +E  D++S G+++  +++G+ P ++     +++
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 23/213 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFL--RPVCTTRDKEFGDL---IELLGCIRHPNL 128
            EVIGK  +  + + + + +G    ++ +      ++      DL     +   ++HP++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSG----EAHKWSIIYRISIGIAGGL 182
           V LL  Y+   G   +V  F    +L   I  R  +G    EA     + +I       L
Sbjct: 89  VELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI----LEAL 143

Query: 183 DYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            Y H      IIH ++K   +LL   + +    +  FG+ + L  + G        +  +
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHF 199

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APE++K +   +  D++  GVI+  L+SG  P
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 22/165 (13%)

Query: 117 IELLGCIRHPNLVPLLGFYAGPRGEKL-IVHPFYKRGNL----AQCIRGGSGEAHK--WS 169
           I +   + H N+V   G           +   +   G L       I     +A +    
Sbjct: 56  ICINKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
           ++         G+ YLH      I H ++K +N+LLD      +SDFGL  +      + 
Sbjct: 114 LM--------AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 230 MLEAS-ASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEP 272
           +L     +  Y APEL+K ++  +E  D++S G+++  +++G+ P
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 50/313 (15%), Positives = 117/313 (37%), Gaps = 77/313 (24%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
              +G+ ++G +Y+ + +               +    + R++ EF +   ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIG-------- 177
           +V LLG      P    L++     RG+L   +R          ++   S+         
Sbjct: 90  VVRLLGVVSQGQPT---LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA G+ YL+       +H +L ++N ++  ++   + DFG+         +++ E     
Sbjct: 147 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM--------TRDIYETDY-- 193

Query: 238 GYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH 284
            Y+            +PE +K    +  +D++SFGV++ E+ +  ++P            
Sbjct: 194 -YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QG---- 243

Query: 285 LPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR 341
               + N  +   + +      PD   C +               F+L   C   +P +R
Sbjct: 244 ----LSNEQVLRFVMEGGLLDKPD--NCPD-------------MLFELMRMCWQYNPKMR 284

Query: 342 PNIKQVLWKLEDL 354
           P+  +++  +++ 
Sbjct: 285 PSFLEIISSIKEE 297

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 47/230 (20%), Positives = 82/230 (35%), Gaps = 52/230 (22%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVR-----LLRFLRPVCTTRDKEFGDLIE-----LLGC 122
           P E++G+     + + + + +          +           +E  +        L   
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 123 IRHPNLVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKW 168
             HPN++ L   Y               GE    L            + +R         
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA-------- 132

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
                    +   +  LH      I+H +LK +NILLD +    ++DFG    L+P  G+
Sbjct: 133 ---------LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GE 178

Query: 229 EMLEASASQGYKAPELIKMKDA------SEETDIYSFGVIMLELISGKEP 272
           ++ E   +  Y APE+I+           +E D++S GVIM  L++G  P
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 29/210 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEF-GDLIELLGCIRHPNLVPLL 132
           +VIG  ++G +Y+A L  SG  V + + L      +DK F    ++++  + H N+V L 
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 133 GFY--AGPRGEKLIVHPF--YKRGNLAQCIRGGSG------EAHKWSIIYRISIGIAGGL 182
            F+  +G + +++ ++    Y    + +  R  S         +    +Y++   +A   
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA--- 170

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKA 241
            Y+H+     I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+A
Sbjct: 171 -YIHS--FG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRA 224

Query: 242 PELI-KMKDASEETDIYSFGVIMLELISGK 270
           PELI    D +   D++S G ++ EL+ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 46/213 (21%), Positives = 83/213 (38%), Gaps = 26/213 (12%)

Query: 70  LDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE-----LLGCIR 124
           LD   + +G+ ++    K + ++S                 K      +     L  C  
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAF-------AVKIISKRMEANTQKEITALKLCEG 64

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGL 182
           HPN+V L   +        +V      G L + I  +    E     I+ ++       +
Sbjct: 65  HPNIVKLHEVFHDQL-HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL----VSAV 119

Query: 183 DYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGY 239
            ++H      ++H +LK +N+L    + N +  + DFG   L  P   Q +     +  Y
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHY 175

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
            APEL+      E  D++S GVI+  ++SG+ P
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 38/261 (14%), Positives = 83/261 (31%), Gaps = 61/261 (23%)

Query: 74  GEVIGKSNYGTLYKAL-------------LQRSGSVRLLRFLRPVCTTRDKEFGDLIELL 120
            + IG      +++ L             L+ + +  L  +          E    I  L
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN--------E----IAYL 108

Query: 121 GCIRHPNL--VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISI 176
             ++  +   + L  +    +   +++       +L   +  +                 
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDP----WERKSYWK 162

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA- 235
            +   +  +H   H  I+H +LK  N L+       + DFG+   + P     + ++   
Sbjct: 163 NMLEAVHTIHQ--HG-IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 236 SQGYKAPELIKMKDA-----------SEETDIYSFGVIMLELISGKEP----------IN 274
           +  Y  PE IK   +           S ++D++S G I+  +  GK P          ++
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 275 ENPTPDEDFHLPTFMRNAVLD 295
               P+ +   P      + D
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQD 299

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 37/253 (14%), Positives = 81/253 (32%), Gaps = 45/253 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL----LRFLRPVCTTR-DKEFGDLIELLGCIRHPNL 128
            + IG      +++ L ++     +    L             E    I  L  ++  + 
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE----IAYLNKLQQHSD 69

Query: 129 --VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDY 184
             + L  +    +   +++       +L   +  +                  +   +  
Sbjct: 70  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDP----WERKSYWKNMLEAVHT 123

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPE 243
           +H   H  I+H +LK  N L+       + DFG+   + P     + ++   +  Y  PE
Sbjct: 124 IHQ--HG-IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 244 LIKMKDA-----------SEETDIYSFGVIMLELISGKEP----------INENPTPDED 282
            IK   +           S ++D++S G I+  +  GK P          ++    P+ +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239

Query: 283 FHLPTFMRNAVLD 295
              P      + D
Sbjct: 240 IEFPDIPEKDLQD 252

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 57/328 (17%), Positives = 117/328 (35%), Gaps = 103/328 (31%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS--------VRLLRFLRPVCTTRDK-EFGDLIELLGCIR 124
              +G+  +G ++ A               V+ L+      +   + +F    ELL  ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTMLQ 101

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI------------ 170
           H ++V   G      P    L+V  + + G+L + +R    +A   +             
Sbjct: 102 HQHIVRFFGVCTEGRPL---LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 171 -IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
            +  ++  +A G+ YL        +H +L ++N L+ +     + DFG+         ++
Sbjct: 159 QLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGM--------SRD 207

Query: 230 MLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINEN 276
           +        Y+             PE I  +  + E+D++SFGV++ E+ + GK+P    
Sbjct: 208 IYSTDY---YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---- 260

Query: 277 PTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE--NPVSEERIL--------KF 326
                                        +     SN E  + +++ R L        + 
Sbjct: 261 --------------------------WYQL-----SNTEAIDCITQGRELERPRACPPEV 289

Query: 327 FQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           + +   C    P  R +IK V  +L+ L
Sbjct: 290 YAIMRGCWQREPQQRHSIKDVHARLQAL 317

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 63/327 (19%), Positives = 118/327 (36%), Gaps = 96/327 (29%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDKEFGDLIELLGCIRHPNL 128
              +G+  +G ++ A        +         L+       K+F    ELL  ++H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 129 VPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------IY 172
           V   G      P    ++V  + K G+L + +R    +A                   + 
Sbjct: 80  VKFYGVCGDGDPL---IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
            I+  IA G+ YL +   +  +H +L ++N L+  N    + DFG+         +++  
Sbjct: 137 HIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM--------SRDVYS 185

Query: 233 ASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTP 279
                 Y+             PE I  +  + E+D++SFGVI+ E+ + GK+P       
Sbjct: 186 TDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------- 235

Query: 280 DEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE--NPVSEERIL--------KFFQL 329
                                     +     SN E    +++ R+L        + + +
Sbjct: 236 -----------------------WFQL-----SNTEVIECITQGRVLERPRVCPKEVYDV 267

Query: 330 AMACCSPSPSLRPNIKQVLWKLEDLGK 356
            + C    P  R NIK++   L  LGK
Sbjct: 268 MLGCWQREPQQRLNIKEIYKILHALGK 294

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 37/253 (14%), Positives = 81/253 (32%), Gaps = 45/253 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRL----LRFLRPVCTTR-DKEFGDLIELLGCIRHPNL 128
            + IG      +++ L ++     +    L             E    I  L  ++  + 
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE----IAYLNKLQQHSD 88

Query: 129 --VPLLGFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDY 184
             + L  +    +   +++       +L   +  +                  +   +  
Sbjct: 89  KIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDP----WERKSYWKNMLEAVHT 142

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPE 243
           +H   H  I+H +LK  N L+       + DFG+   + P     + ++   +  Y  PE
Sbjct: 143 IHQ--HG-IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 244 LIKMKDA-----------SEETDIYSFGVIMLELISGKEP----------INENPTPDED 282
            IK   +           S ++D++S G I+  +  GK P          ++    P+ +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258

Query: 283 FHLPTFMRNAVLD 295
              P      + D
Sbjct: 259 IEFPDIPEKDLQD 271

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 67/320 (20%), Positives = 112/320 (35%), Gaps = 83/320 (25%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
            E +G+  +G +YK  L         +      L+       + EF     L   ++HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------I 171
           +V LLG      P     ++  +   G+L + +   S  +   S                
Sbjct: 74  VVCLLGVVTKDQPL---SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 172 YRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML 231
             +   IA G++YL +     ++H +L ++N+L+       +SD GL         +E+ 
Sbjct: 131 VHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGL--------FREVY 179

Query: 232 EASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPT 278
            A     YK            APE I     S ++DI+S+GV++ E+ S G       P 
Sbjct: 180 AADY---YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG-----LQPY 231

Query: 279 PDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMACCS 335
                       N  +   I +      PD   C                 + L + C +
Sbjct: 232 CG--------YSNQDVVEMIRNRQVLPCPDD--CPAW-------------VYALMIECWN 268

Query: 336 PSPSLRPNIKQVLWKLEDLG 355
             PS RP  K +  +L   G
Sbjct: 269 EFPSRRPRFKDIHSRLRAWG 288

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 29/245 (11%)

Query: 41  QQSKNGGEEGETEDLVTFRGGEDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRLLR 100
           Q      ++     + +    +   I D      +V+G    G + +   +R+     L+
Sbjct: 34  QPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK 93

Query: 101 FLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLLGFY---AGPRGEKLIVHPFYKRGNLAQ 156
            L+     R +E    +EL     + P++V ++  Y      R   LIV      G L  
Sbjct: 94  MLQDCPKAR-RE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 148

Query: 157 CI--RGGSG----EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DR 207
            I  RG       EA   S I +    I   + YLH+     I H ++K +N+L      
Sbjct: 149 RIQDRGDQAFTEREA---SEIMKS---IGEAIQYLHS---INIAHRDVKPENLLYTSKRP 199

Query: 208 NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELI 267
           N    ++DFG            +     +  Y APE++  +   +  D++S GVIM  L+
Sbjct: 200 NAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257

Query: 268 SGKEP 272
            G  P
Sbjct: 258 CGYPP 262

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 62/246 (25%)

Query: 75  EVIGKSNYGTLYKALLQRSG--------------SVRLLRFLRPVCTTRDKEFGDLIELL 120
            +IG+ +YG +Y A  + +                +   R LR        E    I +L
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR--------E----ITIL 79

Query: 121 GCIRHPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRI 174
             ++   ++ L          K     IV       +L +  +      E H  +I+Y +
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNL 138

Query: 175 SIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---------------- 218
                 G +++H      IIH +LK  N LL+++    V DFGL                
Sbjct: 139 ----LLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 219 -----HLLLNPTAGQEMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGKEP 272
                    N    +++     ++ Y+APELI   ++ ++  DI+S G I  EL++  + 
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

Query: 273 INENPT 278
              +PT
Sbjct: 252 HINDPT 257

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 45/211 (21%), Positives = 82/211 (38%), Gaps = 30/211 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLLG 133
           +V+G    G + +   +R+G    L+ L         +    ++        P++V +L 
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILD 89

Query: 134 FYAGPRGEKLIVH---PFYKRGNLAQCI--RGGSG----EAHKWSIIYRISIGIAGGLDY 184
            Y      K  +       + G L   I  RG       EA   + I R    I   + +
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA---AEIMRD---IGTAIQF 143

Query: 185 LHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKA 241
           LH+     I H ++K +N+L    +++    ++DFG            +     +  Y A
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVA 197

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEP 272
           PE++  +   +  D++S GVIM  L+ G  P
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 43/206 (20%), Positives = 87/206 (42%), Gaps = 20/206 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLL 132
            E IG  +Y    + + + +     ++ +        ++  + IE+L    +HPN++ L 
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLK 82

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
             Y   +    +V    K G L   I  +    E    ++++ I       ++YLH    
Sbjct: 83  DVYDDGK-YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI----TKTVEYLHA--- 134

Query: 191 RPIIHGNLKSKNILL---DRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
           + ++H +LK  NIL      N +   + DFG    L       ++    +  + APE+++
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANFVAPEVLE 193

Query: 247 MKDASEETDIYSFGVIMLELISGKEP 272
            +      DI+S GV++  +++G  P
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTP 219

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 58/320 (18%), Positives = 117/320 (36%), Gaps = 85/320 (26%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDKEFGDL---IELLGCI-R 124
           G+ +G   +G + +A     G    +       L+      +KE   L   ++++  + +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQ 108

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNL------------AQCIRGGSGEAHKWSI 170
           H N+V LLG   + GP    L++  +   G+L                   +        
Sbjct: 109 HENIVNLLGACTHGGPV---LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +   S  +A G+ +L +   +  IH ++ ++N+LL   +   + DFGL         +++
Sbjct: 166 LLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGL--------ARDI 214

Query: 231 LEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENP 277
           +  S    Y             APE I     + ++D++S+G+++ E+ S G  P     
Sbjct: 215 MNDSN---YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----- 266

Query: 278 TPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMACC 334
                   P  + N+     + D Y    P                      + +  AC 
Sbjct: 267 -------YPGILVNSKFYKLVKDGYQMAQPAF--APK-------------NIYSIMQACW 304

Query: 335 SPSPSLRPNIKQVLWKLEDL 354
           +  P+ RP  +Q+   L++ 
Sbjct: 305 ALEPTHRPTFQQICSFLQEQ 324

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 51/229 (22%)

Query: 73  PGEVIGKSNYGTLYKALLQRSG------SVRLLRFLRPVCTTRDKEFGDLIE---LLGCI 123
           P +VIG+     + + + + +G       + +           +       E   L    
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 124 RHPNLVPLLGFYAGPR-----------GE---KLIVHPFYKRGNLAQCIRGGSGEAHKWS 169
            HP+++ L+  Y               GE    L              +R          
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS--------- 208

Query: 170 IIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE 229
                   +   + +LH      I+H +LK +NILLD N Q  +SDFG    L P  G++
Sbjct: 209 --------LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEK 255

Query: 230 MLEASASQGYKAPELIKMKDA------SEETDIYSFGVIMLELISGKEP 272
           + E   + GY APE++K           +E D+++ GVI+  L++G  P
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 78/318 (24%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCI-RHP 126
           G+ +G+  +G + +A           R      L+   T  +       +++L  I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------IY 172
           N+V LLG    P G  +++  F K GNL+  +R    E   + +              + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             S  +A G+++L +   R  IH +L ++NILL       + DFGL         +++ +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL--------ARDIYK 200

Query: 233 ASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTP 279
                 Y             APE I  +  + ++D++SFGV++ E+ S G  P       
Sbjct: 201 DPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------- 250

Query: 280 DEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMACCSP 336
                 P    +     R+ +      PD    +              + +Q  + C   
Sbjct: 251 -----YPGVKIDEEFCRRLKEGTRMRAPD--YTTP-------------EMYQTMLDCWHG 290

Query: 337 SPSLRPNIKQVLWKLEDL 354
            PS RP   +++  L +L
Sbjct: 291 EPSQRPTFSELVEHLGNL 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 62/322 (19%), Positives = 123/322 (38%), Gaps = 86/322 (26%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-------LRPVCTTRDK-EFGDLIELLGCI-R 124
           G+ +G+  +G +  A        +           L+   T +D  +    +E++  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNL--------------AQCIRGGSGEAHKW 168
           H N++ LLG     GP     ++  +  +GNL              +  I     E   +
Sbjct: 100 HKNIINLLGACTQDGPL---YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
             +   +  +A G++YL +   +  IH +L ++N+L+  N    ++DFGL         +
Sbjct: 157 KDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGL--------AR 205

Query: 229 EMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINE 275
           ++        YK            APE +  +  + ++D++SFGV+M E+ + G      
Sbjct: 206 DINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG----- 257

Query: 276 NPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMA 332
           +P P         +    L   + + +    P    C+N             + + +   
Sbjct: 258 SPYPG--------IPVEELFKLLKEGHRMDKPA--NCTN-------------ELYMMMRD 294

Query: 333 CCSPSPSLRPNIKQVLWKLEDL 354
           C    PS RP  KQ++  L+ +
Sbjct: 295 CWHAVPSQRPTFKQLVEDLDRI 316

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 26/202 (12%), Positives = 52/202 (25%), Gaps = 39/202 (19%)

Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP 130
               G       ++A    L R  ++  +     +     +E       L  I  P +  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           +L      R   L+V  + + G+L +                R    +A   D  H    
Sbjct: 96  VLDV-VHTRAGGLVVAEWIRGGSLQEVADTSPSPVG----AIRAMQSLAAAADAAH---R 147

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
             +         + +  +    ++                                M DA
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPAT----------------------------MPDA 179

Query: 251 SEETDIYSFGVIMLELISGKEP 272
           + + DI   G  +  L+  + P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP 201

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 34/226 (15%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRLLRFLR-PVCTTRDKEFGDLIE--LLGCIRHPNLVPLL 132
           V+GK  +G +    ++ +G +   + L       R  E   L E  +L  +    +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249

Query: 133 GFYAGPRGEKL-IVHPFYKRGNL----AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
             YA    + L +V      G+L        + G  EA   ++ Y  +  I  GL+ LH 
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFY--AAEICCGLEDLHR 304

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ------GYKA 241
                I++ +LK +NILLD +    +SD GL           + E    +      GY A
Sbjct: 305 ---ERIVYRDLKPENILLDDHGHIRISDLGL--------AVHVPEGQTIKGRVGTVGYMA 353

Query: 242 PELIKMKDASEETDIYSFGVIMLELISGKEPI---NENPTPDEDFH 284
           PE++K +  +   D ++ G ++ E+I+G+ P     +    +E   
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 64/324 (19%), Positives = 124/324 (38%), Gaps = 90/324 (27%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-------LRPVCTTRDKEFGDL---IELLGCI 123
           G+ +G+  +G +  A        +           L+   T +D    DL   +E++  I
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS--DLVSEMEMMKMI 143

Query: 124 -RHPNLVPLLG--FYAGPRGEKLIVHPFYKRGNL--------------AQCIRGGSGEAH 166
            +H N++ LLG     GP     ++  +  +GNL              +  I     E  
Sbjct: 144 GKHKNIINLLGACTQDGPL---YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
            +  +   +  +A G++YL +   +  IH +L ++N+L+  N    ++DFGL        
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGL-------- 249

Query: 227 GQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPI 273
            +++        YK            APE +  +  + ++D++SFGV+M E+ + G    
Sbjct: 250 ARDINNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--- 303

Query: 274 NENPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLA 330
             +P P         +    L   + + +    P    C+N             + + + 
Sbjct: 304 --SPYPG--------IPVEELFKLLKEGHRMDKPA--NCTN-------------ELYMMM 338

Query: 331 MACCSPSPSLRPNIKQVLWKLEDL 354
             C    PS RP  KQ++  L+ +
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDRI 362

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 29/118 (24%), Positives = 50/118 (42%), Gaps = 17/118 (14%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY--VSDFGLHLLLNPTAGQEMLEAS- 234
           +  G+ Y H      I H +LK +N LLD +  P   + DFG       +      +++ 
Sbjct: 125 LLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTV 178

Query: 235 ASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN 291
            +  Y APE++  ++   +  D++S GV +  ++ G  P        ED   P   R 
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-------EDPEEPRDYRK 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 19/115 (16%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL++LH    R II+ +LK +N+LLD +    +SD GL       A +     + ++
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGL-------AVELKAGQTKTK 347

Query: 238 ------GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP---INENPTPDEDF 283
                 G+ APEL+  ++     D ++ GV + E+I+ + P     E     E  
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 52.6 bits (127), Expect = 5e-08
 Identities = 63/324 (19%), Positives = 118/324 (36%), Gaps = 89/324 (27%)

Query: 74  GEVIGKSNYGTLYKA----LLQRSGSVRL-LRFLRPVCTTRDKEFGDL---IELLGCI-R 124
           G+ +G   +G + +A    L++   ++ + ++ L+P     ++E   L   +++L  +  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLSYLGN 85

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNL----------------AQCIRGGSGEAH 166
           H N+V LLG     GP    L++  +   G+L                +  I      A 
Sbjct: 86  HMNIVNLLGACTIGGPT---LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 167 KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA 226
               +   S  +A G+ +L +   +  IH +L ++NILL       + DFGL        
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL-------- 191

Query: 227 GQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPI 273
            +++   S    Y             APE I     + E+D++S+G+ + EL S G  P 
Sbjct: 192 ARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 247

Query: 274 NENPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLA 330
                       P    ++     I + +    P+                     + + 
Sbjct: 248 -----------YPGMPVDSKFYKMIKEGFRMLSPE--HAPAE-------------MYDIM 281

Query: 331 MACCSPSPSLRPNIKQVLWKLEDL 354
             C    P  RP  KQ++  +E  
Sbjct: 282 KTCWDADPLKRPTFKQIVQLIEKQ 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 60/322 (18%), Positives = 126/322 (39%), Gaps = 86/322 (26%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-------LRPVCTTRDK-EFGDLIELLGCI-R 124
           G+ +G+  +G +  A        +  R        L+   T +D  +    +E++  I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI------------ 170
           H N++ LLG     GP     ++  +  +GNL + ++       ++S             
Sbjct: 134 HKNIINLLGACTQDGPL---YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 171 --IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ 228
             +   +  +A G++YL +   +  IH +L ++N+L+  +    ++DFGL         +
Sbjct: 191 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGL--------AR 239

Query: 229 EMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GKEPINE 275
           ++        YK            APE +  +  + ++D++SFGV++ E+ + G      
Sbjct: 240 DIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG----- 291

Query: 276 NPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFFQLAMA 332
           +P P         +    L   + + +    P    C+N             + + +   
Sbjct: 292 SPYPG--------VPVEELFKLLKEGHRMDKPS--NCTN-------------ELYMMMRD 328

Query: 333 CCSPSPSLRPNIKQVLWKLEDL 354
           C    PS RP  KQ++  L+ +
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRI 350

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +   LDYL     + IIH ++K  NILLD +   +++DF +  +L      ++   + ++
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMAGTK 178

Query: 238 GYKAPELIKMKDA---SEETDIYSFGVIMLELISGKEP 272
            Y APE+   +     S   D +S GV   EL+ G+ P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L+YLH    + IIH +LK +NILL+ +    ++DFG   +L+P + Q    A++  
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RANSFV 193

Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
           G   Y +PEL+  K A + +D+++ G I+ +L++G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 41/238 (17%), Positives = 87/238 (36%), Gaps = 53/238 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEFGDL-IELLGCIRHPNLVPLL 132
           + +G  ++G + +     SG    L + L+      D  + +  ++++  + H N++ L+
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII-------------------YR 173
            ++     E+          N       G    HK  I+                   ++
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 174 ISIGIAG-------------------GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY-V 213
           +                          + ++H+     I H ++K +N+L++       +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKL 183

Query: 214 SDFGLHLLLNPTAGQEMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
            DFG    L P   +  +    S+ Y+APEL+    + +   D++S G +  ELI GK
Sbjct: 184 CDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 25/215 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFL-RPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           +V+G+  +  +   +   +     ++ + +     R + F ++  L  C  H N++ L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           F+        +V    + G++   I  R    E     ++      +A  LD+LH    +
Sbjct: 79  FFEEED-RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD----VASALDFLHN---K 130

Query: 192 PIIHGNLKSKNILLDRNYQPY---VSDFGL------HLLLNPTAGQEMLEASASQGYKAP 242
            I H +LK +NIL +   Q     + DF L      +   +P +  E+L    S  Y AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 243 ELIKMKDAS-----EETDIYSFGVIMLELISGKEP 272
           E+++          +  D++S GVI+  L+SG  P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 38/234 (16%), Positives = 86/234 (36%), Gaps = 31/234 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSG-SV--------RLLRFLRPVCTTRDK-EFGDLIELLGCI 123
           G ++GK  +GT++          V        R+L +     +     E   L ++    
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 124 RHPNLVPLLGFYAGPRGEKLIVHPFYKRGN-----LAQCIRGGSGEAHKWSIIYRISIGI 178
            HP ++ LL ++       ++V             + +    G G +      +     +
Sbjct: 96  GHPGVIRLLDWFETQE-GFMLVLERPLPAQDLFDYITEKGPLGEGPSRC---FFG---QV 148

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTAGQEMLEASASQ 237
              + + H+   R ++H ++K +NIL+D       + DFG          +   +   ++
Sbjct: 149 VAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTDFDGTR 202

Query: 238 GYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEP-INENPTPDEDFHLPTFM 289
            Y  PE I      +    ++S G+++ +++ G  P   +    + + H P  +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 30/131 (22%), Positives = 59/131 (45%), Gaps = 15/131 (11%)

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY------VSDFGLHLLL 222
             + +IS  +  GLDY+H      IIH ++K +N+L++    P       ++D G     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGK---EPINENPTP 279
           +    +    +  ++ Y++PE++         DI+S   ++ ELI+G    EP   +   
Sbjct: 189 D----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 280 DEDFHLPTFMR 290
            +D H+   + 
Sbjct: 245 KDDDHIAQIIE 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 57/247 (23%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---------IELLGCIRH 125
            +IG  +YG + +A  +    V  ++ +  V       F DL         I +L  + H
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIAILNRLNH 111

Query: 126 PNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSG--EAHKWSIIYRISIGIA 179
            ++V +L        EK     +V       +  +  R      E H  +++Y + +G+ 
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL--------------------- 218
               Y+H+     I+H +LK  N L++++    V DFGL                     
Sbjct: 171 ----YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 219 -----HLLLNPTAGQEMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGKEP 272
                         +++     ++ Y+APELI   ++ +E  D++S G I  EL++  + 
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 273 INENPTP 279
                  
Sbjct: 284 NVAYHAD 290

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 60/334 (17%), Positives = 110/334 (32%), Gaps = 105/334 (31%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
              IG+  +G +++A                  L+   +   + +F     L+    +PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSI--------------- 170
           +V LLG      P     ++  +   G+L + +R  S                       
Sbjct: 112 IVKLLGVCAVGKPM---CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 171 -------IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN 223
                     I+  +A G+ YL     R  +H +L ++N L+  N    ++DFGL     
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL----- 220

Query: 224 PTAGQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GK 270
               + +  A     YK             PE I     + E+D++++GV++ E+ S G 
Sbjct: 221 ---SRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 271 EPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHE--NPVSEERIL---- 324
           +P                             Y   M     ++ E    V +  IL    
Sbjct: 275 QP-----------------------------Y-YGM-----AHEEVIYYVRDGNILACPE 299

Query: 325 ----KFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
               + + L   C S  P+ RP+   +   L+ +
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 58/327 (17%), Positives = 115/327 (35%), Gaps = 91/327 (27%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
           G+ +G+  +G + KA                  L+   +  +  +      +L  + HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 128 LVPLLG--FYAGPRGEKLIVHPFYKRGNL----------------------AQCIRGGSG 163
           ++ L G     GP    L++  + K G+L                      +  +     
Sbjct: 88  VIKLYGACSQDGPL---LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 164 EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN 223
            A     +   +  I+ G+ YL       ++H +L ++NIL+    +  +SDFGL     
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGL----- 196

Query: 224 PTAGQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS-GK 270
               +++ E  +   Y             A E +     + ++D++SFGV++ E+++ G 
Sbjct: 197 ---SRDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250

Query: 271 EPINENPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILKFF 327
                NP P         +    L + +   +    PD   CS              + +
Sbjct: 251 -----NPYPG--------IPPERLFNLLKTGHRMERPD--NCSE-------------EMY 282

Query: 328 QLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +L + C    P  RP    +   LE +
Sbjct: 283 RLMLQCWKQEPDKRPVFADISKDLEKM 309

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 3e-07
 Identities = 65/411 (15%), Positives = 135/411 (32%), Gaps = 111/411 (27%)

Query: 32  HDHNDLEINQQSKNGGEEGETEDLV-----TFRGGEDLTICDILDAPGEVIGKSNYGTLY 86
           H H D E  +       + + +D++      F   ++    D+ D P  ++ K     + 
Sbjct: 4   HHHMDFETGEH------QYQYKDILSVFEDAFV--DNFDCKDVQDMPKSILSKEEIDHII 55

Query: 87  KALLQRSGSVRLLRFLRPVCTTRDKEF-GDLIE-----LLGCIRHPNLVPLLGF--YAGP 138
            +    SG++RL   L        ++F  +++      L+  I+     P +    Y   
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115

Query: 139 RGEKLI--VHPFYK----RGNLAQCIR-----------------GGSGEAHKWSII---- 171
           R ++L      F K    R      +R                  GSG   K  +     
Sbjct: 116 R-DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVALDVC 171

Query: 172 --YRISIGIAGGLDYLHTG-FHRP-IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG 227
             Y++   +   + +L+    + P  +   L+     +D N+    SD   ++ L   + 
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR-SDHSSNIKLRIHSI 230

Query: 228 QEML-EASASQGYKAPELIKMKDASEETDIYSFGV---IML--------ELISGK----- 270
           Q  L     S+ Y+   L+ + +        +F +   I+L        + +S       
Sbjct: 231 QAELRRLLKSKPYENCLLV-LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 271 --EPINENPTPDEDFHLPTFMRNAVLDHRITDL------YHPDML-LCSNSNHENP---- 317
             +  +   TPDE   L   ++   LD R  DL       +P  L + + S  +      
Sbjct: 290 SLDHHSMTLTPDEVKSL--LLK--YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345

Query: 318 ----VSEERILKFFQLAMACCSPSPS---------LRPNIK------QVLW 349
               V+ +++    + ++    P+             P+         ++W
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 42/226 (18%)

Query: 75  EVIGKSNYGTLYKALLQRSGSV----RLLR-FLRPVCTTRD-KEFGDLIELLGCIR-HPN 127
           + +GK  YG ++K++ +R+G V    ++   F       R  +E    I +L  +  H N
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELSGHEN 70

Query: 128 LVPLLGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYL 185
           +V LL          + +V  + +  +L   IR       HK  ++Y++       + YL
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQL----IKVIKYL 125

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL---------HLLLNPTAGQEMLEASAS 236
           H+G    ++H ++K  NILL+      V+DFGL              P +  E  E    
Sbjct: 126 HSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 237 QG-----------YKAPELI-KMKDASEETDIYSFGVIMLELISGK 270
                        Y+APE++      ++  D++S G I+ E++ GK
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 17/111 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL+++H    R +++ +LK  NILLD +    +SD GL          +  +     
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL--------ACDFSKKKPHA 349

Query: 238 -----GYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDED 282
                GY APE+++   A     D +S G ++ +L+ G  P  ++ T D+ 
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 41/246 (16%), Positives = 83/246 (33%), Gaps = 57/246 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSG-SV--------RLLRFLRPVCTTRDK-EFGDLIELLGCI 123
           G ++G   +G++Y  +       V        R+  +      TR   E    + LL  +
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME----VVLLKKV 103

Query: 124 RH--PNLVPLLGF------------YAGPRGE--KLIVHPFYKRGNLAQCIRGGSGEAHK 167
                 ++ LL +               P  +    I     +RG L +        A  
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQE------ELARS 153

Query: 168 WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY-VSDFGLHLLLNPTA 226
               +     +   + + H      ++H ++K +NIL+D N     + DFG   LL  T 
Sbjct: 154 ---FFW---QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT- 203

Query: 227 GQEMLEASA-SQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEP-INENPTPDEDF 283
              +      ++ Y  PE I+          ++S G+++ +++ G  P  ++        
Sbjct: 204 ---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 260

Query: 284 HLPTFM 289
                +
Sbjct: 261 FFRQRV 266

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 27/101 (26%), Positives = 53/101 (52%), Gaps = 15/101 (14%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   LDYLH+   + +++ +LK +N++LD++    ++DFGL         + + + +  +
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-------CKEGIKDGATMK 307

Query: 238 ------GYKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
                  Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 52/329 (15%), Positives = 114/329 (34%), Gaps = 94/329 (28%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDKEFGDL---IELLGCI-R 124
           G+V+G   +G +  A         +        L+    + ++E   L   ++++  +  
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMTQLGS 107

Query: 125 HPNLVPLLG--FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYR--------- 173
           H N+V LLG    +GP     ++  +   G+L   +R    +  +  I Y          
Sbjct: 108 HENIVNLLGACTLSGPI---YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 174 ------------ISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL 221
                        +  +A G+++L     +  +H +L ++N+L+       + DFGL   
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL--- 218

Query: 222 LNPTAGQEMLEASASQGYK------------APELIKMKDASEETDIYSFGVIMLELIS- 268
                 ++++  S    Y             APE +     + ++D++S+G+++ E+ S 
Sbjct: 219 -----ARDIMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270

Query: 269 GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH---PDMLLCSNSNHENPVSEERILK 325
           G  P             P    +A     I + +    P     +              +
Sbjct: 271 GVNP------------YPGIPVDANFYKLIQNGFKMDQPF--YATE-------------E 303

Query: 326 FFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            + +  +C +     RP+   +   L   
Sbjct: 304 IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 55/298 (18%), Positives = 103/298 (34%), Gaps = 43/298 (14%)

Query: 64  LTICDILDAPGEVIGK-SNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC 122
           L  C     P  VI +   +G L   L  +       +  +     + K++   I +   
Sbjct: 92  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT-KGARFRQGKDYVGAIPVDLK 150

Query: 123 IRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
            R  ++       +    E+             +       +      +   S  +A G+
Sbjct: 151 RRLDSITSSQSSASSGFVEE----KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK-- 240
           ++L +   R  IH +L ++NILL       + DFGL   +       + +  A    K  
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWM 262

Query: 241 APELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRIT 299
           APE I  +  + ++D++SFGV++ E+ S G  P             P    +     R+ 
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------------YPGVKIDEEFCRRLK 310

Query: 300 DLYH---PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +      PD    +              + +Q  + C    PS RP   +++  L +L
Sbjct: 311 EGTRMRAPD--YTTP-------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 13/102 (12%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +   LD +H       IH ++K  N+LLD++    ++DFG  + +N    + M+    + 
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK---EGMVRCDTAV 230

Query: 238 G---YKAPELIKMKDASE----ETDIYSFGVIMLELISGKEP 272
           G   Y +PE++K +        E D +S GV + E++ G  P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 46/228 (20%), Positives = 74/228 (32%), Gaps = 62/228 (27%)

Query: 117 IELLGCIR-----HPN---LVPLLG-F-YAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEA 165
           I LL  +R      PN   +V LL  F  +G  G  + +V       +L + I   + + 
Sbjct: 84  IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG 142

Query: 166 HKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL-------------------- 205
                + +I   +  GLDYLHT     IIH ++K +NILL                    
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 206 --DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-----------------------YK 240
                    VS              E   A   +                        Y+
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR 260

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGK---EPINENPTPDEDFHL 285
           + E++     +   DI+S   +  EL +G    EP +      ++ H+
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 8/100 (8%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +   +D +H       +H ++K  NIL+D N    ++DFG  L L      +   A  + 
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 238 GYKAPELIKMKDASE-----ETDIYSFGVIMLELISGKEP 272
            Y +PE+++  +  +     E D +S GV M E++ G+ P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 28/102 (27%), Positives = 43/102 (42%), Gaps = 10/102 (9%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   +D +H       +H ++K  NILLDR     ++DFG  L L        L A  + 
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 238 GYKAPELIKMKDASEETDIY-------SFGVIMLELISGKEP 272
            Y +PE+++       T  Y       + GV   E+  G+ P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 27/101 (26%), Positives = 54/101 (53%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L+YLH+   R +++ ++K +N++LD++    ++DFGL         + + + +  +
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL-------CKEGISDGATMK 163

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+++  D     D +  GV+M E++ G+ P
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA GL +L +   + II+ +LK  N++LD      ++DFG+         + + +   ++
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-------CKENIWDGVTTK 500

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+I  +   +  D ++FGV++ E+++G+ P
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 46.8 bits (112), Expect = 4e-06
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I+  L+YLH    R II+ +LK  N+LLD      ++D+G+         + +     + 
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTS 168

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+++ +D     D ++ GV+M E+++G+ P
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I+  L+YLH    R II+ +LK  N+LLD      ++D+G+         + +     + 
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTS 211

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+++ +D     D ++ GV+M E+++G+ P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 48/229 (20%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL------RFLRPVCTTRDKEFGDLIELLGCIRHPN 127
           G  +G+  YG +YKA  +     +             +   R+      I LL  ++HPN
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE------IALLRELKHPN 79

Query: 128 LVPLLGFYAGPRGEKL-IVHPF----------YKRGNLAQCIRGGSGEAHKWSIIYRISI 176
           ++ L   +      K+ ++  +          + R + A             S++Y+   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--- 136

Query: 177 GIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY----VSDFGLHLLLNPTAGQEMLE 232
            I  G+ YLH   +  ++H +LK  NIL+           ++D G             L+
Sbjct: 137 -ILDGIHYLHA--NW-VLHRDLKPANILVMGEGPERGRVKIADMGF-----ARLFNSPLK 187

Query: 233 ASASQG-------YKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPI 273
             A          Y+APE L+  +  ++  DI++ G I  EL++ + PI
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L +LH    + II+ +LK  N+LLD      ++DFG+         + +     + 
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM-------CKEGICNGVTTA 182

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+++        D ++ GV++ E++ G  P
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 43/222 (19%), Positives = 86/222 (38%), Gaps = 39/222 (17%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
             IG+  +G ++KA  +++G    L+ +         P+   R+      I++L  ++H 
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------IKILQLLKHE 76

Query: 127 NLVPLLG-FYAGPRGEKLIVHPFY----------KRGNLAQCIRGGSGEAHKWSIIYRIS 175
           N+V L+                 Y              L   +      +    ++  + 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQML- 133

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
                GL Y+H      I+H ++K+ N+L+ R+    ++DFGL    +     +    + 
Sbjct: 134 ---LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 236 ---SQGYKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPI 273
              +  Y+ PE L+  +D     D++  G IM E+ +   PI
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 31/101 (30%), Positives = 55/101 (54%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I  GL +LH+   + I++ +LK  NILLD++    ++DFG+         + ML  + + 
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM-------CKENMLGDAKTN 176

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE++  +  +   D +SFGV++ E++ G+ P
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA  L YLH+     I++ +LK +NILLD      ++DFGL         + +   S + 
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL-------CKENIEHNSTTS 197

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE++  +      D +  G ++ E++ G  P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           IA GL +L +   + II+ +LK  N++LD      ++DFG+         + + +   ++
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-------CKENIWDGVTTK 179

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE+I  +   +  D ++FGV++ E+++G+ P
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 44.8 bits (107), Expect = 2e-05
 Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +A  LD+LH+     II+ +LK +NILLD      ++DFGL       + + +     + 
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL-------SKESIDHEKKAY 184

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE++  +  ++  D +SFGV+M E+++G  P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 50/212 (23%), Positives = 79/212 (37%), Gaps = 50/212 (23%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLL 132
            +V+G    G + +   +R+     L+ L+     R +E    +EL     + P++V ++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-RE----VELHWRASQCPHIVRIV 77

Query: 133 GFY---AGPRGEKLIVHPFYKRGNLAQCI--RGGSG----EAHKWSIIYRISIGIAGGLD 183
             Y      R   LIV      G L   I  RG       EA   S I +    I   + 
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA---SEIMKS---IGEAIQ 131

Query: 184 YLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYK 240
           YLH+     I H ++K +N+L      N    ++DFG                       
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166

Query: 241 APELIKMKDASEETDIYSFGVIMLELISGKEP 272
           A E    +   +  D++S GVIM  L+ G  P
Sbjct: 167 AKETTG-EKYDKSCDMWSLGVIMYILLCGYPP 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 44.4 bits (106), Expect = 2e-05
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 50/222 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
           E IG+  YGT++KA  + +  +  L+ +R        P    R+      I LL  ++H 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE------ICLLKELKHK 61

Query: 127 NLVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
           N+V L       +   L+   F +   +L +     +G+     I+      +  GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLV---FEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFC 117

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG------- 238
           H    R ++H +LK +N+L++RN +  +++FGL              A A          
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGL--------------ARAFGIPVRCYSA 160

Query: 239 ------YKAPE-LIKMKDASEETDIYSFGVIMLELISGKEPI 273
                 Y+ P+ L   K  S   D++S G I  EL +   P+
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 26/171 (15%)

Query: 136 AGPRGEKLIVHP---FYKRG-----------NLAQCIRGGSGEAHKWSIIYRISIGIAGG 181
                   ++H    F  R            NL + I+    +     ++ + +  I   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 182 LDYLHTGFHRPIIHGNLKSKNILLDRNYQPY--VSDFGLHLLLNPTAGQEMLEASASQGY 239
           LD LH      IIH +LK +NILL +  +    V DFG     +    Q +     S+ Y
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----QRVYTYIQSRFY 265

Query: 240 KAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMR 290
           +APE+I         D++S G I+ EL++G  P+   P  DE   L   + 
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY-PL--LPGEDEGDQLACMIE 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 26/101 (25%), Positives = 50/101 (49%), Gaps = 16/101 (15%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I+  L +LH    + II+ +LK +NI+L+      ++DFGL         + + + + + 
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL-------CKESIHDGTVTH 179

Query: 238 ---G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP 272
              G   Y APE++     +   D +S G +M ++++G  P
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 14/104 (13%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I    +YLH      +I+ +LK +N+L+D+     V+DFG        A +         
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF-------AKRVKGRTWTLC 199

Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           G     APE+I  K  ++  D ++ GV++ E+ +G  P   + P
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 49/218 (22%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHPN 127
           + +G+  Y T+YK   + + ++  L+ +R       P    R+      + LL  ++H N
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE------VSLLKDLKHAN 61

Query: 128 LVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
           +V L       +   L+   F Y   +L Q +       +    +      +  GL Y H
Sbjct: 62  IVTLHDIIHTEKSLTLV---FEYLDKDLKQYLDDCGNIINM-HNVKLFLFQLLRGLAYCH 117

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-------- 238
               + ++H +LK +N+L++   +  ++DFGL              A A           
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGL--------------ARAKSIPTKTYDNE 160

Query: 239 -----YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                Y+ P+ L+   D S + D++  G I  E+ +G+
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 55/223 (24%), Positives = 83/223 (37%), Gaps = 48/223 (21%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR-----------PVCTTRDKEFGDLIELLGCI 123
             IG   YGT+YKA    SG    L+ +R           P+ T R  E   L  L    
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR--EVALLRRLEAF- 71

Query: 124 RHPNLVPLLGFYAGPRGEKL----IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIA 179
            HPN+V L+   A  R ++     +V     + +L   +            I  +     
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG- 238
            GLD+LH   +  I+H +LK +NIL+       ++DFGL              A      
Sbjct: 131 RGLDFLHA--NC-IVHRDLKPENILVTSGGTVKLADFGL--------------ARIYSYQ 173

Query: 239 -----------YKAPELIKMKDASEETDIYSFGVIMLELISGK 270
                      Y+APE++     +   D++S G I  E+   K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 29/127 (22%), Positives = 59/127 (46%), Gaps = 16/127 (12%)

Query: 169 SIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPY--VSDFGLHLLLNPTA 226
           ++  + +  +   L +L T     IIH +LK +NILL    +    + DFG       ++
Sbjct: 157 NLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG-------SS 208

Query: 227 ---GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF 283
              GQ + +   S+ Y++PE++         D++S G I++E+ +G+ P+      +E  
Sbjct: 209 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE-PL--FSGANEVD 265

Query: 284 HLPTFMR 290
            +   + 
Sbjct: 266 QMNKIVE 272

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 46/226 (20%), Positives = 81/226 (35%), Gaps = 60/226 (26%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLR--------PVCTTRDKEFGDLIELLGCIRHP 126
             +G+  YG +YKA+   +     ++ +R        P    R+      + LL  ++H 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE------VSLLKELQHR 93

Query: 127 NLVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCI--RGGSGEAHKWSIIYRISIGIAGGLD 183
           N++ L           LI   F Y   +L + +            S +Y++      G++
Sbjct: 94  NIIELKSVIHHNHRLHLI---FEYAENDLKKYMDKNPDVSMRVIKSFLYQL----INGVN 146

Query: 184 YLHTGFHRPIIHGNLKSKNILLDRNYQPY-----VSDFGLHLLLNPTAGQEMLEASASQG 238
           + H    R  +H +LK +N+LL  +         + DFGL              A A   
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL--------------ARAFGI 189

Query: 239 -------------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                        Y+ PE L+  +  S   DI+S   I  E++   
Sbjct: 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 22/119 (18%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           I   L++LH      II+ ++K +NILLD N    ++DFGL       + + + + +   
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL-------SKEFVADETERA 217

Query: 238 G-------YKAPELIKMKDA--SEETDIYSFGVIMLELISGKEP---INENPTPDEDFH 284
                   Y AP++++  D+   +  D +S GV+M EL++G  P     E  +  E   
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 14/104 (13%)

Query: 178 IAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ 237
           +   L+YLH    + II+ +LK +NILLD+N    ++DFG        A           
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGF-------AKYVPDVTYTLC 164

Query: 238 G---YKAPELIKMKDASEETDIYSFGVIMLELISGKEP-INENP 277
           G   Y APE++  K  ++  D +SFG+++ E+++G  P  + N 
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 56/222 (25%)

Query: 75  EVIGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHP 126
             IG+ +YG ++K   + +G  V + +FL             R+      I +L  ++HP
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE------IRMLKQLKHP 62

Query: 127 NLVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCI---RGGSGEAHKWSIIYRISIGIAGGL 182
           NLV LL  +   R ++ +   F Y    +   +   + G  E    SI ++        +
Sbjct: 63  NLVNLLEVF---RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ----TLQAV 115

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---- 238
           ++ H   H   IH ++K +NIL+ ++    + DFG               A    G    
Sbjct: 116 NFCHK--HN-CIHRDVKPENILITKHSVIKLCDFGF--------------ARLLTGPSDY 158

Query: 239 ---------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                    Y++PE L+         D+++ G +  EL+SG 
Sbjct: 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 41.0 bits (97), Expect = 3e-04
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 29/102 (28%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
           GLD+LH+  HR ++H +LK +NIL+  + Q  ++DFGL              A       
Sbjct: 132 GLDFLHS--HR-VVHRDLKPQNILVTSSGQIKLADFGL--------------ARIYSFQM 174

Query: 239 ----------YKAPELIKMKDASEETDIYSFGVIMLELISGK 270
                     Y+APE++     +   D++S G I  E+   K
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 31/104 (29%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
           G+ Y H    R ++H +LK +N+L++R  +  ++DFGL              A A     
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGL--------------ARAFGIPV 154

Query: 239 -----------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                      Y+AP+ L+  K  S   DI+S G I  E+++G 
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 40.6 bits (96), Expect = 4e-04
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 31/104 (29%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
           G+ + H      I+H +LK +N+L++ +    ++DFGL              A A     
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGL--------------ARAFGIPV 173

Query: 239 -----------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                      Y+AP+ L+  K  S   DI+S G I  E+I+GK
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 52/220 (23%)

Query: 75  EVIGKSNYGTLYKALLQRSGS-VRLLRFLR-------PVCTTRDKEFGDLIELLGCIRHP 126
            ++G+ +YG + K   + +G  V + +FL             R+      I+LL  +RH 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE------IKLLKQLRHE 84

Query: 127 NLVPLLGFYAGPRGEKLIVHPF-YKRGNLAQCI---RGGSGEAHKWSIIYRISIGIAGGL 182
           NLV LL      + +K     F +    +   +     G         +++I  GI    
Sbjct: 85  NLVNLLEVC---KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG--- 138

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---- 238
            + H+  H  IIH ++K +NIL+ ++    + DFG        A        A+ G    
Sbjct: 139 -FCHS--HN-IIHRDIKPENILVSQSGVVKLCDFGF-------AR-----TLAAPGEVYD 182

Query: 239 -------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                  Y+APE L+      +  D+++ G ++ E+  G+
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 31/104 (29%)

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG-- 238
           GL + H      I+H +LK +N+L+++  Q  + DFGL              A A     
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGL--------------ARAFGIPV 162

Query: 239 -----------YKAPE-LIKMKDASEETDIYSFGVIMLELISGK 270
                      Y+AP+ L+  +  S   DI+S G I+ E+I+GK
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	356
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.23
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.48
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.44
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.15
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.05
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.87
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.59
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.42
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.15
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.93
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.6
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.92
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.6
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.59
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	91.34
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	89.59
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.48
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	84.04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	83.08

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-61  Score=437.59  Aligned_cols=253  Identities=20%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||+||+|.++     .++..||+|.++.......++|.+|+++|++++|||||+++|+|.++ +..++||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey  124 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLLMVFEY  124 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEEC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence            478999999999999975     35789999999876555567899999999999999999999999854 489999999


Q ss_pred             ccCCChhHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          149 YKRGNLAQCIRGGS-------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       149 ~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      |++|+|.++++...             ..+++|.+++.|+.||+.||+|||+   ++|+||||||+|||+++++++||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcc
Confidence            99999999996422             2468999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          216 FGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       216 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.       .+ +...+
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~-~~~~i  273 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TE-AIDCI  273 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HH-HHHHH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HH-HHHHH
Confidence            999987543322 22345678999999999999999999999999999999999 8999976432       11 11111


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ...                 .+.+.+..++.++.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       274 ~~g-----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          274 TQG-----------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHT-----------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HcC-----------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            111                 011234456678899999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-62  Score=433.84  Aligned_cols=253  Identities=22%  Similarity=0.376  Sum_probs=207.3

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ++.||+|+||+||+|.+.     .++..||+|.++.......++|.+|+++|++++|||||+++|+|.+ ++..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~lV~Ey   96 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEY   96 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEc
Confidence            478999999999999875     3578899999987655555789999999999999999999999985 4589999999


Q ss_pred             ccCCChhHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccc
Q 038580          149 YKRGNLAQCIRGG-----------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFG  217 (356)
Q Consensus       149 ~~~gsL~~~l~~~-----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  217 (356)
                      |++|||.++++..           ....+++..++.++.||++||+|||+   ++|+||||||+|||+++++++||+|||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFG  173 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG  173 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcc
Confidence            9999999999642           24579999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          218 LHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       218 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      +++......... .....||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.+.       .+ +...+..
T Consensus       174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~-~~~~i~~  245 (299)
T 4asz_A          174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NE-VIECITQ  245 (299)
T ss_dssp             CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HH-HHHHHHH
T ss_pred             cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH-HHHHHHc
Confidence            998654332222 223468999999999999999999999999999999999 8999986432       11 1111111


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..                 ..+.+..++.++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       246 ~~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          246 GR-----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             TC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11                 11234456678999999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.3e-61  Score=429.99  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=206.6

Q ss_pred             CcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      +.||+|+||+||+|.+.     .++..||+|.++..... ..++|.+|+.++++++|||||+++|+|.+ ++..++||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~lV~Ey  110 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLSMIFSY  110 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEEC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEEEEEEc
Confidence            67999999999999974     35688999998755433 34689999999999999999999999985 4589999999


Q ss_pred             ccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEe
Q 038580          149 YKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVS  214 (356)
Q Consensus       149 ~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~  214 (356)
                      |++|||.++|....              ...+++..++.++.||+.||+|||+   .+|+||||||+|||+++++++||+
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~  187 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKIS  187 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEEC
Confidence            99999999996421              2458999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHh
Q 038580          215 DFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNA  292 (356)
Q Consensus       215 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  292 (356)
                      |||+++....... .......||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+.       .+ +...
T Consensus       188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~-~~~~  259 (308)
T 4gt4_A          188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QD-VVEM  259 (308)
T ss_dssp             CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HH-HHHH
T ss_pred             CcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HH-HHHH
Confidence            9999986543222 22345578999999999999999999999999999999999 8999976432       11 1111


Q ss_pred             hhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          293 VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      +..                 +...+.+.+++..+.+||.+||+.||++||||++|++.|+.+.
T Consensus       260 i~~-----------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          260 IRN-----------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHc-----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            111                 1112234566778999999999999999999999999999763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-60  Score=420.53  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ++.||+|+||+||+|.++.   .+|+|+++.....  ..+.|.+|++++++++|||||+++|+|..  +..++|||||++
T Consensus        41 ~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~g  115 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCEG  115 (307)
T ss_dssp             EEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCSS
T ss_pred             eeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCCC
Confidence            4789999999999998753   3788888754332  23579999999999999999999998863  468999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Ccce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  230 (356)
                      |||.++++.. ...+++..++.|+.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+...... ....
T Consensus       116 GsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          116 SSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             CBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            9999999743 3469999999999999999999999   999999999999999999999999999998764322 2234


Q ss_pred             ecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+.+..       ..+......    ....|.. 
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~----~~~~p~~-  259 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGR----GYASPDL-  259 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHT----TCCCCCS-
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhc----CCCCCCc-
Confidence            45689999999999863   46899999999999999999999999764321       111111111    0111111 


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ...+.+++..+.+|+.+||+.||++||||.+|++.|+.++
T Consensus       260 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          260 --------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             --------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             --------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    1233456678999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-59  Score=425.82  Aligned_cols=258  Identities=23%  Similarity=0.357  Sum_probs=209.9

Q ss_pred             cCCCCcccccCCceEEEEEEcCC-----CeEEEEEEeccccccc-hHHHHHHHHHHhccCC-CccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRS-----GSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRH-PNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~-----~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~  143 (356)
                      +..++.||+|+||+||+|.+...     ++.||+|.++...... .+.|.+|+++|++++| ||||+++|+|..+++..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            34458899999999999998643     4689999987644332 3579999999999975 999999999986666899


Q ss_pred             EEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC
Q 038580          144 IVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY  209 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  209 (356)
                      +|||||++|+|.++|+...              ...+++..+..++.||++||+|||+   ++|+||||||+|||+++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCC
Confidence            9999999999999996421              3458999999999999999999999   9999999999999999999


Q ss_pred             CeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhH
Q 038580          210 QPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       210 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  287 (356)
                      ++||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |..||.+.....       
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-------  295 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------  295 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999987644332 23345678999999999999999999999999999999998 999998643211       


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .+...+...                 .+.+.+..++.++.++|.+||+.||++|||+++|++.|+++.
T Consensus       296 ~~~~~i~~g-----------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          296 EFCRRLKEG-----------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             HHHHHHHHT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcC-----------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            111111111                 011233445678899999999999999999999999998864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-58  Score=418.78  Aligned_cols=245  Identities=20%  Similarity=0.286  Sum_probs=205.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.++.+|+.||+|+++.......+.+.+|+++|+.++|||||+++++|.++ +..|+|||||++|+
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~  157 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGA  157 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECCCTTEE
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCc
Confidence            46799999999999999999999999999766666667899999999999999999999999864 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... ......
T Consensus       158 L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~  230 (346)
T 4fih_A          158 LTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL  230 (346)
T ss_dssp             HHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCC
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccccc
Confidence            9999974   358999999999999999999999   999999999999999999999999999998765332 233467


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      +||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.       .. ....+...     ..+         
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~-~~~~i~~~-----~~~---------  288 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LK-AMKMIRDN-----LPP---------  288 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH-HHHHHHHS-----SCC---------
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HH-HHHHHHcC-----CCC---------
Confidence            899999999999999999999999999999999999999975321       11 11111111     000         


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..+.....+.++.+|+.+||+.||++|||++|+++
T Consensus       289 -~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11123344567889999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3e-58  Score=414.60  Aligned_cols=247  Identities=20%  Similarity=0.230  Sum_probs=201.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .++||+|+||.||+|.++.+|+.||+|+++...     ...+|+.+++.++|||||++++++.++ +..|+|||||++|+
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~  136 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGS  136 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEECCCTTCB
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCc
Confidence            467999999999999999999999999987532     234699999999999999999999854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCc----
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQ----  228 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~----  228 (356)
                      |.++++.  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+........    
T Consensus       137 L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          137 LGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             HHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9999974  3469999999999999999999999   9999999999999999987 6999999999876543221    


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+....    ...+...    .      +..  
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~----~------~~~--  275 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKIASE----P------PPI--  275 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHHHHS----C------CGG--
T ss_pred             cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHcC----C------CCc--
Confidence            12235799999999999999999999999999999999999999986543322    1111110    0      000  


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                             ...+.+++..+.+++.+||+.||++|||+.|+++.|.+.
T Consensus       276 -------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 -------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                   012334556788999999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-58  Score=418.04  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|.+..+++.||+|+++.....  ..+.+.+|+++|++++|||||++++++.+ ++..|+|||||++
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVmEy~~g  107 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEG  107 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEeCCCC
Confidence            37899999999999999999999999998754332  23578999999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+++.......+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus       108 g~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~  183 (350)
T 4b9d_A          108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELAR  183 (350)
T ss_dssp             CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHH
T ss_pred             CcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC-ccccc
Confidence            999999976566678999999999999999999999   99999999999999999999999999999875421 11223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.       ...+. .+.....             
T Consensus       184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~-~i~~~~~-------------  242 (350)
T 4b9d_A          184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVL-KIISGSF-------------  242 (350)
T ss_dssp             HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHH-HHHHTCC-------------
T ss_pred             ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHH-HHHcCCC-------------
Confidence            56799999999999999999999999999999999999999976421       11111 1111110             


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          .+.+...+.++.+|+.+||+.||++|||++++++
T Consensus       243 ----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0122334567889999999999999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-57  Score=408.04  Aligned_cols=265  Identities=20%  Similarity=0.282  Sum_probs=197.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCC---ceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG---EKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~~  150 (356)
                      ++.||+|+||+||+|.++  |+.||+|+++... .....++.|+..+.+++|||||+++|+|..++.   ..++|||||+
T Consensus         8 ~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            478999999999999984  7889999986432 112234456666778999999999999875432   5799999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF-----HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      +|||.++++.   ..+++..+.+++.|++.||+|||+..     .++|+||||||+|||++.++++||+|||+++.....
T Consensus        85 ~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           85 HGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            9999999974   46899999999999999999999821     238999999999999999999999999999876443


Q ss_pred             CCc---ceecccCCCcccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc-------hhHHH
Q 038580          226 AGQ---EMLEASASQGYKAPELIKMK------DASEETDIYSFGVIMLELISGKEPINENPTPDEDFH-------LPTFM  289 (356)
Q Consensus       226 ~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~  289 (356)
                      ...   ......||+.|||||++.+.      .|+.++|||||||++|||+||..||...........       ....+
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            222   22345799999999998754      367799999999999999999888765432221110       11111


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ......    ...+|.+       +....+.+++..+.+|+.+||+.||++||||.+|++.|+++.
T Consensus       242 ~~~~~~----~~~rp~~-------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          242 RKVVCE----QKLRPNI-------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHTT----SCCCCCC-------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhc----ccCCCCC-------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111111    1111111       001123457788999999999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-57  Score=401.57  Aligned_cols=243  Identities=24%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~  149 (356)
                      +.||+|+||+||+|.+..++..||+|.+......  ..+.|.+|++++++++|||||+++++|.+   .++..++|||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            6799999999999999999999999988654322  23579999999999999999999998864   234689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEcC-CCCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ++|+|.++++.  ...+++..+..++.||+.||+|||+   ++  |+||||||+|||++. ++.+||+|||+|+....  
T Consensus       112 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          112 TSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            99999999974  4578999999999999999999999   77  999999999999984 78999999999986432  


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......+||+.|||||++. +.|+.++|||||||++|||+||..||.+....       ..+...+....     .+. 
T Consensus       185 -~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~-----~~~-  249 (290)
T 3fpq_A          185 -SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGV-----KPA-  249 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTC-----CCG-
T ss_pred             -CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCC-----CCC-
Confidence             2334568999999999986 46999999999999999999999999753211       11111111110     000 


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                ..+...+.++.+|+.+||+.||++|||++++++
T Consensus       250 ----------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      011223346889999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=419.57  Aligned_cols=246  Identities=20%  Similarity=0.281  Sum_probs=205.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.++.+|+.||+|+++.......+.+.+|+.+|+.++|||||+++++|.++ +.+|+|||||++|
T Consensus       155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy~~gG  233 (423)
T 4fie_A          155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGG  233 (423)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTE
T ss_pred             eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeCCCCC
Confidence            347899999999999999999999999999876666667899999999999999999999999864 4899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.++++.   ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+...... .....
T Consensus       234 ~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  306 (423)
T 4fie_A          234 ALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  306 (423)
T ss_dssp             EHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCC
T ss_pred             cHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccccc
Confidence            99999974   358999999999999999999999   999999999999999999999999999998765432 23346


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..       . ....+....     .+        
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~-~~~~i~~~~-----~~--------  365 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------K-AMKMIRDNL-----PP--------  365 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSC-----CC--------
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------H-HHHHHHcCC-----CC--------
Confidence            68999999999999999999999999999999999999999753211       1 111111110     00        


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ........+.++.+|+.+||+.||++|||++|+++
T Consensus       366 --~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 --RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              01112234567889999999999999999999976

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-57  Score=405.28  Aligned_cols=244  Identities=20%  Similarity=0.305  Sum_probs=203.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||+||+|.++.+++.+|+|+++...   ....+.+.+|+++|+.++|||||++++++.++ +..|+|||||
T Consensus        36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yivmEy~  114 (311)
T 4aw0_A           36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYA  114 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCC
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecC
Confidence            3588999999999999999999999999986532   23345799999999999999999999999864 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Cc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQ  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  228 (356)
                      ++|+|.++++.  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus       115 ~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          115 KNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             TTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            99999999973  3569999999999999999999999   999999999999999999999999999998765432 23


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....+||+.|||||++.+..|+.++||||+||++|||+||..||.+.+.       .. +...+....           
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~-~~~~i~~~~-----------  250 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GL-IFAKIIKLE-----------  250 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC-----------
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHcCC-----------
Confidence            34567899999999999999999999999999999999999999975321       11 111111111           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                             ..++...+.++.+|+.+||+.||++|||++|++
T Consensus       251 -------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                   012223445688999999999999999998863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.2e-56  Score=389.21  Aligned_cols=241  Identities=21%  Similarity=0.322  Sum_probs=186.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++....   .....+.+|+++++.++|||||++++++.++ +..++||||+ 
T Consensus        18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~-   95 (275)
T 3hyh_A           18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMVIEYA-   95 (275)
T ss_dssp             EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECC-
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEeCC-
Confidence            4789999999999999999999999999865432   2235789999999999999999999999864 5899999999 


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++++||+|||+|+.....  ...
T Consensus        96 ~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~  168 (275)
T 3hyh_A           96 GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFL  168 (275)
T ss_dssp             CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC--Ccc
Confidence            6799999874  3569999999999999999999999   99999999999999999999999999999765432  223


Q ss_pred             ecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ...+||+.|||||++.+..| +.++||||+||++|||+||..||.+.+.       .. +........            
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~-~~~~i~~~~------------  228 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PV-LFKNISNGV------------  228 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC------------
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHcCC------------
Confidence            45689999999999998876 5799999999999999999999975321       11 111111111            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       229 ------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  0122234566889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.6e-56  Score=397.26  Aligned_cols=243  Identities=20%  Similarity=0.272  Sum_probs=191.6

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||+||+|+..   .+++.+|+|+++.....  ....+.+|+++|++++|||||++++++.++ +..|+||||
T Consensus        29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy  107 (304)
T 3ubd_A           29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLYLILDF  107 (304)
T ss_dssp             EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEEEEECC
T ss_pred             EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEEc
Confidence            478999999999999874   46789999998754322  234688999999999999999999999864 589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |++|+|.+++..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus       108 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~  181 (304)
T 3ubd_A          108 LRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EK  181 (304)
T ss_dssp             CTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC------C
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-Cc
Confidence            999999999974  3469999999999999999999999   99999999999999999999999999999865332 22


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....+||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.       .+ ....+....           
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~-~~~~i~~~~-----------  242 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KE-TMTMILKAK-----------  242 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCC-----------
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HH-HHHHHHcCC-----------
Confidence            33456899999999999999999999999999999999999999976432       11 111111111           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI-----KQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~il~  349 (356)
                             .+.+...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       243 -------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 -------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                   11223345678899999999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.4e-54  Score=383.52  Aligned_cols=246  Identities=21%  Similarity=0.343  Sum_probs=185.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCC-----------Cc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----------GE  141 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----------~~  141 (356)
                      .+.||+|+||+||+|.++.+++.+|+|.++..... ..+.+.+|+++|++++|||||++++++.+.+           ..
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            37899999999999999999999999998754332 2357899999999999999999999886433           24


Q ss_pred             eEEEEecccCCChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          142 KLIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      .|++||||++|+|.++++... ....++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGla~  166 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT  166 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCccce
Confidence            789999999999999997533 2345677788999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCCc-----------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH
Q 038580          221 LLNPTAGQ-----------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM  289 (356)
Q Consensus       221 ~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  289 (356)
                      ........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....      .....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------~~~~~~  237 (299)
T 4g31_A          167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ERVRTL  237 (299)
T ss_dssp             -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------HHHHHH
T ss_pred             ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------HHHHHH
Confidence            76433221           1234579999999999999999999999999999999996   765310      000000


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .....     ...            .+...+....+.+|+.+||+.||++|||+.++++
T Consensus       238 -~~~~~-----~~~------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          238 -TDVRN-----LKF------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHT-----TCC------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHhc-----CCC------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00000     000            0112334456778999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=387.06  Aligned_cols=267  Identities=19%  Similarity=0.249  Sum_probs=198.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC-----CCceEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLIV  145 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv  145 (356)
                      ..+.||+|+||+||+|.++.+|+.||+|+++......  .+.+.+|+++|+.++|||||++++++...     .+..|+|
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence            3478999999999999999999999999997543322  24688999999999999999999987632     3578999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      ||||. |+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       138 mE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          138 LDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            99996 689999973  4579999999999999999999999   99999999999999999999999999999865432


Q ss_pred             C---CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---c
Q 038580          226 A---GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---I  298 (356)
Q Consensus       226 ~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  298 (356)
                      .   .......+||+.|||||++.+. .|+.++||||+||++|||++|..||.+.+....    ...+........   +
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~----l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ----LQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH----HHHHHHHHCCCCGGGT
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH----HHHHHHhcCCCChHHh
Confidence            1   2233466899999999998765 569999999999999999999999986432111    111111000000   0


Q ss_pred             ccccCcccccc-cCCCCCCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLC-SNSNHENPVS-----EERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........... .......+.+     .+.+.++.+|+.+||+.||++|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000000000 0000000111     123456789999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-50  Score=369.78  Aligned_cols=194  Identities=21%  Similarity=0.363  Sum_probs=163.9

Q ss_pred             CCCCcccccCCceEEEEEEc---CCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||+||+|.++   .+++.+|+|.+...  .....+.+|+++|+.+ +|||||++++++.+ +++.++|||
T Consensus        24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~~lvmE  100 (361)
T 4f9c_A           24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHVVIAMP  100 (361)
T ss_dssp             EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEEEEEEE
T ss_pred             EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEEEEEEe
Confidence            33578999999999999875   35788999988643  3445788999999988 69999999999985 458999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEeccccccccCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~  226 (356)
                      |+++|+|.++++     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.+ +.+||+|||+|+......
T Consensus       101 ~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A          101 YLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             CCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             CCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            999999999984     48899999999999999999999   999999999999999877 799999999997653321


Q ss_pred             C---------------------------cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          227 G---------------------------QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       227 ~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      .                           ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.||...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            1                           112345799999999998765 5899999999999999999999999653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-50  Score=390.04  Aligned_cols=246  Identities=18%  Similarity=0.270  Sum_probs=196.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHH---HHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFG---DLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...++||+|+||.||+|..+.+|+.+|+|+++....   .......   .++.+++.++|||||+++++|+++ +.+|+|
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~lylV  270 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFI  270 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEEEEE
Confidence            335889999999999999999999999999864321   1122233   346677788999999999999965 489999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      ||||+||+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       271 mEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             ECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999974  3569999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          226 AGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                         .....+||+.|||||++.. ..|+.++|+||+||++|||++|..||.+.+....    .. +.......        
T Consensus       346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~----~~-i~~~i~~~--------  409 (689)
T 3v5w_A          346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMTLTM--------  409 (689)
T ss_dssp             ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----HH-HHHHHHHC--------
T ss_pred             ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HH-HHHhhcCC--------
Confidence               2345689999999999974 5799999999999999999999999976432211    11 11111110        


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                                ....+...+.++.+|+.+||+.||++|++     +++|++
T Consensus       410 ----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                      01123334567889999999999999998     677754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-50  Score=391.23  Aligned_cols=248  Identities=20%  Similarity=0.278  Sum_probs=204.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.++.+|+.+|+|+++.......+.+.+|+++|+.++|||||++++++.+ ++..+++||||.+|
T Consensus       161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~~~gg  239 (573)
T 3uto_A          161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGG  239 (573)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEECCCCC
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeecCCC
Confidence            35789999999999999999999999999876555555678999999999999999999999985 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC--CCeEEeccccccccCCCCCcce
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN--YQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|.+++... ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+++.....  ...
T Consensus       240 ~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~  313 (573)
T 3uto_A          240 ELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSV  313 (573)
T ss_dssp             BHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEE
T ss_pred             cHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cce
Confidence            999999642 3468999999999999999999999   999999999999999854  89999999999876543  334


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|..||.+.+..       . ....+.....    .       
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~-~~~~i~~~~~----~-------  374 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------E-TLRNVKSCDW----N-------  374 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHTTCC----C-------
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------H-HHHHHHhCCC----C-------
Confidence            4568999999999999999999999999999999999999999764321       1 1111111000    0       


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       375 ---~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 ---MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000112234556789999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.3e-49  Score=353.56  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=207.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ++.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++.+ ++..++||||+++++
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~   93 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEYIKGGT   93 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCTTCB
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEecCCCc
Confidence            4889999999999999999999999998876555556789999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc----
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE----  229 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~----  229 (356)
                      |.++++.. ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..........    
T Consensus        94 L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  169 (310)
T 3s95_A           94 LRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR  169 (310)
T ss_dssp             HHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred             HHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence            99999753 4568999999999999999999999   999999999999999999999999999997654322211    


Q ss_pred             ---------eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccc
Q 038580          230 ---------MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITD  300 (356)
Q Consensus       230 ---------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (356)
                               .....||+.|+|||++.+..++.++||||||+++|||++|..||...............  ..... .   
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~-~---  243 (310)
T 3s95_A          170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--GFLDR-Y---  243 (310)
T ss_dssp             ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--HHHHH-T---
T ss_pred             cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--ccccc-c---
Confidence                     11456899999999999999999999999999999999999998765433322211110  00000 0   


Q ss_pred             ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          301 LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                       .+.+++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       244 -----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          244 -----------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -----------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                             11223345789999999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.4e-48  Score=349.99  Aligned_cols=270  Identities=31%  Similarity=0.545  Sum_probs=217.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.+. ++..+|+|.+........+.+.+|+.+++.++||||+++++++.. .+..++||||+++
T Consensus        42 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  119 (321)
T 2qkw_B           42 DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMEN  119 (321)
T ss_dssp             SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCEEEEECCTT
T ss_pred             CccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEEcCCC
Confidence            34578999999999999975 577889998876655556789999999999999999999999875 4589999999999


Q ss_pred             CChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-c
Q 038580          152 GNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-Q  228 (356)
Q Consensus       152 gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  228 (356)
                      |+|.+++....  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........ .
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999996433  3458999999999999999999999   9999999999999999999999999999876432221 2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......|++.|+|||++.+..++.++||||||+++|||+||..||........ .....+..............++..  
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--  273 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNNGQLEQIVDPNL--  273 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTHHHHTTTCCCSSSSSSC--
T ss_pred             cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhhhccccccHHHhcChhh--
Confidence            22344578899999999888999999999999999999999999986544332 223333332222222222222221  


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ....+.+.+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       274 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          274 ------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             ------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                  23456788999999999999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-48  Score=350.39  Aligned_cols=274  Identities=29%  Similarity=0.554  Sum_probs=215.1

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +...+.||+|+||.||+|.+. ++..+|+|.++..... ....+.+|+++++.++||||+++++++..+ +..++||||+
T Consensus        32 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~  109 (326)
T 3uim_A           32 FSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVYPYM  109 (326)
T ss_dssp             SCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-SCCEEEEECC
T ss_pred             cccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-CceEEEEEec
Confidence            344588999999999999865 5778899988754332 234789999999999999999999998854 4789999999


Q ss_pred             cCCChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          150 KRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       150 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      .+|+|.+++....  ...+++..+..++.|++.||+|||+.+..+++||||||+||+++.++.+||+|||++........
T Consensus       110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  189 (326)
T 3uim_A          110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT  189 (326)
T ss_dssp             TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred             cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence            9999999997543  34599999999999999999999992111999999999999999999999999999987655444


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-CCCCchhHHHHHhhhhcccccccCccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTP-DEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      .......||+.|+|||++.+..++.++||||||+++|||+||..||...... ........+..............+   
T Consensus       190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  266 (326)
T 3uim_A          190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD---  266 (326)
T ss_dssp             CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC---
T ss_pred             cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC---
Confidence            4455566899999999998888999999999999999999999999632111 112223333332222222222222   


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                           .......+.+.+..+.+++..||+.||++|||+.++++.|+..
T Consensus       267 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          267 -----VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             -----TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             -----hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                 2223456788899999999999999999999999999999853

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.2e-48  Score=350.91  Aligned_cols=266  Identities=19%  Similarity=0.288  Sum_probs=202.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCC---CceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR---GEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+.  ++.+|+|+++... .....+..|+.++++++||||+++++++....   ...++||||++
T Consensus        29 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            478999999999999885  7889999986432 22345677888999999999999999987543   24799999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR----------PIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~----------~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      +|+|.++++.   ..+++..+..++.|++.||+|||+   .          +++||||||+|||++.++.+||+|||++.
T Consensus       106 ~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          106 KGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence            9999999974   358999999999999999999999   7          99999999999999999999999999997


Q ss_pred             ccCCCCCc-ceecccCCCcccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH----H
Q 038580          221 LLNPTAGQ-EMLEASASQGYKAPELIKMK-----DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM----R  290 (356)
Q Consensus       221 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~----~  290 (356)
                      ........ ......+|+.|+|||++.+.     .++.++||||||+++|||+||..||.+..............    .
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            65443222 22345789999999998763     45668899999999999999999998754433221110000    0


Q ss_pred             HhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          291 NAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .............+...       ........+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          260 EDMQEVVVHKKKRPVLR-------DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HHHHHHHTTSCCCCCCC-------GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhhhhhhcccCCCCcc-------ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00000000001111110       00113356778999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.8e-48  Score=346.52  Aligned_cols=247  Identities=22%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||+||+|.+..+++.+|+|.+........+.+.+|+.+++.++||||+++++++.. .+..++||||+++
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~  101 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAG  101 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTT
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEECCCC
Confidence            345789999999999999998999999999877666666789999999999999999999999885 4489999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........ ...
T Consensus       102 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  174 (297)
T 3fxz_A          102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (297)
T ss_dssp             CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred             CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence            999999974   358899999999999999999999   9999999999999999999999999999877543322 234


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...||+.|+|||++.+..++.++||||||+++|||++|..||...+.       .......... .              
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~-~--------------  232 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN-G--------------  232 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHH-C--------------
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC-C--------------
Confidence            55789999999999999999999999999999999999999975321       1111110000 0              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ......+...+..+.+++.+||+.||++|||++++++
T Consensus       233 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0011123345567889999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-48  Score=372.58  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=211.1

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +...+.||+|+||.||+|.+..++..+|+|.++... ...++|.+|+.++++++||||++++++|.. .+..++||||++
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~E~~~  299 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMT  299 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEEEccC
Confidence            344578999999999999999889999999987543 345789999999999999999999999885 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.++++......+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..........
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            9999999986556679999999999999999999999   9999999999999999999999999999987654333333


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....++..|+|||++....++.++||||||+++|||+| |..||.+.+..    .....+    ..              
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~--------------  434 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL----EK--------------  434 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH----HT--------------
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----Hc--------------
Confidence            34455778999999998889999999999999999999 99999764321    111111    10              


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ..+...+..++..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus       435 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               0011223445677889999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-47  Score=354.51  Aligned_cols=255  Identities=22%  Similarity=0.403  Sum_probs=204.7

Q ss_pred             CCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCce
Q 038580           72 APGEVIGKSNYGTLYKALLQ-------RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (356)
                      ...+.||+|+||.||+|.+.       .++..+|+|+++..... ..+.+.+|+.+++.+ +||||++++++|.. .+..
T Consensus        84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~  162 (370)
T 2psq_A           84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPL  162 (370)
T ss_dssp             EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-SSSC
T ss_pred             EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-CCCE
Confidence            34578999999999999874       34568999998754332 235789999999999 89999999999885 4589


Q ss_pred             EEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC
Q 038580          143 LIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN  208 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  208 (356)
                      ++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCC
Confidence            99999999999999997432              2357899999999999999999999   999999999999999999


Q ss_pred             CCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchh
Q 038580          209 YQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP  286 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~  286 (356)
                      +.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+...    +.
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----~~  315 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LF  315 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HH
Confidence            9999999999986543222 22234456788999999999999999999999999999999 999997643211    11


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .    .....                 .....+..++..+.+++..||+.||++||++.++++.|+++.
T Consensus       316 ~----~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 K----LLKEG-----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             H----HHHTT-----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHhcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1    11110                 011123345567889999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.8e-48  Score=346.39  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             hcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+...+.||+|+||.||+|.+  ++..+|+|++.......  .+.+.+|++++++++||||+++++++... +..++|||
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e  114 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTE  114 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TCCEEEEE
T ss_pred             HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CceEEEEe
Confidence            344458899999999999987  47789999987544322  25789999999999999999999998854 47899999


Q ss_pred             cccCCChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          148 FYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      |+++|+|.+++.... ...+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.+||+|||++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999997432 2248999999999999999999999   88  99999999999999999999999999875432


Q ss_pred             CCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          225 TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       225 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      . ........||+.|+|||++.+..++.++||||||+++|||++|..||...+.       ..... .....        
T Consensus       192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~-~~~~~--------  254 (309)
T 3p86_A          192 T-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVA-AVGFK--------  254 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHH-HHHHS--------
T ss_pred             c-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhc--------
Confidence            2 2223355789999999999999999999999999999999999999975321       11111 11000        


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ......+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       255 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          255 --------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             --------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                    0011223344567889999999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-47  Score=362.94  Aligned_cols=247  Identities=23%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+.  +..+|+|.++...  ..+.+.+|+.++++++||||+++++++...++..++||||+++|
T Consensus       197 ~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g  272 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  272 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred             EEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence            3478999999999999985  6789999987543  45789999999999999999999999886666899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.++++......+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....    ...
T Consensus       273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~  345 (450)
T 1k9a_A          273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT  345 (450)
T ss_dssp             BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccC
Confidence            99999976544557999999999999999999999   99999999999999999999999999998754321    122


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..++..|+|||++.+..++.++||||||+++|||+| |..||.+.+...    ....    ....               
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~~----i~~~---------------  402 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR----VEKG---------------  402 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHHH----HHTT---------------
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHcC---------------
Confidence            356788999999999999999999999999999998 999998654322    1111    1110               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        .+.+.+..++..+.++|.+||+.||++|||+.++++.|+++.
T Consensus       403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              011233455678899999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.3e-49  Score=363.42  Aligned_cols=254  Identities=23%  Similarity=0.373  Sum_probs=204.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ...+.||+|+||.||+|.+..++..+|+|.++..... ..+.+.+|+++++.++||||++++++|.. ++..++||||++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~  195 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQ  195 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEEEcCC
Confidence            3457899999999999999988999999998754322 22478899999999999999999999875 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.++++.. ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...........
T Consensus       196 ~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          196 GGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             TCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            99999999742 3458899999999999999999999   9999999999999999999999999999876433211111


Q ss_pred             -ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          231 -LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       231 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                       ....++..|+|||++..+.++.++||||||+++|||+| |..||.+...        .........             
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~-------------  330 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEK-------------  330 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHT-------------
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHc-------------
Confidence             11234667999999998889999999999999999998 9999976421        111111110             


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                          ....+.+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       331 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          331 ----GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                0011223345667889999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3e-48  Score=347.44  Aligned_cols=265  Identities=20%  Similarity=0.346  Sum_probs=202.1

Q ss_pred             CCcccccCCceEEEEEE----cCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+    ..++..+|+|.++.......+.+.+|+++++.++||||+++++++... ....++||||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   94 (295)
T 3ugc_A           15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY   94 (295)
T ss_dssp             EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred             hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence            47899999999999984    567899999998865555556899999999999999999999987532 2468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-  227 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  227 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........ 
T Consensus        95 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  170 (295)
T 3ugc_A           95 LPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF  170 (295)
T ss_dssp             CTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--------
T ss_pred             CCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce
Confidence            9999999999743 3358999999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             -cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC----CCCchhHHHHHhhhhccccccc
Q 038580          228 -QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD----EDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       228 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                       .......++..|+|||.+.+..++.++||||||+++|||+||..|+.......    ...............       
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  243 (295)
T 3ugc_A          171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-------  243 (295)
T ss_dssp             -----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH-------
T ss_pred             eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH-------
Confidence             12223456677999999999999999999999999999999999986421100    000000000000000       


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ........+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       244 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          244 ------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             ------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                  00011122234455678899999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-48  Score=368.35  Aligned_cols=252  Identities=21%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.++ ++..+|+|.++... ...+.+.+|+.+++.++||||+++++++.  .+..++||||+++
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~  266 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAK  266 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTT
T ss_pred             EEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCC
Confidence            34578999999999999997 46678999887543 34578999999999999999999999886  3478999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.++++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...........
T Consensus       267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence            999999975444468889999999999999999999   99999999999999999999999999999875432222223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||++....++.++||||||+++|||+| |..||.+.+.       .+... .+...              
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~-~i~~~--------------  401 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIR-ALERG--------------  401 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHH-HHHHT--------------
T ss_pred             CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHHcC--------------
Confidence            3445778999999998899999999999999999999 9999976431       11111 11110              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ...+.+..++..+.+++.+||+.||++|||+++|++.|+++.
T Consensus       402 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          402 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence               011123345677899999999999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=338.99  Aligned_cols=276  Identities=15%  Similarity=0.225  Sum_probs=211.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++.... ...+.+.+|+++++.++||||+++++++.... ...++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence            4789999999999999999999999999875433 33467889999999999999999999887544 378999999999


Q ss_pred             CChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE----cCCCCeEEeccccccccCCCC
Q 038580          152 GNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       152 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ++|.+++.... ...+++..++.++.|++.||+|||+   .+++||||||+||++    +.++.+||+|||++.......
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~  170 (319)
T 4euu_A           94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE  170 (319)
T ss_dssp             CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred             CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence            99999997533 3348999999999999999999999   999999999999999    788889999999998764332


Q ss_pred             CcceecccCCCcccCccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIK--------MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                        ......+|+.|+|||++.        +..++.++||||||+++|||+||..||........................+
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (319)
T 4euu_A          171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (319)
T ss_dssp             --CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred             --ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence              223456899999999986        4678999999999999999999999997544322221111111111111111


Q ss_pred             ccc---cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          299 TDL---YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       299 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ...   .................+......+.+++.+||+.||++|||++++++...+-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            110   00001001111222346778889999999999999999999999999987753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-47  Score=347.74  Aligned_cols=263  Identities=16%  Similarity=0.266  Sum_probs=205.2

Q ss_pred             chhhhhcCCCCcccccCCceEEEEEEc-----CCCeEEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeC
Q 038580           65 TICDILDAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAG  137 (356)
Q Consensus        65 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  137 (356)
                      .+....+...+.||+|+||.||+|.+.     .++..+|+|.++.... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            333334445688999999999999973     3567899999875432 2346799999999999 89999999999885


Q ss_pred             CCCceEEEEecccCCChhHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceec
Q 038580          138 PRGEKLIVHPFYKRGNLAQCIRGGSG---------------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHG  196 (356)
Q Consensus       138 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~  196 (356)
                       .+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||+   .+++||
T Consensus       121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~  196 (344)
T 1rjb_A          121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  196 (344)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence             4589999999999999999975332                     247899999999999999999999   999999


Q ss_pred             CCCCCCeeEcCCCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 038580          197 NLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPIN  274 (356)
Q Consensus       197 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~  274 (356)
                      ||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999765433222 2234456788999999998899999999999999999998 999997


Q ss_pred             CCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          275 ENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      +.....       .........     .            ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       277 ~~~~~~-------~~~~~~~~~-----~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          277 GIPVDA-------NFYKLIQNG-----F------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             TCCCSH-------HHHHHHHTT-----C------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCcHH-------HHHHHHhcC-----C------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            643211       111111110     0            0112223456788999999999999999999999999986


Q ss_pred             c
Q 038580          355 G  355 (356)
Q Consensus       355 ~  355 (356)
                      .
T Consensus       333 ~  333 (344)
T 1rjb_A          333 L  333 (344)
T ss_dssp             C
T ss_pred             H
Confidence            4

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-47  Score=338.44  Aligned_cols=251  Identities=21%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+. ++..+|+|.++... ...+++.+|++++++++||||+++++++.+ ++..+++|||++++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           14 FVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFMEHG   90 (269)
T ss_dssp             EEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTC
T ss_pred             eeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeCCCC
Confidence            3478999999999999987 46668899887543 334679999999999999999999999885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus        91 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           91 CLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             BHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             cHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            999999743 3468999999999999999999999   999999999999999999999999999997654433233334


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |..||.....       .. ........     .         
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~-~~~~~~~~-----~---------  224 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SE-VVEDISTG-----F---------  224 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTT-----C---------
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HH-HHHHHhcC-----c---------
Confidence            456778999999998899999999999999999999 9999975321       11 11111110     0         


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          225 ---RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence               00112223456889999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-47  Score=353.15  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=205.6

Q ss_pred             cCCCCcccccCCceEEEEEE-----cCCCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALL-----QRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.||+|.+     ..+++.+|+|+++...... .+.+.+|+++++++ +||||++++++|..++...+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            33458899999999999984     4567899999997543322 35799999999999 79999999999987666799


Q ss_pred             EEEecccCCChhHhhhcCCC------------------------------------------------------------
Q 038580          144 IVHPFYKRGNLAQCIRGGSG------------------------------------------------------------  163 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------  163 (356)
                      ++|||+++|+|.++++....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999975332                                                            


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-CcceecccCCCc
Q 038580          164 ----EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQEMLEASASQG  238 (356)
Q Consensus       164 ----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~  238 (356)
                          ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....... ........+|+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                128899999999999999999999   999999999999999999999999999997654322 223344567888


Q ss_pred             ccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCC
Q 038580          239 YKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENP  317 (356)
Q Consensus       239 y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (356)
                      |+|||++.+..++.++||||||+++|||+| |..||.+.....       ..........                 ...
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~-----------------~~~  316 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGT-----------------RMR  316 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTC-----------------CCC
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcCC-----------------CCC
Confidence            999999998999999999999999999998 999997643211       1111111100                 011


Q ss_pred             CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          318 VSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       318 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            12234456889999999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.8e-48  Score=363.95  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.+.. +..+|+|.++... ...+++.+|++++++++||||+++++++..  +..++||||+++
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~  262 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK  262 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcC
Confidence            345789999999999999974 4568999887543 345689999999999999999999998874  478999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.++++......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...........
T Consensus       263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence            999999975444568999999999999999999999   99999999999999999999999999999876443333333


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||++....++.++||||||+++|||+| |..||.+...       .+ ........              
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~-~~~~i~~~--------------  397 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------RE-VLDQVERG--------------  397 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTT--------------
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcC--------------
Confidence            4456788999999998899999999999999999999 9999975431       11 11111110              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         .+.+.+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               011223445677889999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.7e-47  Score=343.47  Aligned_cols=242  Identities=21%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+|+|++......  ..+.+.+|+++++.++||||+++++++.+ .+..++||||+++
T Consensus        20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~   98 (328)
T 3fe3_A           20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLIMEYASG   98 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTT
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEECCCC
Confidence            47899999999999999989999999998654322  23568899999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......  ....
T Consensus        99 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~  171 (328)
T 3fe3_A           99 GEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLD  171 (328)
T ss_dssp             CBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGG
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cccc
Confidence            999999963  3468999999999999999999999   99999999999999999999999999998765432  2334


Q ss_pred             cccCCCcccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDAS-EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...||+.|+|||++.+..++ .++|||||||++|||++|..||.+.+.        ...........             
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-------------  230 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGK-------------  230 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------------
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-------------
Confidence            56789999999999887765 789999999999999999999976421        11111111111             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++|||++++++
T Consensus       231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0112233456789999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-47  Score=335.91  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+. ++..+|+|+++... ...+++.+|+++++.++||||+++++++.. ++..+++|||++++
T Consensus        12 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   88 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYISNG   88 (268)
T ss_dssp             EEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTC
T ss_pred             eeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccCCC
Confidence            3478999999999999887 56678999887543 334679999999999999999999999875 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus        89 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           89 CLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             BHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             cHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            999999642 3458999999999999999999999   999999999999999999999999999998765444333344


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+++.|+|||.+.+..++.++||||||+++|||+| |..||.....       ...... .....              
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~-~~~~~--------------  222 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLK-VSQGH--------------  222 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH-HHTTC--------------
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHH-HHcCC--------------
Confidence            556778999999998889999999999999999999 9999965321       111111 11000              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                         ....+...+..+.+++..||+.||++|||+.++++.|+++.+
T Consensus       223 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          223 ---RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               001122234568899999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-47  Score=342.68  Aligned_cols=255  Identities=19%  Similarity=0.265  Sum_probs=199.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+.......   .+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   94 (294)
T 4eqm_A           16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYLVMEYIE   94 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEEEEeCCC
Confidence            478999999999999999899999999885443322   2578899999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ..++++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...........
T Consensus        95 g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  169 (294)
T 4eqm_A           95 GPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT  169 (294)
T ss_dssp             SCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence            9999999974  3468999999999999999999999   9999999999999999999999999999987654433444


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|+|||.+.+..++.++||||||+++|||+||..||.+.+.       .......... ..     +..    
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~-~~-----~~~----  232 (294)
T 4eqm_A          170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKHIQD-SV-----PNV----  232 (294)
T ss_dssp             -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHHHSS-CC-----CCH----
T ss_pred             CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhc-cC-----CCc----
Confidence            456789999999999999999999999999999999999999976421       1111111110 00     000    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-NIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~il~~L~~~~  355 (356)
                          ......+.+..+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus       233 ----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                0001223456788999999999999998 9999999998763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=347.36  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=202.0

Q ss_pred             CCCCcccccCCceEEEEEEcCC---CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||.||+|.+..+   +..+|+|.++..... ..+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus        52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  130 (325)
T 3kul_A           52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMIVTE  130 (325)
T ss_dssp             EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEEEEE
T ss_pred             EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEEEee
Confidence            3458899999999999999744   446999998754332 23579999999999999999999999875 447899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.++++.. ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........
T Consensus       131 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          131 YMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             CCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             CCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            99999999999643 3469999999999999999999999   9999999999999999999999999999987644322


Q ss_pred             c--ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          228 Q--EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       228 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      .  ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....       .. ........        
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~-~~~~~~~~--------  270 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RD-VISSVEEG--------  270 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HH-HHHHHHTT--------
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HH-HHHHHHcC--------
Confidence            2  1223345678999999998889999999999999999999 9999975321       11 11111110        


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                               ...+.+..++..+.+++..||+.||++|||+.++++.|+++.
T Consensus       271 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          271 ---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     011223345567889999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.9e-47  Score=338.93  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=196.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc--cCCCccccccceeeCC---CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAGP---RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~---~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+  ++..+|+|++...   ....+..|.+++..  ++||||+++++++...   ....+++|||
T Consensus        13 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~   87 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY   87 (301)
T ss_dssp             EEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             EEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence            47899999999999988  5888999998642   34456666666665  7999999999986532   3468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH--------TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      +++|+|.++++   ...+++..++.++.|++.||+|||        +   .+++||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           88 HEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             CTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            99999999996   346999999999999999999999        7   999999999999999999999999999987


Q ss_pred             ccCCCCCcc---eecccCCCcccCccccccC------CCCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 038580          221 LLNPTAGQE---MLEASASQGYKAPELIKMK------DASEETDIYSFGVIMLELISG----------KEPINENPTPDE  281 (356)
Q Consensus       221 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~tg----------~~p~~~~~~~~~  281 (356)
                      .........   .....||+.|+|||++.+.      .++.++||||||+++|||+||          ..||........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            654332221   2234789999999999876      445799999999999999999          777765433222


Q ss_pred             CCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ..   ..........    ...+..       .....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       242 ~~---~~~~~~~~~~----~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          242 SF---EDMRKVVCVD----QQRPNI-------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CH---HHHHHHHTTS----CCCCCC-------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ch---hhhhHHHhcc----CCCCCC-------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11   1111111100    000000       01112446788899999999999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-46  Score=348.05  Aligned_cols=246  Identities=20%  Similarity=0.292  Sum_probs=196.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .++||+|+||.||+|.++.+++.+|+|+++......   .+.+..|..++..+ +||||+++++++.+ .+..++||||+
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~lV~E~~  135 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYV  135 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEEEEEEcC
Confidence            478999999999999999999999999997543222   24588899998876 89999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|..++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus       136 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~  209 (396)
T 4dc2_A          136 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDT  209 (396)
T ss_dssp             TTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCC
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc-CCCc
Confidence            99999999974  3468999999999999999999999   9999999999999999999999999999875322 2233


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-chhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-HLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|..||.......... .....+........           
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------  278 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------  278 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----------
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----------
Confidence            446689999999999999999999999999999999999999997543322111 11111222111111           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                             ...+...+.++.+|+.+||+.||++||++
T Consensus       279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   11233345678899999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.8e-47  Score=338.27  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=210.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.+..++..+|+|.++.. ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.+
T Consensus        16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~   93 (288)
T 3kfa_A           16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTY   93 (288)
T ss_dssp             EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTT
T ss_pred             eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEEEcCCC
Confidence            3347899999999999999988999999998753 3344679999999999999999999999875 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++............
T Consensus        94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            999999986666779999999999999999999999   99999999999999999999999999999876554444444


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..    .......    ..              
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~----~~--------------  228 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLE----KD--------------  228 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHH----TT--------------
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHh----cc--------------
Confidence            5566788999999998899999999999999999999 99999754321    1111111    00              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         .....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence               001122334567889999999999999999999999998763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.3e-47  Score=343.46  Aligned_cols=245  Identities=20%  Similarity=0.260  Sum_probs=202.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++.......+.+.+|+.+++.++||||+++++++... +..+++|||+++++
T Consensus        50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~  128 (321)
T 2c30_A           50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-EELWVLMEFLQGGA  128 (321)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEECCCCSCB
T ss_pred             cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEecCCCCC
Confidence            46899999999999999988999999999876666667899999999999999999999998854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........ .....
T Consensus       129 L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  201 (321)
T 2c30_A          129 LTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL  201 (321)
T ss_dssp             HHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred             HHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccc
Confidence            9999863   468999999999999999999999   9999999999999999999999999999876543222 23355


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .||+.|+|||++.+..++.++||||||+++|||++|..||.....       .. ........     ..+.        
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~-~~~~~~~~-----~~~~--------  260 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQ-AMKRLRDS-----PPPK--------  260 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH-HHHHHHHS-----SCCC--------
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHhcC-----CCCC--------
Confidence            789999999999988999999999999999999999999975321       11 11111110     0000        


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .......+..+.+++.+||+.||++|||+.++++
T Consensus       261 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          261 --LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             --CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0112234456889999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-47  Score=338.04  Aligned_cols=253  Identities=18%  Similarity=0.335  Sum_probs=192.5

Q ss_pred             CCCCcccccCCceEEEEEEcC---CCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||.||+|.+..   .+..+|+|..+..... ..+.+.+|+.+++.++||||+++++++.  ++..++|||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e   95 (281)
T 1mp8_A           18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIME   95 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEE
T ss_pred             EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccEEEEe
Confidence            345889999999999999864   3567899987754322 2357899999999999999999999875  347899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           96 LCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             CCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            99999999999743 3468999999999999999999999   9999999999999999999999999999987654333


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      .......+++.|+|||++....++.++||||||+++|||++ |..||.+.....    ...    .....          
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~----~i~~~----------  233 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG----RIENG----------  233 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH----HHHTT----------
T ss_pred             cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHH----HHHcC----------
Confidence            33334456778999999998899999999999999999997 999997643211    111    11100          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ...+.+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       234 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          234 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   001123345567889999999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-47  Score=348.37  Aligned_cols=247  Identities=21%  Similarity=0.296  Sum_probs=200.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|....++..+|+|+++.....      ..+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus        16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~   94 (361)
T 2yab_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTDVVLIL   94 (361)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCEEEEEE
Confidence            357899999999999999999999999998754332      23578999999999999999999999985 45899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----CeEEecccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~  222 (356)
                      ||+++|+|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++    .+||+|||++...
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           95 ELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             ECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            99999999999963  4579999999999999999999999   9999999999999998877    7999999999876


Q ss_pred             CCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ...  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..       . ....+.....  ..
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~-~~~~i~~~~~--~~  237 (361)
T 2yab_A          170 EDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANITAVSY--DF  237 (361)
T ss_dssp             CTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHTTCC--CC
T ss_pred             CCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhcCC--CC
Confidence            432  2234567899999999999889999999999999999999999999764211       1 1111111000  00


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+            ......+..+.+++..||+.||++|||+.++++
T Consensus       238 ~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          238 DE------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CH------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cc------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00            001123456889999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.4e-47  Score=351.52  Aligned_cols=255  Identities=23%  Similarity=0.403  Sum_probs=193.3

Q ss_pred             cCCCCcccccCCceEEEEEEc---CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +...+.||+|+||.||+|.+.   .++..+|+|.++..... ..+.+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  125 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIVT  125 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEEEE
Confidence            344688999999999999886   45678999998754322 23579999999999999999999999875 45899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++|+|.++++.. ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus       126 e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          126 EYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             ECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             eCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            999999999999743 3468999999999999999999999   999999999999999999999999999997754332


Q ss_pred             Ccc--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          227 GQE--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       227 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ...  .....++..|+|||++.+..++.++||||||+++||+++ |..||.....       .. .........      
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~-~~~~i~~~~------  267 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QD-VIKAVDEGY------  267 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HH-HHHHHHTTE------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcCC------
Confidence            211  122334678999999998999999999999999999998 9999975421       11 111111100      


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                 ..+.+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       268 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          268 -----------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             -----------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                       01122344567889999999999999999999999998863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=347.29  Aligned_cols=254  Identities=22%  Similarity=0.418  Sum_probs=193.3

Q ss_pred             CCCcccccCCceEEEEEEcCC---CeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           73 PGEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..+.||+|+||.||+|.+..+   +..+|+|.++.... ...+.+.+|+.++++++||||++++++|...++..++||||
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence            347899999999999987532   34678888865433 23367999999999999999999999887666688999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.++++. ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........
T Consensus       173 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          173 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            999999999974 33468899999999999999999999   99999999999999999999999999999765332211


Q ss_pred             ---ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          229 ---EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       229 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                         ......+++.|+|||++.+..++.++||||||+++|||+| |..||.+.+...    ......    ...       
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~~----~~~-------  313 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL----QGR-------  313 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHHH----TTC-------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHHH----cCC-------
Confidence               1223456778999999999999999999999999999999 677776543221    111111    000       


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                ....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       314 ----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          314 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                      01112334567889999999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.2e-46  Score=339.62  Aligned_cols=254  Identities=14%  Similarity=0.135  Sum_probs=202.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|....+++.+|+|++....  ..+.+.+|+.+++.+ +||||+++++++.. .+..++||||+ ++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~   89 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL-GP   89 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-CC
Confidence            478999999999999999899999999986432  345789999999999 89999999998885 45889999999 89


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC-----eEEeccccccccCCCCC
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ-----PYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.     +||+|||++........
T Consensus        90 ~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           90 SLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            999999753 4579999999999999999999999   99999999999999998887     99999999987543322


Q ss_pred             c------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          228 Q------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       228 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .      ......||+.|+|||++.+..++.++||||||+++|||++|..||.+....................      
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------  239 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT------  239 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS------
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC------
Confidence            1      1235678999999999999999999999999999999999999998754222111111111110000      


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                        +...          .....+ ++.+++..||+.||++||++++|.+.|+++
T Consensus       240 --~~~~----------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          240 --PIEV----------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             --CHHH----------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --CHHH----------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence              0000          001123 788999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-46  Score=338.35  Aligned_cols=243  Identities=20%  Similarity=0.277  Sum_probs=199.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccc---cccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV---CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|..+.+++.+|+|+++..   .......+.+|+.+++.++||||+++++++.+. +..++||||++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv~E~~~   88 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            47899999999999999999999999998753   223345788999999999999999999999854 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++..... ....
T Consensus        89 gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~  162 (337)
T 1o6l_A           89 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  162 (337)
T ss_dssp             TCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCB
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcc
Confidence            9999999873  3468999999999999999999999   99999999999999999999999999998753322 2233


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|+|||++.+..++.++|+||||+++|||++|..||.+.+.        ...........             
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-------------  221 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-------------  221 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------------
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-------------
Confidence            456789999999999999999999999999999999999999975321        11111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 012223456788999999999999999     8999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.7e-47  Score=343.72  Aligned_cols=251  Identities=21%  Similarity=0.413  Sum_probs=195.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeE----EEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~----~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..    +|+|.++.... ...+.+.+|+.++++++||||++++++|...  ..+++++|
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~   97 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQL   97 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEEEEEEC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEe
Confidence            47899999999999998766654    47777654332 3446899999999999999999999999853  58899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........
T Consensus        98 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  173 (327)
T 3poz_A           98 MPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred             cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence            9999999999753 3468999999999999999999999   99999999999999999999999999999876433222


Q ss_pred             -ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 -EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......+|..|+|||++.+..++.++||||||+++|||+| |..||.+.+...    +.....    ..          
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~----~~----------  235 (327)
T 3poz_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE----KG----------  235 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH----TT----------
T ss_pred             ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHH----cC----------
Confidence             2234456778999999999999999999999999999999 999997643211    111111    00          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ...+.+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       236 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          236 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                   011123334567889999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.6e-46  Score=333.40  Aligned_cols=248  Identities=26%  Similarity=0.444  Sum_probs=199.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-------HHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-------KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+........       +.+.+|+.+++.++||||+++++++.++   .+++|
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~lv~  100 (287)
T 4f0f_A           24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVM  100 (287)
T ss_dssp             EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---TEEEE
T ss_pred             hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---CeEEE
Confidence            4789999999999999998999999999865433222       5789999999999999999999988643   37999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEcCCCC-----eEEeccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLDRNYQ-----PYVSDFGLH  219 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~Dfg~~  219 (356)
                      ||+++|+|.+++... ...+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.     +||+|||++
T Consensus       101 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A          101 EFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             ECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             EecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            999999999988643 4579999999999999999999999   88  999999999999988776     999999998


Q ss_pred             cccCCCCCcceecccCCCcccCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTAGQEMLEASASQGYKAPELIK--MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      .....    ......+++.|+|||++.  ...++.++||||||+++|||++|..||.......     ..... ......
T Consensus       177 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~  246 (287)
T 4f0f_A          177 QQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFIN-MIREEG  246 (287)
T ss_dssp             BCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHH-HHHHSC
T ss_pred             ccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHH-HHhccC
Confidence            75432    234567899999999984  4557889999999999999999999997543211     11111 111100


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                      .....+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       247 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 ----------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                            01112334556788999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-46  Score=335.29  Aligned_cols=251  Identities=18%  Similarity=0.309  Sum_probs=200.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+. ++..+|+|+++... ...+++.+|+++++.++||||+++++++.. .+..+++|||++++
T Consensus        28 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~  104 (283)
T 3gen_A           28 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANG  104 (283)
T ss_dssp             EEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCTTC
T ss_pred             hHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccCCC
Confidence            3478999999999999887 67778999887543 234679999999999999999999999875 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus       105 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          105 CLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             BHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             cHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence            999999742 3468999999999999999999999   999999999999999999999999999997654332223334


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..+++.|+|||.+.+..++.++||||||+++|||+| |..||...+.       .. .........              
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~-~~~~~~~~~--------------  238 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SE-TAEHIAQGL--------------  238 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HH-HHHHHHTTC--------------
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hH-HHHHHhccc--------------
Confidence            456778999999998899999999999999999998 9999975321       11 111111100              


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       239 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          239 ---RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence               00112223457889999999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-47  Score=345.50  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             CCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+.     .++..+|+|+++..... ..+.+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~  129 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLF  129 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CCceEEEE
Confidence            3478999999999999987     34588999998754332 23578999999999999999999999875 45899999


Q ss_pred             ecccCCChhHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 038580          147 PFYKRGNLAQCIRGGS----------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNIL  204 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil  204 (356)
                      ||+++|+|.+++....                      ...+++..++.++.|++.||.|||+   .+++||||||+||+
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEE
Confidence            9999999999996432                      1568999999999999999999999   99999999999999


Q ss_pred             EcCCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 038580          205 LDRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDED  282 (356)
Q Consensus       205 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~  282 (356)
                      ++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||+| |..||.+.+.    
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----  282 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----  282 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh----
Confidence            99999999999999876532221 22234467888999999998899999999999999999999 9999975321    


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                          ............                 ...+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       283 ----~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          283 ----EEVIYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             ----HHHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----HHHHHHHhCCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence                111111111110                 11223445678899999999999999999999999998753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.6e-47  Score=344.95  Aligned_cols=257  Identities=20%  Similarity=0.323  Sum_probs=202.5

Q ss_pred             cCCCCcccccCCceEEEEEEcCCC-----eEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSG-----SVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.||+|.+..++     ..+|+|.++..... ..+.+.+|+.+++.+ +||||+++++++.. .+..+
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~  126 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVL  126 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-CCceE
Confidence            344588999999999999987554     37899988754332 235789999999999 89999999999885 45899


Q ss_pred             EEEecccCCChhHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCe
Q 038580          144 IVHPFYKRGNLAQCIRGGS------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP  211 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  211 (356)
                      +||||+++|+|.+++....            ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeE
Confidence            9999999999999986321            3457899999999999999999999   999999999999999999999


Q ss_pred             EEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHH
Q 038580          212 YVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFM  289 (356)
Q Consensus       212 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  289 (356)
                      ||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |..||.+.....       ..
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~  276 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------KF  276 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------HH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------HH
Confidence            99999999765332221 2223455778999999998899999999999999999999 999997643211       11


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ........                 ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       277 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          277 YKLVKDGY-----------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCC-----------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            11111100                 00112223457889999999999999999999999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=341.76  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=200.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...+.||+|+||.||+|....++..+|+|+++.....      ..+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus        14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   92 (326)
T 2y0a_A           14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDVILI   92 (326)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEE
Confidence            3457899999999999999999999999998754322      23579999999999999999999999985 4589999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----CeEEeccccccc
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLL  221 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~  221 (356)
                      |||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++    .+||+|||++..
T Consensus        93 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           93 LELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            999999999999963  4568999999999999999999999   9999999999999999887    799999999977


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|..||.+.+.       ..... .......   
T Consensus       168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~-~~~~~~~---  234 (326)
T 2y0a_A          168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLA-NVSAVNY---  234 (326)
T ss_dssp             CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHH-HHHHTCC---
T ss_pred             CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHH-HHHhcCC---
Confidence            64322  23345789999999999988999999999999999999999999975321       11111 1110000   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..+           .......+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 EFE-----------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCC-----------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcC-----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000           0001123456889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-46  Score=330.97  Aligned_cols=248  Identities=19%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+.  +..+|+|+++.....  ..+.+.+|+.+++.++||||+++++++.++ .+..+++|||++
T Consensus        15 ~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            478999999999999985  778899998754322  235799999999999999999999998765 257899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +|+|.+++.......+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.++++|||++.....    
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----  165 (271)
T 3kmu_A           93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----  165 (271)
T ss_dssp             TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence            9999999987655579999999999999999999999   88  99999999999999999999999988654322    


Q ss_pred             ceecccCCCcccCccccccCCCCC---cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 EMLEASASQGYKAPELIKMKDASE---ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~---~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                        ....+|+.|+|||.+.+..++.   ++||||||+++|||++|..||.+.+.       ...........     .   
T Consensus       166 --~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~-----~---  228 (271)
T 3kmu_A          166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEG-----L---  228 (271)
T ss_dssp             --TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSC-----C---
T ss_pred             --cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcC-----C---
Confidence              2346788999999998765444   79999999999999999999975321       11111111100     0   


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                               ....+...+..+.+++..||+.||++|||++++++.|+++.+
T Consensus       229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ---------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     111233445678899999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=350.61  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=200.6

Q ss_pred             CCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+.     .++..+|+|.++..... ....+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~  153 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILL  153 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCEEEE
Confidence            3478999999999999953     46778999998654322 33478899999999999999999999875 44789999


Q ss_pred             ecccCCChhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEecccc
Q 038580          147 PFYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGL  218 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~  218 (356)
                      ||+++|+|.+++....     ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++   .+||+|||+
T Consensus       154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999996422     2458999999999999999999999   9999999999999999554   599999999


Q ss_pred             ccccCCC-CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          219 HLLLNPT-AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       219 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      ++..... .........+|+.|+|||++.+..++.++|||||||++|||+| |..||.....       .. ........
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~-~~~~i~~~  302 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QE-VLEFVTSG  302 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HH-HHHHHHTT
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcC
Confidence            8754221 1222334567889999999998999999999999999999998 9999975321       11 11111110


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                       .....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       303 -----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 -----------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                             011123344567889999999999999999999999998763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4e-45  Score=328.88  Aligned_cols=264  Identities=26%  Similarity=0.488  Sum_probs=207.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc----ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC----TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ++.||+|+||.||+|.+  ++..+|+|.+....    ....+.+.+|+.+++.++||||+++++++.. .+..+++|||+
T Consensus        36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~  112 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYM  112 (307)
T ss_dssp             CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred             CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CCceEEEEEec
Confidence            47899999999999987  46678888876432    1223578999999999999999999999875 44899999999


Q ss_pred             cCCChhHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          150 KRGNLAQCIRGG-SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       150 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      ++++|.+++... ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            999999998642 24568999999999999999999999   99999999999999999999999999998765433222


Q ss_pred             -ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 -EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       ......+++.|+|||.+.+ .++.++||||||+++|||++|..||...........+.......  ...+....++.  
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--  264 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE--EKTIEDYIDKK--  264 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT--SCCHHHHSCSS--
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh--hhhhhhhcccc--
Confidence             2234568899999998864 57899999999999999999999998754433222221111110  01111111111  


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       265 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          265 -------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                   12346678889999999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-46  Score=332.36  Aligned_cols=256  Identities=24%  Similarity=0.431  Sum_probs=201.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCC---eEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..++.||+|+||.||+|.+..++   ..+|+|.++..... ..+.+.+|+.+++.++||||+++++++.+.++..+++||
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  103 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP  103 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence            34588999999999999975443   37889988754332 235789999999999999999999999876656699999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-  226 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  226 (356)
                      |+.+|+|.+++.. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... 
T Consensus       104 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          104 YMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             cccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            9999999999975 34568999999999999999999999   999999999999999999999999999987653321 


Q ss_pred             --CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          227 --GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       227 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                        ........++..|+|||.+.+..++.++||||||+++|||++|..|+......   ........    ...       
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~----~~~-------  245 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLA----QGR-------  245 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHH----TTC-------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhh----cCC-------
Confidence              11223445678899999999999999999999999999999966664432111   11111111    000       


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       246 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          246 ----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      01122334567889999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=342.50  Aligned_cols=257  Identities=20%  Similarity=0.357  Sum_probs=205.0

Q ss_pred             hcCCCCcccccCCceEEEEEEcC-------CCeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCC
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRG  140 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (356)
                      .+...+.||+|+||.||+|.+..       .+..+|+|+++...... .+.+.+|+++++.+ +||||++++++|.. ++
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~  148 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DG  148 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-CC
Confidence            33445889999999999999742       34678999987543322 25789999999999 89999999999885 45


Q ss_pred             ceEEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      ..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence            8999999999999999997433              2458999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 038580          207 RNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH  284 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~  284 (356)
                      .++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+.      
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------  299 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  299 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999986543322 22334456788999999999999999999999999999999 9999975421      


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       .. .........                 ....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       300 -~~-~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          300 -EE-LFKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             -HH-HHHHHHTTC-----------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HH-HHHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             11 111111110                 01112234567889999999999999999999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-46  Score=338.25  Aligned_cols=255  Identities=20%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             CCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...+.||+|+||.||+|.+.     .++..+|+|+++..... ..+.+.+|+++++.++||||+++++++.. .+..+++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  104 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLI  104 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCceEEE
Confidence            34578999999999999883     45688999998754322 23578999999999999999999998875 4589999


Q ss_pred             EecccCCChhHhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 038580          146 HPFYKRGNLAQCIRGGSG----------------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNI  203 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  203 (356)
                      |||+++++|.+++.....                      ..+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence            999999999999974322                      348899999999999999999999   9999999999999


Q ss_pred             eEcCCCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 038580          204 LLDRNYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDE  281 (356)
Q Consensus       204 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~  281 (356)
                      +++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..  
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--  259 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE--  259 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999998765433222 2233456778999999988889999999999999999999 99999754321  


Q ss_pred             CCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ...    .......                 ....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus       260 --~~~----~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          260 --RLF----NLLKTGH-----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             --GHH----HHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHH----HHhhcCC-----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              111    1111100                 01122334567889999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-46  Score=340.10  Aligned_cols=241  Identities=22%  Similarity=0.325  Sum_probs=197.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|++....   ......+.+|+.+++.++||||+++++++.++ +..++||||+ 
T Consensus        14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~-   91 (336)
T 3h4j_B           14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-   91 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCC-
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEECC-
Confidence            478999999999999999899999999986432   22235789999999999999999999999864 4899999999 


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++......  ...
T Consensus        92 ~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~  164 (336)
T 3h4j_B           92 GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFL  164 (336)
T ss_dssp             CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTT
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--ccc
Confidence            6799998863  3468999999999999999999999   99999999999999999999999999998765432  223


Q ss_pred             ecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.                       
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-----------------------  221 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-----------------------  221 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-----------------------
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----------------------
Confidence            45578999999999987776 689999999999999999999997643322111000                       


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ......+...+..+.+++.+||+.||++|||++++++
T Consensus       222 ---~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 ---SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               0001122334556789999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-45  Score=329.91  Aligned_cols=257  Identities=13%  Similarity=0.189  Sum_probs=206.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+.....  ....+.+|+.+++.++|+|++..++.+....+..+++|||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence            478999999999999999899999999865432  33468999999999999999988887765666889999999 889


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCC---
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAG---  227 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~---  227 (356)
                      |.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++........   
T Consensus        91 L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           91 LEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             HHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             HHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence            99999742 3468999999999999999999999   999999999999999   7899999999999987644322   


Q ss_pred             ---cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          228 ---QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       228 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                         .......+++.|+|||.+.+..++.++||||||+++|||++|..||.+......................       
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  239 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-------  239 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-------
T ss_pred             CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-------
Confidence               1223457889999999999999999999999999999999999999876554433333222222111100       


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       .          ......+..+.+++..||+.||++|||++++++.|+++.
T Consensus       240 -~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          240 -E----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             -H----------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             -h----------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence             0          001122457889999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-46  Score=336.05  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=205.6

Q ss_pred             hcCCCCcccccCCceEEEEEE-----cCCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCce
Q 038580           70 LDAPGEVIGKSNYGTLYKALL-----QRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (356)
                      .+...+.||+|+||.||+|.+     ..++..+|+|.++..... ..+.+.+|+.+++++ +||||+++++++.. .+..
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~  102 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GGPT  102 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CCCc
Confidence            334458899999999999985     356788999998754332 235789999999999 89999999999885 4488


Q ss_pred             EEEEecccCCChhHhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          143 LIVHPFYKRGNLAQCIRGGSG----------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      +++|||+++|+|.+++.....                ..+++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence            999999999999999975332                258999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCcc-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 038580          207 RNYQPYVSDFGLHLLLNPTAGQE-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH  284 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~  284 (356)
                      .++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||+| |..||.+.....    
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----  255 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----  255 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh----
Confidence            99999999999997765433221 223456778999999998899999999999999999999 999997643211    


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ..........                 ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       256 ---~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 ---KFYKMIKEGF-----------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             ---HHHHHHHHTC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHhccCC-----------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               1111111100                 00112234567889999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-47  Score=341.61  Aligned_cols=246  Identities=18%  Similarity=0.264  Sum_probs=199.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++.. ......+.+|+.+++.++||||+++++++.+. +..+++|||+++|+
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~   87 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCB
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEEeCCCCC
Confidence            47899999999999999999999999998743 23345688999999999999999999999854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC--CCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR--NYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++... ...+++..+..++.|++.||.|||+   .+++||||||+|||++.  ++.+||+|||++......  ....
T Consensus        88 L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  161 (321)
T 1tki_A           88 IFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFR  161 (321)
T ss_dssp             HHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEE
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--Cccc
Confidence            99999642 3468999999999999999999999   99999999999999987  789999999999876432  2334


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+++.|+|||++.+..++.++||||||+++|||++|..||.+.+.       ..... .......    ....     
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~-~i~~~~~----~~~~-----  224 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIE-NIMNAEY----TFDE-----  224 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH-HHHHTCC----CCCH-----
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHH-HHHcCCC----CCCh-----
Confidence            56789999999999988889999999999999999999999975321       11111 1111100    0000     


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ....+.+.++.+++.+||+.||++|||+.++++
T Consensus       225 -----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 -----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 001123567889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.6e-46  Score=344.71  Aligned_cols=272  Identities=20%  Similarity=0.272  Sum_probs=199.4

Q ss_pred             CCccccc--CCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKS--NYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G--~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|  +||.||+|.+..+++.+|+|+++......  .+.+.+|+.+++.++||||+++++++.+ ++..++||||+
T Consensus        30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  108 (389)
T 3gni_B           30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFM  108 (389)
T ss_dssp             EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEEEEEEcc
Confidence            4789999  99999999999999999999987543322  2568889999999999999999999985 44899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC---
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA---  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---  226 (356)
                      ++|+|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||.+.......   
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~  185 (389)
T 3gni_B          109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ  185 (389)
T ss_dssp             TTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred             CCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence            99999999986655679999999999999999999999   999999999999999999999999999875432111   


Q ss_pred             ---CcceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc-----
Q 038580          227 ---GQEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH-----  296 (356)
Q Consensus       227 ---~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  296 (356)
                         ........+|+.|+|||++.+  ..++.++|||||||++|||++|..||.+.+.................+.     
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (389)
T 3gni_B          186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA  265 (389)
T ss_dssp             SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred             cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence               111123467888999999987  5789999999999999999999999986543321110000000000000     


Q ss_pred             -c-------------cccccCc-ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 -R-------------ITDLYHP-DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 -~-------------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .             ..+.... ............+.+...+..+.+|+.+||+.||++|||++++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             0             0000000 000000000111233445677999999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-45  Score=343.14  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=191.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHh-ccCCCccccccceeeC---CCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLVPLLGFYAG---PRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~---~~~~~~lv~e~~~  150 (356)
                      +.||+|+||+||+|.+..+++.+|+|+++.     ...+.+|++++. ..+||||+++++++..   ..+..++||||+.
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            679999999999999999999999999863     346778888874 4589999999998763   2447899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|+|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||++......  
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--  217 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--  217 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence            9999999986555679999999999999999999999   99999999999999997   789999999999765422  


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......+|+.|+|||++.+..++.++|||||||++|||++|..||.+.............+..    ...   ..+   
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~---~~~---  287 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY---EFP---  287 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC---CCC---
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc---cCC---
Confidence            2234567899999999999999999999999999999999999999865443322222221111    000   000   


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                              .+.....+.++.+|+.+||+.||++|||+.++++.
T Consensus       288 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          288 --------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             --------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    00112345668899999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-47  Score=365.72  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=204.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.+.. +..+|+|.++... ...++|.+|+++|+.++||||+++++++..  +..++||||+.+
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~  345 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK  345 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred             hhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcC
Confidence            345789999999999999974 4568899887543 345689999999999999999999998874  478999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |+|.++++......+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...........
T Consensus       346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred             CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence            999999975444568999999999999999999999   99999999999999999999999999999765432222222


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||++....++.++||||||+++|||+| |..||.+...       .+ ....+...              
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~-~~~~i~~~--------------  480 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------RE-VLDQVERG--------------  480 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HH-HHHHHHTT--------------
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHcC--------------
Confidence            3456778999999998899999999999999999999 9999976431       11 11111110              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         .+.+.+..++..+.+||.+||+.||++|||+++|++.|+++.
T Consensus       481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               011123345667889999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.7e-46  Score=337.21  Aligned_cols=251  Identities=18%  Similarity=0.295  Sum_probs=180.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ++.||+|+||.||+|.+..+++.+|+|++...   ....+.+|+.+++.+. ||||+++++++.+ ++..++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence            57899999999999999999999999998642   3467889999999997 9999999999985 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEeccccccccCCCCCcc
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++   .+||+|||++...... ...
T Consensus        92 ~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~  165 (325)
T 3kn6_A           92 ELFERIKK--KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP  165 (325)
T ss_dssp             BHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence            99999974  3569999999999999999999999   9999999999999998765   7999999999765432 222


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....+|+.|+|||++.+..++.++||||||+++|||++|..||...+.............. ......           
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~-----------  233 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF-----------  233 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC-----------
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC-----------
Confidence            34556789999999999999999999999999999999999999865443222222222211 111100           


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ....+...+.+..+.+|+..||+.||++|||++++++
T Consensus       234 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 ---SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               0000111234667889999999999999999998763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=343.60  Aligned_cols=245  Identities=19%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+. +..++||||+.
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~   98 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMVVDLLL   98 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCC
Confidence            478999999999999999999999999986432   22335788999999999999999999999854 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......  ...
T Consensus        99 gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~  171 (384)
T 4fr4_A           99 GGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQI  171 (384)
T ss_dssp             TEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CCB
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cce
Confidence            9999999974  4569999999999999999999999   99999999999999999999999999999875432  233


Q ss_pred             ecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....||+.|+|||++..   ..++.++|||||||++|||++|..||.......    ...... ......          
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~-~~~~~~----------  236 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVH-TFETTV----------  236 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHH-HHHHCC----------
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHH-HHhhcc----------
Confidence            45679999999999864   458999999999999999999999997543221    111111 111100          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-IKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~il~  349 (356)
                              ...+...+..+.+++..||+.||++||+ ++++++
T Consensus       237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    1122334567889999999999999998 666653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-45  Score=328.50  Aligned_cols=257  Identities=14%  Similarity=0.200  Sum_probs=206.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..+++.+|+|++....  ....+.+|+.+++.++|+|++..++.+....+..+++|||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence            478999999999999998899999999886532  33578999999999999998888887766666889999999 889


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCCc--
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      |.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++.........  
T Consensus        91 L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           91 LEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             HHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             HHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence            99999632 3469999999999999999999999   999999999999999   48889999999999876543221  


Q ss_pred             ----ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          229 ----EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       229 ----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                          ......+++.|+|||.+.+..++.++||||||+++|||++|..||....................... ..     
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-----  240 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE-----  240 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HH-----
T ss_pred             cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hH-----
Confidence                12355789999999999999999999999999999999999999987554333322222222111100 00     


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                  ......+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       241 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          241 ------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             ------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             ------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence                        001123456889999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5e-46  Score=333.97  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=203.2

Q ss_pred             CCcccccCCceEEEEE----EcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKAL----LQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~----~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.    ...+++.+|+|.++.... ...+.+.+|+.+++.++||||+++++++..+. ...+++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  105 (302)
T 4e5w_A           26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME  105 (302)
T ss_dssp             EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred             hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence            4789999999999999    456789999999875433 23367999999999999999999999988543 46899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus       106 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  181 (302)
T 4e5w_A          106 FLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE  181 (302)
T ss_dssp             CCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC
T ss_pred             eCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCCCc
Confidence            99999999999532 3458999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             --cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------CCCCCchhHHHHHhhhhccc
Q 038580          228 --QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPT-------PDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       228 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~  298 (356)
                        .......+|..|+|||++.+..++.++||||||+++|||+||..|+.....       ................    
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  257 (302)
T 4e5w_A          182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK----  257 (302)
T ss_dssp             EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH----
T ss_pred             ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh----
Confidence              122344677789999999988899999999999999999999988643210       0000000000000000    


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                                   .....+.+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       258 -------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          258 -------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -------------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence                         111122334456778899999999999999999999999998854

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=344.24  Aligned_cols=277  Identities=15%  Similarity=0.217  Sum_probs=212.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++.... ...+.+.+|+++++.++||||+++++++.... ...++||||+++
T Consensus        14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~   93 (396)
T 4eut_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred             EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence            4789999999999999999999999999875433 23467889999999999999999999987544 368999999999


Q ss_pred             CChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE----cCCCCeEEeccccccccCCCC
Q 038580          152 GNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       152 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      |+|.+++.... ...+++..++.++.|++.||+|||+   .+++||||||+|||+    +.++.+||+|||++...... 
T Consensus        94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~-  169 (396)
T 4eut_A           94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-  169 (396)
T ss_dssp             EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG-
T ss_pred             CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC-
Confidence            99999997532 2348999999999999999999999   999999999999999    77888999999999775432 


Q ss_pred             CcceecccCCCcccCcccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIKM--------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                       .......||+.|+|||++.+        ..++.++||||||+++|||++|..||........................+
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (396)
T 4eut_A          170 -EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (396)
T ss_dssp             -GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred             -CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence             22334568999999999865        467789999999999999999999997654333222111111111100000


Q ss_pred             cc---ccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          299 TD---LYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       299 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..   ..................+......+.+++.+||+.||++||++.++++.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            00   0000000011112223456788899999999999999999999999999998763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-46  Score=339.84  Aligned_cols=255  Identities=22%  Similarity=0.389  Sum_probs=189.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCe---EEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCC-----ce
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-----EK  142 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~---~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~  142 (356)
                      ..+.||+|+||.||+|.+..++.   .+|+|+++...  ....+.+.+|+++++.++||||+++++++.....     ..
T Consensus        27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  106 (323)
T 3qup_A           27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP  106 (323)
T ss_dssp             EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred             EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence            34789999999999999876664   78999887542  2234679999999999999999999999875432     23


Q ss_pred             EEEEecccCCChhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccc
Q 038580          143 LIVHPFYKRGNLAQCIRGG----SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL  218 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  218 (356)
                      +++|||+.+|+|.+++...    ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~  183 (323)
T 3qup_A          107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGL  183 (323)
T ss_dssp             EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeeccc
Confidence            8999999999999998532    22358999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          219 HLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       219 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      +........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.....    .   .. .....
T Consensus       184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~---~~-~~~~~  255 (323)
T 3qup_A          184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----I---YN-YLIGG  255 (323)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H---HH-HHHTT
T ss_pred             cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----H---HH-HHhcC
Confidence            976543322 12233456778999999999999999999999999999999 999997643211    1   11 11100


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .                 ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       256 ~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          256 N-----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             C-----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0                 01122334567889999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=333.99  Aligned_cols=245  Identities=18%  Similarity=0.290  Sum_probs=192.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--------------------------chHHHHHHHHHHhccCCCc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--------------------------RDKEFGDLIELLGCIRHPN  127 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~n  127 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++.....                          ..+.+.+|+++++.++|||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   97 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN   97 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence            47899999999999999999999999998654311                          1246889999999999999


Q ss_pred             cccccceeeCC-CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          128 LVPLLGFYAGP-RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       128 iv~~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      |+++++++.++ .+..++||||+++++|.+++.   ...+++..+..++.|++.||+|||+   .+++||||||+||+++
T Consensus        98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~  171 (298)
T 2zv2_A           98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVG  171 (298)
T ss_dssp             BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEC
T ss_pred             CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEC
Confidence            99999998753 457899999999999988764   3468999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCcceecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 038580          207 RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPINENPTPDEDF  283 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~  283 (356)
                      .++.+||+|||++....... .......||+.|+|||++.+..   ++.++||||||+++|||++|..||.+...     
T Consensus       172 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----  245 (298)
T 2zv2_A          172 EDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-----  245 (298)
T ss_dssp             TTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             CCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-----
Confidence            99999999999997754322 2233457899999999997665   37789999999999999999999975321     


Q ss_pred             chhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .. ..........                ..+.....+..+.+++.+||+.||++|||+.++++
T Consensus       246 --~~-~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 --MC-LHSKIKSQAL----------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             --HH-HHHHHHHCCC----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HH-HHHHHhcccC----------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence              11 1111111100                00011123456889999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=348.87  Aligned_cols=248  Identities=18%  Similarity=0.249  Sum_probs=198.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..+.||+|+||.||+|....++..+|+|++......  ..+.+.+|+.+++.++||||+++++++.+ ++..++||||+.
T Consensus        15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~   93 (444)
T 3soa_A           15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYLIFDLVT   93 (444)
T ss_dssp             EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEEEECCCB
T ss_pred             EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEEEEEeCC
Confidence            357899999999999999999999999998654322  23568999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEeccccccccCCCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|+|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++   +++.+||+|||++...... .
T Consensus        94 gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-~  167 (444)
T 3soa_A           94 GGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-Q  167 (444)
T ss_dssp             CCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-C
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-C
Confidence            9999999874  3468999999999999999999999   9999999999999998   5678999999999765432 2


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.        ............. .      
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~-~------  232 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGAYD-F------  232 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCC-C------
T ss_pred             ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCCCC-C------
Confidence            223456789999999999988999999999999999999999999975321        1111111111100 0      


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ..+.....+..+.+++..||+.||++|||+.++++
T Consensus       233 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 -------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   00111233556889999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.5e-46  Score=341.21  Aligned_cols=251  Identities=23%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeE----EEEEEecccc-ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVC-TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~----~a~k~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..    +++|.+.... ....+.+.+|+.+++.++||||+++++++.  ++..++||||
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~   95 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQY   95 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEEEEEEC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccEEEEEe
Confidence            47899999999999999876654    6777765433 223357888999999999999999999886  3478999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        96 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           96 LPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             CCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            9999999999743 3468888999999999999999999   99999999999999999999999999999876543322


Q ss_pred             -ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 -EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......++..|+|||++.+..++.++||||||+++|||+| |..||.+.....    ......    ...         
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~----~~~---------  234 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLLE----KGE---------  234 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHHHHH----TTC---------
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHHHHH----cCC---------
Confidence             2234566778999999998999999999999999999999 999998643211    111111    000         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ....+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       235 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 --------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    00011122335678999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-45  Score=335.74  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=195.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.++.+++.+|+|+++......   .+.+.+|..+++.+ +||||+++++++.+ .+..++||||+
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~e~~   92 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYV   92 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEEEEeCC
Confidence            478999999999999999999999999997653322   24578899999887 89999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus        93 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~  166 (345)
T 3a8x_A           93 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  166 (345)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCC
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC-CCc
Confidence            99999999974  3468999999999999999999999   99999999999999999999999999998753322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-chhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDF-HLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||.......... ..............           
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------  235 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------  235 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----------
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----------
Confidence            345678999999999999999999999999999999999999997533222111 11111111111111           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI  344 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~  344 (356)
                             ...+...+..+.+++.+||+.||++||++
T Consensus       236 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                   11223345678899999999999999995

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-46  Score=339.92  Aligned_cols=247  Identities=19%  Similarity=0.257  Sum_probs=196.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.. ++..++||||+++|
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~   90 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCTTE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEEcCCCC
Confidence            47899999999999999999999999998644322 23578999999999999999999999885 45889999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Cccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  231 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....... .....
T Consensus        91 ~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (323)
T 3tki_A           91 ELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (323)
T ss_dssp             EGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence            99999973  4468999999999999999999999   999999999999999999999999999997653221 12223


Q ss_pred             cccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...||+.|+|||++.+..+ +.++||||||+++|||++|..||........  ....     .....             
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~-----~~~~~-------------  225 (323)
T 3tki_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD-----WKEKK-------------  225 (323)
T ss_dssp             SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHH-----HHTTC-------------
T ss_pred             CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH-----Hhccc-------------
Confidence            5578999999999987765 7789999999999999999999976432211  0000     00000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         .........+..+.+|+.+||+.||++|||+.++++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence               000112234556789999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=362.57  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             cccccCCceEEEEEEc--CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           76 VIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .||+|+||.||+|.++  .++..||+|+++..... ..+++.+|+++++.++|||||+++++|..  +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            6999999999999876  35677999998765333 44689999999999999999999999974  3699999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc--ce
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ--EM  230 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~  230 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........  ..
T Consensus       421 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          421 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             BHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             cHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            999999743 4569999999999999999999999   99999999999999999999999999999875432221  11


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+++.|+|||++.+..++.++||||||+++|||+| |..||.+.+..+        ....+...             
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~-------------  555 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQG-------------  555 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTT-------------
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcC-------------
Confidence            23345678999999998999999999999999999998 999998643211        11111110             


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                          ...+.+..++..+.++|..||+.||++||++.++++.|+++
T Consensus       556 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          556 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                01123445667899999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.6e-45  Score=327.68  Aligned_cols=256  Identities=12%  Similarity=0.175  Sum_probs=203.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|++...  .....+.+|+..++.+ +|+|++++++++.. ....+++|||+ ++
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~   90 (298)
T 1csn_A           15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GP   90 (298)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEEec-CC
Confidence            47899999999999999889999999988643  2345788999999999 79999999998874 45899999999 89


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC-----eEEeccccccccCCCCC
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ-----PYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.     +||+|||++........
T Consensus        91 ~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  166 (298)
T 1csn_A           91 SLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  166 (298)
T ss_dssp             BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             CHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence            999999743 3468999999999999999999999   99999999999999987776     99999999987654322


Q ss_pred             c------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          228 Q------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       228 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .      ......||+.|+|||++.+..++.++||||||+++|||++|..||................... .....   
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~---  242 (298)
T 1csn_A          167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPL---  242 (298)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCH---
T ss_pred             cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-cCccH---
Confidence            1      2335568999999999999999999999999999999999999998754322111111111100 00000   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                          .          ......+..+.+++..||+.||++||+++++++.|+++.
T Consensus       243 ----~----------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          243 ----R----------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             ----H----------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ----H----------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence                0          001123567889999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-45  Score=329.99  Aligned_cols=255  Identities=23%  Similarity=0.421  Sum_probs=198.9

Q ss_pred             CCCCcccccCCceEEEEEEcCC---CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||.||+|.+..+   ...+++|.++..... ..+.+.+|+.++++++||||++++++|...++..+++||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            3358899999999999997533   346788888753332 235789999999999999999999987766678899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++|+|.++++. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus       108 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          108 YMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             CCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             CCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            9999999999974 34568899999999999999999999   9999999999999999999999999999976543221


Q ss_pred             ---cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          228 ---QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       228 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                         .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......    ......    ...      
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~~----~~~------  249 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLL----QGR------  249 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHHHH----TTC------
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHHh----cCC------
Confidence               11234456778999999998899999999999999999999 555565432211    111111    000      


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                 ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       250 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          250 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                       00112233457889999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.7e-46  Score=340.73  Aligned_cols=248  Identities=20%  Similarity=0.264  Sum_probs=199.1

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ...+.||+|+||.||+|.+..++..+|+|+++.....  ..+.+.+|+.+++.++||||+++++++.+ ++..++||||+
T Consensus        32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~e~~  110 (362)
T 2bdw_A           32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLV  110 (362)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecC
Confidence            3457899999999999999999999999998754332  23578899999999999999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~  226 (356)
                      .+|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.+   +.+||+|||++...... 
T Consensus       111 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-  184 (362)
T 2bdw_A          111 TGGELFEDIVA--REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-  184 (362)
T ss_dssp             CSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence            99999999863  3568999999999999999999999   999999999999999865   45999999999765432 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .. ...........   .   
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~-~~~~i~~~~~~---~---  249 (362)
T 2bdw_A          185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HR-LYAQIKAGAYD---Y---  249 (362)
T ss_dssp             -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTCCC---C---
T ss_pred             -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHhCCCC---C---
Confidence             222346789999999999988999999999999999999999999975321       11 11111111000   0   


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              ..+.....+..+.+++.+||+.||++||++.++++
T Consensus       250 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          250 --------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    00011234567889999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-46  Score=329.18  Aligned_cols=250  Identities=21%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+. ++..+|+|.++.... ..+.+.+|+++++.++||||+++++++.. ++..+++|||+++++
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   89 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFMEHGC   89 (267)
T ss_dssp             EEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCCTTCB
T ss_pred             eeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCCCCCc
Confidence            478999999999999987 567789998875433 34689999999999999999999999875 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..............
T Consensus        90 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (267)
T 3t9t_A           90 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  165 (267)
T ss_dssp             HHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             HHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence            99999743 3468999999999999999999999   9999999999999999999999999999876543222222334


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++.+..++.++|+||||+++|||++ |..||.....       .. .........               
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~i~~~~---------------  222 (267)
T 3t9t_A          166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SE-VVEDISTGF---------------  222 (267)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTTC---------------
T ss_pred             cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HH-HHHHHhcCC---------------
Confidence            56778999999998899999999999999999999 8999875321       11 111111100               


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ....+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          223 --RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              00112223457889999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-46  Score=331.28  Aligned_cols=251  Identities=21%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+. ++..+|+|.++... ...+.+.+|+++++.++||||+++++++..  +..+++|||++++
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~   92 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENG   92 (279)
T ss_dssp             EEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTC
T ss_pred             heeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEecCCCC
Confidence            3478999999999999986 56678899886543 345689999999999999999999998763  4689999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus        93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  169 (279)
T 1qpc_A           93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (279)
T ss_dssp             BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence            99999974333468999999999999999999999   999999999999999999999999999998765433333334


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.+...       ..... .....     .         
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~-~~~~~-----~---------  227 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQ-NLERG-----Y---------  227 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHH-HHHTT-----C---------
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHH-HHhcc-----c---------
Confidence            456778999999988889999999999999999999 8999975321       11111 11110     0         


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       228 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence               00112234567889999999999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-46  Score=343.55  Aligned_cols=248  Identities=19%  Similarity=0.295  Sum_probs=201.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+..++..+|+|++..........+.+|+.+++.++||||+++++++.+ .+..++||||+.+|
T Consensus        55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~gg  133 (387)
T 1kob_A           55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGG  133 (387)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCC
T ss_pred             EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEEcCCCC
Confidence            34789999999999999999999999999876544445678999999999999999999999985 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC--CCCeEEeccccccccCCCCCcce
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR--NYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.  ++.+||+|||++.......  ..
T Consensus       134 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~  207 (387)
T 1kob_A          134 ELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV  207 (387)
T ss_dssp             BHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CE
T ss_pred             cHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc--ce
Confidence            999998742 3468999999999999999999999   99999999999999974  5789999999998764332  23


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ..... .......  ..        
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~-~i~~~~~--~~--------  269 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQ-NVKRCDW--EF--------  269 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHH-HHHHCCC--CC--------
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhCCC--CC--------
Confidence            345789999999999988999999999999999999999999975321       11111 1111000  00        


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ........+..+.+++.+||+.||++|||+.++++
T Consensus       270 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          270 ----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                00111234557889999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-46  Score=350.38  Aligned_cols=247  Identities=19%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.++.++..+|+|+++...   ......+.+|+.+++.++||||++++++|.+ ++..++||||++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E~~~  152 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMP  152 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCC
Confidence            478999999999999999999999999986422   2223468899999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.++++.   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       153 gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~  226 (410)
T 3v8s_A          153 GGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC  226 (410)
T ss_dssp             TEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred             CCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence            9999999974   358899999999999999999999   9999999999999999999999999999987654443344


Q ss_pred             ecccCCCcccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          231 LEASASQGYKAPELIKMKD----ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~----~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ....||+.|+|||++.+..    ++.++|+|||||++|||++|..||.+.+..       . ....+..... ....   
T Consensus       227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~~~~-~~~~---  294 (410)
T 3v8s_A          227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMNHKN-SLTF---  294 (410)
T ss_dssp             CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTHHH-HCCC---
T ss_pred             cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------h-HHHHHHhccc-cccC---
Confidence            5678999999999997655    789999999999999999999999753211       1 1111111000 0000   


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~  349 (356)
                                +.....+..+.+|+.+||+.+|.+  ||++++|++
T Consensus       295 ----------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          295 ----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ----------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ----------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                      011123456789999999999988  999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.1e-46  Score=329.32  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=188.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc----chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT----RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+.  +..+|+|+++.....    ..+.+.+|+++++.++||||+++++++.. ++..+++|||+
T Consensus        12 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   88 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEEEECC
T ss_pred             eeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEEEEcC
Confidence            478999999999999985  778999988654322    23578999999999999999999999885 44789999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCCeeEcC--------CCCeEEecccc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP---IIHGNLKSKNILLDR--------NYQPYVSDFGL  218 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~Dfg~  218 (356)
                      ++++|.+++.   ...+++..+..++.|++.||+|||+   .+   ++||||||+||+++.        ++.+||+|||+
T Consensus        89 ~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           89 RGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             TTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             CCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            9999999986   3468999999999999999999999   77   899999999999986        77899999999


Q ss_pred             ccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          219 HLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      +.......   .....+++.|+|||.+.+..++.++||||||+++|||++|..||.+.+.       ...... ....  
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~--  229 (271)
T 3dtc_A          163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYG-VAMN--  229 (271)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHH-HHTS--
T ss_pred             cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHh-hhcC--
Confidence            87654322   2245688999999999988999999999999999999999999975321       011110 0000  


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                    ....+.+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       230 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 --------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                          001112334456788999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-46  Score=344.90  Aligned_cols=262  Identities=15%  Similarity=0.175  Sum_probs=195.4

Q ss_pred             CCcccccCCceEEEEEEcCC-----CeEEEEEEeccccccch-----------HHHHHHHHHHhccCCCccccccceeeC
Q 038580           74 GEVIGKSNYGTLYKALLQRS-----GSVRLLRFLRPVCTTRD-----------KEFGDLIELLGCIRHPNLVPLLGFYAG  137 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~-----~~~~a~k~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~  137 (356)
                      .+.||+|+||.||+|.+..+     ++.+|+|++........           ..+..|+..++.++||||+++++++..
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  119 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH  119 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence            47899999999999999764     47789998765332111           123345556677889999999998864


Q ss_pred             C---CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCCCeE
Q 038580          138 P---RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNYQPY  212 (356)
Q Consensus       138 ~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~k  212 (356)
                      .   ....++||||+ +++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++  .++.+|
T Consensus       120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~~~k  194 (364)
T 3op5_A          120 DKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVY  194 (364)
T ss_dssp             EETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTTCEE
T ss_pred             ccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCCeEE
Confidence            3   23589999999 99999999752 3569999999999999999999999   9999999999999999  889999


Q ss_pred             EeccccccccCCCCCc------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchh
Q 038580          213 VSDFGLHLLLNPTAGQ------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP  286 (356)
Q Consensus       213 l~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  286 (356)
                      |+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||+||..||.+......   ..
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~---~~  271 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK---YV  271 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH---HH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH---HH
Confidence            9999999765432211      11234589999999999998999999999999999999999999985322111   11


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ....... ........++    |.       ...+.+.++.+++..||+.||++||++.+|++.|+++.
T Consensus       272 ~~~~~~~-~~~~~~~~~~----~~-------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          272 RDSKIRY-RENIASLMDK----CF-------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHHHHHH-HHCHHHHHHH----HS-------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHh-hhhHHHHHHH----hc-------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            1111110 0111111110    00       01123567889999999999999999999999998763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=330.72  Aligned_cols=240  Identities=20%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++....+++.+|+|+++...   ....+.+.+|..+++.++||||+++++++.+ .+..++||||++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv~e~~~   89 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEEEeCCC
Confidence            378999999999999999999999999987532   2234568889999999999999999999985 448999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....    ..
T Consensus        90 gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~  160 (318)
T 1fot_A           90 GGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VT  160 (318)
T ss_dssp             SCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CB
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC----cc
Confidence            9999999974  3468999999999999999999999   9999999999999999999999999999976532    22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|+|||++.+..++.++|+||||+++|||++|..||.+.+.       .. .........             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~~-------------  219 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MK-TYEKILNAE-------------  219 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHCC-------------
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhCC-------------
Confidence            355789999999999999999999999999999999999999975321       11 111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           ...+...+.++.+++.+||+.||++||     +++++++
T Consensus       220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 012223445688999999999999999     8888874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-46  Score=331.56  Aligned_cols=252  Identities=20%  Similarity=0.354  Sum_probs=198.3

Q ss_pred             CCCcccccCCceEEEEEEcC---CCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           73 PGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ..+.||+|+||.||+|.+..   ++..+|+|.++.... ...+.+.+|+.+++.++||||+++++++.+  +..+++|||
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   93 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTWIIMEL   93 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCEEEEec
Confidence            34789999999999998753   345689998875432 234678999999999999999999998863  357899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        94 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           94 YPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             CTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            9999999999642 3458999999999999999999999   99999999999999999999999999998876543333


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......++..|+|||++.+..++.++||||||+++|||+| |..||.......    ......    ...          
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~~~----~~~----------  231 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVLE----KGD----------  231 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHHHH----HTC----------
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHHHh----cCC----------
Confidence            3344556788999999988899999999999999999998 999997532211    111111    000          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                   00112234566889999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=344.43  Aligned_cols=243  Identities=20%  Similarity=0.282  Sum_probs=193.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.++.+++.+|+|+++...   ....+.+..|..+++.+ +||||+++++++.+. +..++||||+
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~  106 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLFFVMEFV  106 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEECC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEEEEEeCC
Confidence            378999999999999999999999999987532   22335678899999987 699999999999854 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|..++..  ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus       107 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-~~~~  180 (353)
T 3txo_A          107 NGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-NGVT  180 (353)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc-CCcc
Confidence            99999999974  3468999999999999999999999   9999999999999999999999999999875332 2233


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.        ......+....            
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------------  240 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE------------  240 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------------
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC------------
Confidence            4456799999999999988999999999999999999999999975431        11111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI------KQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~il~  349 (356)
                            ..++...+..+.+++.+||+.||++||++      +++++
T Consensus       241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  01222344567899999999999999998      66654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-45  Score=331.99  Aligned_cols=246  Identities=20%  Similarity=0.310  Sum_probs=193.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCC-------------
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-------------  139 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------------  139 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++..... ..+.+.+|+.++++++||||++++++|....             
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            47899999999999999989999999998754332 3467999999999999999999999875332             


Q ss_pred             -------------------------------------------CceEEEEecccCCChhHhhhcCC-CCCCCHHHHHHHH
Q 038580          140 -------------------------------------------GEKLIVHPFYKRGNLAQCIRGGS-GEAHKWSIIYRIS  175 (356)
Q Consensus       140 -------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~  175 (356)
                                                                 ...+++|||+++++|.+++.... ....++..++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~  170 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF  170 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHH
Confidence                                                       13799999999999999997533 2345677789999


Q ss_pred             HHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-----------cceecccCCCcccCccc
Q 038580          176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-----------QEMLEASASQGYKAPEL  244 (356)
Q Consensus       176 ~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~  244 (356)
                      .|++.||+|||+   .+++||||||+||+++.++.+||+|||++........           .......||+.|+|||+
T Consensus       171 ~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  247 (332)
T 3qd2_B          171 IQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ  247 (332)
T ss_dssp             HHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHH
T ss_pred             HHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHH
Confidence            999999999999   9999999999999999999999999999987654321           12234468999999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHH
Q 038580          245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERIL  324 (356)
Q Consensus       245 ~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (356)
                      +.+..++.++||||||+++|||++|..|+...          .........     ...            .......+.
T Consensus       248 ~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~-----~~~------------~~~~~~~~~  300 (332)
T 3qd2_B          248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRN-----LKF------------PLLFTQKYP  300 (332)
T ss_dssp             HHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHT-----TCC------------CHHHHHHCH
T ss_pred             hcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhc-----cCC------------CcccccCCh
Confidence            99999999999999999999999987664210          000000000     000            011234556


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          325 KFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       325 ~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+.+++.+||+.||++|||+.++++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhh
Confidence            7789999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-45  Score=327.58  Aligned_cols=254  Identities=25%  Similarity=0.435  Sum_probs=189.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..   .+|+|+++......  .+.+.+|+.+++.++||||+++++++.  .+..+++|||+.+
T Consensus        29 ~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~  103 (289)
T 3og7_A           29 GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEG  103 (289)
T ss_dssp             EEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCCE
T ss_pred             eeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEEEecCC
Confidence            4789999999999998753   37888886543322  357899999999999999999999664  3468999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Ccce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  230 (356)
                      ++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ....
T Consensus       104 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          104 SSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            9999999643 4568999999999999999999999   999999999999999999999999999987654321 2223


Q ss_pred             ecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....+++.|+|||++.   ...++.++||||||+++|||++|..||......       ............    .+.. 
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~----~~~~-  247 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSL----SPDL-  247 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTSC----CCCT-
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhccccc----Ccch-
Confidence            3456899999999986   567888999999999999999999999754321       111111111110    0100 


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                              .....+++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       248 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 --------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             --------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                    11223445678899999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=330.27  Aligned_cols=257  Identities=21%  Similarity=0.338  Sum_probs=193.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc--cCCCccccccceeeCCC---CceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAGPR---GEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+.  +..+|+|++...   ....+..|.+++..  ++||||+++++++....   ...++||||
T Consensus        42 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  116 (337)
T 3mdy_A           42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY  116 (337)
T ss_dssp             EEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred             EeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence            488999999999999985  788999988532   23445556666554  48999999999887543   478999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR--------PIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~--------~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      +++|+|.++++.   ..+++..++.++.|++.||+|||+   .        +++||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          117 HENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             CTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            999999999974   368999999999999999999998   7        99999999999999999999999999997


Q ss_pred             ccCCCCCcc---eecccCCCcccCccccccCCCCCc------chhHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 038580          221 LLNPTAGQE---MLEASASQGYKAPELIKMKDASEE------TDIYSFGVIMLELISG----------KEPINENPTPDE  281 (356)
Q Consensus       221 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------sDvwslG~~l~el~tg----------~~p~~~~~~~~~  281 (356)
                      .........   .....||+.|+|||++.+..++..      +||||||+++|||+||          ..||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            654332221   124578999999999987766655      9999999999999999          555543322211


Q ss_pred             CCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .   ............    ..+..       .....+.+++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus       271 ~---~~~~~~~~~~~~----~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          271 S---YEDMREIVCIKK----LRPSF-------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             C---HHHHHHHHTTSC----CCCCC-------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c---hhhhHHHHhhhc----cCccc-------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            1   111111111000    00000       000123478889999999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-45  Score=329.03  Aligned_cols=266  Identities=20%  Similarity=0.244  Sum_probs=196.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++......  ...+.+|+.+++.++||||+++++++.+ ++..++||||+.+
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEEecCCC
Confidence            378999999999999999999999999987544332  2578899999999999999999999885 4589999999986


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+.+.. ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... .....
T Consensus        86 -~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  159 (292)
T 3o0g_A           86 -DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYS  159 (292)
T ss_dssp             -EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCC
T ss_pred             -CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-ccccc
Confidence             66665543 23569999999999999999999999   99999999999999999999999999999765432 22233


Q ss_pred             cccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---cccccc-Cccc
Q 038580          232 EASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---RITDLY-HPDM  306 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~  306 (356)
                      ...+|+.|+|||++.+.. ++.++||||||+++|||++|..||.......   .....+.......   .+.... .+..
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhhhhhcccccc
Confidence            457789999999987665 8999999999999999999888864322110   0111111100000   000000 0000


Q ss_pred             c---cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 L---LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .   ...............+..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   000001111222345567889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=334.49  Aligned_cols=265  Identities=23%  Similarity=0.239  Sum_probs=198.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-----cchHHHHHHHHHHhccC---CCccccccceeeCCCC----c
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-----TRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRG----E  141 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~----~  141 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++....     .....+.+|+.+++.++   ||||++++++|.....    .
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~   93 (308)
T 3g33_A           14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK   93 (308)
T ss_dssp             EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence            4789999999999999988999999999864322     12346778888877765   9999999999875443    4


Q ss_pred             eEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .+++|||+. ++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  169 (308)
T 3g33_A           94 VTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI  169 (308)
T ss_dssp             EEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred             EEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence            789999997 599999986666669999999999999999999999   9999999999999999999999999999976


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRI  298 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  298 (356)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||++|..||.+.+...    ....+......   ..+
T Consensus       170 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          170 YSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             STTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHHHHHHCCCCTTTS
T ss_pred             cCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChhhc
Confidence            5432  22345678999999999999999999999999999999999999997643211    11111110000   000


Q ss_pred             ccc-cCcccccccCCCCC--CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDL-YHPDMLLCSNSNHE--NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ... ..+.. ........  .....+.+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          244 PRDVSLPRG-AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CSSCSSCGG-GSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhcccc-ccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000 00000 00000000  0011124567889999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=345.60  Aligned_cols=247  Identities=21%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|....++..+|+|+++.......+.+.+|++++++++||||+++++++.. .+..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCc
Confidence            3679999999999999998999999999986554555789999999999999999999999985 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE--cCCCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL--DRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||+  +.++.+||+|||++.......  ...
T Consensus       173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~  246 (373)
T 2x4f_A          173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK  246 (373)
T ss_dssp             EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence            99988642 3458899999999999999999999   999999999999999  567889999999998764322  223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ..... .+....+    ..       
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~-~i~~~~~----~~-------  307 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------AETLN-NILACRW----DL-------  307 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH-HHHHTCC----CS-------
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhccC----CC-------
Confidence            45689999999999988899999999999999999999999976431       11111 1111100    00       


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ........+..+.+++.+||+.||++|||+.++++
T Consensus       308 ---~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 ---EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               00011223457889999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-46  Score=350.89  Aligned_cols=250  Identities=18%  Similarity=0.225  Sum_probs=199.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .++||+|+||+||+|.++.+++.+|+|+++....   .....+.+|..+++.++||||++++++|.+ ++..++||||++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lV~Ey~~  157 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCEEEEEEecCC
Confidence            4789999999999999999999999999865321   222358999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       158 gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          158 GGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            99999999742 3569999999999999999999999   9999999999999999999999999999977654444444


Q ss_pred             ecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 LEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ....||+.|+|||++.     ...|+.++|||||||++|||++|..||.+.+..       .... .+..... ....|.
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~-~i~~~~~-~~~~p~  304 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYG-KIMNHKE-RFQFPT  304 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHH-HHHTHHH-HCCCCS
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHH-hhhhccc-cccCCc
Confidence            4568999999999987     456899999999999999999999999753211       1111 1110000 000000


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSL--RPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~il~  349 (356)
                                  .....+..+.+|+.+||+.+|++  ||+++++++
T Consensus       305 ------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          305 ------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                        01123456789999999998888  999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5e-46  Score=365.02  Aligned_cols=248  Identities=21%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             CcccccCCceEEEEEEc--CCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+.  .++..+|+|+++......  .+++.+|++++++++|||||+++++|..  +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            47999999999999654  566889999997643322  3689999999999999999999999873  36899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC--c
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG--Q  228 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  228 (356)
                      +|+|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       453 ~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          453 LGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             TEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999974  4568999999999999999999999   9999999999999999999999999999987643322  1


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..        .....+...           
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~-----------  588 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKG-----------  588 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTT-----------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-----------
Confidence            2233456788999999998899999999999999999998 99999764321        111111110           


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            .....+..++.++.+++..||+.||++||+++++++.|+++
T Consensus       589 ------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                  01123344567889999999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-46  Score=336.83  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=205.3

Q ss_pred             cCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      +...+.||+|+||.||+|.+.     .+++.+|+|+++..... ..+.+.+|+.+++.+ +||||+++++++..+++..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            334588999999999999853     46789999998764332 235789999999999 69999999999887666799


Q ss_pred             EEEecccCCChhHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC
Q 038580          144 IVHPFYKRGNLAQCIRGGSG--------------EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY  209 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~  209 (356)
                      ++|||+++++|.+++.....              ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCC
Confidence            99999999999999975332              227899999999999999999999   9999999999999999999


Q ss_pred             CeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhH
Q 038580          210 QPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       210 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  287 (356)
                      .+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||+| |..||.+.....       
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------  258 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------  258 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-------
Confidence            999999999976543322 22234456788999999998899999999999999999998 999997643211       


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..........                 ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       259 ~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          259 EFCRRLKEGT-----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             HHHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCc-----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111110                 00112223456889999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.4e-45  Score=328.85  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=193.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|.+. +++.+|+|.++......  ...+.+|+++++.++||||+++++++.+ ++..++||||+.+
T Consensus        26 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~  103 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFMEK  103 (311)
T ss_dssp             EEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEEECCSE
T ss_pred             hhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEEcCCCC
Confidence            378999999999999986 57888999887543322  3578899999999999999999999885 4589999999985


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+.+... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....... ....
T Consensus       104 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~  177 (311)
T 3niz_A          104 -DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYT  177 (311)
T ss_dssp             -EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C---
T ss_pred             -CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cccc
Confidence             888888643 3468999999999999999999999   999999999999999999999999999998754322 2233


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---cccccCcccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYHPDML  307 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  307 (356)
                      ...+|+.|+|||++.+ ..++.++||||||+++|||++|..||.+......   +.. +........   +.........
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~-i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPK-IFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHH-HHHHHCCCCTTTSGGGTTSHHH
T ss_pred             CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHHCCCChHHhhhhhccchh
Confidence            4567899999999876 5689999999999999999999999986543322   111 111100000   0000000000


Q ss_pred             cc-cCCCCCC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LC-SNSNHEN----PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~-~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .. .......    ......+.++.+|+.+||+.||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00 0000000    011123456889999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=334.52  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=185.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ...+.||+|+||.||+|.+..+++.+|+|+++...  ..+.+.+|++++++++||||+++++++.. .+..+++|||+++
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  132 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEEeCCC
Confidence            34578999999999999999889999999987532  34578899999999999999999999985 4489999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      ++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.   ++.+||+|||++......  .
T Consensus       133 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~  205 (349)
T 2w4o_A          133 GELFDRIVE--KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--V  205 (349)
T ss_dssp             CBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--c
Confidence            999999974  3468999999999999999999999   99999999999999975   889999999998765432  1


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....       ............   .      
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~---~------  269 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEY---Y------  269 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCC---C------
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCC---c------
Confidence            223456899999999999889999999999999999999999999753221       111111111100   0      


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+.+..+.+++.+||+.||++|||+.++++
T Consensus       270 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 -----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000112234567889999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=335.88  Aligned_cols=251  Identities=21%  Similarity=0.406  Sum_probs=194.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeE----EEEEEecccc-ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSV----RLLRFLRPVC-TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~----~a~k~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..    +++|.++... ....+.+.+|+.+++.++||||+++++++...  ..+++++|
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~v~~~   97 (327)
T 3lzb_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQL   97 (327)
T ss_dssp             EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--CceEEEEe
Confidence            47899999999999998776653    4666665433 23446899999999999999999999999853  58899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +.+|+|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.........
T Consensus        98 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~  173 (327)
T 3lzb_A           98 MPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  173 (327)
T ss_dssp             CSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred             cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence            9999999999753 3468999999999999999999999   99999999999999999999999999999775432222


Q ss_pred             -ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 -EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+...    +.....    ..          
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~----~~----------  235 (327)
T 3lzb_A          174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE----KG----------  235 (327)
T ss_dssp             ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH----TT----------
T ss_pred             ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH----cC----------
Confidence             2233456778999999999999999999999999999999 999997643211    111111    00          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ...+.+...+..+.+++..||+.||++||++.++++.|+++.
T Consensus       236 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          236 -------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                   011122334557889999999999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-45  Score=354.50  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=203.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||+|....++..+|+|+++...   ......+.+|+.+++.++||||+++++++.+ .+..++||||+
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lVmEy~  266 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEEEEEcC
Confidence            3478999999999999999999999999986532   2233568899999999999999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++.......+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++......  ..
T Consensus       267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~  341 (576)
T 2acx_A          267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QT  341 (576)
T ss_dssp             CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC--cc
Confidence            99999999976555569999999999999999999999   99999999999999999999999999999875432  22


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||........    ...+........            
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~~------------  405 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVP------------  405 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHCC------------
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhccc------------
Confidence            3455899999999999988899999999999999999999999986433221    111111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                            ..++...+..+.+|+.+||+.||++||     +++++++
T Consensus       406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  012233456788999999999999999     7888874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-45  Score=332.17  Aligned_cols=257  Identities=21%  Similarity=0.379  Sum_probs=202.4

Q ss_pred             hcCCCCcccccCCceEEEEEEc-------CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCC
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQ-------RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRG  140 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~-------~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  140 (356)
                      .+...+.||+|+||.||+|.+.       .++..+|+|+++..... ..+.+.+|+.+++.+ +||||+++++++.. .+
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~  114 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DG  114 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-CC
Confidence            3344588999999999999985       35678999998754332 235789999999999 89999999999875 45


Q ss_pred             ceEEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD  206 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~  206 (356)
                      ..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence            8999999999999999997532              1348899999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 038580          207 RNYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFH  284 (356)
Q Consensus       207 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~  284 (356)
                      .++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+.      
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------  265 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------  265 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH------
Confidence            9999999999999765443221 2233456788999999988889999999999999999999 9999975321      


Q ss_pred             hhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       .. .........                 ....+..++..+.+++..||+.||++|||+.++++.|+++.
T Consensus       266 -~~-~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          266 -EE-LFKLLKEGH-----------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             -HH-HHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HH-HHHHHhcCC-----------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             11 111111100                 01122334567889999999999999999999999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-45  Score=336.85  Aligned_cols=250  Identities=19%  Similarity=0.262  Sum_probs=198.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccc-----ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC-----TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ...+.||+|+||.||+|.+..+++.+|+|+++...     ....+.+.+|+.+++.++||||+++++++.. ++..++||
T Consensus        27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~  105 (351)
T 3c0i_A           27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLYMVF  105 (351)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEE
Confidence            34588999999999999999999999999986421     1234679999999999999999999999885 45899999


Q ss_pred             ecccCCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC---eEEeccccccc
Q 038580          147 PFYKRGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ---PYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~  221 (356)
                      ||+++++|.+.+...  ....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.   +||+|||++..
T Consensus       106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999998887532  24468999999999999999999999   99999999999999986654   99999999977


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..         ............   
T Consensus       183 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~---  249 (351)
T 3c0i_A          183 LGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKY---  249 (351)
T ss_dssp             CCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCC---
T ss_pred             ecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCC---
Confidence            64322 22334578999999999998899999999999999999999999997521         111111111100   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ....          ......+..+.+++.+||+.||++|||+.++++
T Consensus       250 -~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 -KMNP----------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -CCCH----------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCCc----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0000          000123457889999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-45  Score=339.07  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=188.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||++....+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.++ +..++||||+.+|+
T Consensus        25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~  102 (361)
T 3uc3_A           25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIMEYASGGE  102 (361)
T ss_dssp             EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCB
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEEeCCCCC
Confidence            478999999999999999999999999986533 3346789999999999999999999999854 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC--eEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ--PYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.  +||+|||+++....  .....
T Consensus       103 L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~~~~  175 (361)
T 3uc3_A          103 LYERICN--AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPK  175 (361)
T ss_dssp             HHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--cCCCC
Confidence            9999863  3468999999999999999999999   99999999999999987765  99999999874322  12223


Q ss_pred             cccCCCcccCccccccCCCCCc-chhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDASEE-TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...||+.|+|||++.+..++.+ +|||||||++|||++|..||.+......   ........ .....            
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~-~~~~~------------  239 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRI-LSVKY------------  239 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHH-HTTCC------------
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHH-hcCCC------------
Confidence            4578999999999988877655 8999999999999999999986543222   11111111 11000            


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                00011123456789999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-45  Score=333.45  Aligned_cols=266  Identities=20%  Similarity=0.307  Sum_probs=189.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ..+.+.+|+++++.++||||+++++++.. ++..++||||+. |
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~   87 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-N   87 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-C
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-C
Confidence            47899999999999999989999999998754332 33678999999999999999999999885 458999999998 5


Q ss_pred             ChhHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          153 NLAQCIRGG----SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       153 sL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +|.+++...    ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... .
T Consensus        88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~  163 (317)
T 2pmi_A           88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-N  163 (317)
T ss_dssp             BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-C
T ss_pred             CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-c
Confidence            999988532    23468999999999999999999999   999999999999999999999999999997654321 2


Q ss_pred             ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccc----
Q 038580          229 EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITD----  300 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----  300 (356)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+...    ....+......   ..+..    
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhhhhhhh
Confidence            2234567899999999876 468999999999999999999999997643211    01111100000   00000    


Q ss_pred             -ccCcccccccCCCC----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 -LYHPDMLLCSNSNH----ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 -~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ...+..........    ........+..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00000000000000    00001123457889999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-45  Score=326.47  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             CCcccccCCceEEEEEEcCCC-------eEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSG-------SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~-------~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++       ..+|+|.++.......+.+.+|+.+++.++||||+++++++.. ++..++||
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   91 (289)
T 4fvq_A           13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GDENILVQ   91 (289)
T ss_dssp             EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TTCCEEEE
T ss_pred             eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CCCCEEEE
Confidence            478999999999999987655       5789999876655566789999999999999999999999885 44789999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC--------eEEecccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ--------PYVSDFGL  218 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~  218 (356)
                      ||+.+++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.        +||+|||+
T Consensus        92 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             ECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             ECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999743 3348999999999999999999999   99999999999999998887        99999999


Q ss_pred             ccccCCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          219 HLLLNPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +.....     .....++..|+|||++.+ ..++.++||||||+++|||++|..|+.....      .............
T Consensus       168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~~~~~~~~~~  236 (289)
T 4fvq_A          168 SITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------SQRKLQFYEDRHQ  236 (289)
T ss_dssp             CTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTCC
T ss_pred             cccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc------hHHHHHHhhccCC
Confidence            865422     123456788999999987 6789999999999999999996555432111      1111110000000


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                          .+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       237 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          237 --------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             --------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             --------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                                01111235779999999999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.8e-46  Score=341.04  Aligned_cols=194  Identities=20%  Similarity=0.257  Sum_probs=170.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-----CCccccccceeeCCCCceEEEEe
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-----HPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ..+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+..|+.+++.++     ||||+++++++... +..++|||
T Consensus        39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~~lv~e  116 (360)
T 3llt_A           39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHMCLIFE  116 (360)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TEEEEEEC
T ss_pred             EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-CeeEEEEc
Confidence            347899999999999999989999999998742 223356788999999886     99999999998854 48999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC--------------------
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR--------------------  207 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------------------  207 (356)
                      |+ +++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.                    
T Consensus       117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            99 8899999986666679999999999999999999999   99999999999999975                    


Q ss_pred             -----CCCeEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          208 -----NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       208 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                           ++.+||+|||++......    .....+|+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                 789999999999764332    23457899999999999999999999999999999999999999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-45  Score=328.61  Aligned_cols=253  Identities=18%  Similarity=0.247  Sum_probs=194.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++......   .+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~  117 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYVDMRLIN  117 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEEEEEecC
Confidence            478999999999999999899999999987543332   2578899999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...........
T Consensus       118 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  192 (309)
T 2h34_A          118 GVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL  192 (309)
T ss_dssp             CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence            9999999974  3468999999999999999999999   9999999999999999999999999999876654433333


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|..||.....        ..........    ...+.     
T Consensus       193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~----~~~~~-----  255 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQA----IPRPS-----  255 (309)
T ss_dssp             ----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSC----CCCGG-----
T ss_pred             cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccC----CCCcc-----
Confidence            455788999999999988999999999999999999999999975321        1111111100    00000     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-NIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~il~~L~~~~  355 (356)
                            ..+.+.+..+.+++.+||+.||++|| +++++++.|+++.
T Consensus       256 ------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          256 ------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             ------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence                  11223445688999999999999999 9999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.2e-45  Score=330.52  Aligned_cols=258  Identities=21%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             hcCCCCcccccCCceEEEEEEcC---CCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCC----
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRG----  140 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  140 (356)
                      .+...+.||+|+||.||+|.+..   ++..+|+|.++......  .+.+.+|+.++++++||||+++++++.....    
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            34445889999999999998864   45689999987543322  2568999999999999999999999875432    


Q ss_pred             ceEEEEecccCCChhHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecc
Q 038580          141 EKLIVHPFYKRGNLAQCIRG----GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDF  216 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  216 (356)
                      ..+++|||+++++|.+++..    .....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeec
Confidence            45999999999999999842    234568999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          217 GLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       217 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......    ..   . ...
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~---~-~~~  263 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY---D-YLL  263 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH---H-HHH
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH---H-HHH
Confidence            99876543221 12233456778999999999999999999999999999999 888987543211    11   1 111


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..                 .....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       264 ~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          264 HG-----------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             TT-----------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC-----------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00                 011123344567889999999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.6e-46  Score=337.81  Aligned_cols=242  Identities=19%  Similarity=0.268  Sum_probs=196.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.++.+++.+|+|+++...   ......+..|..+++.+ +||||+++++++.+. +..++||||+
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~  100 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYL  100 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECC
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEEEEEEeCC
Confidence            478999999999999999999999999987532   22345678889988876 899999999999864 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus       101 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~  174 (345)
T 1xjd_A          101 NGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAK  174 (345)
T ss_dssp             TTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCc
Confidence            99999999974  3468999999999999999999999   99999999999999999999999999998754322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.        ...........            
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~------------  234 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN------------  234 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------------
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC------------
Confidence            3456789999999999999999999999999999999999999975321        11111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK-QVL  348 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~il  348 (356)
                            ...+...+..+.+++.+||+.||++||++. +++
T Consensus       235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  011223445688999999999999999987 554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=335.24  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             hcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEE
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVH  146 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  146 (356)
                      .+...+.||+|+||.||++....+++.+|+|.+........+.+.+|+++++.++||||+++++++..   .....+++|
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            33445889999999999999988999999998865544455689999999999999999999998862   234789999


Q ss_pred             ecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          147 PFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       147 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      ||+.+|+|.+++..  .....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999864  234678999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCCc--------ceecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhh
Q 038580          225 TAGQ--------EMLEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAV  293 (356)
Q Consensus       225 ~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  293 (356)
                      ....        ......+++.|+|||++....   ++.++||||||+++|||++|..||........  ........  
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~--  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAVQN--  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHHHC--
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHhhc--
Confidence            1110        012334688999999987554   68999999999999999999999853211110  01100000  


Q ss_pred             hhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                         .                ...+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       263 ---~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          263 ---Q----------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---C------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---c----------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence               0                000112233467889999999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=333.63  Aligned_cols=265  Identities=21%  Similarity=0.337  Sum_probs=190.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHH--HhccCCCccccccceee----CCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIEL--LGCIRHPNLVPLLGFYA----GPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~----~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+  ++..+|+|+++..   ....+..|.++  +..++||||+++++.+.    ......++|||
T Consensus        18 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             eeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            37899999999999977  5788999998643   23344445444  45589999999997543    22335789999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCCeeEcCCCCeEEecccc
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR---------PIIHGNLKSKNILLDRNYQPYVSDFGL  218 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~---------~ivH~dlk~~Nill~~~~~~kl~Dfg~  218 (356)
                      |+++|+|.+++..   ...++..+..++.|++.||+|||+   .         +++||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           93 YYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            9999999999964   345888999999999999999999   7         999999999999999999999999999


Q ss_pred             ccccCCCC-------CcceecccCCCcccCcccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-CC
Q 038580          219 HLLLNPTA-------GQEMLEASASQGYKAPELIKM-------KDASEETDIYSFGVIMLELISGKEPINENPTPDE-DF  283 (356)
Q Consensus       219 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~-~~  283 (356)
                      +.......       ........||+.|+|||++.+       ..++.++||||||+++|||++|..||........ ..
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            97654321       111224468999999999976       3566789999999999999999777654332221 11


Q ss_pred             chhHHHHHh-----hhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          284 HLPTFMRNA-----VLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       284 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .........     ...........+..      ..........+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKF------PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCC------CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCC------CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            111100000     00000000000000      0011123356778999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6e-45  Score=333.46  Aligned_cols=240  Identities=17%  Similarity=0.212  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++...   ....+.+.+|+.+++.++||||+++++++.+ .+..++||||++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~  124 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCC
Confidence            478999999999999999999999999986532   2233578899999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......    .
T Consensus       125 gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~  195 (350)
T 1rdq_E          125 GGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             TCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence            9999999974  2468999999999999999999999   99999999999999999999999999999865432    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.        ......+....             
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-------------  254 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-------------  254 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------------
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCC-------------
Confidence            345789999999999999999999999999999999999999975321        11111111111             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++||+     ++++++
T Consensus       255 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 0122234567889999999999999998     788764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.7e-46  Score=328.93  Aligned_cols=246  Identities=22%  Similarity=0.402  Sum_probs=193.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+.  +..+|+|.++..  ...+.+.+|+++++.++||||+++++++....+..+++|||+++++
T Consensus        26 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~  101 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  101 (278)
T ss_dssp             EEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence            478999999999999874  778999998743  3456799999999999999999999987766668999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......    ....
T Consensus       102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~  174 (278)
T 1byg_A          102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTG  174 (278)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCC
Confidence            9999974333347888999999999999999999   99999999999999999999999999998754322    1233


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||.+.+..++.++||||||+++|||+| |..||...+..       ... ......                
T Consensus       175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~-~~~~~~----------------  230 (278)
T 1byg_A          175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVV-PRVEKG----------------  230 (278)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHH-HHHTTT----------------
T ss_pred             CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHH-HHHhcC----------------
Confidence            56788999999998899999999999999999998 99999754211       111 111100                


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                       .....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          231 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence             001123344567889999999999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.1e-45  Score=328.59  Aligned_cols=252  Identities=19%  Similarity=0.256  Sum_probs=195.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ++.||+|+||.||+|.+..++..+|+|+++.........+.+|++++.++ +||||+++++++.+ ++..++||||++++
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   96 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVFEKMRGG   96 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTC
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEEcCCCC
Confidence            47799999999999999989999999999766555567899999999884 79999999999885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC---eEEeccccccccCCCCC--
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ---PYVSDFGLHLLLNPTAG--  227 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~~~--  227 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++........  
T Consensus        97 ~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           97 SILSHIHK--RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             BHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            99999974  3468899999999999999999999   99999999999999998776   99999999876432111  


Q ss_pred             ----cceecccCCCcccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH-------HHHH
Q 038580          228 ----QEMLEASASQGYKAPELIKM-----KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT-------FMRN  291 (356)
Q Consensus       228 ----~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~~  291 (356)
                          .......||+.|+|||++..     ..++.++||||||+++|||++|..||.+............       ....
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  251 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE  251 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence                11224458999999999875     4578999999999999999999999987654332221110       0111


Q ss_pred             hhhhcccccccCcccccccCCCCCCCCcH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          292 AVLDHRITDLYHPDMLLCSNSNHENPVSE----ERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ......                  ...+.    ..+..+.+++.+||+.||++|||++++++
T Consensus       252 ~i~~~~------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          252 SIQEGK------------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHCC------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhccC------------------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            111100                  00111    23457889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=335.10  Aligned_cols=261  Identities=20%  Similarity=0.349  Sum_probs=203.9

Q ss_pred             CCcccccCCceEEEEEE----cCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCC-CceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-GEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~e~  148 (356)
                      .+.||+|+||.||++.+    ..++..+|+|.++.......+.+.+|+++++.++||||+++++++.... ...++||||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  125 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY  125 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence            47899999999999984    5678999999998755555568999999999999999999999876433 368999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       126 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~  201 (326)
T 2w1i_A          126 LPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY  201 (326)
T ss_dssp             CTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred             CCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence            9999999999753 3458999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             c--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------CCCCCch-hHHHHHhhhhccc
Q 038580          229 E--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPT-------PDEDFHL-PTFMRNAVLDHRI  298 (356)
Q Consensus       229 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~-------~~~~~~~-~~~~~~~~~~~~~  298 (356)
                      .  .....++..|+|||.+.+..++.++||||||+++|||+||..||.....       ....... .........    
T Consensus       202 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  277 (326)
T 2w1i_A          202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK----  277 (326)
T ss_dssp             EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH----
T ss_pred             cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh----
Confidence            1  1233566779999999888899999999999999999999998763210       0000000 000000000    


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                   .....+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       278 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          278 -------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                         00111223445677889999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=334.79  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=186.1

Q ss_pred             hhhcCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceee-------CCC
Q 038580           68 DILDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYA-------GPR  139 (356)
Q Consensus        68 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------~~~  139 (356)
                      +..+...+.||+|+||.||+|.+..+++.+|+|.+........+.+.+|+.+++++. ||||+++++++.       ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            334444588999999999999999899999999886554445567899999999996 999999999884       233


Q ss_pred             CceEEEEecccCCChhHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEcCCCCeEEecc
Q 038580          140 GEKLIVHPFYKRGNLAQCIRG-GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLDRNYQPYVSDF  216 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df  216 (356)
                      ...+++|||+. |+|.+++.. .....+++..++.++.|++.||+|||+   .+  ++||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999996 699998853 234569999999999999999999999   88  999999999999999999999999


Q ss_pred             ccccccCCCCCc-----------ceecccCCCcccCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 038580          217 GLHLLLNPTAGQ-----------EMLEASASQGYKAPELI---KMKDASEETDIYSFGVIMLELISGKEPINENPTPDED  282 (356)
Q Consensus       217 g~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~  282 (356)
                      |++.........           ......+++.|+|||++   .+..++.++||||||+++|||++|..||........ 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            999775432211           11244578899999998   566788999999999999999999999975322110 


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ..     ...    .            .+.....+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       262 ------~~-----~~~----~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          262 ------VN-----GKY----S------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ---------------C----C------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------hc-----Ccc----c------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  00     000    0            0001112234778999999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-45  Score=336.72  Aligned_cols=252  Identities=19%  Similarity=0.257  Sum_probs=193.1

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccc-----cccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV-----CTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ...+.||+|+||.||+|.+..++..+|+|+++..     .....+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus        29 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  107 (345)
T 3hko_A           29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQYICLVM  107 (345)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CCeEEEEE
Confidence            3458899999999999999999999999998643     22334679999999999999999999999985 45899999


Q ss_pred             ecccCCChhHhhhcC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 038580          147 PFYKRGNLAQCIRGG--------------------------------------SGEAHKWSIIYRISIGIAGGLDYLHTG  188 (356)
Q Consensus       147 e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~  188 (356)
                      ||+++|+|.+++...                                      ....+++..+..++.|++.||+|||+ 
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-  186 (345)
T 3hko_A          108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-  186 (345)
T ss_dssp             ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-
Confidence            999999999998420                                      01123567788899999999999999 


Q ss_pred             CCCCceecCCCCCCeeEcCCC--CeEEeccccccccCCCC---CcceecccCCCcccCcccccc--CCCCCcchhHHHHH
Q 038580          189 FHRPIIHGNLKSKNILLDRNY--QPYVSDFGLHLLLNPTA---GQEMLEASASQGYKAPELIKM--KDASEETDIYSFGV  261 (356)
Q Consensus       189 ~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~  261 (356)
                        .+++||||||+||+++.++  .+||+|||++.......   ........+++.|+|||++.+  ..++.++||||||+
T Consensus       187 --~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             --TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             --CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence              9999999999999998776  89999999997653221   112345578999999999865  67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 038580          262 IMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR  341 (356)
Q Consensus       262 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  341 (356)
                      ++|||++|..||.+...       ......... ...              ....+.....+..+.+++.+||+.||++|
T Consensus       265 il~el~~g~~pf~~~~~-------~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVND-------ADTISQVLN-KKL--------------CFENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC--------------CTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHCCCCCCCCCh-------HHHHHHHHh-ccc--------------ccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence            99999999999975432       111111111 000              00001112235678899999999999999


Q ss_pred             CCHHHHHH
Q 038580          342 PNIKQVLW  349 (356)
Q Consensus       342 ps~~~il~  349 (356)
                      |++.++++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-46  Score=346.42  Aligned_cols=249  Identities=20%  Similarity=0.246  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++..+.+++.+|+|+++....   ...+.+.+|..++..++||||+++++++.+ .+..++||||++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lVmE~~~  144 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEcCCC
Confidence            4789999999999999999999999999864321   122458899999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       145 gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          145 GGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             SCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            99999999742 3468999999999999999999999   9999999999999999999999999999987654433334


Q ss_pred             ecccCCCcccCccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          231 LEASASQGYKAPELIK-------MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~-------~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ....||+.|+|||++.       ...|+.++|+|||||++|||++|..||...+..       . ....+..... ....
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~~-~~~~  291 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------E-TYGKIVHYKE-HLSL  291 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTHHH-HCCC
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhccc-CcCC
Confidence            4568999999999987       356899999999999999999999999764311       1 1111110000 0000


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR---PNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~il~  349 (356)
                      +            ..+...+.++.+++.+||+ +|++|   |+++++++
T Consensus       292 p------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          292 P------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             C----------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             C------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0            0112345678899999999 99998   58998864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-45  Score=335.45  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=205.7

Q ss_pred             CCcccccCCceEEEEEE----cCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC-CCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALL----QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG-PRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+    ..++..+|+|.++.......+.+.+|+++++.++||||+++++++.. .....++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  107 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY  107 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence            47899999999999994    56789999999986655555679999999999999999999998764 34468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       108 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  183 (327)
T 3lxl_A          108 LPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY  183 (327)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE
T ss_pred             cCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccCCcc
Confidence            9999999999642 2358999999999999999999999   99999999999999999999999999999876433222


Q ss_pred             --ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC-------CCCchhHHHHHhhhhcccc
Q 038580          229 --EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       229 --~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  299 (356)
                        ......++..|+|||++.+..++.++||||||+++|||++|..||.......       .............      
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  257 (327)
T 3lxl_A          184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL------  257 (327)
T ss_dssp             EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH------
T ss_pred             ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh------
Confidence              1233456778999999998889999999999999999999999986421100       0000000000000      


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                 ......+.+..++..+.+++..||+.||++|||+.++++.|+.+.
T Consensus       258 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          258 -----------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             -----------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                       011112234455677889999999999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-45  Score=329.34  Aligned_cols=248  Identities=20%  Similarity=0.319  Sum_probs=197.4

Q ss_pred             CcccccCCceEEEEEE--cCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALL--QRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~--~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||.||+|.+  ..++..+|+|+++......  .+.+.+|+.+++.++||||+++++++.  .+..+++|||++
T Consensus        23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~  100 (291)
T 1xbb_A           23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE  100 (291)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred             CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCcEEEEEeCC
Confidence            3899999999999965  4567889999987553322  357999999999999999999999985  347899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      +++|.+++..  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......... 
T Consensus       101 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (291)
T 1xbb_A          101 LGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  175 (291)
T ss_dssp             TEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence            9999999974  3468999999999999999999999   999999999999999999999999999987764433221 


Q ss_pred             -eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 -MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...        ...........          
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~----------  237 (291)
T 1xbb_A          176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGE----------  237 (291)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC----------
T ss_pred             ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC----------
Confidence             123345678999999988888999999999999999999 9999975321        11111111100          


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                             ....+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus       238 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   0112334456788999999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=333.06  Aligned_cols=238  Identities=18%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--------chHHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++.....        ....+.+|+.+++.++||||+++++++.. .+..++
T Consensus        28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~l  106 (335)
T 3dls_A           28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-QGFFQL  106 (335)
T ss_dssp             EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-CCEEEE
Confidence            347899999999999999999999999998754321        22467889999999999999999999985 458999


Q ss_pred             EEecccCC-ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          145 VHPFYKRG-NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       145 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +|||+.+| +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus       107 v~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          107 VMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            99999777 99999974  4469999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCcceecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ...  ......||+.|+|||++.+..+ +.++||||||+++|||++|..||.......                  ....
T Consensus       182 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------------~~~~  241 (335)
T 3dls_A          182 RGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------------EAAI  241 (335)
T ss_dssp             TTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------------TTCC
T ss_pred             CCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------------hhcc
Confidence            332  2334578999999999988776 789999999999999999999996421100                  0000


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                                    ..+...+..+.+++..||+.||++|||+.++++.
T Consensus       242 --------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 --------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          0111234568899999999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-45  Score=333.47  Aligned_cols=252  Identities=25%  Similarity=0.429  Sum_probs=195.3

Q ss_pred             CCcccccCCceEEEEEEcCC----CeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRS----GSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~----~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..+    +..+|+|.++..... ....+.+|+.+++.++||||+++++++.. .+..++||||
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  127 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEY  127 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcEEEEeC
Confidence            47899999999999988644    346899998754332 23478999999999999999999999875 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       128 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          128 MENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             CTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            9999999999743 3568999999999999999999999   99999999999999999999999999998765432211


Q ss_pred             --ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 --EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 --~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                        ......++..|+|||++.+..++.++||||||+++|||++ |..||.+...       .. ........         
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~-~~~~~~~~---------  266 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HE-VMKAINDG---------  266 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTT---------
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HH-HHHHHHCC---------
Confidence              1123345678999999998899999999999999999999 9999975321       11 11111110         


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ...+.+..++..+.+++.+||+.||++||++.++++.|+++.
T Consensus       267 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          267 --------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             --------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    001122334567889999999999999999999999998863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=326.09  Aligned_cols=249  Identities=20%  Similarity=0.322  Sum_probs=201.4

Q ss_pred             CcccccCCceEEEEEEc--CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.||+|+||.||+|.+.  .++..+|+|+++..... ..+.+.+|+++++.++||||+++++++.  .+..+++|||+++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   93 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGG   93 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTT
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEEEEEeCCC
Confidence            48999999999999864  46788999998764332 3357899999999999999999999985  3468999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc--
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--  229 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  229 (356)
                      ++|.+++.. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..........  
T Consensus        94 ~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  169 (287)
T 1u59_A           94 GPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  169 (287)
T ss_dssp             EEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             CCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence            999999964 34568999999999999999999999   999999999999999999999999999998764332221  


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .....+++.|+|||++.+..++.++||||||+++|||+| |..||......       . .........           
T Consensus       170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~~~i~~~~-----------  230 (287)
T 1u59_A          170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQGK-----------  230 (287)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHTTC-----------
T ss_pred             cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHhcCC-----------
Confidence            223345788999999988889999999999999999999 99999764321       1 111111100           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ....+...+..+.+++..||+.||++||++.++++.|+++
T Consensus       231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1112334566788999999999999999999999999876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.7e-45  Score=326.34  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=191.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+ .+++.+|+|.++.....  ..+.+.+|+++++.++||||+++++++.+. +..+++|||+.+
T Consensus         7 ~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~   84 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSE
T ss_pred             hhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEEecCC
Confidence            37899999999999998 46778888887654322  236788999999999999999999999854 589999999986


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                       +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ....
T Consensus        85 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  158 (288)
T 1ob3_A           85 -DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT  158 (288)
T ss_dssp             -EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             -CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cccc
Confidence             999988743 3568899999999999999999999   999999999999999999999999999987654321 2223


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---cccc-----cc
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---RITD-----LY  302 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~  302 (356)
                      ...+|+.|+|||++.+. .++.++||||||+++|||++|..||.+.+....   +.. ........   .+..     ..
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHHHHCCCChhhchhhhccccc
Confidence            45678999999998754 589999999999999999999999976432110   000 00000000   0000     00


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ++..... ............+..+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCC-CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccc-cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000000 000000111234566789999999999999999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.3e-45  Score=332.32  Aligned_cols=243  Identities=19%  Similarity=0.250  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|....+++.+|+|+++...   ....+.+..|..+++.+ +||||+++++++.+ .+..++||||+
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~lv~E~~  103 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYV  103 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEEEEEeCC
Confidence            378999999999999999889999999987542   22335688899999887 79999999999885 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus       104 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~  177 (353)
T 2i0e_A          104 NGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVT  177 (353)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-Ccc
Confidence            99999999974  2468999999999999999999999   99999999999999999999999999998753322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.        ......+....            
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------------  237 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN------------  237 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------------
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC------------
Confidence            3456789999999999999999999999999999999999999975321        11111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                            ..++...+..+.+++.+||+.||++||+     ++++++
T Consensus       238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  0122334567889999999999999995     566654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=326.94  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=192.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+.  +..+|+|.++.  ....+.+.+|++++++++||||+++++++.+   ..++||||+++++
T Consensus        13 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~~~~   85 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGS   85 (307)
T ss_dssp             EEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECCTTCB
T ss_pred             eeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCCCCC
Confidence            478999999999999985  67789998864  2344679999999999999999999998763   5799999999999


Q ss_pred             hhHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC-eEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSG-EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ-PYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++..... ..+++..++.++.|++.||+|||+....+++||||||+||+++.++. +||+|||++......    ..
T Consensus        86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~  161 (307)
T 2eva_A           86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT  161 (307)
T ss_dssp             HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence            9999975332 24788899999999999999999843357999999999999998887 799999998754321    22


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...|++.|+|||++.+..++.++||||||+++|||++|..||......     ........ ...               
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~---------------  220 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAV-HNG---------------  220 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHH-HTT---------------
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHH-hcC---------------
Confidence            346889999999999889999999999999999999999999753221     11111110 000               


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                        ...+.+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       221 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          221 --TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             --CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             --CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence              001122334567889999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-45  Score=332.34  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...+.||+|+||.||+|.+..++..+|+|+++.....      ..+.+.+|+.+++.++||||+++++++.+ .+..+++
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   93 (321)
T 2a2a_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTDVVLI   93 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEE
Confidence            3458899999999999999989999999998754332      23579999999999999999999999885 4589999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----CeEEeccccccc
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLL  221 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~  221 (356)
                      |||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++    .+||+|||++..
T Consensus        94 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           94 LELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             ECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999974  4568999999999999999999999   9999999999999999888    799999999876


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ....  .......+++.|+|||++.+..++.++||||||+++|||++|..||.+.+.       ..... ......    
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~-~i~~~~----  234 (321)
T 2a2a_A          169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLA-NITSVS----  234 (321)
T ss_dssp             CCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHH-HHHTTC----
T ss_pred             cCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHH-HHHhcc----
Confidence            5432  222345689999999999988999999999999999999999999975321       11111 111000    


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....          ......+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 YDFDE----------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCCCH----------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccCh----------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000          001123456889999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-45  Score=332.97  Aligned_cols=256  Identities=17%  Similarity=0.324  Sum_probs=202.4

Q ss_pred             cCCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      +...+.||+|+||.||+|.+.     .++..+|+|.+...... ....+.+|+.+++.++||||+++++++.. .+..++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l  105 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLV  105 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-CCccEE
Confidence            344588999999999999876     35678999998754332 23468899999999999999999999875 448899


Q ss_pred             EEecccCCChhHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecc
Q 038580          145 VHPFYKRGNLAQCIRGG--------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDF  216 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  216 (356)
                      +|||+++|+|.+++...        ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcC
Confidence            99999999999998631        12457899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          217 GLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       217 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      |++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+.       .. ......
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~-~~~~~~  254 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQ-VLRFVM  254 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HH-HHHHHH
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HH-HHHHHH
Confidence            99876533221 11223345788999999998899999999999999999999 8899875321       11 111111


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ....                 ...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       255 ~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          255 EGGL-----------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             TTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             cCCc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            1100                 0122334567889999999999999999999999998863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.6e-45  Score=345.64  Aligned_cols=266  Identities=20%  Similarity=0.240  Sum_probs=191.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..+++.+|+|++.....  ...+.+.+|+.+++.++||||+++++++....     ...++||
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  146 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  146 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence            4789999999999999999999999999875422  22357889999999999999999999987433     3579999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+.    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       147 E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  217 (464)
T 3ttj_A          147 ELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  217 (464)
T ss_dssp             ECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-
T ss_pred             eCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-
Confidence            99987 5777764    248899999999999999999999   99999999999999999999999999999765432 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH---hhhh---ccccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN---AVLD---HRITD  300 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~  300 (356)
                       .......+|+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+......   ....   .....
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             -CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             -cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence             2234567899999999999999999999999999999999999999864321110000000000   0000   00000


Q ss_pred             ccCcc-------c-ccccC--CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 LYHPD-------M-LLCSN--SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 ~~~~~-------~-~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....       . ...+.  .............++.+|+.+||+.||++|||++++++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000       0 00000  00000112223677899999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=338.40  Aligned_cols=258  Identities=16%  Similarity=0.179  Sum_probs=198.9

Q ss_pred             CCcccccCCceEEEEEEcC--------CCeEEEEEEeccccccchHHHHHHHHHHhccCCCcccc---------------
Q 038580           74 GEVIGKSNYGTLYKALLQR--------SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVP---------------  130 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~--------~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------------  130 (356)
                      .+.||+|+||.||+|.+..        .+..+|+|.++..     +.+.+|++++++++||||++               
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            4789999999999999986        4788999988642     47889999999999999998               


Q ss_pred             ccceeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-
Q 038580          131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-  209 (356)
Q Consensus       131 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-  209 (356)
                      +++++...++..++||||+ +++|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||+++.++ 
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETTEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCCCC
Confidence            4555654466899999999 8999999986545679999999999999999999999   9999999999999999998 


Q ss_pred             -CeEEeccccccccCCCCCc------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 038580          210 -QPYVSDFGLHLLLNPTAGQ------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED  282 (356)
Q Consensus       210 -~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~  282 (356)
                       .+||+|||++.........      ......+++.|+|||++.+..++.++||||||+++|||++|..||.......  
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  275 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT--  275 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH--
Confidence             8999999999765432111      1133478899999999998899999999999999999999999997643111  


Q ss_pred             CchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          283 FHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..+...... ... .........           ......+..+.+++..||+.||++|||++++++.|+++.
T Consensus       276 ~~~~~~~~~-~~~-~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          276 EDIMKQKQK-FVD-KPGPFVGPC-----------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             HHHHHHHHH-HHH-SCCCEECTT-----------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHh-ccC-Chhhhhhhc-----------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            001111110 000 000000000           001123467889999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-45  Score=332.97  Aligned_cols=263  Identities=18%  Similarity=0.300  Sum_probs=201.9

Q ss_pred             CCcccccCCceEEEEEEc----CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQ----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  147 (356)
                      .+.||+|+||.||++.+.    .+++.+|+|+++..... ..+.+.+|+++++.++||||+++++++.+. ....++|||
T Consensus        36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  115 (318)
T 3lxp_A           36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME  115 (318)
T ss_dssp             EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred             hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence            478999999999888653    46889999998764332 235689999999999999999999998754 347899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++..   ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus       116 ~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          116 YVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             CCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             cccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            9999999999974   348999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             c--ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC---CCchhHHHHHhhhhccccccc
Q 038580          228 Q--EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDE---DFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       228 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      .  ......++..|+|||++.+..++.++||||||+++|||+||..||........   .............. ..    
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----  264 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE-LL----  264 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH-HH----
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH-HH----
Confidence            1  12344567789999999988899999999999999999999999864211000   00000000000000 00    


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ......+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       265 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          265 --------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                    001112233445677899999999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.3e-46  Score=344.30  Aligned_cols=237  Identities=14%  Similarity=0.159  Sum_probs=183.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccc---cccchHHHHHHH---HHHhccCCCcccccc-------ceeeCCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV---CTTRDKEFGDLI---ELLGCIRHPNLVPLL-------GFYAGPRG  140 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~~~~  140 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++..   .....+.+.+|+   +.++.++|||||+++       +++..++.
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            47899999999999999888999999998743   222346788999   455566899999998       54443321


Q ss_pred             ----------------ceEEEEecccCCChhHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 038580          141 ----------------EKLIVHPFYKRGNLAQCIRGGS-----GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK  199 (356)
Q Consensus       141 ----------------~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  199 (356)
                                      ..+++|||+ +|+|.+++....     ...+++..++.++.|++.||+|||+   .+++|||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDik  233 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR  233 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence                            378999999 579999996321     1234468888999999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccccC-----------CCCCcchhHHHHHHHHHHHh
Q 038580          200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK-----------DASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       200 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDvwslG~~l~el~t  268 (356)
                      |+|||++.++.+||+|||++....    .......| +.|+|||++.+.           .++.++|||||||++|||++
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            999999999999999999987632    23344566 899999999877           89999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 038580          269 GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       269 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                      |..||.+.........+.                .              .....+..+.+++.+||+.||++|||+.+++
T Consensus       309 g~~Pf~~~~~~~~~~~~~----------------~--------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          309 ADLPITKDAALGGSEWIF----------------R--------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             SSCCC------CCSGGGG----------------S--------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             CCCCCcccccccchhhhh----------------h--------------hccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999997644322111000                0              0012235688999999999999999999998


Q ss_pred             H
Q 038580          349 W  349 (356)
Q Consensus       349 ~  349 (356)
                      +
T Consensus       359 ~  359 (377)
T 3byv_A          359 E  359 (377)
T ss_dssp             T
T ss_pred             h
Confidence            5

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=337.21  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=193.0

Q ss_pred             CCCcccccCCceEEEEEEcC---CCeEEEEEEecccccc-----------chHHHHHHHHHHhccCCCccccccceeeCC
Q 038580           73 PGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTT-----------RDKEFGDLIELLGCIRHPNLVPLLGFYAGP  138 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  138 (356)
                      ..+.||+|+||.||+|.+..   ++..+|+|........           ....+.+|+..++.++||||+++++++...
T Consensus        41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~  120 (345)
T 2v62_A           41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE  120 (345)
T ss_dssp             EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred             EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence            34789999999999999986   6788899987654321           112466788889999999999999988752


Q ss_pred             ---CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC--CeEE
Q 038580          139 ---RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY--QPYV  213 (356)
Q Consensus       139 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl  213 (356)
                         ....+++|||+ +++|.+++...  ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++  .+||
T Consensus       121 ~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          121 FKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             SSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             cCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEEE
Confidence               45789999999 89999999743  378999999999999999999999   9999999999999999887  9999


Q ss_pred             eccccccccCCCCC------cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH
Q 038580          214 SDFGLHLLLNPTAG------QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       214 ~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  287 (356)
                      +|||+++.......      .......++..|+|||++.+..++.++||||||+++|||++|..||........   ...
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~  271 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV---AVQ  271 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH---HHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH---HHH
Confidence            99999976532211      112345789999999999988999999999999999999999999964221110   001


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .........     .......+.       .....+..+.+++..||+.||++|||++++++.|+++.
T Consensus       272 ~~~~~~~~~-----~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          272 TAKTNLLDE-----LPQSVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHT-----TTHHHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHhhccc-----ccHHHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111000     000000000       00123457889999999999999999999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.8e-45  Score=343.88  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=198.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++....   .....+.+|+.+++.++||||+++++++.++ +..++||||++
T Consensus        21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~   99 (476)
T 2y94_A           21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVS   99 (476)
T ss_dssp             EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCC
Confidence            4789999999999999998999999999864321   2235789999999999999999999999864 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......  ...
T Consensus       100 gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~  172 (476)
T 2y94_A          100 GGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFL  172 (476)
T ss_dssp             SEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCB
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccc
Confidence            9999999973  4568999999999999999999999   99999999999999999999999999999875432  223


Q ss_pred             ecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+.       .... .......            
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~-~~i~~~~------------  232 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLF-KKICDGI------------  232 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHH-HHHHTTC------------
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHH-HHHhcCC------------
Confidence            45678999999999987765 6899999999999999999999975321       1111 1111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       233 ------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 ------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                  0012223456789999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.4e-45  Score=325.58  Aligned_cols=242  Identities=20%  Similarity=0.271  Sum_probs=199.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++.. .+..++||||++++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   91 (277)
T 3f3z_A           13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVMELCTGG   91 (277)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSC
T ss_pred             eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEeccCCC
Confidence            34789999999999999998898999998876656666789999999999999999999999985 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCCcc
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++.......  .
T Consensus        92 ~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~  164 (277)
T 3f3z_A           92 ELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--M  164 (277)
T ss_dssp             BHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--C
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--c
Confidence            99998864  3458999999999999999999999   999999999999999   788999999999987654322  2


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....+++.|+|||++.+ .++.++||||||+++|||++|..||...+.        ............           
T Consensus       165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-----------  224 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTF-----------  224 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-----------
T ss_pred             hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCC-----------
Confidence            334578999999999865 489999999999999999999999975321        111111111000           


Q ss_pred             cCCCCCCCCcH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSE----ERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~----~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ..+.    +.+..+.+++.+||+.||++|||+.++++
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0111    23567889999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=323.85  Aligned_cols=242  Identities=18%  Similarity=0.213  Sum_probs=187.0

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccch--HHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEec
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      ...++||+|+||+||+|.+..+++.+|+|++........  ..+..|+..+.++ +||||++++++|.. ++..++||||
T Consensus        60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv~e~  138 (311)
T 3p1a_A           60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQTEL  138 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEEEec
Confidence            345789999999999999998999999998765433222  2445555555444 89999999999985 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      + +++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......  .
T Consensus       139 ~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~  211 (311)
T 3p1a_A          139 C-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--G  211 (311)
T ss_dssp             C-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC--C
Confidence            9 66999988643 3469999999999999999999999   99999999999999999999999999998765432  2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||+.|+|||++.+ .++.++||||||+++|||++|..|+....          . ........    ..+    
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~-~~~~~~~~----~~~----  271 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------G-WQQLRQGY----LPP----  271 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------H-HHHHTTTC----CCH----
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------H-HHHHhccC----CCc----
Confidence            2334568999999999875 78999999999999999999977764311          0 00111000    000    


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              ..+...+..+.+++..||+.||++|||++++++
T Consensus       272 --------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 --------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                    011223567889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-44  Score=347.29  Aligned_cols=248  Identities=19%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.++.+++.+|+|+++....   ...+.+.+|+.+++.++||||+++++++.+. +..++||||++
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmE~~~  268 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEEEEecc
Confidence            3679999999999999998999999999865322   2335688999999999999999999998854 58999999999


Q ss_pred             CCChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +|+|..++....  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++....... .
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~  344 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-T  344 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-C
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-c
Confidence            999999986433  4568999999999999999999999   999999999999999999999999999998754322 2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||+.|+|||++.+..|+.++|+|||||++|||++|..||.........    ..+........           
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~-----------  409 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQA-----------  409 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCC-----------
T ss_pred             ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcc-----------
Confidence            223458999999999999999999999999999999999999999865322211    11111111110           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI-----KQVL  348 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~il  348 (356)
                             ...+...+..+.+++.+||+.||++||++     ++++
T Consensus       410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence                   01223345678899999999999999965     5665

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.8e-44  Score=328.19  Aligned_cols=258  Identities=20%  Similarity=0.333  Sum_probs=200.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc--cCCCccccccceeeCCC---CceEEEEe
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC--IRHPNLVPLLGFYAGPR---GEKLIVHP  147 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---~~~~lv~e  147 (356)
                      ..+.||+|+||.||+|.+.  ++.+|+|+++..   ....+..|.+++..  ++||||+++++++....   ...+++||
T Consensus        46 ~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           46 LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             EEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             EEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            3578999999999999984  788999998642   34567888888877  78999999999988654   27899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeEcCCCCeEEeccccc
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH--------TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~  219 (356)
                      |+++|+|.+++..   ..+++..++.++.|++.||+|||        +   .+++||||||+||+++.++.+||+|||++
T Consensus       121 ~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          121 YHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             CCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            9999999999974   36899999999999999999999        7   89999999999999999999999999998


Q ss_pred             cccCCCCCc---ceecccCCCcccCccccccCC------CCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 038580          220 LLLNPTAGQ---EMLEASASQGYKAPELIKMKD------ASEETDIYSFGVIMLELISG----------KEPINENPTPD  280 (356)
Q Consensus       220 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~sDvwslG~~l~el~tg----------~~p~~~~~~~~  280 (356)
                      .........   ......+++.|+|||++.+..      ++.++||||||+++|||+||          ..||.......
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            765443322   123456889999999987652      33689999999999999999          67776543222


Q ss_pred             CCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          281 EDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..  . ..+.......    ...+...       ....+.+++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       275 ~~--~-~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          275 PS--V-EEMRKVVCEQ----KLRPNIP-------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CC--H-HHHHHHHTTS----CCCCCCC-------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc--H-HHHHHHHHHH----HhCCCCc-------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            11  1 1111111111    1111110       00023467888999999999999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=329.02  Aligned_cols=266  Identities=20%  Similarity=0.287  Sum_probs=192.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+.......  .+.+.+|+.+++.++||||+++++++.. .+..++||||+++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~   86 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEEEeCCC
Confidence            378999999999999999889999999886543322  3568899999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ....
T Consensus        87 ~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  160 (311)
T 4agu_A           87 TVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYD  160 (311)
T ss_dssp             EHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             chHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cccC
Confidence            999998863  4568999999999999999999999   999999999999999999999999999997754322 2223


Q ss_pred             cccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHH-------HHhhhhcc-ccccc
Q 038580          232 EASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM-------RNAVLDHR-ITDLY  302 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~  302 (356)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|..||.+.........+....       ........ .....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            4567889999999875 568999999999999999999999997643211100000000       00000000 00000


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+...   ..........+.+..+.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          241 IPDPE---DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCS---SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCcc---ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000   000000000124556889999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-45  Score=322.85  Aligned_cols=244  Identities=26%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC---------------C
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG---------------P  138 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------------~  138 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.++..    ...+.+|+++++.++||||+++++++..               .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   91 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK   91 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence            47899999999999999988999999988643    2467889999999999999999998753               1


Q ss_pred             CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccc
Q 038580          139 RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL  218 (356)
Q Consensus       139 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  218 (356)
                      ....+++|||+++++|.+++.......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  168 (284)
T 2a19_B           92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGL  168 (284)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcchh
Confidence            2357999999999999999975555679999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          219 HLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      +.......  ......+++.|+|||++.+..++.++||||||+++|||++|..|+...         .. ......... 
T Consensus       169 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~-~~~~~~~~~-  235 (284)
T 2a19_B          169 VTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SK-FFTDLRDGI-  235 (284)
T ss_dssp             CEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HH-HHHHHHTTC-
T ss_pred             heeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HH-HHHHhhccc-
Confidence            87764332  223456889999999999889999999999999999999998886421         00 111111100 


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                                         .+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       236 -------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 -------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                               111223457799999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-45  Score=339.64  Aligned_cols=241  Identities=21%  Similarity=0.256  Sum_probs=188.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHH-HhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIEL-LGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|..+.++..+|+|+++.....   ....+..|..+ ++.++||||+++++++.+ .+..++||||+
T Consensus        43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~lv~E~~  121 (373)
T 2r5t_A           43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYI  121 (373)
T ss_dssp             EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEEEEeCC
Confidence            48899999999999999999999999998754322   22345666665 577899999999999986 44899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus       122 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~  195 (373)
T 2r5t_A          122 NGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NST  195 (373)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CCC
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC-CCc
Confidence            99999999974  3468888999999999999999999   99999999999999999999999999998763322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.       .. ....+....            
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~-~~~~i~~~~------------  255 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AE-MYDNILNKP------------  255 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HH-HHHHHHHSC------------
T ss_pred             cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HH-HHHHHHhcc------------
Confidence            3456789999999999999999999999999999999999999975321       11 111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV  347 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~i  347 (356)
                            ...+...+..+.+++.+||+.||++||++.+.
T Consensus       256 ------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          256 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             ------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             ------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence                  01122334568899999999999999998543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=321.05  Aligned_cols=244  Identities=18%  Similarity=0.335  Sum_probs=178.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+.....   ...+.+.+|+.+++.++||||+++++++.+ .+..+++|||++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   94 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEEEecCC
Confidence            4789999999999999988899999999864321   223578999999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        95 ~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  169 (278)
T 3cok_A           95 NGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKH  169 (278)
T ss_dssp             TEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             CCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-Ccc
Confidence            99999999743 3568999999999999999999999   999999999999999999999999999987654322 122


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|..||...........                ....      
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~~~------  227 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------------VVLA------  227 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS------
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----------------Hhhc------
Confidence            345688999999999988899999999999999999999999976432211100                0000      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ....+...+..+.+++.+||+.||++|||++++++
T Consensus       228 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 ----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                00112223456889999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-44  Score=336.10  Aligned_cols=197  Identities=23%  Similarity=0.365  Sum_probs=158.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccC-CCccccccceeeCCC-CceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPR-GEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+.....  ...+.+.+|+.+++.+. ||||+++++++..++ ...++|||||
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            4789999999999999999999999998864322  22356788999999997 999999999987543 3689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC---
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA---  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---  226 (356)
                      . ++|..+++.   ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......   
T Consensus        94 ~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           94 E-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             S-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             C-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            8 499999874   368899999999999999999999   999999999999999999999999999997653211   


Q ss_pred             -----------------CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          227 -----------------GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       227 -----------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                                       ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                             111234578999999999876 678999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-46  Score=335.58  Aligned_cols=253  Identities=17%  Similarity=0.239  Sum_probs=190.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCC---ceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRG---EKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++.......   ..+.+|+.+++.++||||+++++++.....   ..++|||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e   96 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   96 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence            4789999999999999999999999999976533332   468899999999999999999998764332   3499999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.++++.  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        97 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           97 YVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             CCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred             cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence            9999999999974  3468999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             --cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          228 --QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       228 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                        .......|++.|+|||++.+..++.++||||||+++|||+||..||.+...       ...........     ..+.
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~-----~~~~  239 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRED-----PIPP  239 (311)
T ss_dssp             ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC-----CCCH
T ss_pred             ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCC-----CCCc
Confidence              122345689999999999999999999999999999999999999975321       11111111100     0000


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHhh
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL-WKLED  353 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il-~~L~~  353 (356)
                      .          ......+..+.+++.+||+.||++||++.+++ ..|.+
T Consensus       240 ~----------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          240 S----------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             H----------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c----------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            0          00112355688999999999999999655544 44443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.6e-45  Score=331.01  Aligned_cols=243  Identities=19%  Similarity=0.271  Sum_probs=188.1

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||++...   .+++.+|+|+++....    .....+.+|+.+++.++||||+++++++.. .+..++||
T Consensus        22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~  100 (327)
T 3a62_A           22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GGKLYLIL  100 (327)
T ss_dssp             EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred             EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CCEEEEEE
Confidence            478999999999999985   5788999999875422    223467889999999999999999999985 45899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...... 
T Consensus       101 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  174 (327)
T 3a62_A          101 EYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-  174 (327)
T ss_dssp             ECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred             eCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccccC-
Confidence            99999999999973  3468889999999999999999999   99999999999999999999999999998754322 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      ........||+.|+|||++.+..++.++||||||+++|||++|..||.+.+.       .... .......         
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~-~~i~~~~---------  237 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTI-DKILKCK---------  237 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH-HHHHHTC---------
T ss_pred             CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHH-HHHHhCC---------
Confidence            1223355789999999999988999999999999999999999999975321       1111 1111110         


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                               ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     011223456788999999999999999     7778765

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.7e-44  Score=321.88  Aligned_cols=255  Identities=19%  Similarity=0.318  Sum_probs=192.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+|+|.++.....   ....+.+|+.+++.++||||+++++++.. .+..+++|||+.
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~  115 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELAD  115 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCC
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEEEecCC
Confidence            47899999999999999888999999998753222   23578899999999999999999999885 448999999999


Q ss_pred             CCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          151 RGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       151 ~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|.+++..  .....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... .
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~  191 (310)
T 2wqm_A          116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-T  191 (310)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-c
Confidence            9999999863  234568999999999999999999999   999999999999999999999999999987654321 2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......++..|+|||++.+..++.++||||||+++|||++|..||.+....     ..... ........     +.   
T Consensus       192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-----~~---  257 (310)
T 2wqm_A          192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLC-KKIEQCDY-----PP---  257 (310)
T ss_dssp             -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHH-HHHHTTCS-----CC---
T ss_pred             cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHH-HHhhcccC-----CC---
Confidence            223446788999999999889999999999999999999999999753211     11111 11111000     00   


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ......+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       258 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          258 --------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             --------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                    011233457889999999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-45  Score=333.07  Aligned_cols=242  Identities=22%  Similarity=0.321  Sum_probs=194.0

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||+|....++..+|+|.+.......   .+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus        58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  136 (348)
T 1u5q_A           58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVMEYC  136 (348)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEEEecC
Confidence            3478999999999999998899999999986543222   2468899999999999999999999885 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      . |+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....     
T Consensus       137 ~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----  206 (348)
T 1u5q_A          137 L-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  206 (348)
T ss_dssp             S-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             C-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence            7 5888887532 3568999999999999999999999   9999999999999999999999999999876532     


Q ss_pred             eecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          230 MLEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      .....||+.|+|||++.   .+.++.++||||||+++|||++|..||...+.       ........ ...     .+..
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~-~~~-----~~~~  273 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNE-----SPAL  273 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHH-HSC-----CCCC
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHH-hcC-----CCCC
Confidence            22457899999999984   56789999999999999999999999975321       11111111 100     0000


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                 .+...+..+.+++..||+.||++|||++++++
T Consensus       274 -----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          274 -----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                       11223456789999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.1e-45  Score=343.26  Aligned_cols=245  Identities=20%  Similarity=0.262  Sum_probs=190.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||+|....++..+|+|+++...   ......+.+|+.+++.++||||++++++|... +..++||||+
T Consensus       152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e~~  230 (446)
T 4ejn_A          152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEEEECCC
T ss_pred             EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEEEEeeC
Confidence            3478999999999999999999999999987532   22234678899999999999999999999854 4899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++..  ...+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||++...... ...
T Consensus       231 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  305 (446)
T 4ejn_A          231 NGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GAT  305 (446)
T ss_dssp             SSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-Ccc
Confidence            99999999964  34689999999999999999999952  68999999999999999999999999998754322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .. .........            
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~-~~~~i~~~~------------  365 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EK-LFELILMEE------------  365 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCC------------
T ss_pred             cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HH-HHHHHHhCC------------
Confidence            3456789999999999999999999999999999999999999975321       11 111111100            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                            ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  012223446788999999999999999     9999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.3e-44  Score=335.57  Aligned_cols=195  Identities=23%  Similarity=0.324  Sum_probs=163.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++.....  ..+.+.+|+.+++.++||||+++++++....    ...++|||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  110 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE  110 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence            47899999999999999999999999998754322  2357889999999999999999999887543    47899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+.+ +|.++++.  ...+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus       111 ~~~~-~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  184 (432)
T 3n9x_A          111 IADS-DLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD  184 (432)
T ss_dssp             CCSE-EHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred             cCCc-CHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence            9874 99999974  4569999999999999999999999   9999999999999999999999999999987643221


Q ss_pred             c---------------------ceecccCCCcccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 038580          228 Q---------------------EMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISGKEPIN  274 (356)
Q Consensus       228 ~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~tg~~p~~  274 (356)
                      .                     ......+|+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            1                     22456789999999986 55679999999999999999998666654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-44  Score=339.95  Aligned_cols=247  Identities=23%  Similarity=0.321  Sum_probs=188.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--------cchHHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--------TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..+.||+|+||.||+|.+..+++.+|+|++.....        .....+.+|+.++++++||||+++++++..  +..++
T Consensus       139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~l  216 (419)
T 3i6u_A          139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--EDYYI  216 (419)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--SEEEE
T ss_pred             EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--CceEE
Confidence            34779999999999999999999999999865321        112358899999999999999999999863  35899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEeccccccc
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLL  221 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~  221 (356)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.+   +.+||+|||++..
T Consensus       217 v~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          217 VLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             EEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            9999999999999863  4568999999999999999999999   999999999999999754   4599999999987


Q ss_pred             cCCCCCcceecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      ....  .......||+.|+|||++.+   ..++.++||||||+++|||++|..||........   +.......    ..
T Consensus       292 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~i~~~----~~  362 (419)
T 3i6u_A          292 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITSG----KY  362 (419)
T ss_dssp             CC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---HHHHHHTT----CC
T ss_pred             cCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---HHHHHhcC----CC
Confidence            5432  22335678999999999853   5678899999999999999999999976432211   11111110    00


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .  ..+            ......+..+.+++.+||+.||++|||++++++
T Consensus       363 ~--~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          363 N--FIP------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             C--CCH------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C--CCc------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0  000            001123567889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-43  Score=316.46  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=194.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+++|.+......  ..+.+.+|+.+++.++||||+++++++..   .....++||||
T Consensus        31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~  110 (290)
T 1t4h_A           31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL  110 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred             eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence            46799999999999999999999999988754322  23568999999999999999999998763   23468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEc-CCCCeEEeccccccccCCC
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~  225 (356)
                      +++++|.+++..  ...+++..+..++.|++.||+|||+   .+  ++||||||+||+++ .++.+||+|||++......
T Consensus       111 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          111 MTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             cCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            999999999974  3568899999999999999999999   88  99999999999998 7899999999998754332


Q ss_pred             CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                         ......+++.|+|||++. +.++.++||||||+++|+|++|..||.....      ... .........     .+ 
T Consensus       186 ---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~-~~~~~~~~~-----~~-  248 (290)
T 1t4h_A          186 ---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ-IYRRVTSGV-----KP-  248 (290)
T ss_dssp             ---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH-HHHHHTTTC-----CC-
T ss_pred             ---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHH-HHHHHhccC-----Cc-
Confidence               223456899999999886 5589999999999999999999999975321      111 111111100     00 


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                ...+...+..+.+++..||+.||++|||++++++
T Consensus       249 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                      0011222356889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=335.25  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=198.0

Q ss_pred             CCCCcccccCCceEEEEEEc---CCCeEEEEEEecccc----ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           72 APGEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVC----TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      ...+.||+|+||.||++...   .+++.+|+|+++...    ....+.+.+|+++++.+ +||||+++++++.. ++..+
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~  135 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLH  135 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TTEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-CceEE
Confidence            33578999999999999984   478899999987532    12335678899999999 69999999998885 44899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +||||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus       136 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999974  3468999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCCcceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ...........||+.|+|||++.+  ..++.++|||||||++|||++|..||........   ....... ....     
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~-~~~~-----  281 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRR-ILKS-----  281 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHH-HHHC-----
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHH-Hhcc-----
Confidence            433334445678999999999985  3478999999999999999999999975433222   1111111 1110     


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLWK  350 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~~  350 (356)
                                   ..+.+.+.+..+.+++.+||+.||++||     +++++++.
T Consensus       282 -------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 -------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                         0112333456688999999999999999     99998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.4e-45  Score=332.79  Aligned_cols=246  Identities=20%  Similarity=0.287  Sum_probs=194.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++.++.+++.+|+|+++...    ....+|++++.++ +||||+++++++.+ ++..++||||+++|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~gg  101 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGG  101 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeCCCCC
Confidence            478999999999999999999999999986543    2345678888777 79999999999985 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC----CCeEEeccccccccCCCCCc
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN----YQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||+.++    +.+||+|||++....... .
T Consensus       102 ~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~  175 (342)
T 2qr7_A          102 ELLDKILR--QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-G  175 (342)
T ss_dssp             BHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-C
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-C
Confidence            99999974  3468999999999999999999999   999999999999998543    359999999998754332 2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......+|+.|+|||++.+..++.++|||||||++|||++|..||......     ....+..........         
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~~~---------  241 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILARIGSGKFS---------  241 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHHHHHCCCC---------
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHHHccCCcc---------
Confidence            234557899999999998888899999999999999999999999753221     111111111111100         


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           .........+..+.+++.+||+.||++||++.++++
T Consensus       242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000112234567889999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-45  Score=331.37  Aligned_cols=265  Identities=18%  Similarity=0.228  Sum_probs=187.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++......  .+.+.+|+.+++.++||||+++++++.. ++..++||||+.+
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLHLIFEYAEN  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEEEEEecCCC
Confidence            478999999999999999999999999987543322  3467899999999999999999999885 4589999999985


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-----CCCCeEEeccccccccCCCC
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-----RNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfg~~~~~~~~~  226 (356)
                       +|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++     .++.+||+|||++...... 
T Consensus       118 -~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-  190 (329)
T 3gbz_A          118 -DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-  190 (329)
T ss_dssp             -EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             -CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-
Confidence             99999974  3458999999999999999999999   9999999999999994     4556999999999765432 


Q ss_pred             CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh--hccccccc-
Q 038580          227 GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL--DHRITDLY-  302 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-  302 (356)
                      ........+|+.|+|||++.+. .++.++|||||||++|||++|..||.+......   +.........  ...+.... 
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhhhhh
Confidence            1223345678999999999764 489999999999999999999999975432110   0110000000  00000000 


Q ss_pred             CcccccccCCCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENP----VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+.............    .+...+.++.+|+.+||+.||++|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000000000000    01113467889999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.3e-45  Score=331.78  Aligned_cols=251  Identities=24%  Similarity=0.415  Sum_probs=198.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEE--EEEEecccc-ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVR--LLRFLRPVC-TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~--a~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..++..+  ++|.++... ....+.+.+|+++++++ +||||+++++++.. .+..+++|||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~  108 (327)
T 1fvr_A           30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA  108 (327)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred             eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEEEEecC
Confidence            478999999999999998777654  888876432 22345789999999999 89999999999885 45899999999


Q ss_pred             cCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          150 KRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       150 ~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ++++|.+++....              ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcc
Confidence            9999999997432              3468999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ||++.....  ........++..|+|||++.+..++.++||||||+++|||+| |..||.+.+.       .. ......
T Consensus       186 fg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~-~~~~~~  255 (327)
T 1fvr_A          186 FGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEKLP  255 (327)
T ss_dssp             TTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHGG
T ss_pred             cCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HH-HHHHhh
Confidence            999864321  112223456778999999988889999999999999999998 9999975431       11 111111


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..     .            ....+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       256 ~~-----~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          256 QG-----Y------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             GT-----C------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC-----C------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            10     0            01112234567889999999999999999999999998763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.1e-44  Score=321.36  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||++....+++.+|+|.++.......+.+.+|+.+++.++||||+++++++.. .+..+++|||+++++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   92 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQLVSGGE   92 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCB
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEEcCCCcc
Confidence            4789999999999999998999999999986554455678999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCCcce
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      |.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++......   ..
T Consensus        93 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~  164 (304)
T 2jam_A           93 LFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IM  164 (304)
T ss_dssp             HHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TT
T ss_pred             HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---cc
Confidence            9999863  3468899999999999999999999   999999999999999   78899999999998754321   22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||++.+..++.++||||||+++|||++|..||.....        ............    .       
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~----~-------  225 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYY----E-------  225 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCC----C-------
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC----C-------
Confidence            344688999999999988999999999999999999999999975321        111111111110    0       


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001112234567889999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.8e-45  Score=322.64  Aligned_cols=241  Identities=21%  Similarity=0.355  Sum_probs=194.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..++..+|+|++....   ......+.+|+.+++.++||||+++++++.+ .+..+++|||++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   92 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEEEEecCC
Confidence            478999999999999999999999999985432   1223568999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......   ..
T Consensus        93 ~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~  164 (279)
T 3fdn_A           93 LGTVYRELQK--LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR  164 (279)
T ss_dssp             TEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence            9999999874  3468999999999999999999999   99999999999999999999999999988654322   22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|..||...+.       .. .........             
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~-------------  223 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QE-TYKRISRVE-------------  223 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHTC-------------
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HH-HHHHHHhCC-------------
Confidence            345788999999999988999999999999999999999999975321       11 111111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 0122234456789999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-44  Score=321.31  Aligned_cols=246  Identities=20%  Similarity=0.268  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..++..+|+|++......  ..+.+.+|+.++++++||||+++++++.. ++..+++|||+++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~   89 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTG   89 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEEEecCCC
Confidence            47899999999999999999999999998654332  22568899999999999999999999885 4588999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC---eEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ---PYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~~~~  228 (356)
                      ++|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++......  .
T Consensus        90 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--~  162 (284)
T 3kk8_A           90 GELFEDIVA--REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--E  162 (284)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--C
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--c
Confidence            999988863  3468999999999999999999999   99999999999999986655   999999998765432  2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+...        .............   .     
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~---~-----  226 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYD---Y-----  226 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCC---C-----
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhcccc---C-----
Confidence            22345789999999999999999999999999999999999999975321        1111111111000   0     


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ..+.....+..+.+++.+||+.||++|||++++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  00011233456889999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8e-44  Score=317.21  Aligned_cols=246  Identities=23%  Similarity=0.367  Sum_probs=191.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||++....++..+|+|.+...... ..+.+.+|+++++.++||||+++++++.+ .+..++||||+++|
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~  105 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGG  105 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCSCC
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEEeCCCC
Confidence            48899999999999999988999999988755433 34679999999999999999999999985 45899999999999


Q ss_pred             ChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCC
Q 038580          153 NLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       153 sL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.+++...  ....+++..+..++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++......  
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--  180 (285)
T 3is5_A          106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--  180 (285)
T ss_dssp             BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             cHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--
Confidence            999988532  24679999999999999999999999   999999999999999   55678999999998765432  


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......+++.|+|||++. +.++.++||||||+++|||++|..||.+.+.       .. .........      +.. 
T Consensus       181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~-~~~~~~~~~------~~~-  244 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EE-VQQKATYKE------PNY-  244 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCC------CCC-
T ss_pred             ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HH-HHhhhccCC------ccc-
Confidence            2233556889999999986 5688999999999999999999999975321       11 111110000      000 


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ..    .....+..+.+++.+||+.||++|||+.++++
T Consensus       245 ----~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 ----AV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cc----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00    00012356779999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=337.07  Aligned_cols=192  Identities=23%  Similarity=0.333  Sum_probs=150.6

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCC----CCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGP----RGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~lv  145 (356)
                      ...+.||+|+||.||+|.+..+++.+|+|.+......  ..+.+.+|+.+++.++||||+++++++...    ....|+|
T Consensus        56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  135 (458)
T 3rp9_A           56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV  135 (458)
T ss_dssp             EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence            3458899999999999999999999999988654322  235788999999999999999999988532    2478999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+. ++|.+++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       136 ~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          136 LEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             ECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             Eeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            99985 699999973  4569999999999999999999999   99999999999999999999999999999875422


Q ss_pred             CC--------------------------cceecccCCCcccCcccc-ccCCCCCcchhHHHHHHHHHHHhC
Q 038580          226 AG--------------------------QEMLEASASQGYKAPELI-KMKDASEETDIYSFGVIMLELISG  269 (356)
Q Consensus       226 ~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~tg  269 (356)
                      ..                          .......||+.|+|||++ ....|+.++|||||||++|||+||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            11                          122345679999999986 456799999999999999999993

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.5e-45  Score=330.62  Aligned_cols=248  Identities=19%  Similarity=0.287  Sum_probs=197.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ++.||+|+||.||+|.+..++..+|+|+++.....  ....+.+|+.+++.+. ||||+++++++.. .+..++||||+.
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~  112 (327)
T 3lm5_A           34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAA  112 (327)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecC
Confidence            37899999999999999999999999998754332  2467899999999985 6999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|+|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.   ++.+||+|||++....... 
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-  188 (327)
T 3lm5_A          113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-  188 (327)
T ss_dssp             TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-
Confidence            9999999976556789999999999999999999999   99999999999999998   7899999999998754322 


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       ......+++.|+|||++.+..++.++||||||+++|||++|..||...+.       ..... .......         
T Consensus       189 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~-~i~~~~~---------  250 (327)
T 3lm5_A          189 -ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-------QETYL-NISQVNV---------  250 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH-HHHHTCC---------
T ss_pred             -ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHH-HHHhccc---------
Confidence             22345789999999999999999999999999999999999999975321       11111 1110000         


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ..........+..+.+++.+||+.||++|||++++++
T Consensus       251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          251 -----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                 0001112234566889999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=323.49  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=195.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCCh
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      ..||+|+||.||+|.+..++..+|+|.++.......+.+.+|+.+++.++||||+++++++.. .+..+++|||+++++|
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCSEEEH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeCCCCCH
Confidence            589999999999999998999999999876655556789999999999999999999999885 4589999999999999


Q ss_pred             hHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccCCCCCcceec
Q 038580          155 AQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       155 ~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      .+++.... ...+++..+..++.|++.||+|||+   .+++|+||||+||+++. ++.+||+|||++....... .....
T Consensus       107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  182 (295)
T 2clq_A          107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET  182 (295)
T ss_dssp             HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred             HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence            99997542 3356788899999999999999999   99999999999999987 8999999999987654321 12234


Q ss_pred             ccCCCcccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          233 ASASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ..++..|+|||++.+..  ++.++||||||+++|||++|..||.......     ..........      .        
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~------~--------  243 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK------V--------  243 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC------C--------
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc------c--------
Confidence            56889999999987653  7899999999999999999999996432110     0000000000      0        


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ....+...+..+.+++.+||+.||++||++.++++
T Consensus       244 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 ----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                01122334567889999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-44  Score=319.06  Aligned_cols=247  Identities=19%  Similarity=0.257  Sum_probs=197.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. .+..+++|||++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~   90 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG   90 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEEEecCCC
Confidence            4789999999999999998899999999865433 234678999999999999999999999885 45889999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Cccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~  231 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....... .....
T Consensus        91 ~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  165 (276)
T 2yex_A           91 ELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (276)
T ss_dssp             EGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             cHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence            99999863  4568999999999999999999999   999999999999999999999999999987643221 11223


Q ss_pred             cccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...++..|+|||.+.+..+ +.++||||||+++|||++|..||........  ....     ......            
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~-----~~~~~~------------  226 (276)
T 2yex_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD-----WKEKKT------------  226 (276)
T ss_dssp             CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHH-----HHTTCT------------
T ss_pred             CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH-----hhhccc------------
Confidence            4568899999999987665 7789999999999999999999976432111  0000     000000            


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ........+..+.+++.+||+.||++|||++++++
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                00011233456789999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-44  Score=329.08  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             CCcccccCCceEEEEEE-----cCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALL-----QRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+     ..++..+|+|.+..... .....+.+|+.++++++||||+++++++.. .+..+++||
T Consensus        35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  113 (327)
T 2yfx_A           35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLPRFILME  113 (327)
T ss_dssp             EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred             EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCCcEEEEe
Confidence            47899999999999984     45677899999864432 233578999999999999999999999885 447899999


Q ss_pred             cccCCChhHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccc
Q 038580          148 FYKRGNLAQCIRGGSG-----EAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLH  219 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~  219 (356)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+   .+++||||||+||+++.   +..+||+|||++
T Consensus       114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~  190 (327)
T 2yfx_A          114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  190 (327)
T ss_dssp             CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccc
Confidence            9999999999975322     458899999999999999999999   99999999999999984   456999999998


Q ss_pred             cccCCCC-CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          220 LLLNPTA-GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       220 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ....... ........+++.|+|||++.+..++.++||||||+++|||+| |..||.....       .. .........
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~-~~~~~~~~~  262 (327)
T 2yfx_A          191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QE-VLEFVTSGG  262 (327)
T ss_dssp             HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HH-HHHHHHTTC
T ss_pred             cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HH-HHHHHhcCC
Confidence            7543222 122234567888999999988899999999999999999998 9999875321       11 111111100


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                                       ....+..++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       263 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          263 -----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                             01122334567889999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=327.65  Aligned_cols=247  Identities=17%  Similarity=0.241  Sum_probs=187.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCC--CccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRH--PNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||.||++.+. ++..+|+|++.......  .+.+.+|+.+++.++|  |||+++++++.. ++..++|||
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e   89 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME   89 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEEEEe
Confidence            33478999999999999985 57788999886543322  2578999999999986  999999999885 458999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                       +.+++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++ ++.+||+|||++........
T Consensus        90 -~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           90 -CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             -CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             -CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence             567799999974  4568999999999999999999999   9999999999999997 56899999999977643322


Q ss_pred             c-ceecccCCCcccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          228 Q-EMLEASASQGYKAPELIKM-----------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       228 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      . ......||+.|+|||++.+           ..++.++||||||+++|||++|..||.....      .......... 
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~-  235 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID-  235 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHC-
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHhc-
Confidence            2 2235578999999999864           6788999999999999999999999964321      1111111100 


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                              +        ......+...+..+.+++..||+.||++|||+.++++.
T Consensus       236 --------~--------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          236 --------P--------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --------T--------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------C--------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    0        00111122234567899999999999999999999853

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=330.53  Aligned_cols=248  Identities=15%  Similarity=0.226  Sum_probs=196.5

Q ss_pred             hcCCCCcccccCCceEEEEE-----EcCCCeEEEEEEeccccccchHHHHHHHHHHhccC---CCccccccceeeCCCCc
Q 038580           70 LDAPGEVIGKSNYGTLYKAL-----LQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGE  141 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~-----~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~  141 (356)
                      .+...+.||+|+||.||+|.     ...+++.+|+|+++..   ...++..|+++++.++   |+||+.+++++... +.
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-~~  141 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-NG  141 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-SC
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-CC
Confidence            34445789999999999994     5567889999998743   4567888888888876   99999999998854 48


Q ss_pred             eEEEEecccCCChhHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-----------
Q 038580          142 KLIVHPFYKRGNLAQCIRG---GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-----------  207 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----------  207 (356)
                      .++||||+++|+|.+++..   .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.           
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence            8999999999999999963   134579999999999999999999999   99999999999999998           


Q ss_pred             CCCeEEeccccccccCC-CCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchh
Q 038580          208 NYQPYVSDFGLHLLLNP-TAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLP  286 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  286 (356)
                      ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||+||..||........     
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence            89999999999975432 223334556789999999999999999999999999999999999999864321100     


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHhhh
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLR-PNIKQVLWKLEDL  354 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~~il~~L~~~  354 (356)
                                .....    .       ...+    ..+.+.+++..|++.+|.+| |++.++.+.|+++
T Consensus       294 ----------~~~~~----~-------~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 ----------KPEGL----F-------RRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ----------EECSC----C-------TTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ----------eechh----c-------cccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                      00000    0       0001    13456789999999999999 6788888888765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.5e-44  Score=338.40  Aligned_cols=257  Identities=14%  Similarity=0.228  Sum_probs=202.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++...  ....+..|+++++.++|++.+..+.++....+..++||||+ ++
T Consensus        11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~   87 (483)
T 3sv0_A           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP   87 (483)
T ss_dssp             CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence            3588999999999999999899999999876432  33468999999999998666665555554566889999999 88


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCCCc-
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      +|.+++... ...+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++........ 
T Consensus        88 sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           88 SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             BHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             CHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            999999742 3469999999999999999999999   999999999999999   68899999999999876543221 


Q ss_pred             -----ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          229 -----EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       229 -----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                           ......||..|+|||++.+..++.++|||||||++|||++|..||.+.........+.......... ...    
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~----  238 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-SIE----  238 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-CHH----
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-cHH----
Confidence                 1225578999999999999999999999999999999999999998754322211111111111110 000    


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                         .          ....++.++.+++..||+.||++||++.+|++.|+++
T Consensus       239 ---~----------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          239 ---A----------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ---H----------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ---H----------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               0          0112346788999999999999999999999999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.4e-44  Score=331.54  Aligned_cols=247  Identities=16%  Similarity=0.227  Sum_probs=188.4

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccC--CCccccccceeeCCCCceEEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIR--HPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +...+.||+|+||.||+|.... +..+|+|++......  ..+.+.+|+.+++.++  ||||+++++++... +..++||
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~  135 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVM  135 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEEEE
Confidence            4445889999999999999875 888999988654322  2357899999999997  59999999988854 4799999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      | +.+++|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||++.......
T Consensus       136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 5678999999743  468888999999999999999999   9999999999999996 5799999999998764332


Q ss_pred             Cc-ceecccCCCcccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh
Q 038580          227 GQ-EMLEASASQGYKAPELIKM-----------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       227 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|..||.....      ....... ..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~-~~  281 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHA-II  281 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHH-HH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHH-Hh
Confidence            21 2235578999999999865           3688999999999999999999999975321      1111111 11


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...        .        ....+...+..+.+++..||+.||++|||+.++++
T Consensus       282 ~~~--------~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPN--------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTT--------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Ccc--------c--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            000        0        00111122456889999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=329.50  Aligned_cols=265  Identities=16%  Similarity=0.220  Sum_probs=189.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++....... ..+.+|+.+++.++||||+++++++.. ++..++||||+.+ 
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-   84 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFEYLDK-   84 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEECCSE-
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEeccccc-
Confidence            3789999999999999998999999999875432222 245679999999999999999999985 4589999999985 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... ......
T Consensus        85 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~  159 (324)
T 3mtl_A           85 DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDN  159 (324)
T ss_dssp             EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccccc
Confidence            999988643 3468999999999999999999999   99999999999999999999999999998764322 222234


Q ss_pred             ccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---cccccccCcc-cc
Q 038580          233 ASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLYHPD-ML  307 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~  307 (356)
                      ..+|+.|+|||++.+ ..++.++||||||+++|||++|..||.+.+...    ....+......   ..+....... ..
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhhcchhhc
Confidence            467899999999876 568999999999999999999999997643211    01111110000   0000000000 00


Q ss_pred             cccCCCCC----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHE----NPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ........    .......+..+.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000    0011123456789999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.6e-44  Score=326.69  Aligned_cols=267  Identities=19%  Similarity=0.251  Sum_probs=195.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC-------CCceEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP-------RGEKLI  144 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~~~~l  144 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+.......  ...+.+|+.+++.++||||+++++++...       .+..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l  101 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL  101 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence            478999999999999999899999999886543322  35788999999999999999999988753       346899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCC
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  224 (356)
                      ||||+.+ +|.+.+... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus       102 v~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  176 (351)
T 3mi9_A          102 VFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSL  176 (351)
T ss_dssp             EEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             EEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence            9999986 787777643 3468999999999999999999999   9999999999999999999999999999976542


Q ss_pred             CC---CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---cc
Q 038580          225 TA---GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HR  297 (356)
Q Consensus       225 ~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  297 (356)
                      ..   ........+|+.|+|||++.+ ..++.++||||||+++|||+||..||.+.....    ....+......   ..
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSITPEV  252 (351)
T ss_dssp             CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTT
T ss_pred             cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhh
Confidence            22   122234567899999999875 458999999999999999999999998643211    11111110000   00


Q ss_pred             cccccCccccc-ccCCCCCCCCcHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLL-CSNSNHENPVSEE------RILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +.......... ............+      ....+.+|+.+||+.||++|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000000 0000000011111      1345889999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-44  Score=353.79  Aligned_cols=254  Identities=17%  Similarity=0.329  Sum_probs=200.1

Q ss_pred             cCCCCcccccCCceEEEEEEcC---CCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQR---SGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      +...+.||+|+||.||+|.+..   .+..+|+|.++...... .+.+.+|+.+++.++||||+++++++.  ++..++||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~lv~  469 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIM  469 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCceEEEE
Confidence            3445789999999999999864   35678899876543222 357899999999999999999999885  34689999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus       470 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          470 ELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             ECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            999999999999743 3468999999999999999999999   999999999999999999999999999998765443


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ........+++.|+|||++.+..++.++||||||+++|||++ |..||.+....       .... ......        
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~-~i~~~~--------  609 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIG-RIENGE--------  609 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH-HHHHTC--------
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHH-HHHcCC--------
Confidence            333334556788999999998899999999999999999997 99999754211       1111 111100        


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                               ..+.+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     01123345567889999999999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-44  Score=321.51  Aligned_cols=247  Identities=21%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++.....      ..+.+.+|+.+++.++||||+++++++.. .+..+++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   87 (283)
T 3bhy_A            9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDVVLIL   87 (283)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeEEEEE
Confidence            347899999999999999988999999988654322      24679999999999999999999999985 45899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----CeEEecccccccc
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~  222 (356)
                      ||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++    .+||+|||++...
T Consensus        88 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           88 ELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             eecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            99999999999963  3468999999999999999999999   9999999999999999877    7999999998765


Q ss_pred             CCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ....  ......+++.|+|||++.+..++.++||||||+++|||++|..||.+...       .. .........    .
T Consensus       163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~----~  228 (283)
T 3bhy_A          163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QE-TLTNISAVN----Y  228 (283)
T ss_dssp             C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHTTC----C
T ss_pred             cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HH-HHHHhHhcc----c
Confidence            4322  22345688899999999988999999999999999999999999975321       11 111111000    0


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....          ......+..+.+++.+||+.||++||++.++++
T Consensus       229 ~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DFDE----------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCCH----------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcc----------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0000          001123456889999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-44  Score=332.79  Aligned_cols=251  Identities=8%  Similarity=-0.036  Sum_probs=177.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhcc--CCCcccccc-------ceeeCCC-
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCI--RHPNLVPLL-------GFYAGPR-  139 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l--~h~niv~~~-------~~~~~~~-  139 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++......   .+.+.+|+.+++.+  +||||++++       +++..+. 
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~  145 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ  145 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence            3478999999999999999999999999998654322   24577775444444  699988754       3332211 


Q ss_pred             ---------------CceEEEEecccCCChhHhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCceecCC
Q 038580          140 ---------------GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSII------YRISIGIAGGLDYLHTGFHRPIIHGNL  198 (356)
Q Consensus       140 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~~ivH~dl  198 (356)
                                     ...++||||+. |+|.+++... ...+++..+      ..++.|++.||+|||+   .+++||||
T Consensus       146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDi  220 (371)
T 3q60_A          146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF  220 (371)
T ss_dssp             CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcC
Confidence                           24799999999 7999999742 122344445      6778999999999999   99999999


Q ss_pred             CCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          199 KSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       199 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      ||+|||++.++.+||+|||++.....    ......+++.|+|||++.+  ..++.++|||||||++|||+||..||.+.
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999986532    2224456689999999987  67999999999999999999999999875


Q ss_pred             CCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          277 PTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........         ...        ...........+.....+..+.+++.+||+.||++|||+.++++
T Consensus       297 ~~~~~~~~~---------~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          297 TPGIKGSWK---------RPS--------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CTTCTTCCC---------BCC--------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             Ccccccchh---------hhh--------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            432211000         000        00000001111112244567889999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-44  Score=328.56  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=190.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+......  ..+.+.+|+++++.++||||+++++++....     ...++||
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  109 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  109 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence            47899999999999999989999999988643322  2356889999999999999999999987543     3569999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+ +++|.++++.   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..... 
T Consensus       110 e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  181 (367)
T 1cm8_A          110 PFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  181 (367)
T ss_dssp             ECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence            999 7799999974   468899999999999999999999   99999999999999999999999999999875422 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---cccccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---RITDLY  302 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  302 (356)
                         .....+|+.|+|||++.+ ..++.++||||+||++|||++|..||.+.+....   + ..+.......   ......
T Consensus       182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l-~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---L-KEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCCHHHHHTCS
T ss_pred             ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHhcCCCCHHHHHHhh
Confidence               234577899999999876 6799999999999999999999999986432110   0 0000000000   000000


Q ss_pred             Cccc----ccccC--CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDM----LLCSN--SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~----~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....    .....  ...-.....+.+..+.+|+.+||+.||++|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0000    00000  00000111234567889999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.6e-44  Score=343.68  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=199.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||+|....++..+|+|++....   ......+.+|+.+++.++||||+++++++.+ .+..++||||+
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  108 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVGEVY  108 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecC
Confidence            3578999999999999999999999999986442   2334679999999999999999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE---cCCCCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL---DRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      .+|+|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+|||+   +.++.+||+|||++.......
T Consensus       109 ~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          109 TGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            99999999874  4568999999999999999999999   999999999999999   567899999999997764332


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.        ......+......       
T Consensus       184 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~-------  245 (484)
T 3nyv_A          184 --KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEKGKYT-------  245 (484)
T ss_dssp             --SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC-------
T ss_pred             --ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCC-------
Confidence              2335578999999999875 689999999999999999999999976431        1111111111100       


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus       246 -------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 -------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   001112234567889999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-44  Score=330.54  Aligned_cols=268  Identities=21%  Similarity=0.290  Sum_probs=196.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCC----CceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPR----GEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+....... .+.+.+|+++++.++||||+++++++..+.    ...+++|||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            478999999999999999999999999987543222 257889999999999999999999886443    468999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +.+ +|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus       112 ~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          112 MET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             CSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             cCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence            985 99999864   358999999999999999999999   99999999999999999999999999999765432211


Q ss_pred             c--eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 E--MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .  .....||+.|+|||++.+ ..++.++||||||+++|||++|..||.+.+.......+....... ............
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~  263 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQEDLNCIINLK  263 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC-CHHHHHTCCCHH
T ss_pred             cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC-CHHHHHHhhhhh
Confidence            1  234578999999998754 458999999999999999999999997644322111110000000 000000000000


Q ss_pred             cc---cccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 ML---LCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~---~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..   .........   ....+.+..+.+|+.+||+.||++|||++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00   000000000   001123456889999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-44  Score=327.88  Aligned_cols=266  Identities=20%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+.......  .+.+.+|+.+++.++||||+++++++.. .+..++||||+.+
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~  108 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCSE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEEecCCc
Confidence            378999999999999999999999999886543332  2457899999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      ++|..++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ....
T Consensus       109 ~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  182 (331)
T 4aaa_A          109 TILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYD  182 (331)
T ss_dssp             EHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred             chHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccC
Confidence            999888763  3468999999999999999999999   999999999999999999999999999987654322 2223


Q ss_pred             cccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH-------HHHHhhhh-ccccccc
Q 038580          232 EASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT-------FMRNAVLD-HRITDLY  302 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~  302 (356)
                      ...++..|+|||++.+. .++.++||||||+++|||++|..||...........+..       ........ .......
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            45688999999998765 689999999999999999999999976432111000000       00000000 0000001


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+...   ............+..+.+++.+||+.||++|||++++++
T Consensus       263 ~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          263 LPEIK---EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCS---SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             Ccccc---ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11000   000000011134567889999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-44  Score=341.89  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|.+..++..+|+|++....  ......+.+|+++++.++||||+++++++.+ .+..++||||+.+
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~  105 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTG  105 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEEEcCCC
Confidence            478999999999999999899999999986432  2334678999999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |+|.+.+..  ...+++..+..++.|++.||.|||+   .+++||||||+|||++   .++.+||+|||++......  .
T Consensus       106 ~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~  178 (486)
T 3mwu_A          106 GELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T  178 (486)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--C
Confidence            999998863  3468999999999999999999999   9999999999999995   5667999999999765432  2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.       .. ....+......         
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~-~~~~i~~~~~~---------  240 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YD-ILKRVETGKYA---------  240 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTCCC---------
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhCCCC---------
Confidence            2345578999999999875 589999999999999999999999976421       11 11111111100         


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus       241 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -----SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 000112234567889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.4e-44  Score=342.81  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=193.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccc--ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC--TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      ..+.||+|+||+||+|.+..++..+|+|+++...  ......+.+|+.+++.++||||++++++|.+ .+..++||||++
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~  119 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYK  119 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCC
Confidence            3578999999999999999999999999987543  2234678999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|+|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.   ++.+||+|||++......  
T Consensus       120 ~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--  192 (494)
T 3lij_A          120 GGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--  192 (494)
T ss_dssp             SCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence            9999998863  3468899999999999999999999   99999999999999976   455999999999776432  


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.       .. ........... .      
T Consensus       193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~-~~~~i~~~~~~-~------  256 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QE-ILRKVEKGKYT-F------  256 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTCCC-C------
T ss_pred             ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhCCCC-C------
Confidence            2234567899999999986 5689999999999999999999999976432       11 11111111100 0      


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                             ..+.....+..+.+++.+||+.||++|||+.++++
T Consensus       257 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 -------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                   00011233456889999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.2e-44  Score=327.98  Aligned_cols=194  Identities=24%  Similarity=0.363  Sum_probs=168.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++..... ..+.+.+|+.+++.++||||+++++++.. ++..++||||++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~  116 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGG  116 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEECCCTTC
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEEECCCCC
Confidence            47899999999999999999999999998754322 23578999999999999999999999885 45899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      +|.+++..  ...+++..+..++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++......   ...
T Consensus       117 ~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~  188 (360)
T 3eqc_A          117 SLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN  188 (360)
T ss_dssp             BHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence            99999974  3468899999999999999999998   6 8999999999999999999999999998654221   223


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINEN  276 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~  276 (356)
                      ...+++.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            457889999999999999999999999999999999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-44  Score=318.03  Aligned_cols=243  Identities=21%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+|+|++......   ..+.+.+|+.+++.++||||+++++++.+ ++..+++|||+.
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~   98 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEEEEecCC
Confidence            47899999999999999999999999998654322   23568899999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        99 ~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~  172 (294)
T 2rku_A           99 RRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERK  172 (294)
T ss_dssp             TCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc-ccc
Confidence            9999999863  3468999999999999999999999   999999999999999999999999999987654322 223


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||.+.+..++.++|+||||+++|||++|..||.....       ..... ......             
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~~~~-------------  231 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYL-RIKKNE-------------  231 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH-HHHTTC-------------
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHhhcc-------------
Confidence            345688999999999988899999999999999999999999975321       11111 111000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++|||++++++
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                 0112233456889999999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=332.11  Aligned_cols=206  Identities=21%  Similarity=0.362  Sum_probs=157.4

Q ss_pred             hhhhhcCCCCcccccCCceEEEEEEc--CCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC-CCCce
Q 038580           66 ICDILDAPGEVIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG-PRGEK  142 (356)
Q Consensus        66 ~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  142 (356)
                      +.+.+...+++||+|+||.||+|.++  .++..+|+|.++..  .....+.+|+.+++.++||||+++++++.. .....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34444445788999999999999976  46788999988643  234578899999999999999999999853 34578


Q ss_pred             EEEEecccCCChhHhhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE----cCCCCe
Q 038580          143 LIVHPFYKRGNLAQCIRG-------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL----DRNYQP  211 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~  211 (356)
                      ++||||+.+ +|.+++..       .....+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999975 88887742       122358999999999999999999999   999999999999999    778899


Q ss_pred             EEeccccccccCCCCC--cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          212 YVSDFGLHLLLNPTAG--QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       212 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      ||+|||++........  .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999987643211  223456789999999998874 58999999999999999999999997654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-43  Score=314.66  Aligned_cols=241  Identities=20%  Similarity=0.320  Sum_probs=197.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....++..+|+|++....   ......+.+|+++++.++||||+++++++.+ .+..+++|||++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   97 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLEFAP   97 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEEEEeCC
Confidence            478999999999999999999999999986432   2233578999999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......   ..
T Consensus        98 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~  169 (284)
T 2vgo_A           98 RGELYKELQK--HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RR  169 (284)
T ss_dssp             TEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CB
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc---cc
Confidence            9999999974  2468899999999999999999999   99999999999999999999999999998664322   22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....+++.|+|||++.+..++.++|+||||+++|||++|..||.....       .. .........             
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~-~~~~~~~~~-------------  228 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TE-THRRIVNVD-------------  228 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHTTC-------------
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hH-HHHHHhccc-------------
Confidence            345688999999999988999999999999999999999999975321       11 111111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+..+.+++..||+.||++||+++++++
T Consensus       229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 0112234456889999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.4e-44  Score=321.55  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=199.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. .+..+++|||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~  105 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGG  105 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCTTE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEEeCCCC
Confidence            4789999999999999998999999999875443 334689999999999999999999999885 44899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|.+++..   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....... .....
T Consensus       106 ~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  178 (303)
T 3a7i_A          106 SALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT  178 (303)
T ss_dssp             EHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCC
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCc
Confidence            99999963   468999999999999999999999   999999999999999999999999999987654322 22234


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+++.|+|||++.+..++.++||||||+++|||++|..||.....       .. .........     .         
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~~~-----~---------  236 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MK-VLFLIPKNN-----P---------  236 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH-HHHHHHHSC-----C---------
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HH-HHHHhhcCC-----C---------
Confidence            5688899999999988999999999999999999999999975321       11 111111100     0         


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       237 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               01112234568899999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.6e-44  Score=324.31  Aligned_cols=243  Identities=21%  Similarity=0.303  Sum_probs=198.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||++.+..+++.+|+|++......   ..+.+.+|+.+++.++||||+++++++.+ .+..+++|||+.
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~  124 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEecCC
Confidence            47899999999999999999999999998654322   23568899999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus       125 ~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~  198 (335)
T 2owb_A          125 RRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERK  198 (335)
T ss_dssp             TCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred             CCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccc
Confidence            9999999864  3468999999999999999999999   999999999999999999999999999987654322 223


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....++..|+|||++.+..++.++||||||+++|||++|..||.....       ..... ......             
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~-~~~~~~-------------  257 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYL-RIKKNE-------------  257 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH-HHHHTC-------------
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHH-HHhcCC-------------
Confidence            345688999999999988899999999999999999999999975321       11111 111100             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ...+...+..+.+++.+||+.||++|||++++++
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0112223456789999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.3e-44  Score=317.71  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeC-CCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAG-PRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|....+++.+|+|.+......  ..+.+.+|+.+++.++||||+++++++.. ..+..+++|||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            47899999999999999989999999998754322  23578999999999999999999998753 3457899999999


Q ss_pred             CCChhHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          151 RGNLAQCIRGG--SGEAHKWSIIYRISIGIAGGLDYLHTGFHRP-----IIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       151 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +++|.+++...  ....+++..++.++.|++.||+|||+   .+     ++||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~  167 (279)
T 2w5a_A           91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  167 (279)
T ss_dssp             TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred             CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence            99999999642  24458999999999999999999999   88     9999999999999999999999999987654


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++|..||...+.        ............     
T Consensus       168 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~~~-----  233 (279)
T 2w5a_A          168 HDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKF-----  233 (279)
T ss_dssp             --C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC-----
T ss_pred             ccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhccc-----
Confidence            321 112344678999999999988899999999999999999999999975421        111111111110     


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                                  ...+...+..+.+++.+||+.||++|||+.++++.+.
T Consensus       234 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                        0112234567889999999999999999999997653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-43  Score=328.55  Aligned_cols=268  Identities=18%  Similarity=0.224  Sum_probs=200.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC--------CCccccccceeeC---CCCc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR--------HPNLVPLLGFYAG---PRGE  141 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~---~~~~  141 (356)
                      ..+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+.+|+.+++.++        ||||+++++++..   ....
T Consensus        41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~  119 (397)
T 1wak_A           41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH  119 (397)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred             EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence            347899999999999999999999999998743 223457889999999885        7889999998762   3347


Q ss_pred             eEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCC-----------
Q 038580          142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNY-----------  209 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~-----------  209 (356)
                      .++||||+ +++|.+.+.......+++..+..++.|++.||+|||+   . +++||||||+|||++.++           
T Consensus       120 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             EEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            89999999 5577777755455679999999999999999999999   8 999999999999999775           


Q ss_pred             --------------------------------------CeEEeccccccccCCCCCcceecccCCCcccCccccccCCCC
Q 038580          210 --------------------------------------QPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS  251 (356)
Q Consensus       210 --------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  251 (356)
                                                            .+||+|||++......    .....+|+.|+|||++.+..++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCC
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCC
Confidence                                                  7999999998765432    2345789999999999999999


Q ss_pred             CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH--HHHhhh--------hcc-cccccCcccccccCCC-------
Q 038580          252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF--MRNAVL--------DHR-ITDLYHPDMLLCSNSN-------  313 (356)
Q Consensus       252 ~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~--------~~~-~~~~~~~~~~~~~~~~-------  313 (356)
                      .++|||||||++|||+||..||...+...........  +.....        ... ....+...........       
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            9999999999999999999999865443321111000  000000        000 0000000000000000       


Q ss_pred             ----CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 ----HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          .....+.+.+..+.+|+.+||+.||++|||++++++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                011346778889999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=313.82  Aligned_cols=249  Identities=19%  Similarity=0.309  Sum_probs=197.2

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccc----ccchHHHHHHHHHHhccCCCccccccceeeC-CCCceEEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC----TTRDKEFGDLIELLGCIRHPNLVPLLGFYAG-PRGEKLIVH  146 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~  146 (356)
                      ...+.||+|+||.||++.+..++..+|+|+++...    ......+.+|+++++.++||||+++++++.. ..+..+++|
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            34588999999999999999899999999987542    2234678999999999999999999998753 345789999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.++ |.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        88 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999886 7777765556679999999999999999999999   999999999999999999999999999987654322


Q ss_pred             -CcceecccCCCcccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          227 -GQEMLEASASQGYKAPELIKMKD--ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       227 -~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                       ........++..|+|||++.+..  ++.++||||||+++|||++|..||.+.+       ... .........      
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~-~~~~i~~~~------  229 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYK-LFENIGKGS------  229 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHH-HHHHHHHCC------
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHH-HHHHHhcCC------
Confidence             22234556889999999987644  3779999999999999999999997532       111 111111110      


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                                  ...+.+++..+.+++.+||+.||++|||+.++++.
T Consensus       230 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                        01122344568899999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-44  Score=333.06  Aligned_cols=264  Identities=18%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC--------------
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP--------------  138 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------------  138 (356)
                      ..+.||+|+||.||+|.+..+++.+|+|.+....    ....+|+++++.++||||+++++++...              
T Consensus        11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A           11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            3478999999999999999999999999886432    2334799999999999999999987432              


Q ss_pred             -----------------------CCceEEEEecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 038580          139 -----------------------RGEKLIVHPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI  193 (356)
Q Consensus       139 -----------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i  193 (356)
                                             ....++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||+   .++
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi  162 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGI  162 (383)
T ss_dssp             -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTE
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CcC
Confidence                                   2247899999985 88777753  235679999999999999999999999   999


Q ss_pred             eecCCCCCCeeEc-CCCCeEEeccccccccCCCCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCC
Q 038580          194 IHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKE  271 (356)
Q Consensus       194 vH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~  271 (356)
                      +||||||+||+++ .++.+||+|||++.......  ......+|+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            9999999999998 68899999999998654322  23355678899999998764 58999999999999999999999


Q ss_pred             CCCCCCCCCCCCchhHHHHHh----hh--hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038580          272 PINENPTPDEDFHLPTFMRNA----VL--DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK  345 (356)
Q Consensus       272 p~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  345 (356)
                      ||.+.+..+....+.......    ..  ........-+...   ........+...+..+.+|+.+||+.||++|||+.
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK---AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC---CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccC---cccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            998643211110000000000    00  0000000000000   00000012223456788999999999999999999


Q ss_pred             HHHH
Q 038580          346 QVLW  349 (356)
Q Consensus       346 ~il~  349 (356)
                      ++++
T Consensus       318 e~l~  321 (383)
T 3eb0_A          318 EAMA  321 (383)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9984

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.7e-44  Score=335.37  Aligned_cols=194  Identities=25%  Similarity=0.341  Sum_probs=168.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc------CCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI------RHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++.. ....+.+.+|+.+++.+      +|+||+++++++.. .+..+++||
T Consensus       102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e  179 (429)
T 3kvw_A          102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNHICMTFE  179 (429)
T ss_dssp             EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTEEEEEEC
T ss_pred             EEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCeEEEEEe
Confidence            47899999999999999999999999998753 22235677888888776      57799999998885 458999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC--eEEeccccccccCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ--PYVSDFGLHLLLNPT  225 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~  225 (356)
                      |+. ++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.  +||+|||++..... 
T Consensus       180 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-  254 (429)
T 3kvw_A          180 LLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-  254 (429)
T ss_dssp             CCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-
T ss_pred             ccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecCC-
Confidence            996 599999986666679999999999999999999999   99999999999999999887  99999999876432 


Q ss_pred             CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                         ......+|+.|+|||++.+..++.++|||||||++|||+||..||.+.+
T Consensus       255 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          255 ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence               2234578999999999999999999999999999999999999997643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=328.20  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-----hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-----DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++......     .+.+.+|+.+++.++||||+++++++.. .+..++||||
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   93 (346)
T 1ua2_A           15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF   93 (346)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CCceEEEEEc
Confidence            478999999999999999889999999987532221     2468899999999999999999999875 4589999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +.+ +|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....... .
T Consensus        94 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~  167 (346)
T 1ua2_A           94 MET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-R  167 (346)
T ss_dssp             CSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-C
T ss_pred             CCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-c
Confidence            986 898888643 3457888899999999999999999   999999999999999999999999999997754322 2


Q ss_pred             ceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc---cccccc-C
Q 038580          229 EMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH---RITDLY-H  303 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~  303 (356)
                      ......+|+.|+|||++.+. .++.++||||||+++|||++|..||.+.....   .+.. +.......   .+.... .
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~-i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTR-IFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCCTTTSSSTTSS
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHH-HHHHcCCCChhhhhhhccC
Confidence            23345789999999998654 58899999999999999999999987643111   0111 11100000   000000 0


Q ss_pred             cccccccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDMLLCSNSNHENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ++.... ......+   .....+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          244 PDYVTF-KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTCCCC-CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccc-cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000 0000000   01233567889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-43  Score=318.39  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=193.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+|+|++........+.+.+|+++++.++||||+++++++.. .+..+++|||+++++
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~  102 (302)
T 2j7t_A           24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIEFCPGGA  102 (302)
T ss_dssp             EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEECCTTEE
T ss_pred             cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEEeCCCCc
Confidence            3779999999999999998899999999887665666789999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...... .......
T Consensus       103 l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  177 (302)
T 2j7t_A          103 VDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSF  177 (302)
T ss_dssp             HHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC----
T ss_pred             HHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccccc
Confidence            99988642 3468999999999999999999999   99999999999999999999999999987532111 1112244


Q ss_pred             cCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          234 SASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       234 ~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .++..|+|||++.     ...++.++||||||+++|||++|..||...+.       ...... ......          
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~----------  239 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK-IAKSDP----------  239 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHH-HHHSCC----------
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHH-HhccCC----------
Confidence            6788999999983     56789999999999999999999999975321       111111 110000          


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           .....+...+..+.+++.+||+.||++|||+.++++
T Consensus       240 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 -----PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 001123334567889999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-44  Score=322.52  Aligned_cols=247  Identities=22%  Similarity=0.322  Sum_probs=193.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--------cchHHHHHHHHHHhccCCCccccccceeeCCCCceEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--------TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..+.||+|+||.||+|.+..++..+|+|++.....        .....+.+|+++++.++||||+++++++...  ..++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~l   91 (322)
T 2ycf_A           14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE--DYYI   91 (322)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--SEEE
T ss_pred             EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--ceEE
Confidence            34789999999999999999999999999865321        1123588999999999999999999998743  4899


Q ss_pred             EEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC---eEEeccccccc
Q 038580          145 VHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ---PYVSDFGLHLL  221 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~  221 (356)
                      ||||+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++..
T Consensus        92 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           92 VLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            9999999999999863  4578999999999999999999999   99999999999999987654   99999999877


Q ss_pred             cCCCCCcceecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      ....  .......+++.|+|||++.   ...++.++||||||+++|||++|..||.......   .+......    ...
T Consensus       167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~----~~~  237 (322)
T 2ycf_A          167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQITS----GKY  237 (322)
T ss_dssp             CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHHH----TCC
T ss_pred             cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHHh----Ccc
Confidence            5432  2223456889999999974   4678999999999999999999999997643321   11111111    000


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .  ..+.            ...+.+..+.+++.+||+.||++||++.++++
T Consensus       238 ~--~~~~------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 N--FIPE------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             C--CCHH------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c--cCch------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0  0000            01123457889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-43  Score=320.54  Aligned_cols=261  Identities=18%  Similarity=0.245  Sum_probs=196.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCC-CCceEEEEeccc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGP-RGEKLIVHPFYK  150 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e~~~  150 (356)
                      ..+.||+|+||.||+|.+..+++.+|+|+++.   ...+.+.+|+.+++.++ ||||+++++++..+ ....+++|||+.
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~  116 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  116 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence            34789999999999999998999999999874   34567999999999997 99999999998864 347899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      +++|.+++.     .++...+..++.|++.||+|||+   .+++||||||+|||++.++ .+||+|||++.......  .
T Consensus       117 ~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~  186 (330)
T 3nsz_A          117 NTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--E  186 (330)
T ss_dssp             CCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--C
T ss_pred             chhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--c
Confidence            999999985     38888999999999999999999   9999999999999999776 89999999997654322  2


Q ss_pred             eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc-------cccc
Q 038580          230 MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR-------ITDL  301 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  301 (356)
                      .....++..|+|||++.+ ..++.++||||||+++|||++|..||........  .+.... .......       ....
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~-~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIA-KVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHH-HHHCHHHHHHHHHHTTCC
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHH-HhcCCchhhhHHHHhccc
Confidence            334568889999999876 6789999999999999999999999954321110  000000 0000000       0000


Q ss_pred             cCccc--------ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDM--------LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .++..        ...+........+...+..+.+++.+||+.||++|||++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000        0000000011112234567889999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-43  Score=326.75  Aligned_cols=265  Identities=22%  Similarity=0.249  Sum_probs=188.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|++......  ..+.+.+|+.+++.++||||+++++++....     ...++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            47899999999999999999999999998653222  2356889999999999999999999987543     2689999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.+ +|.+.+.    ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...... 
T Consensus       110 e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-  180 (371)
T 2xrw_A          110 ELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  180 (371)
T ss_dssp             ECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             EcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccccc-
Confidence            99975 7888886    348899999999999999999999   99999999999999999999999999998765322 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CchhHHHHH------h
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDED--------FHLPTFMRN------A  292 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~--------~~~~~~~~~------~  292 (356)
                       .......+|+.|+|||++.+..++.++|||||||++|||++|..||.+.+.....        ...+.....      .
T Consensus       181 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          181 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             -cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence             1223457889999999999989999999999999999999999999764321100        000000000      0


Q ss_pred             hhhcccccccCccccc-cc--CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          293 VLDHRITDLYHPDMLL-CS--NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       293 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..... .......... ..  ............+..+.+|+.+||+.||++|||++++++
T Consensus       260 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          260 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHSS-CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhC-ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00000 0000000000 00  000001112344678999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=317.99  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=191.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCC-----CCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGP-----RGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+..++..+|+|++.... .....+.+|+.+++++ +||||+++++++...     .+..+++||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e  107 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME  107 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence            478999999999999999899999999986432 3446899999999998 799999999998743     357899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+.+++|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....... 
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  183 (326)
T 2x7f_A          108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-  183 (326)
T ss_dssp             CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred             cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-
Confidence            9999999999976555678999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cceecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          228 QEMLEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      .......+++.|+|||++.     ...++.++||||||+++|||++|..||.+...       ..... ......     
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~-~~~~~~-----  250 (326)
T 2x7f_A          184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF-LIPRNP-----  250 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH-HHHHSC-----
T ss_pred             cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHH-HhhcCc-----
Confidence            1223456889999999987     45689999999999999999999999965321       11111 111100     


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .+..           .+...+..+.+++.+||+.||++||++.++++
T Consensus       251 ~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          251 APRL-----------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCC-----------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccC-----------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000           11123456889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-44  Score=322.08  Aligned_cols=256  Identities=21%  Similarity=0.312  Sum_probs=178.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+..... ...+++.+|+.+++.++||||+++++++... +..+++|||++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~   98 (303)
T 2vwi_A           20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGG   98 (303)
T ss_dssp             EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-SCEEEEEECCTTC
T ss_pred             hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-CCcEEEehhccCC
Confidence            4789999999999999988889999998865432 2345788999999999999999999998854 4899999999999


Q ss_pred             ChhHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          153 NLAQCIRG------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       153 sL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      +|.+++..      .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  175 (303)
T 2vwi_A           99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG  175 (303)
T ss_dssp             BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred             chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence            99999863      134568999999999999999999999   999999999999999999999999999987653321


Q ss_pred             C----cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          227 G----QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       227 ~----~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .    .......+++.|+|||++.+ ..++.++||||||+++|||++|..||...+...       ........ .....
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~-~~~~~  247 (303)
T 2vwi_A          176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQN-DPPSL  247 (303)
T ss_dssp             ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTS-SCCCT
T ss_pred             CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhcc-CCCcc
Confidence            1    11234468899999999875 568999999999999999999999997643211       11111100 00000


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..        ...........+..+.+++.+||+.||++|||+.++++
T Consensus       248 ~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          248 ET--------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TC-------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cc--------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00        00000111223456889999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.2e-44  Score=343.73  Aligned_cols=246  Identities=23%  Similarity=0.315  Sum_probs=194.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc-------------cchHHHHHHHHHHhccCCCccccccceeeCCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-------------TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR  139 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (356)
                      ..+.||+|+||+||+|.+..++..+|+|+++....             ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus        40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  118 (504)
T 3q5i_A           40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-K  118 (504)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred             EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-C
Confidence            35789999999999999999999999999875432             223578999999999999999999999985 4


Q ss_pred             CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC---CeEEecc
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY---QPYVSDF  216 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df  216 (356)
                      +..++||||+++|+|.+.+..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++   .+||+||
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             CEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            589999999999999998863  3468999999999999999999999   9999999999999998776   6999999


Q ss_pred             ccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          217 GLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       217 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      |++......  .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.        ......+...
T Consensus       194 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~  262 (504)
T 3q5i_A          194 GLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QDIIKKVEKG  262 (504)
T ss_dssp             TTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             CCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence            999876432  2234557899999999987 5689999999999999999999999976432        1111111111


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..    ....          +.....+..+.+++..||+.||++|||++++++
T Consensus       263 ~~----~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 KY----YFDF----------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CC----CCCH----------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC----CCCc----------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00    0000          001123466889999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.2e-44  Score=328.88  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=196.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------hHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      ..+.||+|+||.||+|.+..+|..+|+|+++......        .+.+.+|+.+++.+ +||||+++++++.. .+..+
T Consensus        98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~  176 (365)
T 2y7j_A           98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-SSFMF  176 (365)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-SSEEE
T ss_pred             cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-CCEEE
Confidence            3478999999999999998889999999987543211        24578899999999 79999999999885 45899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus       177 lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          177 LVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            99999999999999973  3468999999999999999999999   999999999999999999999999999987764


Q ss_pred             CCCCcceecccCCCcccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKM------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ..  .......||+.|+|||++.+      ..++.++||||||+++|||++|..||.....       .. .........
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~~  321 (365)
T 2y7j_A          252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------IL-MLRMIMEGQ  321 (365)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC
T ss_pred             CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHhCC
Confidence            32  22345678999999999863      3578999999999999999999999975321       11 111111100


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .    ....          +.....+..+.+++.+||+.||++|||+.++++
T Consensus       322 ~----~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          322 Y----QFSS----------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             C----CCCH----------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C----CCCC----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0    0000          000123456889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.5e-43  Score=321.01  Aligned_cols=261  Identities=13%  Similarity=0.198  Sum_probs=198.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch-----------------HHHHHHHHHHhccCCCccccccceee
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-----------------KEFGDLIELLGCIRHPNLVPLLGFYA  136 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~~~~  136 (356)
                      .+.||+|+||.||+|.+  ++..+|+|.+........                 +.+.+|+.+++.++||||+++++++.
T Consensus        36 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            47899999999999998  788999999865432211                 78999999999999999999999998


Q ss_pred             CCCCceEEEEecccCCChhHh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC
Q 038580          137 GPRGEKLIVHPFYKRGNLAQC------IRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ  210 (356)
Q Consensus       137 ~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~  210 (356)
                      .. +..++||||+++++|.++      +.......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.
T Consensus       114 ~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~~~  190 (348)
T 2pml_X          114 NY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGR  190 (348)
T ss_dssp             SS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTTSC
T ss_pred             eC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCCCc
Confidence            64 589999999999999999      6544467899999999999999999999963  78999999999999999999


Q ss_pred             eEEeccccccccCCCCCcceecccCCCcccCccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH
Q 038580          211 PYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK-DASE-ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF  288 (356)
Q Consensus       211 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  288 (356)
                      +||+|||++......   ......++..|+|||++.+. .++. ++||||||+++|||++|..||......      .. 
T Consensus       191 ~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-  260 (348)
T 2pml_X          191 VKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------VE-  260 (348)
T ss_dssp             EEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------HH-
T ss_pred             EEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------HH-
Confidence            999999998765432   33456788999999999877 5666 999999999999999999999764321      11 


Q ss_pred             HHHhhhhcccccccCcc-cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          289 MRNAVLDHRITDLYHPD-MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       289 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ................. .................+..+.+++.+||+.||++|||+.++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111100000000 00000000000111334567889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-43  Score=320.99  Aligned_cols=248  Identities=22%  Similarity=0.282  Sum_probs=171.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~~  150 (356)
                      ++.||+|+||.||+|.+..+++.+|+|++...    .....+....++.++||||+++++++..   .+...++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            46799999999999999999999999998642    2222333344667799999999998864   2335899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|+|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||+++.   ++.+||+|||++......  
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--  184 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--  184 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence            9999999986656679999999999999999999999   99999999999999976   455999999998765422  


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       ......+++.|+|||++.+..++.++||||||+++|||++|..||...................    .   .      
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~---~------  250 (336)
T 3fhr_A          185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG----Q---Y------  250 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------------
T ss_pred             -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc----c---c------
Confidence             2234567899999999988889999999999999999999999997654322111111000000    0   0      


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           ....+.....+..+.+++.+||+.||++|||++++++
T Consensus       251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0000111234567889999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-43  Score=316.05  Aligned_cols=240  Identities=16%  Similarity=0.284  Sum_probs=191.9

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ..+.||+|+||.||+|.+..++..+|+|.++.....  ....+.+|+..+..+ +||||+++++++.+ ++..+++|||+
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~   93 (289)
T 1x8b_A           15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYC   93 (289)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEEec
Confidence            347899999999999999989999999998754332  335788899999988 89999999999885 44899999999


Q ss_pred             cCCChhHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-------------------C
Q 038580          150 KRGNLAQCIRGGS--GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-------------------N  208 (356)
Q Consensus       150 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------------------~  208 (356)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.                   .
T Consensus        94 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             TTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------C
T ss_pred             CCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            9999999996422  2568999999999999999999999   99999999999999984                   4


Q ss_pred             CCeEEeccccccccCCCCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH
Q 038580          209 YQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  287 (356)
                      ..+||+|||.+.......     ...+++.|+|||++.+. .++.++||||||+++|||++|..|+....       .  
T Consensus       171 ~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~--  236 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-------Q--  236 (289)
T ss_dssp             CCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-------H--
T ss_pred             eEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-------H--
Confidence            479999999987754322     23588999999999765 56689999999999999999988764311       0  


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       . ........                 ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       237 -~-~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -W-HEIRQGRL-----------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -H-HHHHTTCC-----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -H-HHHHcCCC-----------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             0 11111100                 0112234467889999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-44  Score=321.29  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=190.7

Q ss_pred             CCcccccCCceEEEEEEcC-CC--eEEEEEEeccccc---cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQR-SG--SVRLLRFLRPVCT---TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-~~--~~~a~k~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|.+.. ++  ..+|+|+++....   ...+.+.+|+++++.++||||+++++++..+  ..++++|
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e  100 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PMKMVTE  100 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEE
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--CceeeEe
Confidence            4789999999999998743 23  3688998875422   2335789999999999999999999988753  4889999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  176 (291)
T 1u46_A          101 LAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  176 (291)
T ss_dssp             CCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             cccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence            99999999999642 2458899999999999999999999   9999999999999999999999999999877644322


Q ss_pred             cc--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          228 QE--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       228 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      ..  .....++..|+|||++.+..++.++||||||+++|||++ |..||...+.       ..... ......       
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~-~~~~~~-------  241 (291)
T 1u46_A          177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILH-KIDKEG-------  241 (291)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH-HHHTSC-------
T ss_pred             chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHH-HHHccC-------
Confidence            21  223456778999999988888999999999999999999 9999975421       11111 111000       


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                               ...+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       242 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          242 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                     011122344567889999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-43  Score=310.24  Aligned_cols=243  Identities=23%  Similarity=0.334  Sum_probs=189.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++.. .+..+++|||++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~   94 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFMVMEYVS   94 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCC
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEEEEeccC
Confidence            478999999999999999889999999986432   2233578899999999999999999999885 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.+++..  ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......  ...
T Consensus        95 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~  167 (276)
T 2h6d_A           95 GGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFL  167 (276)
T ss_dssp             SCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred             CCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC--cce
Confidence            9999999964  2458899999999999999999999   99999999999999999999999999998765432  222


Q ss_pred             ecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+++.|+|||.+.+..+ +.++|+||||+++|||++|..||.....       .. .........            
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~------------  227 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PT-LFKKIRGGV------------  227 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCC------------
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HH-HHHHhhcCc------------
Confidence            34567889999999987765 6899999999999999999999975321       11 111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                            ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  00122234568899999999999999999999873

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=321.24  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=195.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+...  ...+.+.+|+.+++.++||||+++++++.. .+..+++|||+.+++
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~  110 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVMEYCGAGS  110 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEE
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEeecCCCCC
Confidence            47899999999999999988999999998753  345679999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.. ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....... ......
T Consensus       111 L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~  185 (314)
T 3com_A          111 VSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTV  185 (314)
T ss_dssp             HHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCC
T ss_pred             HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCcc
Confidence            9999863 23568999999999999999999999   999999999999999999999999999987654322 223345


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .++..|+|||.+.+..++.++||||||+++|||++|..||.....       ..... ......               .
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~-~~~~~~---------------~  242 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAIF-MIPTNP---------------P  242 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH-HHHHSC---------------C
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHH-HHhcCC---------------C
Confidence            688899999999988999999999999999999999999975321       01010 000000               0


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+...+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            011122334567889999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.1e-43  Score=346.59  Aligned_cols=243  Identities=19%  Similarity=0.249  Sum_probs=198.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccc---cccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPV---CTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++..   .....+.+..|..++..+ +||||+.+++++.+ .+..++||||+
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~E~~  424 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYV  424 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEEEEECC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEEEEeCc
Confidence            46899999999999999999999999998753   223345688899999887 69999999998885 44899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|..++..  ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus       425 ~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~  498 (674)
T 3pfq_A          425 NGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVT  498 (674)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCC
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC-Ccc
Confidence            99999999974  2468999999999999999999999   99999999999999999999999999999764322 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..|+.++|+||||+++|||++|..||.+.+.        ..+...+...             
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~-------------  557 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-------------  557 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-------------
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-------------
Confidence            4466899999999999999999999999999999999999999976421        1111111111             


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI-----KQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~il~  349 (356)
                           ...++...+.++.+|+..||+.||++||++     ++|++
T Consensus       558 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 011233445678899999999999999997     66653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-43  Score=313.06  Aligned_cols=246  Identities=22%  Similarity=0.335  Sum_probs=180.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch--HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.++.......  +.+.++...++.++||||+++++++.. ++..++||||+++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~~   90 (290)
T 3fme_A           12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWICMELMDT   90 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEEEECCSE
T ss_pred             HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEEEehhcc
Confidence            4789999999999999999999999999875432222  234455556888999999999999985 4589999999985


Q ss_pred             CChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                       +|.+++..  .....+++..+..++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++.......  
T Consensus        91 -~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  164 (290)
T 3fme_A           91 -SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--  164 (290)
T ss_dssp             -EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             -chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc--
Confidence             88887753  234679999999999999999999999   8 99999999999999999999999999987654322  


Q ss_pred             ceecccCCCcccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          229 EMLEASASQGYKAPELI----KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~----~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                      ......+++.|+|||++    .+..++.++||||||+++|||++|..||.....      .............      +
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------~  232 (290)
T 3fme_A          165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPS------P  232 (290)
T ss_dssp             -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCC------C
T ss_pred             cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCC------C
Confidence            22334688999999996    456789999999999999999999999964221      1111111111100      0


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                 .......+..+.+++.+||+.||++|||+.++++
T Consensus       233 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 -----------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                       0011223456889999999999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-43  Score=320.12  Aligned_cols=266  Identities=20%  Similarity=0.251  Sum_probs=197.0

Q ss_pred             CCcccccCCceEEEEEEc-CCCeEEEEEEecccccc--chHHHHHHHHHHhcc---CCCccccccceeeC----CCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQ-RSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCI---RHPNLVPLLGFYAG----PRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~~~~~  143 (356)
                      .+.||+|+||.||+|.+. .+++.+|+|.++.....  ....+.+|+.+++.+   +||||+++++++..    .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            478999999999999995 67889999988654322  234677888877766   89999999998861    344789


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      ++|||+. |+|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        96 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  171 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  171 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             EEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence            9999998 599999976555669999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhh---hccccc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVL---DHRITD  300 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  300 (356)
                      .  ........++..|+|||++.+..++.++||||||+++|||++|..||.+.....    ....+.....   ...+..
T Consensus       172 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          172 F--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             G--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCGGGSCT
T ss_pred             C--CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHcCCCCcccCcc
Confidence            2  122334567899999999998899999999999999999999999997643211    0011110000   000000


Q ss_pred             -ccCcccccccC-CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 -LYHPDMLLCSN-SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 -~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ...+....... ...........+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             00000000000 00001112234567889999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-43  Score=325.82  Aligned_cols=261  Identities=20%  Similarity=0.243  Sum_probs=178.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCC-----CCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+......  ..+.+.+|+.+++.++||||+++++++...     ....++++
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            47899999999999999999999999998654322  235788999999999999999999988743     24679999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      |++ +++|.++++.   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....  
T Consensus       114 e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--  184 (367)
T 2fst_X          114 HLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--  184 (367)
T ss_dssp             ECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             ccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccccc--
Confidence            999 6799998863   468999999999999999999999   9999999999999999999999999999876432  


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLY  302 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  302 (356)
                        ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+...    ....+......   ..+....
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCHHHHTTCC
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHHhh
Confidence              2234578999999999876 678999999999999999999999997643211    00111000000   0000000


Q ss_pred             Cccccc---ccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLL---CSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~---~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ......   .........+   ....+..+.+|+.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            000000   0000000000   0122456889999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=316.15  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=190.9

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ...+.||+|+||.||+|.+...   +++|+++....  ...+.+.+|+.+++.++||||+++++++..+ +..+++|||+
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~iv~e~~  111 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLC  111 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-SCEEEECBCC
T ss_pred             EEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CceEEEeecc
Confidence            3458899999999999998642   77787764322  2235688899999999999999999999854 4799999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC----
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT----  225 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~----  225 (356)
                      ++++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++ ++.+||+|||++......    
T Consensus       112 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          112 KGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             cCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            999999999743 3468899999999999999999999   9999999999999998 679999999997654321    


Q ss_pred             CCcceecccCCCcccCcccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          226 AGQEMLEASASQGYKAPELIKM---------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      .........++..|+|||++..         ..++.++||||||+++|||++|..||...+.       ..... .....
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~-~~~~~  258 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIW-QMGTG  258 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHH-HHHTT
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HhccC
Confidence            1112234457889999999864         3578899999999999999999999975321       11111 11110


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                           ..+..           .....+..+.+++..||+.||++|||+.++++.|+++.
T Consensus       259 -----~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          259 -----MKPNL-----------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             -----CCCCC-----------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             -----CCCCC-----------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                 00000           01122345789999999999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.7e-43  Score=319.76  Aligned_cols=265  Identities=19%  Similarity=0.246  Sum_probs=193.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCC----CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGP----RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~lv~e~  148 (356)
                      .+.||+|+||.||+|.+..++..+|+|.++..... ....+.+|+.+++.++||||+++++++...    ....+++|||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            47899999999999999989999999998653322 234688999999999999999999987643    2578999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +. ++|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        96 ~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  168 (353)
T 2b9h_A           96 MQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD  168 (353)
T ss_dssp             CS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             cC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence            97 599999874   468999999999999999999999   99999999999999999999999999999765432111


Q ss_pred             ---------ceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc-
Q 038580          229 ---------EMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR-  297 (356)
Q Consensus       229 ---------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  297 (356)
                               ......||+.|+|||++.+ ..++.++||||||+++|||++|..||.+.+...    ....+........ 
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QLLLIFGIIGTPHS  244 (353)
T ss_dssp             -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCS
T ss_pred             ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCch
Confidence                     1123467899999998764 678999999999999999999999997643110    0000000000000 


Q ss_pred             ---cccccCcccccc---cCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ---ITDLYHPDMLLC---SNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ---~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ......+.....   .......   ......+..+.+++.+||+.||++|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000000000000   0000000   001134567889999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-42  Score=321.52  Aligned_cols=267  Identities=17%  Similarity=0.229  Sum_probs=196.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-----------CCccccccceeeCCC---
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-----------HPNLVPLLGFYAGPR---  139 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~~---  139 (356)
                      .+.||+|+||.||+|.+..++..+|+|+++.. ......+.+|+.++++++           ||||+++++++....   
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  102 (373)
T 1q8y_A           24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG  102 (373)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred             EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence            47899999999999999999999999998742 223356888999988876           899999999887422   


Q ss_pred             CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEc------CCCCeE
Q 038580          140 GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLD------RNYQPY  212 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~------~~~~~k  212 (356)
                      ...+++|||+ +++|.+++.......+++..+..++.|++.||+|||+   . +++||||||+|||++      ..+.+|
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~~k  178 (373)
T 1q8y_A          103 VHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIK  178 (373)
T ss_dssp             EEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             ceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcceEE
Confidence            2689999999 8899999986556679999999999999999999999   8 999999999999994      445799


Q ss_pred             EeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH--HH
Q 038580          213 VSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF--MR  290 (356)
Q Consensus       213 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~  290 (356)
                      |+|||++......    .....+|+.|+|||++.+..++.++||||||+++|||+||..||...............  +.
T Consensus       179 l~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          179 IADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             ECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            9999998765432    23457889999999999999999999999999999999999999865432211110000  00


Q ss_pred             Hhhhh--------cc-cccccCcccccccC-----------CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          291 NAVLD--------HR-ITDLYHPDMLLCSN-----------SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       291 ~~~~~--------~~-~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....        .. ..............           .......+...+..+.+|+.+||+.||++|||++++++
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            00000        00 00000000000000           00012356778889999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-43  Score=332.11  Aligned_cols=263  Identities=19%  Similarity=0.245  Sum_probs=190.9

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-----CCceEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLIV  145 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv  145 (356)
                      +...+.||+|+||.||+|.+..+++.+|+|.+....    ....+|+++++.++||||++++++|...     ....++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            344588999999999999999889999999875432    2345799999999999999999987521     1236789


Q ss_pred             EecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-CCeEEecccccccc
Q 038580          146 HPFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLL  222 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~  222 (356)
                      |||+++ +|.+.+..  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999986 66666542  234679999999999999999999999   999999999999999965 56899999999865


Q ss_pred             CCCCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHh-------hh
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNA-------VL  294 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~  294 (356)
                      ...  .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+...   .+...+...       +.
T Consensus       208 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred             ccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence            432  223345789999999998764 78999999999999999999999998643211   111111100       00


Q ss_pred             --hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          295 --DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       295 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .....+...+....   ..-...++...+.++.+|+.+||+.||++||++.++++
T Consensus       283 ~~~~~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKA---HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCC---CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCC---CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              00000000010000   00000011233567889999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-42  Score=320.91  Aligned_cols=260  Identities=22%  Similarity=0.295  Sum_probs=190.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCC-----ceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-----EKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.++......  .+.+.+|+.+++.++||||+++++++.....     ..+++|
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            478999999999999999999999999987543322  3578899999999999999999999875442     239999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+. ++|.+.+.    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....  
T Consensus       127 e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--  196 (371)
T 4exu_A          127 PFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--  196 (371)
T ss_dssp             ECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred             cccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccccc--
Confidence            9998 58888874    348999999999999999999999   9999999999999999999999999999876432  


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLY  302 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  302 (356)
                        ......+|+.|+|||++.+ ..++.++||||||+++|||++|..||.+.+....   + ..+......   .......
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---L-TQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHHCCCCHHHHTTCS
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---H-HHHHHHhCCCcHHHHHHhh
Confidence              2234577899999999877 6789999999999999999999999976432110   0 000000000   0000000


Q ss_pred             Cccc---ccccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDM---LLCSNSNHENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~---~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....   ...........   .....+..+.+|+.+||+.||++|||++++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0000   00000000000   01123567889999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.5e-43  Score=314.83  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=196.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---------cchHHHHHHHHHHhccC-CCccccccceeeCCCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---------TRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  143 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++....         ...+.+.+|+++++++. ||||+++++++.. ++..+
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~  100 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFF  100 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc-CCeEE
Confidence            3789999999999999999999999999865431         11246788999999996 9999999999885 45899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +||||+++++|.+++..  ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus       101 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            99999999999999974  3468999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCCcccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          224 PTAGQEMLEASASQGYKAPELIK------MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ..  .......+++.|+|||++.      ...++.++||||||+++|||++|..||...+.       .. .........
T Consensus       176 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~  245 (298)
T 1phk_A          176 PG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------ML-MLRMIMSGN  245 (298)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC
T ss_pred             CC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HH-HHHHHhcCC
Confidence            32  2233456888999999985      45678999999999999999999999965321       11 111111111


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..              ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 YQ--------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC--------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cc--------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00              000112234567889999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-43  Score=329.73  Aligned_cols=266  Identities=20%  Similarity=0.264  Sum_probs=187.4

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEE
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIV  145 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv  145 (356)
                      +...+.||+|+||.||+|.+..++.++++|+.+..     ....+|+++++.++||||+++++++....     ...++|
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34458899999999999999877776666655422     22346899999999999999999885322     137899


Q ss_pred             EecccCCChhHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEeccccccccC
Q 038580          146 HPFYKRGNLAQCIR-GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       146 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~  223 (356)
                      |||++++.+..... ......+++..+..++.|++.||+|||+   .+++||||||+|||++ .++.+||+|||+++...
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99998744333321 1234578999999999999999999999   9999999999999999 79999999999997754


Q ss_pred             CCCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH----hhh--hc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN----AVL--DH  296 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~--~~  296 (356)
                      ..  .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+......    .+.  ..
T Consensus       194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          194 AG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             TT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             CC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            32  223355778999999998754 5899999999999999999999999864321111001000000    000  00


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .......+...   .......++...+.++.+|+.+||+.||++|||+.++++
T Consensus       272 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          272 NYMEHKFPQIR---PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             GGSSSCCCCCC---CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccc---CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00000000000   000000011224567889999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-42  Score=315.10  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=174.3

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHH-HHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIE-LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ...+.||+|+||.||+|.+..+++.+|+|.++..... ....+..|+. +++.++||||+++++++..+ +..+++|||+
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv~e~~  103 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWICMELM  103 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEEECCC
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEEEeec
Confidence            3458899999999999999989999999998754322 2234555555 77888999999999998854 5899999999


Q ss_pred             cCCChhHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          150 KRGNLAQCIRG---GSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       150 ~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      .+ +|.+++..   .....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++......
T Consensus       104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            86 88877752   235678999999999999999999999   8 9999999999999999999999999998765432


Q ss_pred             CCcceecccCCCcccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          226 AGQEMLEASASQGYKAPELI----KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .  ......+++.|+|||++    .+..++.++||||||+++|||++|..||.+........           .... ..
T Consensus       180 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----------~~~~-~~  245 (327)
T 3aln_A          180 I--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-----------TQVV-KG  245 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC-CS
T ss_pred             c--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-----------HHHh-cC
Confidence            1  22234688899999998    45678999999999999999999999997532211000           0000 00


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..+..        ........+..+.+++..||+.||++|||+.++++
T Consensus       246 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQL--------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCC--------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCC--------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000        00011223457889999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.5e-43  Score=317.24  Aligned_cols=263  Identities=19%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             CCcccccCCceEEEEEE-cCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc------cccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALL-QRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN------LVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+ ..++..+|+|+++... ...+.+.+|+++++.++|+|      ++++++++.. .+..++||
T Consensus        19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~~~~lv~   96 (339)
T 1z57_A           19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HGHICIVF   96 (339)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CCcEEEEE
Confidence            47899999999999998 5678999999987432 23457889999999887664      8999998885 44899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-------------------
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-------------------  207 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------------------  207 (356)
                      ||+ +++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.                   
T Consensus        97 e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           97 ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             cCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999 7899999986655678999999999999999999999   99999999999999987                   


Q ss_pred             CCCeEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  287 (356)
                      ++.+||+|||++......    .....+|+.|+|||++.+..++.++||||||+++|||++|..||...+....    ..
T Consensus       173 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~  244 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH----LA  244 (339)
T ss_dssp             CCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH----HH
T ss_pred             CCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH----HH
Confidence            678999999998764322    2345788999999999988999999999999999999999999976432110    00


Q ss_pred             HHHHhhh---hccc-----ccccC-ccc-------------ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 038580          288 FMRNAVL---DHRI-----TDLYH-PDM-------------LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK  345 (356)
Q Consensus       288 ~~~~~~~---~~~~-----~~~~~-~~~-------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~  345 (356)
                      .+.....   ....     ..... ...             ..+.........+...+..+.+++.+||+.||++|||++
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            0100000   0000     00000 000             000000001112345678899999999999999999999


Q ss_pred             HHHHH
Q 038580          346 QVLWK  350 (356)
Q Consensus       346 ~il~~  350 (356)
                      ++++.
T Consensus       325 ell~h  329 (339)
T 1z57_A          325 EALKH  329 (339)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=318.00  Aligned_cols=265  Identities=15%  Similarity=0.241  Sum_probs=188.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeC-------------CCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAG-------------PRG  140 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------------~~~  140 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.+........+.+.+|+++++.++||||+++++++..             ..+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            4789999999999999998899999999876544445678999999999999999999998742             234


Q ss_pred             ceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEeccccc
Q 038580          141 EKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLH  219 (356)
Q Consensus       141 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~  219 (356)
                      ..+++|||+. |+|.+++..   ..+++..+..++.|++.||+|||+   .+++||||||+||+++ +++.+||+|||++
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~  168 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLA  168 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence            7899999998 599999963   468899999999999999999999   9999999999999997 5679999999998


Q ss_pred             cccCCCCC--cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh-
Q 038580          220 LLLNPTAG--QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD-  295 (356)
Q Consensus       220 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  295 (356)
                      ........  .......++..|+|||.+.+ ..++.++||||||+++|||++|..||.+.....    ........... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~  244 (320)
T 2i6l_A          169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE----QMQLILESIPVV  244 (320)
T ss_dssp             BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHSCCC
T ss_pred             cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCC
Confidence            76543211  12234456888999998865 678999999999999999999999998643211    00000000000 


Q ss_pred             --cccccccC--cccccccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          296 --HRITDLYH--PDMLLCSNSNHEN---PVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       296 --~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        ....+...  +............   ......+..+.+++.+||+.||++|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence              00000000  0000000000000   011124567889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.8e-43  Score=321.30  Aligned_cols=266  Identities=19%  Similarity=0.248  Sum_probs=182.2

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCC------ceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG------EKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+..++..+|+|.+.... .....+.++++.++.++||||+++++++.....      ..+++|
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~  105 (360)
T 3e3p_A           27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM  105 (360)
T ss_dssp             EC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence            3588999999999999999899999999875432 233466778888899999999999998863221      278999


Q ss_pred             ecccCCChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCceecCCCCCCeeEcC-CCCeEEeccccccc
Q 038580          147 PFYKRGNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLH--TGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLL  221 (356)
Q Consensus       147 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~  221 (356)
                      ||+.+ +|...+..  .....+++..+..++.|++.||.|||  +   .+++||||||+|||++. ++.+||+|||++..
T Consensus       106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            99987 55554432  24557889999999999999999999  8   99999999999999996 89999999999987


Q ss_pred             cCCCCCcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhc--cc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH--RI  298 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  298 (356)
                      .....  ......+|+.|+|||++.+. .++.++||||||+++|||++|..||.+.+....   +..... .....  ..
T Consensus       182 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~-~~~~~~~~~  255 (360)
T 3e3p_A          182 LSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVR-VLGCPSREV  255 (360)
T ss_dssp             CCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH-HHCCCCHHH
T ss_pred             cCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHH-HcCCCCHHH
Confidence            64322  23345678999999998654 489999999999999999999999986432111   111100 00000  00


Q ss_pred             ccccCccc---ccccCCCC-----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDM---LLCSNSNH-----ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+..   ........     ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000000   00000000     00111224677999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-42  Score=322.59  Aligned_cols=196  Identities=21%  Similarity=0.295  Sum_probs=165.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CC-----ccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HP-----NLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++.. .....++..|+.+++.++ |+     +|+++++++.. .+..++|||
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~lv~e  136 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFE  136 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TTEEEEEEE
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CCceEEEEe
Confidence            47899999999999999999999999998743 222356778888888775 44     48999998875 458999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCCCeEEeccccccccCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |+.+ +|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||++......
T Consensus       137 ~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~  214 (382)
T 2vx3_A          137 MLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR  214 (382)
T ss_dssp             CCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             cCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence            9965 999999866556799999999999999999999941 17899999999999994  5788999999999775432


Q ss_pred             CCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          226 AGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                          .....+|+.|+|||++.+..++.++|||||||++|||+||..||.+.+
T Consensus       215 ----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          215 ----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                234578899999999999999999999999999999999999998643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-42  Score=317.75  Aligned_cols=263  Identities=20%  Similarity=0.221  Sum_probs=185.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-----------hHHHHHHHHHHhccCCCccccccceeeC----C
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-----------DKEFGDLIELLGCIRHPNLVPLLGFYAG----P  138 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~----~  138 (356)
                      .+.||+|+||.||+|.+.. +..+|+|.+.......           .+.+.+|+.+++.++||||+++++++..    .
T Consensus        27 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           27 QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred             eEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence            4789999999999999875 7788888876433221           1578999999999999999999998853    2


Q ss_pred             CCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccc
Q 038580          139 RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL  218 (356)
Q Consensus       139 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  218 (356)
                      ....++||||+. |+|.+.+.. ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  180 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNL  180 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred             cceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEecCc
Confidence            236899999998 588888874 34468999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          219 HLLLNPTAGQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      +......  .......+++.|+|||++.+ ..++.++||||||+++|||++|..||.+.+....    ...+........
T Consensus       181 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~  254 (362)
T 3pg1_A          181 AREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ----LNKIVEVVGTPK  254 (362)
T ss_dssp             -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCC
T ss_pred             ccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCC
Confidence            8754322  22334567889999999876 6789999999999999999999999976432110    000000000000


Q ss_pred             -----------cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 -----------ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                 ..+......... ............+..+.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNV-PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCC-CCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHhhhccchhhhHHHHhhcccC-ChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                       000000000000 000000011223456889999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=314.07  Aligned_cols=259  Identities=21%  Similarity=0.278  Sum_probs=191.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCC-----ceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRG-----EKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++..+|+|.+.......  .+.+.+|+.+++.++||||+++++++.....     ..+++|
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            478999999999999999999999999987543222  3578899999999999999999999875432     359999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+. ++|.+++.    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus       109 e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          109 PFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  179 (353)
T ss_dssp             ECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             cccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence            9998 48888774    348999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITDLY  302 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  302 (356)
                         .....+++.|+|||++.+ ..++.++||||||+++|||++|..||.+.+...    ....+......   .......
T Consensus       180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH----HHHHHHHHHCBCCHHHHTTCS
T ss_pred             ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHHHh
Confidence               234567899999999876 678999999999999999999999997643211    00000000000   0000000


Q ss_pred             Cc-------ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HP-------DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      +.       .... .....-.......+..+.+++.+||+.||++|||++++++
T Consensus       253 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          253 DKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHHHHHTSCB-CSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHHHHHHHhCcC-CCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       0000 0000001122344667889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-42  Score=309.03  Aligned_cols=247  Identities=19%  Similarity=0.305  Sum_probs=186.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC------------CCc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP------------RGE  141 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------------~~~  141 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.++.. ....+.+.+|+.+++.++||||+++++++...            .+.
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST   89 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence            47899999999999999989999999998642 22345789999999999999999999987532            346


Q ss_pred             eEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          142 KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       142 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .+++|||+++++|.+++... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  165 (303)
T 1zy4_A           90 LFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN  165 (303)
T ss_dssp             EEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred             eEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence            89999999999999999742 3457888999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCC-------------CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH
Q 038580          222 LNPTA-------------GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT  287 (356)
Q Consensus       222 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  287 (356)
                      .....             ........++..|+|||++.+. .++.++||||||+++|||++   ||....       ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-------~~~  235 (303)
T 1zy4_A          166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-------ERV  235 (303)
T ss_dssp             TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-------HHH
T ss_pred             cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-------hHH
Confidence            54221             1122345678899999998754 68999999999999999998   543210       000


Q ss_pred             HHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          288 FMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..........              .......+...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 NILKKLRSVS--------------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHSTT--------------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccccc--------------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0011111000              00011123344566889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.8e-42  Score=304.26  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|++.....  ...+.+.+|++++++++||||+++++++.. .+..++++||+++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~  105 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTG  105 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEEEEEccCC
Confidence            4789999999999999998899999999865432  234678999999999999999999999885 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC---CCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN---YQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      ++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.+   +.+||+|||++.......  
T Consensus       106 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--  178 (287)
T 2wei_A          106 GELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--  178 (287)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence            999998863  2468999999999999999999999   999999999999999754   479999999987654322  


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+.       .. ..........    ..    
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~----~~----  241 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YD-ILKRVETGKY----AF----  241 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHCCC----CC----
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHcCCC----CC----
Confidence            2223457888999999875 589999999999999999999999975321       11 1111111110    00    


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ..+.....+..+.+++.+||+.||++|||+.++++
T Consensus       242 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                  00011223456889999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.6e-42  Score=314.26  Aligned_cols=266  Identities=18%  Similarity=0.270  Sum_probs=194.7

Q ss_pred             CCcccccCCceEEEEEEcCCC-eEEEEEEeccccccchHHHHHHHHHHhccCCCc------cccccceeeCCCCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSG-SVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN------LVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~-~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~~~lv~  146 (356)
                      .+.||+|+||.||+|.+..++ ..+|+|+++.. ....+.+.+|+.+++.++|+|      ++.+++++.. .+..+++|
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~lv~  101 (355)
T 2eu9_A           24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HGHMCIAF  101 (355)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TTEEEEEE
T ss_pred             EEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CCeEEEEE
Confidence            478999999999999997665 78999998743 223457888999999988766      8888888775 44899999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE-------------------cC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL-------------------DR  207 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-------------------~~  207 (356)
                      ||+ +++|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||+                   +.
T Consensus       102 e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          102 ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             ecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999 5678888765555679999999999999999999999   999999999999999                   67


Q ss_pred             CCCeEEeccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch--
Q 038580          208 NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL--  285 (356)
Q Consensus       208 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~--  285 (356)
                      ++.+||+|||++......    .....+|+.|+|||++.+..++.++||||||+++|||++|..||...........+  
T Consensus       178 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             CCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            889999999998764322    23457899999999999999999999999999999999999999764321100000  


Q ss_pred             -----hHHHHHhhhhccc----ccccCccc-------ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          286 -----PTFMRNAVLDHRI----TDLYHPDM-------LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       286 -----~~~~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           +..+.........    ...+....       ..+.............+..+.+|+.+||+.||++|||+.++++
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 0000000000000    00000000       0000000001123345668999999999999999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-42  Score=313.42  Aligned_cols=236  Identities=17%  Similarity=0.311  Sum_probs=192.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc------hHHHHHHHHHHhccC--CCccccccceeeCCCCceEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR------DKEFGDLIELLGCIR--HPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..+.||+|+||.||+|.+..++..+|+|.++......      ...+.+|+.++++++  ||||+++++++..+ +..++
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-~~~~l  125 (320)
T 3a99_A           47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVL  125 (320)
T ss_dssp             EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-CcEEE
Confidence            3478999999999999999999999999987543322      245778999999996  59999999999854 48899


Q ss_pred             EEecccC-CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEecccccccc
Q 038580          145 VHPFYKR-GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHLLL  222 (356)
Q Consensus       145 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~  222 (356)
                      ++|++.+ ++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+||+++ +++.+||+|||++...
T Consensus       126 v~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          126 ILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             EEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            9999976 899999874  3468999999999999999999999   9999999999999999 7889999999998775


Q ss_pred             CCCCCcceecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ...   ......+++.|+|||++.+..+ +.++||||||+++|||++|..||....         .     ......   
T Consensus       201 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~-----~~~~~~---  260 (320)
T 3a99_A          201 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E-----IIRGQV---  260 (320)
T ss_dssp             CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-----HHHCCC---
T ss_pred             ccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------h-----hhcccc---
Confidence            432   2234568899999999887665 678999999999999999999996421         0     000000   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                     ..+...+..+.+++.+||+.||++|||++++++
T Consensus       261 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 ---------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           011123456889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.3e-41  Score=318.69  Aligned_cols=246  Identities=22%  Similarity=0.257  Sum_probs=180.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      ++.||+|+||+||.+.. .+++.+|+|.+...   ..+.+.+|+.+++.+ +||||+++++++.+ ++..+++|||+. |
T Consensus        20 ~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-g   93 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-E
T ss_pred             cCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-C
Confidence            47799999999987544 46888999987542   335678899999876 89999999998885 458999999996 5


Q ss_pred             ChhHhhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC-------------CCeEEe
Q 038580          153 NLAQCIRGGSGEAH-----KWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN-------------YQPYVS  214 (356)
Q Consensus       153 sL~~~l~~~~~~~~-----~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~  214 (356)
                      +|.+++........     ++..+..++.|++.||+|||+   .+++||||||+|||++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            99999975332111     223457799999999999999   999999999999999754             489999


Q ss_pred             ccccccccCCCCCc---ceecccCCCcccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 038580          215 DFGLHLLLNPTAGQ---EMLEASASQGYKAPELIKM-------KDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDF  283 (356)
Q Consensus       215 Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~  283 (356)
                      |||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||.+....    
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----  246 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----  246 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----
Confidence            99999876543221   1234578999999999865       568999999999999999999 99999653211    


Q ss_pred             chhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ..     .......    ..       ...........+.++.+++.+||+.||++|||+.++++
T Consensus       247 -~~-----~i~~~~~----~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 -ES-----NIIRGIF----SL-------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HH-----HHHHTCC----CC-------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HH-----HHhcCCC----Cc-------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             00     0111000    00       00011124567788999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=306.74  Aligned_cols=246  Identities=21%  Similarity=0.306  Sum_probs=173.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch--HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||.||+|.+..+++.+|+|.++.......  +.+.++..+++.++||||+++++++..+ +..+++|||+ +
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~  107 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIAMELM-G  107 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCC-S
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEEEecc-C
Confidence            4789999999999999998999999999875432221  2344555678888999999999998854 4899999999 4


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +.+..+.. .....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||++......  ...
T Consensus       108 ~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~  181 (318)
T 2dyl_A          108 TCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAK  181 (318)
T ss_dssp             EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             CcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--ccc
Confidence            45555543 234568999999999999999999998   6 9999999999999999999999999998765332  122


Q ss_pred             ecccCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          231 LEASASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ....+++.|+|||++.     ...++.++||||||+++|||++|..||.....      ........... ..     + 
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~~-----~-  248 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQE-EP-----P-  248 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHS-CC-----C-
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhcc-CC-----C-
Confidence            3456889999999984     45688999999999999999999999975321      11111111111 00     0 


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ..+.....+..+.+++.+||+.||++||+++++++
T Consensus       249 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 ---------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                     00011123456889999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=309.94  Aligned_cols=236  Identities=19%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhcc----CCCccccccceeeCCCCce
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCI----RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~  142 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++.....      ....+.+|+.+++++    +||||+++++++... +..
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-~~~  113 (312)
T 2iwi_A           35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-EGF  113 (312)
T ss_dssp             EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------C
T ss_pred             EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-CeE
Confidence            348899999999999999889999999998654322      223466788888888    899999999988754 478


Q ss_pred             EEEEec-ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc-CCCCeEEecccccc
Q 038580          143 LIVHPF-YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD-RNYQPYVSDFGLHL  220 (356)
Q Consensus       143 ~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~  220 (356)
                      ++++|+ +.+++|.+++..  ...+++..++.++.|++.||+|||+   .+++||||||+||+++ .++.+||+|||++.
T Consensus       114 ~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          114 MLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            999999 788999999974  3468999999999999999999999   9999999999999999 88999999999987


Q ss_pred             ccCCCCCcceecccCCCcccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccc
Q 038580          221 LLNPTAGQEMLEASASQGYKAPELIKMKDAS-EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRIT  299 (356)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (356)
                      .....   ......++..|+|||++.+..+. .++||||||+++|||++|..||....         .     .....  
T Consensus       189 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~-----~~~~~--  249 (312)
T 2iwi_A          189 LLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------E-----ILEAE--  249 (312)
T ss_dssp             ECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-----HHHTC--
T ss_pred             hcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------H-----Hhhhc--
Confidence            75432   22345688999999998876664 58999999999999999999996421         0     00000  


Q ss_pred             cccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          300 DLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                      ...+...+..+.+++.+||+.||++|||++++++
T Consensus       250 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 ----------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            0112233456889999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.3e-42  Score=332.26  Aligned_cols=268  Identities=22%  Similarity=0.229  Sum_probs=196.9

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeC-----CCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAG-----PRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~~lv~  146 (356)
                      ..+.||+|+||.||+|.+..++..+|+|+++..... ..+.+.+|++++++++||||+++++++..     .++..++||
T Consensus        18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm   97 (676)
T 3qa8_A           18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM   97 (676)
T ss_dssp             CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence            458899999999999999989999999998754322 23568999999999999999999998653     245789999


Q ss_pred             ecccCCChhHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC---eEEecccccccc
Q 038580          147 PFYKRGNLAQCIRGGS-GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ---PYVSDFGLHLLL  222 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~  222 (356)
                      ||+++|+|.+++.... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++...
T Consensus        98 Ey~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             ECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999999999997533 3368888999999999999999999   99999999999999997765   899999999876


Q ss_pred             CCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          223 NPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       223 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ....  ......+++.|+|||++.+..++.++||||||+++|||++|..||...............  .........+..
T Consensus       175 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~--~~~~~~~~~~~l  250 (676)
T 3qa8_A          175 DQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE--KSNEHIVVYDDL  250 (676)
T ss_dssp             TSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCSCCCC
T ss_pred             cccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc--ccchhhhhhhhh
Confidence            4322  223457899999999999999999999999999999999999999753211000000000  000000000000


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQV  347 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~i  347 (356)
                      ................+...+..+.+++..||+.||++|||+.++
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            000000000111122445577889999999999999999999773

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-41  Score=305.29  Aligned_cols=246  Identities=16%  Similarity=0.235  Sum_probs=185.4

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccC--CCccccccceeeCCCCceEEEEe
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIR--HPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      ...+.||+|+||.||++.+. ++..+|+|++......  ..+.+.+|+.++++++  ||||+++++++.. ++..+++||
T Consensus        31 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e  108 (313)
T 3cek_A           31 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME  108 (313)
T ss_dssp             EEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             EEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEEEEEe
Confidence            33478999999999999986 4778899988654322  2357899999999997  5999999999885 448999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                       +.+++|.+++..  ...+++..+..++.|++.||.|||+   .+++||||||+||++++ +.+||+|||++........
T Consensus       109 -~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          109 -CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             -CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred             -cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence             567899999974  3468899999999999999999999   99999999999999975 7999999999876543222


Q ss_pred             c-ceecccCCCcccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh
Q 038580          228 Q-EMLEASASQGYKAPELIKM-----------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD  295 (356)
Q Consensus       228 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  295 (356)
                      . ......+++.|+|||.+.+           ..++.++||||||+++|||++|..||.....      ......... .
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~-~  254 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII-D  254 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHH-C
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHHH-h
Confidence            1 1234568899999999875           4678899999999999999999999965321      111111111 0


Q ss_pred             cccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              +..        ....+...+..+.+++.+||+.||++||++.++++
T Consensus       255 --------~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          255 --------PNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             --------TTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------ccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                    000        00112222456889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=315.00  Aligned_cols=246  Identities=22%  Similarity=0.252  Sum_probs=178.1

Q ss_pred             cCCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           71 DAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        71 ~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +...+.||+|+||+|+.... .+++.||+|.+....   ...+.+|+++++.+ +|||||++++++.+ ....+++|||+
T Consensus        26 y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~  100 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred             EecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEECC
Confidence            34458899999999764333 367788999886432   23467899999998 79999999998885 44889999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-----CCCeEEeccccccccCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-----NYQPYVSDFGLHLLLNP  224 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~  224 (356)
                      . |+|.+++..... .........++.|++.||+|||+   .+|+||||||+|||++.     ...+||+|||++.....
T Consensus       101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            7 599999975432 33334567899999999999999   99999999999999953     33578999999977543


Q ss_pred             CCC--cceecccCCCcccCccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhccc
Q 038580          225 TAG--QEMLEASASQGYKAPELIK---MKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRI  298 (356)
Q Consensus       225 ~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (356)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||+| |..||.....        ......... ..
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~-~~  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGA-CS  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTC-CC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhcc-CC
Confidence            221  2234557899999999997   4567889999999999999999 8999854211        111100000 00


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                    .............+.+|+.+||+.||++|||+.++++
T Consensus       247 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 --------------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --------------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                          0001112344556789999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.6e-41  Score=298.84  Aligned_cols=226  Identities=13%  Similarity=0.069  Sum_probs=178.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.+..+++.+|+|+++......   .+.+.+|+..++.++||||+++++++... +..++||||++
T Consensus        36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~  114 (286)
T 3uqc_A           36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVVAEWIR  114 (286)
T ss_dssp             EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCC
T ss_pred             EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEEEEecC
Confidence            478999999999999999889999999997654332   25789999999999999999999998854 58999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +++|.++++.+    ........++.|++.||+|||+   .+++||||||+|||++.++.+||+++|             
T Consensus       115 g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          115 GGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             CCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            99999999632    3445678899999999999999   999999999999999999999998543             


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                              |++       .++.++||||||+++|||+||..||.+.+.............         ....+ .    
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---------~~~~~-~----  225 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA---------GQPIE-P----  225 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT---------SCBCC-H----
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc---------cCCCC-h----
Confidence                    333       368899999999999999999999987544321100000000         00000 0    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                           .....+.+..+.+++.+||+.||++| |+.++++.|+++.
T Consensus       226 -----~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 -----ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             -----HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             -----hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence                 00112345668899999999999999 9999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-41  Score=300.76  Aligned_cols=223  Identities=22%  Similarity=0.275  Sum_probs=177.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHH-hccCCCccccccceeeC---CCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELL-GCIRHPNLVPLLGFYAG---PRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~---~~~~~~lv~e~~  149 (356)
                      ++.||+|+||.||+|.+..+++.+|+|+++.     ...+.+|+.++ +..+||||+++++++..   .....++||||+
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            3679999999999999998999999999863     35678888887 56689999999998764   244789999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ++|+|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||+++.   ++.+||+|||++....   
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---  171 (299)
T 3m2w_A           98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---  171 (299)
T ss_dssp             CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence            99999999986666679999999999999999999999   99999999999999998   7899999999875432   


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                                          +..++.++||||||+++|||++|..||..............            ..     
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------~~-----  214 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------RI-----  214 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------------SS-----
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------------HH-----
Confidence                                13467899999999999999999999976433221100000            00     


Q ss_pred             ccccCCCCCCCCc----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVS----EERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                           .......+    ...+..+.+++.+||+.||++|||++++++
T Consensus       215 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          215 -----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -----CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 00000111    224567889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-41  Score=315.81  Aligned_cols=237  Identities=14%  Similarity=0.113  Sum_probs=177.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCC-Cccccccce---------------
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRH-PNLVPLLGF---------------  134 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h-~niv~~~~~---------------  134 (356)
                      ++.||+|+||.||+|.+..+++.+|+|+++......   .+.+.+|+.+++.++| +|......+               
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            478999999999999999999999999987433322   4679999999999987 332211111               


Q ss_pred             ------eeCC----CCceEEEEecccCCChhHhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 038580          135 ------YAGP----RGEKLIVHPFYKRGNLAQCIR-----GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLK  199 (356)
Q Consensus       135 ------~~~~----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk  199 (356)
                            +...    ....+++|+++ +++|.++++     ......+++..++.++.|++.||+|||+   .+|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence                  1110    12456677665 579999884     2334567888999999999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCcccc----------ccCCCCCcchhHHHHHHHHHHHhC
Q 038580          200 SKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI----------KMKDASEETDIYSFGVIMLELISG  269 (356)
Q Consensus       200 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDvwslG~~l~el~tg  269 (356)
                      |+|||++.++.+||+|||+++....    ......| +.|+|||++          ....++.++|||||||++|||+||
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             cceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            9999999999999999999876432    2334566 899999999          555688899999999999999999


Q ss_pred             CCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          270 KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       270 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..||...........                ...        .      ..+.+..+.+|+.+||+.||++||++.++++
T Consensus       314 ~~Pf~~~~~~~~~~~----------------~~~--------~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          314 DLPNTDDAALGGSEW----------------IFR--------S------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SCCCCTTGGGSCSGG----------------GGS--------S------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcchhhhHHH----------------HHh--------h------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999976432111000                000        0      0012356889999999999999999877754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=330.84  Aligned_cols=236  Identities=20%  Similarity=0.236  Sum_probs=187.8

Q ss_pred             CCCcccccCCceEEEEEEcC-CCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCc----eEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGE----KLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~~lv~  146 (356)
                      ..+.||+|+||.||+|.+.. +++.+|+|.+..... .....+.+|+++++.++||||+++++++...+..    .++||
T Consensus        84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~  163 (681)
T 2pzi_A           84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM  163 (681)
T ss_dssp             EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence            34789999999999999975 788999998865332 2234688999999999999999999998754422    69999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+++++|.+++..    .+++..++.++.|++.||.|||+   .+|+||||||+|||++.+ .+||+|||++...... 
T Consensus       164 E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          164 EYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             ECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred             EeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence            99999999987752    68999999999999999999999   999999999999999986 8999999999775432 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                          ....||+.|+|||++.+. ++.++||||||+++|||++|..||.+.......                        
T Consensus       235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------------  285 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------------  285 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------------
T ss_pred             ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------------
Confidence                345689999999998765 488999999999999999999888653211100                        


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhh
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-NIKQVLWKLEDL  354 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~il~~L~~~  354 (356)
                              ........+..+.+++.+||+.||++|| +++++...|..+
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                    0001123345688999999999999999 566676666553

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-39  Score=293.50  Aligned_cols=238  Identities=15%  Similarity=0.137  Sum_probs=177.3

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--------chHHHHHHHHHHhccC---------C----------
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--------RDKEFGDLIELLGCIR---------H----------  125 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~e~~~l~~l~---------h----------  125 (356)
                      ..+.||+|+||.||+|.+  +++.+|+|+++.....        ..+.+.+|+.+++.++         |          
T Consensus        24 ~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~  101 (336)
T 2vuw_A           24 RCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH  101 (336)
T ss_dssp             TCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred             heeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence            358899999999999998  5789999998754321        2267899999988886         4          


Q ss_pred             -------CccccccceeeC------------CCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 038580          126 -------PNLVPLLGFYAG------------PRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH  186 (356)
Q Consensus       126 -------~niv~~~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh  186 (356)
                             |||+++++++.+            ..+..++||||+++|++.+.+..   ..+++..+..++.|++.||+|||
T Consensus       102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH  178 (336)
T 2vuw_A          102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAE  178 (336)
T ss_dssp             EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH
Confidence                   555555554442            25689999999999977776642   46899999999999999999999


Q ss_pred             -cCCCCCceecCCCCCCeeEcCCC--------------------CeEEeccccccccCCCCCcceecccCCCcccCcccc
Q 038580          187 -TGFHRPIIHGNLKSKNILLDRNY--------------------QPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI  245 (356)
Q Consensus       187 -~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  245 (356)
                       +   .+|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+|||++
T Consensus       179 ~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          179 AS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred             Hh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence             8   9999999999999999887                    8999999999875421      34789999999999


Q ss_pred             ccCCCCCcchhHHHHHH-HHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHH
Q 038580          246 KMKDASEETDIYSFGVI-MLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERIL  324 (356)
Q Consensus       246 ~~~~~~~~sDvwslG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (356)
                      .+.. +.++||||++++ .+++++|..||....       ..............           .............+.
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMT-----------FKTKCNTPAMKQIKR  310 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCC-----------CSSCCCSHHHHHHHH
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhc-----------cCcccchhhhhhcCH
Confidence            8666 889999998776 777888998874210       00001101110000           000111123456788


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHH
Q 038580          325 KFFQLAMACCSPSPSLRPNIKQVL  348 (356)
Q Consensus       325 ~l~~l~~~cl~~~p~~Rps~~~il  348 (356)
                      ++.+|+.+||+.|     |+++++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            9999999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.5e-33  Score=268.91  Aligned_cols=187  Identities=14%  Similarity=0.006  Sum_probs=129.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc----------cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT----------TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  143 (356)
                      ...+.|++|.+..+.....|+.+++|++.....          ...++|.+|+++|+++ .|+||+++++++++ ++..|
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~y  318 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGW  318 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEE
Confidence            346777777777766666788899999864311          1124699999999999 69999999999985 45899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      |||||++|++|.+.+..  ..+++..   +|+.||+.||+|+|+   +||+||||||+|||++.++.+||+|||+++...
T Consensus       319 LVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999999974  3456653   578999999999999   999999999999999999999999999998764


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEP  272 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p  272 (356)
                      .. .......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus       391 ~~-~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QD-CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC-CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            33 223345679999999999875 467789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.9e-29  Score=242.77  Aligned_cols=183  Identities=14%  Similarity=0.157  Sum_probs=139.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--------hHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--------DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      .+.||+|+||.||+|...  +..+++|.........        .+.+.+|++++++++||||+++..++.. .+..++|
T Consensus       341 ~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lV  417 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRIM  417 (540)
T ss_dssp             -------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEEE
T ss_pred             CCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEEE
Confidence            478999999999999543  4555666543322111        1347999999999999999966655553 3467999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+++++|.+++..          +..++.|+++||+|||+   .+|+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999874          45789999999999999   99999999999999998  9999999999876543


Q ss_pred             CCcc------eecccCCCcccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 038580          226 AGQE------MLEASASQGYKAPELIKM--KDASEETDIYSFGVIMLELISGKEPIN  274 (356)
Q Consensus       226 ~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~tg~~p~~  274 (356)
                      ....      .....||+.|||||++..  ..|+..+|+||...-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211      135578999999999986  568888999999988888887777664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.4e-25  Score=198.54  Aligned_cols=141  Identities=14%  Similarity=0.190  Sum_probs=114.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc------------------chHHHHHHHHHHhccCCCcccccccee
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------------------RDKEFGDLIELLGCIRHPNLVPLLGFY  135 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~~  135 (356)
                      ++.||+|+||.||+|.+ .++..+|+|+++.....                  ....+.+|+.++++++  | +++.+++
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            47899999999999999 78999999998643221                  1246889999999999  5 7777766


Q ss_pred             eCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          136 AGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       136 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ..  +..++||||+++++|.+ +..        .....++.|++.||.|||+   .+++||||||+|||++ ++.+||+|
T Consensus       171 ~~--~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          171 AW--EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             EE--ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             ec--cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            53  36799999999999998 531        1244699999999999999   9999999999999999 99999999


Q ss_pred             cccccccCCCCCcceecccCCCcccCcccccc
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIKM  247 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  247 (356)
                      ||++...              ..++|||++..
T Consensus       236 FG~a~~~--------------~~~~a~e~l~r  253 (282)
T 1zar_A          236 FPQSVEV--------------GEEGWREILER  253 (282)
T ss_dssp             CTTCEET--------------TSTTHHHHHHH
T ss_pred             CCCCeEC--------------CCCCHHHHHHH
Confidence            9998642              23678888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.8e-21  Score=168.04  Aligned_cols=135  Identities=16%  Similarity=0.102  Sum_probs=103.4

Q ss_pred             CCCcccccCCceEEEEEEcCCCeE--EEEEEeccccccc------------------------hHHHHHHHHHHhccCCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSV--RLLRFLRPVCTTR------------------------DKEFGDLIELLGCIRHP  126 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~--~a~k~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~  126 (356)
                      ..+.||+|+||.||+|.+..+|..  +|+|+++......                        ...+.+|+..++.++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            347899999999999998667888  9999876432110                        12578899999999888


Q ss_pred             cc--ccccceeeCCCCceEEEEecccC-C----ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceecCC
Q 038580          127 NL--VPLLGFYAGPRGEKLIVHPFYKR-G----NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH-TGFHRPIIHGNL  198 (356)
Q Consensus       127 ni--v~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dl  198 (356)
                      |+  ...++  .   +..++||||+.+ |    +|.+....     .++.....++.|++.||.||| +   .+++||||
T Consensus       131 ~i~~p~~~~--~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl  197 (258)
T 1zth_A          131 GVSVPQPYT--Y---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHADL  197 (258)
T ss_dssp             TCCCCCEEE--E---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred             CCCCCeEEE--c---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence            64  22332  1   257899999942 4    66665431     223456789999999999999 8   99999999


Q ss_pred             CCCCeeEcCCCCeEEecccccccc
Q 038580          199 KSKNILLDRNYQPYVSDFGLHLLL  222 (356)
Q Consensus       199 k~~Nill~~~~~~kl~Dfg~~~~~  222 (356)
                      ||.|||++.  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1e-17  Score=152.45  Aligned_cols=141  Identities=15%  Similarity=0.112  Sum_probs=96.5

Q ss_pred             hcCCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc--------------chHHHHHHHHHHhccCCCcccccccee
Q 038580           70 LDAPGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--------------RDKEFGDLIELLGCIRHPNLVPLLGFY  135 (356)
Q Consensus        70 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~~~~~  135 (356)
                      .+..+..||+|+||.||+|... +|+.+|+|+++.....              .......+.++.+...|+|+++++...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3455688999999999999986 6888999998643211              011223333333333455555543321


Q ss_pred             eCCC-----CceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-
Q 038580          136 AGPR-----GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-  209 (356)
Q Consensus       136 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-  209 (356)
                      ....     ...++||||+.+++|.+....      +  ....+..|++.+|.|||.   .++|||||||.|||+++++ 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence            1000     134799999999888765431      1  235678899999999999   9999999999999998876 


Q ss_pred             ---------CeEEecccccccc
Q 038580          210 ---------QPYVSDFGLHLLL  222 (356)
Q Consensus       210 ---------~~kl~Dfg~~~~~  222 (356)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3789999966543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=3.1e-11  Score=105.13  Aligned_cols=136  Identities=12%  Similarity=0.033  Sum_probs=102.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      ..++.|+++.||+....  +..+++|............+.+|..+++.+. +.++.++++++.. .+..+++|||++|.+
T Consensus        20 ~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           20 KDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVL   96 (263)
T ss_dssp             ECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEE
T ss_pred             eeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCee
Confidence            45777888999998753  5678888876432233457899999999885 6677788887764 457899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG---------------------------------------------  188 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------------  188 (356)
                      |.+.+..    .   .....++.+++.+++.||+-                                             
T Consensus        97 l~~~~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A           97 CSEEYED----E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             HHHHCCT----T---TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             hhhccCC----c---ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence            9876421    1   12346778899999999981                                             


Q ss_pred             -----------CCCCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          189 -----------FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       189 -----------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                                 ....++|+|+++.||+++++..+.|+||+.+.
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                       01448999999999999876666799999753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=6.9e-11  Score=102.57  Aligned_cols=129  Identities=14%  Similarity=0.062  Sum_probs=92.4

Q ss_pred             cccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCcc--ccccceeeCCCCceEEEEecccCCChh
Q 038580           78 GKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL--VPLLGFYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        78 g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      +.|..+.||+.... +|..+++|+....   ....+..|+.+++.+.+.++  .+++++... .+..+++|||++|.+|.
T Consensus        29 ~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC
Confidence            35666999999653 5666788886543   23568889999988865454  457776664 45789999999998884


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 038580          156 QCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF----------------------------------------------  189 (356)
Q Consensus       156 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------------  189 (356)
                        ..  .   .+   ...++.+++..|+.||+..                                              
T Consensus       104 --~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 --SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             --TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             --cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence              21  1   11   2356677888888888721                                              


Q ss_pred             ---------CCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          190 ---------HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       190 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                               ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     01299999999999998876677999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=3.2e-10  Score=103.42  Aligned_cols=141  Identities=13%  Similarity=0.117  Sum_probs=101.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEec--ccc-ccchHHHHHHHHHHhccC--CCccccccceeeCCC--CceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLR--PVC-TTRDKEFGDLIELLGCIR--HPNLVPLLGFYAGPR--GEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~--~~~~lv~e  147 (356)
                      +.++.|.++.||+....  +..+++|...  ... ......+.+|..+++.+.  +.++.++++++.+..  +..++|||
T Consensus        44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            56899999999998765  3456677654  221 122357888999999887  455778888776432  45899999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF--------------------------------------  189 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------  189 (356)
                      |++|.++.+..    ...++......++.+++..|+.||+..                                      
T Consensus       122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99998774421    224667778889999999999999720                                      


Q ss_pred             -----------------CCCceecCCCCCCeeEcCCCC--eEEeccccccc
Q 038580          190 -----------------HRPIIHGNLKSKNILLDRNYQ--PYVSDFGLHLL  221 (356)
Q Consensus       190 -----------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~  221 (356)
                                       ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             256999999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=1.2e-09  Score=97.13  Aligned_cols=186  Identities=18%  Similarity=0.158  Sum_probs=113.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCc--cccccceeeCCC--CceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPN--LVPLLGFYAGPR--GEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~--~~~~lv~e~~  149 (356)
                      +.++.|.+..||+..    + .+++|+....  .....+.+|..+++.+. +..  +.+.+.......  ...|+||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~-~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----R-DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST----T-SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC----C-EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            568999999999863    2 3667765432  23457889999998874 322  223333332222  2358899999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG-----------------------------------------  188 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------  188 (356)
                      +|.+|.....    ..++..+...++.+++..++.||+.                                         
T Consensus        99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            9988765322    2355566667777777777777751                                         


Q ss_pred             --------------CCCCceecCCCCCCeeEcC--CCCeEEeccccccccCCCCCccee-cc---cCCC-------cc--
Q 038580          189 --------------FHRPIIHGNLKSKNILLDR--NYQPYVSDFGLHLLLNPTAGQEML-EA---SASQ-------GY--  239 (356)
Q Consensus       189 --------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~-~~---~~~~-------~y--  239 (356)
                                    ....++|+|++|.||++++  +..+.++||+.+....+...-... ..   .+..       .|  
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1135799999999999998  456789999987653221000000 00   0000       01  


Q ss_pred             cC-ccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 038580          240 KA-PELIKMKDASEETDIYSFGVIMLELISGKEPI  273 (356)
Q Consensus       240 ~a-PE~~~~~~~~~~sDvwslG~~l~el~tg~~p~  273 (356)
                      .. |+....  .....+.|+++.++|.+.+|..+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 111110  012258999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=6.3e-07  Score=79.65  Aligned_cols=136  Identities=16%  Similarity=0.155  Sum_probs=87.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC---ccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP---NLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.++.|....||+.     +..+++|+.+.  ......+..|.++|+.+.+.   .+.+.+.++....+..+++|++++|
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45788888999988     23456676432  12335789999999998753   2445555554445678999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG-------------------------------------------  188 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------  188 (356)
                      .++....-    ..++......++.++...|+.||+-                                           
T Consensus        98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88765321    0122333333344444444444431                                           


Q ss_pred             --------------CCCCceecCCCCCCeeEcC---CCC-eEEeccccccc
Q 038580          189 --------------FHRPIIHGNLKSKNILLDR---NYQ-PYVSDFGLHLL  221 (356)
Q Consensus       189 --------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~~~~  221 (356)
                                    ....++|+|+.+.|++++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          1245799999999999987   455 47999997654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.2e-06  Score=76.21  Aligned_cols=135  Identities=16%  Similarity=0.124  Sum_probs=89.9

Q ss_pred             ccccCCc-eEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCCCh
Q 038580           77 IGKSNYG-TLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNL  154 (356)
Q Consensus        77 ig~G~~g-~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~gsL  154 (356)
                      +..|..| .||+.....++..+++|.....   ...++.+|...|+.+. +--+-++++++.++ +..++|||++++.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccc
Confidence            4556555 5899887767777788875432   3356888999888774 22245566767644 578999999999887


Q ss_pred             hHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 038580          155 AQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG----------------------------------------------  188 (356)
Q Consensus       155 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------  188 (356)
                      .+......      .....++.+++..|+-||+.                                              
T Consensus       108 ~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            76543110      11223444555555555530                                              


Q ss_pred             ---------CCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          189 ---------FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       189 ---------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                               ....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     012379999999999999887777999997643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.23  E-value=4.7e-06  Score=75.55  Aligned_cols=81  Identities=4%  Similarity=-0.075  Sum_probs=52.6

Q ss_pred             Ccc-cccCCceEEEEEEc---C---CCeEEEEEEecccc---ccchHHHHHHHHHHhccC-C--CccccccceeeCCC--
Q 038580           75 EVI-GKSNYGTLYKALLQ---R---SGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIR-H--PNLVPLLGFYAGPR--  139 (356)
Q Consensus        75 ~~i-g~G~~g~V~~~~~~---~---~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~--  139 (356)
                      +.| +.|..+.+|+....   .   ++..+++|+.....   ......+..|..+++.+. +  -.+.++++++.+..  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78889999987653   1   15567788765422   111246788888888774 2  24556676665432  


Q ss_pred             CceEEEEecccCCChh
Q 038580          140 GEKLIVHPFYKRGNLA  155 (356)
Q Consensus       140 ~~~~lv~e~~~~gsL~  155 (356)
                      +..+++|||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3578999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=9e-06  Score=74.85  Aligned_cols=75  Identities=13%  Similarity=0.041  Sum_probs=46.8

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc-------cchHHHHHHHHHHhccCC--Cccc-cccceeeCCCCceEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-------TRDKEFGDLIELLGCIRH--PNLV-PLLGFYAGPRGEKLI  144 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~~l  144 (356)
                      +.+|.|.++.||++....++..+++|.......       .....+..|.++++.+..  |..+ +++. +. + +..++
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~-~d-~-~~~~l  112 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-SD-T-EMAVT  112 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-EE-T-TTTEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE-Ec-C-CccEE
Confidence            569999999999998765566788887653211       122356778888887642  4444 3443 33 2 24689


Q ss_pred             EEecccCC
Q 038580          145 VHPFYKRG  152 (356)
Q Consensus       145 v~e~~~~g  152 (356)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.88  E-value=0.00011  Score=65.86  Aligned_cols=30  Identities=27%  Similarity=0.295  Sum_probs=27.2

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEecccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHL  220 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~  220 (356)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            789999999999999878889999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00043  Score=60.55  Aligned_cols=74  Identities=15%  Similarity=0.164  Sum_probs=49.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC---ccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP---NLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.+|.|..+.||+.... +|+.+++|+...........|..|...|+.+.-.   -+.+.+++.     .-+++|||+.+
T Consensus        21 ~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~e~l~~   94 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEEECCCC
T ss_pred             EecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEEEeecc
Confidence            56899999999999986 5667778876544333345688999988877422   223333321     34789999887


Q ss_pred             CCh
Q 038580          152 GNL  154 (356)
Q Consensus       152 gsL  154 (356)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.48  E-value=0.00062  Score=60.24  Aligned_cols=136  Identities=15%  Similarity=0.192  Sum_probs=86.2

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC---CCccccccceeeCCCCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR---HPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      +.|+.|.+..+|+...  ++..+++|+....   ....+..|...|+.+.   ...+.+.++++.. .+..+++|||+++
T Consensus        42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G  115 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNK  115 (312)
T ss_dssp             EEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCC
T ss_pred             EEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccC
Confidence            5689999999999875  3556677876432   2456888988888774   2456777777664 4578999999998


Q ss_pred             CChhH--------h---hhcCCC-C-------------------CCCHHHHH---HHH----------------HHHHHH
Q 038580          152 GNLAQ--------C---IRGGSG-E-------------------AHKWSIIY---RIS----------------IGIAGG  181 (356)
Q Consensus       152 gsL~~--------~---l~~~~~-~-------------------~~~~~~~~---~i~----------------~~i~~~  181 (356)
                      .++..        .   ++.... .                   .-+|....   ++.                ..+...
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76421        1   121111 0                   12454322   111                112222


Q ss_pred             H-HHHhc-CCCCCceecCCCCCCeeEcCCCCeEEeccc
Q 038580          182 L-DYLHT-GFHRPIIHGNLKSKNILLDRNYQPYVSDFG  217 (356)
Q Consensus       182 l-~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  217 (356)
                      + ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23421 2347799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.44  E-value=0.00094  Score=61.76  Aligned_cols=78  Identities=12%  Similarity=0.074  Sum_probs=45.5

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecccCCCcccCccccccCC---CCCcchhHHHHHHHHHHH
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD---ASEETDIYSFGVIMLELI  267 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwslG~~l~el~  267 (356)
                      ..++|+|+++.|||++.++ ++++||+.+..-.+...-...-......|.+|+......   .....++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999876 999999987653211000000000012356665543111   112344556777777776


Q ss_pred             hC
Q 038580          268 SG  269 (356)
Q Consensus       268 tg  269 (356)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.15  E-value=0.0015  Score=57.43  Aligned_cols=30  Identities=17%  Similarity=0.238  Sum_probs=25.3

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5666789999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.05  E-value=0.0034  Score=51.82  Aligned_cols=99  Identities=15%  Similarity=0.081  Sum_probs=64.2

Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCccee
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      -||.+.|+. .+.++++.+++.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|++.+.+ ..+.           
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            388898874 467999999999999999998776210  1111233456889999999988764 1110           


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS  268 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t  268 (356)
                        .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              1112356888763 334577889999999998776

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.96  E-value=0.0039  Score=55.16  Aligned_cols=143  Identities=13%  Similarity=0.159  Sum_probs=76.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc--ccccccee-----eCCCCceEEEEe
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN--LVPLLGFY-----AGPRGEKLIVHP  147 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~-----~~~~~~~~lv~e  147 (356)
                      +.|+.|....+|+.... ++ .+++|+....  .....+..|..+++.+....  +.+++...     ....+..+++++
T Consensus        28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            45777888999998765 33 4677876642  12345666777776654212  22233211     011245789999


Q ss_pred             cccCCChhH--------------hhhc---CCCCC-------CCHHHHHH------------HHHHHHHHHHHHhc----
Q 038580          148 FYKRGNLAQ--------------CIRG---GSGEA-------HKWSIIYR------------ISIGIAGGLDYLHT----  187 (356)
Q Consensus       148 ~~~~gsL~~--------------~l~~---~~~~~-------~~~~~~~~------------i~~~i~~~l~~Lh~----  187 (356)
                      |++|..+..              .++.   ....+       ..|.....            +...+...++++..    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            998865321              0111   00000       11222110            00113344555542    


Q ss_pred             CCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       188 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      .....++|+|+.+.||+++++..+.++||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1235799999999999999876668999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.87  E-value=0.0026  Score=58.96  Aligned_cols=73  Identities=14%  Similarity=0.130  Sum_probs=47.3

Q ss_pred             CcccccCCceEEEEEEcC-------CCeEEEEEEeccccccchHHHHHHHHHHhccCCCcc-ccccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL-VPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~  146 (356)
                      +.|+.|....+|+.....       ++..+++|+....  .....+..|..+++.+...++ .++++.+.  +   .+++
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEEE
Confidence            457888899999998753       2467788887432  111456678888887753344 44555443  2   3899


Q ss_pred             ecccCCCh
Q 038580          147 PFYKRGNL  154 (356)
Q Consensus       147 e~~~~gsL  154 (356)
                      +|++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.63  E-value=0.014  Score=51.86  Aligned_cols=31  Identities=23%  Similarity=0.236  Sum_probs=27.1

Q ss_pred             CCceecCCCCCCeeEcCC----CCeEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRN----YQPYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  221 (356)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            679999999999999874    6789999998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.61  E-value=0.027  Score=49.75  Aligned_cols=141  Identities=13%  Similarity=0.120  Sum_probs=76.3

Q ss_pred             cccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC--ccccccce----eeCCCCceEEEEecc
Q 038580           76 VIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP--NLVPLLGF----YAGPRGEKLIVHPFY  149 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~----~~~~~~~~~lv~e~~  149 (356)
                      .++ |....||+.... +|..+++|..+... .....+..|..+++.+...  .+.+++..    +....+..+++++|+
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            466 888899987654 35557788876321 1335667788777766421  23334432    001134567899999


Q ss_pred             cCCChh-----Hh---------hh----cCC---CCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 038580          150 KRGNLA-----QC---------IR----GGS---GEAHKWSII----------------------YRISIGIAGGLDYLH  186 (356)
Q Consensus       150 ~~gsL~-----~~---------l~----~~~---~~~~~~~~~----------------------~~i~~~i~~~l~~Lh  186 (356)
                      +|.++.     ..         ++    ...   ....++...                      ...+..++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     10         11    000   011222111                      011111222222221


Q ss_pred             c-CCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          187 T-GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       187 ~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      . .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1235689999999999999 4 889999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.59  E-value=0.02  Score=53.34  Aligned_cols=74  Identities=14%  Similarity=0.106  Sum_probs=46.1

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCcc-ccccceeeCCCCceEEEEecccCCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL-VPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +.|+.|-...+|+.....++..+++|+..... ...-+-..|..+++.+...++ .++++.+.  +   .++++|+++.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~---G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T---EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C---eEEEEeeCCcc
Confidence            35778888999999876445778888764321 111223678888888865555 35666552  2   25999998754


Q ss_pred             h
Q 038580          154 L  154 (356)
Q Consensus       154 L  154 (356)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.47  E-value=0.0085  Score=54.17  Aligned_cols=74  Identities=12%  Similarity=0.072  Sum_probs=42.1

Q ss_pred             CcccccCCceEEEEEEcCC--------CeEEEEEEeccccccchHHHHHHHHHHhccCCCccc-cccceeeCCCCceEEE
Q 038580           75 EVIGKSNYGTLYKALLQRS--------GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV-PLLGFYAGPRGEKLIV  145 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~--------~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv  145 (356)
                      ..++.|....+|+.....+        +..+++|+..... ....+...|..+++.+...+++ ++++..  +   -+++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N---GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C---CcEE
Confidence            4578888899999886531        2567888765321 1112346778777777533333 455433  1   2689


Q ss_pred             EecccCCCh
Q 038580          146 HPFYKRGNL  154 (356)
Q Consensus       146 ~e~~~~gsL  154 (356)
                      ++|++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.42  E-value=0.012  Score=53.41  Aligned_cols=141  Identities=14%  Similarity=0.124  Sum_probs=80.1

Q ss_pred             CcccccCCceEEEEEEcC-------CCeEEEEEEeccccccchHHHHHHHHHHhccCCCcc-ccccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL-VPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~  146 (356)
                      +.+..|-...+|+.....       ++..+++|+.-. .........+|..+++.+.-.++ .++++.+.  +   .+|+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---ccEE
Confidence            557778899999988642       345678887532 22234566788888887742222 44555443  2   2899


Q ss_pred             ecccCCChhHh-----------------hhcC---CCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 038580          147 PFYKRGNLAQC-----------------IRGG---SGEAH--KWSIIYRISIGIAG-------------------GLDYL  185 (356)
Q Consensus       147 e~~~~gsL~~~-----------------l~~~---~~~~~--~~~~~~~i~~~i~~-------------------~l~~L  185 (356)
                      ||++|.+|..-                 ++..   .....  -+.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988554311                 1111   11122  24455555443321                   12222


Q ss_pred             ----hc-CCCCCceecCCCCCCeeEcCC----CCeEEeccccccc
Q 038580          186 ----HT-GFHRPIIHGNLKSKNILLDRN----YQPYVSDFGLHLL  221 (356)
Q Consensus       186 ----h~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~  221 (356)
                          .. .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 123569999999999999876    6899999987643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.15  E-value=0.084  Score=47.02  Aligned_cols=31  Identities=19%  Similarity=0.425  Sum_probs=27.4

Q ss_pred             CCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       191 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.93  E-value=0.0054  Score=36.33  Aligned_cols=18  Identities=33%  Similarity=0.462  Sum_probs=9.1

Q ss_pred             HHHHHHHHhheeeecCCC
Q 038580           13 LLIILILIFFFYRKRLPK   30 (356)
Q Consensus        13 ~~~~~~~~~~~~rr~~~~   30 (356)
                      ++++++.+++++|||+.+
T Consensus        24 ~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           24 LLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHhhhhHhh
Confidence            344445555566555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.60  E-value=0.0069  Score=35.79  Aligned_cols=18  Identities=22%  Similarity=0.397  Sum_probs=8.9

Q ss_pred             HHHHHHHHhheeeecCCC
Q 038580           13 LLIILILIFFFYRKRLPK   30 (356)
Q Consensus        13 ~~~~~~~~~~~~rr~~~~   30 (356)
                      ++++++..++++|||+.+
T Consensus        23 v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           23 LVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHhhhhhhh
Confidence            334444555555555444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.92  E-value=0.35  Score=44.47  Aligned_cols=140  Identities=13%  Similarity=0.149  Sum_probs=80.6

Q ss_pred             CcccccCCceEEEEEEcCC-------CeEEEEEEeccccccchHHHHHHHHHHhccCCCcc-ccccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQRS-------GSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL-VPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~-------~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~  146 (356)
                      +.+..|-...+|+.....+       +..+++|+.... ....-+-.+|..+++.+.-.++ .++++.+.     -++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP-----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-----CCEEE
Confidence            4577788999999887531       456788875432 2222244677887777643233 33444321     26899


Q ss_pred             ecccCCChhH-------h-------h---hc----C-------CCCCCCHHHHHHHHHHH-------------------H
Q 038580          147 PFYKRGNLAQ-------C-------I---RG----G-------SGEAHKWSIIYRISIGI-------------------A  179 (356)
Q Consensus       147 e~~~~gsL~~-------~-------l---~~----~-------~~~~~~~~~~~~i~~~i-------------------~  179 (356)
                      +|++|.+|..       .       +   +.    .       ...+..+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865421       0       0   10    0       11222344444443322                   1


Q ss_pred             HHHHHHhc---------------------CCCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          180 GGLDYLHT---------------------GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       180 ~~l~~Lh~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ..+..|..                     .....++|+|+.+.|++ +.++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22233221                     11246899999999999 8888999999987653

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.59  E-value=0.039  Score=32.50  Aligned_cols=17  Identities=12%  Similarity=0.350  Sum_probs=7.5

Q ss_pred             HHHHHHHhheeeecCCC
Q 038580           14 LIILILIFFFYRKRLPK   30 (356)
Q Consensus        14 ~~~~~~~~~~~rr~~~~   30 (356)
                      +++++.+++|+|||+.+
T Consensus        25 vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           25 VVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHhheehhhhh
Confidence            33333444455554433

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=91.34  E-value=0.089  Score=30.07  Aligned_cols=12  Identities=25%  Similarity=0.465  Sum_probs=5.3

Q ss_pred             HHHHHhheeeec
Q 038580           16 ILILIFFFYRKR   27 (356)
Q Consensus        16 ~~~~~~~~~rr~   27 (356)
                      ++++.++++|||
T Consensus        27 i~~l~~~~~rrr   38 (38)
T 2k1k_A           27 LLGILVFRSRRA   38 (38)
T ss_dssp             HHHHHHHHHCCC
T ss_pred             HHHHHHHHeecC
Confidence            334444555443

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=89.59  E-value=0.29  Score=28.41  Aligned_cols=6  Identities=50%  Similarity=1.121  Sum_probs=2.7

Q ss_pred             hheeee
Q 038580           21 FFFYRK   26 (356)
Q Consensus        21 ~~~~rr   26 (356)
                      ++++||
T Consensus        34 ~~~~rR   39 (41)
T 2k9y_A           34 FFIHRR   39 (41)
T ss_dssp             HSSSSS
T ss_pred             eeEeee
Confidence            444444

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.48  E-value=0.041  Score=51.37  Aligned_cols=59  Identities=15%  Similarity=0.035  Sum_probs=15.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEE------EEeccccccc--hHHHHHHHHHHhccCCCcccccccee
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLL------RFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFY  135 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~------k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~  135 (356)
                      .+.||   ||.||+|.+......||+      |..+......  ...+.++..+++.++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            35566   999999999754456666      5554322222  24678888888899999999998864

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=84.04  E-value=0.86  Score=29.07  Aligned_cols=19  Identities=47%  Similarity=0.623  Sum_probs=10.1

Q ss_pred             hhHHHHHHHHHHHHHHHhh
Q 038580            4 LVLGLALATLLIILILIFF   22 (356)
Q Consensus         4 iv~~~~~~~~~~~~~~~~~   22 (356)
                      |++|+++.+++++.+.+|+
T Consensus        12 ivlGg~~~lll~~glcI~c   30 (70)
T 2klu_A           12 IVLGGVAGLLLFIGLGIFF   30 (70)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhHHHHHHHHHHHHHHH
Confidence            4555555555555555553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=83.08  E-value=0.13  Score=48.21  Aligned_cols=30  Identities=13%  Similarity=-0.096  Sum_probs=26.0

Q ss_pred             hHHHHHHHHHHhccCCCccccccceeeCCC
Q 038580          110 DKEFGDLIELLGCIRHPNLVPLLGFYAGPR  139 (356)
Q Consensus       110 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  139 (356)
                      .++|..|++.+.+++|+|+|+++|||.++.
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            568999999999999999999999998654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	356
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-38
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-33
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-31
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-25
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-24
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-23
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-20
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-45
 Identities = 70/285 (24%), Positives = 127/285 (44%), Gaps = 31/285 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           G+ IG  ++GT+YK       +V++L    P      + F + + +L   RH N++  +G
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRHVNILLFMG 71

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           +   P+    IV  + +  +L   +     +  +   +  I+   A G+DYLH    + I
Sbjct: 72  YSTAPQ--LAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSI 125

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPELIKMKDA-- 250
           IH +LKS NI L  +    + DFGL  + +  +G    E  + S  + APE+I+M+D   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 251 -SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D+Y+FG+++ EL++G+ P +     D+           ++         PD+   
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----------IIFMVGRGYLSPDL--- 231

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             S   +   +       +L   C       RP   Q+L  +E L
Sbjct: 232 --SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 4e-42
 Identities = 55/281 (19%), Positives = 105/281 (37%), Gaps = 31/281 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E +G   +G ++         V +    +   +     F     L+  ++H  LV L  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                +    I+  + + G+L   ++  SG     + +  ++  IA G+ ++     R  
Sbjct: 76  VVT--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH +L++ NIL+       ++DFGL  L+          A     + APE I     + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +D++SFG+++ E+++          P      P  ++N    +R+               
Sbjct: 191 SDVWSFGILLTEIVTHGRI------PYPGMTNPEVIQNLERGYRMVR------------- 231

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +   EE     +QL   C    P  RP    +   LED 
Sbjct: 232 -PDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 54/281 (19%), Positives = 100/281 (35%), Gaps = 31/281 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G+  +G ++      +  V +        T   + F    +++  +RH  LV L  
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                     IV  +  +G+L   ++G +G+  +   +  ++  IA G+ Y+        
Sbjct: 80  VV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           +H +L++ NIL+  N    V+DFGL  L+          A     + APE       + +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +D++SFG+++ EL +            E                        +L      
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNRE------------------------VLDQVERG 230

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +  P   E       L   C    P  RP  + +   LED 
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-41
 Identities = 56/281 (19%), Positives = 104/281 (37%), Gaps = 31/281 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + IG   +G ++         V +           +++F +  E++  + HP LV L G
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                     +V  F + G L+  +R           +  + + +  G+ YL       +
Sbjct: 68  VCLEQ-APICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH +L ++N L+  N    VSDFG+   +                + +PE+      S +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +D++SFGV+M E+ S  +   EN +  E           V++   T        L S   
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSE-----------VVEDISTGFRLYKPRLAST-- 229

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                        +Q+   C    P  RP   ++L +L ++
Sbjct: 230 -----------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 2e-40
 Identities = 55/281 (19%), Positives = 110/281 (39%), Gaps = 35/281 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + IGK  +G +        G+   ++ ++       + F     ++  +RH NLV LLG
Sbjct: 12  LQTIGKGEFGDVMLG--DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                +G   IV  +  +G+L   +R           + + S+ +   ++YL        
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           +H +L ++N+L+  +    VSDFGL    + T     L       + APE ++ K  S +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALREKKFSTK 180

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +D++SFG+++ E+ S            +            +  R+   Y  D        
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD------------VVPRVEKGYKMDA------- 221

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +          +++   C     ++RP+  Q+  +LE +
Sbjct: 222 -PDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-39
 Identities = 55/288 (19%), Positives = 119/288 (41%), Gaps = 35/288 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLL----RFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
            EVIG+ ++G +Y   L  +   ++        R        +F     ++    HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LLG      G  L+V P+ K G+L   IR  +       +I    + +A G+ +L    
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLA--- 147

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAPELIK 246
            +  +H +L ++N +LD  +   V+DFGL   +       +   + ++    + A E ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
            +  + ++D++SFGV++ EL++   P      P  D +        +   R+    +   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRLLQPEY--- 258

Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                        +      +++ + C  P   +RP+  +++ ++  +
Sbjct: 259 -----------CPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (349), Expect = 4e-39
 Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 37/289 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
            +VIG   +G +    L+  G     V +          + ++F     ++G   HPN++
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 90

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L G         +I+  F + G+L   +R   G+      +  +  GIA G+ YL    
Sbjct: 91  HLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLA--- 145

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ----GYKAPELI 245
               +H +L ++NIL++ N    VSDFGL   L          ++        + APE I
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
           + +  +  +D++S+G++M E++S  E    + T  +           V++    D   P 
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-----------VINAIEQDYRLPP 254

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            + C +                QL + C     + RP   Q++  L+ +
Sbjct: 255 PMDCPS-------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 8e-39
 Identities = 54/301 (17%), Positives = 107/301 (35%), Gaps = 33/301 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E IGK  +G +++   +  G    ++        R       I     +RH N++  + 
Sbjct: 8   QESIGKGRFGEVWRG--KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIA 64

Query: 134 FYAGPRGEKL---IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH---- 186
                 G      +V  +++ G+L   +   +        + ++++  A GL +LH    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 187 -TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAP 242
            T     I H +LKSKNIL+ +N    ++D GL +  +       +  +   G   Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 243 ELI------KMKDASEETDIYSFGVIMLELISGKEPI---NENPTPDEDFHLPTFMRNAV 293
           E++      K  ++ +  DIY+ G++  E+           +   P  D          +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 294 LDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
                     P++            S E +    ++   C   + + R    ++   L  
Sbjct: 242 RKVVCEQKLRPNI-------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

Query: 354 L 354
           L
Sbjct: 295 L 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-39
 Identities = 51/281 (18%), Positives = 100/281 (35%), Gaps = 31/281 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            + +G   +G +     +    V +        +  + EF +  +++  + H  LV L G
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                     I+  +   G L   +R       +   +  +   +   ++YL     +  
Sbjct: 67  VCTKQ-RPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQF 121

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           +H +L ++N L++      VSDFGL   +        + +     +  PE++     S +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +DI++FGV+M E+ S  +   E  T  E             +H    L      L S   
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSE-----------TAEHIAQGLRLYRPHLASE-- 228

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                      K + +  +C       RP  K +L  + D+
Sbjct: 229 -----------KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 59/293 (20%), Positives = 113/293 (38%), Gaps = 27/293 (9%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLG 133
             +G  N G ++K   + SG V   + +          +    +++L     P +V   G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            +    GE  I       G+L Q ++          I+ ++SI +  GL YL       I
Sbjct: 72  AFYSD-GEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 126

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           +H ++K  NIL++   +  + DFG+   L  +     +    ++ Y +PE ++    S +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 183

Query: 254 TDIYSFGVIMLELISGKEPI------------------NENPTPDEDFHLPTFMRNAVLD 295
           +DI+S G+ ++E+  G+ PI                  +   TP         + +  +D
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            R        +    N       S    L+F      C   +P+ R ++KQ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 5e-38
 Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 29/281 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G   YG +Y+ + ++      ++ L+   T   +EF     ++  I+HPNLV LLG
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLG 80

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
                     I+  F   GNL   +R  + +     ++  ++  I+  ++YL     +  
Sbjct: 81  VCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEE 253
           IH +L ++N L+  N+   V+DFGL  L+          A     + APE +     S +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 254 TDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN 313
           +D+++FGV++ E+ +          P     L         D+R+               
Sbjct: 197 SDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRM--------------- 235

Query: 314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                 E    K ++L  AC   +PS RP+  ++    E +
Sbjct: 236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-37
 Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 33/282 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPL 131
              IG  +YG   K   +  G + + + L     T    +     + LL  ++HPN+V  
Sbjct: 9   LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 132 LGFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHK--WSIIYRISIGIAGGLDYLH-- 186
                      L IV  + + G+LA  I  G+ E        + R+   +   L   H  
Sbjct: 69  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
           +     ++H +LK  N+ LD      + DFGL  +LN            +  Y +PE + 
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMN 187

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
               +E++DI+S G ++ EL +   P       +             L  +I +     +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------------LAGKIREGKFRRI 234

Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                       S+E      ++     +     RP+++++L
Sbjct: 235 --------PYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-36
 Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 36/281 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPL 131
              IG+ ++ T+YK L   +        L+    T+   + F +  E+L  ++HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 132 LGFYAGPRGEK---LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
              +      K   ++V      G L   ++    +  K  ++      I  GL +LHT 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 189 FHRPIIHGNLKSKNILL-DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
              PIIH +LK  NI +        + D GL  L   +  + ++    +  + APE+ + 
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMYEE 187

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
           K   E  D+Y+FG+ MLE+ + + P +E     +            +  R+T    P   
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------------IYRRVTSGVKPASF 234

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                  +     E      ++   C   +   R +IK +L
Sbjct: 235 -------DKVAIPE----VKEIIEGCIRQNKDERYSIKDLL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 36/288 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF----LRPVCTTRDK-EFGDLIELLGCIRHPNL 128
            +VIG   +G +YK +L+ S   + +      L+   T + + +F     ++G   H N+
Sbjct: 12  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 71

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
           + L G     + + +++   Y                     +  +  GIA G+ YL   
Sbjct: 72  IRLEGVI--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 127

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLL--NPTAGQEMLEASASQGYKAPELIK 246
            +   +H +L ++NIL++ N    VSDFGL  +L  +P A            + APE I 
Sbjct: 128 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
            +  +  +D++SFG++M E+++  E      +  E            +   I D +    
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------VMKAINDGFRL-- 232

Query: 307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                     P   +     +QL M C     + RP    ++  L+ L
Sbjct: 233 ----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-35
 Identities = 56/298 (18%), Positives = 110/298 (36%), Gaps = 41/298 (13%)

Query: 62  EDLTICDILDAPGEVIGKSNYGTLYKALLQRSGSVRL--LRFLRPVCTTRD-KEFGDLIE 118
           ++L I DI       +G  N+G++ + + +         ++ L+      D +E     +
Sbjct: 8   DNLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 119 LLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGI 178
           ++  + +P +V L+G         ++V      G L + + G   E    S +  +   +
Sbjct: 62  IMHQLDNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA--S 236
           + G+ YL     +  +H +L ++N+LL   +   +SDFGL   L          ++    
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 237 QGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
             + APE I  +  S  +D++S+GV M E +S  +       P +    P  M       
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------PYKKMKGPEVMAFIEQGK 229

Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           R+                      E   + + L   C       RP+   V  ++   
Sbjct: 230 RM------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 3e-34
 Identities = 61/299 (20%), Positives = 110/299 (36%), Gaps = 48/299 (16%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTTRDKEFGDLIELLG-CIRHPNLV 129
            +VIG+ N+G + KA +++ G      + R          ++F   +E+L     HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRG--------------GSGEAHKWSIIYRIS 175
            LLG     RG   +   +   GNL   +R                +        +   +
Sbjct: 75  NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 176 IGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA 235
             +A G+DYL     +  IH +L ++NIL+  NY   ++DFGL         + M     
Sbjct: 134 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188

Query: 236 SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD 295
              + A E +     +  +D++S+GV++ E++S          P                
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------PYCGMTCAELYEKLPQG 242

Query: 296 HRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
           +R+    +                +E     + L   C    P  RP+  Q+L  L  +
Sbjct: 243 YRLEKPLN--------------CDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 3e-34
 Identities = 50/289 (17%), Positives = 104/289 (35%), Gaps = 36/289 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS-----VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNL 128
            +V+G   +GT+YK L    G      V +           +KE  D   ++  + +P++
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73

Query: 129 VPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             LLG          ++      G L   +R           +    + IA G++YL   
Sbjct: 74  CRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE-- 128

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPELIKM 247
             R ++H +L ++N+L+       ++DFGL  LL     +   E       + A E I  
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
           +  + ++D++S+GV + EL++      +     E            +   +         
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------ISSILEKGERL--- 232

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK 356
                    P      +  + + + C       RP  ++++ +   + +
Sbjct: 233 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-34
 Identities = 52/284 (18%), Positives = 97/284 (34%), Gaps = 37/284 (13%)

Query: 76  VIGKSNYGTLYKALLQRSGSVRL--LRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPL 131
            +G  N+GT+ K   Q    V+   ++ L+          E      ++  + +P +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
           +G         ++V    + G L + ++       K   I  +   ++ G+ YL      
Sbjct: 74  IGIC--EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ES 126

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA--SQGYKAPELIKMKD 249
             +H +L ++N+LL   +   +SDFGL   L         +        + APE I    
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            S ++D++SFGV+M E  S  +         E            +   +           
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------VTAMLEKGERMGC--- 231

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLED 353
                      E     + L   C +     RP    V  +L +
Sbjct: 232 -----PAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 5e-34
 Identities = 58/274 (21%), Positives = 108/274 (39%), Gaps = 31/274 (11%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGF 134
           E IG+   GT+Y A+   +G    +R +      + +   + I ++   ++PN+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 135 YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPII 194
           Y     E  +V  +   G+L   +            I  +       L++LH      +I
Sbjct: 86  YLVG-DELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 195 HGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEET 254
           H ++KS NILL  +    ++DFG    + P    +      +  + APE++  K    + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 255 DIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNH 314
           DI+S G++ +E+I G+ P   N  P    +L       +  +   +L +P+         
Sbjct: 198 DIWSLGIMAIEMIEGEPPY-LNENPLRALYL-------IATNGTPELQNPE--------- 240

Query: 315 ENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
              +S      F      C       R + K++L
Sbjct: 241 --KLSAI----FRDFLNRCLDMDVEKRGSAKELL 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-33
 Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 38/278 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVP 130
           G  +GK  +G +Y A  ++S  +  L+ L      +     +    +E+   +RHPN++ 
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L G++        ++  +   G + + ++  S               +A  L Y H    
Sbjct: 71  LYGYFHDA-TRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---S 124

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + +IH ++K +N+LL    +  ++DFG  +    +          +  Y  PE+I+ +  
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMH 181

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS 310
            E+ D++S GV+  E + GK P   N   +      T+ R + ++    D          
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTFPDFVTEG----- 230

Query: 311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                             L       +PS RP +++VL
Sbjct: 231 ---------------ARDLISRLLKHNPSQRPMLREVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (309), Expect = 3e-33
 Identities = 55/280 (19%), Positives = 98/280 (35%), Gaps = 41/280 (14%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
             IG  ++G +Y A   R+  V  ++ +       ++++ D+   +  L  +RHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
            G Y        +V  +               +  +   I  ++ G   GL YLH     
Sbjct: 81  RGCYLRE-HTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI---KMK 248
            +IH ++K+ NILL       + DFG   ++ P           +  + APE+I      
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILAMDEG 189

Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
               + D++S G+  +EL   K P+         +H        +  +    L       
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------IAQNESPALQSGH--- 238

Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                     SE     F     +C    P  RP  + +L
Sbjct: 239 ---------WSEY----FRNFVDSCLQKIPQDRPTSEVLL 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (303), Expect = 2e-32
 Identities = 55/310 (17%), Positives = 110/310 (35%), Gaps = 57/310 (18%)

Query: 74  GEVIGKSNYGTLYKA-----LLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPN 127
              IG+  +G +++A     L     ++  ++ L+   +     +F     L+    +PN
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK-------------------- 167
           +V LLG  A       ++  +   G+L + +R  S                         
Sbjct: 78  IVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 168 --WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT 225
              +    I+  +A G+ YL     R  +H +L ++N L+  N    ++DFGL   +   
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 226 AGQEMLEASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
              +     A    +  PE I     + E+D++++GV++ E+ S           +E   
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--- 250

Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
                    + + + D                   E   L+ + L   C S  P+ RP+ 
Sbjct: 251 ---------VIYYVRDGNIL------------ACPENCPLELYNLMRLCWSKLPADRPSF 289

Query: 345 KQVLWKLEDL 354
             +   L+ +
Sbjct: 290 CSIHRILQRM 299

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 8e-32
 Identities = 53/280 (18%), Positives = 97/280 (34%), Gaps = 34/280 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G   +G +YKA  + +  +   + +        +++   I++L    HPN+V LL 
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            +        I+  F   G +   +          S I  +       L+YLH      I
Sbjct: 77  AFYYE-NNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 194 IHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-----KMK 248
           IH +LK+ NIL   +    ++DFG+      T  Q       +  + APE++     K +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
               + D++S G+ ++E+   + P +E             +   +       L  P    
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTLAQPS--- 239

Query: 309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                     S      F      C   +   R    Q+L
Sbjct: 240 --------RWSSN----FKDFLKKCLEKNVDARWTTSQLL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-31
 Identities = 45/308 (14%), Positives = 107/308 (34%), Gaps = 56/308 (18%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLG-CIRHP 126
           G+V+G   +G +  A             V +        ++  +     ++++     H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK------------------- 167
           N+V LLG      G   ++  +   G+L   +R    +  +                   
Sbjct: 102 NIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 168 --WSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT 225
             +  +   +  +A G+++L     +  +H +L ++N+L+       + DFGL   +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 226 AGQEMLEASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFH 284
           +   +   +     + APE +     + ++D++S+G+++ E+ S           D +F+
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 285 LPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNI 344
                        I + +  D             +EE     + +  +C +     RP+ 
Sbjct: 278 -----------KLIQNGFKMDQ--------PFYATEE----IYIIMQSCWAFDSRKRPSF 314

Query: 345 KQVLWKLE 352
             +   L 
Sbjct: 315 PNLTSFLG 322

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-31
 Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 32/278 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIELLGCIRHPNLVPLL 132
            + +G+  YG +  A+ + +     ++ +         +     I +   + H N+V   
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
           G        + +   +   G L   I    G         R    +  G+ YLH      
Sbjct: 70  GHRREG-NIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIG 123

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQGYKAPELIKMKD-A 250
           I H ++K +N+LLD      +SDFGL  +      + +L     +  Y APEL+K ++  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS 310
           +E  D++S G+++  +++G+ P          +  P+       D +    Y        
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELP----------WDQPSDSCQEYSDWKEKKTYLNPWKKID 233

Query: 311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           ++                L       +PS R  I  + 
Sbjct: 234 SA-------------PLALLHKILVENPSARITIPDIK 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 55/277 (19%), Positives = 103/277 (37%), Gaps = 31/277 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E +G   +G +++   + +G+    +F+     +  +     I+ +  +RHP LV L  
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            +     E ++++ F   G L + +                   +  GL ++H       
Sbjct: 91  AFEDD-NEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNY 145

Query: 194 IHGNLKSKNILL--DRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
           +H +LK +NI+    R+ +  + DFGL   L+P   Q +   + +  + APE+ + K   
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN 311
             TD++S GV+   L+SG  P       +      T       D  + D           
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMDDSAFSG------ 251

Query: 312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                 +SE+                P+ R  I Q L
Sbjct: 252 ------ISED----GKDFIRKLLLADPNTRMTIHQAL 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 50/289 (17%), Positives = 98/289 (33%), Gaps = 37/289 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
            E +G  ++G + +              V+ L+           +F   +  +  + H N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           L+ L G          +V      G+L   +R   G       + R ++ +A G+ YL  
Sbjct: 73  LIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE- 128

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA--SQGYKAPELI 245
              +  IH +L ++N+LL       + DFGL   L       +++        + APE +
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
           K +  S  +D + FGV + E+ +  +         +           +L     +     
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----------ILHKIDKEGERL- 234

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                      P  E+     + + + C +  P  RP    +   L + 
Sbjct: 235 -----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 45/285 (15%), Positives = 100/285 (35%), Gaps = 34/285 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV 129
           G  IG+  +G +++ +     +    V +         +  ++F      +    HP++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            L+G          I+      G L   ++         + +   +  ++  L YL    
Sbjct: 72  KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLSTALAYLE--- 125

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            +  +H ++ ++N+L+  N    + DFGL   +  +   +  +      + APE I  + 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            +  +D++ FGV M E++       +    ++            +  RI +     M   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND------------VIGRIENGERLPM--- 230

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                            + L   C +  PS RP   ++  +L  +
Sbjct: 231 -----PPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  115 bits (289), Expect = 6e-30
 Identities = 52/277 (18%), Positives = 98/277 (35%), Gaps = 31/277 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E +G   +G +++ + + +G V + +F+            + I ++  + HP L+ L  
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            +     E +++  F   G L   I          + +         GL ++H      I
Sbjct: 94  AFEDK-YEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSI 148

Query: 194 IHGNLKSKNILLDRNYQPYV--SDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
           +H ++K +NI+ +      V   DFGL   LNP   + +   +A+  + APE++  +   
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVG 206

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN 311
             TD+++ GV+   L+SG  P       +      T       D    +           
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDWEFDEDAFSS------ 254

Query: 312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                 VS E                P  R  +   L
Sbjct: 255 ------VSPE----AKDFIKNLLQKEPRKRLTVHDAL 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 56/305 (18%), Positives = 105/305 (34%), Gaps = 51/305 (16%)

Query: 74  GEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTRDKE-FGDLIELLG-CIRHP 126
           G+ +G   +G + +A         +     ++ L+P     ++E     +++L     H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK----------------WSI 170
           N+V LLG      G  L++  +   G+L   +R                           
Sbjct: 88  NIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +   S  +A G+ +L     +  IH +L ++NILL       + DFGL   +   +   +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 231 LEASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM 289
              +     + APE I     + E+D++S+G+ + EL S           D  F+     
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY----- 258

Query: 290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW 349
              ++      L                   E     + +   C    P  RP  KQ++ 
Sbjct: 259 --KMIKEGFRMLSPEH------------APAE----MYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 350 KLEDL 354
            +E  
Sbjct: 301 LIEKQ 305

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-29
 Identities = 46/296 (15%), Positives = 116/296 (39%), Gaps = 43/296 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-----LRPVCTTRDK-EFGDLIELLGCIRHPN 127
              +G+ ++G +Y+ + +               +    + R++ EF +   ++      +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK--------WSIIYRISIGIA 179
           +V LLG  +      L++     RG+L   +R                 S + +++  IA
Sbjct: 85  VVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 180 GGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA-SQG 238
            G+ YL+       +H +L ++N ++  ++   + DFG+   +  T              
Sbjct: 144 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRI 298
           + +PE +K    +  +D++SFGV++ E+ +  E   +  + ++       +   V++  +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEGGL 253

Query: 299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            D               +   +      F+L   C   +P +RP+  +++  +++ 
Sbjct: 254 LDK-------------PDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-28
 Identities = 62/303 (20%), Positives = 112/303 (36%), Gaps = 48/303 (15%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLGCIRH-P 126
           G+ +G+  +G + +A             V +         +  +     +++L  I H  
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHK--------------WSIIY 172
           N+V LLG    P G  +++  F K GNL+  +R    E                    + 
Sbjct: 78  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 173 RISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
             S  +A G+++L     R  IH +L ++NILL       + DFGL   +          
Sbjct: 138 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 233 ASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN 291
            +     + APE I  +  + ++D++SFGV++ E+ S           DE+F        
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 247

Query: 292 AVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKL 351
                R+ +               +  + E     +Q  + C    PS RP   +++  L
Sbjct: 248 ----RRLKEGTRMRA--------PDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 352 EDL 354
            +L
Sbjct: 292 GNL 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-28
 Identities = 49/277 (17%), Positives = 95/277 (34%), Gaps = 32/277 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            E +G+  +G +++ +   S    + +F++    T        I +L   RH N++ L  
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHE 68

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
            +     E +++  F    ++ + I   S        I      +   L +LH      I
Sbjct: 69  SFESM-EELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNI 123

Query: 194 IHGNLKSKNILLD--RNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            H +++ +NI+    R+    + +FG    L P  G        +  Y APE+ +    S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 252 EETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN 311
             TD++S G ++  L+SG  P                    ++++ +   Y  D      
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQ------------IIENIMNAEYTFDEEAFKE 229

Query: 312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                 +S E                   R    + L
Sbjct: 230 ------ISIE----AMDFVDRLLVKERKSRMTASEAL 256

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 7e-28
 Identities = 55/281 (19%), Positives = 95/281 (33%), Gaps = 33/281 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            +V+G    G + +   +R+     L+ L+     R +E           + P++V ++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRAS---QCPHIVRIVD 72

Query: 134 FYAGPRGEK---LIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
            Y      +   LIV      G L   I+    +A        I   I   + YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 191 RPIIHGNLKSKNILLDRNYQPYV---SDFGLHLLLNPTAGQEMLEASASQGYKAPELIKM 247
             I H ++K +N+L        +   +DFG            +     +  Y APE++  
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVLGP 187

Query: 248 KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML 307
           +   +  D++S GVIM  L+ G  P   N        + T +R    +    +       
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE---- 243

Query: 308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                     VSEE       L        P+ R  I + +
Sbjct: 244 ----------VSEE----VKMLIRNLLKTEPTQRMTITEFM 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 3e-27
 Identities = 37/290 (12%), Positives = 82/290 (28%), Gaps = 34/290 (11%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           G  IG  ++G +Y      +G    ++       T+  +     ++   ++    +P + 
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           +        ++V                         +  ++  +   ++Y+H    +  
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 194 IHGNLKSKNIL---LDRNYQPYVSDFGLHLLLNPTAGQEML------EASASQGYKAPEL 244
           IH ++K  N L     +    Y+ DFGL          + +        + +  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
               + S   D+ S G +++    G                    R          +  P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGS--------LPWQGLKAATKRQKYERISEKKMSTP 236

Query: 305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
             +LC           E    F      C S     +P+   +     +L
Sbjct: 237 IEVLCKG------YPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-27
 Identities = 58/279 (20%), Positives = 97/279 (34%), Gaps = 10/279 (3%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           E IG+  YG +YKA  + +G V  L+ +R    T          I LL  + HPN+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                    KL +   +   +L + +   +       +I      +  GL + H      
Sbjct: 68  DVI--HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHR 122

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           ++H +LK +N+L++      ++DFGL             E           L+  K  S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182

Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
             DI+S G I  E+++ +     +   D+ F +   +              PD       
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242

Query: 313 NHENPVSEERI---LKFFQLAMACCSPSPSLRPNIKQVL 348
                 S+           L        P+ R + K  L
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 5e-27
 Identities = 53/287 (18%), Positives = 107/287 (37%), Gaps = 18/287 (6%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLL 132
              IG+  YG +  A    +     ++ + P       +     I++L   RH N++ + 
Sbjct: 13  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 133 GFYAGP---RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
                P   + + + +       +L + ++           I      I  GL Y+H   
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH--- 126

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEAS--ASQGYKAPELIKM 247
              ++H +LK  N+LL+      + DFGL  + +P            A++ Y+APE++  
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 248 KDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
               ++  DI+S G I+ E++S +         D+  H+   + +   +     +     
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 307 LLCSNSNHENPVSEERILK-----FFQLAMACCSPSPSLRPNIKQVL 348
               +  H+N V   R+          L     + +P  R  ++Q L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (265), Expect = 6e-27
 Identities = 53/276 (19%), Positives = 95/276 (34%), Gaps = 28/276 (10%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRP-VCTTRDKEFGDLIELLGCIRHPNLVPLL 132
            +V+G   +  +  A  +R+  +  ++ +       ++    + I +L  I+HPN+V L 
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
             Y    G   ++      G L   I       +      R+   +   + YLH      
Sbjct: 74  DIYESG-GHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
                       LD + +  +SDFGL  + +P  G  +  A  + GY APE++  K  S+
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
             D +S GVI   L+ G  P  +                 + +  +   Y  D     + 
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAK------------LFEQILKAEYEFDSPYWDD- 235

Query: 313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                +S+                 P  R   +Q L
Sbjct: 236 -----ISDS----AKDFIRHLMEKDPEKRFTCEQAL 262

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 9e-27
 Identities = 51/279 (18%), Positives = 106/279 (37%), Gaps = 36/279 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVP 130
           G+++G+ ++ T+  A    +     ++ L      ++          +++  + HP  V 
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +     +      + K G L + IR     +   +     +  I   L+YLH    
Sbjct: 73  LYFTFQDD-EKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH---G 126

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQ-GYKAPELIKMKD 249
           + IIH +LK +NILL+ +    ++DFG   +L+P + Q    +      Y +PEL+  K 
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
           A + +D+++ G I+ +L++G  P               F +   L++   + + P     
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLEYDFPEKFFPKAR-- 238

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                              L         + R   +++ 
Sbjct: 239 ------------------DLVEKLLVLDATKRLGCEEME 259

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  105 bits (262), Expect = 4e-26
 Identities = 44/214 (20%), Positives = 84/214 (39%), Gaps = 16/214 (7%)

Query: 74  GEVIGKSNYGTLYKALLQRSGS------VRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN 127
             +IG+  +G +Y      +G       +   R       T       ++ L+     P 
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +V +   +  P  +   +      G+L   +          + +   +  I  GL+++H 
Sbjct: 69  IVCMSYAFHTP-DKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMH- 124

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPE-LIK 246
             +R +++ +LK  NILLD +    +SD GL    +     +   +  + GY APE L K
Sbjct: 125 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQK 179

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPD 280
                   D +S G ++ +L+ G  P  ++ T D
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-26
 Identities = 52/285 (18%), Positives = 99/285 (34%), Gaps = 21/285 (7%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL-----IELLGCIRHPNLV 129
           + +G+  + T+YKA  + +  +  ++ ++    +  K+  +      I+LL  + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            LL  + G +    +V  F +                  S I    +    GL+YLH   
Sbjct: 64  GLLDAF-GHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLH--- 117

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
              I+H +LK  N+LLD N    ++DFGL             +           L   + 
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPD------EDFHLPTFMRNAVLDHRITDLYH 303
                D+++ G I+ EL+     +  +   D      E    PT  +   +      +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                    +  +   ++       L       +P  R    Q L
Sbjct: 238 KSFPGIPLHHIFSAAGDD----LLDLIQGLFLFNPCARITATQAL 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (258), Expect = 7e-26
 Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 20/232 (8%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKE---FGDLIELLGCIRHPNLVP 130
              +G  ++G ++    + +G    ++ L+     R K+     D   +L  + HP ++ 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           + G +     +++ +   Y  G     +   S       +    +  +   L+YLH    
Sbjct: 69  MWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---S 122

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           + II+ +LK +NILLD+N    ++DFG    +             +  Y APE++  K  
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPY 178

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPD-------EDFHLPTFMRNAVLD 295
           ++  D +SFG+++ E+++G  P  ++ T          +   P F    V D
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 7e-26
 Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 40/285 (14%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL------IELLGCIRHPN 127
           GE +G   +  + K   + +G     +F++   T   +           + +L  I+HPN
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 128 LVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           ++ L   Y     + +++      G L   +     E+            I  G+ YLH 
Sbjct: 75  VITLHEVYENK-TDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLH- 130

Query: 188 GFHRPIIHGNLKSKNILLDRNYQP----YVSDFGLHLLLNPTAGQEMLEASASQGYKAPE 243
                I H +LK +NI+L     P     + DFGL   ++   G E      +  + APE
Sbjct: 131 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPE 186

Query: 244 LIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           ++  +    E D++S GVI   L+SG  P   +   +      T    + +++   D Y 
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYEFEDEYF 240

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            +             S                  P  R  I+  L
Sbjct: 241 SN------------TSAL----AKDFIRRLLVKDPKKRMTIQDSL 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  102 bits (256), Expect = 8e-26
 Identities = 32/292 (10%), Positives = 85/292 (29%), Gaps = 36/292 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
           G  IG+ ++G +++     +     ++F      +   +  D       +     +P + 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPI 193
           ++       ++V      G   + +    G       +   +  +   +  +H    + +
Sbjct: 68  YFGQEGLHNVLV--IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 122

Query: 194 IHGNLKSKNILLDRNYQP-----YVSDFGLHLLLNPTAGQEMLEASASQG------YKAP 242
           ++ ++K  N L+ R         YV DFG+         ++ +     +       Y + 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 243 ELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY 302
                ++ S   D+ + G + +  + G  P                              
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK--------KQS 234

Query: 303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
            P   LC+    E          F++      + +    P+   +      +
Sbjct: 235 TPLRELCAGFPEE----------FYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 15/285 (5%)

Query: 74  GEVIGKSNYGTLYKAL-LQRSGSVRLLRFLRPVCTTRDKEFGDLIEL-----LGCIRHPN 127
              IG+  YG ++KA  L+  G    L+ +R            + E+     L    HPN
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 128 LVPLLGFYAGPRGE---KLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDY 184
           +V L       R +   KL +   +   +L   +            I  +   +  GLD+
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 185 LHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           LH      ++H +LK +NIL+  + Q  ++DFGL  + +      +     +  Y+APE+
Sbjct: 132 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 186

Query: 245 IKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP 304
           +     +   D++S G I  E+   K     +   D+   +   +     +    D+  P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 305 DMLLCSNSNHENPVSEERILK-FFQLAMACCSPSPSLRPNIKQVL 348
                S S          I +    L + C + +P+ R +    L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 55/305 (18%), Positives = 118/305 (38%), Gaps = 52/305 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRF-------LRPVCTTRD-KEFGDLIELLGCI-R 124
           G+ +G+  +G +  A        +  R        L+   T +D  +    +E++  I +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77

Query: 125 HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIR--------------GGSGEAHKWSI 170
           H N++ LLG      G   ++  +  +GNL + ++                  E      
Sbjct: 78  HKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 171 IYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM 230
           +   +  +A G++YL     +  IH +L ++N+L+  +    ++DFGL   ++     + 
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 231 LEASA-SQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFM 289
                    + APE +  +  + ++D++SFGV++ E+ +           +E F L    
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---- 249

Query: 290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW 349
                   + + +  D          +  + E     + +   C    PS RP  KQ++ 
Sbjct: 250 --------LKEGHRMDK--------PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVE 289

Query: 350 KLEDL 354
            L+ +
Sbjct: 290 DLDRI 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 51/280 (18%), Positives = 93/280 (33%), Gaps = 12/280 (4%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           E IG+  YGT++KA  + +  +  L+ +R               I LL  ++H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                 +   L+     +          G        I+      +  GL + H    R 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           ++H +LK +N+L++RN +  +++FGL             E           L   K  S 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
             D++S G I  EL +   P+      D+       +     + +   +           
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 313 NHENPVSEERILK----FFQLAMACCSPSPSLRPNIKQVL 348
                     + K       L       +P  R + ++ L
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 58/290 (20%), Positives = 112/290 (38%), Gaps = 28/290 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
            +VIG  ++G +Y+A L  SG +  ++ +      +++E    ++++  + H N+V L  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRY 80

Query: 134 FYAGPRGEKLIVHPF----YKRGNLAQCIRGGSGEAHK--WSIIYRISIGIAGGLDYLHT 187
           F+     +K  V+      Y    + +  R  S          +      +   L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139

Query: 188 GFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                I H ++K +N+LLD +     + DFG    L    G+  +    S+ Y+APELI 
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIF 195

Query: 247 MKDA-SEETDIYSFGVIMLELISGKEPINENPTPD------EDFHLPTFMRNAVLDHRIT 299
                +   D++S G ++ EL+ G+     +   D      +    PT  +   ++   T
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 300 DLYHPDMLLCSNSNHENP-VSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           +   P +     +    P    E       L       +P+ R    +  
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPE----AIALCSRLLEYTPTARLTPLEAC 301

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 5e-25
 Identities = 53/279 (18%), Positives = 107/279 (38%), Gaps = 37/279 (13%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIE----LLGCIRHPNLV 129
            +++GK ++G ++ A  +++     ++ L+      D +    +     L     HP L 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 130 PLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF 189
            +   +         V  +   G+L   I+  S      S     +  I  GL +LH   
Sbjct: 67  HMFCTFQTK-ENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLH--- 120

Query: 190 HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKD 249
            + I++ +LK  NILLD++    ++DFG+          +      +  Y APE++  + 
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQK 179

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
            +   D +SFGV++ E++ G+ P       +E FH            R+ + ++P     
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFH----------SIRMDNPFYPRW--- 225

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
                   + +E       L +      P  R  ++  +
Sbjct: 226 --------LEKE----AKDLLVKLFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 98.7 bits (245), Expect = 2e-24
 Identities = 44/289 (15%), Positives = 90/289 (31%), Gaps = 37/289 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
           GE++G      ++ A   R      ++ LR         +       +    + HP +V 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 131 LLGFYAGPRGEKL---IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
           +               IV  +     L   +   +           +       L++ H 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH- 128

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASA--SQGYKAPELI 245
                IIH ++K  NI++       V DFG+   +  +       A+   +  Y +PE  
Sbjct: 129 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 246 KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD 305
           +       +D+YS G ++ E+++G+ P   +                V    + +   P 
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------------VAYQHVREDPIPP 234

Query: 306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL 354
                 S     +S +       + +   + +P  R      +    DL
Sbjct: 235 ------SARHEGLSAD----LDAVVLKALAKNPENRYQTAAEM--RADL 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 96.3 bits (239), Expect = 2e-23
 Identities = 53/292 (18%), Positives = 100/292 (34%), Gaps = 46/292 (15%)

Query: 73  PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---------IELLGCI 123
           P E++G+     + + + + +     ++ +                       +++L  +
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 124 R-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGL 182
             HPN++ L   Y        +V    K+G L   +              +I   +   +
Sbjct: 67  SGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVI 123

Query: 183 DYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAP 242
             LH      I+H +LK +NILLD +    ++DFG    L+P  G+++ E   +  Y AP
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAP 178

Query: 243 ELIKMKDA------SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDH 296
           E+I+           +E D++S GVIM  L++G  P                      ++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGNY 232

Query: 297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
           +       D             S+        L        P  R   ++ L
Sbjct: 233 QFGSPEWDD------------YSDT----VKDLVSRFLVVQPQKRYTAEEAL 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 94.6 bits (234), Expect = 7e-23
 Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 16/281 (5%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           E IG+  YG +YKA     G    L+ +R               I +L  ++H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 133 GFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP 192
                   ++L++   +   +L + +    G   +        + +  G+ Y H    R 
Sbjct: 67  DVI--HTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH---DRR 120

Query: 193 IIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASE 252
           ++H +LK +N+L++R  +  ++DFGL         +   E           L+  K  S 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 253 ETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS 312
             DI+S G I  E+++G          D+   +   +      +       P      N 
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD--PNF 238

Query: 313 NHENPVSEERILK-----FFQLAMACCSPSPSLRPNIKQVL 348
               P+  E  LK        L        P+ R   KQ L
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 7e-22
 Identities = 45/293 (15%), Positives = 97/293 (33%), Gaps = 24/293 (8%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
             IG+  +G ++KA  +++G    L+ +                I++L  ++H N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 133 GF-------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
                    Y   +G   +V  F +                         +     L+ L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130

Query: 186 HTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQG---YKAP 242
           +      I+H ++K+ N+L+ R+    ++DFGL    +     +    +       Y+ P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 243 ELI-KMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL 301
           EL+   +D     D++  G IM E+ +    +  N    +   +     +   +      
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 302 YHPDMLLCSNSNHENPVSEERILK------FFQLAMACCSPSPSLRPNIKQVL 348
            +           +    ++R+           L        P+ R +    L
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 2e-21
 Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 11/215 (5%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVP 130
            +++GK  +G +     + +G    ++ LR        E         +L   RHP L  
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 131 LLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFH 190
           L   +         V  +   G L   +                   I   L+YLH    
Sbjct: 70  LKYAFQTH-DRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---S 123

Query: 191 RPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDA 250
           R +++ ++K +N++LD++    ++DFGL        G  M     +  Y APE+++  D 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDY 182

Query: 251 SEETDIYSFGVIMLELISGKEPINENPTPDEDFHL 285
               D +  GV+M E++ G+ P   N   +  F L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFEL 216

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.1 bits (223), Expect = 2e-21
 Identities = 47/285 (16%), Positives = 99/285 (34%), Gaps = 50/285 (17%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL------IELLGCIR--H 125
           G ++G   +G++Y  +         ++ +     +   E  +       + LL  +    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 126 PNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYL 185
             ++ LL ++  P    LI+       +L   I      A +  +       +   + + 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHC 126

Query: 186 HTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL 244
           H   +  ++H ++K +NIL+D N  +  + DFG   LL  T   +      ++ Y  PE 
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEW 180

Query: 245 IKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH 303
           I+          ++S G+++ +++ G  P                              H
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------------------FEH 212

Query: 304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            + ++         VS E       L   C +  PS RP  +++ 
Sbjct: 213 DEEIIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEIQ 253

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 88.7 bits (219), Expect = 2e-20
 Identities = 53/291 (18%), Positives = 105/291 (36%), Gaps = 29/291 (9%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLL 132
              +G+  Y  +++A+   +    +++ L+PV   + K+    I++L  +R  PN++ L 
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLA 96

Query: 133 GFYAGPRGEKL-IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
                P      +V       +  Q  +  +        I      I   LDY H     
Sbjct: 97  DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEILKALDYCH---SM 148

Query: 192 PIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPEL-IKMKD 249
            I+H ++K  N+++D  + +  + D+GL    +P  GQE     AS+ +K PEL +  + 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQM 206

Query: 250 ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC 309
                D++S G ++  +I  KEP        +       +      +   D Y+ ++   
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 310 SNSNHENPVSEERILKFFQLAMACCSPS------------PSLRPNIKQVL 348
            N        +              SP                R   ++ +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 6e-20
 Identities = 58/287 (20%), Positives = 100/287 (34%), Gaps = 24/287 (8%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           + +G   YG +  A+  R+G+   ++ L     +    K     + LL  +RH N++ LL
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 133 GFYAGP-----RGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHT 187
             +          +  +V PF              GE     ++Y     +  GL Y+H 
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY----QMLKGLRYIH- 138

Query: 188 GFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELI-K 246
                IIH +LK  N+ ++ + +  + DFGL    +     EM     ++ Y+APE+I  
Sbjct: 139 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILN 192

Query: 247 MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM 306
               ++  DI+S G IM E+I+GK     +   D+   +         +           
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 307 LLCSNSNHENPVSEERILK-----FFQLAMACCSPSPSLRPNIKQVL 348
                           IL         L           R    + L
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 86.4 bits (213), Expect = 1e-19
 Identities = 38/201 (18%), Positives = 77/201 (38%), Gaps = 13/201 (6%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDL---IELLGCIRHPNLVPL 131
           + +G  ++G +     + SG+   ++ L      + K+         +L  +  P LV L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 132 LGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR 191
              +       +++         +   R G             +  I    +YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SL 160

Query: 192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDAS 251
            +I+ +LK +N+L+D+     V+DFG    +             +    APE+I  K  +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYN 216

Query: 252 EETDIYSFGVIMLELISGKEP 272
           +  D ++ GV++ E+ +G  P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.2 bits (207), Expect = 7e-19
 Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 39/300 (13%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
           + IG    G +  A          ++ L      +   K     + L+ C+ H N++ LL
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 133 GFYAGPR----GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             +   +     + + +       NL Q I+          ++Y++      G+ +LH  
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM----LCGIKHLH-- 136

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
               IIH +LK  NI++  +    + DFGL      +    M     ++ Y+APE+I   
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM 193

Query: 249 DASEETDIYSFGVIMLELISGKEP-------------INENPTPDEDFH------LPTFM 289
              E  DI+S G IM E++  K               I +  TP  +F       +  ++
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 290 RNAVLDHRITDL-YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVL 348
            N      +T     PD L  ++S H    + +       L        P+ R ++   L
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ----ARDLLSKMLVIDPAKRISVDDAL 309

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 1e-18
 Identities = 40/216 (18%), Positives = 87/216 (40%), Gaps = 14/216 (6%)

Query: 74  GEVIGKSNYGTLYKA---LLQRSGSVRLLRFLRPVCTTRDKEFGDL----IELLGCIRHP 126
            +V+G   YG ++         +G +  ++ L+     +  +  +      ++L  IR  
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 127 NLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLH 186
             +  L +      +  ++  +   G L   +        +    + + I +   +  L 
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALE 143

Query: 187 TGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIK 246
                 II+ ++K +NILLD N    ++DFGL         +   +   +  Y AP++++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 247 MKDA--SEETDIYSFGVIMLELISGKEPINENPTPD 280
             D+   +  D +S GV+M EL++G  P   +   +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 4e-18
 Identities = 44/285 (15%), Positives = 91/285 (31%), Gaps = 20/285 (7%)

Query: 75  EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD--KEFGDLIELLGCIRHPNLVPLL 132
             +G   YG++  A   ++G    ++ L     +    K     + LL  ++H N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 133 GFYAGPR----GEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTG 188
             +   R       + +       +L   ++           +  +   I  GL Y+H  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH-- 138

Query: 189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEASASQGYKAPELIKMK 248
               IIH +LK  N+ ++ + +  + DFGL    +      +             ++   
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR---WYRAPEIMLNWM 194

Query: 249 DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL 308
             ++  DI+S G IM EL++G+         D+   +   +     +             
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 309 CSNSNHENPVSEERILK-----FFQLAMACCSPSPSLRPNIKQVL 348
             +      ++   +          L           R    Q L
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.1 bits (196), Expect = 2e-17
 Identities = 53/312 (16%), Positives = 103/312 (33%), Gaps = 40/312 (12%)

Query: 74  GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLG 133
              +G  ++ T++ A    + +   ++ +R       +   D I+LL  +   +      
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 134 F-------------YAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAG 180
                         + GP G  +++       NL   I+           + +IS  +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 181 GLDYLHTGFHRPIIHGNLKSKNILLDRN-YQPYVSDFGLHLLLNPTAGQEMLEASASQ-G 238
           GLDY+H      IIH ++K +N+L++       +    +  L N     E    S     
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 239 YKAPELIKMKDASEETDIYSFGVIMLELISGK---EPINENPTPDEDFH-------LPTF 288
           Y++PE++         DI+S   ++ ELI+G    EP   +    +D H       L   
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 289 MRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILK------------FFQLAMACCSP 336
               + + + T  +     L  N +       E +L                        
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 337 SPSLRPNIKQVL 348
            P  R +   ++
Sbjct: 315 DPRKRADAGGLV 326

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 59.8 bits (144), Expect = 3e-11
 Identities = 29/174 (16%), Positives = 58/174 (33%), Gaps = 23/174 (13%)

Query: 70  LDAPGEVIGKSNYGTLYKALLQRSGSV---------RLLRFLRPVCTTRDKEFGDLIELL 120
           +DA G+++G+     ++    ++ G              + ++      D  F  L    
Sbjct: 1   VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 121 GCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN--LAQCIRGGSGEAHKWSIIYRISIGI 178
                  L  L G          +   +   GN  L + I        +      +   I
Sbjct: 61  ARNEFRALQKLQGLA--------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112

Query: 179 AGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE 232
              +   +   HR I+HG+L   N+L+      ++ DF   + +     +E+LE
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILE 162

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	356
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.15
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.6
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.46
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.37

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-58  Score=409.54  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=211.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.++.++..||+|+++.. ....++|.+|++++++++|||||+++|+|.+ ++..+++||||++|+
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E~~~~g~   99 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGN   99 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECCTTCB
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEeecccCcc
Confidence            47899999999999999989999999998754 3345689999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.............
T Consensus       100 l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_         100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            9999976667789999999999999999999999   9999999999999999999999999999987765544444455


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .+++.|+|||++.++.|+.++|||||||++|||++|..||.....      ... +......                 .
T Consensus       177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~-~~~~i~~-----------------~  232 (287)
T d1opja_         177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ-VYELLEK-----------------D  232 (287)
T ss_dssp             EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHH-HHHHHHT-----------------T
T ss_pred             cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHH-HHHHHhc-----------------C
Confidence            678899999999999999999999999999999997777643211      111 1111111                 0


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ...+.+..++..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111233445677899999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=399.12  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=198.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ...+.||+|+||+||+|+++.   .+|+|+++....  ...+.|.+|+.++++++|||||+++|++..  +..++|||||
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~Ey~   85 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWC   85 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEecC
Confidence            445889999999999998653   388998865432  233679999999999999999999998763  3689999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-c
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-Q  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  228 (356)
                      ++|+|.+++... ...+++..++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus        86 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          86 EGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            999999999743 3469999999999999999999999   9999999999999999999999999999977643322 2


Q ss_pred             ceecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 EMLEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      ......||+.|||||++..   +.|+.++|||||||++|||+||+.||.+.+...       .........    ...+.
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~----~~~p~  230 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QIIFMVGRG----YLSPD  230 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHHHHT----SCCCC
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcC----CCCCc
Confidence            3345678999999999864   358899999999999999999999997643211       111111111    11111


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .         ...+.+++..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       231 ~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         231 L---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             G---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1         0123345677899999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=398.97  Aligned_cols=251  Identities=20%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.+. ++..||+|.++.. ....++|.+|++++++++|||||+++|+|..+ +..++||||+++|+
T Consensus        10 ~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~lv~E~~~~g~   86 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCB
T ss_pred             EEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-CceEEEEEecCCCc
Confidence            377999999999999987 5667899988753 33457899999999999999999999999854 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.............
T Consensus        87 L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          87 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             HHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             HHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence            99998743 4568999999999999999999999   9999999999999999999999999999987655444444456


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISG-KEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .||+.|+|||++.+..|+.++|||||||++|||+|+ .+||...+       ... +...+....               
T Consensus       163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~-~~~~i~~~~---------------  219 (263)
T d1sm2a_         163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSE-VVEDISTGF---------------  219 (263)
T ss_dssp             --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHH-HHHHHHHTC---------------
T ss_pred             ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHH-HHHHHHhcC---------------
Confidence            789999999999999999999999999999999995 44444321       111 111111110               


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                        +...+..++.++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       220 --~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 --RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence              011233345678899999999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-58  Score=401.86  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.++ ++..||+|.++... ...+.|.+|++++++++|||||+++|++.+  +..++||||+++|+
T Consensus        18 ~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCB
T ss_pred             eEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEeCCCCc
Confidence            478999999999999986 56778999887543 345689999999999999999999998763  36799999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..++.++.||++||.|||+   .+|+||||||+|||+++++.+||+|||+++.............
T Consensus        94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_          94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence            9998865445569999999999999999999999   9999999999999999999999999999988765444444456


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .+++.|+|||++.++.++.++|||||||++|||+||..|+.....      ...... .+...                 
T Consensus       171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------~~~~~~-~i~~~-----------------  226 (272)
T d1qpca_         171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQ-NLERG-----------------  226 (272)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHH-HHHTT-----------------
T ss_pred             CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------HHHHHH-HHHhc-----------------
Confidence            788999999999988999999999999999999996665543211      111111 11110                 


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      .+...+..++.++.+|+.+||+.||++|||+++|++.|+++
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            01112334566788999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-57  Score=404.37  Aligned_cols=252  Identities=25%  Similarity=0.444  Sum_probs=193.9

Q ss_pred             CCcccccCCceEEEEEEcCCCe---EEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS---VRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~---~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ++.||+|+||+||+|.++.+++   .+|+|.+...... ..+.|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv~Ey~  109 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMIITEFM  109 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEEEEec
Confidence            4789999999999999875543   6788887654333 23579999999999999999999999875 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.+++... ...+++..++.++.||++||+|||+   ++++||||||+|||++.++++||+|||+++.........
T Consensus       110 ~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  185 (299)
T d1jpaa_         110 ENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  185 (299)
T ss_dssp             TTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence            999999988743 4468999999999999999999999   999999999999999999999999999998764332221


Q ss_pred             ----eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          230 ----MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       230 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                          .....+|+.|||||++.++.++.++|||||||++|||+| |..||.+.+..       . +...+..         
T Consensus       186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~-~~~~i~~---------  248 (299)
T d1jpaa_         186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------D-VINAIEQ---------  248 (299)
T ss_dssp             ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHT---------
T ss_pred             eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHc---------
Confidence                223456889999999999999999999999999999998 89999764321       1 1111111         


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                              ..+.+.+.+++..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       249 --------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         249 --------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    0111234456678899999999999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=396.73  Aligned_cols=248  Identities=20%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             cccccCCceEEEEEEc--CCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           76 VIGKSNYGTLYKALLQ--RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        76 ~ig~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .||+|+||+||+|.++  .++..||+|+++..... ..++|.+|+++|++++|||||+++|+|.+  +..++|||||++|
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~~~g   93 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG   93 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeCCCC
Confidence            4999999999999875  34567999998754433 23679999999999999999999999874  3689999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc--e
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE--M  230 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~  230 (356)
                      +|.+++.. ....+++..++.++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.........  .
T Consensus        94 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          94 PLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             EHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             cHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            99999863 34579999999999999999999999   999999999999999999999999999998765433222  2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      ....+|+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..       + +...+..              
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~-~~~~i~~--------------  227 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQ--------------  227 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHT--------------
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHc--------------
Confidence            34467889999999998999999999999999999998 99999764321       1 1111111              


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                         +.+.+.+..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       228 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         228 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               011123445667889999999999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=402.60  Aligned_cols=253  Identities=17%  Similarity=0.297  Sum_probs=201.1

Q ss_pred             CCCCcccccCCceEEEEEEcCCC-----eEEEEEEecccc-ccchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSG-----SVRLLRFLRPVC-TTRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..++.||+|+||+||+|.+...+     ..||+|.+.... ......+.+|+.+++++ +|||||+++++|.++ +..++
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~l  118 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYL  118 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEE
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-CeEEE
Confidence            34588999999999999986543     368888876443 23345799999999998 899999999999864 48999


Q ss_pred             EEecccCCChhHhhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 038580          145 VHPFYKRGNLAQCIRGGS---------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNI  203 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni  203 (356)
                      |||||++|+|.++++...                     ...+++..++.++.|+++||+|||+   .+|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcc
Confidence            999999999999997432                     1358899999999999999999999   9999999999999


Q ss_pred             eEcCCCCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 038580          204 LLDRNYQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDE  281 (356)
Q Consensus       204 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~  281 (356)
                      |++.++.+||+|||+++........ ......+|+.|||||++.++.|+.++|||||||++|||+| |..||.+.+... 
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999999999875443322 2334567899999999999999999999999999999998 899997643321 


Q ss_pred             CCchhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 038580          282 DFHLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLE  352 (356)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~  352 (356)
                            .+......                 ..+.+.+..++.++.+|+.+||+.||++|||+++|++.|.
T Consensus       275 ------~~~~~~~~-----------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 ------NFYKLIQN-----------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ------HHHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHhc-----------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                  11111110                 0111234445678999999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=394.86  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=204.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.++.+|+.+|+|+++.......+.+.+|+++++.++|||||++++++.++ +..++|||||++|+
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~  103 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGS  103 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCB
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEecCCCc
Confidence            47899999999999999999999999998766656667899999999999999999999999864 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++..   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus       104 L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~  176 (293)
T d1yhwa1         104 LTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTM  176 (293)
T ss_dssp             HHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCC
T ss_pred             HHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccccc
Confidence            9998863   368999999999999999999999   999999999999999999999999999998765332 233456


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNSN  313 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (356)
                      .||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+.       ...........                .
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~~----------------~  233 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNG----------------T  233 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHC----------------S
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCC----------------C
Confidence            799999999999999999999999999999999999999975321       11111111110                0


Q ss_pred             CCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          314 HENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       314 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...+.+...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011223445667889999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=391.55  Aligned_cols=241  Identities=22%  Similarity=0.351  Sum_probs=201.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|.++.+++.+|+|++....   ....+.+.+|+++++.++|||||++++++.+ ++..++|||||+
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~ivmEy~~   89 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAP   89 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEEEeecC
Confidence            478999999999999999999999999986432   2234578999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......   ..
T Consensus        90 ~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~  161 (263)
T d2j4za1          90 LGTVYRELQK--LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR  161 (263)
T ss_dssp             TCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CC
T ss_pred             CCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC---cc
Confidence            9999999973  3468999999999999999999999   99999999999999999999999999999765432   23


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.        ..........              
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~--------------  219 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV--------------  219 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT--------------
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC--------------
Confidence            456799999999999999999999999999999999999999975321        1111111111              


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       220 ----~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                01123334567889999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=394.53  Aligned_cols=248  Identities=21%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             CcccccCCceEEEEEEcC--CCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           75 EVIGKSNYGTLYKALLQR--SGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      +.||+|+||+||+|.++.  +++.||+|+++......  .+.|.+|++++++++|||||+++|+|.+  +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence            569999999999998753  45789999987543322  3579999999999999999999999874  35789999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc-
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE-  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  229 (356)
                      +|+|.++++.  ...+++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++......... 
T Consensus        91 ~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          91 LGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             TEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999999974  4569999999999999999999999   999999999999999999999999999998765433222 


Q ss_pred             -eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          230 -MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       230 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                       .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.       .+ +...+...           
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~-~~~~i~~~-----------  226 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SE-VTAMLEKG-----------  226 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTT-----------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HH-HHHHHHcC-----------
Confidence             234568899999999999999999999999999999998 8999976431       11 11111110           


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                            ...+.+..++.++.+|+.+||+.||++|||+++|++.|+.+
T Consensus       227 ------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                  11123445567889999999999999999999999998864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-56  Score=386.91  Aligned_cols=249  Identities=18%  Similarity=0.322  Sum_probs=207.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|+++ ++..||+|.++... ...++|.+|+.++++++||||++++|+|.+ ++..++||||+++|+
T Consensus         9 ~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECCTTEE
T ss_pred             eEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEccCCCc
Confidence            478999999999999986 67788999987543 345689999999999999999999999885 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |..++... ...+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++.............
T Consensus        86 l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          86 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             HHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             HHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            99997643 3468899999999999999999999   9999999999999999999999999999987655544444556


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .+|+.|+|||++.+..++.++||||||+++|||+| |..||.+.+..       + +...+...                
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~-~~~~i~~~----------------  217 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------E-TAEHIAQG----------------  217 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------H-HHHHHHTT----------------
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------H-HHHHHHhC----------------
Confidence            78999999999999999999999999999999998 89999764321       1 11111110                


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                       .+.+.+..++.++.+|+.+||+.||++|||++++++.|.++
T Consensus       218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence             01122334556789999999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=392.73  Aligned_cols=247  Identities=19%  Similarity=0.256  Sum_probs=198.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||+||+|.++.+++.+|+|+++.... ...+.+.+|++++++++|||||++++++.++ +..++||||+++|
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg   88 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGG   88 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEeccCCC
Confidence            4789999999999999999999999999865432 2335799999999999999999999999864 4899999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-ccee
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-QEML  231 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  231 (356)
                      +|.+++.  ....+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus        89 ~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~  163 (271)
T d1nvra_          89 ELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  163 (271)
T ss_dssp             EGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             cHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence            9999996  34579999999999999999999999   9999999999999999999999999999987643322 2234


Q ss_pred             cccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          232 EASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...||+.|||||++.+..+ +.++|||||||++|||+||+.||........   .   ... .....             
T Consensus       164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~---~~~-~~~~~-------------  223 (271)
T d1nvra_         164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---E---YSD-WKEKK-------------  223 (271)
T ss_dssp             CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---H---HHH-HHTTC-------------
T ss_pred             ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---H---HHH-HhcCC-------------
Confidence            5679999999999988776 5789999999999999999999975432110   0   000 00000             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         .........+.++.+|+.+||+.||++|||++++++
T Consensus       224 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               000112234456789999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=394.63  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=202.5

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.+..++..+|+|+++.......+.+.+|+++++.++|||||++++++.++ +..++|||||++|+
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy~~~g~   95 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGA   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEE
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEecCCCCc
Confidence            47799999999999999999999999999876556667899999999999999999999999864 48999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...... .......
T Consensus        96 L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~  170 (288)
T d2jfla1          96 VDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSF  170 (288)
T ss_dssp             HHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTCC
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC-ccccccc
Confidence            99987532 3569999999999999999999999   99999999999999999999999999998764321 1122356


Q ss_pred             cCCCcccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          234 SASQGYKAPELIK-----MKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       234 ~~~~~y~aPE~~~-----~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      .||+.|+|||++.     ...|+.++|||||||++|||+||..||.+.+...    .   ... .....           
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~---~~~-i~~~~-----------  231 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----V---LLK-IAKSE-----------  231 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H---HHH-HHHSC-----------
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----H---HHH-HHcCC-----------
Confidence            7899999999984     4568999999999999999999999997643211    1   111 11100           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus       232 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 ----PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111223445667889999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=391.29  Aligned_cols=253  Identities=24%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             CCcccccCCceEEEEEEcCCC----eEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSG----SVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      +++||+|+||.||+|.++.++    ..||+|.++...... ..+|.+|+.++++++|||||+++|+|.++ +..+++|||
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~~v~e~   90 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMMIITEY   90 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEEC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceEEEEEe
Confidence            478999999999999987544    478999886543333 34789999999999999999999998854 489999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC-
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG-  227 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  227 (356)
                      +.++++.+.+... ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        91 ~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          91 MENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             CTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             cccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            9999999988643 3569999999999999999999999   9999999999999999999999999999987543222 


Q ss_pred             -cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          228 -QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       228 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       .......||+.|||||++.++.++.++|||||||++|||+||..|+.....      ..+ +...+..           
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~------~~~-~~~~i~~-----------  228 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHE-VMKAIND-----------  228 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH-HHHHHHT-----------
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC------HHH-HHHHHhc-----------
Confidence             122344678899999999999999999999999999999997666543211      111 1111111           


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ..+.+.+.+++..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       229 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         229 ------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             ------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                  0112234445677899999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=396.44  Aligned_cols=196  Identities=23%  Similarity=0.359  Sum_probs=171.8

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ..+.||+|+||+||+|.+..+++.+|+|+++...... .+.+.+|+.+|+.++|||||+++++|.++ ++.++|||||++
T Consensus        10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVmEy~~g   88 (322)
T d1s9ja_          10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDG   88 (322)
T ss_dssp             EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEEECCTT
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCC
Confidence            3478999999999999999999999999987543332 35789999999999999999999999854 489999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHR-PIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      |+|.+++..  ...+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+|......   ..
T Consensus        89 g~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~  160 (322)
T d1s9ja_          89 GSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  160 (322)
T ss_dssp             EEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC
T ss_pred             CcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---cc
Confidence            999999973  3468999999999999999999997   5 8999999999999999999999999999865322   22


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENP  277 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~  277 (356)
                      ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            35689999999999999999999999999999999999999997643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-55  Score=381.95  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeC---CCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAG---PRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~~  149 (356)
                      +.||+|+||+||+|.+..++..+|+|.+......  ..+.+.+|+++|++++|||||++++++.+   .+...++||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            5799999999999999989999999988654322  23578999999999999999999998863   234679999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeEc-CCCCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRP--IIHGNLKSKNILLD-RNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||+   .+  |+||||||+|||++ +++.+||+|||+++..... 
T Consensus        95 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          95 TSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             CCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            99999999973  3568999999999999999999999   77  99999999999996 5789999999999764332 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                        ......||+.|||||++.+ .|+.++|||||||++|||+||..||.+....       ..+........     .+  
T Consensus       169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~-----~~--  231 (270)
T d1t4ha_         169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGV-----KP--  231 (270)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTC-----CC--
T ss_pred             --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCC-----CC--
Confidence              2345689999999999864 6999999999999999999999999753211       11111111100     00  


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       232 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     0112223446889999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=389.98  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .++.||+|+||.||+|.++++ ..||+|+++.. ....+.|.+|+.++++++|||||+++|+|.+  +..++||||+++|
T Consensus        21 i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~~~g   96 (285)
T d1fmka3          21 LEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKG   96 (285)
T ss_dssp             EEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTC
T ss_pred             EeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEecCCC
Confidence            357899999999999999755 56899998654 3345789999999999999999999998863  3689999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|..++.......+++..++.++.||+.||+|||+   .+++||||||+|||+|.++++||+|||+++............
T Consensus        97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  173 (285)
T d1fmka3          97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  173 (285)
T ss_dssp             BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence            99999875555679999999999999999999999   999999999999999999999999999998765444444445


Q ss_pred             ccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          233 ASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      ..+|+.|+|||++..+.++.++||||||+++|||+||..|+.....      ..+.. ..+..                 
T Consensus       174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~------~~~~~-~~i~~-----------------  229 (285)
T d1fmka3         174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVL-DQVER-----------------  229 (285)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHH-HHHHT-----------------
T ss_pred             ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC------HHHHH-HHHHh-----------------
Confidence            6789999999999999999999999999999999997666543221      11111 11111                 


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ....+.+..+++++.+++.+||+.||++||++++|++.|+++
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            011123445567889999999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-56  Score=388.98  Aligned_cols=249  Identities=20%  Similarity=0.280  Sum_probs=189.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC-CCceEEEEecccC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP-RGEKLIVHPFYKR  151 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e~~~~  151 (356)
                      +.||+|+||+||+|.++.+|+.+|+|.++......  .+.+.+|++++++++|||||++++++.+. ++..++|||||++
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~   89 (269)
T d2java1          10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   89 (269)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence            78999999999999999999999999987654332  24688999999999999999999988643 4468999999999


Q ss_pred             CChhHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          152 GNLAQCIRG--GSGEAHKWSIIYRISIGIAGGLDYLHTGF--HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       152 gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+|.+++..  .....+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        90 g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-  168 (269)
T d2java1          90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-  168 (269)
T ss_dssp             EEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----
T ss_pred             CcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-
Confidence            999999853  23467999999999999999999999810  1239999999999999999999999999998765322 


Q ss_pred             cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          228 QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      .......||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.        ..+...+.....         
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~---------  231 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKF---------  231 (269)
T ss_dssp             -------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCC---------
T ss_pred             CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCC---------
Confidence            223456789999999999999999999999999999999999999975321        111111111110         


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                              .+.+...+.++.+|+.+||+.||++|||++|+++
T Consensus       232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    0122334567889999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=386.68  Aligned_cols=252  Identities=18%  Similarity=0.340  Sum_probs=194.1

Q ss_pred             CCCcccccCCceEEEEEEcCC---CeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           73 PGEVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .++.||+|+||.||+|.+..+   +..+|+|.++...... .+.+.+|++++++++|||||+++|++.  ++..++||||
T Consensus        11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~iv~E~   88 (273)
T d1mp8a_          11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMEL   88 (273)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEEC
T ss_pred             EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEEEEEEe
Confidence            357899999999999998643   3568888886543333 357999999999999999999999886  3478999999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++.. ....+++..++.++.||++||.|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          89 CTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             CTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             ccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            999999998764 34568999999999999999999999   99999999999999999999999999999876554444


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ......+|+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+...    +..    .+...           
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~----~i~~~-----------  225 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIG----RIENG-----------  225 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH----HHHTT-----------
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHH----HHHcC-----------
Confidence            4556678899999999999999999999999999999998 898987643211    111    11110           


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                            ...+.+.+++..+.+|+.+||+.||++|||+++|++.|+++.
T Consensus       226 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  011234455678999999999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=382.43  Aligned_cols=246  Identities=22%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.++  +..+|+|.++..  ...+.+.+|++++++++||||++++|+|.++++..++||||+++|+
T Consensus        12 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            477999999999999985  667899998643  3456899999999999999999999988755567899999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceecc
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLEA  233 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  233 (356)
                      |.+++.......+++..+++++.||+.||.|||+   .+++||||||+|||++.++.+|++|||+++.....    ....
T Consensus        88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~  160 (262)
T d1byga_          88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTG  160 (262)
T ss_dssp             HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----Cccc
Confidence            9999975444568999999999999999999999   99999999999999999999999999998765332    2234


Q ss_pred             cCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccCC
Q 038580          234 SASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSNS  312 (356)
Q Consensus       234 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (356)
                      .++..|+|||++.++.++.++||||||+++|||+| |..||...+...    +...+    ..                 
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~i----~~-----------------  215 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV----EK-----------------  215 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHHH----TT-----------------
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHHH----Hc-----------------
Confidence            67888999999999999999999999999999998 677776532211    11111    10                 


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          313 NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       313 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ....+.+...+.++.+|+.+||+.||++|||+.++++.|++++
T Consensus       216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1112234445678899999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-55  Score=388.85  Aligned_cols=241  Identities=22%  Similarity=0.302  Sum_probs=196.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccch---HHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRD---KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|.+..++..+|+|+++.......   +.+.+|++++++++|||||++++++.++ +..++|||||.
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~   98 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL   98 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCS
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEEEecC
Confidence            3779999999999999999999999999875443322   4688999999999999999999999854 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.....     .
T Consensus        99 ~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~  168 (309)
T d1u5ra_          99 GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A  168 (309)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred             CCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence            9999877653  4579999999999999999999999   9999999999999999999999999999976432     2


Q ss_pred             ecccCCCcccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccc
Q 038580          231 LEASASQGYKAPELIKM---KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDML  307 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (356)
                      ....||+.|||||++.+   +.|+.++|||||||++|||++|..||.+.+.       ........ ...     .+.  
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~-~~~-----~~~--  233 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNE-----SPA--  233 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHH-HSC-----CCC--
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-hCC-----CCC--
Confidence            34579999999999864   4589999999999999999999999975321       11111111 100     000  


Q ss_pred             cccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          308 LCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                               ..+...+..+.+|+.+||+.||++|||++++++
T Consensus       234 ---------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                     011223457889999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-54  Score=387.68  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=186.5

Q ss_pred             CCCcccccCCceEEEEEEcCCCeEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccC
Q 038580           73 PGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKR  151 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  151 (356)
                      ..+.||+|+||+||+|.++.+++.+|+|++..... .....+.+|+.+++.++|||||++++++.+ ++..++|||||++
T Consensus        13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE~~~g   91 (307)
T d1a06a_          13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQLVSG   91 (307)
T ss_dssp             EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCS
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCC
Confidence            35789999999999999999999999999865433 233568899999999999999999999985 4589999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEeccccccccCCCCCc
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      |+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++   +++.+||+|||+++.....  .
T Consensus        92 g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~  164 (307)
T d1a06a_          92 GELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--S  164 (307)
T ss_dssp             CBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             CcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC--C
Confidence            999999973  4579999999999999999999999   9999999999999994   5789999999999865432  2


Q ss_pred             ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc
Q 038580          229 EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL  308 (356)
Q Consensus       229 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (356)
                      ......||+.|||||++.+..|+.++|||||||++|||++|..||.+...       .. .........           
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~-~~~~i~~~~-----------  225 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AK-LFEQILKAE-----------  225 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHTTC-----------
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HH-HHHHHhccC-----------
Confidence            23456799999999999999999999999999999999999999975321       11 111111100           


Q ss_pred             ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          309 CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       309 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         .....+...+.+.++.+|+.+||+.||++|||++|+++
T Consensus       226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               00011122344567889999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=383.89  Aligned_cols=254  Identities=21%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             CCcccccCCceEEEEEEcCCC---eEEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSG---SVRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      +++||+|+||+||+|.+..++   ..+|+|.++.... ...++|.+|++++++++|||||+++|+|...++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            478999999999999986543   4688898864332 233679999999999999999999999876666899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc-
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ-  228 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  228 (356)
                      ++|+|.+++.. .....++..++.++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999874 34567888999999999999999999   99999999999999999999999999999876433222 


Q ss_pred             --ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 --EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 --~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                        ......||..|+|||.+..+.++.++||||||+++|||+||..||.......   .+...+.    ..          
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i~----~g----------  250 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL----QG----------  250 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH----TT----------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cC----------
Confidence              1223467889999999999999999999999999999999888876432111   1111111    10          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             .+...+..++..+.+|+.+||+.||++||++.||++.|+++.
T Consensus       251 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   011123344567889999999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-55  Score=387.79  Aligned_cols=244  Identities=20%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|.++.+++.+|+|+++...   ....+.+.+|++++++++|||||++++++.++ +..++||||++
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~   91 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAK   91 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEEEEccC
Confidence            478999999999999999999999999986432   23345789999999999999999999999854 58999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-Ccc
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-GQE  229 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  229 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        92 gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          92 NGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             TEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            9999999873  3569999999999999999999999   999999999999999999999999999998765332 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+.        ......+....            
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~------------  226 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLE------------  226 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC------------
T ss_pred             cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCC------------
Confidence            3456799999999999999999999999999999999999999975321        11111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                            ..++...+.++.+|+.+||+.||++|||++|++.
T Consensus       227 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 ------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                  1122334556889999999999999999998643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=387.74  Aligned_cols=251  Identities=21%  Similarity=0.406  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCe----EEEEEEeccccc-cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS----VRLLRFLRPVCT-TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      .++||+|+||+||+|.+..+++    .||+|.++.... ...++|.+|++++++++|||||+++|+|.+  +..+++++|
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v~e~   91 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQL   91 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEEEEe
Confidence            4789999999999999986664    577887764433 344689999999999999999999999985  367889999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +.+|+|.+++... ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus        92 ~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~  167 (317)
T d1xkka_          92 MPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE  167 (317)
T ss_dssp             CTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred             ccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence            9999999988643 4578999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             c-eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          229 E-MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       229 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                      . .....||+.|+|||++.++.|+.++|||||||++|||+| |..||.+.+..    .+...+..    .          
T Consensus       168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~~----~----------  229 (317)
T d1xkka_         168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----G----------  229 (317)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHHH----T----------
T ss_pred             ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHc----C----------
Confidence            2 234467899999999999999999999999999999999 78888754321    11111111    0          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             .+.+.+..++..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       230 -------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         230 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                   011233445677889999999999999999999999988763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.9e-54  Score=388.62  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.++.+|..+|+|++........+.+.+|+.++++++|||||++++++.+ ++..++|||||++|+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~  109 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGE  109 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECCCCSCB
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCC
Confidence            4789999999999999999999999999976655555678999999999999999999999985 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++... ...+++..+..++.||+.||+|||+   .+++||||||+|||++  .++.+||+|||+++.....  ....
T Consensus       110 L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~  183 (350)
T d1koaa2         110 LFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVK  183 (350)
T ss_dssp             HHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCEE
T ss_pred             HHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--cccc
Confidence            99998642 3469999999999999999999999   9999999999999996  4678999999999876433  2334


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.       .+... .......    .        
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~-~i~~~~~----~--------  243 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLR-NVKSCDW----N--------  243 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH-HHHHTCC----C--------
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhCCC----C--------
Confidence            56889999999999999999999999999999999999999975421       11111 1111000    0        


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .........+..+.+|+.+||+.||++|||++|+++
T Consensus       244 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         244 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             --SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001112234567889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-54  Score=383.90  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             CCcccccCCceEEEEEEc-----CCCeEEEEEEeccccccc-hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTTR-DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||+||+|+++     .++..||+|.++...... .++|.+|+++++.++||||++++++|.. .+..+++||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~~v~e   96 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFE   96 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-CCceEEEEE
Confidence            478999999999999975     356789999987544333 3579999999999999999999999885 458999999


Q ss_pred             cccCCChhHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeE
Q 038580          148 FYKRGNLAQCIRGGS----------------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILL  205 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill  205 (356)
                      |+++|+|.+++....                      ...+++..++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILl  173 (301)
T d1lufa_          97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV  173 (301)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEE
Confidence            999999999985321                      2347889999999999999999999   999999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 038580          206 DRNYQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGK-EPINENPTPDEDF  283 (356)
Q Consensus       206 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~-~p~~~~~~~~~~~  283 (356)
                      |.++.+||+|||+++....... .......+++.|+|||.+.+..|+.++|||||||++|||++|. .||.+.+.     
T Consensus       174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-----  248 (301)
T d1lufa_         174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-----  248 (301)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred             CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-----
Confidence            9999999999999976543222 2233456788999999999999999999999999999999986 56664321     


Q ss_pred             chhHHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhcC
Q 038580          284 HLPTFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLGK  356 (356)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~~  356 (356)
                        .+.. ..+.+..                 ..+.+..++.++.+|+.+||+.||++||||.+|++.|++++|
T Consensus       249 --~e~~-~~v~~~~-----------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 --EEVI-YYVRDGN-----------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --HHHH-HHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --HHHH-HHHHcCC-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              1111 1111111                 112234455678999999999999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=382.05  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEecccccc------chHHHHHHHHHHhccCCCccccccceeeCCCCceEEE
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT------RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ...+.||+|+||+||+|.++.+|+.+|+|+++.....      ..+.+.+|+.+|++++|||||++++++.++ +..++|
T Consensus        13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv   91 (293)
T d1jksa_          13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILI   91 (293)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence            3458899999999999999999999999998643221      235799999999999999999999999864 589999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC----CeEEeccccccc
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY----QPYVSDFGLHLL  221 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~  221 (356)
                      ||||++|+|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++    .+|++|||++..
T Consensus        92 ~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          92 LELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999999974  3469999999999999999999999   9999999999999998776    499999999987


Q ss_pred             cCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          222 LNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       222 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||+||..||.+.+..       +.. ........   
T Consensus       167 ~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~-~~i~~~~~---  233 (293)
T d1jksa_         167 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETL-ANVSAVNY---  233 (293)
T ss_dssp             CTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH-HHHHTTCC---
T ss_pred             cCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHH-HHHHhcCC---
Confidence            6432  2334567889999999999999999999999999999999999999764311       111 11111000   


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       .          .....+.+.+..+.+|+.+||+.||++|||++++++
T Consensus       234 -~----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -E----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -C----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -C----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0          000011234556889999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=382.62  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=194.5

Q ss_pred             CCCcccccCCceEEEEEEcC-----CCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ..+.||+|+||.||+|.+..     +++.||+|.++..... ..+.+..|...+.++ +||||+.+++++..+++..+++
T Consensus        17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv   96 (299)
T d1ywna1          17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   96 (299)
T ss_dssp             EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred             EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence            35789999999999999753     4578999998754332 235677888877776 6899999999888777789999


Q ss_pred             EecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCe
Q 038580          146 HPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQP  211 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~  211 (356)
                      ||||++|+|.++++...              ...+++..++.++.||++||+|||+   ++|+||||||+|||+++++++
T Consensus        97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~  173 (299)
T d1ywna1          97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV  173 (299)
T ss_dssp             EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcE
Confidence            99999999999996422              2358899999999999999999999   999999999999999999999


Q ss_pred             EEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCchhHHH
Q 038580          212 YVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGK-EPINENPTPDEDFHLPTFM  289 (356)
Q Consensus       212 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~  289 (356)
                      ||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||.+....       ...
T Consensus       174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-------~~~  246 (299)
T d1ywna1         174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEF  246 (299)
T ss_dssp             EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-------HHH
T ss_pred             EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence            99999999865433222 233457899999999999999999999999999999999964 567643321       111


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ........                 ..+.+..++.++.+++.+||+.||++|||++++++.|+++.
T Consensus       247 ~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         247 CRRLKEGT-----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCC-----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11111110                 11123334567889999999999999999999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-53  Score=386.67  Aligned_cols=247  Identities=19%  Similarity=0.304  Sum_probs=202.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++.......+.+.+|+++++.++|||||++++++.+ ++..++|||||++|+
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~  112 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGE  112 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCB
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCCh
Confidence            4789999999999999999999999999876544445678899999999999999999999985 458999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc--CCCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD--RNYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+.+.. ....+++..+..++.||+.||+|||+   .+|+||||||+|||++  .++.+||+|||++......  ....
T Consensus       113 L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~  186 (352)
T d1koba_         113 LFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVK  186 (352)
T ss_dssp             HHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEE
T ss_pred             HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--Ccee
Confidence            9988763 34469999999999999999999999   9999999999999998  6789999999999876543  3344


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+|+.|+|||++.+..|+.++|||||||++|||+||..||.+.+..       .... .......    .        
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~-~i~~~~~----~--------  246 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQ-NVKRCDW----E--------  246 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHH-HHHHCCC----C--------
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhCCC----C--------
Confidence            567899999999999999999999999999999999999999753311       1111 1111000    0        


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                        .........+.++.+|+.+||+.||++|||++++++
T Consensus       247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001112234567889999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=372.56  Aligned_cols=265  Identities=20%  Similarity=0.272  Sum_probs=196.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCC---ceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRG---EKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|++  +|..||+|+++... ......+.|+..+..++|||||+++|+|.++..   ..++|||||+
T Consensus         8 ~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   84 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence            47799999999999997  47889999886432 111223445556667899999999999875432   5799999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGF-----HRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      +|+|.++++.   ..+++..+++++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          85 HGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             TCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            9999999974   36999999999999999999999621     268999999999999999999999999999876443


Q ss_pred             CCc---ceecccCCCcccCccccccCC------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc-------hhHHH
Q 038580          226 AGQ---EMLEASASQGYKAPELIKMKD------ASEETDIYSFGVIMLELISGKEPINENPTPDEDFH-------LPTFM  289 (356)
Q Consensus       226 ~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~-------~~~~~  289 (356)
                      ...   ......||+.|+|||++.+..      ++.++|||||||++|||+||..||...........       .....
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence            222   223457899999999987542      56789999999999999999988865432221110       11111


Q ss_pred             HHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          290 RNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .......    ...|.+       .....+.+.+..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       242 ~~~~~~~----~~~p~~-------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         242 RKVVCEQ----KLRPNI-------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHTTS----CCCCCC-------CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcc----ccCCCC-------CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1111111    111111       011123456778999999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=374.76  Aligned_cols=243  Identities=20%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|..+.+++.+|+|+++...   ....+.+.+|+.+|++++||||+++++++.++ +..++|||||+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv~ey~~   88 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCT
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccceeccC
Confidence            478999999999999999999999999987532   22345788999999999999999999999964 48999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|.+++..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++..... ....
T Consensus        89 gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~  162 (337)
T d1o6la_          89 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  162 (337)
T ss_dssp             TCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCB
T ss_pred             CCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-Cccc
Confidence            9999999874  4568899999999999999999999   99999999999999999999999999999865432 2234


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ...+||+.|+|||++.+..|+.++||||+||++|||++|..||.+.+.        ..+........             
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~-------------  221 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-------------  221 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------------
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC-------------
Confidence            456899999999999999999999999999999999999999986432        11111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                           ..++...+.++.+|+.+||+.||++||+     ++++++
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 1123334566889999999999999995     788875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=376.00  Aligned_cols=248  Identities=22%  Similarity=0.273  Sum_probs=198.2

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhc-cCCCccccccceeeC---CCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGC-IRHPNLVPLLGFYAG---PRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~---~~~~~~lv~e~~  149 (356)
                      ++.||+|+||+||+|.+..+++.+|+|+++.     ...+.+|++++.+ .+|||||+++++|.+   .+...|+|||||
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            4679999999999999999999999999863     3567889988655 489999999998864   245789999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC---CCCeEEeccccccccCCCC
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR---NYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ++|+|.+++.......+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus        92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-  167 (335)
T d2ozaa1          92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-  167 (335)
T ss_dssp             CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-
T ss_pred             CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCC-
Confidence            99999999986555679999999999999999999999   99999999999999985   567999999999876442 


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       .......||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+.......+..    .....          
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~----~i~~~----------  232 (335)
T d2ozaa1         168 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMG----------  232 (335)
T ss_dssp             -CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC----------
T ss_pred             -CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH----HHhcC----------
Confidence             233456799999999999999999999999999999999999999976543221111100    00000          


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                          ......+.....+.++.+|+.+||+.||++|||+.++++
T Consensus       233 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 ----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                000001112345678999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=373.33  Aligned_cols=251  Identities=20%  Similarity=0.337  Sum_probs=191.7

Q ss_pred             CcccccCCceEEEEEEcCC---CeEEEEEEecccccc---chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEec
Q 038580           75 EVIGKSNYGTLYKALLQRS---GSVRLLRFLRPVCTT---RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPF  148 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~---~~~~a~k~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  148 (356)
                      +.||+|+||.||+|.+...   ...||+|+++.....   ..++|.+|+.++++++|||||+++|+|.+  +..++||||
T Consensus        14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~~lv~e~   91 (273)
T d1u46a_          14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVTEL   91 (273)
T ss_dssp             EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred             EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cchheeeee
Confidence            6799999999999987533   346889988654322   23579999999999999999999999974  367899999


Q ss_pred             ccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCc
Q 038580          149 YKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQ  228 (356)
Q Consensus       149 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  228 (356)
                      +++|+|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++........
T Consensus        92 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~  167 (273)
T d1u46a_          92 APLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH  167 (273)
T ss_dssp             CTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred             ecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence            9999999988642 3469999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             c--eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          229 E--MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       229 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                      .  .....++..|+|||++.+..++.++||||||+++|||+| |..||.+.+..       +.... +...         
T Consensus       168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~-i~~~---------  230 (273)
T d1u46a_         168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHK-IDKE---------  230 (273)
T ss_dssp             EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHH-HHTS---------
T ss_pred             ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHH-HHhC---------
Confidence            2  223456788999999999999999999999999999998 89999754321       11111 1110         


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                             ....+.+...+..+.+|+..||+.||++||||++|++.|++.+
T Consensus       231 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         231 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence                   0111223445567889999999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=373.00  Aligned_cols=255  Identities=20%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             CCCCcccccCCceEEEEEEcCC-------CeEEEEEEeccccccc-hHHHHHHHHHHhcc-CCCccccccceeeCCCCce
Q 038580           72 APGEVIGKSNYGTLYKALLQRS-------GSVRLLRFLRPVCTTR-DKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEK  142 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~-------~~~~a~k~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  142 (356)
                      ..++.||+|+||.||+|.....       +..||+|.++...... ..++.+|...+.++ +|||||+++++|.+ ++..
T Consensus        16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-~~~~   94 (299)
T d1fgka_          16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPL   94 (299)
T ss_dssp             EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-CCeE
Confidence            3458899999999999987543       3478999987654433 35788899888888 79999999999985 4589


Q ss_pred             EEEEecccCCChhHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC
Q 038580          143 LIVHPFYKRGNLAQCIRGGS--------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN  208 (356)
Q Consensus       143 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  208 (356)
                      ++||||+.+|+|.++++...              ...+++..++.++.|++.||+|||+   .+++||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCC
Confidence            99999999999999996432              3468999999999999999999999   999999999999999999


Q ss_pred             CCeEEeccccccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchh
Q 038580          209 YQPYVSDFGLHLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP  286 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~  286 (356)
                      +.+||+|||+++........ ......+++.|+|||.+.++.|+.++||||||+++|||+| |..||.+.+.        
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--------  243 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------  243 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--------
Confidence            99999999999876443222 2345567889999999999999999999999999999998 6888865332        


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..+...+...                 ...+.+...+.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus       244 ~~~~~~i~~~-----------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 EELFKLLKEG-----------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHHHHHHHTT-----------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcC-----------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            1111111110                 111223345567899999999999999999999999999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-52  Score=374.60  Aligned_cols=240  Identities=20%  Similarity=0.315  Sum_probs=199.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||+||+|+++.+|+.+|+|+++...   ....+.+.+|+.+++.++|||||++++++.+ ++..++|||||.
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~   87 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIE   87 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEEECCCC
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeEeeecC
Confidence            478999999999999999999999999986432   2334678999999999999999999999985 458999999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....    .
T Consensus        88 gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~  158 (316)
T d1fota_          88 GGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T  158 (316)
T ss_dssp             SCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred             Cccccccccc--cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc----c
Confidence            9999999874  4467888889999999999999999   99999999999999999999999999999876432    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.       .. .........             
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~-~~~~i~~~~-------------  217 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MK-TYEKILNAE-------------  217 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHCC-------------
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HH-HHHHHHcCC-------------
Confidence            356899999999999999999999999999999999999999975321       11 111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           ...+...+.++.+++.+||+.||++||     |++++++
T Consensus       218 -----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                 112233445688999999999999996     8999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=377.62  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=198.5

Q ss_pred             CCcccccCCceEEEEEEcCCCe--EEEEEEeccccc-cchHHHHHHHHHHhcc-CCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGS--VRLLRFLRPVCT-TRDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~--~~a~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ++.||+|+||+||+|.++.++.  .||+|.++.... ...+++.+|+++|+++ +|||||+++|+|.+ ++..++||||+
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~iV~ey~   93 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA   93 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEEEECCC
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEEEEEec
Confidence            4789999999999999987775  456776654322 3345799999999998 79999999999985 45899999999


Q ss_pred             cCCChhHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEec
Q 038580          150 KRGNLAQCIRGG--------------SGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSD  215 (356)
Q Consensus       150 ~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D  215 (356)
                      ++|+|.++++..              ....+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|
T Consensus        94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcc
Confidence            999999999643              24679999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCchhHHHHHhhh
Q 038580          216 FGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKE-PINENPTPDEDFHLPTFMRNAVL  294 (356)
Q Consensus       216 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~  294 (356)
                      ||+++.....  .......+|..|+|||.+.++.|+.++||||||+++|||++|.. ||.+.+       ..+... .+.
T Consensus       171 fG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~-~i~  240 (309)
T d1fvra_         171 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE-KLP  240 (309)
T ss_dssp             TTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH-HGG
T ss_pred             cccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH-HHH
Confidence            9998764321  22234568889999999999999999999999999999999765 565432       111111 111


Q ss_pred             hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          295 DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      ..                 .+.+.+..++.++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       241 ~~-----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 QG-----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GT-----------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hc-----------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            10                 011223445678899999999999999999999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.4e-52  Score=366.11  Aligned_cols=255  Identities=16%  Similarity=0.233  Sum_probs=198.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---hHHHHHHHHHHhccCCCccccccceeeCCC---CceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---DKEFGDLIELLGCIRHPNLVPLLGFYAGPR---GEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~e  147 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++......   .+.+.+|+++++.++|||||++++++....   ...|+|||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE   91 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   91 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence            478999999999999999999999999997654333   246899999999999999999999887433   24789999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC-
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA-  226 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  226 (356)
                      |+++++|.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++..+++|||.+....... 
T Consensus        92 ~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          92 YVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             CCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             CCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            9999999998863  3468999999999999999999999   999999999999999999999999999986543322 


Q ss_pred             -CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcc
Q 038580          227 -GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPD  305 (356)
Q Consensus       227 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (356)
                       ........||+.|+|||++.+..++.++|||||||++|||+||..||.+.+.       .+..........     .+.
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~-----~~~  234 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDP-----IPP  234 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCC-----CCG
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCC-----CCC
Confidence             2233456789999999999999999999999999999999999999975321       111111111100     000


Q ss_pred             cccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhc
Q 038580          306 MLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-NIKQVLWKLEDLG  355 (356)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~il~~L~~~~  355 (356)
                                .....+.+.++.+++.+||+.||++|| |+++++..|.++.
T Consensus       235 ----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 ----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                      001123456788999999999999999 8999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=371.43  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=202.5

Q ss_pred             CCCCcccccCCceEEEEEEc-----CCCeEEEEEEecccccc-chHHHHHHHHHHhcc-CCCccccccceeeCCCCceEE
Q 038580           72 APGEVIGKSNYGTLYKALLQ-----RSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCI-RHPNLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  144 (356)
                      ..++.||+|+||.||+|++.     .++..+|+|.++..... ...++.+|+.+++++ +|||||+++|+|.++ ...++
T Consensus        26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-~~~~l  104 (311)
T d1t46a_          26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLV  104 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEE
T ss_pred             EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-CEEEE
Confidence            33588999999999999873     45678999998764433 234789999999998 699999999999854 47999


Q ss_pred             EEecccCCChhHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCC
Q 038580          145 VHPFYKRGNLAQCIRGGS----------------GEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRN  208 (356)
Q Consensus       145 v~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~  208 (356)
                      +||||++|+|.++++...                ...+++..+..++.||+.||+|||+   ++++||||||+||+++.+
T Consensus       105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETT
T ss_pred             EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccccc
Confidence            999999999999996422                2358899999999999999999999   999999999999999999


Q ss_pred             CCeEEeccccccccCCCCC-cceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCchh
Q 038580          209 YQPYVSDFGLHLLLNPTAG-QEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELIS-GKEPINENPTPDEDFHLP  286 (356)
Q Consensus       209 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~  286 (356)
                      +.+|++|||+++....... .......+|+.|+|||++.++.++.++||||||+++|||+| |.+||...+...   .+.
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---~~~  258 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KFY  258 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HHH
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999987654332 23345578999999999999999999999999999999999 455554432211   111


Q ss_pred             HHHHHhhhhcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          287 TFMRNAVLDHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                      ..+.    ..     .            +...+...+..+.+|+.+||+.||++|||+++|++.|+++
T Consensus       259 ~~i~----~~-----~------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         259 KMIK----EG-----F------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHH----HT-----C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHh----cC-----C------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1111    10     0            0112233456788999999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-52  Score=370.53  Aligned_cols=254  Identities=18%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             CCCcccccCCceEEEEEEcC-----CCeEEEEEEeccccccch-HHHHHHHHHHhccCCCccccccceeeCCCCceEEEE
Q 038580           73 PGEVIGKSNYGTLYKALLQR-----SGSVRLLRFLRPVCTTRD-KEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        73 ~~~~ig~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  146 (356)
                      ..+.||+|+||+||+|.++.     ++..||+|.++....... ..|.+|++++++++|||||+++|+|.. ++..++||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~  102 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIM  102 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCceeEEE
Confidence            45789999999999998852     357899998875433222 468999999999999999999999875 45899999


Q ss_pred             ecccCCChhHhhhc--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEecccc
Q 038580          147 PFYKRGNLAQCIRG--------GSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGL  218 (356)
Q Consensus       147 e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  218 (356)
                      ||+++|+|.+++..        .....+++..+..++.|++.||.|||+   .+++||||||+|||++.++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence            99999999998852        223457899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCc-ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCchhHHHHHhhhhc
Q 038580          219 HLLLNPTAGQ-EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGK-EPINENPTPDEDFHLPTFMRNAVLDH  296 (356)
Q Consensus       219 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  296 (356)
                      ++........ ......+++.|+|||.+.++.++.++||||||+++|||+||. .||.+.+.       .+... .+...
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~~-~i~~~  251 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLR-FVMEG  251 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHH-HHHTT
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHHhC
Confidence            9865433222 223446789999999999999999999999999999999985 66654321       11111 11111


Q ss_pred             ccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhc
Q 038580          297 RITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDLG  355 (356)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~~  355 (356)
                      .                 ..+.+..++..+.+++.+||+.||++|||+.+|++.|++..
T Consensus       252 ~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         252 G-----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             C-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             C-----------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            0                 11123345567999999999999999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=371.45  Aligned_cols=264  Identities=21%  Similarity=0.255  Sum_probs=193.9

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccccc-----hHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecc
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR-----DKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      ++||+|+||+||+|.++.+++.+|+|+++......     .+.+.+|+.+++.++|||||++++++.. +++.++||||+
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~~   82 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFM   82 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEECC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhhhh
Confidence            67999999999999999999999999986543222     2468899999999999999999999985 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      .++++.....  ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++....... ..
T Consensus        83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~  156 (299)
T d1ua2a_          83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RA  156 (299)
T ss_dssp             SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CC
T ss_pred             cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc-cc
Confidence            9987776654  34568888899999999999999999   999999999999999999999999999997754432 22


Q ss_pred             eecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---cccccCcc
Q 038580          230 MLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYHPD  305 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  305 (356)
                      .....||+.|+|||++.. ..|+.++|||||||++|||+||..||.+.+..+.    ...+........   +.......
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTTTSSSTTSST
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChhhccchhccc
Confidence            335578999999999865 4679999999999999999999999976432111    111111100000   00000000


Q ss_pred             cccccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLLCSNSNHENP---VSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ...........+   .....++.+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000000000   01123457889999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.2e-52  Score=363.45  Aligned_cols=246  Identities=21%  Similarity=0.316  Sum_probs=199.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc---------hHHHHHHHHHHhccC-CCccccccceeeCCCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR---------DKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  143 (356)
                      .+.||+|+||+||+|++..+++.+|+|+++......         .+.+.+|+.++++++ ||||+++++++.+ ++..|
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~   86 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFF   86 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-CcceE
Confidence            478999999999999999999999999986543221         135788999999997 9999999999985 45899


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      +|||||++|+|.++++.  ..++++..++.++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus        87 ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          87 LVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999974  3479999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCcceecccCCCcccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKM------KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR  297 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  297 (356)
                      ...  ......||..|+|||.+.+      ..++.++||||+||++|||+||..||.+.+.        ...........
T Consensus       162 ~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i~~~~  231 (277)
T d1phka_         162 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMIMSGN  231 (277)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred             CCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHHHhCC
Confidence            422  2345678999999999863      3468899999999999999999999986431        11111111111


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..              ...+...+.++++.+|+.+||+.||++|||++++++
T Consensus       232 ~~--------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 YQ--------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CC--------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CC--------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00              011123345567889999999999999999999976

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-51  Score=376.61  Aligned_cols=244  Identities=18%  Similarity=0.282  Sum_probs=194.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccc---cchHHHHH---HHHHHhccCCCccccccceeeCCCCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT---TRDKEFGD---LIELLGCIRHPNLVPLLGFYAGPRGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  147 (356)
                      .+.||+|+||.||+|++..+|+.+|+|++.....   .....+.+   ++.+++.++|||||++++++.++ +..++|||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~~ivmE   87 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILD   87 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEEEEEEE
Confidence            4789999999999999999999999999864321   12223334   46677788899999999999864 48999999


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      ||++|+|.+++..  ...+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++.....  
T Consensus        88 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--  160 (364)
T d1omwa3          88 LMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  160 (364)
T ss_dssp             CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--
T ss_pred             ecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC--
Confidence            9999999999974  3568899999999999999999999   99999999999999999999999999999876433  


Q ss_pred             cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccc
Q 038580          228 QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDM  306 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (356)
                       ......||+.|+|||++.. ..|+.++|||||||++|||+||..||.+......    .. ......            
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~-~~~~~~------------  222 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HE-IDRMTL------------  222 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HH-HHHHSS------------
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HH-HHHhcc------------
Confidence             2345679999999999875 5689999999999999999999999976433221    11 111100            


Q ss_pred             ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 038580          307 LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPN-----IKQVLW  349 (356)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~il~  349 (356)
                            ......+...+.++.+|+.+||+.||++|||     ++++++
T Consensus       223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  0011122334567889999999999999999     688864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-51  Score=373.19  Aligned_cols=240  Identities=17%  Similarity=0.212  Sum_probs=198.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEeccc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYK  150 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  150 (356)
                      .+.||+|+||.||+|.++.+|+.+|+|+++...   ....+.+.+|+++|+.++|||||++++++.. ....++||||+.
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v~e~~~  124 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-cccccccccccc
Confidence            378999999999999999999999999986432   2233568999999999999999999999985 448899999999


Q ss_pred             CCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcce
Q 038580          151 RGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       151 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      +|+|..++..  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....    .
T Consensus       125 ~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~  195 (350)
T d1rdqe_         125 GGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             TCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             ccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----c
Confidence            9999999863  3468999999999999999999999   99999999999999999999999999999876432    2


Q ss_pred             ecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccccc
Q 038580          231 LEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCS  310 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (356)
                      ....||+.|||||++.+..|+.++|||||||++|||+||..||.+.+.        ......+....             
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~-------------  254 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK-------------  254 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------------
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCC-------------
Confidence            346789999999999999999999999999999999999999975321        11111111110             


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          311 NSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       311 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                           ...+...+.++.+++.+||+.||++|+     |++++++
T Consensus       255 -----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 012223455688999999999999994     8999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=371.38  Aligned_cols=242  Identities=19%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccc---ccchHHHHHHHHHHh-ccCCCccccccceeeCCCCceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC---TTRDKEFGDLIELLG-CIRHPNLVPLLGFYAGPRGEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~lv~e~~  149 (356)
                      .+.||+|+||+||+|.++.+++.+|+|+++...   ....+.+..|..++. .++|||||++++++.+ ++..|+||||+
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yivmEy~   85 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYL   85 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECC
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeEEEeec
Confidence            478999999999999999999999999986432   223345667777665 6899999999999986 45899999999


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcc
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQE  229 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  229 (356)
                      ++|+|.++++.  ...+++..+..++.||+.||+|||+   .+++||||||+|||+++++.+||+|||+++..... ...
T Consensus        86 ~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~  159 (320)
T d1xjda_          86 NGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAK  159 (320)
T ss_dssp             TTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred             CCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc-ccc
Confidence            99999999973  4468899999999999999999999   99999999999999999999999999999865432 223


Q ss_pred             eecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccc
Q 038580          230 MLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLC  309 (356)
Q Consensus       230 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (356)
                      .....||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+.        ..+........            
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~------------  219 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN------------  219 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC------------
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC------------
Confidence            3456789999999999999999999999999999999999999976432        11111111110            


Q ss_pred             cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 038580          310 SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIK-QVL  348 (356)
Q Consensus       310 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~il  348 (356)
                            ...+...+.++.+|+.+||+.||++||++. +++
T Consensus       220 ------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                  112233456788999999999999999985 665

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=370.04  Aligned_cols=246  Identities=18%  Similarity=0.271  Sum_probs=199.3

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||+||+|.+..+++.+|+|+++... .....+.+|+++|+.++|||||++++++.++ +..|+|||||++|+
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~~~gg~   87 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCB
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEecCCCCc
Confidence            478999999999999999999999999997543 2335688999999999999999999999854 58999999999999


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC--CCCeEEeccccccccCCCCCccee
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR--NYQPYVSDFGLHLLLNPTAGQEML  231 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~  231 (356)
                      |.+++... ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ...+||+|||++.....  .....
T Consensus        88 L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~~~  161 (321)
T d1tkia_          88 IFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFR  161 (321)
T ss_dssp             HHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCEEE
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc--CCccc
Confidence            99999742 3468999999999999999999999   99999999999999985  45899999999987543  23344


Q ss_pred             cccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCcccccccC
Q 038580          232 EASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLLCSN  311 (356)
Q Consensus       232 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (356)
                      ...+++.|+|||.+.+..|+.++||||+||++|||++|..||.+.+..       . ....+.....    ..       
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~-~~~~i~~~~~----~~-------  222 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------Q-IIENIMNAEY----TF-------  222 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHTCC----CC-------
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCCC----CC-------
Confidence            567889999999999999999999999999999999999999764311       1 1111111000    00       


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          312 SNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       312 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                         ........+.++.+|+.+||+.||++|||++|+++
T Consensus       223 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00001123456889999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=361.79  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=196.4

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||+||+|.+..+++.+|+|+++.....  ..+.+.+|++++++++|||||++++++.+ +++.++||||+.+ 
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~e~~~~-   85 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLHQ-   85 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEECCSE-
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEEeecCC-
Confidence            7899999999999999999999999998654322  24678999999999999999999999986 4589999999976 


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      ++..++.......+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~  161 (298)
T d1gz8a_          86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTH  161 (298)
T ss_dssp             EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTC
T ss_pred             chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-cccee
Confidence            55555554456679999999999999999999999   999999999999999999999999999997764332 23345


Q ss_pred             ccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCccccc---
Q 038580          233 ASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHPDMLL---  308 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  308 (356)
                      ..||+.|+|||++.... ++.++|+|||||++|||++|..||.+.+....   +..... ...  ...+...+....   
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~-~~~--~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFR-TLG--TPDEVVWPGVTSMPD  235 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH-HHC--CCCTTTSTTGGGSTT
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHH-hcC--CCchhhccccccccc
Confidence            57899999999877655 57899999999999999999999975432110   000000 000  000000000000   


Q ss_pred             ---ccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          309 ---CSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       309 ---~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ..........   ....+..+.+|+.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               0000000000   11234568899999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=358.91  Aligned_cols=266  Identities=20%  Similarity=0.242  Sum_probs=194.4

Q ss_pred             CCcccccCCceEEEEEEcC-CCeEEEEEEecccccc--chHHHHHHHHHHhcc---CCCccccccceeeC----CCCceE
Q 038580           74 GEVIGKSNYGTLYKALLQR-SGSVRLLRFLRPVCTT--RDKEFGDLIELLGCI---RHPNLVPLLGFYAG----PRGEKL  143 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~~~~~~  143 (356)
                      .+.||+|+||+||+|.+.. +++.||+|+++.....  ....+.+|+.+++.+   +||||++++++|..    .....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            3789999999999999864 4788999998654322  234577788877765   79999999998852    234789


Q ss_pred             EEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccC
Q 038580          144 IVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLN  223 (356)
Q Consensus       144 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  223 (356)
                      ++|||+.++++..... .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        92 ~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~  167 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS  167 (305)
T ss_dssp             EEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             EEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence            9999998876654443 345678999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccccc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRITD  300 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  300 (356)
                      .  ........||+.|+|||++.+..|+.++||||+||++|||+||..||.+.+....   + ..+......   ..+..
T Consensus       168 ~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~-~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         168 F--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             G--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHHCCCCGGGSCT
T ss_pred             c--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---H-HHHHHhhCCCchhcccc
Confidence            2  2334566889999999999999999999999999999999999999976432111   0 111110000   00000


Q ss_pred             -ccCccccccc-CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          301 -LYHPDMLLCS-NSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       301 -~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                       ...+...... ............++.+.+|+.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0000000000 000111122334566789999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=356.70  Aligned_cols=235  Identities=17%  Similarity=0.312  Sum_probs=191.0

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc------hHHHHHHHHHHhccC--CCccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR------DKEFGDLIELLGCIR--HPNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv  145 (356)
                      ++.||+|+||+||+|.+..+++.+|+|+++......      ...+.+|+.++++++  |||||++++++.++ +..++|
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~~~~lv   87 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLI   87 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-CeEEEE
Confidence            478999999999999999999999999986543221      234778999999986  89999999999864 489999


Q ss_pred             EecccC-CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-CCCeEEeccccccccC
Q 038580          146 HPFYKR-GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-NYQPYVSDFGLHLLLN  223 (356)
Q Consensus       146 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~  223 (356)
                      |||+.+ +++.+++..  ...+++..+..++.|++.||+|||+   .+++||||||+|||++. ++.+||+|||++....
T Consensus        88 ~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          88 LERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceecc
Confidence            999976 678788763  3568999999999999999999999   99999999999999985 4799999999997654


Q ss_pred             CCCCcceecccCCCcccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhccccccc
Q 038580          224 PTAGQEMLEASASQGYKAPELIKMKDA-SEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLY  302 (356)
Q Consensus       224 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (356)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|||+||..||....         .     ......    
T Consensus       163 ~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~-----i~~~~~----  221 (273)
T d1xwsa_         163 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E-----IIRGQV----  221 (273)
T ss_dssp             SS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H-----HHHCCC----
T ss_pred             cc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------H-----Hhhccc----
Confidence            32   2335679999999999987765 577999999999999999999996421         0     111000    


Q ss_pred             CcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          303 HPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                                    ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       222 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 --------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                          011223456889999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-49  Score=350.75  Aligned_cols=256  Identities=14%  Similarity=0.211  Sum_probs=198.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      .+.||+|+||.||+|.+..+++.||+|++...  ....++..|+++++.++|+|++..++.+....+..++||||+. ++
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~   88 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PS   88 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CB
T ss_pred             eEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cc
Confidence            47899999999999999999999999987653  2335688999999999988877777766656668899999985 47


Q ss_pred             hhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEc---CCCCeEEeccccccccCCCCCc--
Q 038580          154 LAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLD---RNYQPYVSDFGLHLLLNPTAGQ--  228 (356)
Q Consensus       154 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~~~--  228 (356)
                      |...+.. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+|++|||+++........  
T Consensus        89 l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          89 LEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             HHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             hhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            7666643 34569999999999999999999999   9999999999999975   4567999999999876443221  


Q ss_pred             ----ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccCc
Q 038580          229 ----EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYHP  304 (356)
Q Consensus       229 ----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (356)
                          ......||+.|||||.+.+..++.++|||||||++|||+||..||....................... .      
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~------  237 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I------  237 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-H------
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-h------
Confidence                23355789999999999999999999999999999999999999987655444333322222111100 0      


Q ss_pred             ccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          305 DMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                       .          ....+++.++.+++..||+.||++||+++++.+.|+++
T Consensus       238 -~----------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 -E----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -H----------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -h----------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             0          01123456788999999999999999999999888765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-49  Score=351.08  Aligned_cols=263  Identities=20%  Similarity=0.237  Sum_probs=192.3

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||+||+|.++ +++.+|+|+++....  ...+.+.+|+.+|++++|||||++++++.. ++..++++|++.++
T Consensus         8 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e~~~~~   85 (286)
T d1ob3a_           8 EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFEHLDQD   85 (286)
T ss_dssp             EEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEECCSEE
T ss_pred             cEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEEeehhh
Confidence            67999999999999986 678899999865432  224679999999999999999999999985 45899999999887


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      .+..+..  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||.+.....+. .....
T Consensus        86 ~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~  159 (286)
T d1ob3a_          86 LKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTH  159 (286)
T ss_dssp             HHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             hHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccce
Confidence            7666655  34679999999999999999999999   999999999999999999999999999997764332 22334


Q ss_pred             ccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---ccccc-Ccc--
Q 038580          233 ASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLY-HPD--  305 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~--  305 (356)
                      ..+++.|+|||.+.+. .++.++|+|||||++|||++|..||.+.+..+.   +.. .........   +.... .+.  
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~-i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHH-HHHhhCCCChhhccchhhhhhcc
Confidence            5678899999998754 568999999999999999999999976432111   111 000000000   00000 000  


Q ss_pred             ccc-ccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 MLL-CSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ... ..............+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000 00000111122234567889999999999999999999984

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=349.98  Aligned_cols=266  Identities=18%  Similarity=0.229  Sum_probs=190.6

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEeccccc--cchHHHHHHHHHHhccCCCccccccceeeCC-------CCceEEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCT--TRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-------RGEKLIV  145 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------~~~~~lv  145 (356)
                      +.||+|+||+||+|.+..+|+.||+|+++....  .....+.+|+++|++++||||+++++++...       ++..+++
T Consensus        16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv   95 (318)
T d3blha1          16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV   95 (318)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence            789999999999999999999999999865432  2335789999999999999999999987642       2468999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+.++++.....  ....++...+..++.|++.||.|||+   .+|+||||||+|||++.++.+|++|||++......
T Consensus        96 ~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~  170 (318)
T d3blha1          96 FDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLA  170 (318)
T ss_dssp             EECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-
T ss_pred             EeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeecccc
Confidence            99998876665543  34568889999999999999999999   99999999999999999999999999999765432


Q ss_pred             CC---cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhh---ccc
Q 038580          226 AG---QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLD---HRI  298 (356)
Q Consensus       226 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  298 (356)
                      ..   .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+...    ...........   ...
T Consensus       171 ~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSITPEVW  246 (318)
T ss_dssp             ----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTS
T ss_pred             cccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHhcCCCChhhc
Confidence            21   222345689999999998755 68999999999999999999999997533211    11111110000   000


Q ss_pred             ccccCcccccccCCC-CCCCCcHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSN-HENPVSEE------RILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~-~~~~~~~~------~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ............... .......+      ....+.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000000000000000 00111111      1345678999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=351.60  Aligned_cols=267  Identities=19%  Similarity=0.254  Sum_probs=190.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEecccccc-chHHHHHHHHHHhccCCCccccccceeeCCC---CceEEEEecc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT-RDKEFGDLIELLGCIRHPNLVPLLGFYAGPR---GEKLIVHPFY  149 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~e~~  149 (356)
                      .+.||+|+||+||+|.++.+++.+|+|+++..... ..+.+.+|+++|+.++||||+++++++..+.   ...+++++++
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            37899999999999999999999999998754322 2357889999999999999999999986432   1234555667


Q ss_pred             cCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC--
Q 038580          150 KRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG--  227 (356)
Q Consensus       150 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--  227 (356)
                      .+|+|.+++..   ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++........  
T Consensus        93 ~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          93 MGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             CCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             cCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            78999999974   368999999999999999999999   9999999999999999999999999999976543222  


Q ss_pred             cceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---cccccC
Q 038580          228 QEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYH  303 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  303 (356)
                      .......||+.|+|||++.. ..++.++||||+||++|||++|..||...+....    ............   ......
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHTCCC
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH----HHHHhhhccCCChhhhhhhhh
Confidence            12345578999999999854 4678999999999999999999999976432110    000000000000   000000


Q ss_pred             ccccc---ccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          304 PDMLL---CSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       304 ~~~~~---~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                      .....   ........+.   ......++.+|+.+||+.||++|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000   0000000000   11223468899999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=355.19  Aligned_cols=263  Identities=19%  Similarity=0.218  Sum_probs=189.8

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCccccccceeeCC-----CCceEEEEec
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLIVHPF  148 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv~e~  148 (356)
                      .++||+|+||+||+|++..+++.||+|+++...    ....+|+++|++++||||++++++|...     ..+.++||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            478999999999999999999999999986533    2334789999999999999999987532     2357899999


Q ss_pred             ccCCChhHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCC
Q 038580          149 YKRGNLAQCIR-GGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       149 ~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~  226 (356)
                      |+++.+..... ......+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||++...... 
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-  176 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-  176 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCC-
Confidence            98754433332 1245579999999999999999999999   9999999999999999775 8999999999876432 


Q ss_pred             CcceecccCCCcccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHH-------HHHhhhhccc
Q 038580          227 GQEMLEASASQGYKAPELIKM-KDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTF-------MRNAVLDHRI  298 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~  298 (356)
                       .......|+..|+|||.+.+ ..|+.++||||+||++|||++|..||...+.......+...       ....... ..
T Consensus       177 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~-~~  254 (350)
T d1q5ka_         177 -EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP-NY  254 (350)
T ss_dssp             -SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred             -cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc-ch
Confidence             22335678999999998765 57899999999999999999999999754321110000000       0000000 00


Q ss_pred             ccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          299 TDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .....+....   ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~---~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         255 TEFKFPQIKA---HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             -CCCCCCCCC---CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccccc---CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000   00000011223456889999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=347.97  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=188.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCCC-----CceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGPR-----GEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~lv~  146 (356)
                      .+.||+|+||+||+|.++.+|+.+|+|+++......  .+.+.+|+++|+.++|||||+++++|...+     .+.++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            367999999999999999999999999987543322  346889999999999999999999987543     2579999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+ +.+|....+.   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||++...... 
T Consensus       103 e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-  174 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  174 (346)
T ss_dssp             ECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             ecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCCc-
Confidence            999 5578887753   469999999999999999999999   99999999999999999999999999999875432 


Q ss_pred             CcceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhH-------HHHHhhh----
Q 038580          227 GQEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPT-------FMRNAVL----  294 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~----  294 (356)
                         .....+|+.|+|||++.+. .++.++||||+||++|||++|..||.+.+..........       .......    
T Consensus       175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence               2356789999999998764 568999999999999999999999976432110000000       0000000    


Q ss_pred             ---hcccccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 038580          295 ---DHRITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWK  350 (356)
Q Consensus       295 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~  350 (356)
                         ............         ..........+.+|+.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~---------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         252 KNYMKGLPELEKKDF---------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHHSCCCCCCCG---------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhhccCCcccccch---------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               000000000000         01112334567899999999999999999999873

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=349.31  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=198.0

Q ss_pred             CCcccccCCceEEEEEEc---CCCeEEEEEEeccccc----cchHHHHHHHHHHhccCC-CccccccceeeCCCCceEEE
Q 038580           74 GEVIGKSNYGTLYKALLQ---RSGSVRLLRFLRPVCT----TRDKEFGDLIELLGCIRH-PNLVPLLGFYAGPRGEKLIV  145 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~----~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv  145 (356)
                      .+.||+|+||+||+|...   .+|+.+|+|.++....    ...+.+.+|++++++++| |||+++++++.++. ..+++
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-~~~~v  107 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-KLHLI  107 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-EEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-ceeee
Confidence            478999999999999873   4688999999865321    233578899999999977 89999999988644 89999


Q ss_pred             EecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCC
Q 038580          146 HPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPT  225 (356)
Q Consensus       146 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  225 (356)
                      |||+.+|+|.+++..  ...++......++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus       108 ~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         108 LDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             ECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            999999999999974  3456788889999999999999999   99999999999999999999999999999876544


Q ss_pred             CCcceecccCCCcccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccccC
Q 038580          226 AGQEMLEASASQGYKAPELIKMK--DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDLYH  303 (356)
Q Consensus       226 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (356)
                      .........+++.|+|||.+.+.  .++.++|||||||++|||+||..||.+.........    +.......       
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~----i~~~~~~~-------  251 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----ISRRILKS-------  251 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH----HHHHHHHC-------
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhcccC-------
Confidence            44445567889999999998754  468899999999999999999999987544332211    11111110       


Q ss_pred             cccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 038580          304 PDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRP-----NIKQVLW  349 (356)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~il~  349 (356)
                                 ..+.+.+.+.++.+++.+||+.||++||     |++|+++
T Consensus       252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                       0112334567788999999999999999     4788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-47  Score=338.21  Aligned_cols=255  Identities=12%  Similarity=0.186  Sum_probs=199.9

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCC-CccccccceeeCCCCceEEEEecccCC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRH-PNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      .+.||+|+||+||+|.+..+++.+|+|++...  .....+.+|++.++.++| +|++.+++++.. +...++||||+ ++
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~   85 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GP   85 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CC
Confidence            47899999999999999999999999987543  233568889999999976 899999998874 45889999998 67


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcC-----CCCeEEeccccccccCCCCC
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDR-----NYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      +|.++++. ....++......++.|++.||+|||+   .+++||||||+|||++.     ++.+||+|||+++.......
T Consensus        86 ~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          86 SLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             CHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            99998864 34568999999999999999999999   99999999999999974     57899999999987643322


Q ss_pred             c------ceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcccccc
Q 038580          228 Q------EMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHRITDL  301 (356)
Q Consensus       228 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (356)
                      .      ......||+.|||||.+.+..++.++||||||+++|||+||..||.+................... ....+ 
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~-  239 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPLRE-  239 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCHHH-
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-CChHH-
Confidence            1      223457899999999999999999999999999999999999999864433221111111111000 00000 


Q ss_pred             cCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 038580          302 YHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLWKLEDL  354 (356)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~~L~~~  354 (356)
                                      ...+++.++.+++..||+.+|++||+++.+.+.|+++
T Consensus       240 ----------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         240 ----------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             ----------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ----------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                            0112345788999999999999999999999888775

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=338.16  Aligned_cols=265  Identities=19%  Similarity=0.205  Sum_probs=198.5

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccccc--chHHHHHHHHHHhccCCCccccccceeeCCCCceEEEEecccCC
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTT--RDKEFGDLIELLGCIRHPNLVPLLGFYAGPRGEKLIVHPFYKRG  152 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~g  152 (356)
                      +.||+|+||+||+|++..+++.+|+|+++.....  ....+.+|+.+++.++||||++++++|.++ ...+++++++.++
T Consensus         8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~iv~~~~~~~   86 (292)
T d1unla_           8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQD   86 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSEE
T ss_pred             eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-cceeEEeeecccc
Confidence            7899999999999999999999999998654332  235789999999999999999999999864 4889999999999


Q ss_pred             ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCCcceec
Q 038580          153 NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAGQEMLE  232 (356)
Q Consensus       153 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  232 (356)
                      +|..++.  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+........ ....
T Consensus        87 ~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~  160 (292)
T d1unla_          87 LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSA  160 (292)
T ss_dssp             HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCS
T ss_pred             ccccccc--cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-ccee
Confidence            9988876  34578899999999999999999999   9999999999999999999999999999987643322 2234


Q ss_pred             ccCCCcccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---cc---cccCcc
Q 038580          233 ASASQGYKAPELIKMKD-ASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---IT---DLYHPD  305 (356)
Q Consensus       233 ~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~  305 (356)
                      ..++..|+|||++.... ++.++|||||||++|||++|..||........   ....+........   +.   ......
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH---HHHHHHhhcCCCChhhhhhhhhccccc
Confidence            45677899999987654 68999999999999999999999754221110   1111111100000   00   000000


Q ss_pred             c-ccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          306 M-LLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       306 ~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      . ...................+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 0000011111223344567889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.1e-47  Score=342.97  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=194.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCC-CCceEEEEecccC
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGP-RGEKLIVHPFYKR  151 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e~~~~  151 (356)
                      .+.||+|+||+||+|++..+++.||+|+++..   ..+.+.+|+++|+.++ ||||+++++++..+ ....++||||+.+
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~  116 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  116 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence            47899999999999999999999999998743   3467899999999996 99999999998744 3478999999999


Q ss_pred             CChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCC-CeEEeccccccccCCCCCcce
Q 038580          152 GNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNY-QPYVSDFGLHLLLNPTAGQEM  230 (356)
Q Consensus       152 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~  230 (356)
                      ++|....     +.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||++......  ...
T Consensus       117 ~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~  186 (328)
T d3bqca1         117 TDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEY  186 (328)
T ss_dssp             CBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCC
T ss_pred             CcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC--Ccc
Confidence            9997764     358999999999999999999999   9999999999999998655 5899999999876432  223


Q ss_pred             ecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-chhHHHHH-----hhhhc------c
Q 038580          231 LEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDF-HLPTFMRN-----AVLDH------R  297 (356)
Q Consensus       231 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~-----~~~~~------~  297 (356)
                      ....+|+.|+|||.+.+. .++.++||||+||++||+++|..||.......... .+......     .....      .
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            455788999999998765 57999999999999999999999997543211100 00000000     00000      0


Q ss_pred             cccccCcccccccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          298 ITDLYHPDMLLCSNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .........................+.++.+|+.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000000000111122234556889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=341.89  Aligned_cols=266  Identities=21%  Similarity=0.231  Sum_probs=187.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC-----CCceEEEE
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP-----RGEKLIVH  146 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~lv~  146 (356)
                      .++||+|+||+||+|.+..+|+.+|+|+++......  ...+.+|+.+++.++|||||+++++|...     ..+.|+||
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            378999999999999999999999999997543322  24688999999999999999999998643     35789999


Q ss_pred             ecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCC
Q 038580          147 PFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTA  226 (356)
Q Consensus       147 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  226 (356)
                      ||+.++ +.+.+.    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||+++....  
T Consensus       102 Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--  171 (355)
T d2b1pa1         102 ELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--  171 (355)
T ss_dssp             ECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcccc--
Confidence            999765 445543    358899999999999999999999   9999999999999999999999999999876543  


Q ss_pred             CcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCch--------hHHHH------Hh
Q 038580          227 GQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHL--------PTFMR------NA  292 (356)
Q Consensus       227 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~--------~~~~~------~~  292 (356)
                      ........+|+.|+|||++.+..++.++||||+||+++||++|..||.+.+.......+        ++...      ..
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            22334557889999999999999999999999999999999999999754311100000        00000      00


Q ss_pred             hhhcccccccCcccccc--cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          293 VLDHRITDLYHPDMLLC--SNSNHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       293 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      .................  .............+..+.+|+.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000000000000000  0011111223456778999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=339.21  Aligned_cols=262  Identities=19%  Similarity=0.236  Sum_probs=189.7

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccc--hHHHHHHHHHHhccCCCccccccceeeCC----CCceEEEEe
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR--DKEFGDLIELLGCIRHPNLVPLLGFYAGP----RGEKLIVHP  147 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~lv~e  147 (356)
                      .+.||+|+||+||+|.+..+|+.||+|+++......  .+.+.+|+++|+.++|||||++++++...    ....+++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            478999999999999999999999999987543322  24688999999999999999999988632    224466677


Q ss_pred             cccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEEeccccccccCCCCC
Q 038580          148 FYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLLLNPTAG  227 (356)
Q Consensus       148 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  227 (356)
                      |+.+|+|.+++..   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||++....    
T Consensus       103 ~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~----  172 (348)
T d2gfsa1         103 HLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----  172 (348)
T ss_dssp             ECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT----
T ss_pred             eecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC----
Confidence            7889999999963   469999999999999999999999   999999999999999999999999999986543    


Q ss_pred             cceecccCCCcccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHHhhhhcc---cccccC
Q 038580          228 QEMLEASASQGYKAPELIKMK-DASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRNAVLDHR---ITDLYH  303 (356)
Q Consensus       228 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  303 (356)
                      .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+....    ...+........   ......
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCHHHHTTCCC
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCChHHhhhccc
Confidence            233455778889999987665 468999999999999999999999975432110    000000000000   000000


Q ss_pred             cccc---cccCCCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          304 PDML---LCSNSNHENPV---SEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       304 ~~~~---~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ....   ...........   ....+..+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000   00000000000   1123456789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-41  Score=307.53  Aligned_cols=269  Identities=17%  Similarity=0.199  Sum_probs=188.4

Q ss_pred             CCcccccCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-----------CCccccccceeeCC-CCc
Q 038580           74 GEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-----------HPNLVPLLGFYAGP-RGE  141 (356)
Q Consensus        74 ~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~~-~~~  141 (356)
                      .++||+|+||+||+|++..+|+.||+|+++.... ..+.+.+|+++++.++           ||||+++++++... ...
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~   96 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG   96 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence            4889999999999999999999999999975422 2356788888888765           57899999887532 234


Q ss_pred             eEEEEecccCC-ChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCC------eEEe
Q 038580          142 KLIVHPFYKRG-NLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQ------PYVS  214 (356)
Q Consensus       142 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~------~kl~  214 (356)
                      .+++++++..+ +............+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.      ++++
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~kl~  174 (362)
T d1q8ya_          97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIA  174 (362)
T ss_dssp             EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceeeEe
Confidence            55666655443 344444444566789999999999999999999963  78999999999999986654      8999


Q ss_pred             ccccccccCCCCCcceecccCCCcccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCchhHHHHH--h
Q 038580          215 DFGLHLLLNPTAGQEMLEASASQGYKAPELIKMKDASEETDIYSFGVIMLELISGKEPINENPTPDEDFHLPTFMRN--A  292 (356)
Q Consensus       215 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~  292 (356)
                      |||.+.....    ......||+.|+|||++....++.++|+||+||+++||++|+.||..................  .
T Consensus       175 dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         175 DLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             CCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             eccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            9999876432    234567899999999999999999999999999999999999999764332211111000000  0


Q ss_pred             hh---hcc------cccccCcccc--cccCC---------CCCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 038580          293 VL---DHR------ITDLYHPDML--LCSNS---------NHENPVSEERILKFFQLAMACCSPSPSLRPNIKQVLW  349 (356)
Q Consensus       293 ~~---~~~------~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~il~  349 (356)
                      ..   ...      .....+....  .....         ......+...+.++.+|+.+||+.||++|||++|+++
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00   000      0000000000  00000         0012345677888999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.5e-25  Score=182.21  Aligned_cols=162  Identities=14%  Similarity=0.140  Sum_probs=116.5

Q ss_pred             CCCCcccccCCceEEEEEEcCCCeEEEEEEeccccccc------------------hHHHHHHHHHHhccCCCccccccc
Q 038580           72 APGEVIGKSNYGTLYKALLQRSGSVRLLRFLRPVCTTR------------------DKEFGDLIELLGCIRHPNLVPLLG  133 (356)
Q Consensus        72 ~~~~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------------------~~~~~~e~~~l~~l~h~niv~~~~  133 (356)
                      +.++.||+|+||+||+|.+. +|+.+|+|+++......                  ......|...+.++.|+|++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34688999999999999986 67889999876421110                  023456788888999999988876


Q ss_pred             eeeCCCCceEEEEecccCCChhHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeEcCCCCeEE
Q 038580          134 FYAGPRGEKLIVHPFYKRGNLAQCIRGGSGEAHKWSIIYRISIGIAGGLDYLHTGFHRPIIHGNLKSKNILLDRNYQPYV  213 (356)
Q Consensus       134 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl  213 (356)
                      +.     ..+++|||+++..+.+.         +......++.|++.+++|||+   .+++||||||+|||++++ .++|
T Consensus        82 ~~-----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE-----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE-----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred             ec-----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence            42     23799999988665432         222356788999999999999   999999999999999976 4899


Q ss_pred             eccccccccCCCCCcceecccCCCcccC------ccccccCCCCCcchhHHHHHH
Q 038580          214 SDFGLHLLLNPTAGQEMLEASASQGYKA------PELIKMKDASEETDIYSFGVI  262 (356)
Q Consensus       214 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~sDvwslG~~  262 (356)
                      +|||.+.....+....         |..      .+.+ ...|+.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            9999987654322111         111      0111 3567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.15  E-value=1.3e-05  Score=67.08  Aligned_cols=132  Identities=12%  Similarity=0.041  Sum_probs=82.1

Q ss_pred             cCCceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccC-CCccccccceeeCCCCceEEEEecccCCChhHhh
Q 038580           80 SNYGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIR-HPNLVPLLGFYAGPRGEKLIVHPFYKRGNLAQCI  158 (356)
Q Consensus        80 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~gsL~~~l  158 (356)
                      ++.+.||+...  ++..+++|............+.+|...++.+. +--+-+++.+... ++..++||++.++.++.+..
T Consensus        25 ~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          25 MSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceEEEEEecccccccccc
Confidence            34468998753  34445666665444444456788888877664 2223445555553 45789999999998776543


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 038580          159 RGGSGEAHKWSIIYRISIGIAGGLDYLHTG--------------------------------------------------  188 (356)
Q Consensus       159 ~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------------------------------------------------  188 (356)
                      ...    ..   ...++.+++..++.||+.                                                  
T Consensus       102 ~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         102 EDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             ccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            211    11   222344455555555530                                                  


Q ss_pred             ------CCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          189 ------FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       189 ------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                            ....++|+|+.|.||++++++.+-|.||+.+..
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                  012379999999999999876667999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.78  E-value=3.1e-05  Score=64.34  Aligned_cols=74  Identities=11%  Similarity=0.044  Sum_probs=47.4

Q ss_pred             ccccCC-ceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCC--ccccccceeeCCCCceEEEEecccCCC
Q 038580           77 IGKSNY-GTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHP--NLVPLLGFYAGPRGEKLIVHPFYKRGN  153 (356)
Q Consensus        77 ig~G~~-g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~lv~e~~~~gs  153 (356)
                      +..|.. +.||+.... ++..+++|.....   ....+..|...++.+...  .+.+++++..+ ++..+++|++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeeccc
Confidence            444543 578988765 4555777876543   234577788877766432  24455665554 457899999998865


Q ss_pred             hh
Q 038580          154 LA  155 (356)
Q Consensus       154 L~  155 (356)
                      +.
T Consensus        93 ~~   94 (255)
T d1nd4a_          93 LL   94 (255)
T ss_dssp             TT
T ss_pred             cc
Confidence            53

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.60  E-value=0.00013  Score=64.77  Aligned_cols=76  Identities=12%  Similarity=0.018  Sum_probs=44.7

Q ss_pred             CcccccCCceEEEEEEcCCCeEEEEEEecccc----c---cchHHHHHHHHHHhccC-C-C-ccccccceeeCCCCceEE
Q 038580           75 EVIGKSNYGTLYKALLQRSGSVRLLRFLRPVC----T---TRDKEFGDLIELLGCIR-H-P-NLVPLLGFYAGPRGEKLI  144 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~---~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~~l  144 (356)
                      +.||.|....||+.....+++.+++|...+..    .   ........|.+.|+.+. + | .+.+++.+ . +. ..++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d-~~-~~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-TE-MAVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-TT-TTEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-c-CC-CCEE
Confidence            45899999999999887777778888654321    1   11123456777776552 2 3 34444443 2 22 5678


Q ss_pred             EEecccCCC
Q 038580          145 VHPFYKRGN  153 (356)
Q Consensus       145 v~e~~~~gs  153 (356)
                      +||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.46  E-value=0.0057  Score=53.77  Aligned_cols=73  Identities=14%  Similarity=0.132  Sum_probs=48.0

Q ss_pred             CcccccCCceEEEEEEcC-------CCeEEEEEEeccccccchHHHHHHHHHHhccCCCccc-cccceeeCCCCceEEEE
Q 038580           75 EVIGKSNYGTLYKALLQR-------SGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPNLV-PLLGFYAGPRGEKLIVH  146 (356)
Q Consensus        75 ~~ig~G~~g~V~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~  146 (356)
                      +.|+.|-.-.+|+.....       ....+++++.-.  .....+..+|..+++.+.-.+++ ++++++.  +   .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~---g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---ceEE
Confidence            568889999999998753       235567777542  22334567788888877533444 5666553  2   5789


Q ss_pred             ecccCCCh
Q 038580          147 PFYKRGNL  154 (356)
Q Consensus       147 e~~~~gsL  154 (356)
                      +|+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.27  E-value=0.015  Score=49.39  Aligned_cols=136  Identities=13%  Similarity=0.123  Sum_probs=74.2

Q ss_pred             CceEEEEEEcCCCeEEEEEEeccccccchHHHHHHHHHHhccCCCc-----cccccc-eeeCCCCceEEEEecccCCChh
Q 038580           82 YGTLYKALLQRSGSVRLLRFLRPVCTTRDKEFGDLIELLGCIRHPN-----LVPLLG-FYAGPRGEKLIVHPFYKRGNLA  155 (356)
Q Consensus        82 ~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv~~~~-~~~~~~~~~~lv~e~~~~gsL~  155 (356)
                      -..||++... +|..+++|+.++... ...++..|...+..|....     .+..-+ ......+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            4579999885 567788898875422 3456778888877664222     222211 1111234678889998763321


Q ss_pred             -----Hh------h---h----cCC---CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCC
Q 038580          156 -----QC------I---R----GGS---GEAHKWS----------------------IIYRISIGIAGGLDYL-HTGFHR  191 (356)
Q Consensus       156 -----~~------l---~----~~~---~~~~~~~----------------------~~~~i~~~i~~~l~~L-h~~~~~  191 (356)
                           .+      +   +    ...   ....++.                      .....+..+...+.-. .+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 11      0   1    000   1111111                      1122223333333222 222346


Q ss_pred             CceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          192 PIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       192 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      +++|+|+.+.|||++++  ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            78999999999999754  45899998754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.37  E-value=0.018  Score=48.57  Aligned_cols=33  Identities=18%  Similarity=0.209  Sum_probs=28.2

Q ss_pred             CCCCceecCCCCCCeeEcCCCCeEEeccccccc
Q 038580          189 FHRPIIHGNLKSKNILLDRNYQPYVSDFGLHLL  221 (356)
Q Consensus       189 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~  221 (356)
                      ...++||+|+.++|++++++...-+.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCcchhhhhcccccceeEeccccccc
Confidence            346799999999999999987778999998643